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APHPB-0003
SELECTIVE DOUBLE PORTAZYGOUS
DISCONNECTION WITH PRESERVING
VAGUS FOR VARICEAL HEMORRHAGE
OF CIRRHOTIC PORTAL
HYPERTENSION
Z. Guang and F. Yang
General Surgery, 81st Hospital of P.L.A., Nanjing,
China
Objectives: How to reduce the episodes of postopera-
tive complications in patients with cirrhotic portal
hypertension has been discussed extensively among sur-
geons around the world. In China, pericardial devascu-
larization with splenectomy (PDS) has been widely
used in patients, but they were suffered from rebleeding
and gastric stasis ostoperatively.The aim of this study
is to evaluate the effect of selective double portazygous
disconnection with preserving vagus (SDPDPV) for
patients with portal hypertension in the authors’ hospi-
tal.
Methods: 453 patients with cirrhotic portal hyperten-
sion who underwent either SDPDPV or PDS for vari-
ceal bleeding from Feb 2007 to January 2013 were
retrospectively reviewed. The operation-relevant infor-
mation, change of lavatory examination data, postoper-
ative complications and clinical outcomes were
analyzed.
Results: There were no significant difference between
the SDPDPV group and the PDS group of mean oper-
ative time and intraoperative blood loss (p > 0.05). The
free portal hypertension pressure in the SDPDPV
group was much lower than PDS group significantly
after operation (p < 0.05). The test of biochemical pro-
file of hepatocyte functions and Child-Pugh’s score
were significantly more altered in the SDPDPV group
than in the PDS group postoperatively (p < 0.05).
Except encephalopathy, occurrences or development of
postoperative complications including rebleeding, asci-
tes and gastric stasis showed great difference between
the two groups (p < 0.05). The operative mortality rate
and the 3-year survival rates were great difference
between the two groups too (p < 0.05).
Conclusions: The SDPDPV not only controls recurrent
bleeding from varices with portal hypertension effectively
but also maintains normal dynamics of stomach and
physiological function of intestine and hepatobiliary.
Malignant HPB Diseases
APHPB-0004
NOVEL FLUORESCENCE-NAVIGATION
LIVER SURGERY USING ICG-PDE
SYSTEM: TUMOR DIAGNOSIS AND
ANATOMICAL MARKING
N. Atsushi, T. Abo and T. Nagayasu
Department of Surgical Oncology, Nagasaki University
Hospital, Nagasaki, Japan
Objectives: To improve of diagnosis for occult tumor
localization and define the accurate anatomical area for
hepatectomy, we applied the novel fluorescent diagnosis
using the indocyanine green dye-photodynamic eye
(ICG-PDE) system in 125 patients with hepatic tumors.
Methods: For tumor detection, 0.5 mg/kg-weight of
ICG was intravenously administrated 2–7 days prior to
hepatectomy for the conventional liver functional test.
To define the accurate liver segmentation for anatomi-
cal hepatectomy, 0.075 mg/10 mL of ICG was adminis-
trated into the targeted portal vein, which was often
administrated into the bile duct to detect the biliary fis-
tula at the transected planes. Fluorescence of ICG was
precisely detected by the photodynamic eye infrared-
camera.
Results: Detectable liver lesions were 135 nodules. Sen-
sitivity of diagnosis for malignancy was high as 96%
and, however, diagnostic accuracy was lower in the
benign tumor. The newly detected liver lesions were
observed in 3 lesions in hepatocellular carcinomas
(HCC) histologically. In advanced stage HCC with por-
tal vein thrombosis, extension of tumor thrombi was
remarkably detected via portal trunk, which was quite
useful to remove tumor thrombi. In case of the ana-
tomical hepatectomy, marking of ICG-PDE was more
significantly visible in comarison with the conventional
dye injection method (Video). This diagnosctic tool was
also useful to detect the burden of the caudate lobe.
Tiny biliary fistula was sensitively detected by ICG-
PDE system in 5 cases.
Conclusions: The novel fluoresence-navigation surgery
using ICG-PDE system is a powerful diagnostic tool
during hepatectomy to improve surgical results and
curavility of resections in patients with liver malignancies.
Benign HPB Diseases
APHPB-0006
ACUTE CHOLECYSTITIS CAUSED BY
HELMINTHIC INFECTION IN THE
GALLBLADDER AND THE BILIARY
TRACT
M. Vejdani
Parasitology and Mycology, University of Medical
Sciences, Kermanshah, Iran
Objectives: Helminthic infections were reported from
tropical and subtropical locations in the world. The
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parasitic helminths develop and migrate to different
organs. Unusual cases may involve the gallbladder and
the biliary tract. The parasites invade the bile ducts or
migrate to choledacus and cause inflammation, fibrotic
lesions, acute and chronic cholecystitis.
Methods: The patient is undergone cholecystectomy. In
this research, there were three unusual cases of parasitic
infestation in the hospitals of Kermanshah, which is
located in the west of Iran. The worms were isolated
from gallbladder and biliary tract.The patient is under-
gone cholecystectomy. In this research, there were three
unusual cases of parasitic infestation in the hospitals of
Kermanshah, which is located in the west of Iran. The
worms were isolated from gallbladder and biliary tract.
Results: There was a female A. lumbricoides in the fun-
dus of gallbladder of a 77 year-old woman. In addition,
there were proglottid of T.saginata in the bile duct of a
29 year-old woman, and an adult form of F. hepatica
in the bile duct of a 47 year-old woman. Two of the
cases had obstructive jaundice and invasion of helmin-
thic parasites caused progressive pathologic lesions, so
that patients were undergone cholecystectomy opera-
tion.
Conclusion: Helminthic infections of gallbladder and
biliary tracts are rarely in human, but they can be
occurred chronic complications in patients, therefore,
in this study is recommended to carry out the ERCP
method before cholecystectomy for recognizing and
extracting worms from gallbladder and biliary tracts.
Transplantation
APHPB-0007
PANCREAS TRANSPLANT AT TAIPEI
VETERANS GENERAL HOSPITAL
Y. Shyr and S. E. Wang
Surgery, Taipei Veterans General Hospital, Taipei,
Taiwan
Objectives: Type 1 diabetes eventually leads to
nephropathy, neuropathy, retinopathy and angiopathy
after 10–30 years. Currently, pancreas transplant is the
treatment of choice in tight control of blood sugar for
IDDM patients, and further to stabilize, prevent or
even to reverse the diabetic complications. We will
present our experience in pancreas transplant which
was initiated on September 19, 2003.
Methods: From September 2003 to May 2014, there
were 97pancreas transplants performed for 91 patients
at Taipei Veterans General Hospital, with 35 SPK, 9
PAK, 40 PTA and 13 PBK. Most (82.3%) of our pan-
creas transplants were for IDDM patients.
Results: The blood sugar usually returned to normal
level within 5 h (median) after revascularization of the
pancreas grafts. The fasting blood sugar maintained
within normal range thereafter throughout the whole
clinical course in most cases. There were 2 surgical
mortality. The technical success rate was 94.9%.
Excluding the 4 cases with technique failure, overall
1-year pancreas graft survival is 98.5% and 5-year is
94.1%, with 100% 1-year for SPK, 97.1% 1-year for
PTA, 100% 1-year for PAK and 100% 1-year for
PBK.
Conclusion: n conclusion, pancreas transplant provided
an ideal insulin-free solution for DM, especially
IDDM. Pancreas transplant could be performed with
similar successful rate irrespective of the type of
pancreas transplant at our hospital.
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APHPB-0008
LONG-TERM SURVIVAL AFTER
PANCREATICODUODENECTOMY FOR
PANCREATIC AND PERIAMPULLARY
ADENOCARCINOMAS
Y. Shyr and S. E. Wang
Surgery, Taipei Veterans General Hospital, Taipei,
Taiwan
Objectives: This study was to identify predictors for
long-term survival and to compare survivals for pe-
riampullary adenocarcinomas after a pancreaticoduo-
denectomy.
Methods: Clinicopathological factors were compared
between short-term (<5 years) and long-term (≥5 years)
survival groups. Both actuarial and actual 5-year sur-
vival, as well as actuarial 10-year survival for those that
survived over 5 years, were determined.
Results: There were 109 (21.8%) long-term survivors.
Most (76%) of the long-term survivors were those with
ampullary adenocarcinoma. Long-term survival was
highest for ampullary adenocarcinoma (32.8%) and
lowest for pancreatic adenocarcinoma (6.5%). Jaun-
dice, tumor size, and lymph node involvement were
found to be independent predictors for long-term sur-
vival. Prognosis was significantly worse for pancreatic
adenocarcinoma, which had an actuarial 5-year survival
of only 6.7%. There was no difference in subsequent
actuarial 5-year survival (actuarial 10-year survival)
between pancreatic adenocarcinoma and other periam-
pullary adenocarcinomas for patients surviving over
5 years after resection. However, there was a difference
in actuarial and actual 5-year survivals.
Conclusion: Jaundice, tumor size, and lymph node
involvement are independent predictors for long-term
survival after pancreaticoduodnectomy. The biological
factors of pancreatic adenocarcinoma no longer play a
role in determining the prognosis for those who survive
to the 5 year landmark.
APHPB-0009
PANCREATICODUODENECTOMY FOR
PANCREATIC AND PERIAMPULLARY
LESIONS IN THE YOUNG
Y. Shyr and S. E. Wang
Surgery, Taipei Veterans General Hospital, Taipei,
Taiwan
Objectives: The purpose of this study was to clarify
surgical outcomes and to assess the biological behavior
of periampullary malignancy after pancreaticoduoden-
ectomy (PD) in the young. PD remains a formidable
challenge to many pancreatic surgeons. There is no lit-
erature report regarding PD in the young.
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Methods: Data on patients undergoing PD were
retrieved for study between January, 1997, and Decem-
ber, 2010. Demographics, disease patterns, clinical pre-
sentations, operative findings, surgical risks, tumor
pathologic characteristics, and survival outcomes were
evaluated in the young patients <60 years old and com-
pared with those in the older population.
Results: There were 585 patients in our study. Of there,
172 were patients 60 years or younger. Higher propor-
tions of female patients were found in the young age
group compared to old in regards to sex distribution.
Young group had more benign tumor compared to the
old, ex. neuroendocrine tumor. The surgical mortality
rates are significant less in the Young group. However,
there was no significant difference in surgical morbidity
and pancreatic leakage. As for the initial presentations,
young group patients are often asymptomatic (4.7%)
when compared to the old (1.5%, p = 0.026) but less
jaundice and GI upset (p = 0.004, p = 0.012).
Conclusion: PD in the young did not carry more
surgical morbidity or pancreatic leakage, but had less
surgical mortality, as compared to the old. Young
group patients after PD had better 5 year survival in
periampullary malignancy and pancreatic head adeno-
carcinoma.
Transplantation
APHPB-0010
EN BLOC SIMULTANEOUS PANCREAS
AND KIDNEY COMPOSITE GRAFT
TRANSPLANT WITH LIMITED
VASCULAR ACCESS
S. Wang and Y. M. Shyr
Surgery, Taipei Veterans General Hospital, Taipei,
Taiwan
Objectives: Limited vascular access could be encoun-
tered in an obese or re-transplant patient. We described
modifications that facilitated an en bloc simultaneous
pancreas and kidney (SPK) composite graft transplant.
Methods: At the back-table, the superior mesenteric
artery and splenic artery of the pancreas graft were
reconstructed with a long ‘Y’ iliac artery graft. The
smaller left renal artery is anastomosed end-to-side to
the larger and longer common limb of the arterial Y
graft and the shorter portal vein is anastomosed end-
to-side to the longer graft left renal vein. The en bloc
pancreas and kidney composite graft was implanted by
suturing the graft left renal vein to IVC and graft com-
mon iliac artery the recipient distal aorta. Exocrine
drainage was provided by anastomosis of the graft duo-
denum to a roux-en-y jejunum limb in an side-to-side
fashion.
Results: The operative time was 7 h with cold ischemic
time of 6 h and 25 min. and warm ischemic time of
47 min. The patient was discharged on postoperative
day 20, with a serum creatinine level of 1.4 ng/mL and
a blood glucose level of 121 mg/dL. He has not had
any rejection episodes or postoperative complications
in the following 12 months after the en bloc SPK trans-
plant.
Conclusion: En bloc pancreas and kidney composite
graft might be an option for patients with limited
vascular access. This technique (1) facilitates ‘real’
simultaneous pancreas and kidney (SPK) transplant
with only single common artery and vein for implant-
ing the composite graft; (2) minimizes dissection of ves-
sels and conserves recipient vessels.
APHPB-0011
HEPATIC VENO-OCCLUSIVE DISEASE
RELATED TO TACROLIMUS AFTER
PANCREAS TRANSPLANTATION
S. Wang and Y. M. Shyr
Surgery, Taipei Veterans General Hospital, Taipei,
Taiwan
Objectives: Hepatic veno-occlusive disease (HVOD)
describes the nonthrombotic, fibrous obliteration of the
small centrilobular hepatic veins by connective tissue
and centrilobular necrosis in zone 3 of the acini.
Methods: We describe a case of HVOD occurring after
pancreas transplantation, in which tacrolimus might
have played a causative role since complete recovery
was observed after discontinuation of tacrolimus.
Results: A 25-year-old female with NIDDM and ure-
mia. She underwent SPK transplantation. Nine months
after transplantation, she reported development of
fever, mild right abdominal pain and an increase in
abdominal girth. The CT scan showed pictures of
HVOD with hepatomegaly, massive ascites, periportal
edema, diffuse mottled hepatic enhancement and patent
hepatic veinsThe periportal edema and diffuse mottled
hepatic enhancement, in addition to the signs of portal
hypertension, might suggest sinusoidal stasis. Tacroli-
mus was discontinued and replaced by cyclosporine.
Three months after discontinuing tacrolimus, there was
resolution of the patient HVOD demonstrated by CT
scan.
Conclusion: This is the first case of HVOD after pan-
creas transplantation in the literature. HVOD should
be suspected when a recipient presents with hepatomeg-
aly, ascites or jaundice after pancreas transplantation
under tacrolimus.
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APHPB-0012
PERCUTANEOUS
CHOLECYSTOSTOMY FOR ACUTE
CHOLECYSTITIS: IS DEFINITIVE
CHOLECYSTECTOMY NECESSARY?
K. W. Pang1, N. C. H. Tan2, S. Loh3, S. K. Y.
Chang2, S. G. Iyer2, K. K. Madhavan2 and A. W. C.
Kow2
1Yong Loo Lin School of Medicine, National University
of Singapore, Singapore, Singapore; 2Division of
Hepatobiliary and Pancreatic Surgery, Department of
Surgery, National University Health System Singapore,
Singapore, Singapore; 3Department of Diagnostic
Imaging, National University Health System Singapore,
Singapore, Singapore
Objectives: Acute cholecystitis (AC) is a common cause
of emergency hospitalisation for the elderly. The use of
percutaneous cholecystostomy (PC) as definitive treat-
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ment for high-risk patients with moderate and severe
AC is controversial. Objectives: To determine the char-
acteristics, clinical outcomes, predictors of recurrence
of AC and definitive cholecystectomy among patients
who underwent PCs.
Methods: Seventy-one patients who underwent PC for
AC at National University Hospital, Singapore
between January 2007 and September 2013 were
reviewed retrospectively (IRB approved study).
Results: The median age was 73 (38–96) years. All
patients were ASA III (47.9%, n = 34) or IV (52.1%,
n = 37). Sixty-four patients (90.1%) had other comor-
bidities. Twenty patients (28.2%) had procedural-
related complications after transhepatic PC. Six
patients (8.5%) demised despite successful PC due to
worsening sepsis. All deaths were non-procedural
related. Recurrence rates for AC was 11.9% (n = 7)
over a follow up period of 66 (2–1681) days. The pre-
dictors of recurrence of AC following PC were higher
serum alkaline phosphatase (ALP) at diagnosis
(OR = 1.01, 95% CI 1.00–1.02, p = 0.021) and acute
myocardial infarction (AMI) during index admission
(OR = 8.00, 95% CI 1.19–54.0, p = 0.033).
Conclusion: PC is safe and effective in high risk
patients with AC who are not candidates for surgery.
Further studies with longer follow up periods would be
necessary to confirm the low recurrence rate of symp-
toms. However, patients with higher ALP at diagnosis
and AMI during index admission are at potentially
higher risk for recurrence. The main predictor of defini-
tive cholecystectomy is surgical fitness.
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APHPB-0013
KR€UPPEL-LIKE FACTOR 4 REGULATES
HEPATOCYTE NUCLEAR FACTOR-6
AND DRIVES HEPATOCELLULAR
CARCINOMA DIFFERENTIATION AND
PROGRESSION
H. Sun1, H. Tang2, Z. Jia3, Z. Ma4, K. Xie5, S. Zheng6
and Z. Peng7
1Department of General Surgery, Shanghai First
People’s Hospital, School of Medicine Shanghai Jiao
Tong Universit, Shanghai, China; 2Department of
Pathology, Shanghai First People’s Hospital, School of
Medicine Shanghai Jiao Tong Universit, Shanghai,
China; 3Department of Gastroenterology Hepatology and
Nutrition, The University of Texas MD Anderson
Cancer Center, Houston, TX, USA; 4Liver
Transplantation Section Center for Organ
Transplantation, Fudan University, Shanghai, China;
5Department of Gastroenterology Hepatology and
Nutrition, The University of Texas M.D. Anderson
Cancer Center, Houston, TX, USA; 6Department of
Pathology, Hainan Medical College Affiliated Hospital,
Haikou, China; 7Department of General Surgery,
Shanghai First People’s Hospital, School of Medicine
Shanghai Jiao Tong University, Shanghai, China
Objectives: Tumor differentiation is a behavioral index
for hepatocellular carcinoma (HCC) and a prognostic
factor for HCC in patients who undergo orthotopic
liver transplantation (OLT). However, the molecular
basis for HCC differentiation and prognostic value of
the underlying molecules that regulate this differentia-
tion in such patients are unclear. In this study, we
defined a potential driver pathway for HCC differentia-
tion and prognostication.
Methods: The regulation and function of Kr€uppel-like
factor 4 (KLF4) and hepatocyte nuclear factor-6
(HNF-6) in HCC differentiation was evaluated using
human tissues, molecular and cell biology, and animal
models, and its prognostic significance was determined
according to its impact on patient survival.
Results: Reduced KLF4 expression correlated with
high HCC grade. Poorly differentiated HCC cells had
lower expression of KLF4 and differentiation-associ-
ated markers than did well-differentiated cells. Elevated
KLF4 expression induced differentiation of poorly dif-
ferentiated hepatoma cells. KLF4 bound directly to the
promoter of HNF-6 and activated its expression. HNF-
6 expression correlated positively with KLF4 expres-
sion and negatively with HCC grade. Restored HNF-6
expression upregulated expression of differentiation-
associated markers and inhibited HCC cell migration
and invasion, while HNF-6 Knockdown did the oppo-
site. Loss of KLF4 expression in primary HCC corre-
lated with reduced overall survival and shortened
relapse-free survival durations after OLT. Combination
of KLF4 expression and the Milan criteria improved
prognostication for HCC after OLT.
Conclusion: Dysregulated KLF4/HNF-6 pathway
drives dedifferentition and progression of HCC and
KLF4 is a biomarker for accurate prognostication of
HCC patients treated by OLT when integrated with the
Milan Criteria.
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APHPB-0014
LARGE BALLOON DILATATION
VERSUS MECHANICAL LITHOTRIPSY
IN MANAGING DIFFICULT COMMON
BILE DUCT STONES
S. Elkholy1, M. Naga1, A. El-Badri1 and S. Nabil2
1Internal Medicine Department, Faculty of Medicine,
Cairo University, Cairo, Egypt; 2Internal Medicine
Department, Helwan University Hospital, Cairo, Egypt
Objectives: Evaluation of the effectiveness and the pos-
sible complications of large balloon dilatation (LBD) in
comparison to mechanical lithotripsy (ML) in manag-
ing large CBD stones.
Methods: This study was designed to analyze data
from 100 patients presenting with calcular obstructive
jaundice with difficult stone extraction, they were classi-
fied into 3 groups the 1st group included patients in
which ML was used 2nd group included patients with
LBD 3rd group included patients in which both tech-
niques were used. Then success rate was determined
with a final cholangiogram, whereas type and rate of
complications were assessed in all groups.
Results: Failure of stone extraction was encountered in
6.3% of the patients, while the cases with partial stone
extraction was 5.06%. Success rate in the 2nd group
was 93.8% followed by the 3rd group (90%) then 1st
group (87%) (p-value < 0.005). 22% of the patients in
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the 1st group needed repeated sessions while in the 2nd
and 3rd groups only 6.2% and 10% of the patients
needed so respectively. The rate of bleeding was higher
in the 2nd and 3rd groups. No perforation was done,
only 2 cases showed minor tear during dilatation.
Conclusion: LBD could be superior to ML in patients
with difficult stone extraction regarding the success
rate, number and time of sessions. In cases as Mirrizzi
syndrome (especially type 3) & liver cirrhosis lithotripsy
is preferred. Also in cases of associated tight strictures
combined techniques are preferred. Bleeding was higher
in LBD.
APHPB-0015
SIGNIFICANCE OF NUTRITIONAL
ASSESSMENT AND NUTRITIONAL
SCREENING TOOLS IN PREDICTING
COMPLICATIONS IN PATIENTS WITH
LIVER CIRRHOSIS
S. Elkholy, S. Mogawer, M. Mansour, E. Mogawer
and H. Sherif
Internal Medicine Department, Faculty of
MedicineCairo University, Cairo, Egypt
Objectives: Correlate protein energy malnutrition
(PEM) to the incidence of complications in patients
with liver cirrhosis. Also correlate PEM assessment
tools with the incidence of complications of liver cir-
rhosis.
Methods: This study was conducted on 45 cirrhotic
patients child C with or without complications. The
patients were divided into two groups: group I included
3O patients with moderate to severe degree of malnutri-
tion and group II which included 15 patients with mild
degree of malnutrition.
Results: The rate of various complications is higher in
patients with severe malnutrition, TSFT (Triceps skin
Fold Thickness) and MAC (Mid Arm Circumference)
has the highest sensitivity 85.71%, 100% & specificity
90%, 60% respectively to rate of complications (p-
value < 0.0001 &area under the ROC curve = 0.879).
Conclusion: PEM is highly prevalent among patients
with liver cirrhosis &is directly correlated to the degree
of cirrhosis and to the severity of the disease.Complica-
tions of liver cirrhosis are highly correlated to degree of
malnutrition.Anthropometric measures as TSFT
&MAC in comparison to other assessment tools
showed higher sensitivity & specificity to the rate of
complications.Also TSFT showed high sensitivity and
specificity with the body fat %.
APHPB-0016
FAST-TRACK SURGERY PROTOCOLS
IN DEVASCULARIZATION FOR
CIRRHOTIC PORTAL HYPERTENSION
Z. Guang, F. Yang, C. Jian and L. Ren
General Surgery, 81st Hospital of P.L.A., Nanjing,
China
Objectives: Fast-tract surgery (FTS) has been rapidly
embraced by surgeons as a mechanism for improving
patient care and driving down complications and
costs. The aim of this study was to determine if any
improvement in outcomes occurred of a FTS protocol
for selective double portazygous disconnection
(SDPDPV) when compared with non-FTS postopera-
tive care.
Methods: Patients for SDPDPV in the period January
2012-April 2014 were randomly selected for the FTS
group and non-FTS group. A designed protocol was
used in the FTS group with the emphasis on an inter-
disciplinary approach. The non-FTS group was treated
by standard established procedures. The number of
postoperative complications, time of functional recov-
ery and duration of hospital stay were recorded.
Results: Patients in the FTS group (n = 59) and non-
FTS group (n = 57) did not differ in preoperative data
and operative details (p > 0.05). The FTS procedure
led to significantly better control of faster restoration
of gastrointestinal functions, food tolerance, rehabilita-
tion and hospital stay (p < 0.05). Postoperative compli-
cations including nausea/vomiting, severe ascites,
wound infection, urinary tract infection, pulmonary
infection were all significantly lower in the FTS group
(p < 0.05). According to the postoperative morbidity
classification used by Clavien, the overall complications
and grade I complications were both significantly lower
in the FTS group compared with the non-FTS group
(p < 0.05).
Conclusion: Following the FTS protocol helped to
recover gastrointestinal functions, reduce frequency of
postoperative complications and reduced hospital stay.
The FTS strategy is safe and effective in improving
postoperative outcomes.
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APHPB-0017
PROGNOSIS ROLE OF LEUCINE
ZIPPER PROTEIN IN
HEPATOCELLULAR CARCINOMA
G. Li, L. I. Yuan and L. I. U. Jun
Liver surgery, Provincial Hospital Affiliated to Shandong
University, Jinan, China
Objectives: Leucine zipper protein (LUZP) play key
roles in development. Overexpression of LUZP in solid
tmors were documented in many literatures. The cur-
rent study examined the expression of LUZP in human
hepatocellular carcinoma (HCC) and to investigate the
correlation of LUZP with HCC.
Methods: Total RNA was extracted from HCC cancer
and the paired adjacent non-cancerous tissues. Real-
time quantitative reverse transcriptase-polymerase chain
reaction (qPCR) were used to detect the LUZP mRNA
expression. Patients were grouped into LUZP mRNA
high expression group and LUZP mRNA low expres-
sion group using average LUZP mRNA level in adja-
cent non-cancerous tissues as cut off. Correlation of.
LUZP mRNA and clinical parameters were analyzed.
Survival of the patients were analyzed by Kaplan-Meier
method.
Results: LUZP mRNA was significantly higher in
HCC sample than in the adjacent non-cancerous tissue
(p < 0.01). Higer level of alpha-fetoprotein and larger
tumor size were found in the patients with higher level
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of LUZP mRNA. There were significant differences
between the high expression group and low expression
group in term of alpha-fetoprotein (a-FP) (p < 0.001),
portal vein invasion (p < 0.005), TNM stage
(p < 0.0001) and recurrence incidence (p = 0.001. The
current study failed to find significant difference
between the two groups in the following clinical charac-
teristics: age, gender, portal vein invasion, lymphnode
metastasis, hepatitis B virus (HBV) infection and alco-
hol intake. Overall survival in high expression group
and low expression group was 14 vs. 34 months
(p = 0.01).
Conclusion: Up-regulation of LUZP was associated
with progressive pathological feature and poor progno-
sis in HCC patients.
APHPB-0023
HIGHER EFFICACY OF ANTIVIRAL
THERAPY AFTER MAJOR
HEPATECTOMY IN PATIENTS WITH
HEPATITIS B VIRUS-RELATED
HEPATOCELLULAR CARCINOMA OF
LESS THAN 3 CM
Z. Zhang, Z. Zhou, J. Guan, H. Li and G. Zhou
General Surgery, Shanghai Jiaotong University Affiliated
Sixth People’s Hospital, Shanghai, China
Objectives: Little is known about the role of antiviral
therapy for patients with hepatitis B who underwent
curative hepatectomy for hepatocellular carcinoma
(HCC). The aim of this study was to assess whether an-
tiviral therapy after hepatectomy improves the progno-
sis of HCC in preoperatively antiviral-free patients.
Methods: Retrospective study of postoperative antiviral
treatment in patients (n = 87) who underwent curative
hepatectomy for HCC. Clinicopathological features
and disease-free survival (DFS) were assessed. Patients
were followed up to monitor HCC recurrence (median
of 31 months).
Results: In patients with HCC ≤ 3 cm (n = 36), anti-
viral therapy reduced serum alanine transminase levels
(ALT) after 6 months of treatment (26.3%, p < 0.01).
In these patients, there was a significant prolongation
of DFS in patients who received antiviral therapy after
hepatectomy compared with those who did not
(p = 0.006). However, in patients with HCC > 3 cm
(n = 51), antiviral therapy did not decrease ALT levels
(+32.8%, p < 0.01). In these patients, antiviral therapy
had no effect on DFS (p > 0.05). Using multivariate
analysis, postoperative antiviral therapy was an inde-
pendent prognostic factor that was associated with a
better DFS in patients with HCC ≤ 3 cm (OR = 0.220,
95%IC: 0.120–0.434, p = 0.008).
Conclusion: Antiviral therapy improved the prognosis
of hepatitis B virus-related HCC ≤ 3 cm. Antiviral
therapy should be considered as a standard postopera-
tive adjuvant therapy of hepatitis B virus-related HCC.
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APHPB-0024
A PROSPECTIVE ANALYSIS OF THE
DIAGNOSTIC ACCURACY OF
MAGNETIC RESONANCE
CHOLANGIOPANCREATIOGRAPHY
AND PERCUTANEOUS TRANSHEPATIC
CHOLANGIOGRAM IN BENIGN
BILIARY STRICTURES AND
COMPARISON WITH
INTRAOPERATIVE FINDINGS
B. Chigurupati1, T. Yadav1, A. Lal2, V. Gupta1 and
S. Talukder1
1General Surgery, PGIMER, Chandigarh, India;
2Radiodiagnosis, PGIMER, Chandigarh, India
Objectives: To assess the diagnostic accuracy of MRCP
and PTC/TUBOGRAM in benign biliary stricture by
comparing with intraoperative findings.
Methods: Thirty patients with benign biliary stricture
who were to undergo definitive surgery were enrolled in
this study. Patients underwent both MRCP and PTC/
TUBOGRAM before surgery, and the results were
compared with intraoperative findings. Data was ana-
lyzed using SPSS Version 17.
Results: Diagnostic accuracy in detecting correct type
of stricture for MRCP was 89.3% and PTC was
96.4%. There was no statistically significant difference
in determination of type of stricture between PTC and
intraoperative findings (p = 0.317). There was statistical
difference in determination of type of stricture between
MRCP and PTC (p < 0.05) and between MRCP and
intraoperative findings (p < 0.05). The sensitivity (and
specificity) for detecting stones, fistula, variant anatomy
and abdominal collection/ cholangitic abscess for
MRCP in our study was 75% (90%), 61.5% (109%),
100% (95.6%) and 100% (100%) respectively. In
detecting stones, fistula, variant anatomy and abdomi-
nal collection PTC had sensitivity (and specificity) of
75% (100%), 85.7% (100%), 100% (100%) and 45.4%
(100%) respectively. With regards to fistula and intra-
abdominal collection, there was statistical difference in
determination between MRCP and PTC with p = 0.04
and p = 0.014 respectively.
Conclusion: PTC is better in determining type of stric-
ture and presence of fistula. Though MRCP was less
sensitive in diagnosing fistula, it provides cross sec-
tional imaging and better in determining liver status,
presence of collections and cholangitic abscess.
Malignant HPB Diseases
APHPB-0025
THE ROLE OF SALINE-COUPLED
BIPOLAR ELECTROCAUTERY IN
LIVER TRANSECTION
D. Cheng-You, L. De-Wei, G. Jian-Yang and L. Rui
Department of Hepatobiliary Surgery, The First
Affiliated Hospital Chongqing Medical University,
Chongqing, China
Objectives: ClampCrushing (CLAMP) is the most common
surgical method during liver transection. Nevertheless,
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the incidence of postoperative complications remains
high after liver transection in many medical centers. As a
device for hemostasis, bipolar coagulation (BIP) has
aroused increased interest because of its excellent hemo-
static effect and low thermal damage to surrounding tis-
sues. We changed a modified method of the bipolar
coagulation from unilateral water-dripping to bilateral
water-dripping and applyed it in hepatectomy as a pre-
ferred method. This study was designed to investigate
the application and value of BIP during hepatectomy
comparing with CLAMP.
Methods: From April 2012 to April 2014, a total of
332 consecutive patients following liver transection in
our hospital were enrolled in this retrospective study.
Of all patients, 150 patients received BIP (Group A)
and 182 patients received CLAMP (Group B). The pre-
, postoperative clinical manifestations, the effects of
those maneuvers were evaluated and the cost of hospi-
talization was analyzed.
Results: There was no significant difference in the pre-
operative indexes in two groups. Compared to Group
A, more bleeding and higher rates of transfusion during
operation were found in Group B (p < 0.05). Also, the
incidence of postoperative complications and the cost
of operations in Group B were higher than those in
Group A (p < 0.05). However, postoperative liver func-
tion was not significantly different between two groups
(p > 0.05).
Conclusion: Therefore, a simple saline-coupled BIP
shows promise for decreasing intraoperative hemor-
rhage, postoperative complications and the cost of
operations, which would be desirable to consider for a
safe and reliable means of liver transection.
Benign HPB Diseases
APHPB-0026
ROUTINE HISTOPATHOLOGY OF
GALLBLADDER AFTER ELECTIVE
CHOLECYSTECTOMY FOR
GALLSTONES: WASTE OF RESOURCES
OR A JUSTIFIED ACT?
A. A. Memon
Surgery, Liaquat University of Medical & Health
Sciences Jamshoro, Hyderabad, Pakistan
Objectives: Selective approach for sending cholecystec-
tomy specimens for histopathology results in missing
discrete pathologies such as premalignant benign
lesions such as porcelain gallbladder, carcinoma-in-situ
and early carcinomas. To avoid such blunders there-
fore, every cholecystectomy specimen should be rou-
tinely examined histologically. Unfortunately, the
practice of discarding gallbladder specimen is standard
in most tertiary care hospitals of Pakistan including the
primary investigators’ own institution. This study was
conducted to assess the feasibility or otherwise of per-
forming histopathology in every specimen of gallblad-
der.
Methods: 220 patients were included with gallstones for
cholecystectomy. All cases with known secondaries from
gallbladder, local invasion from other viscera, traumatic
rupture of gallbladder, gross malignancy of gallbladder
found during surgery was excluded from the study.
Laparoscopic cholecystectomy was performed in majority
of cases. All gallbladder specimens were sent for histopa-
thology, irrespective of their gross appearance.
Results: 220 patients with symptomatic gallstones were
admitted for cholecystectomy. Most of the patients
were females (88%). 92% of the patients presented with
upper abdominal pain of varying duration. All speci-
mens were sent for histopathology. 203 specimens
showed evidence chronic cholecystitis, 7 acute cholecys-
titis with mucocele, 3 acute cholecystitis with empyema
and one chronic cholecystitis associated with polyp. 6
gallbladders (2.8%) showed adenocarcinoma of varying
differentiation along with cholelithiasis.
Conclusion: The histopathological spectrum of gall-
bladder is extremely variable. Incidental diagnosis of
carcinoma gall bladder is not rare; if the protocol of
routine histopathology of all gallbladder specimens is
not followed, subclinical malignancies would fail to be
identified with disastrous results. We strongly recom-
mend routine histopathology of all cholecystectomy
specimens.
APHPB-0027
XANTHOGRANULOMATOUS
CHOLECYSTITIS (XGC) – A
DIAGNOSTIC DILEMMA
A. A. Memon
Surgery, Liaquat University of Medical & Health
Sciences, Hyderabad, Pakistan
Objectives: Xanthogranulomatous cholecystitis (XGC)
is an unusual form of chronic cholecystitis character-
ized by marked thickening of the gallbladder wall and
accumulation of lipid laden macrophages. It is fre-
quently misdiagnosed preoperatively with gallbladder
carcinoma. The aim of this study was to assess the
preoperative clinical and radiological characteristics,
operative findings and histological features of patients
with XGC based on the experience of a single institu-
tion. In addition a literature search was performed to
identify previously reported cases.
Methods: This prospective study was conducted from
January 2007 to September 2011. 1989 consecutive
patients who underwent elective cholecystectomy at the
Surgical Unit-I, Liaquat University Hospital, Jams-
horo, Pakistan were included in this study. Seventeen
patients were identified to have XGC on histology.
Results: Seventeen (0.8%) cases of XGC were identi-
fied in 1989 cholecystectomy specimens performed. The
female to male ratio was 7.5:1. The average age in our
series was 51.6 (range from 18 to 77 years). Two
(11.7%) cases, shown suspicion of malignancy on
preoperative investigations were reported as XGC on
histology.
Conclusion: Preoperative differentiation between XGC
and carcinoma of the gallbladder remains challenging
due to similarities in clinical presentation, radiological
and operative findings. In view of this there should be
a low threshold for conversion from a laparoscopic to
an open procedure.
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APHPB-0028
MANAGEMENT OF POST-
PANCREATECTOMY HEMORRHAGE
USING AN ARTERIAL STENT-GRAFT
K. Asai, M. Watanabe, H. Matsukiyo, T. Saito,
T. Enomoto, T. Kiribayashi, Y. Nakamura, Y. Saida,
J. I. R. O. Nagao and S. Kusachi
Surgery, Toho Uiversity Ohashi Medical Center, Tokyo,
Japan
Objectives: Perioperative morbidity rates after pancre-
atoduodenectomy (PD) remain high, reaching 20–50%
even in high-volume centers. Post-pancreatectomy hem-
orrhage (PPH) is one of the most serious complica-
tions. Delayed PPH usually originates from a
pseudoaneurysm resulting from a postoperative pancre-
atic fistula (POPF). Placement of an endovascular stent
has recently been used to treat arterial pseudoaneu-
rysms. In this study, intra-arterial stent-graft placement
for pseudoaneurysm after PD was examined.
Methods: Four cases in which intra-arterial stent-grafts
were inserted for pseudoaneurysm secondary to POPF
after PD were evaluated.
Results: The intra-arterial stent-graft was placed at the
common hepatic artery in 3 cases, the splenic artery in
1 case, the right hepatic artery in 1 case, and the supe-
rior mesenteric artery in 1 case (including 2 repeat
cases). A Jostent Graft master (Abbott Vascular, Red-
wood City, CA, USA) was used for all cases. Two
cases required additional stents, and two cases also
needed metallic coil embolization. No vascular adverse
events, including stent-graft obstruction, were encoun-
tered during this procedure. All cases survived and
were discharged after the procedure.
Conclusion: While only selected cases have been treated
with this strategy, the present results suggest that intra-
arterial stent-graft placement is safe and effective for
cases with PPH.
APHPB-0032
EMERGENCY
PANCREATICODUODENECTOMY: THE
MANAGEMENT OF
PANCREATICODUODENAL INJURY
AND TRAUMATIC RETROPERITONEAL
HEMATOMA
H. Wong, S. Huang, Y. Lee, D. Chou, Y. I. J. U. Wu
and H. Wu
Department of Surgery, Changhua Show Chwan
Memorial Hospital, Changhua, Taiwan
Objectives: Injuries of the pancreas and duodenum
occur in about 3–5% of all abdominal trauma, while
retroperitoneal hematomas (RH) are commonly associ-
ated, it is debatable whether a pancreaticoduodenecto-
my (PD) should be carried out on an emergency basis
or not.
Methods: A 54-year-old male was brought to the emer-
gency department following an automobile accident in
which his head and upper abdomen got hit against the
windscreen and steering wheel. The blood pressure was
156/103 and pulse, 67. The abdomen was not
distended. CT showed subarachnoid hemorrhage and
right anterior pararenal hematoma with duodenal and
pancreatic uncinate process contussions. Placement of
an external ventricular drain was initially done because
of the decreased level of consciousness (GCS of
E1V1M4). He had profound hypotension refractory to
resuscitation over the next 8.5 h. Through a Makuuchi
incision, approximately 4000 mL of blood and clot was
found in the retromesenteric plane (zone I inframeso-
colic area and zone II) around the duodenal loop that
caused the duodenum significantly migrating medially.
The bleeding point was identified originating from the
posterior aspect of the marcerated uncinate process.
Pyloric preserving PD and Witzel feeding jejunostomy
were performed.
Results: Jejunostomy feeding was started on second
postoperative day. He was complicated by delirium and
ascending cholangitis which responded to conservative
treatment. Because of these complications, he was not
discharged from the hospital until the 33th postopera-
tive day.
Conclusion: We proposes a more aggresive approach
may prove to be worthwhile to lower mortality and
morbidity, as leaving behind devitalized tissue would
have resulted in postoperative infective complications.
APHPB-0034
ROLE OF INTRAPERITONEAL
BUPIVACAINE IN LAPAROSCOPIC
CHOLECYSTECTOMY
M. Wasim1 and S. Shafqatullah2
1General Surgery, Patel Hospital Karachi, Karachi,
Pakistan; 2General Surgery, JPMCl Karachi, Karachi,
Pakistan
Objectives: My objective of the study was to compare
the mean pain score through VISUAL ANALOGUE
SCALE in patients undergoing laparoscopic cholecys-
tectomy with and without intraperitoneal bupivacaine.
Methods: My study design was a randomized con-
trolled trial done in General surgery ward 3 JPMC
Karachi. My study was conducted in ward 3 from17/3/
11 and the last patient taken on 20/6/11 for a period of
about 3 months.
Total 98 patients were selected for the study. Patients
were admitted through OPD. Two were exempted from
the study. Both groups have 49 patients.Group A
patients received 20 mL of 0.5%of intraperitoneal bup-
ivacaine while Group B patients did not receive intra-
peritoneal bupivacaine. The anesthetic technique was
standardized for the two groups.The degree of postop-
erative pain was assessed using VISUAL ANALOGUE
SCALE at 4, 8, 12 and 24 h after the surgery.
Results: The mean pain scores were lower in group A
than in group B at rest. Consumption of analgesics was
also lower in patients of group A (28%) while it was
71% in patients of group B.The incidence of abdominal
pain was significantly lower in patients receiving intra-
peritoneal bupivacaine.
Mean VAS pain scores from 4 to 24 h postoperatively
of group A was 0.90 + 0.51 with 95% confidence inter-
val while in group B it was 0.96 + 0.90 with 95% confi-
dence interval.
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Conclusion: Instillation of 20 mL of 0.5%of intraperi-
toneal bupivacaine after removal of gall bladder in
laparoscopic cholecystectomy offers good analgesia.
APHPB-0035
MIDDLE PANCREATECTOMY:
CLINICAL ANALYSIS OF 15 CASES
X. Zhi, T. Li and X. Ma
Department of General Surgery, Qilu Hospital of
Shandong University, Jinan, China
Objectives: To explore the value of middle pancreatec-
tomy for treating pancreatic tumors which located at
the neck and body of the pancreas.
Methods: From February 2010 to February 2014, 15
patients, who had benign or low-potential malignant
tumors located at the neck and body of the pancreas,
were performed by middle pancreatectomy, and the
data were analyzed retrospectively.
Results: Among the 15 cases, 6 were male and 9
female. The middle pancreatectomy were performed
successfully, and no death occurred. The major compli-
cation was pancreatic leakage and fistula, and hap-
pened in 6 cases, but most with mild leakage or fistula,
however, one case was severe fistula, who finally be
cured by non-surgical therapies.During the period of
follow-up from 4 months to 4 years, all the patients
were heathy, and no diabetes mellitus occurred.
Conclusion:
1. Middle pancreatectomy has important clinical
value in the treatment of benign or low-potential
malignant tumors located at the neck and body
of the pancreas.
2. This procedure not only removed the lesions but
also preserved the functional pancreatic tissue.
3. The major complication was pancreatic leakage
or fistula, but it can be cured by non-surgical
therapies.
Transplantation
APHPB-0037
EARLY APPLICATION OF AUXILIARY
PARTIAL ORTHOTOPIC LIVER
TRANSPLANTATION IN WILSON’S
DISEASE MURINE MODEL AND ITS
CLINICAL STRATEGY
Q. Cheng1, S. Q. He2 and X. P. Chen1
1Hepatic Surgery Center, Tongji Hospital, Tongji
Medical College, Hua Zhong University of Science and
Tec, Wuhan, China; 2Department of
Hepatopancreatobiliary Surgery, The Affiliated Hospital
of Guilin Medical University, Guilin, China
Objectives: Liver transplantation (LT) is an effective
treatment for Wilson’s disease (WD). However, LT is
limited due to the shortage of donor. Auxiliary partial
orthotopic liver transplantation (APOLT) has been per-
formed successfully in end-stage WD patients, which
expands the donor pool.
Methods: In the present study, we first performed
APOLT in Atp7b/ mice. Hepatic and serum copper
levels in Atp7b/ mice decreased after APOLT, and
copper metabolism disorder of WD mice was relieved
at both terminal and early stages.
Results: The progression of pathology in native livers
was delayed only when transplantation was performed
at early stage. The results suggest that APOLT can
result in a significantly improved outcome in the
Atp7b/ mouse model of WD, and that early trans-
plantation may prevent disease progression.
Conclusion: We put forward a clinical strategy that
APOLT should performed at early stage of WD
patients, because the earlier copper metabolism disor-
der corrected, the less organs injured, and the volume
of donor liver may be less demanded.
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APHPB-0038
THE ROLE OF ABDOMINAL DRAINAGE
TO PREVENT OF INTRA-ABDOMINAL
COMPLICATIONS AFTER
LAPAROSCOPIC CHOLECYSTECTOMY
FOR ACUTE SEVERE CHOLECYSTITIS
J. Y. KIM1, J. H. Kim2, J. K. Kim1, D. S. Yoon1 and
J. S. Park1
1Surgery, Gangnam Severance Hospital, Yonsei
University Health System, Seoul, Korea; 2Radiology,
Gangnam Severance Hospital, Yonsei University Health
System, Seoul, Korea
Objectives: Routine drainage of the abdominal cavity
after surgery has been a robust dogma for many dec-
ades. Nevertheless, the policy of routine abdominal
drainage is increasingly questioned. Many surgeons
believe that routine drainage after surgery may prevent
postoperative intra-abdominal infection. The goal of
this study was to assess the role of drains in laparo-
scopic cholecystectomy for acute cholecystitis.
Methods: From May 2008 to July 2012, 160 patients
that underwent laparoscopic cholecystectomy due to
acute cholecystitis at Gangnam Severance Hospital,
Yonsei University Health System, Seoul, Korea, were
enrolled in this study. After surgery, patients were ran-
domly allocated to undergo drain placement in the sub-
hepatic space (Group A) or no drainage (Group B).
Results: There was no significant difference in the
intra-abdominal abscess rate, which was 0.0% with
Group A and 1.3% with Group B (p = 0.319). The
median subhepatic fluid collection was 4.1 mL
(1.1–60 mL) in Group A and 4.5 mL (1.1–80.0 mL) in
Group B (p = 0.298). However, the median hospital
stay was 2 days (1–4 days) in Group B and 3 days
(2–7 days) in group A (p = 0.001). The subgroup of empy-
ema patients did not have any significant differences in
intra-abdominal fluid collection or intra-abdominal
abscess rate.
Conclusion: This study suggests that postoperative rou-
tine drainage of the abdominal cavity for acute chole-
cystitis does not prevent intra-abdominal infections.
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APHPB-0039
CHOLECYSTECTOMY OR
GALLBLADDER IN SITU AFTER
ENDOSCOPIC CLEARANCE OF
COMMON BILE DUCT STONES IN
ELDERLY PATIENTS
J. Jang and Y. Cho
Internal Medicine, Eulji University Hospital, Daejeon,
Korea
Objectives: The aim of this study is to evaluate whether
cholecystectomy in very elderly patients is justified after
endoscopic clearance of CBD stones.
Methods: From January 2011 to December 2012,
among 854 patients who underwent ERCP, 120
patients older than 80 years old were initially selected.
After excluding patients with previous hepatobiliary
surgery including cholecystectomy, previous ERCP,
IHD stone, ERBD, and/or patients with follow-up
<6 months, 32 cholecystocholedocholithiasis patients
older than 80 years with follow-up more than 6 months
were enrolled.
Results: Enrolled patients included 18 men and 14
women, with a median age of 83 years (ranging from
80 to 92 years). The mean CBD diameter was
12.7  4.1 mm. Single stone (66%) was more common
than multiple, and the mean size of the largest stone
was 8.1  3.8 mm. The median follow-up period was
564 days (ranging from 182 to 1482 days). Patients‘
backgrounds were not significantly different between
cholecystectomy group (9/32, 28%) and gallbladder in
situ group (23/32, 72%). There was no recurrence of
cholecystitis in gallbladder in situ group as well as in
cholecystectomy group. The cumulative incidence of
CBD stone recurrence was not different between the
two groups (3/9 (33%) in cholecystectomy group vs. 6/
23 (26%) in gallbladder in situ group, p = 0.193).
Conclusion: In very elderly patients, preserving the gall-
bladder does not increase the risk of cholecystitis and
CBD stone recurrence after endoscopic treatment of
CBD stones. Therefore, cholecystectomy after endo-
scopic clearance of CBD stones in cholecystocholedo-
cholithiasis patients should not be recommended in
very elderly patients.
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APHPB-0041
CLINICOPATHOLOGICAL FEATURES
AND SURGICAL OUTCOMES
NEUROENDOCRINE TUMORS OF THE
AMPULLA OF VATER
S. Yun and H. Seo
Department of Surgery, Pusan National University
Hospital, Busan, Korea
Objectives: Neuroendocrine tumors of Ampulla of
Vater are extremely rare and their clinical characteris-
tics are unknown. This study investigated the clinico-
pathological features and outcomes for 5
neuroendocrine tumors of Ampulla of Vater patients
who underwent pancreatoduodenectomy
Methods: The study included 5 patients who were
diagnosed as neuroendocrine tumors of Ampulla of
Vater after curative surgery. Clinical data including
age, sex, symptoms, preoperative imaging, biopsy
result, type of operation and pathologic data was ana-
lyzed and immunohistochemistry also was performed.
Results: The patient’s median age was 52.2  10.8 years.
Endoscopic ultrasound guided biopsy was performed in 4
patients and gastroduodenoscopic biopsy was performed
in one patient. All showed neuroendocrine tumor without
mitosis. Two patients underwent conventional pancreato-
duodenectomy and three underwent pylorus-preserving
pancreatoduodenectomy. Median tumor size was
1.9  0.56 cm (range, 1.2–2.0 cm). Lymph node metasta-
ses were detected in two patients. All patients were syn-
aptophysin-positive. Median periods of follow-up were
20.6  9.9 months. All patients were alive at the last fol-
low-up. Recurrence of neuroendocrine tumors of
Ampulla of Vater occurred in two patients.
Conclusion: Due to the high incidence of lymph node
metastases, radical resection seems to be an effective
treatment of neuroendocrine tumors of Ampulla of
Vater. Further investigations are required to determine
and analyze the prognostic factors.
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APHPB-0042
NON-ALCOHOLIC FATTY LIVER
DISEASE IN BREAST CANCER
PATIENTS: PREVALENCE AND RISK
FACTORS
H. Seo and S. Yun
Department of Surgery, Pusan National University
Hospital, Busan, Korea
Objectives: Non-alcoholic fatty liver disease is gradu-
ally increasing and found in 20–30% of general popula-
tion in developed countries. NAFLD is easily
overlooked in patients with breast cancer and is not
nearly evaluated in these patients We evaluated the
prevalence of the NAFLD using liver MRI in breast
cancer patients and investigated the risk factors associ-
ated with NAFLD
Methods: We evaluated a total of 104 breast cancer
patients who scheduled for surgery, between September
and November 2013. Characteristics of patients and the
result of preoperative laboratory test were investigated.
Measurement of hepatic fat accumulation was per-
formed using liver MRI in all patients. The presence or
absence of NAFLD was determined by a threshold
value for hepatic fat signal percentage (FSP) of 5.5%;
therefore, the cohort was divided into two groups, con-
trol (FSP ≤ 5.5%) and NAFLD group (FSP > 5.5%)
Results: By the FSP in liver MRI, 19 patients were
diagnosed with NAFLD among total 104 patients.
Therefore the prevalence of NAFLD was identified as
18.3%. In a univariate analysis, factors associated NA-
FLD were older age, presence of diabetes or hyperten-
sion, high BMI, abnormal serum AST, ALT or TG. In
multivariate analysis, factors associated with NAFLD
were presence of diabets, high BMI and abnormal TG
Conclusion: Breast cancer patients scheduled for
endocrine (tamoxifen) or chemotherapy are needed to
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evaluate the NAFLD. Especially if the patients have risk
factors for NAFLD such as DM, high BMI and elevated
serum TG level. Early diagnosis and treatment for
NAFLD can prevent development to more serious form
of hepatic steatosis such as NASH, liver cirrhosis or HCC.
APHPB-0043
RETROCRURAL SPACE INVOLVEMENT
ON COMPUTED TOMOGRAPHY AS A
PREDICTOR OF MORTALITY AND
DISEASE SEVERITY IN ACUTE
PANCREATITIS
H. Xu1, X. Li2 and F. Tian3
1Radiology, Sichuan Provincial Peoples’ Hospital Supo,
Chengdu, China; 219th institute, China Aerospace
Science and Technology Corporation, Beijing, China;
3General Surgery, Chengdu Army General Hospital,
Chengdu, China
Objectives: To develop more advanced and especially
accurate prediction models for patients with severe
acute pancreatitis (AP), we establish a new scoring sys-
tem based on retrocrural space involvement (RCSI),
and compared its effectiveness at evaluating the mortal-
ity and severity of AP with that of the CT severity
index (CTSI).
Methods: We reviewed CT images of 257 patients with
AP taken within 3–5 days of admission in 2012. The
RCSI scoring system, which includes assessment of
infectious conditions involving the retrocrural space
and the adjacent pleural cavity, was established using
the Delphi method. Two radiologists independently
assessed the RCSI and CTSI scores. The predictive
points of the RCSI and CTSI scoring systems in evalu-
ating the mortality and severity of AP were estimated
using receiver operating characteristic (ROC) curves.
Results: The RCSI score can accurately predict the
mortality and disease severity. The area under the
ROC curve for the RCSI versus CTSI score was
0.962  0.011 vs. 0.900  0.021 for predicting the mor-
tality, and 0.888  0.025 vs. 0.904  0.020 for predict-
ing the severity of AP. Applying ROC analysis to our
data showed that a RCSI score of 4 was the best cutoff
value, above which mortality could be identified.
Conclusion: The Delphi method was innovatively
adopted to establish a scoring system to predict the
clinical outcome of AP. The RCSI scoring system can
predict the mortality of AP better than the CTSI sys-
tem, and the severity of AP equally as well.
APHPB-0044
MODIFIED HEPATICO-JEJUNOSTOMY
FOR SEVERED BILE DUCT: A HYBRID
TECHNIQUE
A. Nabil1, H. Amer1, A. Nassef2 and S. Marei1
1General Surgery, Faculty of Medicine, Cairo University,
Cairo, Egypt; 2Radiology, Faculty of Medicine, Cairo
University, Cairo, Egypt
Objectives: To evaluate the efficacy of a safe time sav-
ing easy method that allows managing the collection,
rerouting bile into the intestine and saving the length
of the proximal stump for further manipulation if
needed.
Methods: A prospective study including 10 cases with
severed bile duct injuries (post cholecystectomy). The
suggested hybrid technique involves preoperative inser-
tion of percutaneous transhepatic draining catheter and
intraoperative introduction of these catheters into a
suitable jejunal conduit. A Follow up MRCP was done
at 6 and 12 months.
Results: the technique showed significant improvement
in the outcome of biliary reconstruction. Eight patients
showed rapid recovery post operatively. One patient
needed a redo surgery after migration of the stent and
leakage from the anastomosis. Another patient in the
follow up MRCP revealed diltated IHBR however with
no rise in bilirubin and cholestatic enzymes.
Conclusion: This technique provides a safe and sound
bilio-enteric continuity with early rehabilitation of the
patients, low incidence of complications & long term
patency of the bilio-enteric anastomosis.
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APHPB-0045
FAST-TRACK RECOVERY
PROGRAMME AFTER PANCREATICO-
DUODENECTOMY REDUCES OVER
ALL MORBIDITY
R. A. Sastry1, N. Muralidhar2 and N. Bheerappa2
1Surgical Gastroenterology and HPB Surgery, Krishna
Institute of Medical Sciences, Hyderabad, India;
2Surgical Gastroenterology, Nizam’s Institute of Medical
Sciences, Hyderabad, India
Objectives: To assess if fast-track pathways reduce
postoperative complications, enhance post operative
convalescence and facilitate early discharge following
pancreatico-duodenectomy (PD).
Methods: In a prospective non randomized study,
patients undergoing elective PD over 2 years were com-
pared with matched historic controls from the previous
2 years. Patients with preoperative cholangitis, those
requiring organ system support for more than 24 h and
those who underwent extended resections were
excluded. Fast track parameters that were followed
were a standardized anaesthesia protocol, early Ryle’s
tube and drain removal, early initiation of oral feeds
and early ambulation.
Results: 44 patients underwent PD during the study
period. 8 were excluded and the remaining 36 were
compared with 36 matched historic controls. The
demographic characteristics, type of disease, type of
procedure, pancreatic texture and duct diameter, type
of pancreatico jejunostomy, operating time, and preop-
erative cholangitis were similar between the groups.
Day of Ryle’s tube removal (2.39  1.32 vs.
5.87  3.85; p < 0.001), initiation of oral feeds
(4.39  1.8 vs. 7.42  4.03; p = 0.034), drain removal
(4.3  1.3 vs. 7.4  5.4; p = 0.002) were significantly
early in the study group. Overall morbidity (36.1%%
vs. 55.5%; p = 0.009) was lower in the study group.
Rate of pancreatic fistula (4 vs. 13; p = 0.013) and
delayed gastric emptying (5 vs. 12; p = 0.052) were
lower in the study group. The 30 day mortality and
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readmission rates were similar between the groups. The
day of discharge was earlier in the study group (12.5
vs. 14.5; p = 0.129)
Conclusion: Fast track pathways in pancreaticoduoden-
ectomy are feasible, safe and enhance postoperative
recovery and reduce the morbidity.
APHPB-0046
RESECTION FOR BISMUTH TYPE IV
PERIHILAR CHOLANGIOCARCINOMA:
AN EVIDENCE TOWARD EXPANDING
SURGICAL INDICATION
T. Ebata, Y. Yokoyama, G. Sugawara, T. Igami,
T. Mizuno and M. Nagino
Department of Surgery, Nagoya University Graduate
School of Medicine, Nagoya, Japan
Objectives: To support a resectional strategy for Bis-
muth type IV perihilar cholangiocarcinoma.
Methods: A total of 383 patients with this tumor was
treated between 2001 and 2013. Of them, 245 (64%)
patients underwent surgical resection. Surgical proce-
dures were individually designed, based on the tumor
extension and the liver functional reserve.
Results: Left trisectionectomy was the most common
(n = 119), followed by left hepatectomy (n = 58), right
trisectionectomy (n = 32), right hepatectomy (n = 30),
and central bisectionectomy (n = 6). Combined resec-
tion of the portal vein and the hepatic artery was per-
formed in 126 (51%) and 76 (31%) patients,
respectively. Median operative time and blood loss was
10.8 hr and 1.8 L, respectively. Surgical complications
(≥Clavien III) were found in 103 (42%) patients, 6
(2.4%) of whom died in hospital. Distant (M1) and
nodal (N1) metastasis was observed in 42 (17%) and
144 (59%) patients, respectively; positive margin was
found in 64 (26%) patients. Survival rate of the 138 un-
resected patients was 2% at 3-years, with a median sur-
vival time (MST) of only 10 months. In contrast,
survival rate of the 245 resected patients was 44% at 3-
years and 30% at 5-years, with a MST of 2.4 years. In
the 76 patients with M0N0disease who received R0
resection, 5-year survival rate was 57%.
Conclusion: Although resection for Bismuth IV tumor
remains a surgical challenge, it offers a prolonged sur-
vival, particularly in patients with M0N0 disease. These
outcomes indicate that a subset of type IV tumor is a
candidate for definitive resection.
APHPB-0047
THE COMPARISON OF ONCOLOGIC
AND CLINICAL OUTCOMES OF
LAPAROSCOPIC LIVER RESECTION
FOR HEPATOCELLULAR CARCINOMA
S. Kim and H. J. Kim
HBP surgery, Yeungnam University Hospital, Daegu,
Korea
Objectives: We evaluate the operative outcome and on-
cologic outcome of laparoscopic liver resection for
hepatocellular carcinoma (HCC), and compare with
open liver resection.
Methods: From January 2004 to December 2012,
clinical data of 70 patients who underwent laparoscopic
liver resection for HCC (Laparoscopic liver resection
group, lapa-group) were collected and analyzed retro-
spectively. Control group (Open liver resection group,
open-group) were retrospectively matched, and com-
pared with lapa-group.
Results: Laparoscopic major liver resections were per-
formed in 4 patients. Laparoscopic anatomical resec-
tions and non-anatomical resections were performed in
39 patients, and 31 patients, respectively. Mean opera-
tive time was shorter in lapa-group (215.5  121.84 vs.
282.30  80.34 min, p-value = 0.001), mean intraopera-
tive transfusion rate and total amount were small in
lapa-group. (24.28%, 148.57  3354.98 cc vs. 40.78%,
311.71  477.01 cc) Open conversion was occurred in 6
patients (8.57%) because of bleeding, inadequate resec-
tion, invisible mass on intraoperative ultrasonography,
and tumor rupture. In lapa-group and open-group3-
year disease free survival rate (DFS) were
58.3  0.08%, and 62.6  0.06%, respectively (p-
value = 0.773). In lapa-group and open-group 3-year
overall survival rate (OS) were 65.3  0.8%, and
65.7  0.6%, respectively (p-value = 0.610).
Conclusion: Laparoscopic liver resection for HCC is
feasible and safe in a large number of patients, with
reasonable operative and oncologic results.
APHPB-0048
CORRELATION OF EARLY
RECURRENCE WITH IN VITRO
ADENOSINE TRIPHOSPHATE BASED
CHEMOTHERAPY RESPONSE ASSAY
IN PANCREATIC CANCER WITH
POSTOPERATIVE GEMCITABINE
CHEMOTHERAPY
J. S. Park, J. K. Kim and D. S. Yoon
Surgery, Gangnam Severance Hospital, Yonsei
University Health System, Seoul, Korea
Objectives: Gemcitabine-based regimens represent the
standard systemic first line treatment after pancreatic
resection. However, the clinical impact of gemcitabine
varies significantly in individuals because of chemoresis-
tance. An in vitro adenosine triphosphate-based chemo-
therapy response assay (ATP-CRA) was designed to
evaluate the sensitivity of cancer cells to various che-
motherapeutic agents. This study investigated the corre-
lation between in vitro gemcitabine chemosensitivity
and early recurrence after curative resection.
Methods: From January 2007 to December 2010, the
ATP-CRA for gemcitabine was tested in 64 patients at
Gangnam Severance Hospital, Seoul, Korea. We ana-
lyzed the relationship between chemosensitivity and
early systemic recurrence in patients with pancreatic
cancer.
Results: The mean cell death rate (CDR) was 20.0
(14.5) and divided into two groups according to the
mean values of the CDR. Gemcitabine resistance group
(CDR < 20) was associated with lymphovascular inva-
sion. In univariate and multivariate analysis, advanced
tumor stage and gemcitabine sensitive group
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(CDR ≥ 20) were identified as independent prognostic
factors for disease free survival.
Conclusion: Gemcitabine sensitivity measured by ATP-
CRA was well correlated with in vivo drug responsibility
to predict early recurrence following gemcitabine based
adjuvant chemotherapy in patients with pancreatic
cancer.
APHPB-0050
LAPAROSCOPIC HEPATIC RESECTION
VERSUS RADIOFREQUENCY
ABLATION FOR LOCAL CONTROL OF
SMALL HEPATOCELLULAR
CARCINOMA LOCATED ON THE
SURFACE OF THE LIVER
S. Tanaka1, S. Iwai2, S. Takemura1, A. Hagiwara2,
S. Uchida2, T. Ito1, M. Kinoshita1, H. Shinkawa1,
N. Kawada2 and S. Kubo1
1Department of Hepato-Biliary-Pancreatic Surgery,
Osaka City University Graduate School of Medicine,
Osaka, Japan; 2Department of Hepatology, Osaka City
University Graduate School of Medicine, Osaka, Japan
Objectives: The aim of this study was to compare the
effectiveness of laparoscopic or laparoscopy-assisted
hepatic resection (LH) versus percutaneous radiofre-
quency ablation (RFA) therapy for small hepatocellular
carcinoma (HCC) located on the surface of the liver
(surface HCC) with respect to local control.
Methods: Between January 2011 and December 2013,
LH and RFA were performed to treat surface HCC
(≤3 cm, 1–3 nodules) in 40 and 52 patients, respec-
tively. We developed a propensity score and controlled
for potential confounding and selection bias. The inci-
dence of local recurrence was compared between the
two matched groups.
Results: A total of 27 patients in each group were
matched according to the propensity score matching
protocol. One patient in the LH group was converted
to open surgery because of hard adhesion. There were
no significant differences in the clinicopathological
characteristics between the two matched groups. Seven
(26%) patients in the RFA group exhibited local recur-
rence after 37–787 days (median, 225 days) after the
RFA procedure, whereas no patients displayed local
recurrence in the LH group (p = 0.01). Four patients
(15%) in the LH group had postoperative complica-
tions (Clavien-Dindo Grade I or II). The mean hospital
stay after treatment was 12.6 days in the LH group
and 7.6 days in the RFA group (p = 0.00003).
Conclusion: Laparoscopic hepatic resection for surface
HCC is safe and may be preferable to RFA, with a low
rate of local recurrence, although the duration of hospi-
tal stay is long.
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APHPB-0051
THE PROGNOSTIC VALUE OF
GALECTIN-3 IN PATIENTS WITH
METABOLIC SYNDROME
T. A. Deeva, O. M. Drapkina and V. T. Ivashkin
Clinic of the Internal Diseases, I.M. Sechenov The First
Moscow State Medical University, Moscow, Russia
Objectives: To evaluate the level of fibrosis seromarker
(galectin-3) in patients with metabolic syndrome
(MetS).
Methods: The research included 76 patients: 43
afflicted persons were with MetS, 33 patients – without
MetS. The average age of 61  12 years. There was
held comprehensive survey, including determination of
the level of galectin-3.
Results: An average level of galectin-3 in the group
with MetS was reliably higher (1.89  1.71 ng/mL),
compared with the group without MetS
(1.03  0.22 ng/mL), p = 0.006. Chronic heart failure
(CHF) was diagnosed more often among patients with
MetS (p = 0.006). Positive correlation was revealed
between the level of galectin-3 and (1) left ventricular
hypertrophy (LVH) (r = 0.297)*, (2) end-diastolic
dimension of the right ventricle cavity (r = 0.280)*, (3)
hepatic (r = 0.433)* and pancreatic (r = 0.240)* steato-
sis, *p < 0.05.
Conclusion:
1. The research revealed the relationships between
the level of galectin-3 and the diseases, closely
associated with MetS, namely LVH, CHF, hepa-
tic and pancreatic steatosis. The basis of the
pathogenesis of these diseases derives from
inflammation and fibrosis, thus it could indicate
that galectin-3 is playing its role in development
of these pathological processes.
2. All patients with MetS had significantly higher
rates of galectin-3, meaning that it can be used
for comprehensive diagnosis and risk stratifica-
tion cardiovascular disasters and may be pathol-
ogy of the hepatobiliary system.
3. Complex examination of patients with MetS with
the use of serum markers of fibrosis (galektin-3)
may be more effective in evaluation of the health
condition of a patient with MetS, and for the
development of patients’ treatment tactics as
well.
APHPB-0054
SURGICAL TREATMENT FOR
RECURRENT CHOLANGITIS DUE TO
THE STASIS OF INTESTINAL
CONTENTS AFTER BILIARY SURGERY
T. Seki, S. Saeki, K. Hiramatsu, T. Amemiya, H. Goto
and T. Arai
Department of Surgery, Anjo Kosei Hospital, Anjo,
Japan
Objectives: Chronic cholangitis after biliary surgery is
often intractable. It lower the quality of life and the
patient can be fatal occasionally. Causes of postopera-
tive cholangitis are cholestasis in the hepatic hilum,
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stasis or reflux of intestinal contents. They are induced
by anastomotic stenosis, intestinal adhesion, or intesti-
nal hypoperistalsis. It is often difficult to treat for
recurrent cholangitis not caused by anastomotic steno-
sis.
Methods: We report two cases in which surgery was
effective for postoperative recurrent cholangitis due to
the stasis or reflux of intestinal contents.
Results: Case 1: The patient was operated on for con-
genital biliary dilatation previously. She was hospital-
ized with cholangitis more than one time a year.
Because the cause of recurrent cholangitis was the stasis
of intestinal contents by adhesion of the jejunum, we
performed adhesiolysis. She is well without having been
hospitalized with cholangitis after the second surgery.
Case 2: The patient was operated on for pancreatic
head cancer, and he had local recurrences 11 months
after the surgery. He developed cholangitis frequently
and we performed stenting by percutaneous transhepat-
ic biliary drainage 20 months after the surgery. How-
ever, he developed cholangitis again and he was
hospitalized many times. Because the cause of recurrent
cholangitis was the reflux of intestinal contents, we per-
formed gastrointestinal tract reconstruction 26 months
after the first surgery. He had not been hospitalized
with cholangitis and died 5 months after the second
surgery.
Conclusion: Surgical treatment for recurrent cholangitis
due to the stasis or reflux of intestinal contents after
biliary surgery is valid.
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APHPB-0056
ENHANCED RECOVERY AFTER
PANCREATODUODENECTOMY (ERAP)
PROTOCOLS – ‘ONE SIZE MAY NOT
FIT ALL’
S. Barreto1, S. Talole2, A. Perwaiz1, T. Singh1,
A. Singh1 and A. Chaudhary1
1GI Surgery GI Oncology & Bariatric Surgery, Medanta
the Medicity, Gurgaon, India; 2Biostatistics and
Epidemiology, Tata Memorial Centre, Mumbai, India
Objectives: Although reported in literature for a dec-
ade, the general implementation of enhanced recovery
after pancreatoduodenectomy (ERAP) protocols have
been less enthusiastic compared to subspecialties such
as colorectal surgery. The aim of the present study was
to determine factors influencing the successful imple-
mentation of ERAP protocols by analyzing their rela-
tion to duration of hospital stay.
Methods: A retrospective analysis of a prospectively
maintained ERAP database of consecutive patients
who underwent PD for pancreatic and periampullary
lesions at a tertiary referral care centre, between April
2010 and July 2013 was obtained. 8 patients who died
during the hospital stay were excluded from analysis.
Results: 200 patients underwent a Classical PD with a
median surgical duration of 285 min (range: 205–480)
and a median blood loss of 200 mL (range: 50–500).
The median duration of hospital stay was 8 days
(range: 4–52) with an overall morbidity rate of 34.5%
and mortality rate of 3.8%. 30-day readmission rate
was 4% (8 patients). Elevated BMI (RR = 1.098, 95%
CI 1.015–1.188; p = 0.02) and presence of respiratory
co-morbidities (RR = 8.024, 95% CI 2.018–31.904;
p = 0.003) independently influenced a longer (>8 days)
hospital stay. Hypoalbuminaemia (RR = 2.44, 95% CI
1.26–4.75; p = 0.009) significantly influenced a longer
hospital stay owing to its role in the development of
complications.
Conclusion: Obesity and pre-existing respiratory co-
morbidities are independent predictors of prolonged
hospital stay despite ERAP protocols. Hypoalbumina-
emia affects length of hospital stay by predisposing to
the development of complications. Implementing new
strategies that address these three factors may not only
contribute to a greater success of ERAP but also widen
its applicability.
APHPB-0057
3-DOSE PERIOPERATIVE ANTIBIOTIC
PROPHYLAXIS WITH ERTAPENEM
REDUCES POST-
PANCREATODUODENECTOMY
INFECTIOUS COMPLICATIONS IN
HIGH-RISK PATIENTS
S. Barreto1, M. K. Singh2, S. Sharma3 and
A. Chaudhary1
1GI Surgery GI Oncology & Bariatric Surgery, Medanta
the Medicity, Gurgaon, India; 2Biostatistics, Medanta
the Medicity, Gurgaon, India; 3Microbiology, Medanta
the Medicity, Gurgaon, India
Objectives: Infectious complications occur in upto 45%
of patients following pancreatoduodenectomy (PD) and
are higher in patients undergoing preoperative endo-
scopic invasive procedures. Surgical morbidity
adversely affects long-term outcomes and thus possible
role of perioperative antimicrobials needs evaluation.
The aim of the study was to compare the impact of Er-
tapenem administered as 3-once daily perioperative
doses on infectious complications in patients at high-
risk for complications (underwent preoperative invasive
endoscopic procedures) versus those at low-risk (up-
front surgery).
Methods: A retrospective analysis of a prospectively
maintained database of consecutive patients who
underwent PD for pancreatic and periampullary lesions
at a tertiary referral centre, between June 2011 and
May 2013 was performed. Based on an analysis of in-
traoperative bile cultures, all patients were administered
3-once daily doses of Ertapenem (1 gram) as follows:
within 1 h prior to induction, on post-operative day 1
and day 2. Antibiotics were ceased following post-oper-
ative day 2 until discharge unless patients developed
infectious complications.
Results: Patients were matched for factors known to
affect outcomes following PD including demographic,
nutritional (age, sex, BMI and serum albumin levels),
surgical (pancreatic duct size and texture, intraopera-
tive blood transfusions) and histopathological parame-
ters. No significant difference between the two groups
in terms of overall morbidity (p = 0.740), infectious
complications (p = 0.334), mortality (p = 0.933) and
post-operative hospital stay (p = 0.745) was noted.
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Conclusion: Perioperative Ertapenem resulted in a
non-significant difference in infectious and overall com-
plications in high-risk patients undergoing PD as com-
pared to low-risk group. This intervention is promising
and needs evaluation in a larger cohort of patients.
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APHPB-0058
ACTIVIN A-SMAD SIGNALING
INDUCES THE EXPRESSION OF
CONNECTIVE TISSUE GROWTH
FACTOR IN HEPATIC PROGENITOR
CELLS
Z. Ding1, G. Jin2, W. E. I. Wang1, Y. Sun1, W. Chen1,
J. Zhao1, H. Liang1, P. R. A. N. Datta3, M. Zhang4,
B. Zhang5 and X. Chen5
1Hepatic Surgery Centre, Tongji Hospital, Tongji
Medical College, Hua Zhong University of Science and
Tec, Wuhan, China; 2Department of Nephrology, Union
Hospital, Tongji Medical College, Hua Zhong University
of Science and Tec, Wuhan, China; 3Department of
Medicine, University of Alabama at Birmingham,
Birmingham, AL, USA; 4Department of Cancer Biology,
Vanderbilt-Ingram Cancer Center, Vanderbilt University
School of Medicine, Nashville, TN, USA; 5Hepatic
Surgery Centre, Tongji Hospital, Tongji Medical
College, Huazhong University of Science and
Technology, Wuhan, China
Objectives: Hepatic progenitor cells (HPCs) are acti-
vated in the cirrhotic liver and may participate in liver
fibrosis. Our previous study reported that HPCs pro-
duced connective tissue growth factor (CTGF), a driver
of liver fibrosis, whereas the regulatory mechanism of
CTGF expression in HPCs remains elusive.
Methods: We measured the expression of Activin-A, a
potential CTGF inducer, and CTGF in liver tissues by
immunohistochemistry. We used HPC cell lines LE/6
and WB-F344 as in vitro models. Cells were treated
with Activin-A, and the expression of CTGF and the
activation of Smads signaling was measured by western
blot analyses and luciferase reporter assays. We
knocked down Activin-A by lentivirus in HPCs to eval-
uate the effects of endogenous Activin-A, and knock
down Smad4 and overexpression of Smad7, both of
which are crucial components of Smads signaling, by
retrovirus to measure the activin-A inducible Smad sig-
naling in the expression of CTGF in HPCs.
Results: Activin-A was up-regulated in cirrhotic liver,
and Activin-A levels were positively correlated with
CTGF expression in liver samples. Besides, we con-
firmed that HPCs were activated in the cirrhotic liver
and secreted Activin-A. Moreover, we found that Acti-
vin-A induced secretion of CTGF through Smad sig-
naling in HPCs. Furthermore, Activin-Smad signaling
was intracellular activated and contributed to the
expression of CTGF in HPCs.
Conclusion: Our results found that both exogenous and
endoenous Activin-A induced the expression of CTGF
in HPCs, and suggested that the production of CTGF
by Activin-A activated Smad signaling in HPCs may be
a therapeutic target of liver fibrosis.
Malignant HPB Diseases
APHPB-0059
ENHANCER OF ZESTE HOMOLOG 2
INHIBITS MIR-34A IN HUMAN
PANCREATIC DUCTAL
ADENOCARCINOMA BY THE
FORMATION OF HETEROCHROMATIN
C. H. Li and Y. Chen
School of Biomedical Sciences, Chinese University of
Hong Kong, Shatin, Hong Kong, China
Objectives: MicroRNA-34a (miR-34a) is frequently
downregulated in human cancers by inactivation of p53
or promoter DNA methylation. However, miR-34a is
suppressed in pancreatic ductal adenocarcinoma
(PDAC) cells without p53 aberration and DNA meth-
ylation, so the silencing mechanism in PDAC remains
unknown. We have previously showed that enhancer of
zeste homolog 2 (EZH2), a H3K27 methyltransferase,
represses microRNA in PDAC. Here, we attempted to
investigate the role of EZH2 in the silencing of miR-
34a.
Methods: PDAC cells were treated with small molecule
inhibitor of EZH2 3-deazaneplenocin A (DZP), and
siRNAs targeting EZH2, DNMTs, SUZ12 and HO-
TAIR. EZH2 and various mutants were overexpressed
in human pancreatic ductal epithelial (HPDE) cells.
miR-34a levels were measured by qRT-PCR. Cell
growth and colony formation rates were also measured.
EZH2, H3K27me3 and heterochromatin-associated fac-
tors occupancies at miR-34a promoter were measured
by chromatin immunoprecipitation (ChIP).
Results: miR-34a was upregulated upon the inhibition
of EZH2, SUZ12 and HOTAIR, but not DNMTs.
EZH2 overexpression in HPDE reduced miR-34a level,
and promoted cell proliferation and colony formation.
EZH2-mediated cell proliferation was attenuated by
miR-34a mimics transfection and miR-34a precursor
lentivirus transduction. EZH2 protein and H3K27me3
occupancy at miR-34a promoter was higher in PDAC
cells than HPDE cells. Knockdown of EZH2 in
SW1990 reduced the occupancy of heterochromatin
markers which were enriched in EZH2-overexpressed
HPDE cells.
Conclusion: EZH2 suppressed miR-34a that contrib-
uted to EZH2-associated cell proliferation in PDAC.
EZH2 promoted trimethylation of H3K27 at the pro-
moter of miR-34a and induced heterochromatin forma-
tion, which reinforced the importance of EZH2 in
microRNA deregulation.
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APHPB-0060
THE EFFECTIVENESS OF ANTIVIRAL
THERAPY IN THE PATIENTS WITH
CHRONIC HEPATITIS C IN
CAUCASIANS AND ASIANS,
CONSIDERING POLYMORPHISM OF
INTERLEUKIN-28B GENE OF
POPULATION
L. Orlova1, S. I. Malov1, P. Namdava2, D. Badrah2
and I. V. Malov1
1Infectious Diseases, Irkutsk State Medical University,
Irkutsk, Russia; 2Infectious Diseases, National Centre
Communicable Diseases, Ulaanbaatar, Mongolia
Objectives: To assess the effectiveness of antiviral ther-
apy in the patients with chronic hepatitis C in Cauca-
sians and Asians, considering polymorphism of
interleukin-28b gene of population.
Methods: 947 healthy people were examined in the Irk-
utsk region, the Republic of Buryatia and Mongolia
(typing the locus rs 12979860 and rs8099917 of gene
IL-28b). Also 97 people with 1 genotype of HCV-infec-
tion were observed. 33% of them were Asians and 67%
– Caucasians. The patients with fibrosis >F3 on Meta-
vir scale were not included in the research. The effec-
tiveness of antiviral therapy (combination of pegylated
a2-interferon with ribavirin) was assessed on frequency
of SVR.
Results: The prevalence of CC-genotype rs12979860
and TT-genotype rs8099917 in the population of Irk-
utsk region, the Republic of Buryatia and Mongolia
were 40.0% and 54.5%; 64.6% and 86.2%; 82.2% and
84.9% accordingly.
Evidently CC-genotype and TT-genotype are more
characteristic for Asians. According census data (Rus-
sia 2010, Mongolia 2010) the portion of Asians was in
the Irkutsk region – 3.75%; the Republic of Buryatia –
30.2%, Mongolia – 96%. The correlation ratio among
Asians in population of each region and prevalence of
CC-genotype was 0.9 (p < 0.05), indicating on strong
straight connection.
The rate of SVR in Caucasians was 53.8  6.2%, in
Asians – 78.1  7.3% (p < 0.05).
Conclusion: The prevalence of CC-genotype locus rs
12979860 and TT-genotype rs8099917 of gene IL-28b is
increased with increasing of Asians in the population
of region. The effectiveness of antiviral therapy in the
patients with chronic hepatitis C was more in Asians
than in Caucasians.
APHPB-0061
COMBINED-LAPAROSCOPIC VERSUS
OPEN SPLENECTOMY AND
ESOPHAGOGASTRIC
DEVASCULARIZATION FOR PORTAL
HYPERTENSION DUE TO LIVER
CIRRHOSIS
L. Zhang, W. G. Zhang and X. P. Chen
Hepatic Surgery Center, Tongji Hospital, Tongji
Medical College, Huazhong University of Science and
Technology, Wuhan, China
Objectives: This study was conducted to compare the
feasibility, safety and effectiveness of the combined-lap-
aroscopic splenectomy and esophagogastric devascular-
ization (C-LSED) with those of open surgery (OSED)
in patients with portal hypertension due to liver cirrho-
sis.
Methods: From February 2011 to February 2014, 68
patients with portal hypertension were diagnosed with
serious gastroesophageal varices and/or hypersplenism
in our center. 30 patients underwent C-LSED and 38
patients received OSED. Results and outcomes were
compared retrospectively.
Results: No patients of C-LSED group required an in-
traoperative conversion to open surgery. Compared
with OSED group, significantly shorter operating time,
less blood loss, lower transfusion rates, shorter postop-
erative hospital stay, lower rates of complications were
found in C-LSED group (p < 0.05). No death and reb-
leeding were documented in both groups during the fol-
low-up periods of 6 months. Postoperative endoscopy
revealed that the patients with varices in both groups
improved significantly from severe to mild, and in a
part of cases, the varices disappeared.
Conclusion: The final results suggest that the C-LSED
technique is superior to open procedure, which brings
about slightly invasive, simplified operative procedure,
significantly shorter operating time, less intraoperative
bleeding and lower complication rates. And C-LSED
offers comparable medium-term effects to OSED
approaches.
APHPB-0062
PARTIAL ISCHEMIA-REPERFUSION
INJURY TO THE LIVER DOES NOT
INDUCE OVAL CELL PROLIFERATION
IN A RODENT MODEL
E. K. Tan1, M. Shuh1, J. A. Sanders2 and A. J. Cohen1
1Institute of Translational Research, Ochsner Clinic
Foundation, New Orleans, LA, USA; 2Division of
Endocrinology and Metabolism, Rhode Island Hospital
and The Warren Alpert Medical School of Brown
University, Providence, RI, USA
Objectives: Hepatic oval cells (hepatic progenitor cells)
proliferate to restore the liver after injury when hepato-
cyte responses are inadequate. Models replicating this
invariably required a toxic carcinogen to deliver a
substantial injury to the liver. Ischemia-reperfusion
injury (IRI) of the liver causes hepatocellular damage
and cell death without chemical toxicity. Since trans-
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planted oval cells can modulate the effects of IRI, we
sought to investigate if oval cells are activated after IRI
to the liver.
Methods: We induced 30 min of warm ischemia in
70% of the total rat liver followed by reperfusion of 1,
3, 5 or 7 days. Serum ALT, TNF-a, as well as cellular
proliferation and changes in Thy-1 expression were
measured.
Results: Peak levels of ALT were measured after
5 days of reperfusion (mean 21.5  7.0 U/L) and this
correlated with histological changes of the extent of
hepatocyte necrosis. TNF-a levels were similar to base-
line. Proliferating oval cells were not observed on light
microscopy or EdU fluorescent labelling. Thy-1 positive
staining was observed around the portal tracts in both
affected and non-affected lobes but this was compara-
ble to sham rats.
Conclusion: The partial-liver IRI model in rats involv-
ing 30 min of warm ischemia followed by various peri-
ods of reperfusion injury demonstrates the peak
biochemical injury and histological injury (in the
affected lobe) at day 5 of reperfusion. Oval cell
responses to partial IRI of 30 min were not seen.
Recovery of normal livers after being exposed to brief
periods of IRI are therefore likely to be hepatocyte
mediated.
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APHPB-0064
LAPAROSCOPIC CENTRAL
PANCREATECTOMY COMBINED WITH
BINDING
PANCREATICOGASTROSTOMY
D. Hong and W. A. N. G. Zhifei
Hepatobiliary Pancreatic and Minimally Invasive
Surgery, Zhejiang Provincial People’s Hospital,
Hangzhou, China
Objectives: To explore the feasibility of of laparoscopic
central pancraeatectomy (LCP) with binding pancreat-
icogastrostomy (BPG)
Methods: Between July 2010 to July 2013, LCP with
LBPG was performed in 5 consecutive patients with
lesions of benign or low malignancy at the pancreatic
neck. Operative and pathological data, complications,
and hospital stay and details on the surgical techniques
were introduced.
Results: The operations were successfully performed in
all the 5 cases, with no conversions. The medium oper-
ation time was 204.0  13.9 min, intraoperative blood
loss was 370.0  83.6 (mL), The time for BPG anasto-
mosis was 20.3  2.6(min), time for the recovery of
bowl movement was 3.4  0.5 days, the time for semi-
fluid dieting was 4.9  1.8 days, the hospital stay was
12  3.7 days, all the intraoperative pathology was
identical to the postoperative pathological findings. The
complications included an emergent upper GI bleeding
early postoperatively due to the bleeding at the pancre-
atic stump and was managed by reoperation with open
approach; a delayed gastric empty which was cured
conservatively. No mortality occurred.
Conclusion: LCP can be performed safely and effectively
in selected patients. LBPG greatly facilitats the pancre-
atic reconstruction under laparoscope.
APHPB-0065
EARLY OUTCOME AFTER HEPATIC
RESECTION – EXPERIENCE FROM A
DEVELOPING COUNTRY WITH
LIMITED RESOURCES
S. Begum, M. R. Khan and M. S. Effandi
General Surgery, Aga Khan University, Karachi,
Pakistan
Objectives: To review the initial experience and early
outcome of hepatic resections performed at our hospi-
tal.
Methods: Formal hepatic resection at our hospital was
started in 2008. All the patients who underwent hepatic
resection for various malignant and benign lesions of
liver between Jan 2008 and June 2013 were included in
the study. The variables studied included indications of
surgery, type of hepatic resection, blood loss, early
morbidity and mortality. The frequencies were calcu-
lated using SPSS v 19.
Results: A total of 50 patients underwent hepatic resec-
tion during this period.Indications of surgery included
primary hepatic malignancy (31), metastatic malignancy
(9) and benign hepatic tumors (9). One third of the
patients underwent a major hepatectomy. Mean dura-
tion of surgery was 300 min with mean estimated blood
loss of 694 mL. Overall morbidity rate was 40%.
30 day hospital mortality rate was 2%, while mortality
rate at 1 year was 12%. In a subgroup analysis of
patients with HCC, 1 year mortality was 15% while
recurrence rate during the follow up period was 19%.
Conclusion: Despite limitations of resources, hepatic
resection can be performed in our setup with reason-
able early postoperative outcome. Mean blood loss is
on higher side and can be improved by modification of
technique and introduction of new technology. The
outcome of cirrhotic patients with HCC is compara-
tively modest.
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APHPB-0066
ENDOSCOPIC TREATMENT FOR
PATIENTS WITH PANCREATIC CYSTS
CAUSED BY PANCREATOLITHIASIS
K. Inui, J. Yoshino, S. Yamamoto, H. Miyoshi,
T. Kobayashi and Y. Katano
Gastroenterology, Fujita Health University Second
Teaching Hospital, Nagoya, Japan
Objectives: Since 1990 we have performed extracorpo-
real shock-wave lithotripsy (ESWL) and/or interven-
tional endoscopy for patients with chronic pancreatitis.
Here we report our treatment results for patients with
pancreatic cysts (pseudocysts or retention cysts) caused
by pancreatolithiasis, a combination of conditions that
is difficult to manage.
Methods: Between 2007 and 2013, we treated 11
patients with pancreatic cysts caused by pancreatolithi-
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asis using ESWL plus interventional endoscopy.
Median follow-up interval was 26 months (range, 1–
69). Median age was 60 years (42–83), and the male:
female ratio was 10:1. Alcoholism was responsible for
stones in 9 patients and hyperparathyroidism in 1; in
another, stones were idiopathic. All patients were
symptomatic; 3 had single stones and 2, multiple cysts.
Results: Cysts disappeared occurred completely with
initial treatment in 10 of the 11 patients who under-
went ESWL plus adjuvant endoscopic procedures,
while 2 of the 10 experienced recurrence 21 and
40 months after treatment and underwent surgery. The
patient with initial treatment failure had multiple cysts.
Of the 2 patients requiring surgery, 1 had multiple
pseudocysts; the other had a large pseudocyst exceeding
100 mm in diameter.
Conclusion: Endoscopic treatment following ESWL for
pancreatolithiasis and retention cysts is effective, but
early surgery should be considered for patients with
pseudocysts complicating pancreatolithiasis, especially
large or multiple cysts.
APHPB-0067
SPATIAL AND TEMPORAL
DIFFERENCES OF HMGB1
EXPRESSION IN THE PANCREAS OF
RATS WITH ACUTE PANCREATITIS
X. Yu
Department of Gastrointestinal and Pancreatic Surgery,
Central South University Third Xiangya Hospital,
Changsha, China
Objectives: To investigate the spatial and temporal dif-
ferences in expression between HMGB1 and early
inflammatory cytokines (IL-1, IL-6 and TNF-a) in pan-
creas in rats with acute pancreatitis.
Methods: SD rats (BW 350  30 g, n = 48) were ran-
domly divided into the experimental group (n = 36)
which were injected with 5% sodium taurocholate into
the bili-pancreatic duct retrogradely to produce acute
necrotic pancreatitis (ANP) rat models, and the sham-
operated (SO) group (n = 12) injected with equal dose
of saline. The rats were sacrificed at different time
points at 0 h, 3 h, 6 h, 12 h, and 24 h post modeling,
respectively. The peripheral blood amylase and differ-
ent inflammatory factors in ANP rats at different time
points were detected by ELISA, and the expression of
HMGB1 in the pancreatic tissue was detected by
immunohistochemistry, Western blot and Q-PCR meth-
ods.
Results: The serum amylase in the ANP model rats
was higher than the sham-operated group (p < 0.05).
The early inflammatory factors increased quickly at 3 h
after the model induction, reached the peak level at 6 h
(higher than SO group, p < 0.05), then decreased at
12 h, and at 24 h the levels were lower than those at
12 h (p < 0.05). The HMGB1 level in the pancreatitis
tissue did not change significantly at 3 h and 6 h
(p > 0.05), however, it increased remarkably at 12 h,
and maintained up to 24 h (p > 0.05).
Conclusion: As a late inflammatory factor, the expres-
sion of HMGB1 in acute pancreatitis was obviously
later than the early inflammatory factors IL-1, TNF-a
and IL-6. HMGB1 may play a key role in maintaining
the development of the acute pancreatitis.
Malignant HPB Diseases
APHPB-0068
DOUBLE STENT PLACEMENT FOR
BILIARY AND DUODENAL
OBSTRUCTION CAUSED BY
UNRESECTABLE PANCREATOBILIARY
CANCER
A. Kubo1, H. Tamaki1, T. Noda1, S. Arasawa1,
M. Izuta1, C. Ogawa1, T. Matsunaka1, M. Shibatoge1,
E. Ishida2 and H. Yamamoto2
1Gastroenterology, Takamatsu Red Cross Hospital,
Takamatsu, Japan; 2Gastroenterology, Kurashiki Central
Hospital, Kurashiki, Japan
Objectives: We know biliary and duodenal metallic
stent placement (DS) is effective and safe respectively
for the palliation of unresectable pancreatobiliary can-
cer. Clinical outcomes of double metallic stent place-
ment are still unclear. The aim of this study was to
clarify its he efficacy and safety for malignant biliary
and duodenal obstruction.
Methods: Reviewed retrospectively between January,
2001 and December 2013 inclusive, at our institution.
In principle, biliary drainage (BD) was performed with
endoscopic transpapillary stent placement (EPD). When
EPD was difficult, percutaneous transhepatic biliary
drainage (PTBD) was performed as an alternative.
Results: 44 consecutive patients of 579 received BD
were included in this study (male 23, mean age
75.4 years). The functional success rate of BD was
100% and that of DS was 90.2% (40/44). Of successful
patients, median time to dysfunction of BD was
156 days (95%CI 41–105) and that of DS was 53 days
(95%CI 14–286). BD was performed with EPD in 34
and PTBD in 10. 33 patients diagnosed as biliary
obstruction only were received BD before duodenal
obstruction. 11 patients diagnosed as biliary and duo-
denal obstructions at the same time were received both
BD and DS. Of 11 patients, BD was performed with
EPD in 7 and PTBD in 4. Mild pancreatitis occurred
in 6 (4 after BD, 2 after DS). Median survival after
both interventions was 95 days (95%CI 33–328).
Conclusion: Double stent placement for biliary and
duodenal obstruction caused by unresectable pancre-
atobiliary cancer was found to be safe and effective as
palliative treatment for patients at the latest stage.
© 2015 The Authors
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APHPB-0070
BERBERINE WITH ALFA LIPOIC ACID
(ALA) IN NON ALCOHOLIC STEATO-
HEPATITIS (NASH). A RANDOMIZED
DOUBLE BLINDED PLACEBO
CONTROL TRIAL. A CLINICAL PILOT–
THE BANISH TRIAL
P. Basu1, N. J. Shah2 and M. M. Aloysius3
1Gastroenterology, Chief Division of Hepatology, Kings
County Medical Center SUNY Downstate, New York
City, USA; 2Internal Medicine, James J. Peters VA
Medical Center, Icahn School of Medicine at Mount
Sinai NY, New York City, NY, USA; 3Medicine, King’s
County Hospital Medical Center NY, New York City,
NY, USA
Objectives: Therapeutic modalities for NASH have not
yet been fully established. Anti-oxidants and insulin
sensitizers altering insulin resistance, inhibiting intra
hepatic oxidative stress with inhibition of formation of
free radicals and blocking inflammatory cytokines to
prevent fibrosis. Berberine is a natural substance
extracted from plants like Berberis which is found to
up-regulate intra hepatic pathways as insulin sensitizer,
via GLP-1 up regulation and Acyl palmotyl mechanism
on fatty acid oxidation, induction of PPAR gama; all
of which blocks the terminal inflammatory Cytokine
release TNF Alfa to prevent fibrosis that prevents End
stage liver disease (ESLD) and liver cancer.
Methods: Hundred and twenty patients (n = 120) with
NASH were recruited. Mean BMI 29.9% (29% to
32%) with 69 males and 51 females. Hispanic 46, Cau-
casians 34, Asian Pacific15, Black 11, Asian 14. Mean
HbA1C 6.2 (5.9- 6.8), Mean HOMA 2.7 (2.1–3.6),
ALT 54 (38–79), Triglyceride 287 (233–344), LDL c
163 (129–176), Leptin 63 (43–98), Adiponectin 0.9 (0.1–
1.1), RBP 4 of 5.8 (4.0–6.8), TNF Alfa 3.8 (2.1–4.8), IL
12 of 5.3 (3.9–7.8), Serum Fibrotic and Steatotic scores
were measured at 0 and then at 6 months.
Results:
p-values ALT HOMA TG Adiponectin TNF-a Leptin
Steatotic
score
Group
A
0.001 0.004 <0.001 0.090 0.005 0.003 0.021
Group
B
<0.001 0.003 <0.001 0.03 0.012 0.015 0.034
Group
C
<0.001 0.003 <0.001 0.001 <0.001 0.003 <0.001
Group
D
0.006 0.001 <0.001 0.001 <0.001 0.016 0.002
Conclusion: All the study arms showed statistically sig-
nificant (p < 0.05) post interventional change except for
Adiponectin in group A (p = 0.09).
APHPB-0071
ROLE OF INTRAVENOUS N-ACETYL
CYSTEINE (NAC) WITH STEROID IN
ACUTE ALCOHOLIC HEPATITIS WITH
HIGH MORBIDITY SCORE: A
RANDOMIZED OPEN LABEL
PROSPECTIVE CLINICAL
RENAISSANCE TRIAL
P. Basu1, N. J. Shah2 and M. M. Aloysius3
1Gastroenterology, Chief Division of Hepatology, Kings
County Medical Center SUNY Downstate, New York
City, NY, USA; 2Internal Medicine, James J. Peters VA
Medical Center, Icahn School of Medicine at Mount
Sinai NY, New York City, NY, USA; 3Internal
Medicine, King’s County Hospital Medical Center NY,
New York City, NY, USA
Objectives: AAH is a severe clinical state with signifi-
cant morbidity with impending mortality in 28 days of
about 49%. Standard of care (SOC) is absolute absti-
nence and nutrition with restricted use of corticoster-
oids and pentoxyphilline.
Methods: Forty five (n = 45) patients with AAH, Age
32–58 (mean 46), mean BMI 24%, Mean Alcohol con-
sumption 80 g/day. DF > 32%, Lilies score > 0.67,
ABCI (Albumin, Total Direct Bilirubin, creatinine and
INR) >9, mean MELD 24 and mean HOMA 0.9
Group A (n = 15): I.V Methyl Prednisolone, i.v. Vita-
min C 500 mg + Pentoxifylline 400 mg orally for
4 days followed by Prednisone 60 g orally for 30 days
Group B (n = 15): I.V NAC + IV Vitamin C + Pentox-
ifylline for 4 days followed by Prednisone for 30 days
Group C (n = 15): IV Methyl Prednisolone + IV
NAC + Pentoxifylline for 4 days followed by Predni-
sone for 30 days
Results:
% d Group A Group B Group C
TB 66.7 78.6 60
Albumin 34.7 52.3 73.7
Creatinine 44.4 45.8 37.5
AST 82.9 86.8 90.4
ALT 76 83.6 81.3
TNF 87 42.9 65.4
IL6 64.7 67.6 72.7
IL8 62.1 62.1 50
MELD 51.5 50 42.1
Conclusion: This study postulates effects of IV NAC to
the SOC in AAH is safe, efficacious with faster recov-
ery time.
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APHPB-0072
ROLE OF MYCOPHENOLATE MOFETIL
(MMF) IN STEROID NON RESPONSIVE
SEVERE ACUTE ALCOHOLIC
HEPATITIS: A RANDOMIZED OPEN
LABEL PLACEBO CONTROL
PROSPECTIVE CLINICAL PILOT TRIAL
P. Basu1, N. J. Shah2 and M. M. Aloysius3
1Gastroenterology, Chief Division of Hepatology, Kings
County Medical Center SUNY Downstate, New York
City, NY, USA; 2Internal Medicine, James J. Peters VA
Medical Center, Icahn School of Medicine at Mount
Sinai NY, New York City, NY, USA; 3Internal
Medicine, King’s County Hospital Medical Center NY,
New York City, NY, USA
Objectives: Severe alcoholic hepatitis (SAH) still
remains a clinical challenge with mortality of 47% with
steroid non-responsiveness immunosuppressives remains
SOC. Mycophenolate mofetil (MMF) is a immunosup-
pressive reduces B and T lymphocytic recruitment and
immune injury. This study evaluates the role of MMF
in steroid unresponsive SAH, reduction of necro-
inflammation, acute liver decompensation needs trans-
plantation which remains controversial
Methods: Thirty patients aged-25–60 diagnosed with
steroid unresponsive SAH, with severity score criteria
(DF > 32%, ABCI > 12, Lile > 0.45, MELD > 26.
Exclusion; hepatits A, B C, Gi bleed, hepatic Encepha-
lopathy sepsis,
Group A MMF 500 mg bid with Ptx 400 mg and Pla-
cebo orally for 30 days.
Group B Prednisolone 30 mg plus Placebo (Vit D) and
Ptx 400 mg orally 30 days.
Group C Prednisolone plus NMF and PTX orally for
30 days.
Results:
Group A Group B Group C
Day 0 Day 90 Day 0 Day 90 Day 0 Day 90
T. bilirubin 14 1.3 13 8 15 2.1
INR 2.1 0.9 2.1 1 2.3 0.8
Albumin 2.3 3.3 2.4 3 1.9 3.1
Creatinine 1.8 0.7 1.5 0.8 2.4 1
Platelets 138 303 121 251 98 187
AST/ALT 321/
187
31/
23
341/
157
39/
25
421/
299
34/
36
TNF 9.7 0.4 8.9 1.1 12.2 0.3
IL-6 7.9 0.2 6.7 1 9.8 0.1
IL-8 5.3 0.03 4.9 0.6 11.4 0.8
Conclusion: This study postulates MMF is well toler-
ated, safe, and effective. MMF independently and pre-
cipitously reduced the necro-inflammatory score
compared with the SOC. A larger trial needs to vali-
date the singular role of MMF in AAH.
APHPB-0073
RESTLESS LEG SYNDROME, (RLS) IS
ASSOCIATED WITH HEPATIC
ENCEPHALOPATHY (HE) IN
DECOMPENSATED CIRRHOSIS. A
CLINICAL PILOT STUDY
P. Basu1, N. J. Shah2 and M. M. Aloysius3
1Gastroenterology, Chief Division of Hepatology, Kings
County Medical Center SUNY Downstate, New York
City, NY, USA; 2Internal Medicine, James J. Peters VA
Medical Center, Icahn School of Medicine at Mount
Sinai NY, New York City, NY, USA; 3Internal
Medicine, King’s County Hospital Medical Center NY,
New York City, NY, USA
Objectives: Decompensated cirrhosis with portal hyper-
tension has multi-organ involvement causing minimal
and overt encephalopathy, sleep disturbances (dysno-
mia, parasomnia) and stupor; all of which has a clear
association with sub acute bacterial peritonitis (SBP)
which has a precipitating clinical state along with
SIBO.
Methods: n = 108 patients were subdivided into three
sub-groups. Group A (n = 36) – decompensated cir-
rhotic (mean MELD of 16, OHE 20/36 (55%), MHE
16/36 (44%), esophageal varices grade II 24/36 (67%).
Group B (n = 36) – chronic liver disease without cir-
rhosis with mean MELD 6: Alcohol related 9/36
(25%), NASH 12/36 (33%), HCV 12/36 (33%), HBV
1/36 (3%) and AIH 2/36 (6%). Group C (n = 36)
healthy controls. Initially all received Xifaxan 550 mg
twice daily for 10 days to eradicate co-existing SIBO.
All underwent Methane breath test for SIBO. Baseline
labs: CBC, CMP, iron studies, Celiac and IBD serol-
ogy, stool lactoferrin & calprotectin and urine toxicol-
ogy screening were collected. Groups A and B
underwent neuro-psychometric and flicker testing for
MHE and OHE and sleep testing for RLS (with Mayo
RLS questionnaire)
Results: Group A 24/36 (67%) had RLS:[ OHE 16/20
(80%), MHE 8/16 (50%), esophageal varices 8/10
(80%), alcoholic cirrhotic 10/14 (71%), CHC 3/6
(50%), NASH 3/6 (50%) and SIBO 14/36 (39%) ].
Group B 1/36 (3%) RLS and SIBO 7/36 (19%). Group
C: 2/36 (6%) RLS and SIBO 3/36 (8%). All individuals
were confirmed by sleep study and RLS questionnaire.
Serum ammonia has no impact on RLS.
Conclusion: This clinical trial postulates that decom-
pensated cirrhotics with Hepatic encephalopathy have
high incidence of RLS with portal hypertension.
© 2015 The Authors
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APHPB-0074
NOVEL COLONOSCOPY
PREPARATION OF COCONUT WATER
WITH MIRALAX AND DULCOLAX IN
SPLIT DOSES FOR DECOMPENSATED
CIRRHOTICS. A RCT DOUBLE
BLINDED CLINICAL PILOT STUDY.
COSMIC STUDY
P. Basu1, N. J. Shah2 and F. Gress3
1Gastroenterology, Chief Division of Hepatology, Kings
County Medical Center SUNY Downstate, New York
City, NY, USA; 2Internal Medicine, James J. Peters VA
Medical Center, Icahn School of Medicine at Mount
Sinai NY, New York City, NY, USA;
3Gastroenterology, College of Physicians and Surgeons,
Columbia University, New York City, NY, USA
Objectives: Screening colonoscopy is routine for
patients been evaluated for OLT. Most aqueous colo-
noscopy preparations are poorly tolerated, cause gross
dyselectrolytemia and even renal dysfunction. This ulti-
mately leads to poor compliance affecting diagnosis.
Methods: Sixty (n = 60) patients aged 45–69 (MELD
16–20, with moderate ascites and MHE on Diuretics,
Lactulose and Xifaxan) were recruited. Single center,
one gastroenterologist, anesthesiologist, nurse and med-
ical assistant.
All were on Lasix (mean dose of 60 mg daily), Aldac-
tone 100 mg, Lactulose 30 mL and Xifaxan 550 mg
BID.
Results:
Group A
Coconut
water + Miralax
N = 30
Group B (control)
Gatorade + Miralax
N = 30
Mean age 58 56
M:F 21:9 20:10
BMI 24.8 25.8
Demographics
Caucasians 8 9
Hispanic 10 9
African American 6 8
Asian 6 4
Mean MELD 18 22
Etiology of CLD
HCV 15 17
HBV 2 4
ALD 10 7
NASH 3 2
Total sedation time, min 30 34
Boston BPS
0–3 1 3
4–6 6 6
7–9 23 21
Likert’s score
1 = severely distressing 0 0
2 = distressing 0 0
3 = bothersome 1 4
4 = mild 5 5
5 = none 24 21
Chicago BPS
>300 mL 6 7
151–300 mL 7 8
51–150 mL 11 9
<50 mL 6 6
Mean time to cecum 17 23
Dry mucosa requiring irrigation 8 11
Complications 0 0
Conclusion: This study postulates a novel organic coco-
nut water preparation with Miralax compared to tradi-
tional preparation to be safe (lesser dyselectrolytemia),
well tolerated with wide satisfactory score and greater
retention. It has greater efficacy with no side events in
special population (decompensated cirrhotics awaiting
OLT).
Malignant HPB Diseases
APHPB-0075
SEVERITY OF LIVER CIRRHOSIS: A
KEY ROLE IN THE SELECTION OF
SURGICAL MODALITY FOR
HEPATOCELLULAR CARCINOMA
E. L. Zhang, B. Y. Liang, Z. Y. Huang and
X. P. Chen
Hepatic Surgical Center, Tongji Hospital, Wuhan, China
Objectives: Hepatocellular carcinoma (HCC) is the
third leading cause of cancer-related deaths worldwide
and primarily arises from cirrhosis, and the selection of
surgical modalities in those patients is still in debate.
This review examines the current status of the selection
of surgical modality for HCC treatment in cirrhotic
patients and aims to emphasize the effects of the sever-
ity of cirrhosis on the selection of surgical modality for
the treatment of HCC.
Methods: Systematic search of English-language litera-
ture published within the past recent years was per-
formed using an electronic search of Pubmed/
MEDLINE and Google Scholar database to identify
the studies related to the investigation and surgical
treatment choice of HCC in cirrhotic or non-cirrhotic
patients.
Results: Liver cirrhosis adversely affect surgical out-
comes, and is critically important in determining the
treatment options. For HCC patients with moderate or
severe cirrhosis, LT should be the first choice if the
tumors fulfill LT criteria, local ablation can be used as
a temporary treatment during the waiting period for
LT. For those tumors that do not meet the LT criteria
but are technically resectable, non-anatomic resection
might be an alternative treatment modality. Anatomic
resection should be recommended for HCC patients
without cirrhosis or with mild cirrhosis.
Conclusion: Liver cirrhosis is an important factor that
cannot be ignored in the surgical treatment of HCC.
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APHPB-0076
INTERFERON INELIGIBLE NAIVE
CHRONIC HEPATITIS C GENOTYPE I
SUBJECTS TREATED WITH
SIMEPREVIR AND SOFOSBUVIR IN
SPECIAL POPULATION
(PSYCHIATRIC). A CLINICAL PILOT
STUDY; INSPIRE C STUDY; INTERIM
RESULTS
P. Basu1, N. J. Shah2, M. M. Aloysius3 and R. S.
Brown Jr4
1Gastroenterology, Chief Division of Hepatology, Kings
County Medical Center SUNY Downstate, New York
City, NY, USA; 2Internal Medicine, James J. Peters VA
Medical Center, Icahn School of Medicine at Mount
Sinai NY, New York City, NY, USA; 3Internal
Medicine, King’s County Hospital Medical Center NY,
New York City, NY, USA; 4Gastroenterology, College
of Physicians and Surgeons, Columbia University, New
York City, NY, USA
Objectives: Chronic hepatitis C (CHC) is no longer a
challenging clinical state with newer DAA’s achieving
SVR within a shorter duration of therapy. Interferon is
contraindicated in psychiatric population (Schizo-
phrenic. major depression, bipolar and schizoaffective
disorder). These population have a majority of co mor-
bidities, substance abuse and advanced fibrosis along
with a poor QOL score.
Methods: Sixty CHC subjects [n = 60, schizophrenia
20/60 (33.3%), major depression 15/60 (25%), bipolar
disorder 20/60 (33.3%) and prior suicidal attempts with
depression 5/60 (8.3%).
GROUP A: (n = 20): Simeprevir 150 mg + Sofosbuvir
400 mg + Ribavirin 1000 mg daily.
GROUP B: (n = 20); Placebo + Sofosbuvir
400 mg + Ribavirin 1000 mg daily.
GROUP C: (n = 20); Simeprevir 150 mg + Sofosbuvir
400 mg + Vitamin D 5000 mg daily.
Laboratory analysis: HCV RNA viral load, CBC with
ANC: Day 0 and 2 day, 1, 4, 8 and 12th week, TFT,
haptoglobin, coombs test, renal function, liver function
test: 14th, 30th, 40th, 60th, 90th day], Q89k polymor-
phism in 90 days, Fibroscan and serum fibrosis mark-
ers.
Results:
Group A
(n = 20)
Group B
(n = 20)
Group C
(n = 20)
Undetectable
48 h 15 13 15
1 week 23 21 25
2 weeks 28 24 25
4 weeks 29 25 27
8 weeks 29 26 27
12 weeks 29 26 27
Retention 29/30, 96.7% (One had
acute gastroenteritis
with dehydration)
29/30, 96.7% (one
dropped due to
severe headache,
r/o meningitis)
100%
Conclusion: Oral combination therapy for Interferon
ineligible group shows similar 12 weeks eradication
rates with better tolerability and safety profile. This
special population should be treated with this regiment
to prevent cirrhosis and HCC.
APHPB-0077
SIMEPREVIR AND SOFOSBUVIR WITH
MODIFIED DOSES OF RIBAVIRIN ON
TELAPREVIR EXPERIENCED CO-
INFECTED (WITH HIV) CIRRHOTICS
WITH CHRONIC HEPATITIS C, STOP C
TRIAL; INTERIM RESULTS
P. Basu1, N. J. Shah2, M. M. Aloysius3 and R. S.
Brown Jr4
1Gastroenterology, Chief Division of Hepatology, Kings
County Medical Center SUNY Downstate, New York
City, NY, USA; 2Internal Medicine, James J. Peters VA
Medical Center Icahn School of Medicine at Mount
Sinai NY, New York City, NY, USA; 3Internal
Medicine, King’s County Hospital Medical Center NY,
New York City, NY, USA; 4Gastroenterology, College
of Physicians and Surgeons, Columbia University, New
York City, NY, USA
Objectives: Co-infected cirrhotics (HIV + CHC) are at
a greater risk for rapid decompensation affecting QOL
and have a higher transplant risk burden. Interferon
based therapy entails a longer duration with an
increased susceptibility of infections and marrow sup-
pression warranting use of growth factors and even dis-
continuation of therapy/treatment failure.
Methods: Fifty (n = 50) co-infected (HIV + CHC, non
AIDS) cirrhotics with mean MELD 16, HIV RNA
undetectable, mean CD 4 count 439, Hb 10.7, HCV
RNA 1.7 million copies, mean platelet count 104, albu-
min 2.9 and WBC 4600. 18 genotype 1a and 32 geno-
type 1b. 16 null responders, 12 relapsers while 12
discontinued treatment.
Group A: Simeprevir 150 mg + Sofosbuvir 400 mg +
RBV for 24 weeks.
Group B: Simeprevir 150 mg + Sofosbuvir 400 mg + RBV
1000 mg for 16 weeks.
Results:
GROUP A (n = 22)
Simeprevir
150 mg + Sofosbuvir
400 mg + RBV
GROUP B (n = 28)
Simeprevir
150 mg + Sofosbuvir
400 mg + RBV 1000 mg
Undetectable
48 h 2/22 (9%) 4 log 11/22(50%) 4/28 (14%) 4
log 19/28 (68%)
1 week 3/22 (14%) 6 log 8/22 (36%) 7/28 (25%) 6
log 22/28 (78%)
4 weeks 16/22 (73%) 19/28 (68%)
8 weeks 17/22 (77%) 22/28 (78%)
12 weeks 17/22 (77%) 23/28 (82%)
16 weeks 17/22 (77%) 23/28 (82%)
24 weeks 18/22 (83%)
Conclusion: The combination of Interferon free oral
regimen in special population with prior experienced PI
demonstrated no difference of eradication rates at 16th
week over 24th weeks. This regimen was well tolerated
and has a better safety profile than conventional trials.
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APHPB-0080
INFLUENCE OF RICTOR AND RAPTOR
EXPRESSION OF MTOR SIGNALING
ON LONG-TERM OUTCOMES OF
PATIENTS WITH HEPATOCELLULAR
CARCINOMA
M. Kaibori, M. Ishizaki, H. Iida, K. Matsui,
T. Sakaguchi, H. Matsushima, K. Inoue and M. Kon
Surgery, Kansai Medical University, Hirakata, Japan
Objectives: Aberrant signaling mediated by the mam-
malian target of rapamycin (mTOR) occurs at high fre-
quency in hepatocellular carcinoma (HCC), indicating
that mTOR is a candidate for targeted therapy. mTOR
forms two complexes called mTORC1 (mTOR com-
plexed with raptor) and mTORC2 (mTOR complexed
with rictor). There are no published studies of the
kinetics of expression of mTORC1 and mTORC2 in
HCC.
Methods: We studied 62 patients with HCC who
underwent curative resection. We used univariate and
multivariate analyses to identify factors that potentially
influence disease- and overall-survival after hepatec-
tomy. The levels of mTOR, rictor, and raptor mRNAs
in cancer and noncancer tissues were analyzed using
immunohistochemistry and quantitative RT-PCR.
Results: High ratio of the levels of rictor and raptor
mRNAs in tumors were identified as independent prog-
nostic indicators for disease-free survival. Low and
high levels of preoperative serum albumin and mTOR
mRNA in the tumor, respectively, were identified as
independent indicators of overall survival. HCC is
likely to recur early after hepatic resection in patients
with high levels of mTOR and rictor mRNAs and high
rictor/raptor ratios in cancer tissues.
Conclusion: We conclude that analysis of mTOR
expression in cancer tissues represents an essential strat-
egy to predict HCC recurrence after curative treatment.
APHPB-0081
A PROSPECTIVE RANDOMIZED
STUDY COMPARING
RADIOFREQUENCY ABLATION AND
HEPATIC RESECTION FOR
HEPATOCELLULAR CARCINOMA
H. Lee1, K. Suh2, H. Kim2, Y. Choi2, S. Suh2,
J. Jeong2, N. Yi2 and K. Lee2
1Department of Surgery, Seoul National University
Boramae Medical Center, Seoul, Korea; 2Department of
Surgery, Seoul National University College of Medicine,
Seoul, Korea
Objectives: Radiofrequency ablation (RFA) are known
to be effective and safe to treat small hepatocellular
carcinomas (HCCs). However, it is still unclear whether
RFA is as effective as hepatic resection (HR) for small
HCCs.
Methods: Patients who were newly diagnosed with a
solitary HCC were randomized to the HR and RFA
groups. Inclusion criteria were as follows; age ≥ 20,
≤70 years, Child-Pugh A, a maximal diameter of the
tumor ≥2 m, ≤4 cm, no previous treatment history, and
platelet count > 80,000/mm3.
Results: Twenty-nine and thirty-four patients were
enrolled and prospectively followed in the HR and
RFA groups, respectively, on intention-to-treat (ITT)
basis. The 5-year overall survival rate was 96.6% and
88.8% in the HR and RFA group, not a statistically
significant difference. HCC recurrence developed in 39
patients: 15 patients in the HR and 24 in the RFA
group. The 3- and 5-year disease-free survival rates for
the HR group were significantly superior to those for
the RFA group (65.4%, 42.9% vs. 44.1%, 31.2%,
p = 0.084 by Log Rank, 0.030 by Breslow). Intrahepat-
ic local recurrence tended to develop more frequently
in the RFA group (p = 0.0416), while the frequency of
intrahepatic distant and extrahepatic recurrence was
similar between two groups. There was no significant
difference in the frequency and severity of complication
between two groups.
Conclusion: HR was significantly superior to RFA in
terms of disease-free survival. However, the overall sur-
vival was not different between the two treatment
modalities.
APHPB-0082
COMPARISON OF TWO DIFFERENT
THERMAL TECHNIQUES FOR THE
TREATMENT OF HEPATOCELLULAR
CARCINOMA
X. Jing1, J. Ding1, J. Liu2, Y. Wang1, F. Wang3,
Y. Wang4 and Z. Du4
1Ultrasound, Tianjin Third Central Hospital, Tianjin,
China; 2Radiology, Thomas Jefferson University,
Philadelphia, PA, USA; 3Gastroenterology and
Hepatology, Tianjin Third Central Hospital, Tianjin,
China; 4Hepatobiliary Surgery, Tianjin Third Central
Hospital, Tianjin, China
Objectives: To compare the safety and efficacy of ra-
diofrequency ablation (RFA) and microwave ablation
(MWA) in treating hepatocellular carcinoma (HCC)
while conforming to the Milan Criteria.
Methods: The study was approved by the Institutional
Review Board, and informed consent was waived due
to the retrospective study design. One hundred ninety-
eight patients met the inclusion criteria and were
included in the study. Eighty-five patients with 98
lesions received RFA, and 113 patients with 131 lesions
underwent MWA. Complete ablation rates, local recur-
rence rates, disease-free survival rates, cumulative sur-
vival rates, and major complications were compared
between the two treatment groups.
Results: Complete ablation rates were 99.0% for RFA
and 98.5% for MWA (p = 1.000). Local recurrence
rates were 5.2% for RFA and 10.9% for MWA
(p = 0.127). Disease-free survival rates at 1, 2, 3, and
4 years were 80.3%, 61.8%, 39.5%, and 19.0% in the
RFA group and 75.0%, 59.4%, 32.1%, and 16.1% in
the MWA group, respectively (p = 0.376). Cumulative
survival rates at 1, 2, 3, and 4 years were 98.7%,
92.3%, 82.7%, and 77.8% in the RFA group and
98.0%, 90.7%, 77.6%, and 77.6% in the MWA group,
respectively (p = 0.729). Major complication rates were
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2.4% and 2.7% in the RFA group and the MWA
group, respectively (p = 1.000). There were no patient
deaths due to treatment.
Conclusion: RFA and MWA have the same clinical
value in treating HCC conforming to the Milan crite-
ria. Importantly, treating HCC with MWA is safe and
effective as a clinical application.
APHPB-0084
CLINICAL UTILITY OF PDSS2
EXPRESSION TO STRATIFY PATIENTS
AT RISK FOR RECURRENCE OF
HEPATOCELLULAR CARCINOMA
M. Kanda1, H. Sugimoto1, S. Nomoto1, H. Oya1,
D. Shimizu1, H. Takami1, R. Hashimoto1, Y.
Okamura2, S. Yamada1, T. Fujii1, G. Nakayama1,
M. Koike1, M. Fujiwara1 and Y. Kodera1
1Department of Gastroenterological Surgery (Surgery
II), Nagoya University Graduate School of Medicine,
Nagoya, Japan; 2Department of Hepato-biliary-
pancreatic Surgery, Shizuoka Cancer Center, Shizuoka,
Japan
Objectives: Identification of novel genetic and epige-
netic alterations is required for optimal stratification of
patients with hepatocellular carcinoma (HCC) at risk
for recurrence and adverse prognosis. Coenzyme Q10
(CoQ10), which mediates apoptosis, is synthesized by
prenyl diphosphate synthase subunit 2 (PDSS2). Here
we evaluated the clinical significance and regulatory
mechanisms of PDSS2 expression in HCC.
Methods: PDSS2 expression levels and those of genes
encoding potentially interacting proteins as well as the
methylation status of the PDSS2 promoter region were
analyzed in HCC cell lines. PDSS2 mRNA levels in
151 pairs of resected specimens were determined to
evaluate the association of PDSS2 expression and clini-
copathological factors. The expression and distribution
of PDSS2 were determined using immunohistochemis-
try.
Results: PDSS2 mRNA expression was decreased in
six of nine HCC cell lines and significantly correlated
with those of hepatocyte nuclear factor 4a. PDSS2
transcription in HCC cells with decreased PDSS2
expression accompanying hypermethylation was reacti-
vated after treating these cells with a methylation inhib-
itor. Mean expression levels of PDSS2 mRNA relative
to that of uninvolved liver diminished gradually in the
order of chronic hepatitis to cirrhosis, and each was
significantly higher than those of HCCs. PDSS2 and
PDSS2 mRNA levels were consistent. Decreased
PDSS2 mRNA levels were detected in HCC tissues of
56 patients, correlated with shorter disease-specific sur-
vival, and was identified as an independent prognostic
factor.
Conclusion: PDSS2 is a putative tumor suppressor, and
promoter hypermethylation is a key regulatory mecha-
nism in HCC. Decreased levels of PDSS2 mRNA
expression may represent a novel biomarker of HCC.
APHPB-0085
ABERRANT EXPRESSION OF
MELANOMA-ASSOCIATED ANTIGEN
D-2 SERVES AS A PROGNOSTIC
INDICATOR OF HEPATOCELLULAR
CARCINOMA OUTCOME AFTER
CURATIVE HEPATECTOMY
R. Hashimoto1, M. Kanda1, H. Sugimoto1,
S. Nomoto1, H. Oya1, D. Shimizu1, H. Takami1,
Y. Okamura2, S. Yamada1, T. Fujii1, G. Nakayama1,
M. Koike1, M. Fujiwara1 and Y. Kodera1
1Department of Gastroenterological Surgery (Surgery
II), Nagoya University Graduate School of Medicine,
Nagoya, Japan; 2Department of Hepato-biliary-
pancreatic Surgery, Shizuoka Cancer Center, Shizuoka,
Japan
Objectives: Because the prognosis of patients with
advanced hepatocellular carcinoma (HCC) is dismal,
development of novel molecular targets for diagnosis
and therapy are urgently required. Here we studied the
expression of the gene (MAGE-D2) encoding mela-
noma-associated antigen-D2 (MAGE-D2) to determine
whether it influences the malignant phenotype of HCC
and serves as a marker of prognosis.
Methods: We analyzed the expression of MAGE-D2
mRNA and MAGE-D2 protein in nine HCC cell lines
and 151 pairs of surgical tissues. Expression levels were
evaluated using the quantitative real-time reverse tran-
scription-polymerase chain reaction and immunohisto-
chemistry and were compared with clinicopathological
parameters of the tumors.
Results: A significant difference in the levels of
MAGE-D2 expression was observed between normal
liver and chronic hepatitis tissues but not among those
of chronic hepatitis, cirrhosis, and HCC. The expres-
sion patterns of MAGE-D2 protein were consistent
with those of its mRNA. The expression levels of
MAGE-D2 mRNA in 66 of 151 (44%) patients were
higher in HCC tissues compared with the correspond-
ing noncancerous tissues. Moreover, disease-specific
survival was significantly shorter for patients with
higher levels of MAGE-D2 mRNA expression. Multi-
variate analysis identified increased expression of
MAGE-D2 mRNA as an independent prognostic fac-
tor for disease-specific survival (hazard ratio 2.65, 95%
confidence interval 1.43–4.98, p = 0.002). Increased
expression of MAGE-D2 mRNA was not significantly
associated with other clinicopathological parameters,
including extrahepatic recurrence.
Conclusion: These results suggest that MAGE-D2
mRNA influences tumor progression and may serve as
a prognostic indicator after curative resection. More-
over, MAGE-D2 may provide a target for the therapy
of HCC.
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APHPB-0086
OUTCOME OF SURGERY FOR
AMPULLA OF VATER CANCER:
PERIOPERATIVE PERSISTENT
LYMPHOPENIA AS A PREDICTOR OF
SURVIVAL AND RECURRENCE
S. Mori, M. Shimoda, G. Tanaka, N. Shibuya,
T. Shiraki, Y. Iso, M. Kato and K. Kubota
Department of Gastroenterological Surgery, Dokkyo
Medical University, Tochigi, Japan
Objectives: Recently, a perioperative low absolute lym-
phocyte count (ALC) has been considered a useful
prognostic indicator in several malignancies. The aim
of this study was to investigate the impact of periopera-
tive ALC on outcome in patients after pancreaticoduo-
denectomy (PD) for ampulla of Vater cancer (AVC).
Methods: A total of 50 AVC patients treated between
2000 and 2013 were investigated. Data on perioperative
ALC were obtained on the day before surgery and
2 weeks after surgery. Lymphopenia was defined as
ALC < 1500/lL and perioperative persistent lymphope-
nia (PPL) was defined as the presence of lymphopenia
both pre- and postoperatively.
Results: The 5-year overall survival rate (OSR) and
recurrence rate (RR) were 79.8% and 36.1%, respec-
tively. Recurrence was observed in 16 patients (32%)
and the median period until recurrence was 11 months.
The 5-year OSR and RR in patients with PPL (n = 15)
were significantly worse (55% and 58%) than in the
lymphopenia (+) group (n = 26; 87.5% and 32.6%) and
the lymphopenia () group (n = 9; 100% and 12.5%)
(p = 0.005 and p = 0.008, respectively). Multivariate
analysis showed that PPL and the number of lymph
nodes (LN) with metastasis were significantly associ-
ated with a poorer OSR and a higher RR after PD
(p = 0.010, p = 0.008 and p = 0.004, p < 0.001, respec-
tively).
Conclusion: Perioperative ALC is a useful prognostic
marker in AVC patients. PPL and the number of LN
with metastasis can be used to predict patient survival
and cancer recurrence.
APHPB-0088
THE IMPACT OF TUMOR DISTANCE
FROM THE LIVER SURFACE ON
SURVIVAL AFTER ANATOMICAL-
HEPATECTOMY FOR SOLITARY HCC
LESS THAN 3 CM IN DIAMETER IN
THE RIGHT LOBE
S. Mori, M. Shimoda, T. Shiraki, Y. Iso, M. Kato and
K. Kubota
Department of Gastroenterological Surgery, Dokkyo
Medical University, Tochigi, Japan
Objectives: Anatomical hepatectomy (AH) has been
reported to control minute intrahepatic metastases of
hepatocellular carcinoma (HCC), with consequent sur-
vival benefits. However, the impact of tumor distance
from the liver surface (LS) on the survival benefit of
AH has not well been investigated.
Methods: Ninety-nine patients who underwent curative
resection for solitary HCCs less than 3 cm in diameter
in the right lobe between September 2006 and Decem-
ber 2012 were assigned to two groups on the basis of
tumor distance from the LS measured by computed
tomography: a peripheral group (tumor within 3 cm
from the LS, n = 47) and a central group (tumor
beyond 3 cm from the LS, n = 52).
Results: Overall, AH (n = 59) yielded better 5-year
overall survival (OS) and relapse-free survival (RFS)
than non-AH (n = 40) (81.5% and 50.8% vs. 50.7%
and 21.8%, p = 0.038 and p = 0.037, respectively). In
the peripheral group, there were no significant differ-
ences in 5-year OS and RFS (88.4% and 26.2% vs.
67.6% and 30.2%, p = 0.270 and p = 0.426, respec-
tively) between AH (n = 23) and non-AH (n = 24).
However, in the central group, there were significant
differences in 3-year OS and 2-year RFS (96.6% and
68.6% vs. 50.1% and 40%, p = 0.003 and p = 0.002,
respectively) between AH (n = 36) and non-AH
(n = 16).
Conclusion: Tumor distance from the LS has a signifi-
cant impact on the survival benefit of AH, especially in
patients with centrally located tumors.
APHPB-0089
EVALUATION OF THE SURVIVAL
BENEFIT OF ADJUVANT
CHEMOTHERAPY IN PATIENTS AFTER
RESECTION OF AMPULLA OF VATER
CANCER
S. Mori, M. Shimoda, T. Shiraki, Y. Iso, M. Kato and
K. Kubota
Department of Gastroenterological Surgery, Dokkyo
Medical University, Tochigi, Japan
Objectives: Although adjuvant chemotherapy (AC) has
been shown to have a survival benefit in patients with
pancreatic cancer, no form of AC has yet been estab-
lished for patients with ampulla of Vater cancer
(AVC). The aim of this study was to investigate
whether AC improves survival after pancreaticoduo-
denectomy (PD) for AVC.
Methods: A total of 26 patients with AVC who under-
went PD were enrolled between January 2008 and
October 2013. Overall survival (OS), relapse-free sur-
vival (RFS), and recurrence rate (RR) were then com-
pared between patients with AC [AC (+)] and without
AC [AC (-)].
Results: Overall, the 3-year OS, RFS, and RR were
83.8%, 45.5%, and 51.3%, respectively. Eleven patients
(42%) received gemcitabine, 6 (23%) received gemcita-
bine + cisplatin, 2 (8%) received S-1, and 7 (27%) were
simply observed without further treatment. Ten
patients completed ≥6 cycles of AC. There were no sig-
nificant differences in OS, RFS, and RR between the
AC (+) and AC () groups (p = 0.930, p = 0.740, and
p = 0.864, respectively). In patients who received ≥6
cycles of AC, the 3-year RR tended to be lower than in
the others, but the difference was not significant (40%
vs. 59.1%, p = 0.149).
Conclusion: The use of AC does not affect the survival
of patients after resection of AVC.
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APHPB-0091
EFFCT OF ROWACHOL ON
PREVENTION OF
POSTCHOLECYSTECTOMY PAIN
AFTER LAPAROSCOPIC
CHOLECYSTECTOMY – PROSPECTIVE
MULTICENTER RANDOMIZED
CONTROLLED TRIAL
I. Han1, O. Kwon1, M. Oh1, Y. Choi2 and S. Lee2
1Surgery, Dongguk University Ilsan Hospital, Goyang,
Korea; 2Surgery, Chung-Ang University Hospital, Seoul,
Korea
Objectives: Postcholecystectomy pain (PCP) is charac-
terized by abdominal pain following gallbladder
removal. The purpose of this trial is to determine
whether Rowachol will be useful in the prevention of
PCP after laparoscopic cholecystectomy (LC).
Methods: from 2012 to 2013, this prospective, random-
ized, single blind, placebo-controlled study had bal-
anced random assignment Rowachol and placebo in
Dongguk University Ilsan Hospital, and Chung-Ang
University Hospital. A total of 138 patients were
enrolled and randomized. Rowachol or placebo 100 mg
three times daily was given to each group of patients
for 3 months. Outcomes were assessed in visit over
3 months after surgery with right upper quadrant
(RUQ) pain on European Organization for Research
and Treatment of Cancer QLQ-C30.
Results: There are no differences in aspect of demo-
graphics, preoperative clinical findings, and surgical
findings between each group. Incidence of PCP in pla-
cebo group (n = 9, 14.3%) was higher than that in
Rowachol group (n = 3, 4.7%) with statistically mar-
ginal significance (p = 0.076). After risk factor analysis
for PCP, the patients with PCS showed a higher diffi-
culty score to perform LC, more frequent pathology
with acute cholecystitis, and absence of postoperative
Rowachol treatment compared to those without PCP.
Among these, higher difficulty score to perform LC
(HR = 5.780, 95% CI 1.355- 24.390, p = 0.018), and
Absence of postoperative Rowachol treatment
(HR = 2.537, 95% CI 1.102- 10.386, p = 0.048) were
identified independent risk factors to develop PCP after
multivariate analysis.
Conclusion: Rowachol can be beneficial for prevention
of PCP after LC.
Malignant HPB Diseases
APHPB-0094
LONG-TERM RESULTS AND OUTCOME
PREDICTING FACTORS IN PATIENTS
UNDERGOING MAJOR HEPATIC
RESECTION FOR KLATSKIN TUMOR
W. Otto1, B. Najnigier1, J. Smaga1, J. Sierdzinski2 and
M. Krawczyk1
1General Transplant & Liver Surgery, Medical
University of Warsaw, Warsaw, Poland; 2Medical
Informatics & Telemedicine, Medical University of
Warsaw, Warsaw, Poland
Objectives: Major hepatic resection is regarded as the
potenially curative procedure for patients with Bismuth
III type bile duct carcinoma. The study objective was
to review the results of 10-year prospective evaluation
of patients that were operated with curative intent for
Bismuth III type lesion at 1- and 3-year follow-up.
Methods: A study was conducted in 134 patients with
Bismuth III type of hilar carcinoma treated between
2000 and 2009; 94 (70.1%) were suitable for surgery
and underwent major hepatic resection. The outcome
was evaluated by assessment of patient-tumor clinic-
pathologic factors, completeness of resection and sur-
vival.
Results: Major hepatic redections comprised 62 right
and 32 left hepatectomies. The R0, R1, and R2 resec-
tion was achieved in 40 (42%), 21 (22.3%) and 33
(35.2%), respectively. Operative mortality rate was
9.5%. The 1- and the 3-year survival were 69.1% and
24.5%, respectively. Univariate analysis showed that
unfavorable tumor biology (v2 = 22.7, p < 0.001), in-
completness of resection (v2 = 43.0, p < 0.001) and the
presence of post-operative complications (v2 = 61.0,
p < 0.001) were associated with patient’s survival. Mul-
tivariate analysis (Wald test) indicated tumor UICC
stage, incompletness in tumor resection and the pres-
ence of serious post-operative complications as the out-
come prognostic factors (W = 10.37, p < 0.006,
W = 4.45, p < 0.003, W = 7.9, p < 0.001, respectively).
Conclusion: A tumor-free margin is of great concern in
major hepatectomy for Bismuth III type of hilar carci-
noma. The stage of tumor development and imperfec-
tion of surgical procedure hinder from gaining the
desired oncologic extension.
APHPB-0096
AMYLASE LEVEL OF PANCREATIC
JUICE AFTER
PANCREATICODUODENECTOMY
PREDICTS POSTOPERATIVE
PANCREATIC FISTULA
K. Furukawa, T. Gocho, T. Horiuchi, Y. Shirai,
R. Iwase, K. Haruki, Y. Fujiwara, H. Shiba, T.
Misawa and K. Yanaga
Surgery, Jikei University School of Medicine, Tokyo,
Japan
Objectives: Postoperative pancreatic fistula (PF) after
pancreaticoduodenectomy (PD) is one of the most fre-
quent life-threatening complications. The aim of this
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study is to evaluate the significance of pancreatic
amylase level of pancreatic juice for PF after PD.
Methods: The subjects were 63 patients who underwent
PD between January 2012 and August 2014 at Jikei
University Hospital. We retrospectively investigated the
relation between patient characteristics including pan-
creatic amylase level of pancreatic juice through the
pancreatic drainage tube and the incidence of PF
(grade B or C according to the International Study
Group on the Pancreatic Fistula) using univariate and
multivariate analyses. Ratio of pancreatic amylase level
in pancreatic juice was represented as those at POD
1/3, 1/5, 3/5, or 3/7 ratio.
Results: In univariate analysis, non-ductal adenocarci-
noma (p = 0.0294), soft pancreatic remnant
(p = 0.0147), serum CRP ³ 5 mg/dL (p = 0.015) and
ratio of pancreatic amylase level in pancreatic juice
<0.2 (p = 0.0085) were significant predictors of the inci-
dence of PF. In multivariate analysis, ratio of pancre-
atic amylase level in pancreatic juice <0.2 (p = 0.0428)
was the only significant independent parameter.
Conclusion: Change in pancreatic amylase level of pan-
creatic juice can predict postoperative PF after PD.
APHPB-0097
THE INTERMITTENT PRINGLE
MANEUVER IS UNLIKELY TO INDUCE
BACTERIAL TRANSLOCATION TO THE
PORTAL VEIN: A STUDY USING
BACTERIUM-SPECIFIC RIBOSOMAL
RNA-TARGETED RT-PCR
N. Yamaguchi, Y. Yokoyama, T. Ebata, T. Igami, G.
Sugawara, T. Mizuno, J. Yamaguchi and M. Nagino
Division of Surgical Oncology, Department of Surgery,
Nagoya University Graduate School of Medicine,
Nagoya, Japan
Objectives: The Pringle maneuver is often used to mini-
mize bleeding during liver surgery. However, this tech-
nique blocks the mesenteric venous drainage and
increases the pressure in the microvascular network of
the intestine, which may induce bacterial translocation
(BT). The occurrence of BT to the mesenteric lymph
nodes following the Pringle maneuver is well estab-
lished; however, BT to the portal circulation remains
unclear. The aim of this study was to evaluate using a
very sensitive method whether the Pringle maneuver
truly induces BT to the portal vein, and to review the
safety of the Pringle maneuver.
Methods: Portal blood of patients with hilar malig-
nancy who underwent hepatobiliary resection was sam-
pled 3 times during surgery: immediately after
laparotomy (PV-1); before liver transection (PV-2); and
after liver transection (PV-3). The samples were ana-
lyzed for microbes with a bacterium-specific ribosomal
RNA-targeted reverse transcription-PCR method.
Results: Fifty patients were enrolled in the study, with
a mean total Pringle time of 86 min. Microbes were
detected in 11 (22%) of the 50 patients. The occurrence
of microbes was not different among the PV-1
(8% = 4/50), PV-2 (14% = 7/50), and PV-3 samples
(14% = 7/50) (p = 0.567). The positivity of the PV-3
samples showed no correlation with the total Pringle
time or with the occurrence of postoperative complica-
tions. The total Pringle time did not affect the surgical
outcomes, including infectious complications, liver fail-
ure, or mortality.
Conclusion: The intermittent Pringle maneuver is unli-
kely to induce BT to the portal circulation and is safe,
even in difficult hepatobiliary resections requiring long
clamping times.
APHPB-0098
THE IMAGING FEATURES IN
ULTRASONOGRAPHY OF
CHOLANGIOLOCELLULAR
CARCINOMA: CORRELATION WITH
PATHOLOGICAL FINDINGS
A. Deguchi1, H. Nagamatsu2, J. Akiba3 and
T. Masaki4
1Division of Gastroenterology, Kagawa Rosai Hospital,
Kagawa, Japan; 2Division of Internal Medicine, Yame
Republic Hospital, Fukuoka, Japan; 3Department of
Pathology, Kurume University School of Medicine,
Fukuoka, Japan; 4Department of Gastroenterology and
Neurology, Kagawa University School of Medicine,
Kagawa, Japan
Objectives: Cholangiolocellular carcinoma (CoCC) is
rare primary liver cancer and currently considered to
originate from hepatic progenitor cells. The purpose of
this study was to evaluate the imaging features in ultra-
sonography of cholangiolocellular carcinoma of the
liver.
Methods: Five cases of surgically resected cases of
CoCC from 2 institutions were retrospectively evalu-
ated. All of the five patients underwent contrast-
enhanced ultrasonography (CEUS), dynamic CT, Gd-
EOB-DTPA MRI and angio-CT including CT during
arterioportography (CTAP) and CT during hepatic
arteriography (CTHA). Histological evaluation was
also performed and was correlated with imaging find-
ings.
Results: In the early vascular phase of CEUS, the
lesions presented diffuse and homogeneous enhance-
ment in 2 cases with less than 2 cm in tumor diameter,
but in 3 cases with lager than 2 cm, the lesions pre-
sented heterogeneous enhancement. In the late vascular
phase, all the lesions became progressively hypoechoic
relative to the adjacent liver parenchyma, but in 3 cases
with lager than 2 cm, peripheral enhancement was
observed simultaneously. In Kupffer phase, all the
lesions showed contrast defects with unclear border.
From the late vascular phase to Kupffer phase, the
continued existence of portal veins or tiny spots of por-
tal flow was identified in the tumors.
Conclusion: CoCC tumors have the dual imaging char-
acteristics of hepatocellular carcinoma and cholangio-
carcinoma. The absence of a fibrous capsule, the
absence of tumor necrosis and the presence of portal
venous penetration within the tumor also appear to be
characteristic features in CEUS.
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APHPB-0099
MOLECULAR MECHANISM OF
ACTIVIN A SIGNALING PATHWAY IN
EMT-MEDIATED HEPATIC CANCER
STEM CELLS INVASION AND
METASTASIS
D. Han-hua, X. Shuai, L. Hui-Fang, L. Chang-Hai
and C. Xiao-Ping
Hepatic Surgery Center, Tongji Hospital, Wuhan, China
Objectives: The existence of cancer stem cells are con-
sidered to be the source of tumor invasion and metasta-
sis. Recent studies suggest the existence of cancer stem
cells in hepatocellular carcinoma (HCC). Our previous
experiment found Activin A expression level increasing
both in early and advanced HCC, So we want to prove
whether Activin A mediate hepatic cancer stem cells
(HCSCs) in HCC invasion and metastasis.
Methods: We use human HCC samples, CD90+ and
EpCAM + SP cell sorting method to sorting HCSCs,
culture, identification and passaged HCSCs. By way of
molecular and biology method of overexpress or
knockdown Activin A receptors and Smad protein
expression in HCSCs, we detect the changes of Activin
A signaling pathway and EMT markers, and prolifera-
tion, invasion and metastasis of HCSCs.
Results: We have established CD90+ Ep-
CAM + HCSCs successfully, and we found Activin A
can inhibit the proliferation of hepatocyes through
Smad signaling pathway, but Activin A can promote
HCSCs proliferation, invasion and metastasis through
EMT, by down regulating the expression of E-cadherin,
up regulation of the expression of N-cadherin in
HCSCs.
Conclusion: Human HCC has CD90+ Ep-
CAM + HCSCs. Activin A may be one of the impor-
tant negative regulatory factors in early HCC, but it
promotes HCSCs occurrence of EMT resulting in
tumor invasion and metastasis in advanced HCC.
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APHPB-0101
TAILORED APPROACH TO
MINIMALLY INVASIVE
NECROSECTOMY FOR NECROTISING
PANCREATITIS BASED ON CT
ABDOMEN
S. Wani, R. Patankar and S. K. Mathur
G.I. and HPB Surgery, Joy Hospital, Chembur,
Mumbai, India
Objectives: Conventional open surgery for infected
pancreatic necrosis is associated with significant surgi-
cal morbidity i.e. wound complications, fascial dehis-
cence and intestinal fistulae. In recent years there has
been attempt to reduce this surgical morbidity by
adopting a number of minimally invasive approaches.
Pancreatic protocol CT scan abdomen plays an inde-
spensible role in planning the approach to necrosecto-
my.
Methods: We demonstrate 40 patients with severe acute
necrotizing pancreatitis – 25 male, 15 female between
age group 25–64 years with mean age 46 years. They
underwent pancreatic protocol CT abdomen followed
by minimally invasive pancreatic necrosectomy. 25
patients underwent pancreatic necrosectomy by laparo-
scopic transperitoneal approach (transmesocolic – 11
patients, transgastrocolic – 12 patients and gastrohepat-
ic omentum – 2 patients), 10 patients by Retroperito-
neal approach and 4 patients underwent a combination
of methods –sinus tract endoscopy over preplaced pig-
tail catheters and 1 patient underwent endoscopic
transgastric drainage followed by Laparoscopic intra-
cavity necrosectomy. Relook laparoscopy was done in
7 patients to assess for residual necrosis.
Results: All patients tolerated procedure well, there
was no mortality. 4 had pancreatic fistula which
responded to conservative treatment. 3 were converted
to open necrosectomy because of bleeding or difficulty
to access the area of necrosis. The mean operating time
was 120  30 min. There were no postoperative com-
plications related to procedure itself, such as major
wound infections, intestinal fistulae, or postoperative
hemorrhage.Mean length of hospital stay after surgery
was 14 days.
Conclusion: CT anatomy guided necrosectomy allows
planning prior to necrosectomy, lesser failure rates and
conversion and low morbidity.
APHPB-0102
SURGICAL TREATMENT OF HEPATIC
ALVEOLAR ECHINOCOCCOSIS:
OUTCOMES AND PROGNOSIS
N. Halkic, G. R. Joliat, E. Melloul, E. Uldry,
D. Petermann and N. Demartines
Department of Visceral Surgery, University Hospital
CHUV, Lausanne, Switzerland
Objectives: Alveolar echinococcosis is an uncommon
parasitosis principally found in the Northern hemi-
sphere. Incidence of alveolar echinococcosis is low, and
studies focusing on surgical procedure outcomes are
scarce. The aim of this study was thus to assess the
postoperative short- and long-term outcomes of
patients with alveolar echinococcosis treated by liver
resection (LR) in a single tertiary referral center.
Methods: We retrospectively analyzed all consecutive
patients suffering from liver alveolar echinococcosis
and treated with surgery at our institution between Jan-
uary 1992 and December 2013. Demographic, intraop-
erative data, types of liver resection, postoperative
outcomes, and negative histological margin (R0) resec-
tion rate were recorded. The surgical approach was
based on the localization of lesions, and further treat-
ments combined medical, endoscopic, or radiological
interventions as necessary.
Results: Curative hepatectomies (56 cases) and pallia-
tive surgical procedures (3 cases) were performed in 59
patients with alveolar echinococcosis. Eight patients
had metastasis and 39 were symptomatic at diagnosis.
Postoperative morbidity was 34%, and two deaths
occurred. Recurrences appeared in 8 cases (14%).
Among them 7 had a positive histological margin (R1)
resection. R0 resection rate was 71% (42 patients), and
R1 resection rate was 29% (17 patients). In case of R1
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resections long-term albendazole treatment stabilized
the disease in 10 patients. Overall survival rate was
97%.
Conclusion: Curative surgery for alveolar echinococco-
sis is feasible when a R0 resection is possible and no
metastasis is found at diagnosis. Albendazole therapy is
effective as a parasitostatic agent after R1 resections.
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APHPB-0103
USEFULNESS OF SERUM DUKE
PANCREATIC MONOCLONAL
ANTIGEN TYPE 2 (DUPAN-2) IN
PANCREATIC CANCER WITH NORMAL
LEVEL OF PRETREATMENT SERUM
CARBOHYDRATE ANTIGEN 19-9 (CA19-
9)
M. Mizuma, F. Motoi, T. Okada, K. Nakagawa,
H. Hayashi, T. Morikawa, H. Yoshida, T. Naito,
Y. Katayose and M. Unno
Surgery, Tohoku University, Sendai, Japan
Objectives: Serum Duke pancreatic monoclonal antigen
type 2 (DUPAN-2) is one of several tumor markers for
pancreatic cancer and independent of the Lewis anti-
gen, while Carbohydrate antigen 19-9 (CA19-9), one of
the most common markers for pancreatic cancer, is not
expressed in patients without the Lewis antigen. The
aim of this study is to elucidate clinical benefit of
serum DUPAN-2 in pancreatic cancer with normal
level of pretreatment serum CA19-9.
Methods: From 2002 to 2012, 263 consecutive cases of
pancreatic cancer who underwent surgical resection at
our institute were retrospectively investigated. In this
cohort, 60 cases showed normal level of pretreatment
serum CA19-9, who were divided into the two groups
according to pretreatment serum DUPAN-2 level (DU-
PAN-2 high and DUPAN-2 normal). Clinicopathologi-
cal features and prognosis were evaluated between the
groups.
Results: DUPAN-2 high and DUPAN-2 normal con-
sisted of 26 cases (43.3%) and 34 cases (56.7%), respec-
tively. In histopathological grading, DUPAN-2 High
included higher grade than DUPAN-2 normal, showing
significant difference (p = 0.0108). Median survival time
and 2-year overall survival rate in DUPAN-2 high and
DUPAN-2 normal were 16.0 months and 36.6%, and
22.7 months and 68.9%, respectively. DUPAN-2 High
showed significantly poorer prognosis than DUPAN-2
normal (p = 0.0029).
Conclusion: In pancreatic cancer patients with normal
level of pretreatment serum CA19-9, high level of pre-
treatment serum DUPAN-2 is related to poor progno-
sis. DUPAN-2 should be measured in the clinical
setting for pancreatic cancer, especially normal level of
pretreatment serum CA19-9.
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REAPPRAISAL OF SHUNT SURGERY
FOR EXTRAHEPATIC PORTAL VEIN
OBSTRUCTION IN ADULTS: REPORT
OF A SINGLE CENTER CASE SERIES
T. Kokudo1, E. Bonnard2, M. Gillet2, N. Kokudo1 and
N. Halkic2
1Department of Surgery, Graduate School of Medicine,
The University of Tokyo, Tokyo, Japan; 2Department of
Visceral Surgery, Centre Hospitalier Universitaire
Vaudois, Lausanne, Switzerland
Objectives: Extra-hepatic portal venous obstruction
(EHPVO) is a disease relatively rare in adults. The clin-
ical significance of shunt surgery for EHPVO in adult
cases remains unclear.
Methods: We retrospectively analysed patient charac-
teristics and the results of shunt surgery in 13 adult
cases of EHPVO treated between March 1995 and
March 2013 in a tertiary care Swiss hospital. The indi-
cation of shunt surgery was recurrent bleeding after
endoscopic treatment. To update outcomes of shunt
surgery in adult cases of EHPVO, we performed a liter-
ature review on this issue.
Results: The mean age of the 13 patients treated was
41.8 years old (range 20–68) and the mean follow-up
duration after surgery was 4.4 years (range 1–16). The
types of shunt surgery performed were mesocaval shunt
(n = 7), portocaval shunt (n = 2), mesospermatic shunt
(n = 1), splenorenal shunt (n = 1), and mesorenal shunt
(n = 2). Two patients (15%) developed postoperative
rebleeding. No patient developed postoperative hepatic
encephalopathy. There was no case of death related to
the operative procedures. Five studies, including our
own, were identified in the literature. The overall mor-
tality rate was 0%–3.7%, and no encephalopathy was
observed among the total of 239 cases in these five case
series. The rebleeding rate ranged from 2.5% to 15%.
Conclusion: Shunt surgery for EHPVO in adults after
failure of endoscopic treatment is feasible, with accept-
able outcomes in specialised centres. This surgical pro-
cedure should always be taken into consideration while
managing adult cases of EHPVO.
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APHPB-0107
NUCLEOT(S)IDE ANALOGUES FOR
HEPATITIS B VIRUS-RELATED
HEPATOCELLULAR CARCINOMA
AFTER CURATIVE TREATMENT: A
SYSTEMATIC REVIEW AND META-
ANALYSIS
P. Sun, X. Dong, X. Cheng, Q. Hu and Q. Zheng
Hepatobiliary Surgery Centre, Union Hospital, Tongji
Medical College, Huazhong University of Science and
Techn, Wuhan, China
Objectives: The benefit of nucleot(s)ide analogues
(NA) for hepatitis B virus (HBV)-related hepatocellular
carcinoma (HCC) after curative treatment has been
widely debated due to the relatively weak evidence.
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The objective of this systematic review was to evaluate
the effect of NA on recurrence and survival after cura-
tive treatment of HBV-HCC.
Methods: A systematic electronic search was performed.
All controlled trials comparing NA versus placebo or
no treatment were considered for inclusion. Results
were expressed as Hazard Ratio for recurrence and
survival with 95% confidence intervals using RevMan
5.2.
Results: We included 13 trials with 6350 patients.
There were significant improvements for recurrence-free
survival (HR 0.66, 95% CI 0.54–0.80; p < 0.0001) and
overall survival (HR 0.56, 95% CI 0.43–0.73;
p < 0.0001) in the adjuvant NA group compared with
the control group. Sensitivity analyses confirmed the
robustness of the results. There were no serious adverse
effects being reported. Lamivudine resistance was from
28.6% to 37.5% but could be rescued by other types of
NA or combination therapy.
Conclusion: Our study suggested benefits of adjuvant
NA therapy following curative treatment of HBV-
HCC. Since the great proven efficacy of NA in improv-
ing clinical and viral parameters besides HCC, further
studies should be focused on broadening the indications
for NA therapy after curative treatment of HBV-HCC.
APHPB-0108
CLINICOPATHOLOGICAL FEATURES
OF HEPATIC RESECTION FOR
HEPATOCELLULAR CARCINOMA IN
ELDERLY PATIENTS
H. Iida, M. Kaibori, M. Ishizaki, K. Matsui and
M. Kwon
Surgery, Kansai Medical University, Hirakata, Japan
Objectives: The number of elderly patients undergoing
hepatic resection for hepatocellular carcinoma (HCC)
has significantly increased along with aging of the pop-
ulation. We aimed to clarify the clinicopathological fea-
tures of hepatic resection for HCCs in elderly patients.
Methods: Between January 1992 and December 2013,
we resected 794 cases of HCCs. We divided them into
3 groups, 652 cases of patients under 74 years old
(Non-elderly group), 94 cases of patients 75–79 years
old (Elderly group), and 48 cases of patients over
80 years old (Super elderly group). We compared the
clinicopathological factors, among the groups.
Results: The numbers of HBV antigen and HCV anti-
body negative patients in the super elderly group were
significantly larger than in the elderly and non-elderly
group. The hepatic function reserve including platelet
count, total bilirubin, PT activity and cholinesterase
were better in the elderly and super elderly groups than
in the non-elderly group. Postoperative complications
and hospital stay were similar among the groups. How-
ever, postoperative delirium in the elderly and super
elderly groups was significantly more frequent than in
the non-elderly group. The recurrence free and over-all
survival rates did not significantly differ among the
groups. In multivariate analysis, postoperative morbid-
ity was one of the independent factors of survival in
the elderly and super elderly groups.
Conclusion: We conclude that hepatic resection for
HCC is feasible in elderly patients. However, we have
to perform the operation more carefully than with non-
elderly patients because postoperative morbidity influ-
ences the prognosis of elderly patients.
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THE MEAN PLATELET VOLUME/
PLATELET COUNT RATIO IS A
POTENTIAL BIOMARKER OF LIVER
CIRRHOSIS PREDICTION
H. Iida, M. Kaibori, M. Ishizaki, K. Matsui and
M. Kwon
Surgery, Kansai Medical University, Hirakata, Japan
Objectives: The standard method of diagnosing liver
cirrhosis is liver biopsy. There are several studies that
have investigated biomarkers of cirrhosis prediction
because liver biopsy is an invasive procedure. Our aim
was to provide a simple biomarker of liver cirrhosis
prediction
Methods: Between January 2006 and December 2012,
we investigated 294 cases of resected specimens for
hepatocellular carcinoma. We divided them into 101
cases with liver cirrhosis (LC group) and 193 cases
without liver cirrhosis (Non-LC group) based on path-
ological findings. Several parameters regarding hepatic
function reserve were compared between the groups.
Results: There were significant differences between the
LC group and Non-LC group in prothrombin activity
(PT), AST, ALT, total bilirubin, albumin, cholinester-
ase, type 4 collagen, hyaluronic acid, indocianine green
retention rate at 15 min (ICGR 15), maximal removal
rate of Tc-GSA (GSA-Rmax) and platelet volume /
platelet count ratio (MPV/PLT). In multivariate analy-
sis, the independent factors of liver cirrhosis prediction
were PT, AST, ALT, total bilirubin, hyaluronic acid
and MPV/PLT. The AUC value of MPV/PLT was 0.78
by the most accurate test of them. The cut off value of
MPV/PLT was 0.71 with a sensitivity of 72% and spec-
ificity of 70%.
Conclusion: The MPV/PLT ratio can only be measured
by a complete blood count (CBC) test. We suggest that
the MPV/PLT ratio becomes simple biomarker of pre-
dicting liver cirrhosis.
APHPB-0111
PANCREATIC PSEUDOCYSTS
LOCATED IN THE SPLEEN AND THE
LIVER: DIAGNOSTICS AND
MINIMALLY INVASIVE TREATMENT
Y. Stepanova1, O. Melekhina1, O. Zhavoronkova1 and
D. Ionkin2
1Radiology Diagnosis and Treatment, A.V. Vishnevsky
Institute of Surgery, Moscow, Russia; 2Abdominal
Surgery, A.V. Vishnevsky Institute of Surgery, Moscow,
Russia
Objectives: To analyse the experience of diagnostics
and treatment of pancreatic pseudocysts (PP) located in
spleen and liver.
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Methods: 37 patients with PP located in spleen – 33
(89.2%) and liver – 4 (10.8%) were estimated (ultra-
sound, CT or/and MRI) and treated (1985–2014). Men
prevailed (83.8%), average age – 45  7 years.
Results: Ultrasound, CT or/and MRI, besides charac-
teristics of PP of spleen/liver, allowed to define mani-
festations of pancreatitis and its prevalence also, that
was important criteria in definition of treatment tactics
of these patients.
Pus-like contents was in 85.0% among pseudocysts of
spleen location. External drainage under US-control, as
the only medical manual, is executed to 10 (30.3%)
patients, distal resection with splenectomy against cal-
culous pancreatitis with primary damage of the pan-
creas tail executed to 23 (69.7%) cases.
Pseudocysts of liver location were complicated by sup-
puration in 100% and underwent external drainage
under US-control with evacuation and the subsequent
fractional or flowing sanitation that was a final type of
treatment.
High level of amylase was revealed in pseudocysts con-
tents in all cases of minimally ivasive treatment.
Conclusion: PP located in spleen/liver come to light not
at once more often as their clinical manifestations mask
manifestations of the main disease – pancreatitis. Ultra-
sound, CT or/and MRI, allows to estimate a condition
of the patient and define treatment tactics.
Using of the external minimally invasive manuals under
US-control allows to improve the results of treatment
at this group of patients as preoperative sanitation, and
also as a final type of treatment, in an optimum case.
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APHPB-0112
DIFFERENTIAL RADIOLOGY
DIAGNOSTICS OF METASTASISES OF
RENAL CELL CARCINOMA IN THE
PANCREAS
Y. Stepanova1, N. Vetsheva1, G. Karmazanovsky1,
A. Krieger2 and A. Teplov3
1Radiology Diagnosis and Treatment, A.V. Vishnevsky
Institute of Surgery, Moscow, Russia; 2Abdominal
Surgery, A.V. Vishnevsky Institute of Surgery, Moscow,
Russia; 3Urology, A.V. Vishnevsky Institute of Surgery,
Moscow, Russia
Objectives: Metastatic lesion of the pancreas is an
extremely rare disease, which occupies 2–5% of all pan-
creatic tumors, and these figures rise to 11% according
to autopsies of patients with malignant tumors. Meta-
static lesion of the pancreas from primary renal cancer
occurs most often (65–74%). The objective of the study
was to show the possibilities and difficulties of differen-
tial radiology diagnostics of metastasises of renal cell
carcinoma in the pancreas.
Methods: 7 patients with histologically confirmed diag-
nosis – metastatic renal cell cancer in the pancreas were
treated in the period from 2009 to 2014 in A.V. Vish-
nevsky Institute of Surgery. Nephrectomy in history
was performed in 4 (57.1%) patients in the period from
4 to 16 years. Tumor of the left kidney in conjunction
with metastatic pancreatic cancer was detected in 3
(42.9%) patients.
Results: Solitary metastases were detected in 5 (71.4%)
patients. Tumors were located in the head of the pan-
creas in 3 patients, in the body – in 2. Multiple multifo-
cal lesion of the pancreas was in 2 (28.6%) patients.
Dimensions secondary structures ranged from 10 mm
to 56 mm.
The most informative diagnostic method in detecting of
focal lesions of the pancreas is computed tomography
with bolus contrast enhancement. Significant difficulties
for interpretation are small tumors that are similar in
structure to hormonally active neuroendocrine neo-
plasm.
Conclusion: Revealed solitary or multiple focal disease
of the pancreas in patients after nephrectomy for renal
cell carcinoma should be regarded primarily as second-
ary.
APHPB-0113
TRANSARTERIAL (CHEMO)
EMBOLIZATION FOR CURATIVE
RESECTION OF HEPATOCELLULAR
CARCINOMA: A SYSTEMATIC REVIEW
AND META-ANALYSES
X. Cheng and P. I. N. G. Sun
Hepatobiliary Surgery Center, Union Hospital, Tongji
Medical College, Huazhong University of Science and
Techn, Wuhan, China
Objectives: To assess the beneficial and harmful effects
of transarterial embolization (TAE) or transarterial
chemoembolization (TACE) for curative resection of
hepatocellular carcinoma (HCC).
Methods: The authors conducted an extensive search
of studies on this strategy. All randomized controlled
trials comparing TACE or TAE plus operation versus
operation only were considered for inclusion, regardless
of blinding, language, or publication status. Results
were performed with disease-free survival (DFS) and
overall survival (OS) as the primary endpoint. Tumor
response and adverse events were secondary endpoints.
Results: A total of 10 studies involving 909 HCC par-
ticipants finally fulfilled the predefined inclusion crite-
ria. Four trials assessed preoperative TACE versus
control and six trials assessed postoperative TACE ver-
sus control. There were significant improvements for
DFS [HR 0.62 (95%CI 0.49–0.79)] and OS [HR 0.60
(0.46–0.79)] in the postoperative TACE compared with
the control when the mean tumor size was bigger than
5 cm. However, preoperative TACE did not improve
DFS [HR 0.92 (0.71–1.20)] and OS [HR 1.07 (0.78–
1.46)] for curative resection of HCC. Substantial differ-
ences in criteria for assessing tumor response did not
allow quantitative analyses. Fever (26.7–85.9%),
abdominal pain (19.3–71.2%), and nausea/vomiting
(27.4–66.3%) were common adverse events. Relatively
rare but more serious complications were also reported.
Conclusion: Postoperative TACE offers potential bene-
fits for curative resection of HCC when the mean
tumor size is bigger than 5 cm.
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APHPB-0114
THE EFFICIENCY OF NEOADJUVANT
THERAPY FOR BORDERLINE
RESECTABLE PANCREATIC CANCER
WITH ARTERY INVOLVEMENT
S. Hirono, M. Kawai, K. Okada, M. Miyazawa, A.
Shimizu, Y. Kitahata, M. Ueno, S. Hayami, S.
Yamaguchi and H. Yamaue
Second Department of Surgery, Wakayama Medical
University, Wakayama, Japan
Objectives: It has been still controversial to perform
surgical resection with borderline resectable pancreatic
cancer with artery involvement (BR-A), because an
aggressive surgery leads to high morbidity and mortal-
ity with low R0 rate for the BR-A patients. In this
study, we evaluated whether or not neoadjuvant ther-
apy followed by surgical resection improves survival
benefits for BR-A patients.
Methods: There were 138 patients with BR-A among
330 pancreatic cancer patients underwent surgical
resection at Wakayama Medical University Hospital.
We compared clinicopathological factors between 38
BR-A patients with neoadjuvant therapy followed by
surgical resection and 100 BR-A patients with upfront
surgery to evaluate the clinical impacts of neoadjuvant
therapy.
Results: The overall survival (OS) of BR-A patients
was significantly shorter than that of the patients with
borderline resectbale pancreatic cancer with portal vein/
superior mesenteric vein (PV/SMV) involvement
(n = 76) and resectable pancreatic cancer (n = 105)
who underwent surgical resection (median OS: 13.6 vs.
20.6 months, p < 0.001). The OS of BR-A patient with
neoadjuvant therapy followed by surgical resection was
significantly longer than those with upfront surgery
(median OS: 20.2 vs. 12.9 months, p = 0.047). Multi-
variate analysis showed that older age (p = 0.027),
pathological PV/SMV invasion (p = 0.031), moderated
or poor differentiated tumor (p = 0.008), positive
lymph node ratio ?0.1 (p = 0.018), and no postopera-
tive adjuvant chemotherapy (p < 0.001) were indepen-
dent poor prognostic factors for BR-A patients.
Conclusion: Neoadjuvant treatment might bring the
clinical benefits for BR-A patients, and it is important
to develop the appropriate regimen of neoadjuvant
therapy and postoperative adjuvant therapy for longer
survival in BR-A patients.
APHPB-0115
TRANSTHORACIC THORACOSCOPIC
METASTASECTOMY FOR
SUBDIAPHRAGMATIC METASTASES
OF HCC
I. S. Choi, J. S. Byun, J. I. Moon, W. J. Choi, Y. M.
Ra, S. E. Lee and J. S. Lee
General Surgery, Konyang University Hospital, Daejeon
City, Korea
Objectives: Post-operative recurrences are major deter-
minants of survival for patients who have undergone
curative resection of hepatocellular carcinoma. If the
recurrent tumors located in segment VII and VIII or
extrahepatic location, such as a subdiaphragm, a
transthoracic transdiaphragmatic approach via thora-
coscopy is feasible. Since the technique has the advan-
tage of better intrathoracic exposure avoiding severe
adhesiolysis, liver mobilization and possible hepatic
congestion. We report a case of extrahepatic metastatic
hepatocellular carcinoma that was successfully resected
by transthoracic thoracoscopic metastasectomy.
Methods: A 68-year-old male patient who has under-
gone posterior sectinectomy with caudate lobectomy
(S1,6,7) and cholecystectomy under a diagnosis of
hepatocellular carcinoma at 3 years ago, was admitted
to our hospital for further evaluation of extrahepatic
metastatic tumor in right subphrenic space during the
routine check-up. On liver dynamic computed tomogra-
phy revealed a well-defined mass of 3.5 cm in diameter,
in right subphrenic space with invading diaphragm and
rt. adrenal gland. The imaging findings suggested an
extrahepatic hepatocellular carcinoma that metastasized
to the diaphragm. LFT was normal and AFP revealed
94.14 ng/mL.
Results: We performed transthoracic thoracoscopic me-
tastasectomy for subdiaphragmatic metastases of HCC
and partial diaphragmatic resection and repair. The
operation time was 3 h 30 min and blood loss was
100 mL. The patient started a diet POD 1 day and dis-
charged POD 11 days due to chest tube. The postoper-
ative course was uneventful, and the patient was
discharged without any complications.
Conclusion: Transthoracic thoracoscopic metastasecto-
my can be feasible even if the recurrent tumors located
in segments VII and VIII or extrahepatic location, such
as a diaphragm.
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TRANSUMBILICAL LAPAROSCOPIC
CHOLECYSTECTOMY: A SINGLE
SURGEON’S EXPERIENCE WITH 291
CASES
J. W. Hwang
Department of Surgery, Hallym University Medical
Center, Chuncheon, Korea
Objectives: Single-port laparoscopic cholecystectomy
may result in more postoperative complication in
patients with cholecystitis compared with conventional
laparoscopic cholecystectomy. Additional right subcos-
tal port could reduce complication rates in these
patients. We suggest the transumbilical laparoscopic
cholecystectomy with an additional port which can be
performed safely regardless of cholecystitis.
Methods: Consecutive 291 patients underwent transum-
bilical laparoscopic cholecystectomy in Department of
Surgery by a single surgeon. Among them, 83 patients
(28.5%) had a cholecystitis from acute cholecystitis to
empyema. We usually have used the globe port in tran-
sumbilical area and additional right subcostal 5 mm
port.
Results: The mean operation time was 44.0  15.2 min
(range: 20–140). The mean hospital stay after operation
was 4.0  2.3 days (range: 1–9). The postoperative
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complications were umbilical hernia (n = 7) and bile
leakage (n = 3). There was no in-hospital mortality.
Conclusion: Transumbilical laparoscopic cholecystec-
tomy can be performed in patients with most of benign
gallbladder disease. And, an additional right subcostal
port could make transumbilical laparoscopic cholecys-
tectomy safe and feasible, even in patients with chole-
cystitis.
APHPB-0117
SURGICAL RESECTION FOR HEPATIC
ANGIOMYOLIPOMA ACCOMPANYING
NECROSIS AND HEMORRHAGE
J. S. Lee, I. S. Choi, J. I. Moon, Y. M. Ra, W. J. Choi
and S. E. Lee
General Surgery, Konyang University Hospital, Daejeon
City, Korea
Objectives: Angiomyolipoma (AML) is a benign mes-
enchymal tumor that is frequently found in the kidney
and, rarely, in the liver. The natural history of hepatic
AML has not been clarified, and some of these tumors
have been overdiagnosed as hepatocellular carcinoma,
hepatic adenoma, or angiosarcoma. We report a case
of hepatic angiomyolipoma accmpanying with necrosis
and hemorrhage that was successfully resected.
Methods: A 59-year-old female patient was accidentally
detected a hepatic tumor in left lateral segment on
2005. The tumor revealed a well-defined mass of mixed
echogenicity, 9.2 cm in diameter, in left lateral segment
and the biopsy was reaveled angiomyolipoma (AML).
In 2014, she complained with epigastric pain, fever,
and general myalgia, and on computed tomography,
the tumor has grown to 15 cm in size and included tu-
moral cystic change, hemorrhage, and necrosis and
extended to segment 4.
Results: We performed laparoscopic assisted left hemi-
hepatectomy. The operation time was 4 h 30 min and
blood loss was 250 mL. The patient started a diet POD
3 day and discharged POD 8 days. The histopathologi-
cal diagnose of the resected specimen was angiomyolip-
oma which consisted of mature lipocytes with
anigomatous and small lymphocytic components, but
no mitotic figures. The tumor showed immnunoreactivi-
ty to smooth muscle antigen (SMA) and homatropine
methylbromide 45 (HMB-45) and no immnuoreactivity
to S100 and AE/E3. The postoperative course was
uneventful, and the patient was discharged without any
complications
Conclusion: Even though hepatic AML shows no pro-
pensity for metastases or malignant potential, hepatic
AML with necrosis and hemorrhage should be treated
with complete surgical resection.
APHPB-0118
RISK FACTORS FOR CONVERSION TO
CONVENTIONAL LAPAROSCOPIC
CHOLECYSTECTOMY IN SINGLE –
INCISION LAPAROSCOPIC
CHOLECYSTECTOMY (SILC)
I. Choi, W. J. Choi, S. E. Lee, Y. M. Ra and
J. I. Moon
General Surgery, Konyang University Hospital, Daejeon
City, Korea
Objectives: Single incision laparoscopic cholecystec-
tomy (SILC) is widely using method in the treatment
of benign gallbladder diseases. However, any definitive
indications and contraindications are not established.
Here we investigate risk factors for conversion to con-
ventional laparoscopic cholecystectomy (conventional
LC) in SILC.
Methods: A total of 697 cases were performed SILC at
Konyang University Hospital, between April 2010 and
July 2014. Nineteen cases (2.7%) of these patients were
undergone conversion to conventional LC. We com-
pared these 2 groups (SILS group versus conversion
group) and analyzed risk factor for conversion to con-
ventional LC.
Results: Our study includes 697 cases with 323 male
and 374 female. 678 cases were SILC and 19 cases
(2.7%) were converted to conventional LC. In univari-
ate analysis, age over 80, ASA score >3, preoperative
PTGBD status and pathologically diagnosis as acute
cholecystitis and GB empyema were significant risk fac-
tors for conversion (p = 0.011, p = 0.003, p = 0.002
and p < 0.001). Conversion rate was relatively higher
in young surgeon than expert surgeon (7.5% vs.
21.1%, p = 0.055) and in BMI over 30 (7.5% vs.
21.1%, p = 0.055). In multivariate analysis, BMI over
30 and pathologically diagnosis as acute cholecystitis
and GB empyema were significant risk factors for con-
version (HR: 4.481, p = 0.021, HR: 4.859 p = 0.007).
Conclusion: Although most of patient with benign gall-
bladder diseases can be applied to SILC, patient with
BMI over 30 and diagnosed as acute cholecystitis and
GB empyema should be considered performing conven-
tional LC rather than SILC.
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GENDER BASED ANALYSIS OF
GALLBLADDER CANCER:
DIFFERENCES IN
CLINICOPATHOLOGICAL
PARAMETERS
V. Gupta, A. Chandra, S. Kumar, H. Hatimi and
R. Rahul
Surgical Gastroenterology, King George Medical
University, Lucknow, India
Objectives: Gallbladder cancer (GBC) predominantly
affects females which may be due to cholelithiasis, sex
hormones, or genetic factors. Objective of this study
was to identify gender-dependent differences in various
clinicopathological parameters.
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Methods: GBC patients admitted to the hospital
between January 2009 and December 2013 were
included in the study while patients managed in out-
door clinic were excluded. Retrospective analysis of 257
patients (males 69, females 188) was performed with
respect to various clinicopathological parameters to
assess gender based differences
Results: At presentation 79.7% patients had abdominal
pain (mean duration 4.65  9.32 months), 54.4% had
jaundice (mean duration 2.07  2.79 months), 27.3%
had metastases and 28.4% had locally advanced unre-
sectable (LAUR) disease. At surgical exploration
(n = 114), 36 had metastatic and 21 had LAUR dis-
ease. Finally 57 (22.1%) underwent curative resection.
With respect to gender (male versus female), no signifi-
cant difference was found in age (mean 52.12  12.55
vs. 49.93  11.73 years, p = 0.19), presence of pain
(77% vs. 81%, p = 0.58) or its duration (mean
5.0  7.0 vs. 4.53  10.05 months, p = 0.78), jaundice
(55% vs. 55%, p = 0.97) or its duration (mean
2.50  4.60 vs. 1.91  1.76 months, p = 0.33), anor-
exia (33% vs. 29%, p = 0.63), weight loss (26% vs.
23%, p = 0.77), gallstones (58% vs. 68%, p = 0.15),
advanced (N1/T4) disease (15% vs. 27%, p = 0.48),
resectability (18% vs. 23%, p = 0.54) and tumor grade
(well vs. moderate/poor, 80% vs. 43%, p = 0.07). Med-
ian survival was 38 months for both sexes with signifi-
cant differences in survival curves (p = 0.03) favoring
females.
Conclusion: GBC behaves similarly in male and female
patients. However, females may have better survival.
APHPB-0120
IS GALLBLADDER CANCER MORE
AGGRESSIVE IN YOUNG PATIENTS?:
AN ANALYSIS OF 257 PATIENTS
V. Gupta, A. Chandra, S. Kumar, R. Rahul and
H. Hatimi
Surgical Gastroenterology, King George Medical
University, Lucknow, India
Objectives: Gallbladder cancer (GBC) is usually diag-
nosed after 60 years of age. Behavior of GBC in young
patients is largely unknown. Objective of study was to
identify age dependent differences in different clinico-
pathological characteristics of GBC.
Methods: This study included GBC patients managed
from January 2009 to December 2013. Young
(≤40 years) patients were compared with patients
>40 years of age with respect to different clinicopatho-
logical parameters.
Results: 257 patients (mean age 50.5 years, 188
females) of GBC were analyzed. At presentation 79.7%
had abdominal pain (mean duration
4.65  9.32 months), 54.4% had jaundice (mean dura-
tion 2.07  2.79 months), 27.3% had metastases and
28.4% had locally advanced unresectable (LAUR) dis-
ease. At exploration (n = 114) 36 patients had meta-
static and 21 had LAUR disease. Finally 57 patients
(22.1%) underwent curative resection.
With respect to age (≤40 vs. >40), no significant differ-
ence was found in sex (females 73.8% vs. 73%,
p = 0.9), presence of pain (81.9% vs. 79%, p = 0.71) or
its duration (mean 4.5  10.7 vs. 4.68  9.04 months,
p = 0.9), jaundice (59% vs. 54%, p = 0.59) or its dura-
tion (mean 2.18  1.66 vs. 2.02  3.04 months,
p = 0.76), anorexia (26.2% vs. 31.6%, p = 0.52), weight
loss (19.7% vs. 21.9%, p = 0.85), gallstones (60.7% vs.
67.3%, p = 0.42), advanced (N1/T4) disease (23.5% vs.
27.5%, p = 1.00) and tumor grade (well versus moder-
ate/poor, 55% vs. 41.3%, p = 0.42).
No significant difference was found in metastatic dis-
ease (47.5% vs. 39.3%, p = 0.99) and resectability
(27.9% vs. 20.4%, p = 0.22). Median survival was
38 months in each group with similar survival curves
(p = 0.7).
Conclusion: GBC doesn’t behave more aggressively in
young patients.
APHPB-0121
SMAD3 REVERSE DRUG RESISTANCE
VIA P38MAPK PATHWAY IN SMMC-
7721 AND BEL-7402 HEPATOCELLULAR
CARCINOMA CELL LINES
L. Chen, H. Zhou, H. Liang, B. Zhang and X. Chen
Hepatic Surgery Centre, Tongji Hospital, Tongji
Medical College, Huazhong University of Science and
Tech, Wuhan, China
Objectives: Hepatocellularcarcinoma (HCC) is highly
resistant to chemotherapeutic drugs, whichmarkedly
reduces the effect of chemotherapy. TGF-b-smad sig-
nalingpathway has been shown to contribute to drug
resistance in HCC. But the exactlyfunction of SMAD3
in drug resistance is controversial and the mechanism
isstill incompletely understood.In this study, we
detected the function of SMAD3in drug resistance of
HCC cell lines
Methods: SMAD3 stable over-expressedcell line 7721-
SMAD3 and 7402-SMAD3 were established and trea-
ted with variousdose of mitomycin and cisplatin. The
cell viability and apoptosisrate were detected by CCK-8
and annexin-V/PI assay. The caspase cleavage, activa-
tion of p-38 pathway, Bcl-2 expression was detected by
western-blot. Thenwe block p-38pathway by SB203580,
in order to confirm the role of p38 pathwayin the drug
resistance.
Results: SMAD3 overexpressed HCC cell lines showed
more sensitivity to mitomycin and cisplatin induceda-
poptosis, activation of P38 pathway and lower expres-
sion of Bcl2. Interruptingp38 pathway could reverse the
expression of Bcl-2 and the impair drugs inducedapop-
tosis.
Conclusion: SMAD3 reversemitomycin and cisplatin
induced apoptosis by down-regulate Bcl-2 via
p38MAPKpathway in HCC cell lines.
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APHPB-0122
ABO INCOMPATIBLE LIVING DONOR
LIVER TRANSPLANTATION USING
RITUXIMAB WITHOUT PLASMA
EXCHANGE
S. Lee1, K. I. M. Seong Hoon1, P. A. R. K. Sang-Jae1,
H. A. N. Sung-Sik1 and K. I. M. Young-Kyu2
1Center for Liver Cancer, National Cancer Center,
Goyang, Korea; 2Department of Surgery, Jeju University
Hospital, Jeju, Korea
Objectives: The number of ABO incompatible (ABO-I)
living donor liver transplantation (LDLT) has been
increased with various strategies. However, the optimal
and simple method to overcome antibody-mediated
rejection (AMR) has not been well known.
Methods: From March 2014 to August 2014, 8 consec-
utive ABO-I LDLT were identified at National Cancer
Center, Republic of Korea. Our protocol for ABO-I
LDLT involved rituximab (300 mg/m2) at preoperative
1 week, basiliximab (20 mg on operation day and post-
operative day 4), and routine surgical procedure with-
out plasma exchange before transplantation.
Results: The 8 patients (4 males, 4 females) who under-
went transplantation comprised liver cirrhosis (n = 2, 1
HBV, 1 Wilson‘s disease) and hepatocellular carcinoma
(n = 6, 6 HBV). Mean age, MELD score, and graft-to-
recipient weight ratio of these patients was 53.1 years,
16.9, and 0.97, respectively. The median isoagglutinin
antibody titer was 1:16 (range, 1:8–1:64). All patients
are alive without graft failure. There was no hyperacute
rejection and antibody-mediated rejection. Mean dura-
tion of hospital stay was 14.6 days. There was no
recurrence of hepatitis B virus and 3 positive antigen-
emia (37.5%) after transplantation. No bacterial and
fungal infections were observed. Complications
included hepatic artery thrombosis in one patient, no
extrahepatic biliary stricture, and no HCC recurrence.
Conclusion: Only rituximab ABO-I LDLT protocol
without plasma exchange showed good graft outcomes
without hyperacute, AMR, and serious infection. This
protocol seems to be a simple and effective modality
for ABO-I LDLT.
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APHPB-0124
MALIGNANT LESIONS OF A SPLEEN:
CRITERIA OF DIAGNOSTICS
Y. Stepanova1, D. Ionkin2, G. Karmazanovsky1, A.
Shurakova1 and A. Shchegolev3
1Radiology Diagnosis and Treatment, A.V. Vishnevsky
Institute of Surgery, Moscow, Russia; 2Abdominal
Surgery, A.V. Vishnevsky Institute of Surgery, Moscow,
Russia; 3Patomorphology, A.V. Vishnevsky Institute of
Surgery, Moscow, Russia
Objectives: To define the spleen malignancies criteria’s
of diagnosis on the basis of own experience.
Methods: 382 patients with spleen’s lesions were trea-
ted at Vishnevsky Institute of Surgery (1985–2014),
there were 13 (3.4%) malignancies: metastasises in a
spleen – 12 (ovaries cancer – 4, colorectal cancer – 2, in
one case of pancreas, duodenum, thyroid cancer,
hepatocellular carcinoma, stomach carcinoid, retroperi-
toneal polymorphcellular sarcoma); malignant true
spleen cyst – 1. All tumors were morphologically/histo-
logically verified.
Results: Malignant true spleen cyst: Spleen’s cystic
lesion (9 9 8 cm) with calcium in walls were revealed
at US and CT at the patient with rather expressed clini-
cal symptoms (pains in the left hypochondrium,
spleen’s sizes increasing).
Spleen metastasis parameters’:
1. clinical manifestations are only at considerable
sizes of lesion(s);
2. multiple nature of lesion (quite often);
3. probability of defeat of several bodies (liver/
lungs/bone system);
4. mainly subcapsular localization;
5. low-resistant arterial blood-groove is registered
in metastasis at duplex scanning;
6. low CT-/MR-density, uniformity of structure of
lesions;
7. at CT: lesions are hypodenses zones without
accurate contours (native); insignificant accumu-
lation of contrast agent, thus lesion remains
hypodense in relation to a parenchyma in all
contrast phases; clearness of contours due to
emergence of hypercontrast rim;
8. the increase in lymph nodes of an abdominal
cavity is possible;
9. the increase in a spleen’s sizes can’t serve as
diagnostic criterion;
10. ascites (quite often).
Conclusion: In case of any spleen lesion detection it’s
necessary to carry out differential diagnostics with
malignant tumoral process, despite a relative rarity of
similar lesions.
APHPB-0125
USAGE OF A SOFT-COAGULATION
DEVICE FOR SAFE PERFORMANCE OF
TOTAL LAPAROSCOPIC
HEPATECTOMY: DETACHMENT AND
TRANSECTION OF BLOOD VESSELS
USING A MONOPOLAR SOFT-
COAGULATION DEVICE
M. Miyazawa, M. Aikawa, K. Okada, K. Okamoto,
Y. Watanabe, K. Okamoto, S. Yamaguchi and
I. Koyama
Gastroenterological Surgery, Saitama Medical
University International Medical Center, Saitama, Japan
Objectives: Among intraoperative complications of
total laparoscopic hepatectomy (TLH), venous hemor-
rhage is the most frequent and difficult-to-treat compli-
cation. The aim of this prospective, nonrandomized
study was to investigate the potential contribution of a
monopolar soft-coagulation device to the limitation of
intraoperative blood loss in patients undergoing TLH.
Methods: From January 2008 to May 2014 at our
department, TEH was performed in 140 cases, including
132 cases of partial hepatectomy and 5 cases of lateral
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sectionectomy of the left hepatic lobe. We keep the fol-
lowing points in mind for the procedure of partial hepa-
tectomy using a monopolar soft-coagulation device for
hepatocellular carcinoma. (1) Even in case of a small
amount of bleeding, hemostasis is immediately per-
formed before moving to the next site of transection. (2)
For detachment of the vein, a monopolar soft-coagula-
tion device is pressed on the resection surface of the liver
to destroy hepatocytes. (3) Regarding the area around
the hepatic vein, holes from which the branches of the
hepatic vein fall out are identified with a monopolar
soft-coagulation device (while dripping water) and
closed.
Results: The blood loss was 62.4 (0–500) mL. The
operative time was 207 (127–468) min. The duration of
hospital stay after surgery was 7.6 (3–21) days. Postop-
erative complications occurred in 5 cases. Although
there were cases showing high AST levels, no sign of
hepatic failure was observed during the perioperative
period in any case.
Conclusion: The use of a monopolar soft-coagulation
device improves surgical results with minimal blood
loss and low rate mobidity
APHPB-0126
IMPACT OF ENERGY DEVICES
DURING LIVER PARENCHYMAL
TRANSECTION: A MULTICENTER
RANDOMIZED CONTROLLED TRIAL
N. Gotohda1, T. Yamanaka2, A. Saiura3, K. Uesaka4,
M. Hashimoto5, M. Konishi1 and K. Shimada6
1Hepatobiliary and Pancreatic Surgery, National Cancer
Center Hospital East, Kashiwa, Japan; 2Biostatics,
National Cancer Center, Tokyo, Japan; 3Gastrointestinal
Surgery, Cancer Institute Hospital, Tokyo, Japan;
4Hepato-Biliary-Pancreatic Surgery, Sizuoka Cancer
Center Hospital, Shizuoka, Japan; 5Digestive Surgery,
Toranomon Hospital, Tokyo, Japan; 6Hepatobiliary and
Pancreatic Surgery, National Cancer Center Hospital,
Tokyo, Japan
Objectives: To clarify the benefit of energy devices such
as ultrasonically activated device and bipolar vessel
sealing device in liver surgeries.
Methods: Patients scheduled to undergo open liver
resection were eligible for this multicenter non-blinded
randomized study. They were randomized to receive an
energy device (experimental group) or not (control
group) during liver transection. The primary endpoint
was the proportion of patients with intraoperative
blood loss > 1000 mL. The primary aim was to show
non-inferiority of hepatectomy with energy device to
that without energy device.
Results: A total of 212 patients were randomized and
211 (105 and 106 in the respective groups) were ana-
lyzed. Intraoperative blood loss > 1000 mL occurred in
15.0% patients with energy device and 20.2% patients
without energy device. The experimental minus control
group difference was 5.2% (95% confidence interval,
13.8% to 3.3%; non-inferiority test, p = 0.0248).
Hepatectomy with energy device resulted in a shorter
median liver transection time (63 vs. 84 min; p < 0.001)
and a lower rate of postoperative bile leakage (4 vs.
16%; p = 0.002).
Conclusion: The hypothesis that hepatectomy with
energy device is not inferior to that without energy
device in terms of blood loss has been demonstrated.
The use of energy devices during liver surgery is clini-
cally meaningful as it shortens the liver transection time
and reduces the incidence of postoperative bile leakage.
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APHPB-0127
IDENTIFICATION OF BILIARY
EPITHELIAL STEM/PROGENITOR
CELLS USING LGR5
M. Miyazawa, M. Aikawa, K. Okada, K. Okamoto, Y.
Watanabe, S. Yamaguchi and I. Koyama
Gastroenterological Surgery, Saitama Medical
University International Medical Center, Saitama, Japan
Objectives: Little is known about how the bile duct
regenerates. We established a model in which a bioab-
sorbable polymer tube was implanted (Am J Trans-
plant 2005). Histological studies using this model
demonstrated that the immature bile duct epithelium
was villous in morphology and had crypts, suggesting
the presence of epithelial stem cells. We sought to
locate these stem cells using Lgr5 (leucine-rich-repeat-
containing G-protein-coupled receptor 5), a marker for
intestinal epithelial stem cells.
Methods: An artificial bile duct (ABD) in tubular form
made of a bioabsorbable polymer was prepared for
implantation. Pigs served as ABD recipients. The com-
mon bile duct was cut, its duodenal end was ligated
and its hepatic stump was anastomosed to the ABD.
The remaining end of the ABD was sutured to the duo-
denum. Neo-bile ducts were collected at various time
points after implantation. Biliary stem cells stained with
the marker Lgr5 were compared with c-kit positive cells
in terms of location.
Results: Lgr5 positive cells were found in accessory
glandular structures 7 weeks after ABD implantation
and in the crypts of villous structures as well as in
accessory glandular structures at 12 weeks. There were
a number of accessory glandular structures at 7 weeks,
while the neo-bile duct showed a nearly single layer of
cuboidal columnar epithelium with accessory glands
decreased in number, looking like the native duct at
6 months.
Conclusion: In this model of extrahepatic bile duct
regeneration, biliary stem/progenitor cells appeared to
be in accessory glands and in the crypts of villous
structures of the epithelium.
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APHPB-0128
ISCHEMIC PRECONDITIONING
PROTECTS AGAINST LIVER
ISCHEMIA/REPERFUSION INJURY VIA
HEME OXYGENASE-1-MEDIATED
AUTOPHAGY
A. Liu1, H. Fang2, W. Wei3, U. Dahmen3 and
O. Dirsch3
1Experimental Medicine Center, Tongji Hospital, Tongji
Medical College, Huazhong University of Science and
Tech, Wuhan, China; 2Department of Pathophysiology,
Anhui Medical University, Hefei, China; 3Experimental
Transplantation Surgery, Department of General
Visceral and Vascular Surgery, Friedrich-Schiller-
University Jena, Jena, Germany
Objectives: Ischemic preconditioning (IPC) exerts a
protective effect in hepatic ischemia/reperfusion (I/R)
injury. Recent studies suggest that autophagy plays an
important role in protecting against I/R injury. How-
ever, the role of autophagy in IPC-afforded protection
and its regulatory mechanisms in liver I/R injury
remain poorly understood. This study was designed to
determine whether IPC could protect against liver I/R
injury via heme oxygenase-1(HO-1)-mediated auto-
phagy.
Methods: IPC was produced by 10 min of ischemia fol-
lowed by 10 min reperfusion prior to 60 min of ische-
mia. In a rat model of hepatic I/R injury, rats were
pretreated with wortmannin or rapamycin to evaluate
the contribution of autophagy to the protective effects
of IPC. HO-1 was inhibited with tin protoporphyrin IX
(SnPP). In a mouse model of hepatic I/R injury, auto-
phagy or HO-1 was inhibited with vacuolar protein
sorting 34 (Vps34) small interfering RNA (siRNA) or
HO-1 siRNA, respectively.
Results: IPC ameliorated liver I/R injury. IPC treat-
ment induced autophagy activation, as indicated by an
increase of LC3-II, degradation of p62 and accumula-
tion of autophagic vacuoles in response to I/R injury.
When IPC-induced autophagy was inhibited with wort-
mannin in rats or Vps34-specific siRNA in mice, liver
I/R injury was worsened, while rapamycin treatment
increased autophagy and mimicked the protective
effects of IPC. Furthermore, IPC increased HO-1
expression. The inhibition of HO-1 with tin protopor-
phyrin IX (SnPP) in rats or HO-1-specific siRNA in
mice decreased IPC-induced autophagy and diminished
the protective effects of IPC against I/R injury.
Conclusion: IPC protects against liver I/R injury, at
least in part, via HO-1-mediated autophagy.
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APHPB-0129
THYMIDYLATE SYNTHASE
EXPRESSION PREDICTS SURVIVAL OF
ADVANCED EXTRA-HEPATIC BILE
DUCT CANCER PATIENTS TREATED
WITH S-1 ADJUVANT
CHEMOTHERAPY AFTER SURGERY
Y. Toyoki, K. Ishido, D. Kudo, N. Kimura,
S. Tsutsumi and K. Hakamada
Gastroenterological Surgery, Hirosaki University
Graduate School of Medicine, Hirosaki, Japan
Objectives: Complete surgical resection is the only
curative treatment option for extra-hepatic bile duct
cancer (EHBDC), but the prognosis of this disease is
still poor. The necessity for adjuvant therapy is consid-
ered after curative resection. However there are very
few reports of effective adjuvant therapy for resected
EHBDC until now. And there were few repots about
useful predictive biomarker in EHBDC patients treated
with adjuvant chemotherapy using S-1. The aim of this
retrospective study was to evaluate whether thymidylate
stnthase (TS) expression in tumor can predict the sur-
vival of advanced EHBDC patients treated with adju-
vant chemotherapy using S-1 after surgery.
Methods: From January 2004 to December 2012, TS
expression was investigated immunohistichemically in
109 patients who had curative resection for EHBDC.
Patients’ characteristics, overall survival (OS), and dis-
ease-free survival (DFS) were analyzed.
Results: Forty-four patients received adjuvant S-1 che-
motherapy, and 65 did not. High and low TS in tumor
expression was found in 49 (44.9%) and 60 patients
(55.1%), respectively. There were no differences in clin-
icopathological factors between patients with high TS
expression and those with low expression. Survival of
patients with low TS expression were significantly bet-
ter than those with high TS expression among patients
who received S-1 (p = 0.0088), but not among patients
who did not (p = 0.7018).
Conclusion: TS expression in tumor may be a potent
predictive marker for advanced EHBDC patients trea-
ted with S-1.
APHPB-0130
A RARE CASE OF METASTATIC LIVER
TUMOUR. CASE REPORT AND REVIEW
OF LITERATURE
A. R. Yusoff1, S. Mokhtar1, N. A. M. Shabery2,
M. Roslan3, K. Raman1 and H. Singh1
1Hepatobiliary Surgery, Selayang Hospital, Batu Caves,
Malaysia; 2Anatomic Pathology, Selayang Hospital,
Batu Caves, Malaysia; 3Radiology, Selayang Hospital,
Batu Caves, Malaysia
Objectives: To report a rare case of metastatic liver
tumour.
Methods: Patient’s clinical presentation, imaging and
histopathological examination were reviewed.
Results: A 68-year-old lady, who had craniotomy, exci-
sion of meningeal haemangiopericytoma and adjuvant
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radtotherapy in 2007, was referred to our clinic with
painless abdominal swelling. Physical examination
revealed an otherwise fit elderly lady with anicteric
sclera and palpable right hypochondrium mass. Her
haemogloblin was 11 g/dL, serum bilirubin 8 umol/L,
alanine transaminase 19 U/L and aspartate transami-
nase 34 U/L. Hepatitis B surface antigen and anti-Hep-
atitis C virus were negative with normal AFP (2.8 ng/
mL) and CEA (1.4 ng/mL). Multiphasic computed
tomography revealed large encapsulated arterially
enhancing hepatic tumour with central necrosis and
washout on portovenous phase in the right lobe of liver
with another smaller lesion in segment V. With a provi-
sional diagnosis of non-Hepatitis B or C multicentric
hepatocellular carcinoma, she underwent right hemi-
hepatectomy. Histopathological examination confirmed
the diagnosis of metastatic solitary fibrous tumour. The
tumour was positive for CD34, Vimentin, BCL2 and
STAT6 on immunohistochemistry.
Conclusion: Meningeal haemangiopericytoma is not
only a rare tumour but it can recur at a distant site
after a long disease free interval. We hereby report a
rare metastatic liver tumour which occurs 7 years after
curative resection of meningeal haemangiopericytoma.
APHPB-0131
LAPAROSCOPIC LIVER RESECTION
USING INTRAOPERATIVE NEAR NEAR-
INFRARED FLUORESCENCE IMAGING
SYSTEM
S. Hayami, M. Ueno, S. Yamaguchi, M. Kawai,
S. Hirono, K. Okada, M. Miyazawa, A. Shimizu and
H. Yamaue
2nd Department of Surgery, Wakayama Medical
University, Wakayama, Japan
Objectives: Intraoperative hepatic segmentation is
required in performing an anatomical liver resection,
however, it is sometimes difficult to determine the seg-
mental borderline in laparoscopic liver surgery.
Recently, near-infrared fluorescence (NIRF) imaging
system under indocyanine green (ICG) injection was
provided safely at open liver surgery. In this time, we
have applied this system to the laparoscopic anatomical
liver resection and evaluated its usefulness.
Methods: In this preliminary study, one patient with
HCC at segment 3 was administered anatomical liver
resection using the laparoscopic NIRF imaging system
(D-light P system, Karl Storz, Germany). Laparoscopic
liver resection using this NIRF system was performed
as follows: (1) Encircle and clamp the Glissonian pedi-
cle of segment 3. (2) Inject 1 mL of ICG water solution
(2.5 mg/mL) intravenously and observe the florescent
area. (3) Determine the cutting line and perform paren-
chymal resection. (4) Observe NIRF imaging several
times and re-estimate the accurate direction of anatomi-
cal resection.
Results: The predicted resection area of segment 3
could be clearly detected as a non-fluorescent area
(counter perfusion). Fluorescent navigation was contin-
uously visible during the liver parenchymal resection.
Operation time was 220 min and the amount of intra-
operative blood loss was a little.
Conclusion: Our novel navigation technique using
NIRF imaging might be useful for laparoscopic ana-
tomical liver resection.
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APHPB-0132
ESTABLISHMENT OF AN ACELLULAR
FATTY LIVER EXTRACELLULAR
MATRIX AS A THREE-DIMENSIONAL
SCAFFOLD FOR LIVER ENGINEERING
X. Zheng, J. Xiang, Y. I. Lv, L. Yang, R. U. I. Gao,
X. Liu, W. Liu and D. Dong
Hepatobiliary Surgery, First Affiliated Hospital of Xi’an
Jiaotong University, Xi’an, China
Objectives: To improve a new decellularization method
for fatty liver, and establish an acellular fatty liver
extracellular matrix as a three-dimensional scaffold for
liver engineering.
Methods: The fatty liver which was collected from clin-
ical inapplicable DCD (donation after cardiac death)
organ underwent a process consist of repeated freezing-
thawing, perfusion with gradient SDS and 1% Triton
X-100 through portal vein and hepatic artery and a
procedure of adipose tissue decellularization. The de-
cellularized livers were examined by morphologic, bio-
chemical and immunolabeling techniques for
preservation of the native matrix architecture and com-
position. L-02 cells were seeded into the decellularized
scaffolds to evaluate cell survival and function.
Results: The decellularized process preserved the three-
dimensional macrostructure, the ultrastructure, the
composition of the extracellular matrix components
(ECM) and the native vascular network of the fatty
liver. Residual DNA content in the decellularized scaf-
folds was 25.3  14.6 ng/mg dry weight, less than 1%
of total DNA in the fatty liver. L-02 cells were forma-
tion multicellular spheroids in scaffolds, and exhibited
a spindle-like morphology with microvilli. Cell viability
assay indicated 2D culture had a faster growth rate
than scaffold culture.
Conclusion: The decellularized scaffold of fatty liver is
a potnetial three-dimensional scaffold for liver engi-
neering.
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APHPB-0133
COMPARATIVE STUDY BETWEEN
DUCT TO MUCOSA AND
INVAGINATION
PANCREATICOJEJUNOSTOMY AFTER
PANCREATICODUODENECTOMY: A
PROSPECTIVE RANDOMIZED STUDY
A. El Nakeeb
Gastroenterology Surgical Center, Faculty of Medicine,
Mansoura University, Mansoura, Egypt
Objectives: The ideal technical pancreatic reconstruc-
tion following pancreaticoduodenectomy (PD) is still
debated. The aim of the study was to assess the surgical
outcomes of duct to mucosa pancreaticojejunostomy
(PJ) (G1) and invagination PJ (G2) after PD.
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Methods: Consecutive patients treated by PD at our
center were randomized into either group. The primary
outcome measure was the rate of postoperative pancre-
atic fistula (POPF); secondary outcomes included oper-
ative time, day to resume oral feeding, postoperative
morbidity and mortality, exocrine and endocrine pan-
creatic functions.
Results: One hundred and seven patients treated by
PD were randomized. The median operative time for
reconstruction was significantly longer in G1 (34 vs.
30 min, p = 0.002). POPF developed in 11/53 patients
in G1 and 8/54 patients in G 2, p = 0.46 (6 vs. 2
patients had a POPF type B or C, p = 0.4). Steatorrhea
after 1 year was 21/50 in G1, and 11/50 in G2, respec-
tively (p = 0.04). The albumin level after 1 year was
3.4 g% in G1, and 3.6 gm in G2 (p = 0.03). There was
no statistically significant difference regarding the inci-
dence of DM preoperatively and 1 year postopera-
tively.
Conclusion: Invagination PJ is easier to perform than
duct to mucosa especially in small pancreatic duct. Soft
friable pancreatic tissue can be problematic for invagi-
nation PJ as the parenchymal laceration. Invagination
PJ was not associated with a lower rate of POPF but
was associated with a decreased severity of POPF and
a decrease in incidence of postoperative steatorrhea.
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APHPB-0134
INTRAOPERATIVE ENDOSCOPIC
RETROGRADE CHOLANGIO-
PANCREATOGRAPHY, A USEFUL
TOOL IN HANDS OF HEPATOBILIARY
SURGEON
A. El Nakeeb
Gastroenterology Surgical Center, Faculty of Medicine,
Mansoura University, Mansoura, Egypt
Objectives: Endoscopic Retrograde Cholangio-Pancrea-
tography (ERCP) is done by physicians, radiologists
and rarely by surgeons. This study was planned to eval-
uate the efficacy of intraoperative ERCP combined
with laparoscopic cholecystectomy (LC) for patients
with gall bladder stone (GS) and common bile duct
stone (CBDS) and to show the importance of ERCP
for hepatobiliary surgeon.
Methods: Patients treated for GS with CBDS were
included. LC and intraoperative transcystic cholangoi-
gram (TCC) was done in most of cases. Intraoperative
ERCP was done for cases with evidence of obstruction
after doing intraoperative transcystic cholangoigram.
Results: Eighty patients had GS with CBDS were
included. LC was successful in all cases. Intraoperative
TCC revealed passed CBD stone in 4 cases so intraop-
erative ERCP was done only for 76 patients. Intraoper-
ative ERCP showed dilated CBD with stones in 64
cases (84.2%) where removal of stones were successful,
passed stone in 6 cases (7.9%), short lower end stric-
ture with small stone present in two cases (2.6%) were
treated by removal of stone with stent insertion, long
stricture lower 1/3 CBD in one case (1.3%) was treated
by open choledochojejunostomy, and one case (1.3%)
was proved to be ampullary carcinoma and whipple’s
operation was scheduled. Operative time was
98.5  27.96 (75–200) min. The hospital stay was
21  2 h with a mean cost 4430  27.96 EP
Conclusion: The hepatobiliary surgeon should be aqu-
isted with operative ultrasound, endoscope and ERCP
as the 3rd hand to expand his field of therapeutic
options.
APHPB-0135
EFFECT OF TRADITIONAL CHINESE
HERBAL FORMULA ALF ON LIVER
FIBROSIS
X. Zhang, C. Koon, C. Ko, T. Yew, B. Lau, P. Leung
and K. Fung
The Chinese University of Hong Kong, Institute of
Chinese Medicine, Hong Kong, China
Objectives: Liver fibrosis is a common pathologic out-
come of all chronic liver injuries which have caused
about 800,000 deaths per year worldwide. This project
aims to investigate the efficacy of a novel anti-liver
fibrosis Chinese herbal formula ALF, which consists of
Fructus Schisandrae, Artemisiae Scopariae Herba,
Astragali Radix and Salviae Miltiorrhizae Radix et Rhi-
zoma in anti-liver fibrosis.
Methods: HPLC analysis was performed to identify the
main bioactive compounds in ALF. A human hepatic
stellate cell line LX-2 was treated with ALF to assess
the inhibitory effects in hepatic stellate cells. Bile duct
ligation (BDL) was used to induce liver fibrosis. Mice
were administered orally with either water or ALF
3 days before BDL and 14 days after BDL.
Results: Four major bioactive compounds in ALF were
found, including chlorogenic acid (3.669 lg/mg), calyc-
osin-7-O-b-D-glucoside (0.359 lg/mg), salvianolic acid
B (5.812 lg/mg) and schisandrin A (1.471 lg/mg). It
was found that the migration and fibrotic collagen
induced by TGF-b1 was significantly inhibited by ALF
at 250 lg/mL and 1 mg/mL (p < 0.05) in a dose-depen-
dent manner. The in vivo model was successfully estab-
lished. With high dose of ALF treatment, less
apoptotic hepatocytes and fibrosis collagen accumula-
tion were found in the liver tissues, when compared
with control group. In addition, MMP1a an d MMP2
mRNA levels were significantly up-regulated while
Col1a1, Col3a1 and TIMP1 mRNA levels were signifi-
cantly down-regulated by high dose of ALF.
Conclusion: We have presented the first evidence that
aqueous extract of herbal formula ALF showed benefi-
cial effects in liver fibrosis.
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Malignant HPB Diseases
APHPB-0136
CARBON ION BEAM COMBINED WITH
GEMCITABINE AND CISPLATIN
EFFECTIVELY DESTROYS
CHOLANGIOCARCINOMA STEM-LIKE
CELLS IN VITRO AND IN VIVO
S. Sai1, T. Wakai2 and T. Shirai3
1Research Center for Charged Particle Therapy,
National Institute of Radiological Sciences, Chiba,
Japan; 2Division of Digestive and General Surgery,
Niigata University Graduate School of Medical and
Dental Sciences, Niigata, Japan; 3Research Center for
Charged Particle Therapy, National Institute of
Radiological Sciences, Niigata, Japan
Objectives: To investigate whether carbon ion beam
alone or in combination with gemcitabine and cisplatin
is effective in targeting putative human cholangicarci-
noma stem cells in vitro and in vivo
Methods: Putative cancer stem cells (CSCs) sorted
from HuCCT1 and Huh28 cells were treated with or
without carbon ion beam, X-ray alone or in combina-
tion with gemcitabine and cisplatin, then colony and
spheroid formation assay, FACS analysis, ϒH2AX foci
assay as well as xenograft tumor growth control analy-
sis were performed.
Results: Colony and spheroid formation assay as well
as in vivo tumorigenic assay confirmed that CD44 + /
ESA+ in HuCCT1, CD133+/CD90+ cells in Huh28
have CSC properties compared to CD44/ESA and
CD133-CD90 cells. The percentage of CSCs was
increased in a dose-dependent manner by X-ray com-
pared to carbon-ion beam alone, and it was signifi-
cantly enhanced when combine with gemcitabine and/
or cisplatin. The number of colony and spheroid
formed from CSCs was remarkably reduced and a
more large number and large-sized ϒH2AX foci were
observed in CSCs after 24 h by carbon ion beam com-
bined with gemcitabine and cisplatin compared to that
of X-ray or carbon ion beam alone. Carbon ion beam
with 35 Gy alone or with 25 Gy of carbon ion beam
combined with gemcitabine and cisplatin induced severe
xenograft tumor cell cavitation, fibrosis, necrosis, and
significant tumor regression compared to that of X-ray
irradiation.
Conclusion: Carbon ion beam combined with gemcita-
bine and cisplatin effectively eliminated putative chol-
angicarcinoma stem cells with unrepairable DNA
damage in vitro and remarkably destroyed tumors in
vivo.
APHPB-0139
SURGICAL STRATEGY FOR HEPATO-
BILIARY PANCREATIC MALIGNANCIES
USING 3D MDCT SIMULATION IN
JAPANESE COMMUNITY HEALTH
CARE
J. Yamanaka1, T. Okamoto1, K. Ohashi1, A. Yada1,
H. Sueoka1, M. Hai1, H. Kosaka1, Y. Kondo1, I.
Nakamura1, K. Suzumura1, N. Uyama1, Y. Asano1,
T. Okada1, T. Hirano1, K. Nakajima2, S. Satake2,
Y. Yamasaki2, Y. Iimuro1 and J. Fujimoto1
1Surgery, Hyogo College of Medicine, Nishinomiya,
Japan; 2Surgery, Shiso Municipal Hospital, Shiso, Japan
Objectives: Because of geographic inconvenience,
patients with hepato-biliary pancreatic (HBP) malig-
nancy are likely to have disadvantage in terms of access
to surgical resection, postoperative adjuvant chemo-
therapy, and survival. Authors assessed availability of
preoperative simulation, surgical procedures, and long-
term results for HBP malignancies in Japanese commu-
nity health care.
Methods: Between 1997 and 2014, 41 patients in rural
Japan were diagnosed and received surgery for HPB
malignancy. Fifteen of 41 patients underwent preopera-
tive multi-detector computed tomography (MD-CT),
using three-dimensional (3D) virtual hepatectomy simu-
lation. Software was programmed to reconstruct
detailed 3D vascular structure and calculate liver vol-
ume based on hepatic circulation.
Results: There were 14 patients with cholangiocarcino-
ma (CC), 11 hapatocellular carcinoma (HCC), 9 pan-
creas cancer, and 7 metastatic liver cancer. Three
patients underwent portal vein embolization preopera-
tively. Forty three surgical procedures were carried out,
including right tri-sectionectomy with combined inferior
vena cava (IVC) resection, segment 6 + 7 + 8 tri-seg-
mentectomy, laparoscopic hepatectomy, left tri-section-
ectomy, and pancreaticoduodenectomy with portal vein
reconstruction. Postoperative surgical complication
occurred in 13% and majorities were managed conser-
vatively. Postoperative 5 year overall survival rates
were 86%, 53%, and 33% in patients with liver, bili-
ary, and pancreatic neoplasm, respectively. Six patients
survived more than 5 years postoperatively and
included a patient with CC undergoing right tri-section-
ectomy with IVC resection.
Conclusion: Despite geographic disadvantage, compre-
hensive surgical strategy was applied safely to the
patients with HBP malignancies in Japanese community
health care and achieved satisfactory long-term
survival.
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APHPB-0140
MIGRATED FISH BONE CAUSED LIVER
ABSCESS PRESENTED AS A
GASTROINTESTINAL STROMAL
TUMOR DIAGNOSED BY
ECHOENDOSCOPY
M. Basaranoglu
Gastroenterology, Ankara YIH, Ankara, Turkey
Objectives: A 63-year-old man was presented with a 1-
month history of abdominal pain in the clinic.
Methods: Methods for Image Capture/Processing: A
curvilinear echoendoscope (EG-530UT; Fujinon,
Japan) was used during this procedure.
Results: Esophagogastroduodenoscopy revealed a
40 mm in size, subepithelial lesion at antrum. GIST
was suspected. Echoendoscope (EUS) revealed a
23 9 27 mm hypoechoic mass arising from gastric wall
with a lineer hyperechoic tract (video imaging), from
gastric antrum to the 3th segment of the left liver lobe.
Subepitelial lesion producing pus by the EUS pressure.
On this hepatic segment, there was a hypo- izo-echoic
mass with 24 mm in diameter. During the surgical
operation, a fibroneous fistul tract with a 35 mm lenght
was found between stomach and the liver. It was ex-
ized. A foreign body, fish bone, was found within the
fistula.
Conclusion: Hepatic abscess due to fish bone penetra-
tion is a very rare and could be fatal. EUS provides
further information in the evaluation of this kind of
patients and a fundamental on the diagnosis of suspect
foreign bodies and their complications.
Malignant HPB Diseases
APHPB-0141
PERCUTANEOUS LIVER BIOPSY ON
THE DIAGNOSIS OF
CHOLANGIOCARCINOMA:
EXPERIENCE OF A TERTIARY GI
CENTER
M. Basaranoglu
Gastroenterology, Ankara YIH, Ankara, Turkey
Objectives: Diagnosis of cholangiocarcinoma (CC) is a
difficult and challenging issue. We investigated our
pathology results to define the patients with CC.
Methods: We evaluated our pathology records from
2008 to 2013. In our lab, every year approximately13.000
specimens were examined. All of the materials, 70% was
GI specimens and 7% was liver origin.
Results: We found 44 patients by using the ICQ code.
Any specimen with primer other than pancreas and bil-
iary system which was detected by immunohistochemi-
cal stains was excluded from the further analysis.
Anyone showed pancreas origin during the clinical and
laboratuary examinations was also excluded from the
study. At the end, we had 19 patients with CC.
Of the 19 patients with CC, one was diagnosed from
the operation material, and one from the lymph node
biopsy by endosonographic examination and diagnosis
confirmed by ERCP brush cytology. The rest of them
were diagnosed by percutaneous liver biopsy via the
transabdominal ultrasonography or computerized
tomography.
Conclusion: Diagnosis of CC is still a challenging issue,
and early diagnosis is not possible. Any clinical or lab
examination such as tumor markers or radiologic imag-
ing alone was not be found helpful. We stil need histo-
pathologic examination which is gold standard to reach
a desicion.
APHPB-0142
PROGNOSTIC FACTORS AFFECTING
SURVIVAL AFTER
PANCREATICODUODENECTOMY FOR
PANCREATIC HEAD
ADENOCARCINOMA
W. Askr and A. El Nakeeb
Gastroenterology Surgical Center, Faculty of Medicine-
Mansoura University, Mansoura, Egypt
Objectives: Background: Pancreatic cancer is considered
to have the worst prognosis of the periampullary carci-
nomas.
Objective: This retrospective study was to determine
prognostic factors for survival after pancreaticoduoden-
ectomy in patients had pancreatic carcinoma
Methods: Patients and method: Demographic data, pre-
operative, intraoperative and postoperative variables
were collected from January 1996 to January 2011.
Results: The study included 480 patients (282 males and
198 females with a median age of 53 years (range 30–
80 years). At the time of analysis, 180 (37.5%) patients
were still alive. The median survival was 19 months
(range; 3–105 months). This corresponded to a 1-, 3-,
and 5-year actuarial survival of 44%, 20%, and 15%
respectively. Mass size less than 2 cm (p = 0.0001),
lymph node ratio (p = 0.0001), safety margin
(p = 0.0001), perineural, perivascular infiltration, age
above 60 years (p = 0.03), gender, preoperative biliru-
bin, SGPT, liver status, pre and postoperative CEA,
CA19-9 (p = 0.0001) were significant predictors of sur-
vival in patients undergoing PD for pancreatic cancer.
Conclusion: Mass size <2 cm, lymph node ratio, safety
margin, perineural, perivascular infiltration, age above
60 years, gender, preoperative bilirubin, SGPT, liver
status, pre and postoperative CEA, CA19-9 are impor-
tant predictors of survival in patients undergoing PD
for pancreatic cancer.
APHPB-0143
COMPARATIVE STUDY BETWEEN
UNCINATE PROCESS CARCINOMA
AND PANCREATIC HEAD CARCINOMA
AFTER PANCREATICODUDENECTOMY
(CLINCOPATHOLOGICAL FEATURES
AND SURGICAL OUTCOMES)
W. Askr and A. El Nakeeb
Gastroenterology Surgical Center, Faculty of Medicine,
Mansoura University, Mansoura, Egypt
Objectives: Background: Pancreatic head cancer is con-
sidered to have the worst prognosis of the periampullary
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carcinomas. The clinicopathological features of uncinate
process pancreatic cancer are poorly published.
Methods: We retrospectively studied patients who
underwent pancreaticodudenectomy (PD) for pancre-
atic head adenocarcinoma. This study included three
groups of patients. Group A patients with pure pancre-
atic head carcinoma (PPHC), group B patients with
combined head and uncinate process carcinoma
(CPHUC) and group C patients with pure uncinate
process carcinoma (PUPC). Preoperative, intraoperative
and postoperative variables were collected
Results: The study included 157 patients. Jaundice was
the most common presenting symptoms in PPHC and
CPHUC. Abdominal pain was the most common pre-
senting symptoms in PUPC. The mean common bile
duct (CBD) and pancreatic duct diameters were signifi-
cantly smallest in PUPC group (p = 0.0001). The
venous invasion was significantly observed more in
PUPC group and vascular resection was done in 50%
of cases. The number of patients with microscopically
residual tumor was significantly highest in PUPC group
after PD than in other two groups (p = 0.001). Recur-
rence rate occurred in 54.2% in PUPC group, 34.8% in
CPHUC group and 22.7% in PPUC group after PD
(p = 0.007). The median survival was 19 months in
PPHC groups, 16 months in CPHUC group, and
14 months in PUPC group (p = 0.02).
Conclusion: PUPC presented with abdominal pain with
more vascular infiltration. The recurrence rate was
common after PD for uncinate process carcinoma espe-
cially locoregional recurrence and the overall survival
rate was found to be lower.
Benign HPB Diseases
APHPB-0144
LONG TERM OUTCOMES OF
CHOLEDOCHODUODENOSTOMY FOR
COMMON BILE DUCT STONES IN THE
ERA OF LAPAROSCOPY AND
ENDOSCOPY
T. Elshehawy and A. El Nakeeb
Gastroenterology Surgical Center, Faculty of Medicine,
Mansoura University, Mansoura, Egypt
Objectives: Background: Choledochoduodenostomy
(CDD) has been reported as an effective treatment of
Common bile duct stones (CBDS). This study was
designed to analyze short term and long term outcomes
of CDD for CBDS
Methods: Demographic data, preoperative, intraopera-
tive and postoperative variables were collected. The
long term assessment was done in a prospective manner
included clinical examination, liver function, abdominal
ultrasound, MRCP, upper GIT endoscopy and assess-
ment of quality of life using Gastrointestinal Quality of
Life Index (GIQLI).
Results: A total of 388 consecutive patients underwent
CDD, the mean age was 57.92  13.25 years. The
mean CBD diameter was 18.22  4.01 mm. The mean
operative time was 81.21  20.23 min. Two patients
had recurrent stone (0.06%) and managed successfully
by endoscope. Gastritis was observed in 16.9%
patients. No patient developed sump syndrome, deteri-
oration in liver function or cholangiocarcinoma. Total
and subgroup scores on the GIQLI before and after
CDD differed significantly at follow-up (p = 0.0001).
Conclusion: CDD is a safe and effective method of
drainage of CBD after clearance of CBDS. Long term
outcomes are acceptable with good quality of life.
Sump syndrome is extremely rare; CDD may be associ-
ated with mild to moderate gastritis. CDD doesn’t lead
to development of cholangiocarcioma.
Malignant HPB Diseases
APHPB-0145
ISOLATED ROUX LOOP
PANCREATICOJEJUNOSTOMY
VERSUS
PANCREATICOGASTROSTOMY AFTER
PANCREATICODUODENECTOMY A
PROSPECTIVE RANDOMIZED STUDY
T. Elshehawy and A. El Nakeeb
Gastroenterology Surgical Center, Faculty of Medicine,
Mansoura University, Mansoura, Egypt
Objectives: Background: The optimal reconstruction of
the pancreas following pancreaticoduodenectomy (PD)
is still debated. The aim of this study was to compare
the outcomes of an isolated Roux loop pancreaticojej-
unostomy (IPJ) with that of pancreaticogastrostomy
(PG) after PD.
Methods: Consecutive patients treated by PD were ran-
domized to either reconstruction. The primary outcome
measure was the rate of POPF; secondary outcomes
included operative time, day to resume oral feeding,
postoperative morbidity and mortality, exocrine and
endocrine pancreatic functions.
Results: Ninety patients treated by PD were random-
ized. The median total operative time was significantly
longer in IPJ (320 vs. 300 min, p = 0.047). POPF devel-
oped in 9/45 patients in IPJ and 10/45 patients in PG,
p = 0.796 (7 vs. 4 patients had a POPF type B or C,
p = 0.710). The time to resume oral feeding was earlier
in IPJ (p = 0.03). Steatorrhea after 1 year was 9/42 in
IPJ, and 18/41 in PG (p = 0.029). The albumin level
after 1 year was 3.6 gm% in IPJ, and 3.3 gm in PG
(p = 0.001).
Conclusion: IPJ was not associated with a lower rate of
POPF but was associated with a decrease in incidence
of postoperative steatorrhea. IPJ allowed early oral
feeding and maintained oral feeding even if POPF
developed.
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APHPB-0146
VALIDATION OF THE SEVENTH
EDITION OF THE UICC
CLASSIFICATION OF DISTAL
CHOLANGIOCARCINOMA
F. Miura1, K. Sano1, H. Amano1, N. Toyota1, K.
Wada1, M. Ito1, Y. Aoyagi1, S. Makoto1, M. Yutaka1,
M. Kainuma1, K. Takahashi1, T. Takada1, K. Hayano2
and H. Matsubara2
1Department of Surgery, Teikyo University School of
Medicine, Tokyo, Japan; 2Department of Frontier
Surgery, Graduate School of Medicine Chiba University,
Chiba, Japan
Objectives: The seventh edition of the UICC TNM
classification separates carcinoma of the extrahepatic
bile duct into perihilar and distal cholangiocarcinoma
and further changes the definition of the TNM classifi-
cation. We validated the seventh edition of the TNM
classification of distal cholangiocarcinoma.
Methods: Among 135 patients with distal cholangiocar-
cinoma undergoing surgery, a survival analysis was per-
formed to evaluate the sixth edition of the TNM
classification.
Results: The numbers of patients classified with pT1
and pT2 disease were 21 and 46, respectively, according
to both the sixth and seventh editions. Patients previ-
ously classified as having pT3 (n = 41) and pT4
(n = 27) disease were newly classified with pT3 disease
(n = 68). There were no new pT4 patients. According
to the sixth edition, there were significant differences in
survival rates between the categories of pT1 and pT3
and pT1 and pT4. According to the seventh edition,
significant differences were observed in survival rates
between the categories of pT1 and pT3. We analyzed
our proposal for revising the new T categories. In our
proposal, portal vein invasion is included in the new
T4. According to the revised T categories, significant
differences were observed in survival rates between the
categories of pT1 and pT4, pT2 and pT3, pT2 and
pT4, and pT3 and pT4 as well as between pT1 and
pT3.
Conclusion: Portal vein invasion should be included in
the T4 group of the T category in the seventh edition
of the TNM classification.
APHPB-0147
USEFULNESS OF PORTAL VEIN
STENTING FOR POSTOPERATIVE
PORTAL VEIN STENOSIS
S. Tsutsumi, Y. Toyoki, N. Kimura, D. Kudo, K.
Ishido and K. Hakamada
Gastroenterological Surgery, Hirosaki University
Graduate School of Medicine, Hirosaki, Japan
Objectives: Portal vein (PV) stenosis due to inflamma-
tory change after liver transplantation or recurrent
malignant tumor encasement causes portal hyperten-
sion, leading to varices. These varices can lead to gas-
trointestinal bleeding, which may be life-threatening. In
malignant tumor, PV stenosis which causes liver dys-
function, ascites and splenomegaly leading to pancyto-
penia, makes it impossible to continue chemotherapy.
It is reported that PV stenting is safe and effective as a
treatment option for PV stenosis.Herein we report
about 5 cases underwent PV stenting in our institution.
Methods: We retrospectively reviewed the records of 5
patients who underwent PV stenting. Three of the
patients were men and 2 were women. The median age
of the patients was 56 (range 11–72 years). The causes
of PV stenosis consisted of 4 recurrent malignant tumor
encasements after surgery and one inflammatory
change after liver transplantation.
Results: In patients with malignant tumor, the median
time from surgery to PV stenosis was 464 (range
279–466 days), and the median patency time of the PV
stent was 149 (range 22–149 days). Two of those could
have resumed chemotherapy after PV stenting. On the
other hand, in a patient with PV stenosis due to inflam-
matory change after liver transplantation, pancytopenia
caused by secondary splenomegaly had been improved
after PV stenting. In all patients, there were no compli-
cations.
Conclusion: PV stenting improved complications by PV
stenosis minimally invasively, so it appears to be the
effective therapeutic option for postoperative PV
stenosis.
APHPB-0148
NEOADJUVANT HEPATIC ARTERIAL
INFUSION CHEMOTHERAPY FOR
INOPERABLE HEPATOCELLULAR
CARCINOMA: A CASE REPORT
Y. J. Chen1, Y. Y. Chen2, C. C. Wang1, S. H. Wang1,
C. C. Lin1, Y. W. Liu1, C. C. Yong1, T. L. Lin1, W. F.
Li1 and C. L. Chen1
1General Surgery, Koahsiung Chang Gung Memorial
Hospital, Kaohsiung City, Taiwan; 2Oncology,
Koahsiung Chang Gung Memorial Hospital, Kaohsiung
City, Taiwan
Objectives: The aim of this case report is to evaluate
the effect of neoadjuvant therapy by using hepatic arte-
rial infusion chemotherapy (HAIC) for unresectable
hepatocellular carcinoma (HCC) to impact the hepatec-
tomy with curative intent.
Methods: A 33-year-old female patient, with underlying
hepatitis B virus infection, was found to have huge
HCC with AJCC staging T3bN0M0, and BCLC stag-
ing B. The diameter of main tumor was measured of
13 cm with IVC compression. She received three
sequential courses of HAIC with formula of doxorubi-
cin (50 mg/m2) and cisplatin (50 mg/m2) every 4 weeks.
Computed tomography angiography (CTA) showed
significant down-size of main tumor from 13 to 6 cm
after 3 months. Resection of tumor was proposed to
patient.
Results: Good partial response was achieved after three
courses of HAIC according to RECIST criteria
(version 1.1). The toxicities of treatment were Grade I
fatigue and alopecia. Patient received extended left
lobectomy with complication of bile leakage.
Conclusion: This case demonstrated that neoadjuvant
HAIC could be considered a option of treatment for
patients with locally advanced HCC, which were
assumed to be inoperable at diagnosis. Curative intent
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hepatectomy could be expected for cases with good
response to neoadjuvant HAIC.
APHPB-0149
EFFECTS OF MICRORNA-638 ON
TUMORIGENICITY OF
HEPATOCELLULAR CARCINOMA
J. Cheng1, Y. Chen2, J. Han2, X. Wang2, J. Dong1,
C. Huang2 and Y. Lv1
1Department of Hepatobiliary Surgery, First Affiliated
Hospital of Xi’an Jiao Tong University, Xi’an, China;
2Key Laboratory of Environment and Genes Related to
Diseases College of Medicine, College of Medicine,
Xi’an Jiaotong University, Xi’an, China
Objectives: To date, microRNA-638 (miR-638) has
been suggested to play a substantial role in human gas-
tric cancer, and has been identified as one of the miR-
NAs invasion front-specific down-regulated in
colorectal liver metastases, but the expression levels of
miR-638 in hepatocellular carcinoma (HCC) and its
functions in the context of HCC remain unknown. The
aim of this study was to investigate the expression and
functional role of miR-638 in human HCC
Methods: We examined the expression level of miR-
638 levels in 60 paired HCC and adjacent nontumor
liver tissues and HCC cell lines by quantitative real-
time reverse transcription polymerase chain reaction
(qRT-PCR). The effects of miR-638 on the biological
behavior of the human HCC cell line were further
investigated in this study. Based on a bioinformatics
analysis, the vascular endothelial growth factor
(VEGF) is predicted to be a target of miR-638. A lucif-
erase reporter assay confirmed target association
between miR-638 and VEGF.
Results: The proportion of miR-638 low expression
was 78% among the 60 HCC patients, and the expres-
sion level of miR-638 in clinical HCC specimens and
HCC cell lines were significantly lower than in non-
tumor controls. Enhanced expression of miR-638 sup-
pressed HCC cell proliferation, migration, invasion and
G1–S transition in vitro. Using a luciferase reporter
assay, VEGF was determined to be a direct target of
miR-638.
Conclusion: These findings indicate that miR-638 may
target the VEGF suppresses HCC cell growth, migra-
tion and invasion, suggesting that miR-638 may play a
tumor suppressive role in human HCC pathogenesis.
APHPB-0150
POST-ABLATION SAFETY MARGIN OF
RADIOFREQUENCY ABLATION OF
HEPATOCELLULAR CARCINOMA:
PRECISE ASSESSMENT WITH A THREE
DIMENSIONAL RECONSTRUCTION
TECHNIQUE
M. Kuang1, C. Jiang2, X. Xie3, B. Liu3, M. Lin3 and
M. Lu1
1Department of Hepatic Surgery, The First Affiliated
Hospital of Sun Yat-sen University, Guangzhou, China;
2Division of Interventional Ultrasound, The First
Affiliated Hospital of Sun Yat-sen University,
Guangzhou, China; 3Department of Medical Ultrasonics,
The First Affiliated Hospital of Sun Yat-sen University,
Guangzhou, China
Objectives: To analyze the precise ablative margin pro-
duced by radiofrequency ablation (RFA) by the fusing
three-dimensional (3-D) images of tumor zones and
ablated zones with a reconstruction technique.
Methods: From March 2011 to May 2013, 134 patients
(21 female and 113 male) with 159 primary or recurrent
hepatocellular carcinoma tumors less than 5 cm received
RFA were enrolled. All tumors were treated by RFA
with curative intention. Three dimensional tumor and
ablated zones were reconstructed and fused to show the
ablation margins for accurate measurement.
Results: Follow-up was conducted on all patients for a
median of 16 months (range, 2–44 months). The recon-
structed ablated zone covers the original tumor zone
completely each tumor, but the minimal ablative mar-
gins (AM) varied in all directions. The minimal AM
ranged from 1 to 9.3 mm (mean, 4.3  1.8 mm) on the
fusion image. During the follow-up, local tumor pro-
gression (LTP) was observed in 19 tumors, with cumu-
lative LTP rates at 1, 2, and 3 years of 6.7%, 12.3%,
and 28.0%, respectively. In the group analysis, an mini-
mal AM of 3.3  1.6 mm (ranged, 1–7.1 mm) was
found at where LTP happened, while the minimal AM
of those without LTP was 4.5  1.8 mm (range, 1.3–
9.3 mm) (p = 0.023). Multivariate analysis identified
that only insufficient minimal AM was independent risk
factor for LTP after RFA (p = 0.044).
Conclusion: Post-ablation evaluation of ablative margin
with 3-D technique provides more information for local
response of RFA. To achieve the best local efficacy, a
post-ablation safety margin of at least 5 mm is necessary.
APHPB-0151
IMMUNOHISTOCHEMICAL AND
CLINICOPATHOLOGICAL STUDY FOR
SURGICALLY RESECTED AMPULLARY
ADENOCARCINOMA
E. Asano, K. Okano, M. Nishimura, M. Oshima,
N. Yamamoto, S. Akamoto, H. Takahashi, M.
Fujiwara, H. Usuki and Y. Suzuki
Department of Gastroenterological Surgery, Faculty of
Medicine, Miki-cho, Kita-gun, Japan
Objectives: This study aimed to clarify immunohisto-
chemical and clinicopathological characteristics and
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prognostic factor for surgically resected ampullary
adenocarcinoma.
Methods: Thirty one patients underwent pancreatoduo-
denectomy for an ampullary cancer at Kagawa Univer-
sity Hospital between 1990 and 2012.
Immunohistochemical expression of CK20, CK7,
CDX2, MUC1, MUC2, p53, p16, Smad4/Dpc4 and
bcatenin were evaluated, and examined the relations
with the clinicopathologic factors and prognosis after
surgery.
Results: The patients included 19 men and 12 women,
and the average age was 68.4 (46–83). The distribution
of the patients according to the Union for International
Cancer Control (UICC) stage was as follows; 6
(19.4%) in IA, 6 (19.4%) in IB, 3 (9.7%) in IIA, 13
(41.9%) in IIB, and 3 (9.7%) in IV (no patients pre-
sented with UICC stage III). The actual 1-, 3-, and
5-year survival rates were 85.7%, 60.9%, and 50.0%,
respectively. The recurrence of cancer occurred in
9 patients. MUC1 (p = 0.028) and p53 (p = 0.007) were
significantly associated with recurrence of disease after
surgery. Histological grade (p = 0.028), pancreatic inva-
sion (p = 0.003), UICC stage (p = 0.040), MUC1
(p = 0.036), and p53 (p = 0.045) were significantly asso-
ciated with disease-free survival rate. Pancreatic inva-
sion (p < 0.001), and p53 (p = 0.029) were significantly
associated with overall survival rate.
Conclusion: It was suggested that immunohistochemical
expression of MUC1 and p53 were useful prognostic
factor for ampullary cancer.
APHPB-0152
SALVAGE RESECTION FOR
UNCONTROLLABLE
HEPATOCELLULAR CARCINOMA
UNDERGONE PRIOR PERCUTANEOUS
ABLATION THERAPY
M. Kuang1, W. Hu1, D. Li1, S. Shen1, B. Liu2, M. Lin2
and M. Lu1
1Department of Hepatic Surgery, The First Affiliated
Hospital of Sun Yat-sen University, Guangzhou, China;
2Department of Medical Ultrasonics, The First Affiliated
Hospital of Sun Yat-sen University, Guangzhou, China
Objectives: To summarize the experience with salvage
resection for uncontrolled hepatocellular carcinoma
(HCC) undergone percutaneous ablation therapy
(PAT) in a single center.
Methods: From September 2006 and September 2013,
50 consecutive patients who undergone salvage resec-
tion after PAT were enrolled. Salvage surgery was per-
formed for uncontrolled local recurrence in 29 cases.
The remaining 21 patients underwent salvage resection
for multiple intrahepatic recurrences (n = 6), recurrence
in difficult location for PAT (n = 2), uncontrolled
PAT-related complications (n = 3), or resectable extra-
hepatic metastases (n = 10). Safety, efficacy and surviv-
als of these patients were analyzed. Moreover, the
survival outcomes of patients those underwent salvage
resection for PAT-related local recurrence were com-
pared with those performed repeated PAT (n = 63).
Results: Among the patients performed salvage resec-
tion, curative treatment was achieved in all the patients.
Postoperative follow-up ranged from 1 to 69 months.
The disease-free survival was 38.6% at 1 year and
12.1% at 3 years after salvage resection. The median
overall survival after salvage resection was 40 months,
with 1-, 3-, 5-year overall survival (OS) rates of 85.2%,
46.4% and 34.8%, respectively. According to subgroup
analysis in patients associated with post-PAT local
recurrence, the 1-, 3-, and 5-year OS rates were 93.8%,
57.9%, and 28.9%, respectively, after salvage resection;
and were 78.7%, 52.7%, and 45.8%, respectively, after
repeated PAT (p = 0.284).
Conclusion: Salvage resection is a feasible when abla-
tion fails or is inapplicable, and helps improve the
overall prognosis in treatment of HCC. Compared with
repeated PAT, salvage liver resection is a more radical
treatment for patients with local recurrence after PAT,
showing comparable survival outcomes.
Benign HPB Diseases
APHPB-0153
CLINICAL SIGNIFICANCE OF BILE
REFLUX INTO THE PANCREATIC
DUCT WITHOUT
PANCREATICOBILIARY
MALJUNCTION ASSESSED BY
INTRAOPERATIVE
CHOLANGIOGRAPHY
K. Shinozaki, K. Ueno, T. Ajiki, T. Matsumoto, S.
Murakami, Y. Yoshida, T. Fujita, T. Okazaki, T.
Fukumoto and Y. Ku
Division of Hepato-Biliary-Pancreatic Surgery,
Department of Surgery, Kobe University Graduate
School of Medicine, Kobe, Japan
Objectives: Bile reflux into the pancreatic duct (BRPD)
is sometimes demonstrated during intraoperative chol-
angiography (IOC) even in patients without pancretob-
iliary maljunction (PBM). However, the clinical
significance of the finding is unclear. We examined the
rate of BRPD in routine IOC, and the change in gall-
bladder mucosa was investigated in patients with
BRPD.
Methods: Among 484 patients who underwent chole-
cystectomies, patients whose pancreatic duct was
depicted in routine IOC were retrospectively extracted.
The value of pancreatic amylase (p-amylase) of the
gallbladder bile and histological changes as well as the
immunohistochemical expression of proliferating cell
nuclear antigen (PCNA) in the gallbladder mucosa
were analyzed in patients with BRPD, and the data
were compared to those in patients without BRPD
(control group).
Results: The rate of BRPD was 5.0% (24/484). The
value of gallbladder bile p-amylase in patients with
BRPD was significantly higher than that of the control
group (25031.6 vs. 42.5, p = 0.034). The value of
PCNA-labeling index (LI) in patients with BRPD was
significantly higher than that of the control group (15.7
vs. 4.3, p = 0.0026). Among the 24 patients with
BRPD, pathological changes in the gallbladder mucosa
were detected in 5 cases (2 hyperplasia and 3 metapla-
sia), but there was no correlation between the presence
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of pathological change and PCNA-LI or p-amylase in
gallbladder bile.
Conclusion: Since the levels of gallbladder bile p-amy-
lase and PCNA-LI in patients with BRPD presented as
high, these patients should be clinically dealt with simi-
larly to patients with PBM.
APHPB-0154
GALLBLADDER PERFORATION:
SINGLE CENTER EXPERIENCE OF 50
PATIENTS
V. Gupta, A. Chandra, H. Hatimi, A. Maurya,
P. Singh and M. Naushif
Surgical Gastroenterology, King George Medical
University, Lucknow, India
Objectives: To present our experience with gallbladder
perforation (GBP).
Methods: Prospectively collected data from January
2009 to June 2014 was retrospectively analyzed to iden-
tify patients with GBP. Post-traumatic and iatrogenic
perforations were excluded. Data was analyzed for
demographics, clinical features, co-morbidity, perfora-
tion types (1: free; 2: contained; 3: cholecystoenteric fis-
tula), management, and perioperative outcomes.
Results: Fifty (33 females; mean age 51 years; range
16–75) were found to have GBP. All except 1 had pain
(mean duration 14.27 months, range 0.33–180), 50%
had fever (mean duration 2.63 months, range 0.22–18),
and 34% had jaundice (mean duration, 6.52 months,
range 0.4–30 months).
Causes were acute cholecystitis (47), carcinoma gall-
bladder (2) and periampullary carcinoma (1). Associ-
ated co-morbidities were present in 24% and additional
pathology e.g. choledocholithiasis in 40% patients. Per-
foration was diagnosed preoperatively in only 19 (38%)
patients. Nine patients were managed conservatively
while remaining 41 underwent surgery with a mean
post-operative stay of 9.73 days (range 3–39), and post-
operative morbidity of 39% (16/41) with no mortality.
Most of the patients had type 2 (56%) or type 3 (38%)
perforation.
Nine patients had xanthogranulomatous cholecystitis.
Subgroup analysis showed significantly more co-mor-
bidities in type 1 than type 2 (p < 0.01) and type 3
(p < 0.05) with no difference in other variables (age,
sex, symptoms, leucocytes counts, associated pathology,
site of perforation, post-operative morbidity or stay).
Conclusion: GBP is usually diagnosed intraoperatively
and is associated with high post-operative morbidity.
Patients with co-morbidities have high risk of free per-
foration. High index of suspicion is required for preop-
erative diagnosis of GBP.
Malignant HPB Diseases
APHPB-0156
RADIOLOGICAL AND PATHOLOGICAL
CHARACTERISTICS IN
OCCUPATIONAL
CHOLANGIOCARCINOMA
DEVELOPING AMONG YOUNG
WORKERS AT A PRINTING COMPANY
IN JAPAN
M. Kinoshita1, Y. Nakanuma2, S. Takemura1,
S. Tanaka1, H. Shinkawa1, T. Nishioka1, G. Hamano1,
T. Itou1, M. Koda1 and S. Kubo1
1Hepato-Biliary-Pancreatic Surgery, Osaka City
University, Osaka City, Japan; 2Pathology, Shizuoka
Cancer Center, Shizuoka Prefecture, Japan
Objectives: An outbreak of cholangiocarcinoma has
been reported in young workers at a printing company
in Japan. All of them were exposed to 1.2-dichloropro-
pane and/or dichloromethane. This study aimed to
identify the radiological and pathological characteristics
of the cholangiocarcinoma.
Methods: We examined retrospectively the findings of
diagnostic imaging and pathological examination in 9
patients with occupational cholangiocarcinoma. In 3
patients in whom the whole resected liver was available,
we evaluated the location of the carcinoma, atypical
epithelium, and bile duct injuries. We also examined
the association with the pathological findings and the
diagnostic imaging findings.
Results: According to the diagnostic imaging, regional
dilatation of the intrahepatic bile ducts without tumor-
induced obstruction was observed in 5 patients. In a
total of 9 patients, biliary intraepithelial neoplasia and/
or intraductal papillary neoplasm of the bile duct were
observed in various regions of the bile ducts in non-
cancerous hepatic tissue. In the 3 patients in whom the
whole resected liver was available, either precancerous
or early cancerous lesions, and also chronic bile duct
injuries were observed throughout almost the entire bile
duct, including those cases without any changes in the
diagnostic imaging. Finally, invasive cancer or mucin-
producing precancerous and/or early cancerous lesions
were pathologically found in the regional dilatation of
bile ducts on diagnostic imaging.
Conclusion: In the patients with occupational cholan-
giocarcinoma, bile duct injury, precancerous or early
cancerous lesions were observed in the various part of
the bile ducts. The findings of the bile ducts on the
diagnostic imaging reflect the characteristics of the
pathological findings.
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APHPB-0157
FATE OF THE PORTAL VEIN AFTER
PANCREATODUODENECTOMY FOR
PERIAMPULLARY CANCERS: PATENCY
RATE AND ASSOCIATED
COMPLICATIONS
M. J. Kang, J. Y. Jang, Y. R. Chang, W. Jung, Y. C.
Shin, J. Jang and S. W. Kim
Department of Surgery, Seoul National University
College of Medicine, Seoul, Korea
Objectives: Previous studies have analyzed acute com-
plications of pancreatoduodenectomy, but little is
known about the fate of the portal vein (PV), especially
its long-term patency and associated complications.
The aim of this study was to explore the long-term fate
of the PV after pancreatoduodenectomy, as determined
by patency rate, risk factors for PV stenosis/occlusion
and associated complications.
Methods: Serial CT images of patients who underwent
curative pancreatoduodenectomy for periampullary
cancers were evaluated for PV stenosis/occlusion.
Results: Of 826 study subjects, the PV stenosis/occlu-
sion rate after curative pancreatoduodenectomy was
19.6%, and the 5-year patency rate was 69.9%. The
most frequent cause of PV stenosis/occlusion was local
recurrence followed by postoperative change and PV
thrombosis. Patency rate was highest in patients with
ampulla of Vater cancer and lowest in patients with
pancreatic cancer (p < 0.001). Patients who underwent
PV resection had significantly poorer 5-year PV
patency rates (17.2% vs. 72.7%, p < 0.001). Multivari-
ate analysis showed that risk factors for PV stenosis/
occlusion included primary tumor location, chemora-
diotherapy and PV resection. PV stenosis/occlusion
without disease recurrence was observed in 17.3% of
the patients with PV resection, with grade B or C pan-
creatic fistula being an independent risk factor for PV
stenosis/occlusion. Among patients with PV stenosis/
occlusion, 2.5% experienced fatal recurrent gastrointes-
tinal bleeding.
Conclusion: PV resection increases the risk of PV ste-
nosis/occlusion after curative pancreatoduodenectomy.
Although recurrence is the most frequent cause of PV
stenosis/occlusion, a significant proportion of patients
without disease recurrence experience PV stenosis/
occlusion. The possibility of rare but fatal complica-
tions indicates the importance of PV monitoring after
pancreatoduodenectomy.
APHPB-0158
GLIOMA-ASSOCIATED ONCOGENE-1
INHIBITOR AFFECTS THE CELL
PROLIFERATION AND INVASIVENESS
OF HUMAN HEPATOCELLULAR
CARCINOMA
K. S. Jeng1, C. F. Chang2, Z. H. Hung2, M. C. Yu2,
H. I. Hsiau2, F. Y. Chang2 and S. Y. Li2
1Surgery, Far Eastern Memorial Hospital, New Taipei
City, Taiwan; 2Medical Research, Far Eastern Memorial
Hospital, New Taipei City, Taiwan
Objectives: The sonic hedgehog (Shh) pathway is cru-
cial for the development of hepatocellular carcinoma
(HCC). To study whether the inhibitor of Shh pathway
may affect the proliferation and invasiveness of HCC,
we conducted this study.
Methods: Cell culture and sorting of CD133+ cells of
human HCC cell line PLC/PRF/5 cells were performed.
HPI-1, the Gli-1 inhibitor, with concentration of 0, 10,
and 40 lM was added to PLC/PRF/5 cells. After treat-
ment, we examined the mRNA expression of Shh,
Ptch-1, Gli-1and Smoh of PLC/PRF/5 cells. Cell prolif-
eration, cell invasion assay, and mRNA expression of
the factors of apoptosis or other related pathway were
studied respectively.
Results: The percentage of the sorted CD133+ cells
was about 35% in PLC/PRF/5 cells and the purity was
over 90%.
Gli-1 inhibitor HPI-1 altered the Shh signaling pathway
by decreasing Shh, Smoh and Gli-1 expression in PLC/
PRF/5 cells. High dose HPI-1 could inhibit cell prolif-
eration in both CD133+ and CD133 cells. In addi-
tion, HPI-1 could reduce the cell invasion in both
CD133+ (40%) and CD133 (15%) cells. CD133+
expression was also reduced. Whereas, the percentage
of CD133+CD44+ increased after HPI-1 treatment.
Conclusion: Gli-1inhibitor decreased cell proliferation
via apoptosis and decreased invasiveness via down-reg-
ulation of factors of Shh signaling pathway with
reduced CD133 expression. To inhibit Shh pathway
may become a potential therapy for HCC.
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APHPB-0159
CLINICO-PATHOLOGICAL CO-
RELATION IN PATIENTS OF PORTAL
BILIOPATHY
S. Pujari, C. Kantharia, R. Prabhu, A. Supe and
R. Bapat
Surgical Gastroenterology, Seth GS Medical College &
KEM Hospital, Parel, Mumbai-12, India
Objectives: Patients with Portal Biliopathy usually are
asymptomatic, This study analyses Clinical and radio-
logical co-relation and Outcome of intervention in PB
patients.
Methods: This is a Prospective analysis from March
2010 to 2012. Patients with EHPVO were assessed with
regards to: etiology of PVT, Symptoms, serum alkaline
phosphatase and total bilirubin. Doppler USG and
MRCP were done in all. Patients were grouped into
Clinically Symptomatic and Asymptomatic group.
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ERCP and CT-Angiography to assess shuntable vessels
performed in symptomatic patients. F/U of serum alka-
line phosphatase and total bilirubin was done at end of
30, 90 and 180 days and thereafter 6 monthly. MRCP
was done at end of 1 year in whom intervention was
done. Statistical analysis done using SPSS v11.
Results: 39 patients were studied. 34 had radiological
evidence of PB (87.17%). 9 (23.07%) were clinically
symptomatic, 5 had Jaundice with cholangitis and 4
only jaundice.
Radiological abnormality in 34 was: Varicoid: 23,
Fibrotic: 7 Mixed: 4. Five of nine symptomatic patients
were subjected to ERCP stenting. PSRS shunt done in
two, Choledocho Jejunostomy in 1, and cholecystec-
tomy with T-Tube insertion in 1
Conclusion:
1. There is definite Clinico-Radiological-Biochemi-
cal co-relation in patients with Symptomatic Por-
tal Biliopathy.
2. Biochemical parameters are more realistic as
compared to radiological parameters alone to
investigate clinical condition.
3. Epicholedochal venous plexus, Stricture with
dilatation, Delayed enhancement were found to
be statistically significant.
4. Biochemical and Radiological parameters were
statistically significant with the p-value < 0.0001
in the clinically symptomatic group.
APHPB-0160
PANCREATIC DUCT ASCARIASIS:
CLINICAL PRESENTATION,
MANAGEMENT AND OUTCOME
G. Javid, A. Showkat and S. Zargar
Gastroenterology, Sheri-Kashmir Institute of Medical
Sciences (SKIMS), Srinagar, Jammu & Kashmir, India
Objectives: Infection with ascaris is seen globally. The
adult roundworm frequently migrates into the biliary
tree from the small intestine. Migration into the pan-
creatic duct is a rare event due to its narrow caliber
and tortuosity. The aim is to present the incidence,
clinical features, diagnostic modalities and outcome of
pancreatic duct ascariasis.
Methods: This is a retrospective cum prospective study
over a period of 18 years. During this period 3357
cases of hepatobiliary and pancreatic ascariasis were
seen and 51 had pancreatic duct ascariasis.
Results: There were 28 females; 10(19.6%) patients
were below 18 years of age. The mean age was
38  5.3 years (range 7–48 years). Three types of pan-
creatic duct ascariasis were identified. 1) Isolated pan-
creatic duct ascariasis (15 patients); 2) concomitant
pancreatic and bile duct ascariasis in (27patients); 3)
worm across ampulla of Vater entering into the pancre-
atic duct (9 patients). Pancreatitis was mild in 43
(84.31%) and severe in 8 patients (15.69%).Ultrasonog-
raphy is an excellent diagnostic tool. Majority of
patients responded to conservative management.
Endoscopy was performed in 23 patients with severe
pain and in 9 patients’ worms hanging across the
ampulla was extracted. Endoscopic retrograde cholan-
giopancreatography was performed in 11patients with
pyogenic cholangitis, severe pancreatitis and worsening
cholecystitis. Surgery was done in 2 patients. Patients
with concomitant worms in the biliary tree and pancre-
atic duct had significantly higher incidence of severe
pancreatitis (p < 0.05), more complications and need
for surgery (p < 0.05).Mortality was 1.9%.
Conclusion: In Western countries occurs in travelers or
imigrant population.
APHPB-0161
UNAVOIDABLE RIGHT HEPATIC DUCT
INJURY DURING LAPAROSCOPIC
CHOLECYSTECTOMY
T. Lin1, K. C. Chen1, T. S. Lin2, Y. C. Chiu3,
L. Tsang4, C. C. Wang1 and C. L. Chen1
1General Surgery, Kaohsiung Chang Gung Memorial
Hospital, Kaohsiung, Taiwan; 2Plastic and
Reconstructive Surgery, Kaohsiung Chang Gung
Memorial Hospital, Kaohsiung, Taiwan; 3Hepato-
Gastroenterology, Kaohsiung Chang Gung Memorial
Hospital, Kaohsiung, Taiwan; 4Diagnostic Radiology,
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung,
Taiwan
Objectives: Biliary complication during cholecystec-
tomy is not unusual and will impact patients’ recovery.
We present a patient with unusual biliary anatomy and
encountered unavoidable bile duct injury during lapa-
roscopic cholecystectomy.
Methods: A 63 year old female with gallstones pre-
sented right upper abdominal pain. Preoperative
MRCP and ERCP didn’t show definite biliary anatomy
variation. During laparoscopic cholecystectomy, the
cystic duct was divided as close to GB as possible.
However bile duct injury was found and the operation
was converted to laparotomy. Right hepatic duct injury
was confirmed and micro-surgeon performed anasto-
mosis between right hepatic duct and cystic duct. After
operation, the bile leakage was controlled with low
pressure drain suction and endoscopic retrograde bili-
ary drainage (ERBD). The patient was discharged with
normal liver function. The ERCP 4 months after oper-
ation showed patent right hepatic duct and the ERBD
was removed.
Results: In review the preoperative image and opera-
tive finding, the right hepatic duct drained into GB
neck. Injury of the right posterior duct seems unavoid-
able. After recognizing the bile duct injury, immediate
reconstruction was done. A micro-surgeon being experi-
enced in bile duct anastomosis during liver transplanta-
tion performed duct to duct anastomosis. The patient
recovered well without another operation.
Conclusion: Right hepatic duct injury during cholecys-
tectomy is unavoidable when it drains into GB. Preop-
erative image is difficult to identify this bile duct
variation. Management methods should be considered
according to facilities of institution.
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APHPB-0162
THE IMPACT OF MAIN-PANCREATIC-
DUCTAL SPREADS ON SURGICAL AND
ONCOLOGICAL OUTCOMES IN
RESECTED INVASIVE DUCTAL
CARCINOMA PATIENTS
Y. Kimura1, M. Ishii1, S. Sugita2, M. Imamura1,
M. Meguro1, T. Itoh1, T. Nobuoka1, T. Mizuguchi1
and K. Hirata1
1Surgery Surgical Oncology and Science, Sapporo
Medical University School of Medicine, Sapporo, Japan;
2Surgical Pathology, Sapporo Medical University
Hospital, Sapporo, Japan
Objectives: Invasive ductal adenocarcinoma of the pan-
creas (IDC) also spreads through the pancreatic ductal
system. The aim of this study was to clarify the surgical
and oncological impact of the main pancreatic duct
spread (i.e. ‘mpd’) in IDC patients.
Methods: We retrospectively examined the incidence of
mpd in IDC and its correlation with clinicopathologic
parameters in a series of 184 patients who underwent
surgeries through 1990–2013 in our hospital.
Results: Mpd was identified in 42 patients (22.8%) and
the average distance was 18.7 mm (range 4–70). The
distance to the proximal (ampullary side) and the distal
side were 11.1(5–45) mm, 11.6(4–50) mm respectively.
The presence of mpd was significantly frequent in more
localized tumor (UICC T1-2 vs. 3–4, p < 0.05), and the
tumor with fewer microscopic perineural invasion
(p = 0.002). The presence or absence of mpd did not
correlated with overall patients’ survival. In patients
underwent with pancreatoduodenectomy (PD), mpd
was present in 11.6%, its average distance to distal side
was 11.4 mm (4–23) and mpd ≥2 cm was 3.3%,
whereas in distal pancreatectomy (DP), mpd in 21.8%,
its average distance to proximal side 11.6 mm (range
5–45) and mpd ≥2 cm 4.7%. The frequencies of mpd
≥2 cm in PD and DP are similar.
Conclusion: To secure resectional margin 2 cm in per-
forming radical surgery for invasive ductal carcinoma
seemed to be appropriate in our study, however 3.8%
of patients require surgical margins more than 2 cm.
The patients with localized tumor had better be more
taken care for pancreatic cut margin positive for cancer
cell and intraoperative frozen section examination will
be usually required.
APHPB-0163
LIVER METASTASES FROM
COLORECTAL CANCER AFTER
METALLIC STENT PLACEMENT FOR
COLORECTAL OBSTRUCTION
H. Matsukiyo, M. Watanabe, K. Asai, T. Saito,
S. Kusachi, Y. Saida, Y. Nakamura, T. Enomoto and
J. Nagao
Surgery, Toho University Ohashi Medical Center,
Tokyo, Japan
Objectives: Colorectal stent placement is a procedure
to treat colorectal obstruction using self-expandable
metallic stent (SEMS). Traditionally, obstructive
colorectal cancer was treated by performing temporary
colonostomy. However, this technique has decreased
patients’ quality of life (QOL). In this study, we ana-
lyzed the patients with liver metastasis from obstructive
colorectal cancer with SEMS avoiding the temporary
colonostomy.
Methods: From 2004 to 2014, 68 cases with obstructive
colorectal cancer were inserted SEMS. Among these
cases, 18 cases with liver metastases were analyzed.
Results: Synchronous liver metastases in 13 cases,
asynchronous in 5 cases. Ireus before colorectomy was
observed in 16 cases, depth of tumor invasion of pri-
mary colorectal cancer over SS in all, lymph node
metastases in 11 cases. Hepatectomy was performed in
9 cases, unresectable in 9 cases including distant metas-
tases in 5 cases, multiple liver metastases over H2 stage
in 3cases, peritoneal dissemination in 2 cases. Preopera-
tive percutaneous transhepatic portal embolization was
performed in 2 cases. 9 Hepatectoies included 4 cases
of right hepatectomy, one case of medial sectionecto-
my, and 2 cases of partial resection, 2 cases of laparo-
scopic lateral hepatectomy. Regarding to the recurrence
after hepatectomies, 3 cases were occurred hepatic
recurrence, which were operated re-hepatectomies, and
2 cases were occurred lung metastasis, which were oper-
ated peunectomy. Chemotherapy was introduced after
surgery in 8 cases.
Conclusion: Regarding to the therapeutic strategy of
the obstructive colorectal cancer, SEMS is a preferable
management, which is possible to perform one stage
colorectomy avoiding the temporary colostomy. This
management seems to perform hepatetomies and che-
motherapy in short interval and may improve QOL.
Benign HPB Diseases
APHPB-0164
ST2 IS A BIOMARKER FOR LIVER
CIRRHOSIS CAUSED BY
SCHISTOSOMA JAPONICUM
INFECTION
X. Long1, Q. Chen2, J. P. Zhao1, N. Rafaels3, H. F.
Liang1, J. Potee3, M. Campbell3, B. X. Zhang1, K. C.
Barnes3 and X. P. Chen1
1Hepatic Surgery Center, Tongji Hospital, Wuhan,
China; 2Gastroenterology, Tongji Hospital, Wuhan,
China; 3Allergy and Clinical Immunology, School of
Medicine, The Johns Hopkins University, Baltimore,
MD, USA
Objectives: Schistosoma japonicum infection is a signifi-
cant public health problem in Asia, and chronic infec-
tion often leads to liver cirrhosis, which is life-
threatening. ST2, a potent Th2 molecule, has been
associated with hepatic fibrosis; however, the relation-
ship between ST2 and schistosomiasis-induced liver cir-
rhosis is unknown. This study aims to elucidate the
role of ST2 in liver cirrhosis associated with schistoso-
miasis.
Methods: 646 patients with schistosomiasis (339 with
and 307 without liver cirrhosis) and 301 unaffected
controls were recruited from Hubei province, China, an
area endemic for S. japonicum. Six single nucleotide
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polymorphisms (SNPs) in IL1RL1, the gene encoding
ST2, were genotyped in all samples. Soluble ST2 (sST2)
was measured by ELISA in serum samples from a sub-
set of 868 participants and tests for association between
ST2 SNPs and sST2 levels were performed using R and
PLINK. The study was approved by the IRBs that sub-
jects gave written consent.
Results: sST2 levels in the end-stage group were signifi-
cantly higher than the chronic group (p = 0.000) and
controls (p = 0.000). SNP rs12712135 was positively
associated with sST2 levels after adjusting covariates
(p = 1.30E-14). SNPs rs1420101, rs6543119, rs10206753
were negatively associated with sST2 levels (p = 1.25E-
07; p = 2.08E-07; p = 0.002). SNPs rs12712135,
rs1420101, rs6543119 were more strongly associated
with risk of disease in the end-stage group (p = 3.72E-
08, 2.84E-05, 2.44E-05 respectively) compared to the
chronic group (p = 3.90E-07, 0.007, 0.008, respectively)
and controls (p = 0.0002, 0.003, 0.007, respectively).
Conclusion: Our results implicate ST2 as a biomarker
for S. japonicum-induced liver cirrhosis, and a role for
ST2 polymorphisms in schistosomiasis.
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APHPB-0165
POSTOPERATIVE OUTCOME AFTER
MAJOR LIVER RESECTION IN
JAUNDICED PATIENTS WITH
PROXIMAL BILE DUCT CANCER
WITHOUT PREOPERATIVE BILIARY
DRAINAGE
E. El Hanafy, M. Abdel Wahab, A. El Nakeeb and
E. H. A. B. Atef
Gastroenterology and Transplantation Center, Mansoura
Faculty of Medicine, Mansoura, Egypt
Objectives: The need for routine use of preoperative
biliary drainage (PBD) before major liver resection in
jaundiced patients has recently been questioned. Our
aim was to present our experience of patients with
proximal bile duct cancer who undergo major liver
resection without PBD and compare these results with
patients without biliary obstruction who underwent
major liver resection
Methods: Eighty-six consecutive jaundiced patients
underwent major liver resection without PBD. For each
patient with malignant obstructive jaundice, subjects
with underlying liver tumor were selected. Eighty-nine
patients fulfilled all selection criteria and formed the
control group.
Results: Forty-eight patients underwent right or
extended right hepatectomy and 38 patients underwent
left or extended left hepatectomy. Fifty-four jaundiced
patients (63%) and 19 non jaundiced patients (21%)
received blood transfusion (p = 0.04). Fifty-three
patients (62%) in the jaundiced group and 17 (19%) in
the control group experienced postoperative complica-
tions (p = 0.003) [Subphrenic collections (p = 0.02),
wound infection (p = 0.02) and bile leaks (p < 0.001)].
In contrast, there were no significant differences for
mortality (6% vs. 2%) and transient liver failure (10%
vs. 3%) between both groups. Those patients who
underwent extended right hepatectomy (more than
50% resection) express high morbidity and mortality.
Conclusion: Major liver resection without PBD leaving
a liver remnant of more than 50% is safe in jaundiced
patients. However, transfusion requirement and inci-
dence of post operative complications are higher in
jaundiced patients than in control. There is no evidence
that PBD can reduce the rate of these complications.
APHPB-0166
HEPATIC RESECTION FOR HCC IN
PATIENTS WITH PORTAL
HYPERTENSION: A LONG-TERM
BENEFIT COMPARED WITH
TRANSARTERIAL
CHEMOEMBOLIZATION AND
THERMAL ABLATION
B. H. Zhang, H. Xiao, B. Mei, G. Wei, R. Wang,
B. X. Zhang and X. P. Chen
Surgery, Tongji Hospital, Tongji Medical College, Hua
Zhong University of Science and Tec, Wuhan, China
Objectives: The optimal treatment for HCC in cirrhotic
patients with portal hypertension (PHT) is still contro-
versial. The objective of this study is to compare the
outcomes of hepatic resection for HCC in cirrhotic
patients with PHT with those without PHT, and those
with PHT but managed with transarterial chemoembo-
lization (TACE) or thermal ablation.
Methods: A total of 167 cirrhotic patients with HCC
were retrospectively analyzed. Patients were divided
into 3 groups: presence (PHT-R group, n = 58) or
absence (NPHT-R group, n = 67) of PHT at the time
of hepatic resection, and those with PHT who were
performed other treatments including TACE or thermal
ablation (PHT-O group, n = 42). The short- and long-
term outcomes were compared among the 3 groups.
Results: The PHT-R group had better liver function
compared with those in the PHT-O group (patients had
Child-Turcotte-Pugh class B liver function: 5.2% vs.
31%, p = 0.001). Operative mortality and morbidity
were all similar among the 3 groups. The 1-, 3-, 5-year
survival rates were 80.4%, 55.6% and 28.1% in the
PHT-R group, which were similar compared with the
NPHT-R group (79.1%, 64.2% and 39.8%, p = 0.313),
but significant better than those in the PHT-O group
(60.7%, 24.4%, and 7.3%, p < 0.001). Multivariate
analysis identified only serum alpha-fetoprotein level
and number of tumors as independent predicting fac-
tors for survival.
Conclusion: Hepatic resection is associated with similar
shout-term outcomes and better long-term results for
HCC in selected cirrhotic patients with PHT compared
with TACE and thermal ablation.
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APHPB-0168
RADIOFREQUENCY-ASSISTED RIGHT
HEPATECTOMY FOR
HEPATOCELLULAR CARCINOMA
THROUGH ANTERIOR APPROACH – 32
CASES REPORTS
K. Ma, J. U. N. Yan, X. Feng, F. E. N. G. Xia, X. Li
and P. I. N. G. Bie
Hepatobiliary Surgery, Southwest Hospital, Third
Military Medical University, Chongqing, China
Objectives: To study the efficacy of radiofrequency-
assisted right hepatectomy for hepatocellular carcinoma
(HCC) through anterior approach.
Methods: The clinic datas of 32 HCC patients who
underwent radiofrequecy-assisted right hepatectomy
through anterior approach from December 2012 to
August 2014 were collected retrospectively. The 31
patients were male, 1 Famle, range from 39 to 73 years
with a mean of (50  7) years. 29 of the 32 patients
were infected with hepatitis B virus. A retrohepatic tun-
nel anterior to the surface of the inferior vena cava
(IVC) was created. The liver was hanged away from
the IVC and radiofrequency ablation was carried out
along the Cantline’s line. Clamp crushing was used to
divide off the liver parenchyma along the middle of the
ablated area until the parenchyma was fully resected.
After short hepatic veins and the right hepatic vein
were ligated, ligaments of right liver were fully isolated
and right liver was resected.
Results: The surgical time was 195–445 min, with a
mean of (281  58) min. The bleeding was 200–
1800 mL, with a mean of (574  381) mL. The postop-
erative hospital stay was 4–54 days, with a mean of
(16  8) days. There were 8 medical complications and
1 postoperative death. Except one death patient, all
other patients were cured and discharge.
Conclusion: Radiofrequency-assisted right hepatectomy
for HCC through anterior approach is safe and effec-
tive.
Benign HPB Diseases
APHPB-0169
ENDOSCOPIC NASO-GALLBLADDER
DRAINAGE FOR ACUTE
CHOLECYSTITIS IN HIGH RISK
PATIENTS
H. Kimura, S. Takahata, T. Fujimoto, K. Date,
T. Matsunaga, K. Tamura, Y. Miyasaka, D. Yamada,
T. Ohtsuka and M. Tanaka
Department of Surgery and Oncology, Kyushu
University Hospital, Fukuoka, Japan
Objectives: This study aimed to clarify the usefulness
of endoscopic naso-gallbladder drainage (ENGBD) for
acute cholecystitis (AC) in patients at high risks to
undergo percutaneous transhepatic gallbladder drainage
(PTGBD).
Methods: Medical records of 6 patients who underwent
ENGBD for AC were retrospectively reviewed. Five-
French nasobiliary tube was used for drainage.
Results: The indications for ENGBD were usage of
anticoagulation or antiplatelet drugs in 5 patients, and
thrombocytopenia due to hematologic malignancy in
the remaining one. In addition, there were anatomical
obstacles against PTGBD such as ascites due to the
presence of a ventriculoperitoneal shunt or a vascular
graft in the right upper abdomen. AC was relieved by
ENGBD in all of the 6 patients. Three of them under-
went laparoscopic cholecystectomy (LC) with the
ENGBD tube in place, and the tube was used for intra-
operative cholangiography or as the guide to identify
the cystic duct during LC. The patient with hematolog-
ic malignancy could be transferred to chemotherapy
smoothly after removal of the ENGBD tube. The
remaining 2 patients could be discharged after cutting
the tube for conversion to internal stenting.
Conclusion: ENGBD is useful for patients who cannot
undergo PTGBD or emergency LC safely. By enabling
easy identification of the cystic duct, the ENGBD tube
contributes to avoidance of bile duct injury during LC.
Furthermore, because the ENGBD tube can be cut or
removed immediately without the need for percutane-
ous fistula formation, patients can be discharged or
transferred to the treatment of comorbidities quickly.
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APHPB-0173
IDENTIFICATION OF NEW TISSUE
BIOMARKERS TO PREDICT BIOLOGIC
FEATURES OF HEPATOCELLULAR
CARCINOMA
Y. Nomura1, H. Yano2, O. Nakashima3,
S. Ogasawara2, Y. Hirakawa1, K. Takahashi1,
Y. Gotou1 and K. Okuda1
1Surgery, Kurume University School of Medicine,
Fukuoka, Japan; 2Pathology, Kurume University School
of Medicine, Fukuoka, Japan; 3Clinical Laboratory
Medicine, Kurume University School of Medicine,
Fukuoka, Japan
Objectives: Biologic features of hepatocellular carcino-
mas (HCCs) relate with the treatment and the progno-
sis. Previously, we isolated the side population (SP)
cells from 2 HCC cell lines established from a single
HCC nodule. We further performed cDNA microarray
analysis of both SP cells and found 11 increased gene
expression in common. In the present study, we per-
formed immunohistochemical examination and deter-
mined the relationship between the expression and
biological features.
Methods: We used 100 cases of HCC (<5 cm in diame-
ter) obtained from the patients who undergone curative
hepatectomy. Immunoreactivity of Annexin A1
(ANXA1), E74-like factor 3 (ELF3), and Janus kinase
and microtubule interacting protein 3 (JAKMIP3) was
evaluated with IHC score obtained by multiplying inten-
sity of positive cells by area of positive cells. The relation-
ship between each or sum of IHC score of 3 molecules
and clinicopathological parameters were examined.
Results: Each of IHC score was significantly higher in
poorly differentiated HCCs, in HCCs with high inci-
dence of portal vein invasion, and in HCCs with intra-
hepatic metastasis. Sum of 3 IHC scores could show
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the same or more significant results. When 100 cases
were classified into 2 groups according to the sum of
IHC score of 3 molecules, low IHC score group
showed significantly better overall survival rate than
high IHC group.
Conclusion: ANXA1, ELF3, and JAKMIP3 are
strongly expressed in HCCs with more malignant bio-
logic features and poor prognosis. Immunostaining of 3
molecules in HCC tissues may be useful to predict the
biologic feature and prognosis.
APHPB-0174
NEOPLASTIC SPINDLE CELLS ARE AN
INDEPENDENT PROGNOSTIC FACTOR
IN PANCREATIC CANCER
K. Takahashi1, T. Hisaka1, H. Horiuchi1,
H. Ishikawa1, M. Nakayama2, O. Nakashima2, H.
Yano2, K. Okuda1 and Y. Akagi1
1Surgery, Kurume University School of Medicine,
Fukuoka, Japan; 2Pathology, Kurume University School
of Medicine, Fukuoka, Japan
Objectives: Several reports showed that Neoplastic
spindle cells (NSCs) may be strongly involved in the
invasion, metastasis and poor prognosis and epithelial-
mesenchymal transition (EMT). It has not yet been
investigated that NSCs relate to the recurrence and
prognosis in various cancers, Furthermore, NSCs are
participate in EMT in pancreatic cancer (PC) too. We
clinicopathologically investigated the association
between NSCs and the recurrence, prognosis, and
EMT in PC.
Methods: We studied 68 PC patients. Cancer cells with
a spindle or oval shape that do not exhibit luminal
structures were defined as NSCs. We graded NSCs
regarding to an area of NSCs at hematoxylin and eosin
stain (NSC grade) and examined the participation in
NSCs and EMT by immunohistostaining of Snail anti-
body and E-cadherin antibody.
Results: In multivariate analysis, NSC grade was an
independent risk factor for disease-free survival and
overall survival. This was independent of TNM stage
and histological grade. NSCs were related to EMT pat-
tern in immunohistostaining, significantly.
Conclusion: NSC grade significantly related to the
recurrence and prognosis of PC. NSC grade assessment
can be not only performed inexpensively and conve-
niently, but also used to guide future individualized
therapeutic approaches. Furthermore, NSCs was found
to relate to EMT, profoundly.
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APHPB-0176
LAPAROSCOPIC COMMON BILE DUCT
EXPLORATION: PATIENT SELECTION
FOR NON EXPERIENCED SURGEON
E. El Hanafy, T. Kandiel, E. H. A. B. Atef and A. El
Nakeeb
Gastroenterology and Transplantation Center, Mansoura
Faculty of Medicine, Mansoura, Egypt
Objectives: Most laparoscopic surgeons prefer the ‘sin-
gle-stage’ laparoscopic approach to cholelithiasis and
choledocholithiasis in an attempt to decrease the need
for multiple procedures and their associated morbidity
and mortality. This is a preliminary experience aiming
at evaluation of laparoscopic common bile duct explo-
ration in a selected group of patients with choledocho-
lithiasis to choose good selection criteria.
Methods: From March 2011 to May 2013, 50 patients
with CBD stones underwent laparoscopic common bile
duct exploration
Results: Fifty patients with common bile duct stones
underwent laparoscopic common bile duct exploration,
with successful completion in 47 cases and the remain-
ing 3 cases requiring conversion to open surgery; Two
patients underwent laparoscopic trans-cystic approach
with successful CBD clearance in both patients as they
have small stones below 0.5 cm. Forty-five patients
requires laparoscopic choledochotomy. Hospital mor-
bidity occurred in 2 (4%) patients; one with minor bile
leak which managed conservatively, one with missed
common bile duct stone who requires endoscopic stone
removal 5 days postoperatively. There was no operative
mortality.
Conclusion: Laparoscopic common bile duct explora-
tion is a feasible, safe and effective procedure that car-
ries a low morbidity and mortality. Patient selection is
mandatory especially in the first few cases till the learn-
ing curve approached
APHPB-0177
COMPARISON OF SELECTIVE
LAPAROSCOPIC COMMON BILE DUCT
EXPLORATION WITH LAPAROSCOPIC
CHOLECYSTECTOMY VERSUS
ENDOSCOPIC RETROGRADE
PANCREATOGRAPHY AND
LAPAROSCOPIC CHOLECYSTECTOMY
FOR CHOLEDOCHOLITHIASIS: A CASE
SERIES STUDY
M. Sharifudin1, D. Klokol1 and K. Vishakan2
1Unit of HPB Surgery, Department of Surgery, Hospital
Queen Elizabeth, Kota Kinabalu, Malaysia; 2Department
of Surgery, Hospital Queen Elizabeth, Kota Kinabalu,
Malaysia
Objectives: The management of choledocholithiasis in
the era of key-hole surgery is fraught with conundrums.
An array of options exist (1) Laparoscopic CBD Explo-
ration + Laparoscopic Cholecystectomy (2)
ERCP + Lap Chole. The aim of our study is to prove
the efficacy, safety, surgical outcomes and cost- effec-
tiveness of performing selective Lap CBD explorations
as a single stage treatment modality as opposed to a 2
stage procedure.
Methods: 27 patients were selected to the main group
for laparoscopic cholecystectomy with CBD explora-
tion. The control group was comprised of 39 patients
whom ERCP followed by laparoscopic cholecystectomy
was performed. The following data in both groups were
analyzed and compared: complications rate, duration
of hospital stay, total cost of treatment.
Results: In all 27 selected patients laparoscopic
operation was successful, with zero conversion rate. No
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significant intra-operative or post-operative complica-
tions were observed in the main group. 1 patient
(3.7%) had minor post-operative bile leak. No cases of
residual CBD stones noted. Mean hospital stay was 3–
6 days.
Control group had higher rate of complications (post-
ERCP pancreatitis and cholangitis) – 10.26%. Conver-
sion rate in this group was 5.1%.
Conclusion: Single stage laparoscopic cholecystectomy
with CBD exploration is a safe and effective procedure
which can be recommended with the proper selection
of patients.
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APHPB-0178
LAPAROSCOPIC RIGHT
HEPATECTOMY VERSUS OPEN RIGHT
HEPATECTOMY: META-ANALYSIS
M. Kasai1 and M. Hilal2
1Department of Gastroenterological Surgery, Sendai
Kousei Hospital, Sendai, Japan; 2Department of Hepato-
Biliary and Pancreatic Surgery, University Hospital
Southampton NHS Foundation Trust, Southampton, UK
Objectives: Laparoscopic right hepatectomy (LRH)
have been reported as a most challenging but capable
procedure by the number of experienced centers in the
world. However the short-term outcomes including
postoperative morbidity and mortality compared with
open right hepatectomy (ORH) have not been properly
evaluated. The purpose of this study to assessed the
safety and benefits of LRH as the standard procedure.
Methods: Pubmed was searched for articles which
reported LRH compared with ORH up to July 2014.
Short-term outcomes including blood loss, operative
time, length of hospital stay and postoperative compli-
cation and mortality were analyzed.
Results: There were a total of 131 patients in the LRH
group and 175 in the ORH group. A total of 15
conversions (11.5%) from laparoscopic to Open or
Lap-assist surgery were reported. Blood loss was signif-
icantly decreased in LRH (mean difference: 265 mL;
95% CI: 398 to 133 mL; p < 0.001). Hospital stay
was significantly shorter in LRH (mean difference:
2.2 days; 95% CI: 3.1 to 1.3 days; p < 0.0001). The
pooled odds ratios for postoperative morbidity was
found to be 0.54 (OR: 0.54; 95% CI: 0.315–0.9098,
p = 0.02). No significant difference was observed
between the both groups for operative time and post-
operative mortality.
Conclusion: This meta-analysis demonstrated that LRH
may have potential short-term advantages in terms of
blood loss and postoperative complications and hospi-
tal stay without prolonging operative time and increas-
ing mortality rate. Lager prospective randomized
studies with longer observation periods are ideal to ver-
ify long-term benefits of LRH.
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APHPB-0179
TECHNIQUES AND INNOVATIONS IN
LAPAROSCOPIC CHOLECYSTECTOMY
VIA A SINGLE-INCISION APPROACH
IN PATIENTS WITH DENSE
ADHESIONS
M. Watanabe, K. Asai, H. Matsukiyo, T. Saitoh,
Y. Saida, S. Kusachi and J. Nagao
Surgery, Toho University Ohashi Medical Center,
Tokyo, Japan
Objectives: The laparoscopic approach is sometimes
rejected in favor of open surgery in cholecystectomy
patients with dense adhesions from previous multiple
or upper abdominal surgeries that require adhesiolysis
and reduce intraperitoneal visibility, thus preventing
ports from being safely placed. We present techniques
and innovations for an multichannel access port +1
port single-incision approach for laparoscopic cholecys-
tectomy (LC) in patients with dense adhesions. This
approach is recommended for its safety rather than its
cosmetic benefits.
Methods: The access ports are placed in a secure posi-
tion following ultrasound assessment of abdominal wall
adhesions. Minilaparotomy comprising a 2.5-cm verti-
cal incision at the access port site is performed without
cosmetic consideration. The access ports are inserted
after adhesiolysis based on direct observation of adhe-
sions surrounding the incision site. Despite the exis-
tence of dense adhesions such as omental adhesions,
the single-incision approach facilitates safe adhesiolysis
under a good field of vision. An additional 5-mm port
placed in the right hypochondrium further facilitates
gall bladder access and manipulation.
Results: In all our patients treated using this method,
no intra- or postoperative complications were observed
and no additional port placements or conversions to
laparotomy were required.
Conclusion: In patients with dense adhesions, a single-
incision laparoscopic approach extends the field of
vision and enables safe and easy adhesiolysis with mini-
mal invasiveness. Multichannel access port +1 port LC
in patients with dense adhesions due to previous
abdominal surgery offers an effective surgical technique
from the perspective of safety rather than cosmetic con-
siderations.
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APHPB-0180
EFFECT OF SPLENECTOMY ON
IMMUNE CELL STATE IN HEPATITIS C
VIRUS RELATED CIRRHOTIC
PATIENTS WITH PORTAL
HYPERTENSION
N. Huang1, F. Ji2, S. Zhang3, Z. Cai2, A. Jiang3,
R. Zhou3, B. Li1, S. Ren3 and Z. Li3
1National-Local Joint Engineering Research Center of
Biodiagnostics & Biotherapy, The Second Affiliated
Hospital, College of Medicine, Xi’an Jiaotong
University, Xi’an, China; 2Infectious Disease, The
Second Affiliated Hospital, College of Medicine, Xi’an
Jiaotong University, Xi’an, China; 3General Surgery,
The Second Affiliated Hospital, College of Medicine,
Xi’an Jiaotong University, Xi’an, China
Objectives: To investigate the immunological changes
after splenectomy in hepatitis C virus (HCV) related
cirrhotic patients with portal hypertension, and then to
evaluate the immunological function of hypertensive
spleen in this populations.
Methods: From December 2011 to 2013, 12 HCV
related cirrhotic patients with portal hypertension
underwent splenectomy were included in this prospec-
tive study. We evaluated natural killer (NK) cell and
NKT cell activity, T-lymphocyte subsets such as
CD4+, CD8+ and CD4+/CD8+ ratio, and the ratio of
CD19+B cells to all lymphocytes by flow cytometry in
peripheral blood just before and 2–6 weeks after sple-
nectomy.
Results: The activity of CD3-CD56+ NK cell and
CD3-CD56+CD16+ NK were significantly enhanced in
2 and 6 weeks after splenectomy (all p < 0.05), espe-
cially in the subsets of CD56dim NK cell (both
p < 0.01). The activity of CD3+CD56+ NKT cell also
was significantly enhanced in 2 weeks after splenectomy
(p < 0.05). Compared with pre-operation, the ratio of
CD4+ T cells to all lymphocytes were significantly
decreased (both p < 0.01) and the ratio of CD8+ T
cells to all lymphocytes were significantly increased
(both p < 0.05) in 2 and 6 weeks post-operation, result-
ing in a significant decrease in the CD4+/CD8+ ratio
(both p < 0.05). Compared with pre-operation, the
ratio of CD19+B cells to all lymphocytes was slightly
decreased in 2 weeks (p > 0.05), and it was significantly
decreased 6 weeks post-operation (p < 0.05).
Conclusion: Hypertensive spleen may play a negative
role in immune regulation function in patients with
HCV cirrhosis. Splenectomy may cause beneficial
immunological changes in cirrhotic patients with HCV
infection.
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APHPB-0182
SURVIVAL AFTER
PANCREATICODUODENECTOMY FOR
PERIAMPULLARY CARCINOMAS,
MANSOURA EXPERIENCE – EGYPT
E. Negm, A. El Nakeeb, T. Salah, E. El Hanafy,
T. Abd Allah and M. Abd El Wahab
Gastroenterology Surgical Center, Faculty of Medicine,
Mansoura University, Mansoura, Egypt
Objectives: Although the safety of pancreaticoduoden-
ectomy has notably improved over the past several dec-
ades, the reported survival of patients remains poor.
Methods: This study was held in Mansoura Gastroenter-
ology Center, Mansoura University, Egypt. 555 consecu-
tive patients underwent pancreaticoduodenectomy for
periampullary carcinomas between 1992 and 2011.
Patients from 1992 to 2001 (Group I) were compared with
patients from 2002 to 2011 (Group II). Detection of
patient survival was the main outcome measure. The
effects of various factors on patient survival were studied.
Results: During the time period analyzed, 555 patients
underwent pancreaticoduodenectomy to treat periam-
pullary carcinomas. There were no operative deaths.
Hospital mortality was 34/555 (6.1%); 22/105 (21%)
among group I and 12/450 (2.7%) among group II
(p < 0.05). Missed cases from follow up were 51/555
(9.2%). One year survival was 65%; 45.5% (Group I)
and 69.5% (Group II). Three years survival was
39.9%; 26.8% and 43.8% respectively. Five years sur-
vival was 14.9%; 10.6% and 16.6% respectively. Both
groups had equivalent demographic and pathological
characteristics. Predictors of poor survival were pancre-
atic carcinoma, poorly differentiated tumors, lymph
node metastases, perineural invasion, operative blood
loss of more than 500 mL and undergoing an operation
before 1998 (p < 0.05).
Conclusion: Survival after pancreaticoduodenectomy
for periampullary carcinomas has substantially
improved due to improved operative technique. Factors
associated with prolonged survival were being well dif-
ferentiated ampullary carcinomas, the absence of lymph
node metastases and perineural invasion in the resected
tumor specimen, less blood loss and undergoing an
operation more recently.
APHPB-0183
PANCREATIC JUICE CYTOLOGY IS A
GOOD PREDICTOR FOR MALIGNANT
BRANCH DUCT INTRADUCTAL
PAPILLARY MUCINOUS NEOPLASMS
OF THE PANCREAS HAVING
WORRISOME FEATURES
K. Date, T. Ohtsuka, T. Fujimoto, H. Kimura, T.
Matsunaga, Y. Watanabe, K. Tamura, S. Takahata
and M. Tanaka
Surgery and Oncology, Kyushu University Hospital,
Fukuoka, Japan
Objectives: It still remains difficult to predict malignant
intraductal papillary mucinous neoplasm (IPMN)
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preoperatively. This study aimed to elucidate the preop-
erative clinical factors which could predict the malig-
nant IPMN precisely.
Methods: The medical records of 120 patients who
underwent pancreatectomy for IPMN at the Depart-
ment of Surgery and Oncology, Kyushu University,
between January 2006 and April 2014 were retrospec-
tively reviewed. Patients with concomitant pancreatic
ductal adenocarcinoma were excluded. High grade dys-
plasia and invasive carcinoma were classified as malig-
nant. The clinical factors evaluated in this study were
as follows; ‘high-risk stigmata’ and ‘worrisome features’
defined in Fukuoka international consensus guidelines,
abnormal level of carcinoembryonic antigen and carbo-
hydrate antigen 19-9, presence of symptom, mural nod-
ules, pancreatic juice cytology (PJC).
Results: Twenty-three of 38 main duct IPMN (MD-
IPMN) (61%) and 32 of 82 branch duct IPMN (BD-
IPMN) (39%) were malignant. Eighteen of 22 ‘high-
risk BD-IPMNs’ (82%), 14 of 52 (27%) ‘worrisome
BD-IPMNs’, and none of 8 (0%) ‘low risk BD-IPMNs’
were malignant. In the ‘worrisome BD-IPMNs’, PJC
was a significant predictive factor for malignancy by
univariate and multivariate analyses. The sensitivity,
specificity, accuracy of PJC in ‘worrisome BD-IPMNs’
were 67%, 94%, 87%, respectively.
Conclusion: ‘Worrisome BD-IPMNs’ with positive PJC
as well as MD-IPMNs and ‘high-risk BD-IPMNs’ are
good predictors for malignant IPMNs.
APHPB-0184
IS THERE THE DIFFERENCE OF THE
LOCATION OF LYMPH NODE
METASTASIS DEPENDING ON THE
SITE OF TUMOR IN THE
EXTRAHEPATIC BILE DUCT CANCER?
Y. Kato, S. Takahashi, N. Gotohda, K. Kitaguchi, Y.
Nakayama, Y. Nishida, R. Okada, D. Takahashi, S.
Ohkubo and M. Konishi
Hepatobiliary Pancreatic Surgery, National Cancer
Center Hospital East, Kashiwa, Japan
Objectives: We planned to reveal the frequent site of
the lymph node metastasis depending on the location
of tumor in the extrahepatic bile duct cancer.
Methods: 94 patients underwent pancreatoduodenecto-
my (PD) for extrahepatic bile duct cancer with curative
intent in our institution. The clinicopathological factors
and survival outcomes of the patients were analyzed
retrospectively. We measured the distance from papilla
to lowermost margin of tumor, uppermost margin of
tumor, upper margin of pancreas and orifice of cystic
duct to investigate the correlation tumor location and
the frequent site of nodal metastasis.
Results: The frequency of nodal metastasis was as fol-
lows; common hepatic artery (CHA) node in 7 (7.4%),
celiac artery (CA) node in 1 (1.1%), hepatoduodenum
ligament (HDL) node in 17 (18.1%), posterior pancre-
aticoduodenal (PPD) node in 26 (27.7%), anterior pan-
creaticoduodenal (APD) node in 3 (3.2%), superior
mesenteric artery (SMA) node in 6 patients (6.4%). In
the cases that the length from papilla to lower margin
was more than 30 mm (n = 28), the frequency of nodal
metastasis to PPD node (7.1%) and SMA node (0.0%)
is significantly lower than the cases <30 mm (n = 66);
the frequency of nodal metastasis to PPD node
(36.4%) and SMA node (9.0%). In the cases that the
length from papilla to upper margin was <40 mm
(n = 30), the frequency of nodal metastasis to CHA
node (0.0%) and HDL node (6.7%) is significantly
lower than the cases more than 40 mm (n = 64); the
frequency of nodal metastasis to CHA node (10.9%)
and HDL node (23.4%).
Conclusion: The frequency of nodal metastasis is differ-
ent according to tumor location.
APHPB-0186
HISTOLOGICAL SEVERITY OF
CIRRHOSIS DETERMINES LONG-TERM
OUTCOMES OF LIVER RESECTION
FOR HEPATOCELLULAR CARCINOMA
B. Liang, Z. Huang and X. Chen
Research Laboratory and Hepatic Surgery Center,
Department of Surgery, Tongji Hospital, Tongji Medical
College, Huazhong University of Science & Technology,
Wuhan, China
Objectives: The impact of histological severity of cir-
rhosis on long-term outcomes of liver resection for
hepatocellular carcinoma (HCC) has not been well
defined. This study aims to investigate the impact of
histological severity of cirrhosis on long-term outcomes
of liver resection in patients with HCC.
Methods: 1537 patients with HCC undergoing liver
resection were retrospectively studied. By analyzing sur-
gical specimen, these patients were stratified into 4
groups (no cirrhosis, mild cirrhosis, moderate cirrhosis,
and severe cirrhosis) based on evaluation of severity of
cirrhosis according to the Laennec system. The long-
term outcomes and clinicopathologic factors were ana-
lyzed.
Results: The 5-year recurrence-free and overall survival
rates were 38.0% and 67.8%, respectively, in the group
of no cirrhosis; 36.0% and 62.8%, respectively, in the
group of mild cirrhosis; 16.7% and 44.9%, respectively,
in the group of moderate cirrhosis and 6.0% and
25.6%, respectively, in the group of severe cirrhosis.
There was no significant difference between the group
of no cirrhosis and the group of mild cirrhosis in recur-
rence-free or overall survival, whereas the recurrence-
free and overall survivals in the groups of moderate or
severe cirrhosis were significantly worse than those in
the groups of no cirrhosis or mild cirrhosis.
Conclusion: Histological severity of cirrhosis signifi-
cantly affects long-term outcomes of liver resection in
patients with HCC. For those HCC patients with no
cirrhosis or mild cirrhosis, liver resection achieves
favorable long-term outcomes and therefore is the ideal
treatment. For those with moderate or severe cirrhosis,
liver transplantation could be a consideration.
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APHPB-0187
SIMULTANEOUS RESECTION FOR
COLORECTAL CANCER AND
SYNCHRONOUS LIVER METASTASES
Y. Fukami, Y. Kaneoka, A. Maeda, Y. Takayama, S.
Onoe and M. Isogai
Surgery, Ogaki Municipal Hospital, Gifu-shi, Japan
Objectives: The correct timing of hepatectomy in
patients with synchronous colorectal liver metastases is
unclear. The aim of this study was to assess the clinical
value of simultaneous resection (SR) for patients with
colorectal cancer and synchronous liver metastases.
Methods: Between January 2006 and December 2013,
158 patients underwent the resection of primary colo-
rectal cancer and liver metastases. Ninety-five patients
possessed metachronous colorectal liver metastases, and
the remaining 63 had synchronous colorectal liver
metastases. Of those with synchronous colorectal liver
metastases, 41 patients (65%) underwent SR, and 22
(35%) underwent delayed resection (DR). The clinico-
pathologic and operative data and the surgical out-
comes of patients in the SR and DR groups were
retrospectively analyzed and compared.
Results: The mortality rates were zero in both groups.
The type of primary/liver resection, liver resection time,
total blood loss volume, R0 resection rate, and morbid-
ity rate were similar in the two groups. The SR group
was associated with a shorter total postoperative hospi-
tal stay (21 vs. 32 days, p < 0.001). The overall survival
rate was similar in the two groups (3-year survival,
65.6% in the SR group versus 66.8% in the DR group,
p = 0.054). Multivariate analysis indicated that male
gender (p = 0.004) and a liver tumor size of ≥5 cm
(p = 0.031) were independently associated with overall
survival after surgery.
Conclusion: When compared with DR, the simulta-
neous resection of colorectal cancer and synchronous
liver metastases in patients is associated with a compa-
rable morbidity rate and shorter hospital stay, even
when following a rectal resection and major hepatec-
tomy.
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COMPARISON BETWEEN TOKYO
GUIDELINES 2007 (TG07) AND 2013
(TG13) IN OUR CASES OF THE ACUTE
CHOLECYSTITIS
T. Abe, T. Naito, T. Okada, K. Nakagawa, H.
Hayashi, T. Morikawa, H. Yoshida, F. Motoi, Y.
Katayose and M. Unno
Surgery, Tohoku University Hospital, Sendai, Japan
Objectives: TG07 were reported in 2007 as the first
international practical guidelines for management of
acute cholangitis and cholecystitis. Recently the Tokyo
guideline were revised as TG13. This study aimed to
verify TG13 compared to TG07.
Methods: We investigated retrospectively the patients
underwent cholecystectomy for acute cholecystitis from
January 2010 to September 2014.
Results: A total of 35 (open cholecystectomy: 3,
laparoscopic cholecystectomy: 32) patients were
included in the analysis. Of these, 19 patients (54%)
underwent operation within 3 days fron onset. The
mean age was 65.2  15.6 years. Most of patients had
some kind of preoperative complication (ASA class 1:
3, class 2: 20, class 3: 12). The severity grades according
to TG07 were mild in 11, moderate in 11, and severe in
13 patients. According to TG13, on the other hand,
they were mild in 12, moderate in 19, and severe in 4
patients. The mean operating time was 162 min. The
mean bleeding was 169.4  191.3 mL. No patients died
and morbidity rate associated with operation were
2.9%.
Conclusion: We performed early cholecystectomy for
acute cholecystitis safely. In TG13, as for the patient
who has ‘severe’ severity, an operation is not recom-
mended, but it is thought that some of them will be
permitted to have an operation. The condition for
operation is a subject for future analysis.
Malignant HPB Diseases
APHPB-0189
PREOPERATIVE NUTRITION SCORE IS
A USEFUL PROGNOSTIC INDICATOR
OF PALLIATIVE SURGERY IN
PATIENTS WITH UNRESECTABLE
PANCREATIC CANCER
N. Ozaki, S. Sugiyama, K. Doi, K. Ogata, H. Tanaka,
M. Iwatsuki, K. Yamamura, K. Shimizu and H.
Takamori
Surgery, Saiseikai Kumamoto Hospital, Kumamoto City,
Japan
Objectives: Patients with unresectable cancer are some-
times required to perform palliative surgery to relief
unpleasant symptom. When obstruction of the gastro-
intestinal tract and/or biliary tract occurs in patients
with unresectable pancreatic cancer, we need to con-
sider bypass surgery. However, there is a possibility
that bypass surgery disadvantage to the patients with-
out improvement. Therefore, it is important that clarifi-
cation of indication for bypass surgery. The aim of this
study was to determine the prognostic factors associ-
ated with an indication for palliative surgery in patients
with unresectable pancreatic cancer.
Methods: Between January 2011 and June 2014, 25
patients with unresectable pancreatic cancer underwent
palliative bypass operation. We assessed tumor-related
factors and patients factors, including CONUT (Con-
trolling Nutritional Status) score as nutritional status
to identify a useful indicator, using a prospective data-
base.
Results: The median survival time (MST) of these
patients was 108 days, with a 6-month survival rate of
32%. An unitivariate cox proportional regression
analyses revealed that CONUT ≥3, presence of dissemi-
nation, presence of other organ invasion, absence of
postoperative chemotherapy were significant negative
prognostic factors. A multitivariate cox proportional
regression analyses revealed that CONUT ≥3 and pres-
ence of dissemination were significant prognostic indi-
cators. Cut-off value of CONUT score was indicated to
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2.5 in ROC analysis. The MST of patients with
CONUT<2.5, and >2.5 was 194 and 60.5 days, respec-
tively.
Conclusion: This study demonstrated that CONUT
score is one of the most useful indicators for palliative
bypass operation in patients with unresectable pancre-
atic cancer.
Benign HPB Diseases
APHPB-0191
RANDOMIZED CONTROLLED TRIAL
OF PREEMPTIVE ADMINISTRATION
OF PARECOXIB AS PREPROCEDURE
ANALGESIA IN REDUCING PAIN POST
ENDOSCOPIC RETROGRADE
CHOLANGIO PANCREATOGRAPHY
(ERCP)
N. A. Nur Dzainuddin1, A. C. Ariffin2, Z. Zuhdi1, A.
Azman1, H. A. Othman1 and R. Jarmin1
1Hepatobiliary Unit, Universiti Kebangsaan Malaysia,
Kuala Lumpur, Malaysia; 2Surgery, Universiti Sains
Islam Malaysia, Kuala Lumpur, Malaysia
Objectives: Pain during endoscopic retrograde cholan-
giopancreatography (ERCP) are common. Parecoxib
has been used for acute pain. The aim of this study is
to determine the clinical efficacy of preemptive adminis-
tration of parecoxib for diagnostic and therapeutic
endoscopic retrograde cholangiopancreatography
(ERCP) patients.
Methods: Sixty patients were randomly assigned to
placebo group (P, n = 30) and parecoxib group
(C, n = 30). Group P received normal saline and group
C received 40 mg parecoxib which given 60 s before
administration of the sedative agents. All patients were
sedated with titrated midazolam as well as pethidine.
Pain visual analog scale (VAS: 0–10) were recorded
before and after procedure at 2 and 6 h respectively.
Results: The demographics were similar in both
groups. There were no significant differences in pre-
procedural VAS score between the two groups
(p = 0.0555). However, VAS score at 2 and 6 h post-
endoscopic retrograde cholangiopancreatography
(ERCP) show significant differences with p = 0.011 and
0.025, respectively. COX-2 have better pain control at
2 and 6 h post procedure with median (IQR) were 0
(0.1) and 0 (0.0) respectively as compared to placebo: 2
(0.4) and 0 (0.2) respectively. Complications during and
immediately after endoscopic retrograde cholangiopan-
creatography (ERCP) were not statistically significant.
Conclusion: Preemptive intravenous parecoxib (40 mg)
significantly reduced postoperative pain in patients who
had undergone an endoscopic retrograde cholangiopan-
creatography (ERCP) procedure. The analgesic efficacy
of a standard dose of parecoxib was clearly demon-
strated during the first 2 h post-procedure. Addition-
ally, patient VAS score in the parecoxib group was also
less than in the control group.
APHPB-0192
BILIARY OBSTRUCTION IN CHRONIC
PANCREATITIS – RESULTS OF A
MODIFIED TECHNIQUE OF
CHOLEDOCHO DUODENAL
ANASTOMOSIS
N. Shellagi and P. J. Halder
Surgical Gastroenterology, Jagjivan Ram Western
Railway Hospital, Mumbai, India
Objectives: Biliary obstruction is one of the known
complications of chronic pancreatitis leading to
obstructive jaundice. The aim of the study was to assess
the feasibility of performing a modified technique of
Choledocho – duodenostomy, in patients with chronic
pancreatitis with biliary obstruction.
Methods: Patients with Chronic pancreatitis with bili-
ary obstruction were included in the study over an
11 year period from June 2003 to 2014. Clinical, bio-
chemical and imaging criteria were used for establishing
biliary obstruction.
Results: Out of 110 patients operated for chronic pan-
creatitis, 36 had biliary obstruction, of which 24 under-
went modified Choledocho – duodenal anastomosis.
Pre – operative serum bilirubin levels were up to
5.0 mg/dL in 14 patients, between 5.1 and 10 mg/dL in
14 patients and more than 10 mg/dL in 8 patients.
Intra operative bile duct diameter measured up to
15 mm in 16 patients, between 15.1 and 20 mm in 14
patients and more than 20 mm in 6 patients.
On regular follow – up, only 2 patients had anasto-
motic narrowing successfully dilated endoscopically.
Conclusion:
1. The modified choledocho – duodenal anastomo-
sis is a safe and effective bilioenteric bypass.
2. The technique can be used even in bile ducts
<20 mm diameter.
3. Technically easier to perform than a hepatico –
jejunostomy/choledocho – jejunostomy.
4. CBD transaction is not required.
5. Endoscopic management is feasible.
APHPB-0193
POST-CHOLECYSTECTOMY BILE
DUCT INJURIES. A SINGLE CENTER
EXPERIENCE OF 330 PATIENTS
G. Elebidy
General Surgery, Faculty of Medicine, Mansoura
University, Mansoura, Egypt
Objectives: Iatrogenic bile duct injuries continue to
occur despite increase in experience with laparoscopic
cholecystectomy.
Methods: Between 1995 and 2012, 330 patients with
post-cholecystectomy bile duct injuries presented to
Gastroenterology Surgical Center, Mansoura Univer-
sity, Egypt. Of these patients, 232 were females and 98
patients were males. Their mean age was
38  12 years. 63% of the patients were referred from
private hospitals while 34.5% were referred from
primary hospitals. 252 patients had open cholecystecto-
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mies while 78 patients had laparoscopic cholecystecto-
mies. Regarding the type of injuries according to Stras-
berg-Bismuth classification, the most common was type
E2 injury (31.2%) followed by type A injury (20.6%).
According to the time of diagnosis, 10 patients were
diagnosed intra-operatively, 236 patients were diag-
nosed early (within 1 month of the cholecystectomy)
and 84 patients were lately diagnosed (more than 1
month after the cholecystectomy). Patients presented
with generalized peritonitis, localized peritonitis with
fistulae or with progressive jaundice.
Results: 229 patients were managed surgically where
217 patients underwent bilio-enteric reconstruction
while 122 were managed by endoscopic dilatation and
stent out of which 21 patients needed surgical recon-
struction after failed repeated dilatations.
87.3% of patients who were managed surgically showed
excellent outcomes according to Johns Hopkins criteria
compared to 78.6% for endoscopic management.
Conclusion: As a conclusion, early diagnosis of iatro-
genic bile duct injuries together with management by
experienced hepatobiliary surgeon greatly improves the
patient outcomes.
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APHPB-0194
USEFULNESS OF GNAS AND KRAS
MUTATION STATUS TO DISTINGUISH
INVASIVE CARCINOMA DERIVED
FROM INTRADUCTAL PAPILLARY
MUCINOUS NEOPLASMS OF THE
PANCREAS FROM CONCOMITANT
PANCREATIC DUCTAL
ADENOCARCINOMA
K. Tamura1, T. Ohtsuka1, K. Date1, T. Fujimoto1, T.
Matsunaga1, H. Kimura1, S. Takahata1, Y. Oda2, K.
Mizumoto1 and M. Tanaka1
1Surgery and Oncology, Kyushu University Hospital,
Fukuoka, Japan; 2Anatomic Pathology, Kyushu
University Hospital, Fukuoka, Japan
Objectives: Although pancreatic ductal adenocarci-
noma (PDAC) concomitant with intraductal papillary
mucinous neoplasms (IPMN) of the pancreas has been
widely recognized, it is sometimes hard to distinguish
invasive carcinoma derived from IPMN (Inv-IPMC)
from concomitant PDAC when these two lesions exist
in close vicinity. This study aimed to clarify the useful-
ness of GNAS and KRAS mutation analyses to distin-
guish Inv-IPMC from concomitant PDAC.
Methods: The data of 15 patients with resected con-
comitant PDAC were retrospectively reviewed, and
GNAS and KRAS mutation analyses were performed in
both IPMN and distinct PDAC lesions. As controls,
the mutational patterns were assessed between invasive
and non-invasive components in one lesion, and
between primary Inv-IPMC and metastatic site. Muta-
tional analysis was performed using high resolution
melting curve (HRM) analysis and subsequent Sanger
sequencing and/or pyrosequencing.
Results: GNAS and KRAS mutation status of invasive
and non-invasive components of Inv-IPMN was consis-
tent in 9 of 10 (90%), and the mutational patterns were
also identical between the primary tumor and meta-
static site in 3 Inv-IPMC patients (2 with lymph node
and one with lung metastases). On the contrary, muta-
tional patterns of IPMN and distinct PDAC lesions in
the same pancreas were different with each other in all
15 patients.
Conclusion: It may be possible to distinguish Inv-
IPMC from concomitant PDAC by assessing GNAS
and KRAS mutation status.
APHPB-0195
ADEQUATE TREATMENT STRATEGY
FOR AMPULLARY CARCINOMA BASED
ON THE CLINICOPATHOLOGICAL
ASSESSMENTS
T. Fujimoto1, T. Ohtsuka1, K. Date1, H. Kimura1, T.
Matsunaga1, Y. Watanabe1, K. Tamura1, S.
Takahata1, Y. Oda2 and M. Tanaka1
1Surgery and Oncology, Kyushu University Hospital,
Fukuoka, Japan; 2Anatomic Pathology, Kyushu
University Hospital, Fukuoka, Japan
Objectives: To assess the adequate treatment strategy
for ampullary carcinoma.
Methods: Clinicopathological data of 41 patients who
underwent resection of ampullary carcinoma between
January 2000 and May 2014 were retrospectively ana-
lyzed by univariate and multivariate analyses to detect
prognostic and recurrent factors.
Results: There were 21 males and 20 females with the
mean age of 66.4 years. Five year overall survival rate
was 62%. Poorhistological differentiation, lymph node
metastasis, pancreatic, neural, lymphatic, and venous
invasion were significantly correlated with shorter sur-
vival time after surgery by univariate analysis. Multi-
variate analysis revealed that lymph node metastasis
and elevation of carbohydrate antigen 19-9 were signifi-
cant factors related with poor prognosis. On the other
hand, with regard to recurrence, lymph node metasta-
sis, lymphatic invasion, and venous invasion were sig-
nificant factors associated with recurrence by univariate
analysis and multivariate analysis demonstrated that
lymph node metastasis was the only significant factor.
There was no single case having lymph node metastasis
in carcinoma in situ, while there were patients who had
positive lymph node metastases if the neoplastic cells
invaded to the sphincter of Oddi. Adjuvant chemother-
apy didn’t have significant effects on the overall sur-
vival time and disease free survival.
Conclusion: It is urgent to establish effective diagnostic
strategy for non-invasive ampullary carcinoma and new
adjuvant treatment strategy for advanced ampullary
carcinoma.
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APHPB-0196
REMNANT PANCREATIC RESECTION
FOR PANCREATIC CANCER
A. Urakami1, M. Takaoka1, Y. Hirabayashi1, J.
Hayashi1, K. Shigemitsu1, K. Yoshida1, Y. Naomoto1,
H. Nakashima2, M. Nakamura2 and T. Tsunoda2
1General Surgery, Kawasaki Medical School, Okayama,
Japan; 2Gastroenterological Surgery, Kawasaki Medical
School, Kurashiki, Japan
Objectives: Long-term survival is rarely achieved in
patients with pancreatic cancer. Recurrence and/or
metastasis frequently develop in multiple organs,
including the liver, lymph nodes, peritoneum, lung and
bone, even after curative resection. Only a few reports
of recurrence or second primary lesions in the remnant
pancreas after a pancreatectomy have been reported in
the literature. The value of surgical treatment is unclear
in such situations. The aim is to evaluate the outcome
of surgical treatment in patients with pancreatic cancer
recurrence in the remnant pancreas.
Methods: All patients who underwent surgical resection
for pancreatic cancer from 1990 to 2011 (n = 115) were
evaluated from the database. Surgical outcomes were
examined in patients who underwent remnant pancre-
atic resection for pancreatic cancer recurrence.
Results: Five patients, 3 males and 2 female, with a
mean age of 68 years old at the initial operation were
studied. The mean interval period between the initial
and second operations was 26 months. The operative
procedures were pancreaticoduodenectomy (PD) fol-
lowed by distal pancreatectomy (DP) in 4 patients and
DP followed by PD for another. Histologically, tubular
adenocarcinoma was diagnosed in both lesions in all
patients. Four patients died with peritoneal dissemina-
tion or liver metastasis, with mean survival time of
40 months. Only one patient is alive without recurrence
for 72 months.
Conclusion: Resection for recurrence or second primary
lesions in the remnant pancreas might result prolonged
survival. When a suspected lesion develops in the rem-
nant pancreas, surgical resection might be considered
as an option for the treatment of recurrent pancreatic
cancer.
Benign HPB Diseases
APHPB-0197
THE RISK FACTOR OF
POSTOPERATIVE COMPLICATIONS IN
PATIENTS WITH ACUTE
CHOLECYSTITIS
T. Niitsuma, M. Watanabe, K. Asai, H. Matsukiyo, T.
Saito, Y. Nakamura, Y. Okamoto, Y. Saida, J. Nagao
and S. Kusachi
Surgery, Toho University, Tokyo, Japan
Objectives: We analyzed the risk factor of postopera-
tive complications in patients withacute cholecystitis
(AC).
Methods: Two-hundred fifty-five AC patients were
enrolled in this study. The risk factor of postoperative
complications was divided into the preoperative factors,
therapeutic strategy, intraoperative factors, and severity
factors.
Results: Postoperative complications were occurred in
21 patients (8.2%) including superficial SSI in 12
patients, organ space SSI in 2 patients, and postopera-
tive bile leak in 4 cases. There was one mortality
patients after surgery due to the cerebralhemorrhage.
Univariate analysis of the risk factor for postoperative
complication revealed that age, comorbidity, body tem-
perature, white blood cell count, and c-reactive protein
was a significant risk factor in preoperative characteris-
tics. Regarding to the therapeutic strategy, preoperative
gallbladder drainage, open surgery including conversion
to open surgery, no performance of early laparoscopic
cholecystectomy, operation time, and estimated blood
loss revealed significant risk factor of postoperative
complications. Regarding to the severity factor, the
presence of marked local inflammation such as gangre-
nous cholecystitis revealed the significant risk factor of
postoperative complication. Multivariate analysis
showed elderly patients more than 72 years old and in-
traoperative blood loss more than 90 g revealed signifi-
cant risk factor for postoperative complications.
Conclusion: Age more than 72 years and intraoperative
blood more than 90 g may reveal significant predict
parameter for postoperative complications.
APHPB-0199
XANTHOGRANULOMATOUS
CHOLECYSTITIS: CASE SERIES AT
ARMED FORCES HOSPITAL, MUSCAT,
SULTANATE OF OMAN
A. A. Memon, A. Al-Kindy, I. Al-Alawi, Y. Al-Sawafi,
S. A. Al-Sharif, M. K. Al-Sibani and S. M. El-Sayed
Department of Surgery, Armed Forces Hospital, Muscat,
Oman
Objectives: Xanthogranulomatous cholecystitis (XGC)
is an unusual variant of chronic cholecystitis, character-
ized by marked thickening of the gallbladder wall with
accumulation of lipid laden macrophages and forma-
tion of multiple yellow-brown intramural nodules in
areas of destructive inflammation and this may mimic
with carcinoma of the gallbladder.
Methods: Twelve cases of histologically proven XGC
were identified from prospective analysis of 673
patients who underwent elective cholecystectomy at the
Department of Surgery, Armed Forces Hospital, Mus-
cat, Sultanate of Oman, from January 2011 to Decem-
ber 2013.
Results: The incidence of XGC was (1.7%) in this
study. Five (41%) of the patients required emergency
admission at first presentation. Ten (83%) patients had
gallbladder stones. Two patients (16%) presented with
a right upper quadrant mass, when a gallbladder carci-
noma was suspected preoperatively. The most common
sonographic finding was diffuse or focal thickening of
the gallbladder wall. A gallbladder carcinoma was sus-
pected radiologically in two patients (16%), perforated
gallbladder with biloma formation was found in one
patient. Increased serum carbohydrate antigen 19-9
(CA19-9) was observed in 4 (33%) patients, however,
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the elevated levels of CA19-9, returned to normal after
surgery.
Conclusion: XGC is difficult to recognize and distin-
guish from carcinoma of the gallbladder both pre-oper-
atively or intra-operatively. Laparoscopic surgery is
often complex due to firm adhesions of the gallbladder
to neighboring tissues and may result in high conver-
sion rate. Intra-operative frozen-section examination
should be carried out to allow the adoption of an
appropriate treatment.
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APHPB-0200
CLINICOPATHOLOGICAL FEATURES
OF DISTAL CHOLANGIOCARCINOMA:
COMPARISON BETWEEN EXTRA- AND
INTRAPANCREATIC BILE DUCT
S. Aoki, M. Mizuma, H. Yoshida, H. Hayashi, K.
Nakagawa, T. Okada, F. Motoi, T. Naitoh, Y.
Katayose and M. Unno
Surgery, Tohoku University Graduate School of
Medicine, Aoba-ku, Sendai, Japan
Objectives: Organs around distal bile duct are different
between extra and intrapancreatic bile duct. The aim of
the present study is to elucidate clinicopathological dif-
ferences between extra- and intrapancreatic distal cho-
langiocarcinoma (DCC).
Methods: This retrospective study included 129 consec-
utive patients with distal cholangiocarcinoma who
underwent pancreaticoduodenectomy or bile duct resec-
tion. According to tumor position, they were divided
into the two groups, namely extrapancreatic DCC (EP-
DCC) and intrapancreatic DCC (IPDCC). Clinicopath-
ological factors and prognosis were comparatively
analyzed.
Results: Incidence of pancreatic or duodenal invasion
was lower in EPDCC than in IPDCC (25.9% vs.
65.3%: p < 0.001; 5.6% vs. 29.3%: p < 0.001). EPDCC
included T2 and Stage I more than IPDCC (48.2% vs.
25.7%: p = 0.009, 46.3% vs. 29.7%: p = 0.050, respec-
tively). T3 was significantly less in EPDCC than in IP-
DCC (38.9% vs. 68.9%: p < 0.001). In IPDCC, Stage I
indicated a significantly more favorable prognosis than
Stage IIA (3-year OS, 85.9% vs. 59.5%, p = 0.047),
whereas in EPDCC did not (70.5% vs. 60.0%,
p = 0.945). Stage I in EPDCC had a poorer prognosis
than that in IPDCC (p = 0.050), while there was no
difference in Stage IIA between EPDCC and IPDCC.
Prognostic factors identified by multivariate analysis
were different between EPDCC and IPDCC; duodenum
invasion (p = 0.008), portal vein invasion (p = 0.003)
and lymph node metastasis (p < 0.001) for EPDCC,
neural invasion (p = 0.076) for IPDCC.
Conclusion: Clinicopathological features are likely to
be different between EPDCC and IPDCC, not showing
that factors defining T category are significant predic-
tors of survival in EPDCC. Staging for EPDCC might
not reflect prognosis between Stage I and IIA due to
including underestimated T2 cases.
APHPB-0201
LAPAROSCOPIC ANATOMICAL
HEPATECTOMY FOR
HEPATOCELLULAR CARCINOMA
T. Ryu, G. Honda, M. Kurata, S. Kobayashi, K.
Sakamoto and M. Honjo
Department of Surgery, Tokyo Metropolitan Cancer and
Infectious Diseases Center, Komagome Hospital, Tokyo,
Japan
Objectives: Anatomical hepatectomy is ideal for cura-
tive treatment of hepatocellular carcinoma (HCC). We
have performed laparoscopic anatomical hepatectomy
(LAH) as successfully as open anatomical hepatectomy.
Methods: From November 2008 to April 2014, we per-
formed totally LAH for HCC in 40 patients with a
median age of 69 years (range, 33–86). Liver function
was Child A in all patients. The median number of
resected tumors was 1 (range, 1–2). The median largest
dimension of the resected tumor was 3.9 cm (range,
1.1–17.0). Postoperative complications, local therapeu-
tic efficacy, and long-term outcome were retrospectively
analyzed.
Results: Lobectomy was performed in 7 patients, sec-
tionectomy was performed in 15, and segmentectomy
was performed in 18. The median operative time was
382 min (range, 117–605), with median blood loss of
250 g (range, 0–1600). The conversion rate was 5.0%.
Postoperative morbidity rate was 12.5% (prolonged
ascites in 1, bile leakage in 2, and intra-abdominal
abscess in 2) and mortality was zero. The median
length of hospital stay after surgery was 8 days (range,
5–129). The median follow-up time after surgery was
16.0 months (range, 1.4–67.6) and no local recurrence
was found. The 1- and 3-year overall survival rates
were 89.0% and 81.2%, respectively. The 1- and 3-year
disease-free survival rates were 68.5% and 40.7%,
respectively.
Conclusion: Totally LAH for HCC could be performed
safely and we could significantly raise the quality of
LAH toward the level of open anatomical resection.
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APHPB-0203
GALLSTONE DISEASE; A DIFFERENT
DISEASE IN SRI LANKA. A STUDY TO
DETERMINE THE PREVALENCE OF
DIFFERENT TYPES OF GALLSTONES
IN SRI LANKAN POPULATION
S. De Silva1, N. S. Amarasighe2, S. K. Kollure1, S. C.
Siriwardene2 and S. G. H. D. Hemachandra3
1Surgery, National Hospital of Sri Lanka, Colombo, Sri
Lanka; 2Chemical Pathology, National Hospital of Sri
Lanka, Colombo, Sri Lanka; 3Anaesthesia, University of
Peradeniya, Peradeniya, Sri Lanka
Objectives: This study was carried out to determine the
prevalence of different types of gallstones in Sri Lanka
and to identify the association of known risk factors to
the formation of a particular type of stone.
Methods: Gallstones were harvested from a continuous
sample of 60 patients who underwent cholecystectomy
for symptomatic gallstone disease in Colombo, Sri
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Lanka over a period of one year. Gallstones were
analyzed physically and chemically and categorized into
the three major types.
Results: 55.3% had pigmented stones, 38.3% had
mixed cholesterol stones and only 8.3% had pure cho-
lesterol stones. Advancing age is significantly associated
with the occurrence of pigmented stones (p = 0.003).
Majority of the study population were overweight
(36.7%) or obese (56.7%), but no correlation between
the BMI and the stone type was observed. Total cho-
lesterol was significantly higher in patients with mixed
cholesterol stones (p = 1.000). No positive correlations
were observed between the type of stone and any co-
morbid condition or between demographic variables
except age.
Conclusion: Pigmented stones are the commonest stone
type in Sri Lankan population and the prevalence of it
is associated with advancing age. Mixed cholesterol
stones were associated with high serum total cholesterol
levels. Pure cholesterol stones are very rare in Sri Lan-
kan population.
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APHPB-0204
POSTOPERATIVE INFECTIOUS
COMPLICATIONS AFTER PANCREATIC
SURGERY
K. Okano, N. Yamamoto, M. Oshima, E. Asano, S.
Akamoto, M. Fujiwara and Y. Suzuki
Gastroenterological Surgery, Kagawa University, Miki-
cho Kita-gun, Japan
Objectives: This study aimed to identify the clinical
features and impact of infectious complications on
immediate surgical outcome after pancreatic surgery.
Methods: The Japanese Society of Pancreatic Surgery
conducted a nationwide multi-institutional retrospective
analysis of infectious complications for patients who
underwent pancreatoduodenectomy (PD; 4147 patients)
or distal pancreatectomy (DP; 1692 patients) from Jan-
uary 2010 to December 2012.
Results: The incidence of infectious complications was
35.2% in the PD group and 25.2% in the DP group,
respectively. The major types of infections were ISGPF
grade B or C pancreatic fistula, intra-abdominal
abscess, and wound infection. Nine significant risk fac-
tors for infectious complications after PD were identi-
fied: male sex, age ≥70 years, body mass index ≥25 kg/
m2, other previous malignancy, liver disease, bile con-
tamination, operative time ≥7 h, intraoperative blood
transfusion, and soft pancreas. Five significant risk fac-
tors for infectious complications after DP were identi-
fied: chronic steroid use, Brinkman index ≥400,
operative time ≥5 h, intraoperative blood transfusion,
and non-laparoscopic surgery. There was no significant
difference in the incidence of infectious complications
after PD between the patients with external (n = 772)
and internal (n = 1170) biliary drainage. Postoperative
infectious complication was significantly associated with
mortality, readmission, and reoperation in the patients
who underwent both PD and DP.
Conclusion: This study demonstrates the clinical
landscape and specific risk factors for infectious
complications after PD or DP. Reduction of infectious
complications must be an approach for improving the
immediate outcomes in pancreatic surgery.
APHPB-0207
CLINICAL SIGNIFICANCE OF
POSTHEPATECTOMY HEPATIC
FAILURE IN PATIENTS WITH
COLORECTAL CANCER LIVER
METASTASIS
D. S. Kim, H. S. Jo, S. W. Jung, Y. D. Yu and S. O.
Suh
Division of HBP Surgery & Liver Transplantation,
Korea University College of Medicine, Seoul, Korea
Objectives: Liver resection can provide the best long
term outcome for patients with colorectal cancer
(CRC) liver metastasis. Posthepatectomy hepatic failure
(PHF) is one of the most feared and serious complica-
tion after liver resection. For hepatocellular carcinoma,
PHF was significantly associated with overall survival
(OS) and recurrence free survival (RFS). We investi-
gated various factors affecting occurrence of PHF after
liver resection for CRC liver metastasis and its effect
on OS and RFS.
Methods: We reviewed clinical data of patients who
was diagnosed with CRC liver metastasis and under-
went hepatectomy with curative intent from 2003 to
2010 in our center. A total of 143 patients were divided
into PHF and non-PHF group based on definition by
the International Study Group of Liver Surgery (IS-
GLS). We compared clinicopathologic and liver resec-
tion-related factors between two groups. We also
assessed OS and RFS.
Results: Nineteen patients (13.3%) satisfied the ISGLS
definition of PHF. Extent of liver resection (p = 0.001),
metachronous metastasis (p = 0.013) was identified as
independent risk factors for development of PHF. The
5-year OS rate of PHF group and non-PHF group was
32.9% and 63.8% respectively, and 5-year RFS rate
was 53.0% and 57.3% [kimds 1] respectively. However,
there was no statistically significant difference between
the two groups. Multivariate analysis revealed colon
cancer differentiation (p < 0.001), resection margin
(p = 0.001), extent of surgery (p = 0.007) was signifi-
cantly associated with overall survival.
Conclusion: For CRC liver metastasis patients, extent
of resection was an important factor for development
of PHF. In terms of overall survival and recurrence,
primary tumor biology and margin-free resection was
more important.
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APHPB-0208
NEGATIVE MODULATION OF THE
EPIGENETIC REGULATOR BY
THYROID HORMONE RECEPTORS
SUPPRESSES LIVER CANCER CELL
GROWTH
S. M. Wu, P. J. Tai and K. H. Lin
Graduate Institute of Biomedical Sciences, Chang Gung
University, Taoyuan, Taiwan
Objectives: Thyroid hormone (T3) and its receptor
(TR) are involved in metabolism and growth. In addi-
tion to their developmental and metabolic functions,
TRs play a tumor suppressor role, and therefore, their
aberrant expression can lead to tumor transformation.
Aberrant epigenetic silencing of tumor suppressor genes
promotes cancer progression. The epigenetic regulator,
Ubiquitin-like with PHD and ring finger domains 1
(UHRF1), is overexpressed in various cancers.
Methods: Real-time qRT-PCR or immunoblot analysis
was conducted to determine the expression of UHRF1.
To determine the UHRF1 promoter activity, 50-flanking
regions were cloned and reporter actitivies were
assayed. The physical interaction of Sp1 with UHRF1
promoter region was determined by chromatin immu-
noprecipitation (ChIP). To confirm the clinical signifi-
cance of UHRF1 expression in liver cancer,
immunohistochemistry and tissue microarray were per-
formed.
Results: In the current study, we demonstrated that T3
negatively regulates UHRF1 expression, both in vitro
and in vivo. Our results further indicate that UHRF1
regulation by T3 is indirect and mediated by Sp1. Sp1-
binding elements of UHRF1 were identified at posi-
tions 664/505 of the promoter region using the
luciferase and chromatin immunoprecipitation assays.
Notably, UHRF1 and Sp1 levels were elevated in sub-
groups of hepatocellular carcinoma (HCC) patients and
inversely correlated with TRa1 expression. Knockdown
of UHRF1 expression should therefore provide a
means to inhibit hepatoma cell proliferation. Expres-
sion of UHRF1 was downregulated by TRs, in turn,
relieving silencing of the UHRF1 target gene, p21.
Conclusion: Collectively, we propose that T3/TR signal-
ing induces hepatoma cell growth inhibition via
UHRF1 repression.
APHPB-0209
LARGE SCALE ANALYSIS FOR
TREATMENT STRATEGY ACCORDING
TO GENETIC ALTERATIONS OF K-RAS
AND DPC4 (SMAD4) GENES IN
PANCREATIC DUCTAL
ADENOCARCINOMA
S. H. Shin, S. C. Kim, K. B. Song, D. W. Hwang, J.
H. Lee, D. J. Lee, J. W. Lee, H. E. Kim, E. S. Jun, K.
M. Park and Y. J. Lee
Surgery, Asan Medical Center, Seoul, Korea
Objectives: To investigate correlation of genetic altera-
tions of pancreatic ductal adenocarcinoma (PDAC)
with patients’ survival, recurrence patterns, and treat-
ment for recurrent disease.
Methods: We reviewed genetic alterations of major 4
genes (K-ras, DPC4, p53, and c-erbB-2) in 699 patients
who underwent surgical resection, and correlated with
clinical outcomes.
Results: Median survival of all patients was
21.7 months, and 5-year survival rate was 20.4%. Alt-
erational rates of each gene were as follows: K-ras,
48.3%; DPC4, 68.1%; p53, 40.8%; c-erbB-2, 14.0%.
Mutation of K-ras and inactivation of DPC4 genes
were associated with shorter patients’ survival in uni-
variate analysis. In multivariate analysis, mutation of
K-ras gene was independently correlated with patients’
survival (especially, GAT and TGT subtypes). Inacti-
vated DPC4 gene had no independent correlation with
overall survival, but it was strongly associated with dis-
tant metastasis following pancreatectomy. Survival
after recurrence (SAR) was evaluated in subdivided
groups according to DPC4 gene function (intact or
loss)/recurrence patterns (locoregional or distant)/treat-
ment options (local control or systemic therapy). In
these 8 groups, patients in intact/locoregional/local
control group showed the longest survival (24.2 months
of median SAR), and intact/locoregional/systemic ther-
apy and loss/distant/systemic therapy groups were asso-
ciated with much shorter survival (9.5 and 9.2 months
of median SAR, respectively).
Conclusion: Assessment of genetic features of PDAC
may assist in deciding targeted surveillance or treat-
ment for primary as well as recurrent PDAC, and fur-
ther studies for therapeutic strategies according to
genetic analyses should be devised.
APHPB-0210
BRANCH DUCT INTRADUCTAL
PAPILLARY MUCINOUS NEOPLASM
OF THE PANCREAS: A LARGE SINGLE
CENTER EXPERIENCE WITH 324
PATIENTS WHO UNDERWENT
RESECTION
S. H. Shin, S. C. Kim, K. B. Song, D. W. Hwang, J.
H. Lee, D. J. Lee, J. W. Lee, H. E. Kim, E. S. Jun, K.
M. Park and Y. J. Lee
Surgery, Asan Medical Center, Seoul, Korea
Objectives: International treatment guidelines for
branch duct intraductal papillary mucinous neoplasm
(BD-IPMN) of the pancreas have been proposed in
terms of features associated with malignancy and inva-
siveness. We investigated clinicopathologic characteris-
tics predictive of malignancy/invasiveness and
recurrence of the disease.
Methods: A review of 324 patients with resected and
pathologically confirmed BD-IPMN between March
1997 and December 2013 was conducted.
Results: One hundred forty four patients (44.4%) had
low grade dysplasia (LGD), 138 (42.6%) intermediate
grade dysplasia (IMGD), 17 (5.3%) high grade dyspla-
sia (HGD), and 25 (7.7%) invasive carcinoma (invI-
PMC). The 5 year survival rates were 98.1% in LGD,
95.3% in IMGD, 100% in HGD, and 71.8% in invI-
PMC. In univariate analysis, male sex was associated
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with malignancy and CA19-9 was related with both
malignant and invasive IPMN. High risk or worrisome
features of international guideline were associated with
both malignant and invasive IPMN; total bilirubin of
head/uncinate lesion, tumor size, mural nodule, size of
main pancreatic duct (MPD). In multivariate analysis,
male sex, elevated CA19-9, mural nodule, and dilated
MPD diameter were independently correlated with
malignant IPMN. Elevated CA19-9 and dilated MPD
diameter were also correlated with invasive carcinoma.
Patient age and initial pathologic diagnosis were
strongly associated with disease recurrence following
surgical resection.
Conclusion: High risk or worrisome features of current
treatment guideline for BD-IPMN is confined to mor-
phologic characteristics of the disease. Patient factors
and biological features should be considered in terms
of optimal therapeutic or surveillance strategies.
APHPB-0211
SERUM HCC MARKERS DIFFERENTLY
INFLUENCE ON SURVIVAL OF
SURGICAL RESECTION AND
RADIOFREQUENCY ABLATION IN
MILAN CRITERIA’S
HEPATOCELLULAR CARCINOMA
M. Ueno, M. Kawai, S. Hirono, S. Hayami, S.
Yamaguchi, K. Okada and H. Yamaue
Second Department of Surgery, Wakayama Medical
University Hospital, Wakayama, Japan
Objectives: Serological markers of hepatocellular carci-
noma (HCC) indicate its invasiveness. We aimed to
investigate whether the prognostic influences of surgical
resection (SR) and radiofrequency thermal ablation
(RFA) on HCC patients were different among positiv-
ity conditions of following three HCC markers: Alpha-
fetoprotein (AFP), Lens culinaris agglutinin-reactive
fraction of AFP (AFP-L3) and des-c-carboxy pro-
thrombin (DCP).
Methods: Retrospectively 362 Milan criteria’s HCC
patients with Child-Pugh score from 5 to 7 were
reviewed. Patients received either SR (n = 156) or RFA
(n = 206) curatively. Recurrence free survival and over-
all survival were compared between SR and RFA based
on positivity conditions of previous three HCC markers
(defined as none-positive, single-positive, double-posi-
tive, and triple-positive).
Results: Two-year recurrence free survival rates in
none, single, double, and triple-positive patients of the
SR group were 64.7%, 59.5%, 51.8%, and 53.9%,
respectively. Those of the RFA group were 81.5%,
66.2%, 34.0%, and 23.2%, respectively (p values were
0.04, 0.06, 0.02, and <0.01, respectively). According to
multivariate analyses, RFA itself became independent
prognostic factors for recurrence in the double-positive
and triple-positive groups and their odds [95% conf-
identical interval (CI)] were 1.6 [1.0–2.5] and 1.4 [1.0–
1.9], respectively. RFA itself also independently
affected on overall survival in the triple-positive group
and the odds [95%CI] was 1.6 [1.0–2.5].
Conclusion: Positivity conditions of HCC markers
influenced on prognosis differently between SR and
RFA when treating Milan criteria’s HCC. RFA itself
became an independent prognostic factor when all three
HCC markers were positive. Preoperative evaluation of
multiple HCC markers might become an index for
selecting treatment modalities.
APHPB-0212
MANAGEMENT OF INCIDENTAL
CARCINOMA OF THE GALLBLADDER
C. Kantharia, R. Prabhu, S. Pujari, A. Supe and R.
Bapat
Surgical Gastroenterology, KEM Hospital, Seth GS
Medical College, Parel, Mumbai-12, India
Objectives: There is an increase in frequency of detec-
tion of incidental gallbladder carcinoma. No guidelines
exist with respect to its optimum management. The
present study assesses the optimal management of Inci-
dental Ca GB.
Methods: Clinical records of patients presenting with
Ca GB over last 5 year (2008–2013) were reviewed. Of
48 patients of Ca GB (34 female) identified, 11 were
identified to have Incidental Ca GB (8 females, age 29–
80 years). All 11 had undergone Laparoscopic chole-
cystectomy. They were subjected to CECT-Scan,
detailed Histopathological assessment and restaged.
Their further treatment was planned accordingly. Sur-
vival and QOL based on SF-36 score were assessed.
Follow up ranged from 6 to 80 months with post oper-
ative monitoring by USG and CECT Scan.
Results: CECT Scan revealed no evidence of malig-
nancy in 4, LN involvement in 5 and liver infiltration
in 2 patients.
Histopathology showed involvement of Lamina Propria
in 4, perimuscular layer in 5 and serosa in 2 patients.
On restaging 4 had Stage I (T1, N0, M0), 5 had Stage
II (T1, N1, M0) and 2 had Stage III (T3, N0, M0).
4 with mucosal involvement were left alone, (median
survival 64 months with QOL 8). 5 with LN involve-
ment, were subjected to extended cholecytsectomy with
bile duct excision in 2 (median survival 54 months
QOL 6). Segmental Resection performed in 2 patients
with Liver infiltration (median survival 48 months,
QOL 6).
Conclusion: Re –Surgery is a must for patients beyond
Stage I of Carcinoma Gall Baldder, with acceptable
survival and good Quality of Life.
APHPB-0213
IMPACT OF VISCERAL OBESITY ON
PANCREATICODUODENECTOMY
A. Miyamoto, S. Maeda, N. Hama, K. Yamamoto,
M. Miyake, K. Nishikawa, M. Ikeda, M. Hirao,
M. Sekimoto and S. Nakamori
Surgery, National Hospital Organization Osaka
National Hospital, Osaka, Japan
Objectives: It is still controversial whether obesity
influences postoperative complications after gastroen-
terological surgery. In this study, we investigated an
influence of visceral obesity on pancreaticoduodenecto-
my.
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Methods: We enrolled 106 patients undergoing
pancreaticoduodenectomy in this study. Visceral Fat
Area (VFA) was used as an indicator of visceral obes-
ity. VFA was measured by bioelectrical impedance
analysis using body composition analyzer In Body 720
(BIOSPACE Co. Ltd.). We inquired a correlation
between intraoperative blood loss, operation time, post-
operative complications and VFA.
Results: According to VFA assessment, 51 patients
with VFA over 100 cm2 were judged as visceral obesity
(OB group). The remaining 55 patients with VFA
under 100 cm2 were categorized as non-OB group.
Median blood loss of OB group was much more than
that of non–OB group (900 vs. 730 mL, p = 0.06).
Also, median operation time of OB group was signifi-
cantly longer than that of non-OB group (580 vs.
531 min, p = 0.04). As for the postoperative complica-
tions, pancreatic fistula, surgical site infection and
delayed gastric empting were observed in 41, 18 and 14
patients, respectively. The incidence rate of grade B/C
pancreatic fistula in ISGPF classification was signifi-
cantly higher in OB group (27% vs. 11%, p = 0.04).
Furthermore, visceral obesity was an independent risk
factor of grade B/C pancreatic fistula with multiple
logistic regression analysis, (p = 0.04, HR: 3.22, 95%
CI: 1.07–9.71).
Conclusion: It was suggested that visceral obesity influ-
ences intraoperative blood loss and operation time of
pancreaticoduodenectomy, and also that grade B/C
pancreatic fistula after pancreaticoduodenectomy would
increase in patients with visceral obesity.
APHPB-0215
PANCREATIC FISTULAE SECONDARY
TO TRYPSINOGEN ACTIVATION BY
PSEUDOMONAS AERUGINOSA AND
ENTEROBACTER CLOACAE
INFECTIONS AFTER
PANCREATODUODENECTOMY
K. Yamashita1, T. Sasaki1, Y. Yamashita1, R. Itoh2,
D. Kato1, N. Hatano3, T. Soejima2, K. Ishii2, T.
Takenawa3 and K. Hiromatsu2
1Gastroenterological Surgery, Fukuoka University School
of Medicine, Fukuoka, Japan; 2Microbiology and
Immunology, Fukuoka University School of Medicine,
Fukuoka, Japan; 3Integrated Center for Mass
Spectrometry, Kobe University, Kobe, Japan
Objectives: The development of pancreatic fistula after
pancreatoduodenectomy (PD) is associated with high
mortality and morbidity. Trypsinogen activation has
been postulated to play a role, as have bacteria, in the
development of pancreatic fistula, yet the relationship
between the two and the mechanism involved have not
been elucidated. Consequently, we examined the impact
of bacteria on the activation of pancreatic juice in the
perioperative period of PD at foci of infection at sites
of pancreatic fistula formation.
Methods: One hundred patients underwent PD and the
pancreatic fistulae that developed were graded based on
the International Study Group for Pancreatic Fistula
grading criteria. Bacteria were isolated from cultures of
drainage fluid. Digested peptides from trypsinogen and
bacterial culture supernatants were separated with
SDS–PAGE and analyzed with mass spectrometry. Zy-
mography was used to detect the trypsinogen activator.
Results: Several bacterial species, including Enterobact-
er cloacae and Pseudomonas aeruginosa, were isolated
from drainage fluid. Pseudomonas aeruginosa was found
only in patients with grades B and C pancreatic fistu-
lae. These bacteria were able to cause trypsinogen acti-
vation, which was prevented by use of a serine protease
inhibitor. Zymography suggested that a protease in the
supernatant of Pseudomonas aeruginosa acted as the
trypsinogen activator.
Conclusion: The present results suggest that infection
with Pseudomonas aeruginosa and Enterobacter cloacae
during the perioperative period of PD entails secretion
of a protease that processes trypsinogen into trypsin.
Providing measures of bacterial infection control in the
perioperative PD period could be crucial for preventing
the development of pancreatic fistula.
Benign HPB Diseases
APHPB-0216
EVALUATION OF BISAP SCORE IN
ASSESSING MORTALITY AND
INTERMEDIATE MARKERS OF
SEVERITY IN ACUTE PANCREATITIS
S. Kurunkar, C. Kantharia, S. Pujari and R. Prabhu
Surgical Gastroenterology, KEM Hospital, Seth GS
Medical College, Parel, Mumbai-12, India
Objectives: Evaluation of the ability of BISAP score in
identifying patients at risk for increased morbidity and
mortality, in patients of Acute Pancreatitis.
Methods: Prospective analysis undertaken over last
6 years from May 2008 to 2013. All patients of Acute
Pancreatitis were included in the study. They under-
went a complete hemogram, coagulation profile studies,
serum calcium, RFT, LFT, Blood gas analysis within
48 h of admission. CECT of abdomen was performed
after 4 days of onset of disease and repeated as indi-
cated, depending upon the course of disease. All
patients were managed conservatively. BISAP score
was evaluated in all patients within 24 h of presenta-
tion.
Results: 90 cases of AP were identified. BISAP scores
were calculated in all, using data within 24 h of presen-
tation. The study revealed 34.4% patients had BISAP
score more than or equal to 3% and 65.6% had BISAP
score <3. Overall mortality was 3.3% and organ failure
seen in 20% and pancreatic necrosis in 15.5% of
patients. It was revealed that BISAP scores of ≥ 3 rep-
resent a simple way to identify patients at risk of
increased mortality and the development of intermedi-
ate markers of severity within 24 h of presentation.
Conclusion: BISAP score represents a simple way to
identify patients at risk of increased mortality and the
development of intermediate markers of severity within
24 h of presentation.
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APHPB-0217
SOLID PSEUDOPAPILLARY TUMOR
(SPT): LITERATURE REVIEW AND
CURRENT CONSENSUS OF
MANAGEMENT OF MALIGNANT SPT
S. Seow, C. Tee, V. Leow, L. Vasupillai and K.
Manisekar
Surgical Department, Hospital Sultanah Bahiyah, Alor
Setar, Malaysia
Objectives: Solid pseudopapillary tumor (SPT) is a rare
cystic pancreatic tumor with low grade malignant
potential and uncertain origin. This disease entity
accounts for about 1–3% of all pancreatic tumors. It
usually occurs in young women in second to third dec-
ade of life. Metastatic disease can occur, usually involv-
ing the liver, but the current consensus on the
management is not well defined. Our objective is to
review a single institution’s experience of this rare
tumor.
Methods: A retrospective study of patients who diag-
nosed with SPT and managed in Hospital Sultanah
Bahiyah, a tertiary referral center, between January
2008 and December 2013 was performed. The clinical
features, radiological findings and surgical interventions
were analyzed.
Results: Five cases of solid pseudopapillary tumor were
diagnosed and treated in our institution in the study
period. Four of them were young lady with the age
ranging 13–22 years old and a 56-year-old gentleman.
Distal pancreatectomy was performed for 3 patients,
one patient underwent distal pancreatectomy and liver
resection for liver metastasis. The other patient had
whipple procedure only. Two patients developed liver
metastases after resection of tumor where one of them
is still on chemotherapy and the other patient had mul-
tiple recurrence despite multiple operations and com-
pletion of gemcitabine. The rest of the patients are still
well and asymptomatic.
Conclusion: SPT of pancreas should be considered as a
potentially malignant disease in all patients. Complete
resection is the mainstay of treatment, however long
term regular follow-up is mandatory for vigilance of
recurrence.
Malignant HPB Diseases
APHPB-0220
RISK FACTORS FOR RECURRENCE
FREE SURVIVAL AFTER CURATIVE
HEPATECTOMY IN
HEPATOCELLULAR CARCINOMA, A
PREDICTION OF RECURRENCE’S
TERM AND TYPE
S. Nomoto, F. Sonohara, Y. Inokawa, M. Kanda, H.
Sugimoto, M. Fujiwara, M. Koike, T. Fujii and Y.
Kodera
Gastroentrological Surgery, Nagoya University Graduate
School of Medicine, Nagoya, Japan
Objectives: HCC prone to frequent recurrences after
operation. The type of recurrences was divided into int-
rahepatic metastases (IM) and multicentric occurrences
(MO). We hypothesized highly malignant tumor tended
to make early IM, and poor background liver status
tended to make MO.
Methods: A retrospective search of our database identi-
fied consecutive 320 cases that underwent curative hep-
atectomy for HCC at our department between 1994
and 2012. The periods for recurrences were divided
three terms as the early (until 15.2 months, half of the
recurrences occurred: n = 129), the middle (between
15.2 and 34.1 months, next quarter recurrences
occurred: n = 76), and the late (after 34.1 months:
n = 115). Risk factors for recurrence free survival
(RFS) were analyzed by Cox proportional hazard
model.
Results: 185 patients (57.8%) showed recurrences. Mul-
tivariate analyses showed ICGR15 (>17%) (p = 0.0049)
as a background liver factor, and higher AFP value
(p < 0.0001), poorly differentiated tumor (p = 0.0020),
infiltrating growth (p = 0.0300), capsule formation
(p = 0.0024), serosal invasion (P = 0.0027), and vascu-
lar invasion (p = 0.0014) as tumor factors were inde-
pendently correlated with worth RFS in early term.
Recurrences in the middle term did not show any inde-
pendent factors. Whereas, the recurrences in the late
term were correlated with only ICGR15 (>17%)
(p = 0.0209) independently. The results implied that the
higher malignant tumor showed early relapses of IM,
and damaged background liver showed early and late
recurrences of MO. In the middle terms, IM and MO
seemed intermingled.
Conclusion: We could predict recurrence’s term and
type by analyzing tumor and background liver factors.
Transplantation
APHPB-0222
LIVING DONOR LIVER
TRANSPLANTATION FOR
HEPATOCELLULAR CARCINOMA.
FACTORS AFFECTING SURVIVAL AND
RECURRENCE
O. Fathy
General Surgery, Gastroenterology Surgical Center,
Mansoura University, Mansoura, Egypt
Objectives: Living donor liver transplantation (LDLT)
for hepatocellular carcinoma (HCC) offer potential
cure for both cirrhosis and tumour.
Methods: From January 2005 to December 2013, 70
patients with HCC underwent LDLT in Gastroenterol-
ogy Center, Mansoura University out of 270 patients
underwent LDLT in the same period. All are adult
LDLT and all are related except 12 patients. Right lobe
without MHV as used in all cases.
Results: The mean age 50.3  55 years, 68 were Male
and 2 Female, HCV was the main cause of cirrhosis in
67 Pts. MELD score 16.6  49 (R 7–27) the mean size
of the tumor 4.8  3 cm (R 1–15.5 cm). Majority of
the Pts were child B, 29 Pts while child A and C were
15, 26 respectively. Alfa Feto Protein 124  281 (R
1.2–1283), the mean waiting time 119  84.
Postoperative outcome, the median survival >5 years
were 75.4 years. The only factor affecting survival are
Alfa Feto Protein >200 ng/mL and +ve vascular invasion.
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Conclusion: The recurrence occur in 9/70 (12.8%). In
univariate analysis many factors affecting recurrence.
Mean while, in multivariate analysis, the only signifi-
cant factor is Alfa Feto Protein >200 ng/mL.
Malignant HPB Diseases
APHPB-0223
PREOPERATIVE SARCOPENIA
NEGATIVELY IMPACTS
POSTOPERATIVE OUTCOMES
FOLLOWING MAJOR HEPATECTOMY
WITH EXTRAHEPATIC BILE DUCT
RESECTION
H. Otsuji, Y. Yokoyama, T. Ebata, T. Igami, G.
Sugawara, T. Mizuno and M. Nagino
Division of Surgical Oncology, Department of Surgery,
Nagoya University Graduate School of Medicine,
Nagoya, Japan
Objectives: The objective was to analyze the relation-
ship between preoperative sarcopenia and postoperative
morbidity/mortality in patients who underwent major
hepatectomy with extrahepatic bile duct resection.
Methods: This study included 256 patients who under-
went major hepatectomy with extrahepatic bile duct
resection from December 2008 to February 2014. Pre-
operative sarcopenia was assessed by a measurement of
the total psoas muscle area (TPA). The measured TPA
was normalized by height. Preoperative sarcopenia was
defined as the presence of a normalized TPA in the
lowest sex-specific tertile.
Results: A total of 54 males and 31 females were deter-
mined to have preoperative sarcopenia. The length of
the postoperative hospital stay for patients with sarco-
penia was significantly longer than for those without
sarcopenia (39 vs. 30 days, p < 0.001). Patients with
sarcopenia experienced a significantly higher rate of
liver failure (International Study Group of Liver Sur-
gery grade ?B) (33% vs. 16%), major complications
with Clavien grade ?3 (54% vs. 37%), and intra-
abdominal abscess (29% vs. 18%) than those without
sarcopenia (all p < 0.05). After a multivariate analysis,
preoperative sarcopenia was identified as an indepen-
dent risk factor for the development of liver failure
(odds ratio = 2.19).
Conclusion: This study demonstrated that preopera-
tive sarcopenia increased the morbidity rate including
the rate of liver failure, in patients who underwent
major hepatectomy with extrahepatic bile duct resec-
tion.
APHPB-0224
ADULT HEPATOBLASTOMA – A CASE
REPORT
S. Balakumaran, V. Rajendran, S. Sugaprakash, A.
Amuthan, D. Bennet, R. Prabhakaran, D. Kannan and
S. M. Chandramohan
SGE Department, Madras Medical College, Chennai, India
Objectives: Adult hepatoblastoma is a rare malignant
liver neoplasm. Surgery is the treatment of choice, but
recurrence is common even after complete resection.
No standard therapeutic strategy has been established
so for.
Methods: A 14-year-old female presented with a right
hypochondrial mass. Pain preceded the appearance of
the mass. Clinical examination revealed a
15 cm 9 15 cm mass occupying the right hypochondri-
um and epigastrium. CECT Abdomen (64 slice) showed
15 9 11 9 9 cm multiseptated locuated mass lesion
involving right lobe of liver segment 5, 6, 7, 8. USG
guided biopsy done revealed suspected Hepatic Ade-
noma. Preop AFP was more than 30,000. With this
preoperative diagnosis the tumor was completely
resected off the inferior vena cava with Right hepatec-
tomy. The histopathological diagnosis was mixed he-
patoblastoma. The postoperative course went
smoothly.
Results: Hepatoblastoma is a rare malignant tumor of
the liver and usually occurs in the first three years of
life. Most of these tumors arise in the embryo; hence it
seems to be unusual that hepatoblastomas occur in
adult age patients. Early detection may lead to
improved prognosis and survival but they are often
detected late.
Conclusion: We report here the first case of adult
hepatoblastoma in India to our best of our knowledge.
We are presenting this case due to the rarity of hepato-
blastoma in adults and its preoperative diagnostic diffi-
culty and successful surgical treatment with
hepatectomy.
APHPB-0225
GOOD CANDIDATES FOR A THREE
TIMES LIVER RESECTION OF
COLORECTAL METASTASIS
S. Yamazaki, T. Takayama and T. Higaki
Digestive? Surgery, Nihon University School of
Medicine, Tokyo, Japan
Objectives: To assess the feasibility and survival bene-
fits of three liver resections.
Methods: Between 2004 and 2011, 273 consecutive
patients with colorectal metastases were analyzed. The
patient characteristics, tumor status, operation-related
variables, degree of liver steatosis, and short- and long-
term outcomes were compared according to the number
of liver resections.
Results: The history of preoperative chemotherapy was
higher for patients who had a three liver resections as
compared with other resections (one resection, two
resections, and three resections: 41.0% vs. 56.8% vs.
81.8%, p = 0.04). Patients receiving three liver resec-
tions had a high rate of liver steatosis (17.9% vs.
32.4% vs. 59.1%, p = 0.03). The median operation time
for three resections was significantly longer [359 min
(range: 115–579 min) vs. 395 (178–740) vs. 482 (195–
616), p = 0.04] than for the other resections. However,
the complication rate and the postoperative hospital
stay did not differ among the three groups. The 1-, 3-
and 5-year-survival rates did not differ significantly
among the three groups (83.3%, 57.5% and 44.6% for
one resection vs. 92.3%, 52.1% and 35.7% for two
resections vs. 93.3%, 49.0% and 34.1% for three resec-
tions). Patients who had <5 tumors at third liver
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resection and a recurrence interval of ≥500 days from
the second resection were good candidates for three
resections.
Conclusion: Three resections of colorectal metastasis is
feasible and provides a similar survival benefit as one
or two resections, without increasing morbidity or mor-
tality.
APHPB-0227
DOES CEFUROXIME-AMIKACIN-
METRONIDAZOLE PROVIDE
ADEQUATE AND APPROPRIATE
ANTIOBIOTIC COVERAGE FOR
PANCREATICODUODENECTOMY IN
DEVELOPING COUNTRIES: A
PROSPECTIVE STUDY
R. Gaurav1, S. Banerjee1, S. Bhattacharya2, S.
Chatterjee3, M. Mallath3 and M. Roy1
1GI Surgery Unit, Tata Medical Center, Kolkata, India;
2Clinical Microbiology, Tata Medical Center, Kolkata,
India; 3Digestive Disease, Tata Medical Center,
Kolkata, India
Objectives: Antibiotic stewardship is mandatory in con-
temporary clinical practice. This new oncology hospital
in Eastern-India had instituted antibiotic policies based
on practices prevalent in developed nation. The present
study explores their relevance in biliary microflora in
patients undergoing pancreatico-duodenectomy (PD).
Methods: During PD, bile was aspirated from bile duct
and detailed record of microbiology and antibiogram
was maintained. The data were prospectively captured
in a bespoke electronic database.
Results: Between October 2011 and August 2014, 52
patients underwent PD for myriad malignant condi-
tions [male: 37, female: 16; median age: 57 years, IQR
51–64]. Of this, 37 (71%) had pre-operative biliary
stenting (plastic: 23, metal: 9, both types: 1). Median
interval between stent placement and PD was 28 days
(IQR 22–42). Of the 15 non-stented patients, bile was
sterile in 11 (73%), while all, but 2, stented patients
harboured microbes. In these 35 stented patients, bile
from 8, 15 and 12 patients grew 1, 2 and 3 flora respec-
tively. Of these 74 samples, 45 (61%) were gram nega-
tive, 24 (32%) gram positive and 5 were candida.
Amongst the gram negatives, Klebsiella pneumoniae
(38%) and Escherichia coli (33%) constituted the
predominant organisms and their sensitivity towards
commonly used antibiotics were: Amikacin (67%),
Co-amoxyclav (20%), Carbapenem (62%), Piperacillin-
Tazobactam (42%) and Colistin (96%). Cefuroxime,
tested in 29 samples, was found sensitive in 5 (17%)
only.
Conclusion: High incidence of multi-drug resistant bac-
teria in bile samples in stented is an ominous finding.
This mandates close cooperation between the gastroen-
terologist and the surgeon and revision of antibiotic
policies.
Benign HPB Diseases
APHPB-0228
DIABETES MELLITUS IS MORE
COMMONLY ASSOCIATED WITH IL28B
NON-C/C GENOTYPE THAN IN C/C
GENOTYPE IN PATIENTS WITH HCV
V. Gupta, A. Kumar, P. Sharma, P. Tyagi, N. Bansal,
V. Singla and A. N. I. L. Arora
Department of Gastroenterology and Hepatology, Sir
Ganga Ram Hospital, Delhi, India
Objectives: IL28b polymorphism is an important pre-
dictor for HCV response to therapy; and IL28b C/C
genotype is considered to have favorable response as
compared to non-C/C genotype. However, whether
IL28b genotypes also influence other non-treatment
related clinical parameters is not clear.
Methods: In this retrospective analysis, patients with
HCV related chronic liver disease attending Sir Ganga
Ram Hospital, New Delhi, from 2013 to 2014 were
analyzed. The SNPs rs12979860 (IL28B) was investi-
gated by RT-PCR and IL28b genotypes were correlated
with various clinical parameters.
Results: A total of 115 patients were included in the
study (median age 48, 70% males). The most common
IL28b genotype was C/C 53% (61/115), while rest 47%
were non-C/C [C/T 42% (48/115) and T/T 5% (6/115)].
Overall, 43/115 (37%) patients had chronic hepatitis,
while rest 72/115 (63%) were cirrhotics. Clinical and
laboratory parameters like Hb, WBC, platelets, biliru-
bin, AST, ALT, and albumin were similar in C/C and
non-C/C genotypes. Diabetes mellitus was found in
22% (25/115) of patients. Patients with non-C/C geno-
type had significantly higher prevalence of diabetes
mellitus than patients with C/C genotype [31% (17/54)
vs. 13% (8/61); p = 0.023].
Conclusion: Diabetes Mellitus was found to be more
commonly associated with IL28b non-C/C genotype
than in C/C genotype in patients with HCV. Since insu-
lin resistance is more common in carriers of the T allele
of SNP rs12979860 than in CC homozygotes, this may
explain higher prevalence of diabetes in non-C/C geno-
types. We recommend doing IL28b genotype in all
HCV patients to predict occurrence of diabetes.
Transplantation
APHPB-0229
PORTAL VEIN THROMBOSIS AND
ARTERIOPORTAL SHUNTING DUE TO
CHRONIC CHOLANGITIS: A RARE
COMPLICATION OF LIVING DONOR
LIVER TRANSPLANTATION
C. Hsieh1, C. Chou2, K. Lin3, C. Lin3 and Y. Chen3
1Liver Transplantation, Changhua Christian Hospital,
Changhua, Taiwan; 2Department of Radiology,
Changhua Christian Hospital, Changhua, Taiwan;
3Attending Physician General Surgery, Changhua
Christian Hospital, Changhua, Taiwan
Objectives: The incidence of late onset portal vein throm-
bosis after living donor liver transplantation (LDLT) is
approximately 6% in adults and 8% in children. To the
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best of our knowledge, portal vein thrombosis and
arterioportal shunting due to chronic cholangitis after
LDLT has never been reported.
Methods: We present a patient with portal vein throm-
bosis due to chronic cholangitis after liver donor liver
transplantation (LDLT).
Results: A 52-year-old woman with a history of hepati-
tis B virus-related liver cirrhosis underwent LDLT.
After the surgery, the patient had recurrent episodes of
cholangitis due to common bile duct and intrahepatic
bile duct stricture. Biliary stricture due to cholangitis
eventually resulted in acute portal vein thrombosis. A
stent was inserted via percutaneous transluminal por-
tography. Blood flow through the portal vein progres-
sively improved from the third through the 10th day
after stent placement. The anticoagulation regimen was
change to acetylsalicylic acid and clopidogrel hydrogen
sulfate (Plavix). On post-stenting day 10, follow-up
CT scan showed good patency of the main portal vein
and no evidence of arterioportal shunting.
Conclusion: Cholangitis after liver transplantation is a
rare cause of portal vein thrombosis. Regular follow-up
examinations with color Doppler ultrasound are needed
to monitor portal vein flow in patients with biliary
complications after LDLT.
Malignant HPB Diseases
APHPB-0232
SEROSAL INVASION SHOULD BE
CONSIDERED AS ONE OF THE
STRONGEST PROGNOSTIC FACTORS
AFTER CURATIVE RESECTION OF
HEPATOCELLULAR CARCINOMA: A
RETROSPECTIVE SEARCH FOR
CONSECUTIVE 275 CASES
F. Sonohara, S. Nomoto, Y. Inokawa, M. Kanda, S.
Yamada, T. Fujii, H. Sugimoto, M. Koike, M.
Fujiwara and Y. Kodera
Gastroenterological Surgery, Nagoya University
Graduate School of Medicine, Nagoya, Japan
Objectives: In this study, we intended to clarify the
individual prognostic factors after curative and primary
resection of hepatocellular carcinoma (HCC). Reliable
prognostic factors and tumor staging for HCC have
been required to predict appropriate prognosis. How-
ever, in HCC, no staging system is still received univer-
sal acceptance and there are several tumor factors that
seemed to relate HCC prognosis but they are not defin-
itive. At present, few studies have mentioned the
importance of serosal invasion as a prognostic factor.
Methods: A retrospective search of our database identi-
fied consecutive 275 cases that underwent primary and
curative hepatectomy for HCC at our department,
between January 1998 and December 2012. Risk
factors for recurrence free survival (RFS) and overall
survival (OS) were analyzed with Cox proportional hazard
model, Kaplan–Meier method and log-rank tests.
Results: Multivariate analyses showed that serosal
invasion [hazard ratio (HR); 2.40, p = 0.0019] and vas-
cular invasion (HR; 1.75, p = 0.0237) were indepen-
dently correlated with RFS and that also showed liver
cirrhosis (HR; 2.52, p = 0.0018), tumor differentiation
(poor versus well/moderate, HR; 4.26, p = 0.0056),
serosal invasion (HR; 2.22, p = 0.0290) and vascular
invasion (HR; 2.69, p = 0.0014) were independently
correlated with OS. Kaplan–Meier method and log-
rank tests revealed that the patients with serosal inva-
sion showed significantly worse prognosis both in RFS
(p < 0.0001) and OS (p = 0.0035) as well as vascular
invasion (RFS, OS; p < 0.0001)
Conclusion: Serosal invasion as well as vascular inva-
sion should be regarded as one of the strongest inde-
pendent predictors for both RFS and OS in curatively
resected HCC cases.
APHPB-0233
DECREASED EXPRESSION OF
RETINOIC ACID RECEPTOR-RELATED
RECEPTOR ALPHA (RORALPHA) IS
ASSOCIATED WITH A POOR
PROGNOSIS IN HEPATOCELLULAR
CARCINOMA
M. Q. Lu and R. D. Fu
Hepatic Surgery, The Third Affiliated Hospital of Sun
Yat-sen University, Guangzhou, China
Objectives: RORalpha has been proven to play a
tumor suppressive role in certain types of solid tumors.
However, the clinical characteristic of RORalpha has
not been reported by far. This study investigated the
expression of RORalpha in HCC and evaluated its
relationship with clinical parameters and prognosis in
HCC patients.
Methods: qRT-PCR and Western blots were performed
to detect RORalpha expression levels in 20 paired
HCC and corresponding adjacent non-cancerous tis-
sues. Immunohistochemistry was performed on 100
archived paraffin-embedded HCC samples. Statistical
analyses evaluated the correlations between RORalpha
expression and clinicopathological features.
Results: qRT-PCR and Western blots showed that
RORalpha mRNA and protein expression were down-
regulated in tumors compared to the adjacent non-can-
cerous tissues. Immunohistochemistry revealed that
decreased RORalpha expression was present in 65% of
HCC patients. Correlation analyses showed that ROR-
alpha expression was correlated with AFP (p = 0.005),
pathology grade (p < 0.001), tumor recurrence
(p = 0.008), and vascular invasion (p < 0.001). Kaplan–
Meier analysis revealed that patients with low RORal-
pha expression levels had shorter overall and disease-
free survival than patients with high expression
(p < 0.001 and p = 0.002, respectively). Multivariate
regression analysis indicated that RORalpha was an
independent predictor for overall survival (HR 0.362;
95%CI 0.168–0.780; p = 0.001) and disease-free sur-
vival (HR 0.391; 95%CI 0.207–0.735; p = 0.004).
Conclusion: RORalpha mRNA and protein expression
were significantly down-regulated in HCC tissues.
Down-regulated RORalpha expression was associated
with poorer prognosis in HCC patients. RORalpha
may be a new potential prognostic marker for HCC
patients.
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APHPB-0234
POST CHOLECYSTECTOMY RIGHT
ANTERIOR SECTORAL DUCT INJURY –
DELAYED PRESENTATION LEADING
TO MISDIAGNOSIS
N. Shivathirthan and C. Shivannaiah
Surgical Gastroenterology, Apollo BGS Hospital,
Mysore, India
Objectives: To report a case of post cholecystectomy
right anterior sectoral injury, discuss its presentation
and management.
Methods: A 30 years female was referred 6 months
post laparoscopic cholecystectomy with recurrent right
upper quadrant pain and collection. Patient had been
evaluated earlier with CECT and multiple attempts at
percutaneous drainage done. She had also been treated
with Anti Tuberculosis medicines for the recurrent col-
lection as a ERCP had failed to reveal a biliary leak.
She was referred to our department after 6 months of
surgery with a large right upper quadrant cyst. MRCP
showed large collection 20 9 15 9 14 cm, right ante-
rior sectoral duct communicating with the biloma and
cut off sign on right anterior sectoral duct.
A diagnosis of right anterior sectoral duct injury (Stras-
berg type C) was made. Ultrasound guided pig-tail cath-
eter drainage was done to make it a controlled fistula.
Results: Surgical exploration and restoration of bilio-
enteric continuity was planned. Intraoperatively on
opening the biloma cavity, an opening was seen
through which the injured sectoral duct was traced. A
Roux-en-Y cholangio-jejunostomy to the right anterior
sectoral duct was done. Recovery was good and patient
was discharged on post operative day 6.
Conclusion: Anterior sectoral duct injury after laparo-
scopic cholecystectomy is an extremely rare complica-
tion. High index of suspicion coupled with
ERCP + MRCP is necessary to map the injury and to
avoid mismanagement of this condition. Surgical man-
agement is similar to other injuries and involves main-
taining bilio enteric anastomosis.
Malignant HPB Diseases
APHPB-0235
PRIMARY HEPATIC
NEUROENDOCRINE TUMOUR
MIMICKING INTRAHEPATIC
CHOLANGIOCARCINOMA. A CASE
REPORT AND LITERATURE REVIEW
V. Leow1, N. Misron2, T. Kumar3, C. Tee3, V.
Letchumanan3 and M. K. Subramaniam3
1HPB Unit, Division of Surgery, Department of General
Surgery, Advanced Medical and Dental Institute
(AMDI), Science University of Malaysia (USM) and
Sultanah Bahiyah Hospital, Penang, Malaysia;
2Department of Pathology, Sultanah Bahiyah Hospital,
Kedah, Malaysia; 3HPB Unit, Division of Surgery,
Department of General Surgery, Sultanah Bahiyah
Hospital, Kedah, Malaysia
Objectives: Primary hepatic neuroendocrine tumour
(PHNET) is an extremely rare disease entity. Extensive
workup and long term follow up are required for the
diagnosis as well as treatment of this tumour.
Methods: We present a 49 year-old female patient with
vomiting, anorexia and weight loss for 6 months. Clini-
cally, there were no remarkable findings. A series of
laboratory blood results were in normal range. A tri-
phase computed tomography (CT) of the liver showed
features of intrahepatic cholangiocarcinoma. Her Ca
19-9 was normal and carcinoembryonic antigen (CEA)
was 7.2 lg/L. She was tested negative for hepatitis B
and C screening. Preoperative upper and lower gastro-
intestinal endoscopies revealed no positive findings.
Subsequently, she underwent extended right hemihepa-
tectomy. Following this she had a stormy recovery.
Her histopathological report revealed grade 3 neuroen-
docrine carcinoma with resection margin involvement.
The tumour cells were positive for chromogranin, syn-
aptophysin, CDX-2 and CK19. The proliferative index
was approximately 30%. Endoscopic ultrasound per-
formed postoperatively showed no lesions in the pan-
creas.
Results: Literatures documented primary neuroendo-
crine tumour of the liver can mimic intrahepatic cho-
langiocarcinoma and hepatocellular carcinoma. Careful
preoperative interpretation of the radiographic images
is vital for accurate diagnosis and planning for further
investigations. Complete resection of the tumour is still
the mainstay of treatment. Adjuvant treatment is rec-
ommended for incomplete resection.
Conclusion: Meticulous preoperative evaluation and
workup of primary liver tumour is of paramount
important. R0 liver resection is desired for curative
intent. Lengthy surveillance and adjuvant treatment is
recommended for residual disease.
© 2015 The Authors
HPB 2015, 17 (Suppl. S2), 25–266 HPB © 2015 Americas Hepato-Pancreato-Biliary Association
Poster Abstracts 93
APHPB-0236
NEUTROPHIL TO LYMPHOCYTE
RATIO PREDICTS THERAPEUTIC
OUTCOME AFTER
PANCREATICODUODENECTOMY FOR
CARCINOMA OF THE AMPULLA OF
VATER
K. Haruki, T. Misawa, H. Shiba, Y. Shirai, T.
Horiuchi, R. Iwase, Y. Fujiwara, K. Furukwa, T. Iida,
R. Saito, T. Gocho, Y. Futagawa, Y. Toyama, Y.
Ishida and K. Yanaga
Department of Surgery, Jikei University School of
Medicine, Tokyo, Japan
Objectives: Preoperative systemic inflammatory
response is associated with a poor long-term prognosis
after resection for malignant tumors. Several markers
of systemic inflammation have been reported to be a
predictor of outcomes, but have not been fully investi-
gated. Therefore, we retrospectively investigated the
relation between preoperative neutrophil to lymphocyte
ratio (NLR) and disease-free as well as overall survival
after pancreaticoduodenectomy for carcinoma of the
ampulla of Vater.
Methods: The study comprised 37 patients who had
undergone pancreaticoduodenectomy for carcinoma of
the ampulla of Vater between January 2000 and
December 2011. We retrospectively investigated the
relation between preoperative NLR and disease-free as
well as overall survival.
Results: In multivariate analysis, preoperative biliary
drainage (p = 0.044) and advanced lymph node metas-
tasis (p = 0.027) were independent and significant pre-
dictors of disease-free survival, while significant
predictors of overall survival consisted of advanced
lymph node metastasis (p = 0.025) and NLR ≥3
(p = 0.026). Moreover, preoperative biliary drainage
(p = 0.006) and greater T factor (p = 0.007) were signif-
icantly greater in high NLR group.
Conclusion: Preoperative NLR is an independent and
significant indicator of long-term outcomes in patients
with carcinoma of the ampulla of Vater after pancreati-
coduodenectomy.
Benign HPB Diseases
APHPB-0237
LAPAROSCOPIC DISTAL
PANCREATECTOMY USING A NOVEL
TECHNIQUE FOR ENSURING
OPERATIVE FIELD
T. Morikawa, T. Naitoh, T. Aoki, K. Nakagawa, T.
Okada, H. Hayashi, H. Yoshida, F. Motoi, Y.
Katayose and M. Unno
Surgery, Tohoku University Graduate School, Sendai,
Japan
Objectives: Laparoscopic distal pancreatectomy (LDP)
is an emerging operation for managing benign and low-
grade malignant lesions of the pancreatic body and tail.
One of the most important elements in laparoscopic
pancreatectomy is to ensure the operative fields by
retracting the stomach. Although various types of tech-
niques performed for securing the operative fields in
LDP, they were far away from satisfaction. Herein, we
described a new surgical technique, which we refer to
as the ‘stomach roll-up technique’, for securing suitable
surgical field in LDP.
Methods: The first step of this technique is to expose
the pancreas by opening the greater omentum. The left
gastroepiploic vessels and short gastric vessels were
divided if Warshow’s procedure is not indicated, and
the stomach was thoroughly separated from the spleen.
Subsequently, the round ligament and falciform liga-
ment of the liver was divided and the round ligament
was ligated by Endo-loopTM. After dividing the lesser
omentum, the round ligament was retracted upward
through the lesser and greater curvature by pulling
Endo-loopTM out of abdominal cavity. Then, the stom-
ach was rotated over the liver and the pancreas is well
identified in a laparoscopic view.
Results: From January 2014 we performed LDP using
this technique in 7 cases. There was no significant dif-
ference between this technique and conventional LDP
in operation time, blood loss, and morbidity.
Conclusion: The stomach roll-up technique is simple
and easy and can ensure a suitable surgical field during
LDP. This new surgical procedure can improve the
safety of laparoscopic pancreatic surgery.
APHPB-0238
TWO-INCISION THREE-PORT (TILC)
LAPAROSCOPIC CHOLECYSTECTOMY.
A FEASIBLE AND SAFE TECHNIQUE
V. Leow1, F. Mohamed Sikandar2, M. Sharif2, C. Tee2,
V. Letchumanan2, K. Yang2 and M. K. Subramaniam2
1HPB Unit, Division of Surgery, Department of General
Surgery, Advanced Medical and Dental Institute
(AMDI), Science University of Malaysia (USM) and
Sultanah Bahiyah Hospital, Penang, Malaysia; 2HPB
Unit, Division of Surgery, Department of General
Surgery, Sultanah Bahiyah Hospital, Kedah, Malaysia
Objectives: Standard laparoscopic cholecystectomy
(LC) involved the use of four ports. Gradually as cos-
metic reason has become the primary goal, the numbers
of port used have reduced to one. This has been
achieved with single incision laparoscopic cholecystec-
tomy. However, these techniques may necessitate cer-
tain degree of learning curve and technically more
demanding. The aim of this clinical study was to
explore an alternative technique of laparoscopic choley-
cystectomy which offers a simpler learning curve and
less demanding technique.
Methods: This was a prospective descriptive study per-
formed from September 2009 to February 2011 in Sul-
tanah Bahiyah Hospital. A total of 58 patients
underwent two incisions three ports laparoscopic chole-
cystectomy (TILC) which were being performed by the
senior consultant hepato-pancreato-biliary (HPB) sur-
geon and two HPB trainees. The study end points
included operative time, postoperative pain, length of
hospital stay and early postoperative complications.
The follow up period was 4 weeks.
Results: The overall operative time taken was
44  18 min. None of the patients had major compli-
© 2015 The Authors
HPB © 2015 Americas Hepato-Pancreato-Biliary Association HPB 2015, 17 (Suppl. S2), 25–266
94 Poster Abstracts
cation or incisional hernia postoperatively. A total of
98% of the patients discharged within 24 h. Postopera-
tive analgesia used was mainly NSAIDs.
Conclusion: Two-incision three-port laparoscopic chole-
cystectomy is feasible and safe to be performed.
Malignant HPB Diseases
APHPB-0240
THE SURVIVAL BENEFIT FOR THE
PATIENTS WITH INTERMEDIATE AND
ADVANCED HEPATOCELLULAR
CARCINOMA BY LIVER RESECTION
WITHOUT BLOOD TRANSFUSION
T. Miura, N. Kimura, D. Kudo, K. Ishido, Y. Toyoki
and K. Hakamada
Gatroenterological Surgery, Hirosaki University
Graduate School of Medicine, Hirosaki, Japan
Objectives: The aim of this study was to elucidate the
patient characteristics that would be suitable to liver
resection for intermediate and advanced hepatocellular
carcinoma (stage B/C HCC) in order to obtain the sur-
vival benefit.
Methods: The 166 patients with HCC who underwent
initial liver resection at Hirosaki University Hospital
between January 2001 and December 2012 were ana-
lyzed in a retrospective manner. Demographic, clinical
and pathological data were analyzed using Mann–
Whitney U, v2, and log-rank tests. Multivariate analysis
was performed by Cox proportional hazards model.
Results: The 142 patients were classified as early HCC
(stage A) and 24 patients as stage B/C. The patients
with stage B/C had significantly lower rate of 5-year
overall survival than those with stage A, 17% and 63%
respectively. The multivariate analysis among 166
patients identified that stage B/C [HR 4.01 (95% CI
2.12–7.59)], vascular invasion [HR 2.48 (95% CI 1.37–
4.47)], and allogenic blood transfusion [HR 2.06 (95%
CI 1.16–3.66)] were independently poor prognostic fac-
tors. The allogenic blood transfusion was the only sig-
nificant factor associated with short-term overall
survival among stage B/C patients. The predictive scor-
ing system characterized by platelet counts (10 9 104/
mm3), a-fetoprotein (≥80 ng/mL), tumor size (≥4 cm)
and major hepatectomy was useful for assessing the
need for allogenic blood transfusion and could predict
the survival benefit of liver resection for the patients
with stage B/C HCC.
Conclusion: The survival benefit would be expected for
the patients with stage B/C HCC who underwent liver
resection without blood transfusion, which could be
predictive using preoperative factors.
APHPB-0242
IS IT TRUE THAT THE LEFT HEPATIC
DUCT IS LONGER THAN THE RIGHT
HEPATIC DUCT?
T. Hirose, T. Igami, T. Ebata, Y. Yokoyama, G.
Sugawara, T. Mizuno and M. Nagino
Division of Surgical Oncology, Department of Surgery,
Nagoya University Graduate School of Medicine,
Nagoya-shi, Japan
Objectives: To investigate whether the anatomic con-
sideration that ‘the left hepatic duct is longer than that
of the right hepatic duct’ is correct.
Methods: In surgical study, the lengths of the resected
bile duct were measured in 475 patients with perihilar
cholangiocarcinoma who underwent right- or left-sided
hepatectomy. In radiological study, estimated lengths
of the bile duct to be resected were measured, using
cholangiograms reconstructed from portal phase multi-
detector-row computed tomography (MDCT) images,
in 61 patients with distal bile duct obstruction who
underwent MDCT.
Results: In surgical study, the length of the resected left
hepatic duct was 25.1  6.4 mm in anatomic right tri-
sectionectomy (n = 37) and 14.9  5.7 mm in right
hepatectomy (n = 167). The length of the right hepatic
duct was 14.1  5.7 mm in left hepatectomy (n = 149)
and 21.3  6.4 mm in left trisectionectomy (n = 122).
In radiological study, the lengths of the bile duct corre-
sponding to the surgical study were 34.1  7.8 mm,
22.4  7.1 mm, 20.8  4.8 mm, and 31.6  5.3 mm,
respectively. Both studies showed that the length of the
resected bile duct was (1) similar between right and left
hepatectomies, (2) significantly shorter in right hepatec-
tomy than in left trisectionectomy, and (3) the longest
in anatomic right hepatic trisectionectomy with statisti-
cal significance.
Conclusion: Anatomical consideration that ‘the left
hepatic duct is longer than the right hepatic duct’ lacks
scientific validation and is just surgeon’s biased view. A
‘blind selection’ of right hepatectomy should be recon-
sidered.
APHPB-0243
THE USEFULNESS OF MICROBIAL
CULTURE IN THE DRAIN FLUID AS A
PREDICTOR OF PANCREATIC FISTULA
AFTER PANCRETODUODENECTOMY
N. Kimura, Y. Toyoki, K. Ishido, D. Kudo, S.
Tsutsumi and K. Hakamada
Department of Gastroenterological Surgery, Hirosaki
University Graduate School of Medicine, Hirosaki,
Japan
Objectives: Early bacterial contamination in the ascitic
fluid after pancreatoduodenectomy (PD) may lead to
the development of clinically relevant pancreatic fistula
(CR-POPF). We investigated the relationship between
CR-POPF after PD and bacteria isolated from the
drain fluid.
Methods: Seventy-eight consecutive patients underwent
PD at our institute from 2012 to 2014. Microbial cul-
ture was routinely obtained from the drain fluid on
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postoperative day (POD) 1, 3, and 6. The relationship
between CR-POPF and clinical factors was assessed by
univariate and multivariate analysis.
Results: CR-POPF occurred in 30.8%. In univariate
analysis, significant predictors of CR-POPF were esti-
mated blood loss (p = 0.009), smaller pancreatic duct
(p = 0.004), soft pancreas (p = 0.007) and bacterial
contamination in the drain fluid on POD1 or 3
(p = 0.001). In multivariate analysis, bacterial contami-
nation in the drain fluid on POD1 or 3 was the only
independent predictor of CR-POPF (OR = 6.18, 95%
CI 1.68–22.72). In 45.8% of the patients with CR-
POPF, bacteria were isolated from the drain fluid up to
POD3. The most commonly isolated bacteria were
Enterococcus faecalis (25.0%), Pseudomonas aeruginosa
(16.7%), and Enterobacter cloacae (8.3%). Further-
more, imipenem, meropenem and levofloxacin had
strong sensitivity for them.
Conclusion: Early bacterial contamination of the ascitic
fluid might be responsible for CR-POPF. Routine
microbial culture obtained from the drain fluid in the
early postoperative period is useful to predict CR-
POPF. Therefore, it is important to prevent the surgical
field from becoming contaminated with enteric bacteria
intraoperatively and to perform the early administra-
tion of more sensitive antibiotics.
APHPB-0244
RISK FACTORS ASSOCIATED WITH
MORTALITY AND RECURRENCE FOR
PATIENTS WITH HUGE
HEPATOCELLULAR CARCINOMA
AFTER HEPATECTOMY
W. Zhang, X. Wang, G. Yuan and X. Chen
Hepatic Surgery Center, Tongji Hospital, Tongji
Medical College, Hua Zhong University of Science and
Tec, Wuhan, China
Objectives: Controversy still exists in deciding whether
surgical resection can be performed on the patients
with huge hepatocellular carcinoma (HCC) ≥10CM,
but some cases do indeed have good prognosis. How-
ever, risk of operative morbidity and mortality for huge
HCC increase in the hepatic resection because of the
need for major hepatic resections. Here we describe
whether hepatic resection carried out for huge HCC is
safe and effective.
Methods: From January 2010 to December 2012, 58
patients with huge HCC underwent surgical resection
were enrolled in this study. Survival and recurrence
data were collected. Prognostic factors were analyzed.
Results: Major postoperative complications (clavein
classification ≥Grade III) may occur in up to 13%
platelet, PTA, postoperative TP and Ishak score were
independent risk factor. 3 patients (5.17%) died within
60 days followed hepatectomy. Multivariate analysis
showed that 60-day mortality was significantly associ-
ated with platelet (p = 0.04), Ishak score (p = 0.009),
and future liver remnant (p = 0.034). Ishak score in
survival and mortality group is 9.53  1.95 and
14.00  1.00 (p = 0.001). 36.2% of the patients suf-
fered from early recurrence (within 1 year after hepatic
resection). The presence of vascular invasion (p = 0.05)
and satellite nodules (p < 0.001) were independent risk
factors for early recurrence.
Conclusion: Surgical resection is safe and feasible for
selected huge primary liver cancer, and our data
showed that platelet <150 9 109/L, high Ishak score,
and future liver remnant <40% were the independent
risk factors for the mortality within 60 days after hepa-
tectomy. Vascular invasion and satellite nodules are
strongly associated with early recurrence.
APHPB-0245
EMBRYONAL RHABDOMYOSARCOMA
OF LIVER IN A 16 YEAR OLD MALE-
RARE CASE REPORT
R. Rajendran, D. Benet, A. Amudhan, R.
Prabhakaran, D. Kannan and S. M. Chandramohan
Gastroenterology, Madras Medical College, Chennai,
India
Objectives: Primitive mesenchymal tumors represent
about 9–15% of all hepatic tumors in children. Only
about 150 cases have been reported in the literature so
far. Hereby we report a case of Ruptured Embryonal
Rhabdomyosarcoma.
Methods: A boy aged 16 years old with weight of
26 kg presented to us with sudden onset of abdominal
pain and fever. Clinical examination revealed a tender
hepatomegaly about 6 cm below Right costal margin.
CECT abdomen revealed 15 9 11 9 9 cm heteroge-
nous multi septated loculated mass lesion involving
right lobe of liver involving segments 5, 6, 7, 8. Diag-
nostic laparoscopy was done which showed a tumor
occupying the entire right lobe of liver with no other
deposits. The tumor capsule was seen ruptured on the
right lateral side for which we did emergency right
Hepatectomy. Weight of the specimen was 2.8 kg.
Results: Histopathology revealed the lesion as Embryo-
nal Rhadomyosarcoma with co-existing mesenchymal
hamartoma. Immunohistochemistry showed Vimentin
and Desmin positive. Patient was started on carbopla-
tin and Ifosfamide based chemotherapy. Patient expired
on 30th postoperative day due to acute respiratory dis-
tress.
Conclusion: Improved survival can be expected only if
we detect the disease early. This case report will
enlighten this type of rare tumor in young children and
an early referral to the specialist.
Benign HPB Diseases
APHPB-0246
THE FREQUENCY AND THE
CHARACTERISTICS OF
EXTRAHEPATIC MANIFESTATIONS
ASSOCIATED WITH CHRONIC
HEPATITIS C
L. Coldea
Faculty of Medicine, Lucian Blaga University, Sibiu,
Romania
Objectives: The aim of study is to establish the charac-
teristic and frequency of extrahepatic manifestations.
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Methods: The study is retrospective based on 162 cases
of chronic hepatitis with antibodies HCV positive, 78
cases with chronic hepatitis C were followed up pro-
spective for duration of hospitalisation.
Each patient had a clinical observation paper with per-
sonal dates, personal pathological and heredity history,
the anamnesis and clinical dates, the results of lab tests
and paraclinical investigations.
Results: The group of 162 cases with chronic hepatitis
with antibodies HCV positive are composed by 102
females (63%) and 60 males (37%). In my study I
observed that it was a preponderant affection of age
60–69 years (27.16%).
In my group, 53 patients (33%) present without hepatic
manifestation, extrahepatic manifestations, and 109
patients present only hepatic manifestations. The distri-
bution of cases with extrahepatic manifestations is: 16
patients with endocrine manifestations (30.18%), 22
patients with crioglobulinemia (41.53%); 5 patients
with skin manifestations (9.43%); 8 patients with hema-
tological manifestations (15.09%), 2 patients other
manifestations (3.77%).
One third of patients present extrahepatic manifesta-
tions which showed high frequency of extrahepatic
manifestations.
Conclusion: Chronic hepatitis C is frequently associated
with extrahepatic manifestations, the most frequent
extrahepatic manifestations is cryoglobulinemia mixed.
In some of extrahepatic manifestations the role of
HCV is well established, while in others it is still specu-
lative. The number of extrahepatic manifestations in
chronic hepatitis C is in continues growth and became
a open filed of research.
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NEOPLASTIC NEEDLE TRACK
SEEDING FOLLOWING
PERCUTANEOUS RFA FOR
HEPATOCELLULAR CARCINOMA: A
CASE REPORT
S. Mathur1, G. Goel2, D. Amrapurkar3 and D.
Chhabra1
1Surgical Oncology, Bombay Hospital and Medical
Research Centre, Mumbai, India; 2General Surgery,
Shushrusha Citizen’s Cooperative Hospital, Mumbai,
India; 3Gastroenterology, Bombay Hospital and Medical
Research Centre, Mumbai, India
Objectives: Background: Neoplastic needle tract seed-
ing (NNTS) may arise after diagnostic or therapeutic
percutaneous procedures for hepatocellular carcinoma
(HCC). The risk of seeding is greater with diagnostic
biopsy as compared to therapeutic percutaneous proce-
dures such as Radiofrequency ablation (RFA). Litera-
ture reports 0.5–2.8% incidence of post RFA NNTS
and the time to recurrence is not well documented. We
present here a case of NNTS after percutaneous RFA,
in a patient surviving with HCC for 8 years.
Methods: Case: A 42 year old, HBsAg positive cir-
rhotic male underwent a Transarterial Chemoemboliza-
tion in 2006 for a 5.1 cm HCC. The AFP levels were
normal at diagnosis and no biopsy was performed. A
percutaneous RFA was done 4 years later for a
recurrent 31 mm intrahepatic nodule detected adjacent
to the previous tumor. Two passes were made for abla-
tion. A follow up MRI scan at 24 months that showed
non enhancing 8 mm nodule in the parities and attrib-
uted to a scar increased to 13 9 14.4 9 10.5 cm over
subsequent 12 months; its base reaching upto the liver
capsule. The primary tumor in the liver was stable and
the ablated lesion showed no activity.
Results: The patient underwent a wide local excision
with segmental excision of 10th and 11th ribs. There
was no intraperitoneal tumor extension. The histology
confirmed a metastatic well differentiated HCC of ante-
rior abdominal wall. Tumor cells expressed hepatocyte
specific antigen (OCH1E5) and glypican 3.
Conclusion: Post RFA NNTS remains a potential com-
plication despite non-subcapsular, non AFP secreting
well differentiated HCC.
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APHPB-0249
SALVAGE LIVER TRANSPLANTATION
FOR HEPATOCELLULAR CARCINOMA
RECURRENCE IN YOUNG AGE
PATIENTS
Y. J. Hung, K. H. Lin, C. J. Ko and Y. L. Chen
Surgery, Changhua Christian Hospital, Changhua,
Taiwan
Objectives: Salvage liver transplantation (SLT) is con-
sidered a feasible option for the treatment of recurrent
hepatocellular carcinoma (HCC). Little is known about
outcomes for SLT in young age patients with recurrent
HCC. The aim of this study was to evaluate the clinical
efficacy and prognostic factors for SLT for HCC recur-
rence in young age patients.
Methods: During 2002–2013, 218 patients younger than
50 years old undergoing liver resection (LR) for HCC,
69 of them experienced recurrence and 23 of them were
intrahepatic. 9 patients (SLT group) received SLT for
tumor recurrence treatment while the other 14 patients
(nSLT group) had TACE, RFA and repeat LR. The
clinical findings and outcomes were compared between
the two groups.
Results: 1 patient in SLT group dies because of tumor
recurrence, the overall survival rate was 88.8% in SLT
group. 9 out of 14 patients died in nSLT group and the
overall survival rate was 35.7%. The average of time to
recurrence was 5.7 months for nSLT group and
19.6 months for SLT group. No perioperative mortality
was noted in SLT group.
Conclusion: Our single institution experience demon-
strated that salvage liver transplantation followed by
liver resection is a feasible treatment for HCC patients
youger than 50 years old. With the shortage of graft
and preserved liver function in young HCC patients,
LR may considered as first line treatment and followed
by SLT if intrahepatic recurrence occurred.
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PREOPERATIVE S-1 AND
CONCURRENT RADIATION FOR
PATIENTS WITH POTENTIALLY
RESECTABLE PANCREATIC
CARCINOMA
N. Yamamoto, K. Okano, E. Asano and Y. Suzuki
Gastroenterological Surgery, Kagawa University,
Kitagun, Japan
Objectives: Standardization of adjuvant chemotherapy
have improved the prognosis for pancreatic cancer
(PC), but still not sufficient. Therefore preoperative
treatment is expected for improving the prognosis with
a resectable PC. We report the results of neoadjuvant
chemoradiotherapy (NACRT) for resectable PC, and
examined its safety and efficacy.
Methods: The study retrospectively reviewed 57
patients who underwent pancreatectomy for PC in
2009.9–2014.9. Patients with NACRT (n = 15) were
treated before surgery with S1 (60 mg/m2, day 1–14)
and radiation (30 Gy in 3Fr). Perioperative results and
prognosis were analyzed and compared with patients
who received surgery first (SURGERY, n = 42).
Results: NACRT was indicated for patients with a
resectable PC. Neutropenia (2 patients), nausea and
anorexia (2 patients) and cholangitis (1 patient) were
experienced as adverse events. Preoperative leukocytes,
lymphocytes, platelets, and cholinesterase values were
significantly lower in comparison with SURGERY
(p < 0.005), but there was no significant difference in
Hemoglobin and Albumin. There was no significant
difference between the groups for patient background,
perioperative result, complications, tumor size and
lymph node metastasis. Thirteen of 15 patients with
NACRT (86.7%) received surgery and all cases were
confirmed R0 in pathologic evaluation. 1-, 2-year sur-
vival rate were 88%, 70% in NACRT and 79%, 54%
in SURGERY, respectively. There was no significant
difference between the groups in overall survival and
recurrence free survival.
Conclusion: Although NACRT affected the preopera-
tive nutrition or several blood components, NACRT is
well tolerated and safe in perioperative results. In addi-
tion, the present preliminary results suggested NACRT
may improve the prognosis for resectable PC.
APHPB-0251
THE PROGNOSTIC VALUE OF
HEPATOCYTE GROWTH FACTOR
RECEPTOR EXPRESSION IN PATIENTS
WITH PERIHILAR
CHOLANGIOCARCINOMA
H. Watanabe, Y. Yokoyama, T. Kokuryo, T. Ebata,
T. Igami, G. Sugawara, T. Mizuno, J. Yamaguchi and
M. Nagino
1Surgery, Nagoya University Graduate School of
Medicine, Nagoya, Japan
Objectives: The overexpression of mesenchymal-epithe-
lial transition factor (MET) and Recepteur d’Origine
Nantais (RON) has been shown to be associated with
poor prognosis in some types of cancer. The aim of this
study was to determine the expression profile of MET
and RON in histologically curatively resected surgical
specimens of perihilar cholangiocarcinoma (PHC). The
strength of MET or RON expression and its associa-
tion with patient prognosis were also analyzed.
Methods: One hundred and sixty-nine patients who
underwent histologically curative resection for PHC
were subjected to immunohistochemical analysis for
MET and RON.
Results: There were 27 patients (16%) who revealed a
positive expression for both MET and RON. Although
clinicopathological features in the either MET- or
RON-negative group were not significantly different
compared to the both MET and RON-positive group,
the prognosis tended to be worse in the patients with
both MET and RON positivity. When the analysis was
limited to the advanced stage patients (stage III and
IVa), a multivariate analysis revealed that both MET
and RON positivity and lymph node metastasis were
identified as independent poor prognostic factors.
Conclusion: This study demonstrated that the overall
survival rate with both MET and RON positivity was
worse than that with either MET or RON negativity in
the patients with advanced PHC. The poor prognosis
in these patients was not associated with unfavorable
clinicopathological features. The examination of MET
and RON expression in PHC may enable a tailored
method for patient classification that could not other-
wise be achieved using the conventional pathological
classification system.
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THE FIRST REPORTED HEPATIC
ACTINOMYCOTIC MASS IN MALAYSIA
C. S. Tee, V. M. Leow, L. Vasupillai and S. Manisekar
Hepato-Pancreto-Biliary, Hospital Sultanah Bahiyah,
Alor Setar, Malaysia
Objectives: Primary hepatic actinomycotic mass is a
rare occurence with a reported incidence of <5%. This
is a case report of isolated hepatic actinomycosis mas-
querading as hepatocellular carcinoma. It was diag-
nosed on histopathological examination of the surgical
specimen and is the first such reported case in Malay-
sia.
Methods: History, physical examination, blood tests,
computed tomography and laparotomy with left hepa-
tectomy were done to establish the presence and origin
of the mass in the left liver. Histopatholigcal findings
of eosinophilic ‘Splendor-Hoeppli material’ with appar-
ent normal liver parenchymal were confirmed to estab-
lish the diagnosis.
Results: A 42-year-old man came with complaint of
1 month history of dull epigastric pain. On examina-
tion, a mass arising from the left liver was felt.
Computed tomography revealed a unequivocal soild
mass on the arterial phase, occupying the whole left
liver. No evidence of vascular invasion or abdominal
lymphadenopathy or other focal lesions. Alpha feto-
protein and other blood tests were normal.
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The patient underwent left hepatectomy. Grossly, the
cut section appeared solid. Histology revealed greenish
microabscesses with the presence of eosinophilic ‘Splen-
dor-Hoeppli material’ and apparent liver parenchyma.
The patient was treated and discharged with penicillin
based antibiotic for 6 months upon established diagno-
sis.
Conclusion: Due to its rarity, primary hepatic actino-
mycosis is often overlooked etiology for a liver mass.
Given its non-descript symptomatology and indolent
course, surgeons should be made aware of this differen-
tial, especially in endemic area, and the potential pit-
falls in diagnosis and management.
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APHPB-0253
FACTORS THAT PREDISPOSE TO
HEPATOCELLULAR CARCINOMA
RECURRENCE POST LIVER
RESECTION
J. Gan1 and S. Chang2
1Trauma and Orthopaedics, Royal Albert Edward
Infirmary, Wigan, UK; 2Hepatobiliary Surgery, National
University Hospital, Singapore, Singapore
Objectives: We aim to determine the factors influencing
recurrences following curative resection for Hepatocel-
lular Carcinoma.
Methods: Data from patients who underwent curative
resection for hepatocellular carcinoma at our hospital
(National University Hospital) from 2000 to 2008 were
reviewed retrospectively. Univariate and multivariate
analysis were conducted to identify prognostic factors
associated with recurrence- free survival and overall
survival.
Results: The mean overall patient survival was
86.3 months (95% confidence interval 74.31–97.47).
Gross vascular invasion was significantly associated
with overall survival (p = 0.049). Fifty three patients
(52%) had recurrences; the median recurrence- free sur-
vival was 22.6 months (95% confidence interval [CI]
11.77–33.39). Microscopic vascular invasion
(p = 0.0001, Hazard Ratio [HR] = 3.53, 95% CI 1.83–
6.80), pretreatment with radiofrequency ablation
(RFA) (p = 0.007, HR = 4.79, 95% CI 1.56–14.74) and
transcatheter chemoembolization (TACE) (p = 0.013,
HR = 2.48, 95% CI 1.22–5.07) were associated with
recurrence- free survival. Pre-operative RFA treatment
(p = 0.001), multiple tumours (p = 0.029), microvascu-
lar invasion (p = 0.01), higher pre-operative Alphafeto-
protein levels (p = 0.002), and gross vascular invasion
(p = 0.04) had significant association with intrahepatic
recurrence; microscopic vascular invasion (p = 0.043)
and a larger tumour size (p = 0.008) were associated
with increased risk of extrahepatic recurrence.
Conclusion: Microscopic vascular invasion remains a
consistent predictor of hepatocellular carcinoma recur-
rence. We also found tumour size and microscopic vas-
cular invasion as predictors of extrahepatic recurrences,
which may preclude patients from therapy like liver
transplantation.
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THE TIMING OF CHOLECYSTECTOMY
AFTER PERCUTANEOUS
TRANSHEPATIC GALLBLADDER
DRAINAGE
D. Park and K. Kim
Surgery, Wonkwang University Hospital, Iksan, Korea
Objectives: Laparoscopic cholecystectomy is the stan-
dard treatment for acute cholecystitis. The percutane-
ous gallbladder drainage (PTGBD) is an alternative
treatment option to resolve acute cholecystitis in
patients with severe cormobitities. However, time for
cholecystectomy after PTGBD is still controversial. The
objective of this study is to determine optimal timing
for laparoscopic cholecystectomy after PTGBD for
acute cholecystitis.
Methods: This retrospective study was conducted on
patients who underwent cholecystectomy after PTGBD
from January, 2012 through June, 2014. For-five
patients were included in this study and patients were
divided into two groups. Gruop 1 patients underwent
cholecystectomy within 10 days after PTGBD (n = 23).
Whereas group 2 patients underwent cholecystectomy
at more than 10 days after PTGBD (n = 22).
Results: There were no significant differences between
groups in conversion rate to open surgery, operation
time, periopeative complications and hospital stay after
cholecystectomy. But, complications related to PTGBD
was significantly higher in gruop 2 than that in group 2
(p > 0.032).
Conclusion: In this study, the timing of laparoscopic
choleystectomy after PTGBD didn’t influence the rate
of conversion to open surgery, operation time, periop-
erative complications and hospital stay after cholecys-
tectomy. So the best timing of laparoscopic
cholecystectomy after PRGBD be made after consider-
ing patient general condition and surgeon’s experiences.
And further prospective study is required to suppot this
findings.
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COMPARISON OF OPEN
PANCREATODUODENECTOMY AND
LAPAROSCOPIC
PANCREATODUODENECTOMY
H. Sunagawa, N. Oshiro, T. Orokawa and K. Ogura
Surgery, Nakagami Hospital, Okinawa, Japan
Objectives: Currently, laparoscopic procedure has been
used in many organs. Laparoscopic pancreatoduoden-
ectomy (PD) has not spread yet. Laparoscopic PD rep-
resents one of the most advanced abdominal operations
owing to the necessity of a complex dissection and
reconstruction. In this report, we compared the feasibil-
ity between open pancreatoduodenectomy (PD) and la-
paoscopic PD.
Methods: The 62 patients with periampullary and pan-
creatic disease during 2009–2014 were divided into
open PD group (OG) and laparoscopic PD group
(LG). All PD were performed by one surgeon. We
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underwent a pyrolus preserving methods and Child’s
reconstructions. A totally laparoscopic approach was
used for the entire procedure using a five-port tech-
nique in LG basically. Clinical, perioperative and out-
come data were retrospectively analyzed.
Results: The ratios of pancreatic cancer patients were
17% (OG) and 0% (LG). But there was no difference
in background other factors between the two groups.
The median operative time in LG was longer than in
OG (585 vs. 410 min, p = 0.036). The median blood
loss in LG was less than in OG (250 vs. 750 mL,
p = 0.001). The pancreatic fistula (PF) rate in OG was
13.5% (>grade B). The PF rate in LG was 12%
(>grade B). The median hospital stay in LG were
shorter than in OG (12 vs. 22 days, p = 0.0005).
Conclusion: Laparoscopic PD is a feasible for well-
selected patients.
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APHPB-0256
LOW CALORIC INTAKE AND GRAFT
FUNCTION IN THE EARLY PERIOD
AFTER LIVER TRANSPLANTATION
Y. Nah1, K. Kyoung2, C. Nam1, H. Park1 and S. Lee3
1Surgery, Ulsan University Hospital, Ulsan, Korea;
2Emergency Medicine, Ulsan University Hospital, Ulsan,
Korea; 3Surgery, Asan Medical Center, Seoul, Korea
Objectives: Effects of caloric supplementation on the
graft function after deceased donor liver transplanta-
tion (DDLT) have not been investigated much. The
authors investigated the correlation between the caloric
intake and early graft function and compared calorie/
body weight ratio (C/BWR) and calorie/graft weight
ratio (C/GWR) as a guidance for nutritional provision.
Methods: 40 patients who underwent DDLT between
January 2010 and December 2013 were divided into the
low caloric group (<18 kcal/kg/day) and eucaloric
group (≥18 kcal/kg/day) according to caloric intake
until 48 h post-DDLT. To check the impact of caloric
intake on the graft function, aminotransferase level, bil-
irubin level, and international normalized ratio (INR)
on postoperative days (POD) 0, 2, and 7 were com-
pared between the 2 groups. Recovery of graft function
was compared according to the C/BWR and C/GWR.
Results: 32 patients received low caloric intake during
the first 48 h after DDLT and 8 patients received eucal-
oirc intake. INR on POD 2 was significantly better in
the low caloric group (p = 0.018). C/GWR was more
strongly correlated with INR on POD 2 than C/BWR
(r = 0.08, p = 0.63 vs. r = 0.36, p = 0.024).
Conclusion: Low caloric intake was better than eucalo-
ric intake in the restoration of early graft function. C/
GWR was superior to C/BWR as a standard for nutri-
tional supplementation.
APHPB-0257
EFFECT OF BETEL NUT
CONSUMPTION ON TACROLIMUS
TROUGH CONCENTRATION IN LIVER
TRANSPLANT RECIPIENTS
C. Y. Lee1, C. J. Ko2, K. H. Lin2, C. C. Lin2, P. Y.
Lin3 and Y. L. Chen2
1Pharmacy, Changhua Christian Hospital, Changhua,
Taiwan; 2General Surgery, Changhua Christian Hospital,
Changhua, Taiwan; 3Transplant Medicine & Surgery
Research Centre, Changhua Christian Hospital,
Changhua, Taiwan
Objectives: A number of studies shown that betel nut
chewing is related to submucosal fibrosis and esopha-
gus cancer. However, studies on the pharmacokinetics
of tacrolimus with betel nut chewing are rare. Herein,
we aimed to investigate tacrolimus level in liver trans-
plant (LT) recipients with and without betel nut con-
sumption.
Methods: This was a retrospective study during Janu-
ary 2013 to June 2014. 42 patients with LT at the
Changhua Christian Hospital were stratified into two
groups depending on patients had chewed betel nut or
not. Of these patients, 14 was betel nut chewer (group
1) and 28 had never chewed betel nut (group 2). All
clinical and laboratory data were obtained, including
age, tacrolimus dosage and level, serum creatinine, and
estimated glomerular filtration rate (eGFR). We used a
one-to-two matching analysis, the chi-square test for
categorical comparisons of data and the Mann–Whit-
ney U-test to determine differences in the means of
continuous variables.
Results: Our results shown that mean eGFR were simi-
lar between two groups, 71.6 mL/min/1.73 m2 in group
1 (mean age, 50.29  5.58 years) and 73.7 mL/min/
1.73 m2 in group 2 (mean age, 51.93  7.04 years).
However, the mean tacrolimus levels after adjusted
tacrolimus daily-dose were significantly lower in the
group 1 at fifth month (0.626 vs. 0.984 ng/mL;
p < 0.035).
Conclusion: In the present study, patients with betel
nut chewing tends to have low tacrolimus level. With
this preliminary finding, we suggest that it is necessary
to adjust tacrolimus dosage in order to prevent rejec-
tion in LT recipients with betel nut chewing.
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APHPB-0258
HEPATIC– BONE – ADIPOKINES
METABOLISM:
PATHOPHYSIOLOGICAL LINKS AND
CLINICAL IMPLICATIONS IN OLDER
PATIENTS WITHOUT OVERT LIVER
DISEASE
A. Fisher
Geriatric Medicine, The Canberra Hospital, Australian
National University Medical School, Canberra, ACT,
Australia
Objectives: To examine liver function tests (LFTs) in
relation to age, comorbidities, mineral-bone metabo-
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lism, adiponectin, leptin and resistin status and their
predictive value in patients with hip fracture
Methods: In 294 older patients (mean age
82.2  7.9 years, 72.1% women) with osteoporotic HF
we measured serum levels of alanine aminotransferase
(ALT), gamma-glutamyltransferase (GGT), alkaline
phosphatase (ALP), bilirubin, albumin, adiponectin,
leptin, resistin, 25(OH) vitamin D, PTH, calcium, phos-
phate, magnesium, osteocalcin (OC), bone-specific alka-
line phosphatase (BAP), and urinary concentration of
cross-linked N-telopeptide of type 1 collagen (corrected
for creatinine, NTx/Cr).
Results: Abnormal LFTs were observed in <10% of
patients. Ageing was associated with decline in GGT,
ALT and leptin and increase in adiponectin and PTH
levels. In multivariate linear regression analyses, lower
OC was an independent predictor of higher GGT, ALT
and bilirubin, whereas BAP and NTx/Cr were posi-
tively associated with GGT and ALP. Adiponectin was
an independent predictor of GGT, leptin was a deter-
minant of OC and NTx/Cr, and PTH was an indepen-
dent determinant for adiponectin. Higher GGT levels
(>30 U/L) were associated with coronary artery disease
(CAD), diabetes mellitus, low OC levels and prolonged
hospital length of stay (>20 days). The risk of in-hospi-
tal death was 3 times higher if albumin <33 g/L.
Conclusion: Parameters of liver, adipokines and min-
eral-bone metabolism are significantly interrelated.
Adiponectin (but not leptin, resistin, 25(OH) vitamin D
or PTH) is an independent determinant of GGT.
Higher GGT may indicate impaired bone metabolism
and is predictive of prolonged hospital stay; low albu-
min is associated with in-hospital death.
APHPB-0260
SINGLE INCISION LAPAROSCOPIC
CHOLECYSTECTOMY WITH
CONVENTIONAL INSTRUMENTS AND
PORTS: A STUDY AT A TERTIARY
CARE HOSPITAL IN PAKISTAN
A. Shaikh
Surgery, Liaquat University of Medical Health &
Sciences Jamshoro, Hyderabad, Pakistan
Objectives: To assess the safety, feasibility and short
term outcome of single incision laparoscopic cholecys-
tectomy with conventional instruments.
Methods: A prospective study conducted at surgical
department of Liaquat University of Medical Health
and sciences Jamshoro Pakistan from January 2010 to
December 2011 of all fit cases of symptomatic choleli-
thiasis who consented for laparoscopic surgery and
wanted better cosmetic results. The exclusion criteria
were acute cholecystitis, acute gall stone pancreatitis,
common bile duct stones and patients with comorbids.
Results: Total no of cases were 50. The age ranged
from 30 to 59 years (mean 35.20 years). There were 43
females and 07 males.
A midline incision made supraumbilically and 10 mm
port placed. Two 5 mm ports placed on either side of
umbilicus slightly superior and laterally in order to tri-
angulate. A 2/0 prolene suture placed through the
infundibulum of the gall bladder. The rest of the proce-
dure is like standard laparoscopic cholecystectomy.
The operating time was 80 min (range 50–120). Four
case were converted to standard four incision laparo-
scopic cholecystectomy due to bleeding and difficult
dissection in calot’s triangle. There was minimal blood
loss during the operation. There was no postoperative
complication. The median pain scale was three. The
cosmetic results were satisfactory. The length of hospi-
tal stay was 01 day (range 1–2).
Conclusion: The laparoscopic cholecystectomy can be
done safely with conventional laparoscopic instruments
and ports without additional cost of single port and
articulated instruments, the cosmetic results are excel-
lent with minimal increase in the operating time.
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APHPB-0261
COMPARATIVE ANALYSIS OF
LAPAROSCOPIC VERSUS OPEN
SURGICAL RADIOFREQUENCY
ABLATION FOR MALIGNANT LIVER
TUMORS
K. S. Chun and I. S. Song
Department of Surgery, Chungnam National University
Hospital, Daejeon, Korea
Objectives: This study aims to evaluate the compara-
tive effectiveness of the two surgical approaches on the
treatment outcomes of radiofrequency ablation (RFA)
for malignant liver tumors.
Methods: Fifty-seven patients with maligant liver
tumors, hepatocellular carcinoma, cholangiocarcinoma
and liver metastases, were candidates for radiofrequen-
cy ablation underwent laparoscopic or open surgical
approach.
Results: The patients’ characteristics were comparable
in the two groups, as were open (n = 33, 57.9%) and
laparoscopic (n = 24, 42.1%) surgical approach. There
were no statistically significant differences between the
two groups in terms of recurrence rate (p = 0.337) and
overall survival (p = 0.423). However, patients in the
laparoscopic RFA group had significantly shorter hos-
pital days (14.13 vs. 5.89, p < 0.05) and experieced less
complications (Grade I, 62.5% vs. 26.3%, p = 0.102).
Conclusion: Laparoscopic RFA can be performed for
malignant liver tumors with lower mobidity rates, less
invasiveness and expense comparative to open surgical
approach
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APHPB-0262
PERCUTANEOUS TRANSHEPATIC
PORTAL VEIN STENTING FOR
RECURRENT PERIHILAR BILIARY
CANCER WITH MALIGNANT SEVERE
PORTAL VEIN STENOSIS
T. Mizuno1, T. Ebata1, Y. Yokoyama1, T. Igami1, G.
E. N. Sugawara1, Y. Mori2, K. Suzuki2, S. Naganawa2
and M. Nagino1
1Department of Surgery, Nagoya University Graduate
School of Medicine, Nagoya, Japan; 2Department of
Radiology, Nagoya University Graduate School of
Medicine, Nagoya, Japan
Objectives: To assess the clinical efficiency of transhe-
patic portal vein (PV) stenting in patients with severe
PV stenosis due to the recurrence of perihilar biliary
malignancy.
Methods: Between 2007 and 2013, nine consecutive
patients (5 male, 4 females; mean age, 66 years) with
severe PV stenosis due to the recurrence of perihilar
biliary malignancy underwent transhepatic PV stenting.
Their medical records were retrospectively analyzed
with regard to the procedure, both technical and clini-
cal success rate, and following anticancer therapy after
the PV stent insertion.
Results: The primary tumor location was perihilar in 8
and gallbladder in one patient. The surgery for the
primary lesion was left trisectionectomy with pancreato-
duodenectomy (PD) in 4, and left trisectionectomy in
3, left hepatectomy in 1 and resection of the gallbladder
bed with PD in one, respectively, and concomitant vas-
cular resection was performed in 6. The median interval
between the primary resection and the PV stenting was
19 months. Six of the 9 patients were symptomatic; gas-
trointestinal bleeding in 2, thrombocytopenia in 4, and
hepatic coma in one patient. Technical- and clinical suc-
cess was achieved in 7, and 5 of the 9 patients, respec-
tively. Seven patients could be resumed following anti-
cancer treatment. Median survival time after PV stent
insertion was 11 months.
Conclusion: PV stenting appears to be feasible in cases
of severe PV tumor invasion and stenosis. This proce-
dure does not only improve the quality of life, but
allow a following anticancer therapy and may contrib-
ute to improve survival.
APHPB-0264
PROGNOSTIC FACTORS OF
CLINICOPHYSIOLOGICAL FINDINGS
IN PANCREATIC CANCER
S. Suzuki1, Y. Goto1, H. Kajiyama1, A. Takemura1, S.
Konishi1, J. Shimazaki1, T. Nakachi1, T. Tabuchi1, K.
Nishida1, H. Ubukata1, N. Harada2 and M. Suzuki2
1Gastroenterological Surgery, Ibaraki Medical Center,
Tokyo Medical University, Amimachi, Inashikigun,
Ibaraki, Japan; 2Gastroenterological Surgery, Hachioji
Digestive Disease Hospital, Hachioji, Tokyo, Japan
Objectives: We aimed to evaluate the prognostic fac-
tors of clinicophysiological findings in pancreatic cancer
(PDAC).
Methods: A total of 75 patients who underwent
pancreatic resections for PDAC between 2007 and 2013
at our center and related hospitals were examined ret-
rospectively. Clinicophysiological parameters (T-Bil,
albumin, creatinine, HbA1c, amylase, CRP, BMI,
WBC, lymphocyte number, Neutrophil-to-lymphocyte
ratio (NLR), Hb, Plate, prognostic nutritional index
(PNI) CA19-9, CEA, decompression of jaundice, com-
plications, postoperative hospital days, R, and TNM
stage ≤2) were collected and analyzed for predictors of
recurrence-free and overall survivals. Univariate and
multivariate analyses were performed using the Cox
proportional hazards model. Survival curves were ana-
lyzed using the Kaplan–Meier method.
Results: There were 31 male and 44 female patients.
The mean age was 68.8 years (range, 48–83 years). All
the patients had pathologically confirmed PDAC. Pri-
mary distal pancreatectomy and pancreatoduodenecto-
my (PD) were performed on 23 and 52 patients,
respectively. Of these, 3, 40, and 9 patients underwent
conventional, pylorus-preserving, and subtotal stom-
ach-preserving PDs, respectively. Univariate analysis
showed that NLR, R and TNM stage ≤2 were indepen-
dent prognostic factors for recurrence-free and overall
survivals. Multivariate analysis showed that R and
TNM stage ≤2 were independent prognostic factors for
recurrence-free and overall survivals, and NLR was
independent prognostic factors for overall survivals.
Conclusion: Our results show that R and TNM stage
<2 were independent predictors of survival after pan-
creatic resection in PDAC patients. NLR was indepen-
dent prognostic factors for overall survivals
APHPB-0265
RISK FACTORS ASSOCIATED WITH
SURGICAL SITE INFECTION AFTER
HEPATECTOMY FOR LIVER DISEASE
M. Sakoda1, S. Ueno2, S. Iino1, K. Hiwatashi1,
K. Minami1, H. Kurahara1, Y. Mataki1, K. Maemura1,
H. Shinchi1 and S. Natsugoe1
1Department of Digestive Surgery Breast and Thyroid
Surgery, Kagoshima University, Kagoshima, Japan;
2Department of Clinical Oncology, Kagoshima
University, Kagoshima, Japan
Objectives: The incidence of postoperative surgical site
infection (SSI) after hepatic resection has decreased
gradually with the refinement of surgical techniques
and perioperative management. However, postoperative
SSI still develops in a few patients after hepatic resec-
tion, leading to increased medical costs, longer hospi-
talization, and a reduced quality of life in the
postoperative course. The purpose of this study was to
analyze the risk factors of SSI and to assist in predict-
ing the occurrence of SSI after hepatic resection.
Methods: A retrospective analysis of 227 patients who
underwent hepatic resection without biliary reconstruc-
tion for liver disease between January 2006 and Decem-
ber 2012 was performed. Patients were divided into two
groups according the occurrence of SSI. The associa-
tion between SSI and various clinical parameters was
investigated.
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Results: 19 patients developed SSI: 9 with superficial
or deep SSI and 10 with organ/space SSI. In univariate
analysis, preoperative platelets, aspartate aminotrans-
ferase and alanine aminotransferase concentrations, in-
traoperative blood loss, perioperative transfusion,
procedure of skin closure, and postoperative bile leak-
age differed statistically between the two groups.
Patients with SSI required significantly longer hospital-
ization than those without SSI. In multivariate analysis,
conventional skin closure and postoperative bile leak-
age were the significant risk factors.
Conclusion: It is important to prevent bile leakage to
reduce postoperative SSI. Moreover, subcuticular
suture for skin closure would be effective in preventing
incisional SSI. Continuous efforts should be made to
prevent SSI and further study is needed to develop
additional new strategies for preventing SSI.
APHPB-0266
SIGNIFICANCE OF PROXIMAL
RESECTION MARGIN IN HILAR BILE
DUCT CANCER
S. J. Park, S. S. Han, S. H. Kim, S. D. Lee, S. A. Lee,
S. M. Woo, W. J. Lee and E. K. Hong
Center for Liver Cancer, National Cancer Center,
Goyang, Korea
Objectives: To evaluate the prognostic significance of
resection margin (RM) status in resected hilar cholan-
giocarcinoma (HCCA) patients and to identify prog-
nostic factors that affect survival.
Methods: We reviewed the records of 96 HCCA
patients who underwent operation from 2001 to 2012
and analyzed the RM status and prognostic factors
that affecting survival.
Results: Of 96 patients, 31 (32.3%) patients with nega-
tive RM had better survival than those (n = 65, 67.7%)
with positive margin (p = 0.011). In histological classifi-
cation, 6 (6%) patients who had ductal margin with
carcinoma in situ have survival outcome similar to 54
(68%) patients who had free margin (p = 0.45) but
marginal difference from 65 (67.7%) patients who had
margin with invasive carcinoma (p = 0.097). 22 patients
with free margin of >5 mm had an improvement in sur-
vival compared with patients with positive RM
(p = 0.012). According to location of RM, however,
there was no survival difference between positive distal
and negative RM group (p = 0.62). In analysis of prog-
nostic factors, only lymph node involvement is indepen-
dently associated with survival.
Conclusion: The length and location of RM status have
prognostic significance in patients with HCCA. Clear
proximal RM is also one of most important prognostic
factors for survival especially in patients with node-neg-
ative HCCA. Therefore, surgeon should aim at com-
plete clearance of tumor with adequate proximal RM
and aggressive distal bile duct resection may not be
optional to improve survival.
APHPB-0267
LAPAROSCOPIC LEFT LATERAL
SECTIONECTOMY IN PATIENTS WITH
CIRRHOSIS
C. Im, J. Y. Cho, H. S. Han, Y. S. Yoon, Y. Choi, W.
Lee, J. Y. Jang and H. Choi
Surgery, Seoul National University Bundang Hospital,
Seong-nam si, Gyounggi-do, Korea
Objectives: Laparoscopic treatment is considered as
standard procedure for left lateral sectionectomy
(LLS), showing better outcome compared to open LLS.
However, laparoscopic LLL in patients with cirrhosis is
still controversial.
Methods: We evaluated data of 108 patients who
underwent laparoscopic LLS between July 2003 and
2013. The patients were classified into two groups
according to the presence of pathologically proven cir-
rhosis or not; group A (presence of cirrhosis; n = 22)
and group B (absence of cirrhosis; n = 86). Intraopera-
tive and postoperative functional outcomes were com-
pared between two groups.
Results: There were no differences between two groups
in terms of operation time and blood loss (p = 0.912
and 0.155, respectively). The rate of transfusion was
also similar between two groups (13.6% vs. 2.3%;
p = 0.384). Conversion to laparotomy occurred in no
patient in group A and two patients in group B (2.3%;
p = 1.000). Postoperative peak results of total bilirubin
was higher in group A than group B (median 1.3 vs.
1.0; p = 0.019). However, there was no difference in
postoperative complication rate (9.1% vs. 7.0%;
p = 0.660) and hospital stay (7 vs. 7 days; p = 0.760).
No mortality or postoperative liver failure occurred in
cirrhotic patients.
Conclusion: Laparoscopic LLS could be standard oper-
ation even in patients with cirrhosis.
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APHPB-0268
A CASE REPORT ON THE USEFULNESS
OF EARLY ENDOSCOPIC
ULTRASOUND (EUS)-GUIDED
TRANSGASTRIC INTERNAL STENTING
FOR SEVERE BLUNT PANCREATIC
TRAUMA
S. Iino, M. Sakoda, S. Ueno, K. O. J. I. Minami, K.
Hiwatashi, H. Kurahara, Y. U. K. O. Mataki, K.
Maemura and H. Shinchi
Digestive Surgery Breast and Thyroid Surgery, Graduate
School of Medical and Dental Sciences, Kagoshima
University, Kagoshima, Japan
Objectives: Introduction: Therapeutic strategies for
pancreatic trauma vary greatly depending on its sever-
ity. Surgical intervention is recommended in cases of
severe pancreatic injuries for which standard therapy is
not advised. We present a two-step treatment method
for severe pancreatic injury using an endoscopic ultra-
sound (EUS)-guided transgastric internal stent.
Methods: Clinical case: A 50 year-old male with blunt
abdominal trauma sustained in a traffic accident was
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transported with vital signs indicating shock and CT
findings of complete transection of the proximal pan-
creas and a huge hematoma. A life-saving primary
emergency damage control operation was performed. A
secondary EUS-guided transgastric internal stent was
placed into the pancreatic fluid collection on post-oper-
ative day 8 (POD 8). The pancreatic juice secreted from
the transected pancreatic tail eventually flowed along
the internal stent and emptied completely into the
stomach. The patient did not display prognostic symp-
toms at discharge.
Results: Discussion: EUS-guided transgastric internal
stenting is currently considered the first line of therapy
for pancreatic pseudocysts. It is recommended that
pseudocyst drainage occur at least four weeks or more
after its formation. In this severe case of blunt pancre-
atic trauma, the primary damage control operation
saved the patient’s life. Following primary surgery, a
secondary early peration involved insertion of an EUS-
guided transgastric internal stent into the collection of
pancreatic juice secreted from the transected pancreatic
tail, which allowed complete recovery without surgical
extraction or reconstruction of the pancreatic tail.
Conclusion: In cases of severe pancreatic trauma, prac-
titioners should consider the value of early EUS-guided
transgastric internal stenting.
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APHPB-0269
ORAL S-1 WITH CONCURRENT
RADIOTHERAPY VERSUS S-1 ALONE
IN PATIENTS WITH LOCALLY
UNRESECTABLE PANCREATIC
CANCER
H. Shinchi1, K. Maemura2, Y. Mataki2, H. Kurahara2,
K. Hiwatashi2, K. O. J. I. Minami2, S. Ino2, M.
Sakoda2, S. Ueno2, S. Takao2 and S. Natsugoe2
1Department of Health Sciences, Faculty of Medicine,
Kagoshima University, Kagoshima, Japan; 2Department
of HBP Surgery, Faculty of Medicine, Kagoshima
University, Kagoshima, Japan
Objectives: We have confirmed the efficacy and safety
of S-1 combined with radiotherapy in patients with
locally advanced and unresectable pancreatic cancer
(Br J Cancer 2007; JHBP Sciences 2012). This random-
ized trial was conducted to evaluate the survival benefit
of S-1 combined with radiotherapy compared to S-1
alone.
Methods: Eligible patients had locally advanced and
unresectable pancreatic cancer without distant metasta-
ses, an ECOG performance status of 0-1, adequate
organ and marrow functions, and no prior anticancer
therapy. Patients were randomized to receive S-1 com-
bined with radiotherapy versus S-1 alone. S-1 was given
orally at a dose of 80 mg/m2/day twice daily on days
1–21 in both groups. Radiotherapy was delivered in
fractions of 1.25 Gy twice daily, 5 days per week for
4 weeks.
Results: A total of 33 patients were evaluated. Seven-
teen patients received S-1 combined with radiotherapy,
and 16 patients received S-1 alone. There was no treat-
ment-related death or grade 4 toxicity in the both
groups. Median overall survival of 19.7 months in the
S-1 with radiotherapy group was significantly better
than 14.9 months in the S-1 alone group (p = 0.073).
Survival rates at 1 and 2 years were 79% and 32% in
the S-1 with radiotherapy group and 67% and 10% in
the S-1 alone group, respectively.
Conclusion: Combination therapy with S-1 and radia-
tion is considered a promising, well-tolerated regimen
that can be recommended as a more effective treatment
compared to S-1 alone for locally advanced pancreatic
cancer.
APHPB-0270
IS PURE LAPAROSCOPIC LEFT
LATERAL SECTIONECTOMY FOR
HEPATOCELLULAR CARCINOMA IN
PATIENTS WITH CIRRHOSIS A
STANDARD APPROACH? A
COMPARATIVE STUDY IN A SINGLE
INSTITUTE
T. T. Cheung, A. C. Chan, S. H. Chok, S. C. Chan
and C. M. Lo
Surgery, Li Ka Shing Faculty of Medicine, The
University of Hong Kong, Hong Kong, Hong Kong
China
Objectives: The data on long term outcome of laparo-
scopic left lateral section resection in patients with
HCC and cirrhosis is still limited. The aim of this study
is to analyze the survival outcome of laparoscopic left
lateral sectionectomy in patients with HCCs.
Methods: Between Janurary 2004 and December 2013,
21 patients had undergone pure laparoscopic left lateral
sectionectomy for hepatocellular carcinoma (HCC). 33
patients who had received open left lateral sectionecto-
my for HCC were included for comparison. These
patients were comparable in terms of age, sex, tumour
number, tumour size and preoperative liver function
evaluations. The immediate operation outcome includ-
ing operation morbidity and survival results were com-
pared.
Results: Comparing laparoscopic group to open resec-
tion group, the median operation time was 235 vs.
195 min (p = 0.33), the median blood loss was 150 vs.
400 mL (p = 0.002). Hospital stay was 5 days in lapa-
roscopic group versus 6 days in the open group
(p = 0.15). There was no difference between the two
groups in terms of complications. The median survival
in laparoscopic group was 104 vs. 114 months in the
open group (p = 0.372). The annual percentage of per-
forming left lateral sectionectomy for HCC by pure
laparoscopic approach raises from 0% to 100% over a
period of 10 years.
Conclusion: Laparoscopic left lateral sectionectomy for
HCC is a safe and simple procedure associated with
less blood loss. The survival outcome is comparable
with conventional open approach.
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APHPB-0271
OUTCOME OF CONSERVATIVE
PERCUTANEOUS
CHOLECYSTOSTOMY IN HIGH-RISK
PATIENTS WITH ACUTE
CHOLECYSTITIS AND RISK FACTORS
LEADING TO SURGERY
K. Joo1, S. Joo2 and J. Lim1
1Gasteroenterology, Kyung Hee University School of
Medicine, Seoul, Korea; 2Surgery, Kyung Hee University
School of Medicine, Seoul, Korea
Objectives: Laparoscopic cholecystectomy (LC) is the
treatment for acute cholecystitis. However, the morbid-
ity and mortality rates are high in elderly patients or in
those with co-morbidities at the time of surgery. Percu-
taneous cholecystostomy (PC) is also well known treat-
ment for acute cholecystitis. This study aimed to
evaluate the safety and efficacy of PC for acute chole-
cystitis and investigate the post-PC factors leading to
subsequent LC.
Methods: Ninety-three patients with acute cholecystitis
who underwent PC were enrolled. We evaluated patient
age, presence of co-morbidities, American Society of
Anesthesiologists (ASA) score, duration of drainage of
the PC tube, performance of LC, and 30-day mortality.
We compared these characteristics in two study groups:
31 were treated with only conservative PC (group I)
and 62 with PC followed by elective LC (group II).
Results: Patients in group I were older than those in
group II (80.4 vs. 70.5 years, p < 0.05). More group I
patients had an ASA score of III or IV compared to
group II patients (80.6% vs. 37.0%, p < 0.05). Age,
ASA score, and CVA were significantly correlated
when analyzing factors used to decide surgery
(p < 0.05). Two patients in group I died within
30 days. Six patients (19.3%) in group I experienced
recurrent cholecystitis after PC tube removal.
Conclusion: PC is a safe and effective therapeutic
option in high-risk patients with acute cholecystitis, or
for preoperative management. The decisive risk factors
for surgery after PC were ASA score, age, and CVA.
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APHPB-0272
THE PREDICTION AND IMPACT OF
INTRA-OPERATIVE POSITIVE BILIARY
CULTURES ON OUTCOMES
FOLLOWING
PANCREATICODUODENECTOMIES
S. I. Wijerathne, G. K. Bonney, A. Kow, S. G. Iyer,
K. Y. S. Chang and K. K. Madhavan
General Surgery, National University Health System,
Normanton Park, Singapore
Objectives: We aim to analyse the predictors of posi-
tive biliary cultures and its impact on outcome after
pancreaticoduodenectomies. Secondarily we aimed to
identify predictors of atypical biliary cultures.
Methods: A prospectively held database of pancreatico-
duodenectomies was analysed. Clinico-pathological
patient variables, pre-operative stenting procedures and
duration as well as outcome such as complications and
length of stay was identified. Positive biliary cultures
were subdivided into typical (gram negative) and atypi-
cal (gram positive and fungal) growth. Predictors of
positive cultures were identified and impact of this on
outcome detailed. In a subset analysis, predictors of
atypical growth were identified.
Results: Between January 2000 and December 2010, 83
pancreaticoduodenectomies were carried out. Intra-
operative positive bile cultures were associated with
greater complications (82% vs. 5% p < 0.001) but not
length of hospital stay. Predictors of positive bile cul-
tures include male gender, pre-operative stenting
(p = 0.02 and p < 0.0001) but not age, the presence of
diabetes, length of days with biliary stent and pre-oper-
ative bilirubin. When classified into typical and stypical
growth, only age <60 years was associated with
increased probability of atypical growth. However,
atypical growth had no impact on complications or
length of hospital stay.
Conclusion: Pre-operative biliary stenting is associated
with an increased likelihood of positive biliary cultures
and this in turn increased the post-operative complica-
tion rate. Only age <60 was associated with atypical
cultures that may require appropriate modification of
anti-microbial therapy. However, in this small single
centre series, atypical growth had no added adverse
impact on outcome.
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APHPB-0273
SURGICAL OUTCOMES IN THE
MANAGEMENT OF BLEEDING
PSEUDOANEURYSMS FOLLOWING
ACUTE PANCREATITIS
N. Swamygowda, V. K. Gunasekaran, V. Nanjegowda,
T. Gutti, V. Giriyappa and K. V. Ashok Kumar
Surgical Gastroenterology, Victoria Hospital, Bangalore
Medical College, Bangalore, India
Objectives: The overall incidence of pseudoaneurysms
following pancreatitis is 8–15%. Bleeding Pseudoaneu-
rysms, if left alone, have significant mortality up to
90%. Though, Angioembolisation is considered the
standard of care in the management of Pseudoaneu-
rysms, surgery is required in cases of failed Embolisa-
tion and hemodynamic instability. Our objective is to
present the surgical outcomes in patients with bleeding
Pseudoaneurysms following acute pancreatitis.
Methods: The records of patients with bleeding Pseud-
oaneurysms associated with acute pancreatitis treated
between August 2008 and September 2014 were retro-
spectively reviewed. Alcohol was the predisposing fac-
tor in all patients (24/24, 100%). All were male patients
with a mean age of 38 years. Median follow-up in our
study was for 36 months (4–80 months). Surgery or
angiographic embolization was determined by the
patient’s clinical condition.
Results: Twelve patients (50%) underwent operation, 6
urgently without angiographic evaluation. Splenic
artery aneurysm was identified and ligated in 7
patients, GDA in 3 patients; in 2 patients both splenic
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artery and GDA were ligated. Seven patients who
underwent surgery had an associated Pseudocyst which
was managed by cystoenterostomy. Mean duration of
surgery was 210 min. Angiographic embolization was
done in 12 patients (66.6%) as primary treatment;
Angiography had a sensitivity of 83.3% (15/18). The
overall mortality rate was 8.3% (2/24; 1-faecal fistula,
1-DIC). The overall morbidity was 22% (6/24).
Conclusion: Surgery in Bleeding Pseudoaneurysms fol-
lowing acute pancreatitis is a real challenge because of
the associated inflammation and necrosis. Bleeding
pseudoaneurysms associated with pseudocysts have bet-
ter outcome compared to aneurysms with free intraab-
dominal rupture.
APHPB-0275
REEVALUATION OF THE TREATMENT
STRATEGY OF TOKYO GUIDELINES
2013
Y. Mayama, H. Sunagawa, K. Ogura, T. Orokawa and
N. Ooshiro
Surgery, Nakagami Hospital, Okinawa, Japan
Objectives: Tokyo guidelines 2013 (TG13) have recom-
mendations of treatment for acute cholecystitis (AC)
based on severity assessment criteria. In our hospital,
conventionally most of patients with Grade II AC
underwent laparoscopic cholecystectomy (LC) and
many of patients with Grade III AC underwent emer-
gency surgery. This study aimed to examine the validity
of the treatment strategy of TG13.
Methods: We retrospectively analyzed 254 patients with
AC between January 2006 and July 2014. We com-
pared our conventional treatments strategy for Grade
II or Grade III AC with the treatment strategy of
TG13.
Results: We compared LC with open cholecystectomy
for Grade II AC. There was no significantly difference
in severity of local inflammation and duration of symp-
tom. There was no significantly difference in complica-
tions but LC tends to lower intraoperative blood loss
and shorter length of post-operative stay. We also com-
pared emergency surgery with elective surgery after
gallbladder drainage for Grade III AC. Operative time
was significantly shorter in the emergency surgery
group, and there was no difference in intraoperative
blood loss, length of post-operative stay and complica-
tions.
Conclusion: We conclude that LC for Grade II AC is
feasible and all of Grade III patients don’t need gall-
bladder drainage.
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APHPB-0276
IMPACT OF SINGLE LAYER END-TO-
SIDE PANCREATICOJEJUNOSTOMY
BY INVAGINATION METHOD AFTER
PANCREATICODUODENECTOMY
J. Kadono1, A. Furoi2, H. Kumemura2, T. Nakazono1,
S. Motoi1, M. Inoue1, I. Kitazono1, H. Futawatari2
and Y. Imoto1
1Advanced Therapeutics Cardiovascular and Respiratory
Disorders, Kagoshima University Graduate School of
Medical and Dental Science, Kagoshima, Japan;
2Surgery, Kirishima Medical Center, Kirishima, Japan
Objectives: Postoperative pancreatic fistula (POPF) is
still a major morbidity after pancreaticoduodenectomy
(PD). We present a novel technique for pancreaticojej-
unostomy (PJ) by single layer end-to-side invagination
technique.
Methods: (1) Patients. Twenty-five patients (11 pancre-
atic cancer, 9 bile duct cancer, 3 cancer of ampulla of
Vater, 2 Intraductal papillary mucinous tumor) under-
went PD. POPF is defined according to International
study group of POPF (ISGPF). (2) Anastomotic tech-
nique. PJ is performed by interrupted single layer
suture using 4-0 polypropylene. Pancreatic juice is
totally drained by external stent tube. A full-thickness
jejunotomy in two third of pancreatic lateral diameter
was created. The suture is started at 1.5 cm from the
edge to 0.5 cm from the edge. Then, whole layer of the
jejunotomy is sutured. Number of sutures: upper and
lower edge, three sutures in the posterior wall, three to
five in anterior wall. It is important to place the suture
where the pancreatic capsule exists. (3) Evaluation.
Pancreatic duct diameter, hardness of pancreatic paren-
chyma, amylase level in the drained fluid and frequency
of POPF.
Results: Median pancreatic duct diameter: 3 mm. Soft
pancreatic parenchyma/hard: 11/14. Median amylase
level on postoperative day 1 and 3: 519 and 73 IU/L.
Median duration of peritoneal drainage: 6.5 days.
POPF: Grade A 5 (soft/hard: 4/1), B 1 (soft), C 1
(hard). Frequency of grade B and C was 8%.
Conclusion: Single layer end-to-side PJ by invagination
technique is a feasible technique with low POPF inci-
dence. However, long-term results should be evaluated.
Transplantation
APHPB-0277
EVALUATION OF SPRAY DIATHERMY
AS A PARENCHYMATOUS DIVISION IN
LDLTX
M. El Shobari, T. Salah, A. Sultan, M. Abdelwahab,
A. Nabih, O. M. A. R. Fathy, O. Sheha, M. Morshedy
and M. Sadany
Surgery, Gastroenterology Surgical Center, Mansoura
University, Mansoura, Egypt
Objectives: Evaluation of spray diathermy as division
technique of liver in rt lobe LDLTX compared to har-
monic scalpel.
Methods: 23 donors for rt lobe donationation, 16
males and 5 females, age (18–42) were included.spray
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or non touch diathermy was used as parenchymal
division.coparing it to harmonic scalpel in time, blood
loss cut surface, fever, postoperative complications and
one week liver function and pathology of cut surface.
Results: Time of liver transection ranges (40–135 min)
including bile duct closure.averge blood loss 543 mL
(200–1700) transiet fever ocurs in most cases.ultrasound
show collection of serous fluid in 35%passing conserva-
tive one case mild biliary leak and one case explored
for internal haemorrhage.
Conclusion: Spray diathermy is good alternative for
parenchymal division of liver in LDLTX with less time
and cost than harmonic scalpel.
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APHPB-0278
PANCREATIC STELLATE CELLS ARE
MAJOR CELLULAR COMPONENTS
DURING PANCREATIC
REGENERATION
K. Joo1, S. Joo2 and J. Lim3
1Gasteroenterology, Kyung Hee University School of
Medicine, Seoul, Korea; 2Surgery, Kyung Hee University
School of Medicine, Seoul, Korea; 3Gastroenterology,
Kyung Hee University School of Medicine, Seoul, Korea
Objectives: Pancreatic regeneration is initiated by
newly generated epithelial cells forming tubular
complexes and spindle shaped mesenchymal cells. The
origin of the epithelial cells is well characterized,
expressing the embryonic marker PDX-1. However,
that of the mesenchymal cells has not still been eluci-
dated. The aim of our study is to clarify characteristics
of spindle shaped mesenchymal cells in the processes of
the regeneration in an animal model.
Methods: We adopted previous our new animal model
for necrotizing pancreatitis (Pancreatology 2012).
Results: After pancreatic necrosis, three distinct cellular
areas were noted; hypercellular area, consisted of mes-
enchymal cells (Zone 1); area of epithelial cells forming
tubular structure, which were surrounded by mesenchy-
mal cells (Zone 2); mixed area with tubular structures
and regenerated acini (Zone 3). Among them, the most
predominant portion was Zone 1. At the beginning of
regeneration, the tubular structure first was noted at
the periphery of the lesion. They were scattered sepa-
rately or nested in the area of mesenchymal cells or
intermingled with newly formed acinar cells. In particu-
lar epithelial cells within the cluster of acinar cells were
more swallowed and showed abundant cytoplasm,
looked like acinar cells, compared to those as nested or
scattered epithelial cells. Immunohistochemical stain-
ings for pancreatic stellate cells (a-SMA and desmin)
were strongly positive for mesenchymal cells in Zone 1-
2, but negative for epithelial cells forming tubular
structures and acini.
Conclusion: The results of this study suggest that
pancreatic stellate cells are major cellular components
and may participate in regeneration after pancreatic
necrosis.
APHPB-0279
GIANT HEPATIC HEMANGIOMAS
RESECTIONS- A TERTIARY CENTER
EXPERIENCE
B. Santhanamuthukrishnan, A. Amudhan, D. Benet,
R. Prabhakaran, S. M. Chandramohan and D. Kannan
Surgical Gastroenterology, Madras Medical College,
Chennai, India
Objectives: Aim: The aim of this study is to discuss the
outcomes of surgical resection for giant hemangiomas.
The study also discusses the various modalities of resec-
tion like Non anatomical resection and anatomical
resections.
Methods: Patients and methods: This is a retrospective
analysis of the Hepatic hemangiomas treated in our
hospital from March 2012 to 2014. We included only
the patients who are Symptomatic and treated by surgi-
cal resection and size of the lesion more than 10 cm.
Results: We included 20 patients with symptomatic
Giant hemangiomas in this study, Out of them 16
patients underwent anatomical resection and 4 patients
underwent Non anatomical resection. The median
blood loss is 380 mL, average duration is 3 h and
15 min, Intra operatively we had no major complica-
tions other than one patient who had persistent bleed-
ing from the raw area who was managed with peri
hepatic packing and the pack removed successfully on
the next day. Liver resection was done using Kelly
clause and Diathermy technique in 14 cases. Raw area
bleeding was arrested with suture ligation in majority
of the cases. Post operatively only one patient devel-
oped liver failure and expired. Median duration of stay
was 8 days post operatively.
Conclusion: We conclude at this point that for symp-
tomatic giant hemangiomas the best method of man-
agement is surgical resection.
APHPB-0280
OUTCOME OF BILE DUCT INJURIES
C. Kantharia, R. Prabhu, S. Pujari, A. Supe and R.
Bapat
Surgical Gastroenterology, KEM Hospital, Seth GS
Medical College, Parel, Mumbai-12, India
Objectives: Review of our results of outcome of BDI
presenting to us over the last ten years (2004–2013).
Methods: 63 patients were identified to have BDI (45
females; age range 25–68 years). 54 were following
Laparoscopic Cholecystectomy and 9 following Open
Cholecystectomy. BDI were classified according to the
Strasberg and Bismuths classification following Laparo-
scopic and open cholecystectomy respectively, and
treatment was instituted accordingly. Outcome was
assessed with respect to return of LFT to normal.
Follow up ranged from 120 to 7 months. HIDA scan
performed six weeks post surgery.
Results: 5 had Type A injury, 2 type B and C (Right
accessory duct), 10 type D, 16 Type E1, 10 type E2, 8
E3, 2 E4 and 1 E5. In the open group 6 had E3 injury
and 3 E4 injury.
Type A, B, C and D were managed with ERCP stent-
ing with good outcome. Type E1, E2, E3, E4 and E5
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were subjected to Hepp Couinauds side to side hepati-
co-jejunostomy. 2 had restricture and were treated with
PTC guided balloon, and 1 patient required re-surgery.
Conclusion: Delayed Surgical repair for bile duct injury
in a tertiary referral centre yields good results.
Malignant HPB Diseases
APHPB-0283
HOW TO OPERATE LAPAROSOCPY
ASSISTED RIGHT
HEMIHEPATECTOMY SAFELY;
USEFULNESS OF DOUBLE
LAPAROSCOPES FOR DISSECTION OF
MAJOR HEPATIC VEINS
R. Hirai and T. Yamano
Gastroenterological Surgery, Japanese Redcross
Okayama Hospital, Okayama-shi, Japan
Objectives: As well as open right hemihepatectomy, the
hanging maneuver is a useful technique in laparosocpy
assisted right hemihepatectomy (LARH). However,
since passing a tape between the right hepatic vein
(RHV) and the middle hepatic vein (MHV) behind liver
is a quite difficult and dangerous procedure, it might
cause injury of RHV, MHV or the inferior vena cava
(IVC) and sudden massive bleeding. In this report, we
propose use of two laparoscopes in LARH (named
‘Double-scope Technique’). By using this method, pass-
ing the hanging tape between RHV and MHV behind
liver will be easier and safer.
Methods: Procedures of the ‘Double-Scope Technique’
in LARH:
1. Perform the dissection between IVC and the cau-
date lobe completely to the root of RHV and
MHV under the first laparoscopic view.
2. Insert an additional access port from the right
anterior seventh intercostal area into the abdomi-
nal cavity via diaphragm.
3. Insert 5 mm flexible fiberscope through this
access port, then, the root of RHV and supra-
hepatic area should be dissected carefully under
the second laparoscopic view.
4. By simultaneous use of two laparoscopes, pass
the liver hanging tape through easily and safely
between RHV and MHV under two directional
views.
Results: Surgical outcomes of previous cases.
8 patients were perf ormed LARH from 2011 to 2013.
Conversion to laparotomy; 3pts of 8
Post-operative complication; Bile leakage (1pts).
Post-operative hospital stay (mean); 10.6 day
Mortality; none
Conclusion: We consider that this method could pre-
vent injury of major hepatic veins and conversion to
laparotomy in LARH.
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APHPB-0285
HEAD CORING FOR CHRONIC
CALCIFIC PANCREATITIS (CCP)
WITHOUT HEAD MASS- SHORT TERM
OUTCOME ANALYSIS
R. Rajendran, A. Amudhan, R. Prabhakaran, D.
Benet, D. Kannan and S. M. Chandramohan
Gastroenterology, Madras Medical College, Chennai,
India
Objectives: Debilitating abdominal pain remains the
most common presentation of chronic pancreatitis and
the treatment remains challenging. As head is the pace-
maker of pain in chronic pancreatitis coring out the
head even in the absence of inflammatory head mass
provides better pain relief.
Methods: This retrospective cum prospective study
analyzed the outcome of Frey procedure in Chronic
Calcific Pancreatitis patients without inflammatory
head mass. For the period between 2010 and 2013, 140
patients with chronic pancreatitis underwent Frey pro-
cedure for intractable abdominal pain. Of them 80
patients without head mass were included in the study.
The mean follow-up was 6 months. Using Visual ana-
logue scale score Pain was analyzed both preoperatively
and postoperatively. Endocrine and exocrine insuffi-
ciency is also analyzed.
Results: There was no 30-day mortality. Statistical
analysis showed significant improvement of Pain score.
The improvement of Pain score in the patients without
head mass is comparable to the patients with head
mass for whom Frey procedure was done. Though
there is improvement in Endocrine and exocrine insuffi-
ciency they are not statistically significant as per Chi-
square test.
Conclusion: This study shows that the head coring Pan-
creatico jejunostomy procedure described by Frey pro-
vides a better quality of life and better pain relief with
acceptable morbidity and nil mortality even in the
patients with no head mass. Head coring procedure can
be therefore strongly recommended for pain relief even
in pancreatitis without head mass.
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APHPB-0286
PANCREATIC STUMP MANAGEMENT
FOLLOWING PANCREATICO
DUODENECTOMY- TERTIARY CENTRE
EXPERIENCE
A. Duraisamy, R. Rajendran, R. Prabhakaran,
A. Amudhan, R. Sandeep, D. Kannan and S. M.
Chandramohan
Surgical Gastroenterology, Madras Medical College,
Chennai, India
Objectives: Primary aim is to analyse the outcome of
pancreatic stump anastomosis of various types in rela-
tion to major and minor morbidities and mortality.
Secondary end point is to analyse and compare isolated
PJ technique outcome to conventional methods.
Methods: Retrospective data from 2010 to 2014 on 138
patients who underwent Whipple procedure was done.
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Preoperative, Intraoperative and postoperative
variables were analysed. Patients who underwent Pan-
creatic stump anastomosis were categorised into three
groups - A- PG, B-PJ, C- Isolated PJ. C group further
categorised into Dunking type C1 and duct to mucosa
C2. Incidence of mortality, major complications like
leak, hemorrhage, DGE and Intra-abdominal abscess
and Minor morbidities like Pneumonitis, UTI and
wound infection have been compared with different
anastomotic techniques
Results: The mean age is 51.7. The Indications for
Whipple were periampullary 102 (79.68%), Pancreatic
cancer 15 (11.7%), Distal CBD growth 6 (6%) and
duodenal growth 6 (6%) were analysed. Among them
after pancreatico duodnectomy- PG (A, n = 40), PJ (B,
n = 60) and Isolated PJ (C, n = 39) was done. DGE is
the most common complication 44% (n = 57). Overall
complications include pancreatic leak - 30.96%, haem-
orrhage- 5.4%, Intraabdominal collection- 5%. Minor
complications were 31%.
Conclusion: Among various techniques of pancreas
stump reconstruction, none of them showed statistical
significant morbidity or mortality of the existing stan-
dard. Isolated loop PJ has had statistically significant
lower grade leak and increased DGE. Subgroup analy-
sis within the isolated loop has no difference in
outcome.
APHPB-0287
SURGICAL OUTCOME OF A
LAPAROSCOPIC MAJOR LIVER
RESECTION – A LARGE VOLUME
CENTER’S 10 YEARS’ EXPERIENCE
W. Cho, C. D. Kwon, J. Joh, S. Kim, J. Kim, G. Choi,
J. Choi and S. Lee
General Surgery, Samsung Medical Center, Seoul, Korea
Objectives: The application of laparoscopic liver resec-
tion (LLR) has had little progress since the first case
was performed two decades because of technical diffi-
culty of the operation, fear of gas embolism, potential
massive bleeding, and possible inferior outcome in
malignant diseases. This study reports the surgical out-
come and how we can overcome difficulties of major
LLR.
Methods: Between August 2004 and 2014, a total of
569 patients of Samsung Medical Center were under-
went LLR. Among this the major LLR was 226 cases.
All major LLRs were intended totally laparoscopic and
anatomical resection.
Results: We start to apply bipolar electro-cautery, tem-
porary increase of intra-abdominal pressure (IAP), and
Temporary Inflow Control of Glissonean pedicle (TIC-
GL) method after 2012. So we divided major liver
resection into two groups, before and after 2012. Open
conversion rate in major LLR was 29.7% (n = 11)
before 2012, and 6.9% (n = 13) between 2012 and
August, 2014. Open conversion rate and estimated
blood loss decreased, but there were no statistical sig-
nificance in operation time, and hospital stay between
two periods. Postoperative complication rate of major
LLR was 9.3% and bile leakage was most common
complication (3.1%).
Conclusion: Advance laparoscopic surgical technique
induced the good result in approach for major liver
resection. We are now in an era where major LLR is
being accepted more widely and it has become impor-
tant for institutions to have a good laparoscopic pro-
gram.
APHPB-0288
HEPATIC BLOOD INFLOW
OCCLUSION WITHOUT HEMIHEPATIC
ARTERY CONTROL IN RESECTION OF
HEPATOCELLULAR CARCINOMA
C. Dai, C. Jia, X. Zhao, F. Xu, S. Peng, Y. Xu, Y.
Zhao, C. Zhao and L. Zhao
Hepatobiliary Surgery, Shengjing Hospital of China
Medical University, Shenyang, China
Objectives: To investigate the efficacy of hepatic blood
inflow occlusion without hemihepatic artery control
(BIOwHAC) in resection of hepatocellular carcinoma
(HCC).
Methods: Ninety-four patients of resection of HCC
with liver cirrhosis from January 2006 to November
2013 in our department were compared retrospectively.
Based on the inflow occlusion techniques, thses cases
were divided two groups: Pringle maneuver group
(n = 38); BIOwHAC group (n = 56). The characteris-
tics of patients and perioperative parameters including
the demographics, types of virus hepatitis, severity of
liver cirrhosis, size and location of the tumors, liver
function, operative method and time, numbers and time
of hepatic blood inflow occlusion, intraoperative blood
loss, intraoperative transfusion requirements, incidence
of postoperative complications, and length of hospital
stay were summarized and compared between two
groups.
Results: Patient characteristics were comparable and
there were no significant differences in the types of
virus hepatitis, size and location of the tumors, preop-
erative liver function (serum AST, total bilirubin, albu-
min levels), operative method and time, numbers and
time of hepatic blood inflow occlusion, intraoperative
blood loss, intraoperative transfusion requirements,
incidence of postoperative complications, and length of
hospital stay between two groups. Although the sever-
ity of liver cirrhosis and preoperative ALT level were
significantly higher in BIOwHAC group, the recovery
of the postoperative liver function was more rapid in
BIOwHAC group with statistical significance.
Conclusion: For patients with HCC, BIOwHAC was a
better inflow occlusion method than Pringle manoeu-
vre, especially for cases with cirrhosis.
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Transplantation
APHPB-0289
EXPERIENCE OF THE 105 LIVING
RELATED LIVER TRANSPLANTATION
IN THE STATE RESEARCH CENTER
BURNAZYAN FMBC OF THE FMBA OF
RUSSIA
S. E. Voskanyan, K. V. Kotenko, A. I. Artemiev, D.
A. Zabezhinsky, E. V. Naydenov, A. L. Voevodin, I.
Y. Kolyshev, M. V. Shabalin, V. S. Rudakov and S. H.
Iskhagi
Center for Surgery and Transplantology, State Research
Center Burnazyan FMBC of the FMBA of Russia,
Moscow, Russia
Objectives: To study the immediate and long-term
results of the living related liver transplantation.
Methods: Liver Transplantation Program was started
in 2010. 105 liver transplantations of the right liver
lobe from closely related donors in the form ‘adult-to-
adult’ have been performed from June 2010 to Septem-
ber 2014. Liver cirrhosis in the outcome of autoimmune
hepatitis, primary sclerosing cholangitis, viral hepatitis,
Wilson’s disease, Budd-Chiari syndrome, primary and
secondary biliary cirrhosis, liver alveococcosis, alimen-
tary cirrhosis and cryptogenic cirrhosis were indications
for surgical treatment. 2 liver transplantations were
performed in 2010, 13 – in 2011, 34 – in 2012, 37 – in
2013 and 19 – from January 2014 to September 2014.
‘Complicated’ reconstruction of portal venous inflow or
outflow from the cava vein from liver graft was
required in 65 cases (61.9%) because of the donors vas-
cular anatomy abnormalities and lesions of the cava
gate of the recipients liver.
Results: Hospital mortality among recipients was
2.8%, morbidity was 20.9%. Vascular complications
were 1.9%. Frequency of biliary complications was
8.6%. The long-term survival in recipients was 97.1%
in the 1 year, 96.1% in the 2 year and 96.1% in the
3 year. Morbidity among donors was 10.5%. Mortality
among donors was absent. Mean postoperative hospital
stay was 21 (18–30) days for recipients and 13 (10.5–
18.5) days for donors.
Conclusion: Presented technologies allows to achieve a
good venous inflow and outflow from the liver trans-
plant and thereby provide a satisfactory immediate and
long term results of the living-related liver transplanta-
tions, even in ‘complicated’ cases.
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APHPB-0290
NEW TRENDS IN THE SURGICAL
TREATMENT OF PANCREATIC HEAD
CANCER
S. E. Voskanyan, K. V. Kotenko, A. I. Artemiev, E. V.
Naydenov and D. A. Zabezhinsky
Center for Surgery and Transplantology, State Research
Center Burnazyan FMBC of the FMBA of Russia,
Moscow, Russia
Objectives: To study the influence of the extended lym-
phadenectomy and neurodissection to immediate and
long-term results of the surgical treatment of pancreatic
head cancer.
Methods: Pancreaticoduodenectomy with extended
lymphadenectomy and total celiac and mesenteric neu-
rodissection have been performed to 75 patients.
Results: Mortality was 1.3%. Morbidity was 34.7%.
The postoperative hospital stay was 21 (15–30.5) days.
24 different sites of the perineural invasion of the pan-
creatic cancer were found at the morphological study
of the postoperative material. In addition, perineural
invasion was found in 40% of the patients with the
stage IA, 59.1% in stage IB, 91.7% in stage IIA and
100% in stage IIB. The overall frequency of the peri-
neural invasion was 81.7%. The frequency of the loco-
regional recurrence was 16.0%. Long-term survival was
78.2% after first year, 64.0% after 2 years, 52.2% in
after 3 years, 32% after 4 years, 21.3% after 5 years.
The median of the survival of the patients was
28.4 months. The median of the disease-free period was
24.5 months.
Conclusion: Perineural invasion can be found in any
parts of the celiac and mesenteric plexus even in the
early stages of the disease, therefore, neurodissection is
a necessary step of the surgical treatment of the proxi-
mal pancreatic cancer, and extirpation of the celiac and
mesenteric plexus should be satisfied always. Using of
the technologies of the extended lymphadenectomy and
neurodissection can significantly reduce the incidence of
the locoregional recurrence and significantly improve
the long-term survival of the patients after surgical
treatment.
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APHPB-0291
GALLBLADDER PERFORATION:
STRUGGLING FOR A DIAGNOSIS AND
TREATMENT STRATEGY
COMPLICATED BY UNSTABLE ANGINA
H. Oya, S. Komukai and Y. Ohashi
Surgery, Niigata Medical Center, Niigata, Japan
Objectives: Bile peritonitis is considered to indicate
urgent operation. However, the medical treatment of
abdominal disease occurring with unstable angina
needs a priority considering the illness severity. In this
case, a patient scheduled for gallstone operation exhib-
ited symptoms of ischemic heart disease. It was diag-
nosed as bile peritonitis, which occurred with unstable
angina, and it was difficult to determine a treatment
strategy.
Methods: A 64-year-old male was scheduled for gall-
stone operation. He was admitted to the hospital due
to upper abdominal pain. He was diagnosed with acute
coronary syndrome since he had electrocardiographic
abnormalities with chest pain and heart type fatty acid-
binding protein (H-FABP) became positive. CT
revealed slight ascites, but no gallbladder swelling. The
circulatory organ ICU performed medical treatment of
unstable angina. Ascites increased after five days, and
bile leaked to the abdominocentesis. It resulted in a
diagnosis of bile peritonitis due to gallbladder perfora-
tion, which occurred with unstable angina.
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Results: Intra-aortic-balloon-pumping support was
required in case an urgent laparotomy. Clinical symp-
toms and inflammation improved, so conservative med-
ical management was continued. Four branches of
coronary artery bypass grafting (CABG) were per-
formed. Cholecystectomy was planned electively. The
cholecystectomy and the abscess drainage were per-
formed 24 days after CABG. He left our hospital
13 days after the biliary operation.
Conclusion: In addition to the bile peritonitis due to gall-
bladder perforation, this case had unstable angina.
Although it was difficult to determine a treatment strat-
egy, his general state was improved by intensive care, and
there were no complications from the two operations.
APHPB-0292
COMPARISON OF LAPAROSCOPIC
VERSUS OPEN LEFT SIDE
HEPATECTOMY FOR INTRAHEPATIC
DUCT STONES
Y. Shin, J. Jang, M. Kang, W. Jung, J. Chang and S.
Kim
Surgery, Seoul National University College of Medicine,
Seoul, Korea
Objectives: This study was sought to evaluate and
compare the perioperative and clinical outcomes
between laparoscopic and open hepatectomy for left
IHD stones.
Methods: From January 2002 to December 2013, 40
patients underwent laparoscopic hepatectomy [left
hemihepatectomy (n = 7) or left lateral sectionectomy
(n = 33)] and 201 patients underwent open hepatec-
tomy: among them, 54 patients underwent left side hep-
atectomy without co-operation and previous operation
histories were included [left hemihepatectomy (n = 24)
or left lateral sectionectomy (n = 30)]. We analyzed the
perioperative and clinical outcomes including the stone
clearance rate, stone recurrence rate, and median fol-
low-up duration.
Results: There was no difference in age (56.8  8.2 vs.
55.6  9.6 years, p = 0.531), sex (1.0:4.0 vs. 1.0:1.8,
p = 0.108), or BMI (22.8  2.8 vs. 22.9  3.0,
p = 0.802) between laparoscopic and open hepatectomy
group. Laparoscopic group had higher proportion of
lateral sectionectomy (33/40 vs. 30/54, p = 0.010),
shorter operation time (174.2  56.6 vs. 210.4  51.6
min, P = 0.002), shorter postoperative hospital stay
(7.9  2.6 vs. 14.3  5.5 days, p < 0.001), and lower
complication rate (17.5 vs. 40.7%, p = 0.016), especially
surgical site infection (5.0% vs. 18.5%, p = 0.052) com-
pared with open hepatectomy group. It also showed
similar results in comparisons of the subgroup accord-
ing to the operation. There was no operation related
mortality. There were no significant differences in
initial stone clearance rate (85% vs. 75.9%, p = 0.279),
final clearance rate (95.0% vs. 96.3%, p = 0.758), stone
recurrence rate (2.5% vs. 5.6%, p = 0.468) within com-
parable follow-up periods (48  33.6 vs. 59.2  41.7
months, p = 0.235)
Conclusion: Laparoscopic hepatectomy can be a safe
and effective option for well-selected left IHD stones
when performed by experienced surgeons.
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APHPB-0294
SYNCHRONOUS HEPATIC AND
PULMONARY METASTASES IN
ADENOID CYSTIC CARCINOMA OF
LACRIMAL GLAND-SURGERY
REVISITED
G. Daga, S. Sharma and S. Lamba
Oncosurgery, Bombay Hospital, Mumbai, India
Objectives: To our knowledge, only few cases of meta-
static adenoid cystic carcinomas (ACC) of the lacrimal
to the liver has been reported where surgical resection
of the metastases was performed. ACC of lacrimal
gland are rare, aggressive but slow growing malignant
tumours accounting for 1.6% of orbital tumours which
may locally invade and occasionally metastasise via ha-
ematogenous spread to lungs, brain and bone. Our
patient probably represents the first case of lacrimal
ACC with synchronous hepatic and pulmonary metas-
tases four years after primary resection and was still
managed surgically.
Methods: A middle-aged female operated for left lacri-
mal ACC, with adjuvant chemoradiation, presented
after four years of follow up with right upper abdomi-
nal pain and tenderness. The liver profile, tumour
markers, orbital studies were normal and CT revealed
10 9 8 9 5 and 4 9 3 9 3 cm lesions in segment VI
and IVB respectively alongwith multiple bilateral irreg-
ular pulmonary nodules. FNAC of liver lesion con-
firmed metastatic ACC. The decision was to treat liver
metastases firstly as Standardized Uptake Value of lung
lesions was comparatively less and static. She under-
went classical right hepatectomy with wide excision of
segment IVB. On follow up, multiple pulmonary nod-
ules marginally increased in size and staged pulmonary
metastasectony was done
Results: Histopathology confirmed metastases of ade-
noid cystic carcinoma to the liver and lungs-cribriform
type. She is presently doing well.
Conclusion: Unpredictability of ACC emphasises a life
long follow up. Hepatic metastasectomy should always
be considered since adjuvant therapy has minimal role.
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MANAGEMENT OF HEPATOLITHIASIS
IN A TERTIARY CARE CENTER IN
SOUTH INDIA: RETROSPECTIVE
STUDY
R. Vellaisamy, B. Sathyamoorthy, A. Anbalagan, P.
Raju, B. Duraisamy, C. Servarayan Murugesan and K.
Devygounder
Institute of Surgical Gastroenterology, Rajiv Gandhi
Government General Hospital, Madras Medical College,
Chennai, India
Objectives: Hepatolithiasis is rare in this part of world.
We are presenting 10 cases of Hepatolithiasis managed
in our center.
Methods: This is a retrospective study from August
2011 to august 2014. The age range was between 24
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and 56 years. The demography, clinical presentation,
surgical management and outcome were analysed.
Results: Ten patients including 7 female and 3 male
were treated. They were treated with hepatectomy 3,
choledochoduodenostomy alone 4, choledochoduode-
nostomy with access loop 1, Hepaticojejunostomy with
Jejunojejunostomy 1, PTBD with stricturoplasty 1 and
CDD with cholangiojejunostomy 1.
SNo Age Sex Diagnosis Procedure
1 24 F Choledocholithiasis/
hepatolithiasis
CDD
2 29 F Hepatolithiasis
3 41 F Choledocholithisis/
hepatolithiasis
4 42 M Choledocholithisis/
hepatolithiasis
5 45 M Hepatolithisis CDD with access loop
6 54 F Choledocholithisis/
hepatolithisis
CDD/
Cholangiojejunostomy
7 50 F Choledochalcyst
type 4/left lobe
hepatolithisis/post
cholecystectomy status
Left hepatectomy
8 56 F Choledocholithisis/
post cholecystectomy
status/bilateral
hepatolithiasis/atrophy
of segment 2, 3, 6, 7
Left lateral
segmentectomy/6, 7
segmentectomy/CDD
9 36 M Caroli disease/
hepatolithiasis/post
right hepatectomy/IVC
thrombosis/left
hepatolithisis/CBD
calculus with hilar
stricture
Hepaticojejunostomy
with jejunostomy
10 34 F Post cholecystectomy
status/post
hepaticojejunostomy
status/anastomotic
stricture /cholangitis
PTBD/Balloon
stricturoplasty
Conclusion: Hepatolithaisis is rare in southindia. Surgi-
cal management depends on the liver parenchymal sta-
tus, cholangitis, diameter of CBD, biliary stricture and
distribution of stones. Anatomical hepatectomy, Chole-
dochoduodenostomy following cholangioscopic removel
of stones with or without access loop, hepaticojejunos-
tomy and cholangiojejunostomy were the various meth-
ods used in our practice.
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APHPB-0297
EN-BLOC RESECTION OF
HEPATOCELLULAR CARCINOMA
WITH SURROUNDING ORGANS
S. Chok, T. Cheung, C. Chan, W. Dai, S. Tsang, T.
Wong, S. Chan, R. Poon and C. Lo
Surgery, Queen Mary Hospital, Hong Kong, China
Objectives: T4 hepatocellular carcinoma (HCC) carries
poor prognosis. This study aims to determine the sur-
vival outcomes after en-bloc resection of HCCs with
surrounding organs at a tertiary referral center.
Methods: Data of the 59 patients (Group 1) who
underwent en-bloc resection of HCCs with surrounding
organs (invasion confirmed by histology) in the period
from 1989 to 2010 were reviewed. A control group of
118 patients (2:1 match) (Group 2) without HCC inva-
sion (tumour adhesion only) of surrounding organs was
matched to age, tumor size, tumor number, and TNM
staging (AJCC 5th edition). Survival was estimated by
the Kaplan-Meier method and compared by the log-
rank test. p values of <0.05 were regarded as statisti-
cally significant and all p values were two-tailed.
Results: The two groups had no statistical difference in
demographics, postoperative complication rate, and
survival rates. The 5- and 10-year overall survival rates
in Group 1 were 21.7% and 16.7% respectively and
those in Group 2 were 25.1% and 18.2% respectively
(p = 0.430). The 5- and 10-year disease-free survival
rates in Group 1 were both 14.8% and those in Group
2 were 13.4% and 10.9% respectively (p = 0.459).
Conclusion: The survival outcomes of patients with
HCC with and without direct invasion are comparable.
At centers with expertise, en-bloc resection should be
attempted for clinical T4 disease if the patient is fit for
operation.
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APHPB-0298
THORACOABDOMINAL APPROACH
FOR SYMPTOMATIC GIANT HEPATIC
HEMANGIOMA AFTER FAILED
ANGIOEMBOLISATION AND
SORAFENIB THERAPY
R. Vellaisamy, J. S. Jesudason, B. Sathyamoorthy, A.
Anbalagan, B. Duraisamy, P. Raju, C. Servarayan
Murugesan and K. Devygounder
Institute of Surgical Gastroenterology, Rajiv Gandhi
Government General Hospital, Madras Medical College,
Chennai, India
Objectives: Surgical resection of Symptomatic Giant
Hepatic hemangiomas can be very challenging due to
their large size and its relation to IVC and diaphragm.
We report a challenging case of 5200 g symptomatic
hepatic hemangioma of size 37 9 19 9 15 cm in a
34 year old female who was managed by throcoabdom-
inal approach after failed chemoembolisation and so-
rafenib therapy.
Methods: Considering the post hepatectomy liver fail-
ure, Staged Procedure was planned. At first, we per-
formed transcatheter arterial chemoembolisation by
injecting the gelatin particles to the right hepatic artery
but patient failed to show any improvement. After liter-
ature review, we found similar lesion managed with so-
refenib. The patient was started on sorafenib and
followed up with ultrasound. Sorafenib was stopped
later due to toxicity even though it showed 55.6%
reduction in size.
Since the patient continued to be symptomatic, she was
planned for right hepatectomy by using combined thro-
coabdominal approach due to its huge size and its rela-
tion to IVC and Diaphargam. By making makucchi
incision and median sternotomy, suprahepatic and inf-
rahepatic control achieved. Right hepatectomy done
using pringle maneuver. 14 units of blood products
were tranfused during the 7 h surgery.
Results: After initial inotropic and ventilatory support
patient was started on oral diet on third day with good
outcome. Patient is asymptomatic after one year
followup.
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Conclusion: Thoraco abdominal approach may be
safely employed with less morbidity with good surgical
outcome in a case of Giant Hepatic Hemangioma.
APHPB-0299
CLINICAL CHARACTERISTICS OF
PATIENTS WITH SEVERE ALCOHOLIC
HEPATITIS
H. Tanaka, H. Sasaki and M. Arita
Internal Medicine, Kihoku Hospital, Wakayama Medical
University, Wakayama, Japan
Objectives: The patients with alcoholic hepatitis
develop by one repeats drinking a great deal of alcohol
continuously. Among them, patients with severe alco-
holic hepatitis (SAH) with the complications such as
hepatic encephalopathy, pneumonia, acute renal failure,
and gastrointestinal bleeding may die within 1 month
without the improvement of hepatic enlargement, even
if one abstains from drinking. Although this disease is
a bad prognosis like a fulminant hepatitis, the knowl-
edge of this disease is only little. We report the clinical
characteristics of SAH.
Methods: The subjects were eight patients (mean ages
43.3  10.2 year) who were diagnosed based on the cri-
teria by Takada, et al. in Japan. The control were six
patients (mean ages 59.3  7.0 year) with acute viral
hepatitis (AH) who were hospitalized at the same per-
iod. The expected formula of mortality rate which was
reported by Horia Y, et al was used.
Results: On admission, the age of SAH was signifi-
cantly lower than that of AH. The serum value of
ALT, albumin and PT% of SAH were also significantly
lower than those of AH. On the contrary, the serum
value of total bilirubin and WBC of SAH significantly
increased. Although the expectation of mortality rate
which was formulated was 78.3  49.3%, the actual
mortality rate was 25%. The analysis of period of hos-
pitalization between SAH and AH (44.4  17.5 days
vs. 29.7  10.2 days) was no significance.
Conclusion: For 7 years, we experienced 8 patients with
SAH and recognized the improved outcomes of treat-
ment.
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CORRELATION BETWEEN
PREOPERATIVE BILIARY DRAINAGE,
BILE CONTAMINATION AND
POSTOPERATIVE INFECTIOUS
COMPLICATIONS FOR
EXTRAHEPATIC BILE DUCT
RESECTION
K. Arakawa1, R. Kurosaki1, K. Kobayashi1, H. S.1,
K. Iwamatsu1, Y. Enokida1, N. Tomizawa1, T. Ando1
and I. Takeyoshi2
1Surgery, Maeabashi Redcross Hospital, Maebashi,
Japan; 2Thoracic Visceral Organ Surgery, Gunma
University School of Medicine, Maebashi, Japan
Objectives: The relationship between preoperative bili-
ary drainage, intraoperative bile culture, and postoper-
ative infectious complications remains controversial.
The aim of this study is to investigate the effects of pre-
operative biliary drainage on intraoperative bile culture
and postoperative infectious complications.
Methods: Eighty-four patients underwent operation for
malignant biliary, pancreatic and duodenal tumor, con-
sisting of hepatobiliary resection with cholangiojejunos-
tomy and pancreatoduodenectomy. An intraoperative
bile specimen was prospectively collected immediately
after division of bile duct. Postoperative infectious
complication was evaluated.
Results: Of 90 patients evaluated, 57 patients (63.3%)
had preoparetive biliary drainage, 33 did not. The inci-
dence of positive bile culture was higher in the preoper-
ative drainage group (84.2%) than in the nondrainage
group (21.2%) (p < 0.05). The incidence of postopera-
tive infectious complications in the drainage group was
higher but not statistically significant compared to the
incidence in the nondrainage group (43.9% vs. 30.3%).
The incidence of postoperative infectious complications
was higher in the intraoperative bile culture positive
group (45.5%) than in the negative group (28.6%).
Microorganisms identified by intraoperative bile cul-
tures highly corresponded to those isolated from infec-
tious site (71.0%).
Conclusion: Preoperative biliary drainage increased
bacterial contamination of bile, but did not significantly
increased the incidence of postoperative infectious com-
plications. However, intraoperative bile culture positive
patients have increased risk of developing infectious
complications. When infectious complication occurs,
Intraoperative bile culture is useful for the prediction
of infected microorganisms.
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EFFICIENCY OF LIPOSOMAL
ALBENDAZOLE IN TREATING
COMPLEX ALVEOLAR
ECHINOCOCCOSIS: A COMPARATIVE
ANALYSIS OF CEUS, CT AND PET/CT
H. Li1, T. Song2, Y. Shao1, Y. Qin3, W. Liu4, X. Li3
and H. Wen1
1Hepatobiliary & Hydatid Department of Digestive and
Vascular Surgery Centre, The First Affliated Hospital of
Xinjiang Medical University, Urumqi, China;
2Department of Ultrasonography, The First Affliated
Hospital of Xinjiang Medical University, Urumqi, China;
3Department of Nuclear Medicine, The First Affliated
Hospital of Xinjiang Medical University, Urumqi, China;
4State Key Lab Incubation Base of Xinjiang Major
Diseases Research (2010DS890294) and Xinjiang Key
Laboratory of Echinococcosis, The First Affliated
Hospital of Xinjiang Medical University, Urumqi, China
Objectives: To investigate the clinical efficiency of lipo-
somal albendazole (L-ABZ) in treating complex alveo-
lar echinococcosis (CAE) using CEUS, CT and PET/
CT, respectively.
Methods: Twelve patients with complex alveolar
echinococcosis (CAE) admitted to our hospital from
June 2000 to 2011 were included in this retrospective
analysis. CEUS, CT and PET/CT were performed to
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evaluate the clinical efficiency of these patients.
Effectiveness with clinical significance was defined as
complete response after chemotherapy. Effectiveness
was defined as significant response after chemotherapy.
Non-effectiveness was defined as no response after che-
motherapy. The follow up duration was 3–11 years.
Results: Ten patients (83.3%) showed a ratio of aver-
aged gray scale in the enhanced band to the hepatic tis-
sues of ≤1.1, among which 6 patients (50.0%) showed a
ratio of ≤0.9 as revealed by CEUS. A total effective
rate of 91.6% was noticed according to the CT scan-
ning results. With regard to the PET/CT, a maximal
standard uptake value (SUVmax) of <2.5 was reported
in 9 patients (75.0%) and were evaluated as effective,
while high uptake of FGD was noticed in 3 patients
(25.0%) with the SUVmax of ≥2.5 and were defined as
non-effective.
Conclusion: L-ABZ is effective for treating CAE as
revealed by CEUS, CT and PET/CT, respectively.
These techniques provide objective evaluation of the
clinical efficiency of L-ABZ.
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THE USEFULNESS OF RISK
ASSESSMENT AND EARLY ENTERAL
NUTRITION FOR ?
PANCREATODUODENECTOMY
S. Sekine1, T. Nagata1, S. Sawada2, K. Hirano1, K.
Shibuya1, I. Yoshioka1, K. Matsui1, T. Okumura1, K.
Tazawa3 and K. Tsukada1
1Department of Surgery and Science, University of
Toyama, Toyama City, Japan; 2Department of Surgery,
Toumei Atsugi Hospital, Atsugi City, Japan;
3Department of Surgery, Itoigawa Hospital, Itoigawa
City, Japan
Objectives: Pancreaticoduodenectomy (PD) is a highly
invasive surgery. Evaluation of low nutritional status of
pre-operative patients and appropriate nutrition ther-
apy contribute to the improvement of compromised
immune function. It is useful for the reduction of post-
operative complications. Early enteral nutrition has
also been recommended in recent years.
Methods: Patient (n = 148) who had undergone PD/
PpPD were studied. We examined the utility for the
post-operative infection risk of Body mass index
(BMI), Prognostic Nutrition Index (PNI) and Control-
ling Nutritional Status Score (CONUT). Presence or
absence of infection onset, the effect of early enteral
nutrition in PD (Surgical site infection; SSI, Remote
infection; RI).
Results: Of the 148 patients, 44 suffered from SSI
(29.7%) and 54 suffered from RI (36.7%). Postopera-
tive infection rate by CONUT are as follows; Low: 51/
121 (42.2%), Moderate: 15/25 (60%), High: 2/2
(100%). In PNI cases, 45 ? PNI: 28/71 (39.4%), 40 ?
PNI <45: 21/45 (46.7%), PNI <40: 19/32 (61.3%). Both
CONUT and PNI, the incidence of infection was
higher postoperative preoperative poor nutritional state
cases. SSI rates were also similar results. It was more
pronounced in CONUT. There was a significant differ-
ence both CONUT and PNI incidence of the RI
(p < 0.05). In the early EN group, the incidence of
postoperative infection was lower than the Control
group (p = 0.06).
Conclusion: Postoperative infection incidence of PD/
PpPD is a high rate, but by early enteral nutrition and
postoperative preoperative screening by PNI and
CONUT, it is possible to reduce these events.
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MANAGING AN UNPREDICTABLE
DISEASE: A PROSPECTIVE ANALYSIS
OF THE REVISED ATLANTA
CLASSIFICATION
J. Rajasekar, S. M. Chandramohan, D. Kannan, S. M.
K. Babu, A. Amudhan, D. Benet, P. Selvarathinam
and R. Rajamahendran
Institute of Surgical Gastroenterology, Madras Medical
College, The TN Dr MGR Medical University, Chennai,
India
Objectives: With numerous prognostic systems in use
and the changing indications for intervention, our aims
were:
1. A Prospective study to evaluate the outcome of
severe acute pancreatitis (SAP) in a cohort of 118
patients
2. Does the severity as defined by Revised Atlanta
Classification (RAC) predict prognosis compared
to earlier systems.
3. Does the severity categories classified by RAC
predict Intervention.
Methods: 118 patients admitted with AP to a Surgical
gastroenterology ward between 2012 and 2014. BISAP,
CT severity scores and RAC scores were calculated at
admission. Statistical correlation between these scoring
systems with the current RAC were carried out. The
treatment included primary surgery, radiological or
endoscopic procedures in line with international Proto-
cols. Primary outcome was mortality. Secondary out-
comes were rate of ICU admission, organ failure, local
complications and Interventional procedures used. A
quantitative analysis of the moderately severe and
severe classes of RAC was done.
Results: CT severity score has higher accuracy but very
low sensitivity and BISAP score has higher negative
predictive value in SAP. There is no difference in the
rate of endoradiological interventions versus surgical
intervention in either moderately severe or severe
groups of the RAC but the timing of the intervention
is predicted.
Conclusion: This is the largest prospective cohort of
patients with SAP reported in South India. The RAC
has high reliability in predicting prognosis in terms of
mortality and morbidity while previous scoring systems
are limited in predicting SAP. The RAC can also pre-
dict the timing of intervention in AP but not the rate
or need for intervention.
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INTRAHEPATIC MIGRATION OF
PERFORATED FOREIGN BODIES – A
CASE REPORT AND REVIEW OF
LITERATURE
J. S. Rajasekar, S. M. Chandramohan, D. Kannan, A.
Amudhan, D. Benet, R. Rajamahendran and S. M. K.
Babu
Institute of Surgical Gastroenterology, Madras Medical
College, The TN Dr MGR Medical University, Chennai,
India
Objectives: Our aims: Report of a 14 year old with
successfully managed intra-hepatic foreign body.
A systematic review of well described cases of paediat-
ric and adult migrated intra-hepatic Foreign bodies to
define the best available evidence for presentation,
management and outcome
To analyse the differences between adult and paediatric
presentations.
Methods: The authors report a case of 14 year old girl
with a personality disorder who had a history of multiple
sharp foreign body ingestion and was serially monitored
and treated with endoscopic removal. She was referred
when her symptoms did not improve and xrays suggested
a possible impaction of the Foreign Body. A CECT con-
firmed that the ingested FB had migrated into the left
lobe. As diagnostic laparoscopy was not successful, a
laparotomy and removal of the foreign body was done.
Results: Data were collected from a systematic review
that identified 67 well-described cases. In the paediatric
cases, presentation was more commonly incidental,
asymptomatic with right lobe location and fewer com-
plications. Conservative treatment is reported in only 1
case. While in Adults, abdominal pain and related
symptoms were seen in 85% of cases. Presence of com-
orbidities like diabetes can lead to complications like
abscess. Surgery is the rule while conservative treatment
is reported in 2 adult cases.
Conclusion: There is a lack of evidence regarding the
recommended management of ingested foreign bodies
with intrahepatic migration (no randomized studies).
The concerns raised is the delay in diagnosis accurate
CT reading, surgical exploration where necessary and
prompt reassessment of treatment failure.
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USEFULNESS OF MEASURING
FUNCTIONAL LIVER VOLUME BY
USING 99MTC-GALACTOSYL HUMAN
SERUM ALBUMIN SCINTIGRAPHY
SINGLE-PHOTON EMISSION
COMPUTED TOMOGRAPHY
T. Kumamoto, K. Takeda, F. Asano, Y. U. Sawada,
Y. Ota, Y. U. K. I. Homma, R. Mori, R. Matsuyama,
H. Akiyama and I. Endo
Gastroenterological Surgery, Yokohama City University,
Yokohama, Japan
Objectives: We investigated the usefulness of measuring
functional liver volume using 99mTc-galactosyl human
serum albumin (GSA) scintigraphy single-photon
emission computed tomography/computed tomography
(SPECT/CT) imaging.
Methods: We performed a prospective analysis of 34
patients with colorectal liver metastases or hepatocellu-
lar carcinomas, underwent hepatic resection after portal
vein embolization (PVE), and evaluated their functional
liver volume perioperatively with GSA SPECT/CT.
The percentage of the non-tumorous remnant liver vol-
ume (%LV) and the percentage of functional remnant
liver volume (%FLV) were estimated. We have been
using the prediction score (PS) (Yamanaka et al. Ann
Surg. 1994; 219(4): 342–6) which was consists of %LV,
indocyanine green retention rate, and patient’s age for
predicting postoperative liver failure. We compared the
PS and modified PS (mPS) which adopted %FLV
instead of %LV for prediction of postoperative liver
failure using Area under receiver operatorating charac-
teristic curve (AUC).
Results: The %LV increased significantly, from 39.5%
to 53.2%, and the increment was 13.7% (p < 0.01).
The %FLV was also increased significantly, from
42.3% to 63.1%, and the increment was 20.8%
(p < 0.01). The increment was 7.1% greater for the %
FLV compared to that of the %LV (p = 0.01). All
patients were received subsequent operation following
PVE. Postoperative liver failure of grade B and C (IS-
LGS definition) occurred in 2 cases. AUC of PS and
mPS were 0.753 and 0.968, respectively.
Conclusion: Increment of %FLV was greater than that
of %LV between before and after PVE. Accuracy of
the prediction of the postoperative liver failure may be
improved by FLV using GSA SPECT/CT.
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APHPB-0309
PAEDIATRIC LIVING DONOR LIVER
TRANSPLANTATION AND
HEPATOCELLULAR CARCINOMA
K. Palaniappan, N. Shanmugam, M. Vij, G.
Narashiman, S. Reddy and M. Rela
Institute of Liver Disease & Transplantation, Global
Hospitals Chennai, Chennai, India
Objectives: Primary liver tumors in children are rare
and accounts for 1–4% of all solid tumors in children.
The most common cause of primary liver cancer in
children is hepatoblastoma with a 43% incidence rate.
Hepatocellular carcinoma (HCC) is the second most
common paediatric malignancy with a 23% incidence
rate. The median age for children with HCC is 10–
11.2 years. The male to female ratio is 2:1 in young
children, but increases with age. We report our data on
outcomes of childhood hepatocellular carcinoma, who
underwent liver transplantation.
Methods: A total of 354 transplants were done between
January 2010 – Till August 2014. Of this, 102 were pae-
diatric liver transplants (age <18 years). Of these 6
patients were found to have evidence of hepatocellular
carcinoma in the explants. Two children had HCC,
detected pre-operatively who underwent TACE as a
bridging treatment.
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Results: Age group varied from 12 months to 12 years.
Male/Female ratio was 4:2. Size varied from 1 to
3.5 cm in size. Pathology revealed Tyrosinemia Type I
in 3, Progressive Familial Intrahepatic Cholestasis in 2
and Congenital hepatic fibrosis in 1 child. Sr.Alfa feto
protein was elevated in only one child. Two children
underwent TACE as bridging therapy. All underwent
living donor liver transplantation. Immunostaining
revealed Epcam positivity in all tumors. None had vas-
cular invasion. All children had uneventful recovery.
Conclusion: HCC develops in small percentage of chil-
dren. CECT Abdomen revealed hypervascularity in all.
Alfa fetoprotein is not a reliable tumor marker for sur-
veillance. Liver transplantation is an effective treatment
option.
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APHPB-0311
TWO CASES OF ADENOSQUAMOUS
CARCINOMA ARISING FROM THE
PANCREAS
K. Hasebe, T. Seki, K. Hiramatsu and T. Arai
Surgery, Anjo Kisei Hospital, Anjo, Japan
Objectives: Adenosquamous carcinoma of the pancreas
is rare and its prognosis is poor. We try to clarity the
prognosis.
Methods: We report two cases of adenosquamous car-
cinoma arising from the pancreas and review the litera-
tures.
Results: Case 1: A 71-year-old man with upper abdom-
inal pain visited our hospital. CT showed a tumor,
measuring 3.5 cm in diameter, in the uncus of the pan-
creas. Subtotal stomach-preserving pancreaticoduoden-
ectomy (SSPPD) was performed. Histological
examination revealed the mixture of adenocarcinoma
and squamous cell carcinoma (50%) and histological
diagnosis was adenosquamous carcinoma, T3N0M0,
Stage IIA (UICC). He was not given surgical adjuvant
chemotherapy because of repeated cholangitis. He had
liver metastasis 12 months after the surgery, and gem-
citabine was administered. He died 17 months after the
surgery.
Case 2: A 77-year-old woman with upper abdominal
pain visited our hospital. CT showed a tumor, measur-
ing 3.5 cm in diameter, in the head of the pancreas.
SSPPD was performed. Histological examination
revealed the mixture of adenocarcinoma and squamous
cell carcinoma (30%). Histological diagnosis was ade-
nosquamous carcinoma, T3N1M0, Stage IIB (UICC).
She was not given surgical adjuvant chemotherapy. She
had liver metastasis and local recurrence 3 months after
the surgery, and she died 7 months after the surgery.
Median survival of resected cases in the literatures was
about 12 months. 1 year survival was 51.5% and
3 years survival rate was 21.4%.
Conclusion: The prognosis of our cases was poor as
well as the literatures. Development of effective thera-
pies for this cancer is desired.
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TYROSINEMIA AS A CAUSE OF
NEONATAL CHOLESTASIS
M. Rezaie1, S. Karami Magham1 and F. Hashemi2
1Pediatrics, Shiraz University of Medical Sciences,
Shiraz, Iran; 2Plant Pathology, Shiraz Azad University,
Shiraz, Iran
Objectives: Genetic tyrosinemia is an autosomal reces-
sive disorder with wide range of manifestations. Type1
tyrosinemia (prevalence 1/100,000 in general popula-
tion) is the most severe form that can be presented in
neonatal period with liver failure, vomiting, bleeding,
septicemia, hypoglycemia and/or renal tubulopathy and
impaired cognitive function after neonatal period.
Diagnosis is possible by detection of elevated succiny-
lacetone in urine and elevated tyrosine and methionine
in plasma. Nitisinone (NTCB), phenylalanine and tyro-
sine-restrited diet can be effective for treatment if
started before onset of acute liver failure.
Methods: In June and July 2014 we had two cases of
prematurity and cholestasis. These neonates were man-
aged for prematurity, RDS and their complications in
level 2 NICUs of peripheral hospitals, and refered to
our NICU (Shiraz Namazee Hospital) because of
severe acute liver failure.
Results: We started mangement of of liver failure and
sent laboratory tests for diagnosis of the cause of cho-
lestasis. Results of these tests were in favour of tyrosin-
emia type 1 and treatment started for them.
Conclusion: Tyrosinemia type 1 is a genetic disorder
with pontential of mortality and morbidity in neonatal
period, and must be considered in early diagnostic eval-
uation of neonatal cholestasis.
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RESULTS OF NEOADJUVANT HEPATIC
ARTERIAL INFUSION
CHEMOTHERAPY IN INOPERABLE
HCC PATIENTS WITH CHILD-PUGH
CLASS A
S. Yun, H. Kim, D. Lee and M. Kim
Department of Surgery, HBP Division, Yeungnam
University Hospital, Daegu, Korea
Objectives: The prognosis of HCC patients with main
portal vein tumor thrombosis (PVTT) or multiple intra-
hepatic lesions, or both is extremely poor and many
surgeons regard them inoperable disease and also not
suitable for liver transplant. We tried neoadjuvant
hepatic arterial infusion chemotherapy (HAI) for them
to improve their survival and convert operability
Methods: Between April 2003 to March 2013, 46 inop-
erable HCC patients with Child-Pugh class A were
treated with neoadjuvant HAI chemotherapy. HAI was
performed via a port inserted through femoral artery.
The patients were treated with 5-FU (750 mg/m2) and
cisplatin (25 mg/m2) from days 1 to 4. HAI was
repeated every 4 weeks. We analysed the chemore-
sponse with RECIST guidelines and survival rate.
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Results: Twelve patients who could not receive more
than 2 cycles HAI chemotherapy were excluded in this
study. We analysed chemoresponse rate and survival in
remaining 34 patients; overall CR, PR, SD and PD
were 11.8% (four), 26.5% (nine), 47.1% (16) and
14.7% (five), respectively. The median survival were
10.0 months. The 6, 12, 18 and 24-month cumulative
survival rate 70.0%, 67.62%, 52.9% and 34.6%,
respectively. We could do liver surgery in 8 patients
(17.3%) and the median survival was 32.0 months. The
6, 12, 18 and 24-month cumulative survival rates were
87.5%, 65.6%, 65.6%, and 65.6%, respectively. Among
of these patients, 3 patients live now and have no
recurrence for 54, 51, 14 months, respectively.
Conclusion: Neoadjuvant HAI chemotherapy can be
another good option to treat inoperable HCC patients
with good liver function.
APHPB-0314
TWO CASE TRIALS OF
NEOADJUVANTCHEMORADIOTHERAPY
WITH TS-1+GEMCITABINE +50 GY
RADIOTHERAPY INUNRESECTABLE
(BORDERLINE RESECTABLE)
PANCREAS BODY CANCER
S. Yun, H. Kim, D. Lee and M. Kim
Department of Surgery, HBP Division, Yeungnam
University Hospital, Daegu, Korea
Objectives: Pancreatic cancer has a dismal prognosis.
Especially in advanced stage, there is no standard ther-
apy. But, several studies showed us higher rates of neg-
ative margin and better survival with neoadjuvant
therapy for unresectable (borderline resectable) pancre-
atic cancer. We report two cases of complete resection
with negative resection margin in unresectable (border-
line resectable) pancreas body cancer after neoadju-
vantchemoradiotherapy.
Methods: Enrolled two patients had pancreas body
cancer with celiac trunk encasement. They were diagnosed
with unresectable (borderline resectable) pancreatic
body cancer. They received neoadjuvant chemoradiation
regimen with TS-1 (80 mg/BSA, alternative day, for
5 weeks) and Gemcitabine (1000 mg/BSA, at 1.8 day,
for 3 weeks) plus concurrent radiotherapy (50 Gy).
Results: After neoadjuvantchemoradiation therapy, fol-
low up study shows regression of tumor. They received
surgery for remained cancer, and negative resection
margin were achieved. All of them had experienced 1
episode of NCI grade 3 myelosuppression after gemcit-
abine IV infusion. One patient had experienced postop-
erative intestinal obstruction and enterocutaneous
fistula, and another had experienced postoperative
acute renal failure. We don’t think both complications
were related to neoadjuvantchemoradiotherapy. They
all recovered from complication, and survived until
now (Survival months were 8, 11 months, respectively).
Conclusion: Our trial for unresectable (borderline
resectable) pancreas body cancer can be a promising
option. But controlled randomized trials are needed.
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DOUBLE TROUBLE IN LIVING DONOR
LIVER TRANSPLANTATION –
IMPLICATIONS OF DOUBLE DONOR
GRAFT ARTERY
K. Palaniappan, A. Bharathan, R. Rajalingam, V.
Kota, S. Govil, J. O. Y. Varghese, D. Jothimani, S.
Reddy and M. Rela
1Institute of Liver Disease & Transplantation, Global
Hospitals Chennai, Chennai, India
Objectives: Hepatic artery thrombosis (HAT) after
LDLT is a potentially life-threatening complication.
Introduction of microsurgical techniques has signifi-
cantly decreased incidence of HAT after LDLT, still a
challenge for surgeons. The need for revascularisation
of multiple graft arteries in living donor liver transplan-
tation is controversial. The aim of this retrospective
study is to analyse the outcomes of recipients who had
grafts with multiple graft arteries.
Methods: Of 352 total liver transplants, 244 patients
underwent LDLT between January 2010 and August
2014 at our institution. Donors were evaluated by stan-
dard protocol and had preoperative Triphasic CECT
Scan for analysing graft anatomy. Grafts with more
than artery were included.
Results: No grafts had more than two arteries. 29
grafts (11.8%) had multiple arteries. The liver grafts
were grouped into three. Group I (n = 215) had single
artery which was reconstructed. Group II (n = 22) sin-
gle artery being reconstructed and Group III (n = 7)
where two arteries were reconstructed. The decision to
reconstruct was based on vascular supply based on the
preoperative CECT and also intra operatively in the
donor (looking for back bleed, by simultaneously
clamping the portal venous inflow and clamping one of
the arteries). In two patients, back table reconstruction
was done to the graft and two patients had two sepa-
rate anastomosis. Two patients (9.09%) in group II
had bile leak. No arterial thrombosis. The biliary stric-
ture rates were not statistically significant (p = 0.08)
Conclusion: Based on our criteria, we had an excellent
outcome of grafts with multiple arteries. We recom-
mend a single arterial revascularisation of the graft, if
the above criterion is fulfilled.
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ADULT HEPATOBLASTOMA – A CASE
REPORT
B. Sathyamoorthy, R. Vellaichamy, A. Anbalagan, P.
Raju, B. Duraisamy, C. Servarayan Murugesan and K.
Devygounder
Institute of Surgical Gastroenterology, Rajiv Gandhi
Government General Hospital, Madras Medical College,
Chennai, India
Objectives: Adult hepatoblastoma is a rare malignant
liver neoplasm. Surgery is the treatment of choice, but
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recurrence is common even after complete resection.
No standard therapeutic strategy has been established
so for.
Methods: A 14-year-old female presented with a right
hypochondrial mass. Pain preceded the appearance of
the mass. Clinical examination revealed a 15 cm 9 15
cm mass occupying the right hypochondrium and
epigastrium. CECT Abdomen (64 slice) showed
15 9 11 9 9 cm multiseptated locuated mass lesion
involving right lobe of liver segment 5, 6, 7, 8. USG
guided biopsy done revealed suspected Hepatic Ade-
noma. Preop AFP was more than 30,000. With this
preoperative diagnosis the tumor was completely
resected off the inferior vena cava with Right hepa-
tectomy. The histopathological diagnosis was mixed
hepatoblastoma. The postoperative course went
smoothly.
Results: Hepatoblastoma is a rare malignant tumor of
the liver and usually occurs in the first 3 years of life.
Most of these tumors arise in the embryo; hence it
seems to be unusual that hepatoblastomas occur in
adult age patients. Early detection may lead to
improved prognosis and survival but they are often
detected late
Conclusion: We report here the first case of adult he-
patoblastoma in India to our best of our knowledge.
We are presenting this case due to the rarity of hepato-
blastoma in adults and its preoperative diagnostic diffi-
culty and successful surgical treatment with
hepatectomy.
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LONG-TERM SURVEILLANCE OF
INTRAHEPATIC
CHOLANGIOCARCINOMA DIAGNOSED
AFTER 20 YEARS FOLLOW-UP FOR
HEPATIC HEMANGIOMA: A CASE
REPORT AND LITERATURE REVIEW
Q. Zheng, M. Li, B. Shu and Z. Song
Hepatobiliary Surgery, Union Hospital, Tongji Medical
College, Huazhong University of Science and
Technology, Wuhan, China
Objectives: Intrahepatic cholangiocarcinoma is the sec-
ond most common primary malignancy of liver with
poor prognosis. Four patients of intrahepatic cholan-
giocarcinoma were diagnosed after several years’ obser-
vation, ranging from 3 to 5 years, with hepatic
hemangioma in recent reports. Herein, we present a
rare case of much longer surveillance of intrahepatic
cholangiocarcinoma diagnosed after 20 years follow up
for hepatic hemangioma.
Methods: We collected the medical records and imag-
ing data of the patient during hospitalization as well as
20 years’ follow up. We also searched medical database
for relevant literature.
Results: An asymptomatic 74-year old Chinese man
was admitted to our hospital for recent enlarged liver
mass lesion after 20 years follow-up for hepatic heman-
gioma. He was first diagnosed with a hemangioma in
segment 8 of liver by abdominal ultrasound in Febru-
ary 1994, on basis of slightly hyperechoic feature with
1.6 1.1 cm in size. The mass lesion has enlarged
markedly since 2013, which was approved by ultraso-
nography, computed tomography, magnetic resonance
imaging and positron emission tomography. Thus, hep-
atectomy was performed and histological characteristic
revealed that the mass lesion was intrahepatic cholan-
giocarcinoma.
Conclusion: We reported the longest disease course of
intrahepatic cholangiocarcinoma, which may change
the former understanding of the biological behavior of
intrahepatic cholangiocarcinoma and worth further
studied.
APHPB-0320
DOES AGGRESSIVE APPROACH FOR
LARGE AND MULTIFOCAL HCC
JUSTIFY
J. Chinburen1, M. Gillet2, E. Tsiiregzen3, E. Chinbold1,
T. Erdenebileg1 and N. Punsagdulam4
1HPBS Department, National Cancer Center of
Mongolia, Ulanbator, Mongolia; 2National Cancer
Center of Mongolia, Ulanbator, Mongolia; 3General
Surgery, Intermed Hospital, Ulanbator, Mongolia;
4General Surgery, Health Science University, Ulanbator,
Mongolia
Objectives: Indications for surgical treatment of
patients with large or vascular invasive HCC remain
controversial. According to the BCLC classification,
hepatic resection should be performed only in patients
with early stage HCC, but no for patients with interme-
diate and advanced stages. This study aimed to deter-
mine whether hepatic resection improves survival for
patients with BCLC stages B and C.
Methods: A retrospective review of 347 HCC patients
who underwent hepatic resection at the National Can-
cer Center (NCC) of Mongolia between 2008 and 2012
was conducted. Of 347 patients, 125 had BCLC stage
0/A disease, 211 had stage B disease and 11 had stage
C disease. Mortality and survival outcomes were ana-
lyzed.
Results: For patients with BCLC stages 0/A, B and C
disease 30-day hospital mortality was 1.6%, 2.8% and
0%, respectively. The 1-year overall survival rates were
91.2% in BCLC stage 0/A patients, 80.1% in stage B
patients and 31.2% in stage C patients (p < 0.001); and
the 2-year overall survival rates were 68% in stage 0/A
patients and 51.8% in stage B patients (p = 0.05). All
patients with stage C disease died within 432 days after
surgery. Serum alpha-fetoprotein (AFP) level above
600 ng/mL was found to be an independent predictor
of overall survival.
Conclusion: Patients with BCLC stages B and C HCC
can tolerate hepatic resection with low mortality and
survival benefits, especially those with serum AFP
below 600 ng/mL. These results show that hepatic
resection can provide survival benefit for patients with
advanced HCC especially in resource-poor settings with
limited access to adjuvant therapy.
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RISK FACTORS AND OUTCOME OF
PATIENTS WITH PANCREATIC
FISTULA AFTER RADICAL
PANCREATICODUODENECTOMY
W. C. Dai, T. T. Cheung, K. S. Chok, A. C. Y. Chan,
W. Sharr, S. H. H. Tsang, T. C. L. Wong, S. C. Chan,
C. M. Lo and R. Poon
Surgery, Queen Mary Hospital, Hong Kong, China
Objectives: This study aimed to evaluate the risk fac-
tors and outcome of patients with pancreatic fistula
after radical pancreaticoduodenectomy.
Methods: Retrospective study of 277 patients with radi-
cal pancreaticoduodenectomy performed in Queen
Mary Hospital, Hong Kong.
Results: The 30-day mortality and hospital mortality
rate in this series was 2.5% and 5.1% respectively. 40
patients (14.5%) developed pancreatic fistula. Risk fac-
tors associated with pancreatic fistula as identified by
univariate analysis included presence of co-morbid ill-
ness, intra-operative blood transfusion, non-pancreatic
pathology, pylorus-preserving pancreaticoduodenecto-
my and normal pancreatic consistency. By multivariate
analysis, presence of co-morbid illness (risk ratio 3.66;
95% confidence interval 1.48–9.01; p = 0.005), non-
pancreatic pathology (risk ratio 3.68; 95% confidence
interval 1.36–9.91; p = 0.01) and normal pancreatic
consistency (risk ratio 8.2; 95% confidence interval 1.7–
38.06; p = 0.007) were identified as independent risk
factors for pancreatic fistula. All patients with biochem-
ical leak were managed conservatively. For those
patients with clinical leak, 12 out of 19 were managed
conservatively. 4 required image-guided drainage and
only 3 patients required re-laparotomy. Those with
clinical leak were associated with statistically signifi-
cantly prolonged intensive care unit stay, hospital stay,
ventilation, total parenteral nutrition as well as time in
resuming oral diet.
Conclusion: Pancreatic fistula rate remained high after
radical pancreaticoduodenectomy. Risk factors for pan-
creatic fistula included presence of co-morbid illness,
normal pancreatic consistency and non-pancreatic
pathology. Majortiy of patients with pancreatic fistula
could be treated conservatively with low mortality.
APHPB-0322
CLINICOPATHOLOGIC DIFFERENCE
OF PERIPHERAL INTRAHEPATIC
CHOLANGIOCARCINOMA (PICC) AND
PERIHILAR INTRAHEPATIC
CHOLANGIOCARCINOMA (HICC)
Y. Kikuchi, R. Matuyama, R. Mori, S. Hiratani, K.
Nojiri, T. Kumamoto, K. Taniguchi, K. Takeda and I.
Endo
Department of Gastroenterological Surgery, Yokohama
City University School of Medicine, Yokohama, Japan
Objectives: We evaluate the clinicopathological charac-
teristics between PICC and HICC.
Methods: The basis of this study was 92 patients, who
received operation for intrahepatic cholangiocarcinoma
in our hospital since 1993–2013. We divided them to
two groups, the one was PICC group (n = 55) and
another was HICC group (n = 27). We compared clini-
copathological factors and therapeutic results between
two groups.
Results: The frequency of preoperative jaundice, blood
loss, vascular reconstruction, periductal infiltrative type,
positive for lymph node metastasis: n(+) was signifi-
cantly higher than that of PICC. According to cumula-
tive survival rate, MST of HICC (24.8 months) was
significantly poor than that of PICC (50.7 months)
(p = 0.022). In PICC, there was significant difference in
cumulative survival rate between n() (MST:52.9
months) and n(+) (MST:15.1 months) (p = 0.012), but
there was no significant difference in HICC (p = 0.573).
Adjuvant chemotherapy (AC) of gemcitabine was per-
formed in 13 cases of 18 cases of HICC with n(+). AC
improved cumulative survival rate of HICC with n(+),
whereas there was no significant difference. There was
no significant difference in cumulative survival rate
between intrahepatic metastasis positive: im(+) and neg-
ative: im() either in HICC or in PICC.
Conclusion: The prognosis of HICC was poor than
that of PICC. AC may improve the prognosis of
patients of HICC with n(+). Prognosis of patients of
HICC with im(+) is extremely poor and AC can’t
improve the prognosis.
Benign HPB Diseases
APHPB-0323
CORRELATION OF FIBROSCAN WITH
LIVER BIOPSY (LB) IN BENIGN
BILIARY STRICTURES
S. Bannoth1, T. D. Yadav1, V. Singh2 and A. Das3
1General Surgery, Postgraduate Institute of Medical
Education & Research, Chandigarh, India; 2Hepatology,
Postgraduate Institute of Medical Education &
Research, Chandigarh, India; 3Histopathology,
Postgraduate Institute of Medical Education &
Research, Chandigarh, India
Objectives: Aim of this study was to evaluate the utility
of fibroscan in assessment of liver fibrosis in patients
with benign biliary strictures (BBS).
Methods: This prospective observational study was
conducted in 40 patients of BBS from January 2013 to
June 2014. Patients with ascites and raised ALT (>10
times normal) were excluded from study. A preopera-
tive fibroscan was performed in all the patients and an
LB was taken intraoperatively from suspicious part of
liver. Histopathology findings were graded from no
fibrosis to stage IV fibrosis and liver elasticity (derived
from fibroscan) was compared with the grade of fibro-
sis by Spearman’s correlation.
Results: A total of 40 patients (11 males, 29 females;
mean BMI 23.5  4.16) with BBS were evaluated.
Mean liver function parameters including serum biliru-
bin, AST, ALT and ALP were was 3.56  4,
86.6  53.23, 100.3  72.7 and 412.93  315.5 respec-
tively. Liver stiffness measurement (LSM) ranged from
4 to 75 in the patient population. Mean LSM for no
fibrosis to stage 4 fibrosis was 6.26 kpa, 11.98 kpa,
15.26 kpa, 18.2 kpa, 46.05 kpa respectively. The 50th
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and 75th percentiles of individual stages were 5.8 kpa,
7.2 kpa (stage 0); 8.5 kpa, 11.05 kpa (stage I); 9.1 kpa,
19.4 kpa (stage II); and 46.05 kpa and 56.75 (stage IV)
respectively. Spearman’s correlation coefficient was
0.546 which was significant.
Conclusion: Our study showed that fibroscan findings
correlate well with stages of fibrosis on LB. Thus fibro-
scan may be a simple, noninvasive, reproducible alter-
native modality to evaluate liver fibrosis in patients
with biliary strictures.
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APHPB-0324
THE ROLE OF EPITHELIAL-
MESENCHYMAL TRANSITION AND
MESENCHYMAL-EPITHELIAL
TRANSITION IN THE
DIFFERENTIATION OF HEPATIC OVAL
CELLS INTO HEPATOCELLULAR
CARCINOMA IN VIVO
C. Li and Z. Tu
Liver Department, Huzhong University of Science &
Technology, Wuhan, China
Objectives: To study the plasticity of hepatic oval cells
and the role of epithelial-mesenchymal transition
(EMT) and MET in the differentiation of oval cells
into hepatocellular carcinoma (HCC) with the coopera-
tion of the HBx gene and AFB1 in vivo.
Methods: The transfected HBx oncogene rat hepatic
oval cells were implanted into the subcutaneous tissue
of nude mice to develop tumor for 10 weeks, then the
subcutaneous tumors were collected and divided to
transplant into liver parenchyma, at the same time
treating with aflatoxin B1 for 18 weeks. The subcutane-
ous tumors and intrahepatic tumors were collected and
stained by haematoxylin and eosin (H&E) and immu-
nohistochemistry staining, as well as observed by Wes-
tern-Blot.
Results: We found that subcutaneous implanted HBx-
oval cells formed mesenchymal tumors with EMT,
which was associated with decreased expression of E-
cadherin, and increased expression of TGF-b1/Smad3,
Snail and vimentin. Then part of HBx mesenchymal
tumor can trans-differentiate into HCC with MET
when these subcutaneous tumors were transplanted into
the liver parenchyma, associated with increased E-cadh-
erin expression, and decreased expression of TGF-b1/
Smad3, Snail and vimentin. By contrast, the control
group did not present MET.
Conclusion: These data illustrated that HBx can pro-
mote HBx mesenchymal cells transiting to epithelial
cells MET by inhibiting TGF-b1/Smad3 and Snail sig-
naling pathways, and EMT-MET may play an impor-
tant role in these processes.
APHPB-0325
THE IMPACT OF VISCERAL FAT
VOLUME ON SURGICAL SITE
INFECTION AFTER
PANCREATICODUODENECTOMY
K. Doi, H. Takamori, S. Shinichi, K. Shimizu, K.
Yamamura, K. Ogawa, N. Ozaki, M. Iwatsuki, H.
Tanaka and K. Ogata
Surgery, Saiseikai Kumamoto Hospital, Kumamoto,
Japan
Objectives: The aim of this prospective study was to
evaluate the impact of visceral fat on surgical site infec-
tion (SSI) after pancreaticoduodenectomy (PD).
Methods: Seventy-two patients underwent PD for pe-
riampullary carcinoma at Saiseikai Kumamoto hospital
between 2007 and 2013. Their visceral fat volume was
estimated by CT scan, using Fat Scan software. Risk
factors associated with SSI were following variables:
laboratory examination data, including visceral fat and
intraoperative factors. We first investigated significant
factors associated with SSI in a univariate logistic
regression analyses, and significant variables were sub-
sequently tested in a multivariate analysis. Statistical
difference was considered to be significant at p < 0.05.
Results: Study subjects included 26 women and 46
men. The average age of the patients was 70 years.
Pancreatic cancer was in 25 pts, and biliary tract cancer
was in 47 pts. SSI after PD occurred in 31 pts (43%).
A univariate logistic regression analyses revealed that
BMI, visceral fat volume, age, prognosis neutrition
index (PNI), operation time, and bleeding volume was
the significant risk factors. A multivariate analysis of
the factors that significantly predicted risk of SSI in the
univariate analyses revealed that age (OR 7.76,
p = 0.015), PNI (OR 12.4, p = 0.019) and visceral fat
(OR 6.14, p = 0.049) were the independent risk factors
of SSI. Moreover, visceral fat volume were correlated
with operation time (r = 0.29, p = 0.004) and blood
loss (r = 0.30, p = 0.034).
Conclusion: Visceral fat volume was one of the inde-
pendent risk factors of SSI after PD. In addition, vis-
ceral fat volume was correlated with operation time
and blood loss.
APHPB-0326
LAPAROSCOPIC VERSUS OPEN
HEPATECTOMY FOR HCC
K. Sakamoto, G. O. R. O. Honda, M. Kurata, S. H. I.
N. Kobayashi, M. Honjo, Y. Kohira and T. Ryu
Surgery, Komagome Hospital, Tokyo, Japan
Objectives: We introduced laparoscopic hepatectomy in
2008, and it is also standardized in anatomical hepatec-
tomy.
Methods: We conducted a retrospective study for each
of laparoscopic hepatectomy (L) and open hepatectomy
(O) as the primary hepatectomy for HCC in the period
of August 2008 to December 2013. Patient background,
liver function, surgical procedures, tumor-related data
and postoperative outcomes were investigated.
Results: O group included 45 cases and L group
included 60 cases. Indocyanine green retention rate at
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15 min was higher in O group (18.0%) than in L group
(14.6%) (p = 0.04). No other significant differences
were found in patient background and liver function.
No differences were found in tumor size, tumor num-
ber and surgical procedures. No difference was found
in mean operative time, but the blood transfusion rate
[11% (5/45) vs. 0% (0/60), p = 0.01], mean blood loss
(849 vs. 317 g, p < 0.05) and postoperative hospital
stay (12 vs. 8 days, p < 0.05) were significantly better
in L group. Regarding the fluctuations in blood bio-
chemical tests, CRP was lower, and AST and ALT
were higher in L group in the early postoperative per-
iod. However, there were no significant differences in
these data after patient discharge. Relapse-free survival
and overall survival showed no significant difference
between the two groups.
Conclusion: L group had better results in terms of
short-term outcomes than O group against almost the
same background. We considered that laparoscopic-
specific factors, such as pneumoperitoneum, have no
effect.
APHPB-0328
SURGICAL MANAGEMENT OF
HEPATOCELLULAR CARCINOMA
WITH CAVO-ATRIAL TUMOR
THROMBUS
K. Palaniappan, M. Shrivastava, A. Bharathan, S.
Govil, G. Narashiman, S. Reddy, V. Kota and M.
Rela
Institute of Liver Disease & Transplantation, Global
Hospitals Chennai, Chennai, India
Objectives: HCC is currently third leading cause of
cancer-related deaths worldwide. Tumor thrombus into
IVC/RA is a rare occurrence and found in 3–4% of
cases. Outcome for HCC patients with symptomatic,
intra-atrial tumor growth is dismal, with median sur-
vival of 1–4 months. Currently there is no consensus
on the management of patients with IVC/RA tumor
thrombus. Hereby we report our results of patients
who presented with IVC/RA thrombus.
Methods: Retrospective review was undertaken of
patients with HCC and IVC/RA tumor thrombus who
were potential candidates for surgery but who were
finally treated surgically and nonsurgically between
January 2010 and Till March 2014. The patients were
subdivided according to therapeutic modalities, and the
results for each group were compared.
Results: Of total of 352 patients who presented with
HCC, 26 (7.3%) had IVC/RA tumor thrombus at pre-
sentation. 5 cases (19.2%) underwent hepatectomy and
thrombectomy. TACE was offered in 12 (57.1%), only
Sorafenib in 9 (42.2%). Operative mortality was 20%.
The one and three year survival was 80% and 40%
respectively with a median survival of 28 months. In
TACE group, 1 and 3 year survival was 41.6% and
16.6% (Median survival 8.5 months). In sorafenib
group 1 year survival was 11.1% and no patient sur-
vived for 3 years. Patients managed surgically survived
longer (p < 0.001) than other groups.
Conclusion: Surgery for HCC with IVC/RA tumor
thrombus can be safely performed in selected patients
and should be considered in patients with resectable
primary tumor and sufficient hepatic reservoir. Surgery
significantly improves survival when compared with
TACE or Sorafenib.
APHPB-0329
SURVIVAL COMPARISON BETWEEN
SURGICAL RESECTION AND
TRANSARTERIAL EMBOLIZATION FOR
HEPATOCELLULAR CARCINOMA
MORE THAN 10 CM- A PROPENSITY
SCORE MODEL
Y. Chan, C. Wang, C. Kabiling, G. Aguilar, P. Vinod,
T. Lin and W. Li
General Surgery, Kaohsiung Medical Center, Chang
Gung Memorial Hospital, Kaohsiung, Taiwan
Objectives: Recommended management for BCLC
stage B and C hepatocellular carcinomas (HCC) are
TACE and Sorafenib. HCC ≥10 cm may have better
outcomes with surgical resection (SR). This study
reviews survival outcomes of patients with HCC
≥10 cm treated at a tertiary level hospital in Taiwan,
and aims to find survival advantage of surgical resec-
tion over embolization therapy using a propensity
scores matching model.
Methods: Data of 192 patients newly diagnosed with
HCC ≥10 cm between 2005 and 2010, who had SR
(n = 104) and TAE (n = 88) were retrospectively stud-
ied. Patient demography, tumor characteristics, thera-
peutic intervention, cumulative overall survival (OS)
and disease-free survival (DFS) were analysed. Thirty-
two patients in each group were selected by propensity
scores matching models for comparison.
Results: Survival rates at 1, 3, 5 years of patients in
BCLC stage B who had SR and TAE were 78.5%,
61.4%, 54.2% and 30%, 12.9%, 12.9%, (p < 0.001)
respectively. For stage C, survival rates were 77.8%,
56.4% and 47% at 1, 3, 5 years in SR group while it
was 12.7% at 1 year in TAE group, p < 0.001. Match
analysis based on propensity score showed estimated 1-
, 3-, and 5-year survival rates of patients receiving SR
and TAE were 90.2 vs. 26.4%, 64.3 vs. 3.3%, and 51.5
vs. 3.3%, respectively (p < 0.001).
Conclusion: Propensity scores matching analysis
showed that SR group had significantly better 5 year
survival than TAE group. Overall survival of BCLC
stage B may be improved by considering SR as first
treatment option for resectable large HCCs, provided
patient is fit for surgery with good liver remnant.
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APHPB-0330
MYRIADS OF ISOLATED IGG4
CHOLANGIOPATHY MASQUERADING
AS BILIARY MALIGNANCIES
A. Arora1, N. Agrawal1, K. S. Arvind1, A. Murali1, C.
Bihari2, A. Arora3, V. Pamecha1 and T. K.
Chattopadhyay1
1HPB Surgery, Institute of Liver and Biliary Sciences,
Delhi, India; 2Pathology, Institute of Liver and Biliary
Sciences, Delhi, India; 3Radiology, Institute of Liver and
Biliary Sciences, Delhi, India
Objectives: Isolated IgG4 cholangipathy is a very rare
entity. We herein describe a spectrum of presentation
involving the various sites of hepatobiliary system and
mimicking malignancy.
Methods: We report four cases all involving different
sites and presenting as malignant masquerade.
Results: Patient one and two presented as painless,
fluctuating jaundice of 1 month duration with peak bil-
irubin levels of 4.6 and 8.0 mg/dL respectively. CECT
revealed a hilar mass in first and a mid CBD mass in
second patient. They underwent right hepatectomy and
CBD excision with RYHJ respectively. Patient three
presented with vague upper abdominal pain and
investigations revealed a SOL in segment VIII of liver,
radiologicaly suggestive of intrahepatic cholangiocarci-
noma. Patient underwent right hepatectomy. Patient
four presented with pain right hypochondrium of
6 month duration. CECT revealed a mass in the fundus
of gall bladder suggestive of gall bladder cancer.
Patient underwent radical cholecystectomy. Final histo-
pathology of all these patients revealed IgG4 related
disease with no evidence of malignancy.
Conclusion: Isolate IgG4 cholangiopathy can involve
any site of biliary tree from ampulla of vater to intra-
hepatic bile ducts, can mimic malignancy and should
be kept as a differential diagnosis. Any atypical presen-
tation and/or atypical radiological imaging findings
should alert an astute clinician to this entity. Serum
IgG4 levels may not always be elevated in this disease.
Most of these cases are still diagnosed postoperatively
but awareness of this entity can avoid surgery in many.
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APHPB-0332
OPTIMAL EXTENT OF LYMPH NODE
DISSECTION FOR LEFT-SIDED
PANCREATIC CANCER
H. Lee, J. S. Heo, J. Y. Park, S. Youn, W. Kwon, S.
H. Choi and D. W. Choi
Surgery, Samsung Medical Center, Sungkyunkwan
University School of Medicine, Seoul, Korea
Objectives: Lymph node metastasis is a poor prognos-
tic factor in the patients with pancreatic cancer. How-
ever, there is still controversy that extended lymph
node dissection is essential for left-sided pancreatic can-
cer. The aim of this study is to evaluate the outcomes
according to the extent of lymph node dissection and
tumor location in patients with left-sided pancreatic
cancer.
Methods: From January 2005 to December 2013, we
retrospectively identified 120 patients who underwent
curative intent surgery for left-sided pancreatic cancer.
We included only patients with grossly and microscopi-
cally no residual tumor. The left-sided pancreatic can-
cer were divided into pancreatic body or tail cancer.
The lymph nodes were divided into three groups; celiac
group, superior mesenteric group, and peripancreatic
group.
Results: We included 65 patients with pancreatic body
cancer and 55 patients with pancreatic tail cancer. The
median follow-up period was 16 months (range, 4–
101 months). The 49 patients with pancreatic body can-
cer and 33 patients with pancreatic tail cancer under-
went celiac group lymph node dissection. In patients
with pancreatic body cancer, the celiac group lymph
node dissection was associated with improved disease
free survival (DFS) (p = 0.011). However, celiac group
lymph node dissection could not enhance DFS in
patients with pancreatic tail cancer (p = 0.833). Supe-
rior mesenteric group lymph node dissection was not
associated with survival outcomes in both pancreatic
body and tail cancer patients.
Conclusion: Celiac group lymph node dissection
improves survival in patients with pancreatic body
cancer. However, it is not necessary in pancreatic tail
cancer.
APHPB-0335
DEBAKEY FORCEPS CRUSHING
TECHNIQUE FOR HEPATIC
PARENCHYMAL TRANSECTION IN
LIVER SURGERY: A REVIEW OF 100
CASES AND ERGONOMIC
ADVANTAGES
S. Jain1, B. Sharma2 and L. Jain1
1G.I. HPB Minimal Access & Bariatric Surgery, Fortis
Hospital, Jaipur, India; 2General & Laparoscopic
Surgery, Soni Manipal Hospital, Jaipur, India
Objectives: Bleeding is an important complication in
liver transections. To determine the safety and efficacy
of Debakey forceps for liver parenchymal transection
and its ergonomic advantages over clamp crushing
method we analysed our data.
Methods: We used Debakey crushing technique in 100
liver resections and analysed data for transection time,
transfusion rate, morbidity, mortality, hospital stay,
influence of different types of liver conditions and ergo-
nomical features of Debakey forceps.
Results: Mean age, transection time and hospital stay
of 100 patients were 52.38  17.44 years,
63.36  33.4 min and 10.27  5.7 days. Transection
time and hospital stay in patients with cirrhotic liver
(130.4  44.4 min, 14.6  5.5 days), and cholestatic
liver (75.8  19.7 min, 16.5  5.1 days), was signifi-
cantly greater than in patients with normal liver
(48.1  20.1 min., 6.7  1.8 days) (p < 0.01). Transec-
tion time improved significantly with experience (first
fifty versus second fifty cases – 70.2  31.1 min vs.
56.5  34.5 min, p < 0.04). Qualitative evaluation
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revealed that Debakey forceps had ergonomic advanta-
ges over Kelly clamp.
Conclusion: Debakey forceps crushing technique is safe
and effective for liver parenchymal transection in all
kinds of liver. Transection time improves with sur-
geon’s experience. It has ergonomical advantages over
Kelly clamp and is better choice for liver transection.
APHPB-0337
PANCREATICODUODENECTOMY (PD)
WITH CONCOMITANT MAJOR VESSEL
RESECTIONS (BOTH VENOUS &
ARTERIAL) FOR BORDERLINE
RESECTABLE DUODENAL AND
PANCREATIC HEAD CANCERS –
FEASIBILITY AND PERIOPERATIVE
OUTCOME
S. Jain and N. Bhateja
G.I. HPB Minimal Access & Bariatric Surgery, Fortis
Hospital, Jaipur, India
Objectives: Pancreaticoduodenectomy (PD) with vascu-
lar resections is associated with high morbidity and
mortality. We analysed our data to assess the feasibility
and perioperative outcome.
Methods: We performed concomitant vascular resec-
tion in 10 patients of total 202 pancreaticoduodenecto-
mies (PD). Sleeve resection of the portal vein was
carried out when <1/3rd and segmental resection was
done when >1/3rd of circumference of portal vein was
involved. Arterial resections were performed only when
the replaced right hepatic artery or small segment of
common hepatic artery away from the celiac axis, was
involved in the tumor. Arterial reconstructions were
done using gastroduodenal and splenic arteries.
Results: Portal vein sleeve resections with repair was
done in 4/10 patients, 3/10 patients had segmental por-
tal venous resections ranging from 2.5 to 4 cm length
with end to end reconstructions, 3/10 patients had con-
comitant hepatic artery and portal vein sleeve resec-
tions. The operative time was 5 1/2 to 8 h. Blood was
transfused in 4/10 patients. Postoperative ICU stay was
12–18 h with total Hospital stay of 8–25 days. There
was no 30-day mortality. Post-operative complications
included ascites, hepatic encephalopathy and pneumo-
nitis with sepsis.
Conclusion: Pancreaticoduodenectomy with concomi-
tant vascular (both venous and arterial) resections is a
feasible operation in patients with borderline resectable
cancers of head of pancreas and periampullary region,
though with high perioperative morbidity.
Benign HPB Diseases
APHPB-0338
BILE DUCT INJURIES AFTER
CHOLECYSTECTOMY – TIMING AND
PRESENTATION IN SOUTH INDIA
K. Sivakumar, S. M. Chandramohan, D. Kannan, R.
Prabhakaran and A. Benet Duaraisamy
Surgical Gastroenterology, Madras Medical College,
Chennai, India
Objectives: Bile duct injury (BDI) is a dreaded compli-
cation of cholecystectomy, often caused by misinterpre-
tation of biliary anatomy. This paper presents bile duct
injuries after cholecystectomy – Timing and presenta-
tion in south India.
Methods: This study analyses 32 cases of bile duct
injury managed by the Department of Surgical Gastro-
enterology at Rajiv Gandhi Government General Hos-
pital/Madras Medical College from July 2010 to March
2014.
Results: Bile duct injuries occurred after laparoscopic
cholecystectomy-18 cases and after open method-14
cases. Age distribution ranging from 29 to 72 years
with female sex preponderance. Bilioma as initial pre-
sentation-19, established biliary stricture-17, on table
recognised-1, biliary peritonitis-3. Most common type
of bile duct injury is Strasberg type A and D followed
by E3. Type E1-5 cases, Type E2-5 cases, Type E3-7
cases. 2 cases presented with secondary biliary cirrho-
sis.
Immediate PCD 19 cases, ERCP and stenting-8, open
drainage-3 patients. Hepaticojejunostomy-13. Choledo-
choduodenostomy-1. PTBD-1.
Conclusion: Bile duct injuries most commonly occurs
after lap cholecystectomy than open cholecystectomy.
Female are most affected than male. In our centre type
A and D type of injuries managed with both PCD and
ERCP stenting .Type E1 to E5 injuries are best treated
with definitive surgical management like hepaticojejun-
ostomy.PTBD useful in cholangitis when ERCP unsuc-
cessful Best results are obtained if delayed surgical
procedure are performed than early surgical interven-
tion.
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HEPATIC EPITHELOID
ANGIOMYOLIPOMA (PECOMA): A
RARE HEPATIC TUMOR!
S. Mathur1, C. Tampi2 and D. Chhabra3
1Surgical Oncology, Bombay Hospital and Medical
Research Centre, Mumbai, India; 2Pathology, Lilavati
Hospital and Research Centre, Mumbai, India; 3Surgical
Oncology, Lilavati Hospital and Research Centre,
Mumbai, India
Objectives:
Background: Hepatic angiomyolipoma (HAML) is a
rare, benign mesenchymal neoplasm composed of vary-
ing amounts of smooth muscle cells, adipose tissue, and
vessels. Perivascular epithelioid cells (PEC), which have
no known normal cellular counterpart, are intimately
related to blood vessels and are involved in a growing list
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of unusual tumors and tumor-like lesions (PEComas)
sharing the expression of homatropine methylbromide
45 (HMB45) and smooth muscle actin (SMA). Its mor-
phological diversity often poses diagnostic problems. PE-
Comas can display characteristics of both benign and
malignant tumors and the primary treatment is resection.
The authors report a peculiar case of epithelioid HAML.
Methods:
Case Report: A 59-year-old female presented with
abdominal pain and discomfort. CECT demonstrated a
12.3 9 9.2 9 11 cm heterogeneous hypodense exophy-
tic mass arising from segment II of the liver and in
close proximity to left hepatic vein. The mass indented
the gastric fundus. The AFP levels were normal. A
diagnosis of Hepatic adenoma versus a well-differenti-
ated Hepatocellular carcinoma was suspected. No
biopsy was performed and the patient underwent left
lateral sectionectomy.
Results: Histologically, the tumour was mainly com-
posed of epithelioid cells arranged in trabeculae and
sheets admixed with mature adipose tissue and thick-
walled blood vessels. Most of the epithelioid tumour
cells were immunoreactive to HMB-45 and SMA with
faint positivity for S-100. Morphological pattern and
immunophenotype were consistent with epithelioid
HAML.
Conclusion: Our case adds to the volume of reported
rare cases of epithelioid HAML/primary hepatic PECo-
mas, and helps to increase awareness and understand-
ing of this rare tumor.
APHPB-0340
EXPRESSION AND
CLINICOPATHOLOGICAL
SIGNIFICANCE OF SURVIVIN PROTEIN
IN GALLBLADDER CANCER
V. Gupta1, M. Goel2 and A. Chandra1
1Surgical Gastroenterology, King George Medical
University, Lucknow, India; 2Pathology, King George
Medical University, Lucknow, India
Objectives: Clinical significance of survivin (inhibitor
of apoptosis protein) in gallbladder cancer is not yet
established. This study was performed to assess the
expression pattern of survivin in benign and malignant
gallbladder lesions, and to assess its clinicopathological
significance.
Methods: After due approval from the ethics commit-
tee of the hospital and after having written informed
consent, tissue samples from resected gallbladder for
cholelithiasis (n = 27) and carcinoma gallbladder
(n = 24) were evaluated for survivin expression by
immunohistochemistry. Its expression was correlated
with different clinicopathological parameters and sur-
vival.
Results: Benign group [19 females, age (mean  SD)
45  14 years] and malignant group [20 females, age
(mean  SD) 48.9  13.4 years] were comparable with
respect to age, sex, menopausal status, presence, size
and types of stones. However, survivin expression was
significantly higher [66.7%, 95% confidence interval
(CI) 24–75] in gallbladder cancer than in cholelithiasis
group [33%, (CI 46–83), p = 0.025]. Its expression did
not correlate with gender, age, menopausal status,
presence of gallstones or their size, number and type,
tumor grade, tumor stage, and overall survival.
Conclusion: Significantly higher expression of survivin
protein in gallbladder cancer as compared to cholelithi-
asis group suggests its role in gallbladder carcinogenesis
though it may not have prognostic value. Targeting
survivin for therapeutic purpose in gallbladder cancer
may be a possibility in future.
APHPB-0341
ALPPS AFTER THE LEARNING PHASE
IS A SAFE PROCEDURE WITHOUT
MORTALITY OR SEVERE SURGICAL
COMPLICATION – PERSONAL
EXPERIENCE OF 22 CONSECUTIVE
CASES
J. Li1, F. Ewald1, A. Kantas1, A. Koops2, E. Achilles1,
L. Fischer1 and B. Nashan1
1Hepatobiliary Surgery and Visceral Transplantation,
University Medical Center Hamburg-Eppendorf,
Hamburg, Germany; 2Diagnostic and Interventional
Radiology, University Medical Center Hamburg-
Eppendorf, Hamburg, Germany
Objectives: Associating liver partition and portal vein
ligation for staged hepatectomy (ALPPS) was reported
as a procedure associated with a relevant morbidity
and mortality. The current study aims to access the
safety of ALPPS after the learning period.
Methods: Lessons from the initial learning period
(November 2010 to April 2012), regarding the patient
selection, surgical technique and perioperative manage-
ment, were respected since ALPPS was introduced in
authors institute in May 2012. Following instructions
were followed: (1) simplifying the stage I operation to
avoid bile leakage, infection and unnecessary manipula-
tion of the disease liver; (2) choosing the length of the
waiting time of average 2 weeks till stage II operation
to avoid liver failure; (3) regarding hilar cholangiocarci-
noma as a contraindication. The postoperative compli-
cation, mortality as well as the oncological efficacy
were analyzed accordingly.
Results: 13 consecutive ALPPS have been performed
for radical resection of colorectal liver metastasis
(n = 9), gall bladder carcinoma (n = 2), intrahepatic
cholangiocarcinoma (n = 1), hepatocellular carcinoma
(n = 1). The efficacy of ALPPS in form of future liver
remnant hypertrophy, completion of the tumor resec-
tion and residual tumor status were comparable to the
results from the largest ALPPS registry. The postopera-
tive complications were found in 11 of 13 patients with-
out mortality. All complications were Clavien-Dindo
classification grade I or II, except a grade IIIA in one
patient undergoing right trisectionectomy with pancrea-
ticoduodenectomy.
Conclusion: Being the first case series without severe
complication and mortality after ALPPS, the authors
found that by following the fundamental instructions
mentioned above, ALPPS itself is a safe procedure.
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APHPB-0342
DAMAGE CONTROL SURGERY FOR
LIVER LACERATION WITH MAJOR
VESSEL INJURY: VASCULAR
CONTROL FOLLOWED BY DELAYED
HEPATECTOMY
H. Kim, E. Park, W. Kang and J. Kim
Department of Surgery, Chonnam National University
Medical School, Gwangju, Korea
Objectives: Grade V liver laceration with major hepatic
vein injury and hemodynamic instability requires an
immediate surgery. Herein, we report a case of severe
liver laceration with major hepatic vein and portal vein
injury successfully managed by the portal pedicle and
hepatic vein ligation, followed by delayed hepatectomy.
Methods: A 10-year-old boy referred to our hospital with
an abdominal distension and hemodynamic instability
after traffic accident. Blood pressure was 70/40 mmHg.
On laboratory findings, hemoglobin was 8.3 g/dL, plate-
let count was 85,000/mm3, prothrombin time interna-
tional normalized ratio (PT INR) was 2.13. An
abdominal computed tomography (CT) showed an active
bleeding from right hepatic vein, right portal vein, and
right inferior hepatic vein with extensive liver laceration
of right hepatic lobe and large amount hemoperitoneum.
Results: An immediate laparotomy was performed.
After ligation and division of gallblader neck, the right
portal pedicle was secured using Glissonean approach.
The coronary ligament and the right triangular liga-
ment were dissected, and the root of right hepatic vein
was ligated.
After lotating the liver to left side, injured inferior vena
cava; the root of right inferior hepatic vein, was
sutured. However, parenchymal resection could not be
performed because of diffuse oozing from disseminated
intravascular coagulopathy (DIC). Perihepatic pad
packing was performed and the abdominal wall was
closed temporarilly.
After 2 days from the initial operation, completion
right hemihepatectomy was performed without massive
uncontrollable bleeding tendency.
Conclusion: Severe liver injury in hemodynamically
unstable patient was could be successfully managed
with an immediate vascular control and delayed hepatic
parenchymal resection.
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APHPB-0343
THE DEVELOPMENT OF A MORE
RELIABLE APPROACH DURING
LAPAROSCOPIC
PANCREATITCODUODENECTOMY
C. Liao1, S. Wang1, C. Fu1, C. Hsu1, C. Tsai2, K. Liu2
and T. Yeh2
1Trauma and Emergency Surgery, Chang Gung
Memorial Hospital, Taoyuan, Taiwan; 2General Surgery,
Chang Gung Memorial Hospital, Taoyuan, Taiwan
Objectives: The feasibility and safety of laparoscopic
pancreaticoduodenectomy (LPD) had been proved by
several authors with experienced laparoscopic skills.
However, there were still limited centers who per-
formed LPD as a routine procedure. Due to its diffi-
culty, the approach method was still not concluded.
Methods: We conducted a prospective data collection
and retrospective review of all patients underwent LPD
from April 2012 until April 2014 at Chang Gung
Memorial Hospital (CGMH), Linkou, Taiwan.
For patients’ superior mesenteric artery (SMA) was
approached as the first step of operation were included
into artery-first group, the others were included non-
artery-first group.
Demographic data, operative approach method, anas-
tomosis method, postoperative, and information
regarding complications were recorded.
Results: Totally 21 patients who underwent LPD or
LPPPD in this periods. The median operation time was
380 min. There were 14 patients had arterial-first
approach and the other 7 patients didn’t. The blood
loss amount were significant shorted in artery-first
group and the respectability could be identified in first
stage of operation. The pancreatic fistula rate is lower
in artery-first group without significant difference. The
length of hospital stay were similar in both groups.
Conclusion: Like conventional open surgery, the artery-
first approach was appreciated in LPD. By this
approach, we can identified the respectability in early
phase operation. After control of SMA and SMV, the
bleeding during dissection could be minimized.
APHPB-0344
PROBLEMS OF LONG SURVIVAL
FOLLOWING SURGERY IN PATIENTS
WITH NONBNONC-HCC: COMPARISON
WITH HBV AND HCV RELATED-HCC
K. Hiwatashi, S. Ueno, M. Sakoda, S. Iino, K. O. J. I.
Minami, H. Kurahara, M. Yuko, M. Kosei, H. Shinchi
and S. Natsugoe
Department Digestive Surgery Breast and Thyroid
Surgery, Kagoshima University Graduate School of
Medical and Dental Science, Kagoshima, Japan
Objectives: The number of patients with hepatocellular
carcinoma (HCC) in the absence of both hepatitis B
virus surface antigen (HBsAg) and hepatitis C virus
antibody (HCVAb) (NBNC-HCC) has been rapidly
increasing in Japan. The objective of this study was to
compare the clinical and pathological characteristics
between patients with NBNC-HCC and those with
HBsAg positive or HCVAb positive HCC (BC-related
HCC). A better understanding will facilitate the devel-
opment of postoperative strategies to better manage
patients with NBNC-HCC.
Methods: Consecutive 219 patients with primary HCC:
(BC related, n = 139; NBNC, n = 80) were treated by
hepatic resection or ablation. Clinicopathological char-
acteristics including postoperative course were retro-
spectively compared between the two groups.
Results: When comparing within stage I and II, the
NBNC-HCC group had improved recurrence free sur-
vival (RFS) (p = 0.041) but tended to have lower over-
all survival (OS). Moreover, the NBNC-HCC group
showed higher rate of death due to other cancers and
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cardiovascular disease (p = 0.041). Multivariate analy-
sis revealed that the only prognostic factor for RFS in
the NBNC-HCC group was high total bilirubin.
Conclusion: In the patients with NBNC-HCC, elevated
bilirubin could predict poor RFS after surgery. Fur-
thermore, patients must be carefully followed-up not
only for HCC but also for the occurrence of other criti-
cal diseases including multiple other cancers.
Transplantation
APHPB-0345
INTIMAL FIXATION FOR HEPATIC
ARTERY DISSECTION, EVALUATION
OF A NEW TECHNIQUE
M. El Shobari, T. Salah, A. Sultan, A. Anwer, M.
Abdelwahab and H. Hamed
Surgery, Gastroenterology Surgical Center, Mansoura
University, Mansoura, Egypt
Objectives: Evaluation of the technique of intimal fixa-
tion in hepatic artery dissection (three quadrant and
four quadrant) in LDLTX.
Methods: From May 2004 to July 2014, 313 cases of
LDLTX were done in MANSOURA GASTROEN-
TEROLOGY SURGICAL CENTER. Single anasto-
mosis in 303 cases and double in 10 cases.arterial
anastosis was done using 8/0 prolene interrupted using
surgical loop 4,5. Mean diameter is 3 mm.
288 cased were anstomosed to rt hepatic artery branch
and 23 to left hepatic.
4 quadrant complete arterial dissection was found in 15
cases-intimal fixation using 8/0 prolene was done in all
cases.
Results: In 14 cases INTIMAL FIXATION was suc-
cessful.in one case failure to do anastomsis was noted
and splenic artery was used.splenic artery anastomosis
was successful in 2 cases. Long term follow up using
Doppler and in suspected cases ct angiography show
good patency in 13 cases.one case show thrombosed
HA IN DAY 1.
Interventional radiology using angio was successful.
Conclusion: Intimal fixation technique is a useful alter-
native to interposition grafts in LDLTX with good
results.
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APHPB-0346
A CASE OF PANCREATIC DUCTAL
ADENOCARCINOMA CONCOMITANT
WITH IGG4-RELATED DISEASE
Y. Ikeda, K. Wada, M. Kainuma, K. Takahashi, A.
Takako, I. T. O. U. Hiromichi, N. Toyota, F. Miura,
H. Amano and K. Sano
Surgery, Teikyo University School of Medicine, Tokyo,
Japan
Objectives: IgG4-related disease (IgG4-RD) is an
increasingly recognized syndrome of unknown etiology
comprised of a collection of disorders including auto-
immune pancreatitis (AIP) and sclerosing cholangitis,
and relationship between IgG4-RD and malignant
tumors is unknown.
Methods: Here, we reported a case of pancreatic ductal
adenocarcinoma (PDAC) arisen in the treatment for
IgG4-RD.
Results: A 55-year-old man presented with upper
abdominal pain with elevation of serum amylase level,
making a clinical diagnosis of acute pancreatitis with
unknown etiology. He did not have history of alcohol
abuse and no gallstones were identified. MRCP showed
stricture both in the main pancreatic duct and distal
bile duct (double duct sign), and CT scan showed a
vague low density tumor-like lesion in the head of pan-
creas with positive uptake of FDG-PET. Serum CA19-
9 level was normal and IgG4 level was elevated. A ste-
roid challenge test was administrated under the clinical
diagnosis of IgG4-related AIP rather than PDAC, and
it was dramatically effective with normalized serum
IgG4 level and improved biliary and pancreatic duct
stricture. However, he had obstructive jaundice with re-
elevation of IgG4 level. In addition, CA19-9 level was
also elevated this time, and multiple liver tumors
appeared. A systemic chemotherapy was administrated,
and liver tumors were disappeared. After additional
chemotherapy, we performed PPPD. Pathological diag-
nosis showed a focal IgG4-related sclerosing cholangitis
and T1N0 pancreatic ductal adenocarcinoma.
Conclusion: The relationship between IgG4-RD and
PDAC has not been proven. It should be noted that
pancreatic ductal cancer may be occurred during the
course of IgG4-RD.
APHPB-0347
SUITABLE TREATMENT FOR HCC
FROM THE POINT OF VIEW OF
RECURRENT PATTERN
T. Minagawa, O. Itano, M. Shinoda, M. Kitago, H.
Yagi, Y. Abe, T. Hibi and Y. Kitagawa
Surgery, Keio University, Tokyo, Japan
Objectives: The aim of this study was to clarify the
most suitable treatment for both primary and recurrent
hepatocellular carcinoma (HCC).
Methods: Retrospective studies were performed based
on the medical records of 117 patients who were trea-
ted from 1993 to 2014 for recurrent HCCs after cura-
tive hepatic resection (HR) and/or ablative therapy
(AT). Patients were divided into two groups with
regards to recurrent pattern. Prognostic factors associ-
ated with recurrence and survival on each groups were
evaluated using Cox proportional hazard models.
Results: The mean recurrence-free survival (RFS) after
HR for primary HCC was 39.4  4.7 months, com-
pared to 19.9  2.5 months after AT (p < 0.001). Fac-
tors affecting early recurrence after the secondary
therapy were female (p = 0.002), T2/3/4 of primary
HCC (p = 0.02), platelet count (p = 0.028) and tumor
size of recurrent HCC (p = 0.046) in the multicentric
recurrence group, and HR + AT for primary HCC
(p = 0.04) and tumor multiplicity of primary HCC
(p = 0.031) in the intrahepatic recurrence group. Multi-
variate analysis also identified that platelet count
(p = 0.012) and T3/4 of recurrent HCC (p < 0.001)
were associated with overall survival (OS) in the multi-
centric recurrence group, and that AT for primary
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HCC (p = 0.027), the Child-Pugh class B (p = 0.005)
and T3/4 of recurrent HCC (p < 0.001) were associated
with OS in the intrahepatic recurrence group.
Conclusion: AT has been more likely to cause intrahe-
patic recurrence. The first treatment for primary HCC
can strongly affect the prognosis in spite of the second-
ary treatment for recurrence.
APHPB-0348
USEFULNESS OF THE EVALUATION
OF PREOPERATIONAL LIVER
FIBROSIS BEFORE HEPATECTOMY
M. Ishii, O. Itano, M. Shinoda, M. Kitago, Y. Abe, H.
Yagi, T. Hibi and Y. Kitagawa
Surgery, Keio University, Tokyo, Japan
Objectives: To assess the dynamic liver function, we
investigated the new parameter of postoperative liver
failure.
Methods: Total of 66 patients were performed hepatec-
tomy in our Hospital by July, 2014 from May, 2013.
These people were examined by Fibroscan, ARFI US
(these US showed liver fibrosis), serous fibrosis marker,
the indocyanine green (ICG) clearance test, liver bio-
chemistry and coagulation profile before operation.
Results: These liver tumors included hepatocellular car-
cinoma in 23 patients, colorectal metastases in 20,
hepatic portal region bile duct cancer in eight, intrahe-
patic cholangiocarcinoma in seven, metastatic liver
tumor (other than colorectal cancer) in six and benign
tumor in two. There were 11 liver failure cases after the
operation in our Hospital (ISGLS classification A/B/
C = 6/5/0). The factors, type 4 collagen 7s (p < 0.001)
and PT-INR in preoperation (p = 0.038) showed clear
significant relationships with the outcome of liver fail-
ure in both univariate and multivariate models. ICG-15
clearance rate that is said to be useful in a liver func-
tion evaluation did not show the relationship
(p = 0.163) in univariate analysis. The score of ARFI
was marginally significant in univariate analysis, so it
was included in a secondary multivariate model
(p = 0.054).
Conclusion: Preoperative liver fibrosis is associated
with postoperative liver failure from the analysis in our
Hospital. The preoperative hepatic fibrosis evaluation
may be new parameter of preoperative liver function
that we decide operative method.
APHPB-0349
SURGICAL RESECTION VERSUS
ABLATION FOR HEPATOCELLULAR
CARCINOMA LESS THAN 3 CM: A
POPULATION BASED ANALYSIS
J. T. Miura, R. T. Groeschl, F. M. Johnston, S. Tsai,
K. K. Christians, K. K. Turaga and T. C. Gamblin
Surgery, Medical College of Wisconsin, Milwaukee, WI,
USA
Objectives: Ablation for ≤3 cm hepatocellular carci-
noma (HCC) has been demonstrated to be an effective
treatment strategy. Whether ablation achieves a similar
survival benefit as compared to surgical resection for
early stage HCC remains ill defined. The present study
sought to examine the outcomes of patients with ≤3 cm
HCC following ablation versus resection.
Methods: Patients treated by ablation or surgical resec-
tion for ≤3 cm T1 HCC were identified from the
National Cancer Database (2002–2011). Cox propor-
tional hazards models were used to assess overall sur-
vival (OS) between treatment types (ablation versus
resection) following adjustment for age, gender, alpha-
fetoprotein (AFP), Charlson Comorbidity Score, and
cirrhosis.
Results: A total of 2804 patients underwent ablation
(n = 1984) or resection (n = 820) for solitary
HCC ≤ 3 cm. The median age of the collective cohort
was 61 (IQR: 55–70) with the majority being male
(n = 1967, 70.1%). Patients treated with ablation as
compared to resection had a higher frequency in AFP
elevation (46.5% vs. 39.1%, p < 0.01) and presence of
cirrhosis (22.2% vs. 14.5%, p < 0.01). Unadjusted OS
at 3 and 5 years was greater following resection (67%,
55%) versus ablation (52%, 36%, p < 0.01). In multi-
variable models, resection was independently associated
with improved OS (HR: 0.65, 95% CI: 0.51–0.83;
p < 0.01).
Conclusion: While more invasive, resection of HCC
≤3 cm results in better long-term survival as compared
to ablation. Treatment strategies for small solitary
HCC should emphasize a resection first approach, with
ablation being reserved for patients precluded from
surgery.
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APHPB-0351
CAN WE PREDICT POST ERCP
PANCREATITIS? A PROSPECTIVE
STUDY IN A TERTIARY CARE CENTER
T. Samarasinghe, T. Wijeratne, B. D. Gamage, M. De
Silva, G. Nanayakkara and C. Alahakoon
Department of Surgery, Faculty of Medical Sciences,
University of Sri Jayewardenepura, Nugegoda, Sri
Lanka
Objectives: Accurate prediction of risk of complica-
tions can improve the safety of ERCP. Objectives of
this study were to describe the basic patient characteris-
tics and to identify the risk factors related to post
ERCP pancreatitis (PEP).
Methods: Prospective study with relevant ethical
approval of 246 consecutive patients undergoing ERCP
at a tertiary care center in Sri Lanka from 2012–2014
with regard to epidemiology, indications, outcomes and
PEP. Univariate and multivariate analysis of risk fac-
tors associated with post-ERCP pancreatitis (PEP)
using logistic regression was done using SPSS software.
Results: Our patients’ ages ranged from 21–85 years
(mean = 57.6 years). Majority 134 (54.5%) were males.
Commonest findings were biliary calculi (43.9%),
benign strictures (18.7%) and malignancies (16.3%).
There were no mortalities following procedure. PEP
which was the commonest post procedure complication
developed in 25 (10.2%) of the patients. Univariate
analysis of 16 described risk factors for PEP showed
statistical association only with male gender (p = 0.023)
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and contrast injections (p = 0.048). However multivari-
ate analysis revealed male gender (OR = 3.17; 95% CI
1.1–9.1), contrast injection (OR = 11.15; 95% CI 1.1–
109.9), presence of biliary stricture (OR = 7.38; 95%
CI 1.3–40.7) and balloon dilatation (OR = 4.85; 95%
CI 1.2–18.8) as significantly associated with develop-
ment of PEP. PEP was not associated with age, inad-
vertent pancreatic duct cannulation, previous ERCP or
abnormal ampulla in our cohort.
Conclusion: Some risk factors associated with PEP in
our study group were different from the previously
described risk factors for PEP in western populations.
Proper identification of risk factors using further multi-
center randomized studies with larger number of
patients will enable accurate prediction of complica-
tions in our population.
APHPB-0352
PANCREATIC ARTERIOVENOUS
MALFORMATION
S. Chou, Y. Shyr and S. Wang
Division of General Surgery, Department of Surgery,
Taipei Veterans General Hospital, Taipei, Taiwan
Objectives: Pancreatic arteriovenous malformation is
very rare, but may cause significant clinical symptoms
such as catastrophic bleeding. Herein, we discuss the
clinical presentation and management of pancreatic
arteriovenous malformations.
Methods: The data pool for the analysis was collected
from pancreatic arteriovenous malformation cases
encountered by our institution and sporadic case
reports in the English literature.
Results: A total of 89 cases of pancreatic arteriovenous
malformation were collected for this study, including
59 cases of arteriovenous malformation in the pancre-
atic head (62.3%) and 30 in the pancreatic body-tail
(33.7%). The most commonly associated complications
for overall cases of pancreatic arteriomalformation
were bleeding (50.6%), pancreatitis (16.9%), portal
hypertension (6.7%), and pseudocyst (3.4%). The most
common presenting symptom of pancreatic arteriove-
nous malformation was gastrointestinal bleeding
(47.2%), followed by epigastric pain (46.1%). Surgery
(43.8%) was the most common treatment for pancre-
atic arteriovenou malformation cases, followed by tran-
sarterial embolization (11.2%), a combination of
surgery and transarterial embolization (10.1%), and
radiotherapy (2.2%). No intervention was done for
29.2% of the cases of pancreatic arteriovenous malfo-
mation.
Conclusion: Pancreatic arteriovenous malformation
occurs most commonly in pancreatic head; gastrointes-
tinal bleeding is the main symptom. Surgical resection
or transarterial embolization appears to be indicated in
patients with symptomatic pancreatic arteriovenous
malformation.
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APHPB-0354
LONGTERM SURVIVAL AFTER
PANCREATICODUODENECTOMY FOR
PERIAMPULLARY
ADENOCARCINOMAS
S. Chen, S. Wang and Y. Shyr
General Surgery Department, Veterans General
Hospital, Taipei, Taiwan
Objectives: The aim of this study was to identify pre-
dictors for longterm survival following pancreaticoduo-
denectomy (PD) for pancreatic and other
periampullary adenocarcinomas.
Methods: Clinicopathological factors were compared
between short-term (<5 years) and longterm (more than
5 years) survival groups. Rates of actual 5-year and
actuarial 10-year survival were determined.
Results: There were 109 (21.8%) longterm survivors
among a sample of 501 patients. Patients with ampul-
lary adenocarcinoma represented 76.1% of the long-
term survivors. Favourable factors for longterm
survival included female gender, lack of jaundice, lower
blood loss, classical PD, absence of postoperative
bleeding or intra-abdominal abscess, non-pancreatic
primary cancer, earlier tumour stage, smaller tumour
size (≤2 cm), curative resection, negative lymph node
involvement, well-differentiated tumours, and absence
of perineural invasion. Independent factors associated
with longterm survival were diagnosis of primary
tumour, jaundice, intra-abdominal abscess, tumour
stage, tumour size, radicality, lymph node status and
cell differentiation. The prognosis was best for ampul-
lary adenocarcinoma, for which the rate of actual 5-
year survival was 32.8%, and poorest for pancreatic
head adenocarcinoma, for which actual 5-year survival
was only 6.5%.
Conclusion: The majority of longterm survivors after
PD for periampullary adenocarcinomas are patients
with ampullary adenocarcinoma. The longterm progno-
sis in pancreatic head adenocarcinoma remains dismal.
APHPB-0355
PANCREATICOJEJUNOSTOMY:
CONTINUOUS DUNKING TECHNIQUE
EXPERIENCE
R. Singh Bhandari and D. Joshi lakhey
Surgery, IOM, Kathmandu, Nepal
Objectives: Pancreaticoenteric anastomosis technique
used by pancreatic surgeons at Alfred, Melbourne
involves end to end dunking with continuous suturing.
This technique was applied by two surgeons following
pancreatic resections at Tribhuvan University Teaching
Hospital in Kathmandu, Nepal, one of whom had com-
pleted hepatopancreaticobiliary fellowship at Alfred.
We present our perioperative results of pancreatic
resections performed over two and half years period
with described technique.
Methods: Prospectively maintained database of patients
undergoing pancreatic resections between October 2011
to March 2014 was analyzed and all who had pancreatico-
enteric anastomosis performed by described technique
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were included. Reporting of complications was done in
accordance to definitions by ISGPS.
Results: Total 45 pancreatic resections requiring pan-
creaticoenteric anstomosis were performed. Total 30
patients had pancreaticoenteric anstomosis according
to the described technique and were analyzed. Total
87% had classical while two had pylorus preserving
and one central. Commonest indication was ampullary
(47%) followed by dudenal tumor (17%) then pancre-
atic (13%) and others (23%). Age ranged between 30
and 75 years. Only 2 underwent preoperative biliary
drainage. None recieved neoadjuvant while 47% reci-
eved adjuvant therapy. Octeotride was routinely used.
Overall, 90% had curative while 10% R1 resections.
Fistula rates (all grades) was 30% while clinically rela-
vant fistula rate was 10%. Two fulfilled the criteria for
DGE and both had PPPD. Incidence of PPH was 10%
and were successfully managed conservatively. Periop-
erative moratlity rate was 10%.
Conclusion: Continuous dunking technique of pancrea-
ticoenteric anastomosis following pancreatic resections
is simple and teachable technique which has been
adapted to achieve satisfactory outcomes at Tribhuvan
University Teaching hospital, Nepal.
APHPB-0356
EFFICACY OF ADJUVANT
CHEMOTHERAPY FOR COLORECTAL
LIVER METASTASIS BY THE CLINICAL
RISK SCORE
T. Nakai, H. Ishikawa, T. Tokoro, Y. Takeyama and
K. Okuno
Surgery, Kinki Unversity Faculty of Medicine, Osaka-
Sayama, Japan
Objectives: Efficacy of adjuvant chemotherapy after
hepatectomy of colorectal liver metastases (CRLM)
remains controversial. We investigated adjuvant chemo-
therapy for CRLM with the clinical risk score (CRS)
proposed by Fong et al. (Ann Surg 1999).
Methods: Patients with CRLM who were treated
between 1992 and 2012 were classified as having low
CRS (0–1), intermediate CRS (2–3), or high CRS (4–5).
The efficacy of adjuvant chemotherapy was retrospec-
tively analyzed in each CRS.
Results: 161 patients who underwent hepatectomy, 100
received adjuvant chemotherapy (group A) and 61 did
not (group N). In intermediate CRS, 5-year disease free
survival rates (DFS) was statistically significant differ-
ence between the groups (group A 33.9% vs. group B
23.2% p = 0.008) and 5-year overall survival rates (OS)
of group A was higher than group N (53.5% vs. 36.5%
p = 0.048). In low CRS and high CRS, 5-year DFS
and OS were similar between the groups, respectively.
Multivariate analysis of OS extracted major resection
(p = 0.05) for low CRS and adjuvant chemotherapy
(p = 0.05) for intermediate CRS. High CRS was not
identified prognostic factor.
Conclusion: Adjuvant chemotherapy for CRLM was
effective in intermediate CRS patients. In low CRS
patients, adjuvant chemotherapy is not necessary, ade-
quate surgical resection is important.
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APHPB-0357
A CASE OF INTRAHEPATIC ARTERIO-
PORTAL SHUNT WITH MASSIVE
ASCITES 7 YEARS AFTER LIVER
RESECTION
T. Yamaguchi, K. Hasegawa, T. Kokudo, N.
Akamatsu, J. Kaneko, T. Aoki, Y. Sakamoto, Y.
Sugawara and N. Kokudo
Hepato-Biliary-Pancreatic Surgery Division, Department
of Surgery, Graduate School of Medicine, The
University of Tokyo, Tokyo, Japan
Objectives: Arterio-portal shunt is a rare vascular dis-
order caused through trauma, iatrogenic procedures,
congenital vascular malformation, tumor, aneurysm.
Iatrogenic procedure includes surgical maneuver (such
as manual exploration, mobilization, and temporary
vessel occlusion) which occasionally causes tissue dam-
age and circulatory disturbance. We experienced a case
of successfully-treated arterio-portal shunt through
radiologic intervention.
Methods: A 78-year-old man, suffering from remark-
able weight gain (8 kg/month) was admitted to our
department. An abdominal ultrasound revealed massive
ascites. The patient had been regularly followed up
since liver resection for colorectal liver metastasis for
7 years without recurrence. A contrast-enhanced CT
revealed the left portal vein and the hepatic artery in
arterial phase, suggesting the presence of arterio-portal
shunt. Angiography of the left hepatic artery revealed
the left portal vein through the shunt. Since there were
no other causes for massive ascites, we suspected that
this arterio-portal shunt increased the portal pressure
and thus causing massive ascites.
Results: We occluded the shunt by interventional radi-
ology techniques, and the symptoms of portal hyper-
tension remarkably improved. He lost 8.3 kg of weight
during the 3 weeks after the embolization. The CT
imaging 3 months after embolization revealed signifi-
cant decrease of ascites.
Conclusion: The arterio-portal shunt in this case might
be related to the past surgical maneuvers. The shunt
had remained for 7 years without symptom, but portal
hypertension gradually developed and finally led to
massive ascites. During the follow-up patients of post
hepatectomy, the arterio-portal shunt should be always
kept in mind as one of causes of ascites.
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APHPB-0358
PREOPERATIVE VOLUME-BASED PET
PARAMETER MTV2.5 AS A POTENTIAL
SURROGATE MARKER FOR TUMOR
BIOLOGY AND RECURRENCE IN
RESECTED PANCREATIC CANCER
S. Lee1, C. Kang1, H. Hwang1, S. Choi1, J. Lee2 and
W. Lee2
1Department of Surgery, Yonsei University College of
Medicine, Seoul, Korea; 2Department of Nuclear
Medicine, Yonsei University College of Medicine, Seoul,
Korea
Objectives: This study aims to evaluate the role of vol-
ume-based PET parameters as potential surrogate
markers for tumor recurrence in resected pancreatic
cancer.
Methods: Between January 2008 and October 2012, the
medical records of patients who underwent surgical
resection for pancreatic ductal adenocarcinoma and
completed 18F-FDG PET/CT as part of a preoperative
staging work-up were retrospectively reviewed. Not
only clinicopathologic variables, but also PET parame-
ters, such as SUVmax, MTV2.5 (METABOLIC TUMOR VOL-
UME), and TLG (TOTAL LESION GLYCOLYSIS) were
obtained.
Results: Twenty-six patients were female and 31 were
male with a mean age of 62.9  9.1 years. R0 resection
was achieved in all patients. Forty-five patients (78.9%)
received postoperative adjuvant chemotherapy with or
without radiation therapy. Median overall disease-free
survival was 12.8 months with a median overall dis-
ease-specific survival of 25.1 months. SUVmax did not
correlate with radiologic tumor size (p = 0.501); how-
ever, MTV2.5 (p = 0.001) and TLG (p = 0.009) were
significantly associated with radiologic tumor size. In
addition, MTV2.5 (p < 0.001) and TLG (p < 0.001)
were significantly correlated with tumor differentiation.
There were no significant differences in TLG and SUV-
max according to LNR (lymph node ratio); only MTV2.5 was
related to LNR with marginal significance (p = 0.055).
In multivariate analysis, LNR (Exp(b)=2.425,
p = 0.025) and MTV2.5 (Exp(b)=2.273, p = 0.034) were
identified as independent predictors of tumor recur-
rence following margin-negative resection.
Conclusion: A preoperatively determined volume-based
PET parameter, MTV2.5, can potentially be used as a
surrogate marker to estimate tumor biology. Thus,
more effective treatment strategies for pancreatic cancer
can be determined based on the results of preoperative
MTV2.5.
APHPB-0359
RECOMBINANT ADENOVIRUS
ENCODING FAT10 SMALL
INTERFERING RNA INHIBITS HCC
GROWTH IN VITRO AND IN VIVO
C. Ping and C. Jingxiang
Hepatobiliary Surgery, Daping Hospital, The Third
Military Medical University, Chongqing, China
Objectives: To explore the effects on Hepatocellular
carcinoma by knocking down FAT10 expression in
Hepatocellular carcinoma cells.
Methods: Utilized adenovirus-mediated RNA interfer-
ence to knock down FAT10 expression in hepatocellu-
lar carcinoma cells and observed its effects on
hepatocellular carcinoma cell growth in vitro and in
vivo.
Results: Interference of FAT10 could inhibit cell prolif-
eration by inhibiting the cell cycle S-phase entry and
inducing cell apoptosis. In addition, in vivo experi-
ments showed that adenovirus Ad-siRNA/FAT10 sig-
nificantly suppressed tumor growth and prolonged the
lifespan of tumor-bearing mice.
Conclusion: Knock down of FAT10 by adenovirus-
delivered siRNA may be a promising therapeuticial
strategy for treatment of Hepatocellular carcinoma.
Transplantation
APHPB-0361
LONG-TERM OUTCOME OF
ISCHEMIA-TYPE BILIARY STRICTURE
AFTER ENDOSCOPIC TREATMENT IN
LIVER LIVING DONORS
S. Kim, H. Shin, G. Song, D. Jung, T. Ha, G. Park,
C. Ahn, D. Moon, K. Kim and S. Lee
Division of Hepatobiliary Surgery and Liver
Transplantation, Department of Surgery, Asan Medical
Center, Seoul, Korea
Objectives: The wall of normal proximal bile duct is
often thin with close approximation of the right hepatic
artery (RHA), thus isolation of RHA can result in
excessive thinning of the remnant proximal bile duct
wall during right liver graft harvest. This injury can
induce delayed stricture of the donor common bile
duct. This study intended to review the clinical course
of such ischemia-type donor bile duct injury which
were managed with endoscopic treatment.
Methods: A retrospective review of medical records
was performed with 4 donors who suffered from ische-
mia-type donor bile duct injury and followed up for
more than 5 years.
Results: A right liver graft was harvested from these 4
donors (incidence of 0.1%), whose mean age was
29.5  3.1 years and all were male. Bile duct anatomy
was normal bifurcation in 2 and anomalous branching
in 2. All of them recovered from donor surgery and
discharged uneventfully, but liver function abnormality
and/or subclinical left hepatic duct dilatation was iden-
tified 1–2 months after surgery. After imaging study
including magnetic resonance cholangiography, they
underwent endoscopic balloon dilatation and tempo-
rary stent [endoscopic retrograde biliary drainage
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(ERBD)] insertion. With ERBD tube change per
2 months, ERBD tubes were successfully removed after
4–6 month. On yearly follow-up for 5 years, none of
these patients showed any evidence of recurrence of bil-
iary stricture.
Conclusion: Based on our experience, endoscopic treat-
ment and subsequent long-term follow-up appears to
be an effective and reasonable treatment for ischemia-
type biliary stricture in liver living donors.
Benign HPB Diseases
APHPB-0362
ARE SYMPTOMATIC GALLSTONES
PROTECTIVE AGAINST H. PYLORI
INFECTION? A PROSPECTIVE TRIAL
E. Jeyarajan, A. Sebastian, M. Phegan and H. Puhalla
Surgery, Gold Coast University Hospital, Southport,
Qld, Australia
Objectives: H. pylori infection and symptomatic gall-
stones are both highly prevalent worldwide. Studies
suggest that global prevalence of H. pylori may exceed
50%. Previous studies postulate that the two diseases
may be causally related, but thus far studies are incon-
clusive. Some studies suggest that duodenogastric reflux
observed occasionally in symptomatic gallstones may
influence H. pylori infection rate. This study aims to
identify whether there is an increased risk of developing
H. pylori infection when duodenogastric reflux has not
been observed, in patients with symptomatic gallstones.
Methods: Patients referred to the Gold Coast Univer-
sity Hospital between 2013 and 2014 with symptomatic
gallstones were considered for inclusion. Patients with
atypical features were excluded, as well as patients with
significant comorbidities and age >75. Patients under-
went upper gastrointestinal endoscopy prior to chole-
cystectomy. Presence of duodenogastric reflux was
noted. Biopsies were taken at the gastroesophageal
junction and antrum for CLO test and histopathology.
Results: 36 patients were included at time of report.
H. pylori incidence was 11.1% (n = 4). Duodenogastric
reflux incidence was 30.6% (n = 11). In patients with
duodenogastric reflux (n = 11) no concomitant
H. pylori was observed, whilst those with confirmed
H. pylori infection (n = 4) demonstrated no duodenog-
astric reflux. The relative risk of H. pylori in patients
exposed to no duodenogastric reflux was 4.15, com-
pared to 0.24 in those with duodenogastric reflux.
Conclusion: Our data suggests that duodenogastric
reflux in symptomatic gallstones may be protective
against H. pylori infection. It has also revealed that
overall prevalence of H. pylori may be reduced in the
symptomatic gallstone population, when compared to
the overall population.
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APHPB-0363
UP DATED STATUS OF DECEASED
DONOR LIVER GRAFT ALLOCATION
FOR HIGH-URGENCY ADULT
PATIENTS IN A KOREAN HIGH-
VOLUME TRANSPLANTATION CENTER
S. Kim, S. Hwang, G. Song, D. Jung, T. Ha, G. Park,
C. Ahn, D. Moon, K. Kim and S. Lee
Division of Hepatobiliary Surgery and Liver
Transplantation, Department of Surgery, Asan Medical
Center, Seoul, Korea
Objectives: The number of deceased organ donors in
Korea was gradually increasing to reach 8 per million
population. This study intended to analyze the status
of urgent deceased donor (DD) liver transplantation
(LT) in Asan Medical Center.
Methods: A retrospective study was performed with
4-year study period of 2010–2013.
Results: During the study period, 328 adult patients
were enrolled for urgent LT as status 1 in 56 (17.1%)
and status 2A in 272 (82.9%). In status 1, liver grafts
were initially allocated to 33 (58.9%) and 6 were
excluded from LT due to clinical improvement (4 from
acute liver failure and 2 from initial graft dysfunction),
thus 27 (48.2%) actually underwent LT. In status 2A,
168 (61.8%) underwent LT within 2 weeks of priority
waiting period and only 5 of 104 patients who did not
receive LT survive to date. According to ABO blood
group of actual LT cases, the allocation probability
was in 66% (66 of 100) in group A, 58.6% (58 of 99)
in group B, 61.5% (24 of 39) in group AB and 52.2%
(47 of 90) in group O. Mean waiting period for LT was
5.7  2.1 days. During this period, urgency proportion
of living donor LT was <5% and a small number of
non-urgent patients underwent DDLT.
Conclusion: Deceased donor incidence around 8 per
million population contributed to meet the demand for
urgent DDLT with 60% probability, thus further
increase of deceased donor number is necessary to
improve organ shortage.
Benign HPB Diseases
APHPB-0364
THE VASOPRESSIN ANALOGUE
TERLIPRESSIN PROTECTS THE LIVER
FROM OXIDATIVE STRESS INDUCED
APOPTOSIS VIA THE WNT-BETA-
CATENIN-SGK1-FOXO3 PATHWAY
R. TAO1, X. Q. Liu1, T. H. Ma2, D. S. Huang1 and
X. Z. Lin3
1Hepatobiliary-Pancreatic Surgery, Zhejiang Provincial
People’s Hospital, Hangzhou, China; 2Zhejiang Institute
of Clinical Medicine, Zhejiang Provincial People’s
Hospital, Hangzhou, China; 3Radiology, Ruijin Hospital,
Shanghai Jiaotong University, Shanghai, China
Objectives: The synthetic vasopressin analogue, terli-
pressin, has been extensively used in the management
of certain complications associated with end-stage liver
diseases, however concerns have been raised regarding
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its impact on liver function. Study of a cohort of
patients unexpectedly identified significantly improved
hepatic function after use of terlipressin.
Methods: We therefore used both mouse nonlethal
hepatic ischemia-reperfusion (IR) model and hepatocyte
hypoxia-reoxygenation model to study the effect of ter-
lipressin on hepatic function as well as the underlying
mechanisms.
Results: Terlipressin administration either prior to lo-
betic pedicle occlusion or after reperfusion markedly
attenuated IR-induced liver apoptosis and necrosis,
hepatic MPO activity and proinflammatory gene
expression. Furthermore, terlipressin ameliorated apop-
tosis in HMGB1/ but not TLR4/ mouse livers
undergone IRI, suggesting such hepatoprotective effect
is TLR4- but not HMGB1-dependent. In vitro, the
active component of terlipressin, lysine vasopressin
effectively conferred hepatocyte resistant to oxidative
stress induced apoptosis. Mechanistic studies revealed
the vasopressin receptor engagement mediated calcium
influx and activation of the Wnt-b-catenin-SGK1 path-
way, which subsequently circumvented the proapoptot-
ic events driven by FoxO3 and AP-1 mediated
transcription of P27 and Bim, thus ameliorated hepato-
cyte apoptosis; while blockade of this signaling path-
way with small molecule compounds targeting V1R
(SR49059), calcium channels (Verapamil) or Wnt/b-
catenin (XAV-939) offset terlipressin’s hepatoprotective
effect. Finally, hemodynamic evaluation of murine
hepatic tissue after IR revealed terlipressin didn’t signif-
icantly alter the total hepatic blood flow in comparison
to control group.
Conclusion: Our study highlights the novel role of the
vasopressin signaling in protecting hepatocytes from
injury and has practical implications in both liver sur-
gery and transplantation.
APHPB-0365
ACUTE RESPIRATORY DISTRESS
SYNDROME AFTER
PANCREATODUODENECTOMY-RISK
FACTOR ANALYSIS
T. Yamaguchi, J. Kaneko, T. Kokudo, M. Shiozawa,
N. Akamatsu, T. Aoki, Y. Sakamoto, K. Hasegawa, Y.
Sugawara and N. Kokudo
Hepato-Biliary-Pancreatic Surgery Division, Department
of Surgery, Graduate School of Medicine, The
University of Tokyo, Tokyo, Japan
Objectives: Acute respiratory distress syndrome
(ARDS) after surgery is associated with a significant
mortality. It has not been established how to identify
patients at high risk for ARDS after abdominal sur-
gery.
Methods: We retrospectively analyzed postoperative
pulmonary complications and preoperative chest CT
scan images of 208 patients who underwent pancreato-
duodenectomy (PD) between January 2009 and May
2014 in a tertiary care Japanese hospital.
Results: Among 208 patients, 2 patients developed
postoperative fatal ARDS. Compared with the non-
ARDS group, the ARDS group had significantly higher
rates of asymptomatic interstitial pulmonary inflamma-
tion in the preoperative CT scan images (100% vs.
4.8%, p = 0.003). Among the 12 patients who showed
asymptomatic interstitial pulmonary inflammation,
serum KL-6 level was measured in 6 patients. Serum
KL-6 level was elevated (>500 U/mL) in 2 patients and
one out of these 2 patients developed ARDS after PD.
Conclusion: These data raise the possibility that the
interstitial pulmonary inflammation in preoperative CT
scan images is a risk factor of ARDS after PD.
Malignant HPB Diseases
APHPB-0366
PANCREATIC SOLID-
PSEUDOPAPILLARY NEOPLASM
DEVELOPED IN MALE: REPORT OF
TWO CASES
J. Sato, S. Yabuuchi, H. Karasawa, T. Morikawa, T.
Okada, F. Motoi, T. Naito, Y. Katayose and M. Unno
Department of Surgery, Tohoku University Graduate
School of Medicine, Sendai, Japan
Objectives: Pancreatic solid-pseudopapillary neoplasm
(SPN) is an uncommon tumor. It represents 3% of all
pancreatic tumors and is predominantly observed in
females (male : female ratio, 1 : 9).
Methods: We herein report two cases of pancreatic
SPN developed in male.
Results: Case 1: a 69-year-old male presented with
upper abdominal pain. Contrast-enhanced computed
tomography (CECT) showed delayed-enhanced solid
pancreatic head tumor. Endoscopic ultrasound-guided
fine-needle aspiration biopsy (EUS-FNAB) was per-
formed, and uniformly sized neoplastic cells with eosin-
ophilic cytoplasm were histologically observed. The
cells were positively stained for progesterone receptor,
b-catenin, and CD10, although chromogranin A and
synaptophysin were negative. Thus, the tumor was
diagnosed as a pancreatic SPN, and subtotal stomach-
preserving pancreaticoduodenectomy was performed.
Case 2: Pancreatic tail tumor was detected by CECT in
a 40-year-old male who had no symptom, and EUS-
FNAB was subsequently performed. The histological
findings were almost the same as those in Case 1.
Therefore, laparoscopic distal pancreatectomy was per-
formed with the diagnosis of pancreatic SPN. Both of
our cases are still alive with no evidence of recurrence.
Conclusion: Pancreatic SPN is generally considered to
be a low malignant potential tumor. However, the pre-
operative diagnosis had been difficult only in the
CECT. Recently EUS-FNAB has become popular and
a useful examination for the preoperative diagnosis of
pancreatic tumors. Although pancreatic SPN developed
in male is very rare, the prognosis is favorable and a
complete resection of the tumor is recommended under
the accurate preoperative diagnosis.
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APHPB-0367
COMPARISON OF DIAGNOSTIC
ACCURACY BETWEEN MDCT AND ERC
FOR LONGITUDINAL CANCER EXTENT
OF BILE DUCT CANCER
Y. Nakama1, R. Kawahara1, M. Yasunaga1, O. Koji1,
Y. Ishida2, Y. Okabe2, T. Tounan3, Y. Kuno3, M.
Nakayama4 and N. Yoshiki4
1Department of Surgery, Kurume University School of
Medicine, Kurume, Japan; 2Division of
Gastroenterology, Department of Medicine, Kurume
University School of Medicine, Kurume, Japan;
3Department of Radiology, Kurume University School of
Medicine, Kurume, Japan; 4Department of Pathology,
Kurume University School of Medicine, Kurume, Japan
Objectives: The purpose of the present study was to
compare the diagnostic accuracy of multidetector-row
computed tomography (MDCT) and endoscopic retro-
grade cholangiography (ERC) in the preoperative eval-
uation of the longitudinal spread of bile duct cancer
for curative resection.
Methods: Images obtained from MDCT and from
ERC of 26 patients with histopathologically proven bile
duct cancer were retrospectively interpreted. The longi-
tudinal cancer extent interpreted in MDCT and ERC
were coresponded to the histrogical findings of the re-
cected supecimens.
Results: The sensitivity and specificity of MDCT were
81% and 92%, respectively, and these of ERC were
88% and 92%. In both modarity, hilar margin is
tended to be overestimated. There is no difference
between MDCT and ERC in diagnostic accuracy for
longitudinal cancer extent.
Conclusion: Diagnostic reliability of ERC and MDCT
was equivalent. MDCT is a less invasive alternative
imagings over ERC in preoperative evaluation for
resectability.
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APHPB-0368
NEW SURGICAL PROCEDURE,
SPLENIC DEVASCULARIZATION IS AN
ALTERNATIVE PROCEDURE TO
SPLENECTOMY IN PATIENT WITH
HYPERSPLENISM SECONDARY TO
LIVER CIRRHOSIS
G. C. Park, S. Hwang, C. S. Ahn, D. B. Moon, T. Y.
Ha, G. W. Song, D. H. Jung and S. G. Lee
Surgery, Asan Medical Center, Seoul, Korea
Objectives: Hypersplenism occurs in patients with
chronic liver disease, and splenectomy is the definitive
treatment. In LT recipients, splenectomy is mainly per-
formed for the purpose of improving thrombocytopenia
due to hypersplenism, controlling portal vein pressure
in small-for-size syndrome, and/or immunotherapy for
ABO incompatibility. Splenectomy itself potentially has
disadvantages associated with multiple complications,
such as portal vein thrombosis, pancreatic leaks, bleed-
ing, and infection. Therefore, we considered splenic
devascularization to keep the effectiveness, but to avoid
complications of splenectomy.
Methods: Several complications after splenectomy
often occur. To avoid these complications, we consid-
ered splenic devascularization which means blocking
the inflow of spleen. This procedure includes splenic
artery ligation, and cutoff of the short gastric artery.
From August 2013 to January 2014, we performed 35
cases of splenic devascularization. The hematologic
parameters were evaluated before and after this proce-
dure.
Results: The mean follow-up period was 6 months.
There was marked improvement in platelet and leuko-
cytic counts, and the counts remained at appropriate
levels during the follow-up period. To date, no death
and severe complications related to procedure has been
reported. The data are sparse with regard to its long-
term outcomes, including hematologic response and
liver function after the surgery.
Conclusion: Splenic devascularization is an effective
therapeutic modality for the treatment of hypersple-
nism secondary to chronic liver disease. It is more sim-
ple and less complicated procedure than splenectomy,
and it allows preservation of adequate splenic tissue to
safeguard against overwhelming infection.
APHPB-0369
WARM DISSECTION IN LIVER GRAFT
HARVEST FROM DECEASED DONOR
D. Jung, S. G. Lee, S. Hwang, K. H. Kim, C. S. Ahn,
D. B. Moon, T. Y. Ha, G. W. Song, G. C. Park, Y. I.
Yoon and W. J. Kim
Surgery, Asan Medical Center, University of Ulsan
College of Medicine, Seoul, Korea
Objectives: In the early days of organ procurement,
exposure and complete dissection of each organ was
preferred while the heart was still beating. Recently
most dissection for liver harvest from deceased donor
was performed by cold dissection technique. However,
there were few reports about safety of cold or warm
dissection technique. Herein, we share experience of
our warm dissection technique.
Methods: Our center performed 262 cases of deceased
donor liver transplantation from January 2010 to Octo-
ber 2013. In this study, we excluded cold dissection,
split liver transplantation and pediatric liver transplan-
tation. We included warm dissection in adult by one
experienced surgeon.
Results: Total enrolled cases of warm dissection in
organ harvest from deceased donor were 146. Paren-
chymal injuries were detected in 7 cases (6 capsular
tear, 1 subcapsular hematoma). Vascular injuries were
detected in 6 cases. There were 6 cases of arterial injury
(5 Celiac axis, 1 Common hepatic artery). There was
no right hepatic artery or left hepatic artery injury,
venous and portal injury. Also, there was no bile duct
injury.
Conclusion: Warm dissection is safe and also has
advantage in donors whose liver are of a questionable
quality by decreasing cold ischemic time.
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APHPB-0370
PRE-OPERATIVE ASSESSMENT OF
MUSCLE MASS TO PREDICT
PROGNOSIS IN PATIENT WITH
HEPATOCELLULAR CARCINOMA
R. Kubota, T. Kumamoto, K. Takeda, F. Asano, Y.
Sawada, Y. Ota, Y. Homma, R. Mori, R. Matsuyama,
H. Akiyama and I. Endo
Gastroenterological Surgery, Yokohama City University,
Yokohama, Japan
Objectives: This study aimed to examine the impact of
sarcopenia on survival outcomes in patients with hepa-
tocellular carcinoma (HCC) after hepatectomy. Sarco-
penia is the degenerative loss of skeletal muscle mass
quality, and strength.
Methods: A retrospective review of 149 HCC patients
who underwent hepatectomy from 2007 to 2013 in
department of gastroenterological surgery, Yokohama
City University. Sarcopenia was assessed on pre-opera-
tive computed tomography (CT) scan by measurement
of the skeletal muscle. We analysed the relationship
between sarcopenia and, overall survival rate, recur-
rence free survival rate, peri-operative laboratory data,
surgical, and histopathological factors.
Results: Sarcopenia was present in 46 (30.8%) of 149
patinets. Pre-operative laboratory data showed white
blood cell count, pre-albumin, albumin was signifi-
cantly lower in the patients with sarcopenia than with-
out sarcopenia. In patients with sarcopenia and
without sarcopenia, the 5 –year overall survival rate
was 69.4% and 44.8% respectively. Overall survival
rate was significantly lower in patients with sarcopenia
(p = 0.026).
Conclusion: The nutritional status and the prognosis of
the patients with sarcopenia, was poor. Therefore
intensive nutrition intervention is necessary for the
patients with sarcopenia.
Transplantation
APHPB-0371
DONOR SAFETY AND RECIPIENT
LIVER FUNCTION FOLLOWING
RIGHT-LOBE LIVER
TRANSPLANTATION FROM DONOR
WITH GILBERT SYNDROME
W. Kang, S. Hwang, G. Song, D. Jung, K. Kim, G.
Park, T. Ha, C. Ahn, D. Moon and S. Lee
Division of Hepatobiliary Surgery and Liver
Transplantation, Department of Surgery, Asan Medical
Center, Seoul, Korea
Objectives: Donor safety is the most important point
of living donor liver transplantation (LDLT). Gilbert
syndrome is an autosomal recessive condition that is a
common cause of non-hemolytic unconjugated hyperbi-
lirubinemia, and its prevalence is not negligibly low in
healthy population. Gilbert’s syndrome can be classed
as a minor inborn error of metabolism. This study
intended to assess donor safety and recipient liver func-
tion following right-lobe LDLT from donor with
Gilbert syndrome.
Methods: Among 2140 right-lobe graft donors per-
formed between 2002 and 2011, we identified 12 donors
(0.6%) who showed serum total bilirubin level > 2 mg/
dL. They were clinically diagnosed of Gilbert syn-
drome, but genetic mutation study was not performed.
Results: Mean donor age was 24.6 years (range: 18–44)
and 11 were male. All met the preoperative evaluation
conditions of right liver donation except for unconju-
gated hyperbilirubinemia. Serum total bilirubin level of
donors was 2.3 mg/dL (range: 2.0–2.5) before surgery
and 2.2 mg/dL (range: 1.6–4.7) at 1 year after surgery.
Preoperative direct bilirubin level was 0.4 mg/dL
(range: 0.2–0.7). Preoperative indocyanine green reten-
tion rate at 15 min was 8.3% (range: 0.2–15.8). All
donors recovered uneventfully following right-lobe
graft donation. All recipients recovered uneventfully
and are alive to date with serum total bilirubin level of
normal limit except one recipient.
Conclusion: LDLT with donors of Gilbert syndrome
can be safely performed, but special attention should
be paid for meticulous preoperative evaluation.
Malignant HPB Diseases
APHPB-0372
SURGICAL TREATMENT FOR THE
DISTANT METASTASIS DERIVED
FROM IPMC. 2 CASES REPORT
G. Akasu, M. Suzuki, K. Shinozaki, Y. Iwasaki and Y.
Mihara
Surgery, Asakura General Hospital, Asakura, Japan
Objectives: Several studies reported that patients with
invasive carcinoma derived from IPMN (invasive
IPMC) have a same poor prognosis as those with pan-
creatic ductal carcinoma. We report 2 cases experience
that underwent surgical treatment for the distant
metastasis derived from invasive IPMC, and get long-
term survival.
Case 1: A 62-year-old man who underwent distal pan-
createctomy for invasive IPMC in pancreas tail in July
2007. Abdominal CT detected a metastatic lesion in the
left subdiaphragm in June 2008. The metastatic lesion
got larger and the tumor marker increased, though che-
motherapy and radiotherapy had been performed for
the lesion.
Case 2: A 72-year-old woman who underwent distal
pancreatectomy for invasive IPMC in pancreas tail in
November 2011. Cervical CT detected a metastatic
lesion to the left supraclavicular lymph node in Septem-
ber 2013. In this case, it was difficult to continue che-
motherapy, since the side effect of chemotherapy was
strong.
Methods: Case 1: CT and PET detected no other recur-
rence or metastatic lesion, tumor resection was per-
formed in January 2010.
Case 2: CT and PET detected no other recurrence or
metastatic lesion, lymphoidectomy was performed in
February, 2014.
Results: Case 1: Now, the patient is still alive with no
recurrence or metastasis after the tumor resection.
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Case 2: Now, the patient is still alive with no
recurrence or metastasis after the lymphoidectomy.
Conclusion: Surgical treatment could be provided a
long-term survival for patients with distant metastasis
derived from invasive IPMC after initial surgery.
APHPB-0373
THE POTENTIAL OF DEATH
RECEPTOR 5 EXPRESSION AS AN
INDICATOR OF TARGETED THERAPY
IN GALLBLADDER CANCERS
B. Kim1, J. Sung1, C. Nam1, Y. Nah2, H. Choi2 and S.
Jung2
1Surgery, Ulsan University Hospital, Ulsan, Korea;
2Pathology, Ulsan University Hospital, Ulsan, Korea
Objectives: The death receptor (DR)5 has been studied
extensively in cancer cells recently, because of the abil-
ity of the tumor necrosis factor-related apoptosis-induc-
ing ligand (TRAIL) to kill malignant cells selectively.
Endothelial cells within tumor blood vessels can also
selectively express DR5. DR5 activation in tumor endo-
thelial cells induces apoptotic death thereby compro-
mising vascular integrity and causing vessel congestion,
intratumoral hemorrhage, decreased vascular density,
and diminished tumor growth. But these are very little
known in gallbladder cancers.
Methods: We investigated the expression of DR5 by
immunohistochemistry and its prognostic significance
in 102 cases of resected gallbladder cancers.
Results: DR5 immunoexpression is not associated with
clinical parameters. But more strong stained the cancer
cells are likely to DR5 immunostain on vascular endo-
thelial cells in tumor. In Gallbladder cancer cell, DR5
was expressed as ‘high’ in 58 among total 102 patients.
In tumor endothelial cell, DR5 was expressed in 34
among total 102 patients. 27 patients among the 34
patients also revealed as high DR expression in gall-
bladder carcinoma cells. There was a significant statisti-
cal correlation between degree of DR5 expression in
gallbladder cancer cells and DR5 expression of tumor
endothelial cells (p = 0.002). This result suggests that
when DR5 is expressed as high in gallbladder cancer
cell, the probability of DR5 expression in tumor endo-
thelial cells is increased.
Conclusion: Our study suggests that DR5 has signifi-
cance as an indicator when considering target therapy
or predicting the response. But this study has limitation
of retrograde cross sectional study. Additional research
including DR and TNF superfamily is needed through
a systemic approach.
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APHPB-0374
ROLE OF ENDOSCOPIC SCREENING
FOR DE NOVO GASTRIC CANCER IN
KOREAN LIVER TRANSPLANT
PATIENTS
W. Kang, S. Hwang, C. Ahn, K. Kim, D. Moon, G.
Song, D. Jung, G. Park, S. Kim and S. Lee
Division of Hepatobiliary Surgery and Liver
Transplantation, Department of Surgery, Asan Medical
Center, Seoul, Korea
Objectives: De novo malignancy is not uncommon
after LT. Gastric cancer is one of the most common
malignancy in Korean general population as well as in
Korean LT recipients.
Methods: Among 3300 adult recipients who performed
LT from January 1999 and December 2012, we identi-
fied 26 cases of gastric cancer through routine cancer
screening with GFS and imaging studies.
Results: Mean patient age was 55 years (range: 44–65)
and male were 24patients. After a mean period of
60 months posttransplantation (range: 6–128 months),
26cases of de novo gastric cancer was detected through
routine endoscopic screening with imaging studies in 17
and work-up with clinical symptoms in 9. Routine
screening found early gastric cancer in 14 and advanced
gastric cancer in 4. Of them, 8 underwent endoscopic
mucosal resection and 10 did open surgery including
one case of repeat resection after EMR. In contrast, in
8 patients with symptoms, only one had early gastric
cancer. EMR was performed in 2 patients, but they
underwent repeat surgery due to AGC. Other 6
patients underwent open surgery and one received palli-
ative stenting only. No significant surgical complication
occurred after cancer treatment. Systemic chemother-
apy was given to 4 patients with AGC. Two patients
currently administer immunosuppresants including m-
TOR inhibitor. Overall 3-year patient survival rate
after gastric cancer diagnosis was 80.8%.
Conclusion: LT recipients must be checked periodically
for various de novo malignancies throughout their
lives, especially for cancers common in the general pop-
ulation. Annual-to-biannual endoscopic screening
depending on stomach status contributed to detection
of EGC, by which survival outcome would be
improved.
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APHPB-0375
TIF1G PLAYS A PROTECTIVE ROLE IN
THE PROCESS OF LIVER CIRRHOSIS
J. Zhao1, Z. Ding1, J. Wang2, W. Zhang1, H. Liang1,
W. E. I. Wang1, W. Chen1, Y. Sun1, B. Zhang1 and X.
Chen1
1Hepatic Surgery Centre, Tongji Hospital Affiliated to
Tongji Medical College HUST, Wuhan, China;
2Department of Gastroenterology, Tongji Hospital
Affiliated to Tongji Medical College HUST, Wuhan,
China
Objectives: The process of liver cirrhosis that is life-
threatening, is ambiguous. TIF1c, a RBCC/TRIM family
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protein, is well-known to exert its function on embryonic
development, hematopoiesis and maturation of immune
cells, and involves in TGFb pathway which is associated
with hepaticfibrosis. However, the relationship between
TIF1c and liver cirrhosis is largely unknown. This study
aims to illuminate the role of the TIF1c plays in the pro-
cess of liver cirrhosis.
Methods: In vitro, TIF1c was knocked out and overex-
pressed in AML-12 murine hepatocytes, which were
stimulated by TGFb1 separately. EMT was determined
by Western blot and immuofluorescence (IF); the pro-
liferation and apoptosis assays were measured by cck-8
and FACS respectively. In vivo, the expression of
TIF1c, TGFb1 and other factors were assessed by IHC
in human liver cirrhosis tissues and mouse liver cirrho-
sis tissue induced by CCl4.
Results: In vitro, the EMT was apparently impaired in
TIF1c-overexpressed AML-12 cells, but facilitated in
TIF1c-knockdown AML-12 cells. Simultaneously, we
observed that TIF1c has the ability to reverse the effect
of proliferation inhibition and apoptosis induced by
TGFb1. The vivo experiment is now in process.
Conclusion: The results demonstrates that TIF1c plays
a protective role in the process of liver cirrhosis.
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APHPB-0376
DYNAMIC CHANGES OF
IMMUNOCYTES IN SPLEEN DURING
THE PROGRESSION OF MURINE
LIVER CANCER
B. Li1, S. H. U. Zhang1, N. A. Huang1, H. Chen1, P.
Wang2, J. U. N. Li1, Y. Pu2, F. Ji3 and Z. Li2
1National & Local Joint Engineering Research Center of
Biodiagnosis and Biotherapy, The Second Affiliated
Hospital, College of Medicine, Xi’an Jiaotong
University, Xi’an, China; 2General Surgery, The Second
Affiliated Hospital, College of Medicine, Xi’an Jiaotong
University, Xi’an, China; 3Infective Diseases, The
Second Affiliated Hospital, College of Medicine, Xi’an
Jiaotong University, Xi’an, China
Objectives: To explore the dynamic changes of immu-
nocytes in spleen during tumor progression.
Methods: Orthotopic hepatocellular carcinoma (HCC)
was established in BALB/c mice, the spleens of normal
mice and tumor-bearing mice were collected on day 7,
14 and 19 respectively, 106 splenocytes were resus-
pended for further staining. The splenocytes were
stained with CD16/CD32 antibody for FcR blocking,
then stained with Gr-1, CD11b, CD3, CD4, CD8a,
CD49b, CD25 and foxp3 antibody, respectively. The
percentages of MDSC, CD3+ T cell, CD3+CD4+
T cell, CD3+CD8+ T cell, NK cell, Treg cell were
analysed using flow cytometry.
Results: CD3+CD4+ T cell, CD3+CD8+ T cell and
total CD3+ T cell were decreased on day 14
(30.63  2.34% vs. 36.42  4.35%, 14.48  0.86% vs.
17.28  1.72%, 47.28  2.80% vs. 54.77  6.19%,
respectively). While the ratio of CD4+/CD8+ T cell was
not changed during tumor progression. NK cells were
decreased on day 14 (2.00  1.08%) and day 19 (1.40 
0.46%) compared to normal mice (4.55  0.98%). The
percentage of MDSC was increasing during the progres-
sion of HCC (7 days: 4.83  1.10%; 14 days:
9.53  5.48%; 19 days: 9.93  3.67% vs. normal:
2.15  1.24%). Treg cells in spleen were elevated on day
14 (15.43  2.45%), but declined on day 19
(2.78  1.00%) compared to normal spleen
(9.95  1.39%).
Conclusion: T cells and NK cells were decreased in
tumor-bearing mice. Treg and MDSC cells, both have
immune suppressive function, were increased in HCC.
It is indicated the spleen play a negative role during the
progression of murine liver cancer.
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APHPB-0377
LARGE CHOLEDOCHOLITHIASIS IN
ELDERLY – NON OPERATIVE
MANAGEMENT WITH BILIARY
STENTING, TREATMENT OF STENT
COMPLICATIONS AND COMPLICATED
WITH GALLSTONE ILEUS BY STONES
WITH STENT IN-SITU
K. V. Tay and A. Shaik
General Surgery, NUH, Singapore City, Singapore
Objectives: To report a case of large choledocholithisis
in an elderly lady treated with biliary stenting initially
and complicated by stent blocked and rooted in com-
mon bile duct (CBD) due to defaulted follow up, man-
agement and later on complicated with gallstone ileus.
Methods: Paitent is a 86-year-old lady who has multi-
ple comorbidities presented with gallstone disease since
2004. She had cholangitis due to large CBD stone
(2 9 2 cm) hence underwent ERCP and biliary stent
insertion in 2010. Multipe stone extraction attempts
were failed and she refused surgical intervention at that
point of time due to age and risks. She remained well
but she defaulted subsequent follow up and represented
with blocked stent in 2013. Stent exchange was failed
due to chronic placement hence another stent inserted
to decompress the bile duct.
Results: Patient underwent routine stent exchange since
after and remained asymptomatic. Unfortunately she
represented with gallstone ileus and underwent emer-
gency laparotomy to remove the stones. Intra op we
found multiple large gallstones and noted one of the
large stone with stent in-situ.
Conclusion: Conservative management of large chole-
docholithiaisis via biliary stenting can be a feasible
option for elderly with multiple comorbidities. How-
ever, routine stent replacement should be keep in mind
to prevent stent complications.
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APHPB-0380
UPREGULATION OF MIR-128 IN THE
PATHOGENESIS OF HPATOCELLULAR
CARCINOMA
C. Cho, C. Kim, E. Park, H. Kim, D. Park, Y. Koh,
Y. Hur, S. Yoon and H. Kim
Surgery, Chonnam National University Medical School,
Gwangju, Korea
Objectives: microRNAs (miRNAs) are endogenous
non-coding 21–23 nucleotide RNAs that are involved
in post-transcriptional regulation and they control vari-
ous cellular processes, one of which is tumorigenesis.
miRNAs were reported to be implicated in the patho-
genesis of hepatocellular carcinoma (HCC) and the aim
of this study is to evaluate the role of miRNAs in the
development of HCC.
Methods: To find yet-to-be-identified miRNAs associ-
ated with HCC tumorigenesis, we carried out miRNA
microarray analysis with miRNAs extracted from nor-
mal and HCC liver tissues resected from same patients.
Of the miRNAs showing significantly different expres-
sion levels between normal and HCC liver tissues, we
focused on miR-128. The difference in expression levels
of miR-128 was verified by real-time PCR. In addition,
the target gene of miR-128, axin1, was determined by
bioinformatics study, luciferase assay and Western blot-
ting.
Results: Four pairs of liver tissues were selected for
RNA extraction. miRNA microarray and FDR calcula-
tion were performed and four genes were selected due
to the previous report on their correlation with HCC.
The results of luciferase assay and transfection of
HepG2 cells indicated that miRNA-128 indeed binds to
the 30 UTR of Axin1. In Western blotting miR-128
indeed decreased Axin1 protein levels, demonstrating
that Axin1 is a target of miR-128 in HepG2 cells.
Conclusion: In our study miR-128 is up-regualted in
clinical HCC tissues and miR-128 binds to 30 UTR of
Axin1. The identification of miR-128 as oncomir and
determination of its target gene Axin 1 will shed light
on the pathogenesis of HCC.
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DIFFERENTIAL EXPRESSION OF
CYTOKINES IN MACROPHAGES OF
RAT SPLEEN IN THE PRESENCE OF
LPS
Y. Zhang1, R. U. I. Zhou1, H. Zhu1, Z. Zhang1, Y. U.
Li1, A. N. Jiang1, P. Wang1, Z. Li1 and S. H. U.
Zhang2
1General Surgery, The Second Affiliated Hospital,
College of Medicine, Xi’an Jiaotong University, Xi’an,
China; 2National & Local Joint Engineering Research
Center of Biodiagnosis and Biotherapy, The Second
Affiliated Hospital, College of Medicine, Xi’an Jiaotong
University, Xi’an, China
Objectives: To identify the differentially expressed cyto-
kines from macrophages of Rat spleen in the absence
and presence of lipopolysaccharide (LPS) conditions.
Methods: Macrophages were isolated and purified from
spleen by anchoring cultivation. The supernatants were
harvested in the absence and presence of LPS and
detected by the AAR-BLG protein chip technology.
Results: Totaling 90 cytokines were identified to be
detected by the chips, and 19 cytokines showed differ-
ential expression in the chips, most of them are cyto-
kines associated with monocytes chemotaxis and
macrophages activation, such as MCP-1, IL-10,
CXCR4, CCR4, IP-10, and so on. In addition, cyto-
kines associated with angiogenesis, fibrosis and tissue
remodeling up-regulate, such as MIF, IL-3, IL-4,
CD106, and so on. Cytokines associated with regula-
tion of neuron growth, development, such as, b-NGF,
GFR-alpha, cytokines associated with inflammation,
such as IL-6, MIP-1, MIP-2, IL-1b, IL-1, R6/IL-1,
Rrp2, and so on.
Conclusion: Cytokines are significant differential
expression in the absence and presence of LPS condi-
tions by the AAR-BLG protein chip. Differential
expression of cytokines may be new clues for inflamma-
tory reaction of macrophages and immune response of
spleen.
APHPB-0382
EFFECTS OF SPLENECTOMY ON THE
PROCESS OF LIVER REPAIR AND
REGENERATION IN A RAT MODEL OF
ACUTE HEPATIC INJURY
H. Zhu1, J. Lv2, S. H. U. Zhang3, Z. Zhang1, R. U. I.
Zhou1, C. H. E. N. Zhang3, J. U. N. Yan3, C. H. E.
N. Huang3 and Z. Li1
1General Surgery, The Second Affiliated Hospital,
College of Medicine, Xi’an Jiaotong University, Xi’an,
China; 2Nursing, The Second Affiliated Hospital,
College of Medicine, Xi’an Jiaotong University, Xi’an,
China; 3National & Local Joint Engineering Research
Center of Biodiagnosis and Biotherapy, The Second
Affiliated Hospital, College of Medicine, Xi’an Jiaotong
University, Xi’an, China
Objectives: To study the effects of splenectomy on the
liver repair and regeneration in the SD rat model of
acute hepatic injury induced by CCl4, and explore the
role of spleen in the process of liver regeneration.
Methods: Rats were divided into four experimental
groups: A, normal control; B, CCl4 group; C, splenec-
tomy + CCl4 group; D, sham operation + CCl4 group.
All rats were sampled at the appointed time (24 h,
72 h, 7 days, and 14 days post intraperitoneal injection
of CCl4). Serum liver enzyme and HE staining were
applied for evaluating the improvement of hepatic his-
tological damage. The expression of proliferating cell
nuclear antigen (PCNA) of liver tissues was detected by
western-blot.
Results: At 24 h, extensive macrovesicular fatty change
in the midzonal lobe with some hepatocellular necrosis
and inflammation were observed in group B and D; the
liver was fully recovered with normal histology in
14 days post CCl4 injection. In contrast, the rats in
group C exhibited much more rapid liver regeneration
(7 days). The liver function of group C was also
improved markedly as compared with the B and D
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groups. Little expression of PCNA was detected in the
group A. In group C, the protein level of PCNA was
increased significantly at 24 h, then was decreased at
72 h, and was recovered to the normal level at 7 days.
The up-regulated expression of PCNA in group B and
D was observed at 72 h, and then was down-regulated
slowly.
Conclusion: Splenectomy enhances the liver repair and
regeneration after acute hepctic injury, indicating that
spleen may play an important regulatory role in the
process of liver regeneration.
APHPB-0383
BAICALEIN IMPROVES
DYSREGULATION OF THE
INFLAMMATORY RESPONSE AND
LYMPHOCYTE APOPTOSIS IN A RAT
MODEL OF POLYMICROBIAL SEPSIS
H. Chen1, J. U. N. Li1, S. Rui2, N. A. Huang1, J. U.
N. Yan1, F. Ji3, Z. Li2 and J. Li4
1National & Local Joint Engineering Research Center of
Biodiagnosis and Biotherapy, The Second Affiliated
Hospital, College of Medicine, Xi’an Jiaotong
University, Xi’an, China; 2General Surgery, The Second
Affiliated Hospital, College of Medicine, Xi’an Jiaotong
University, Xi’an, China; 3Infectious Diseases, The
Second Affiliated Hospital, College of Medicine, Xi’an
Jiaotong University, Xi’an, China; 4Infection Control,
The Second Affiliated Hospital, College of Medicine,
Xi’an Jiaotong University, Xi’an, China
Objectives: Dysregulation of the inflammatory response
and lymphocyte apoptosis are key reasons for the high
mortality rate in sepsis. Baicalein, as a traditional Chi-
nese medicine, has more biological characteristics
including anti-inflammatory and anti-apoptotic. There-
fore this study was designed to investigate the thera-
peutic efficacy of baicalein in polymicrobial sepsis.
Methods: Sepsis was induced in Sprague-Dawley rats
via cecal ligation and puncture (CLP). Rats were
injected with saline or baicalein (10 mg/kg, intrave-
nously) after CLP and sepsis investigated at three time
points (6, 12 and 24 h after surgery). Survival, bacterial
clearance, changes in T lymphocyte subsets, lymphocyte
apoptosis, blood cytokine production and tissue dam-
age were evaluated.
Results: Baicalein treatment significantly improved
survival of septic rats and decreased the bacterial
burden, which was also associated with moderate tissue
damage. Compared with the CLP alone group, rats
treated with baicalein had increased proportions of
CD3+CD4+ helper T cells in the blood at 6, 12 and
24 h and a higher ratio of CD4+/CD8+ T cells at 6 h
after surgery. Baicalein also dramatically raised apopto-
sis of lymphocyte at 6 h but attenuated at 24 h. The
levels of TNF-a were significantly decreased at all time
points investigated in the CLP + baicalein group versus
CLP alone, while IL-6 was significantly decreased only
at 24 h. Corresponding to this anti-inflammatory effect
of baicalein, the levels of IL-10 were significantly
increased at 24 h.
Conclusion: Baicalein may be an effective immunomod-
ulator to combat immune dysregulation in the rat CLP
model of polymicrobial sepsis.
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BAICALEIN PROTECTS AGAINST
PANCREATIC INJURY IN RATS WITH
SEVERE ACUTE PANCREATITIS BY
INHIBITING PROINFLAMMATORY
CYTOKINE EXPRESSION
J. U. N. Li1, J. Qi2, A. Zhang2, T. I. N. G. Tan2, B.
Bie1, G. Wang1, H. Chen1, H. Liu3 and Z. Li2
1National & Local Joint Engineering Research Center of
Biodiagnosis and Biotherapy, The Second Affiliated
Hospital, College of Medicine, Xi’an Jiaotong
University, Xi’an, China; 2General Surgery, The Second
Affiliated Hospital, College of Medicine, Xi’an Jiaotong
University, Xi’an, China; 3Nursing, The Second
Affiliated Hospital, College of Medicine, Xi’an Jiaotong
University, Xi’an, China
Objectives: Inflammatory cytokines play an important
role in the pathogenesis of severe acute pancreatitis
(SAP). Systemic inflammatory response syndrome and
the development of multiple organ failure are the main
reasons for a high mortality rate in SAP. Elevated
serum levels of interleukin (IL)-6 and tumor necrosis
factor (TNF)-a are reliable markers of SAP severity. In
our study, a natural flavonoid Baicalein was evaluated
in vivo in a rat model of SAP.
Methods: Rat SAP was induced by retrograde injection
into the common biliopancreatic duct of 5% sodium
taurocholate. The rats with pancreatitis were intrave-
nously injected with or without Baicalein immediately
after SAP induction. The 12-h mortality was deter-
mined by counting the surviving and dead rats. The
scites fluid volume was measured by the difference of
dry/wet gauze weight. Amylase activity and proinflam-
matory cytokine production were assessed by spectro-
photometry and ELISA. Histopathology score was
evaluated by HE stain.
Results: The SAP rats treated with sodium taurocho-
late exhibited pancreatitis-like histopathology changes
and showed increased fluid production, amylase activity
and proinflammatory cytokine expression. When pre-
treated with Baicalein, above dysfunction induced by
sodium taurocholate were attenuated.
Conclusion: Baicalein attenuated the severity of SAP
by reducing the production of proinflammatory media-
tors and inhibiting pancreatic injury. Baicalein could
therefore be a promising novel therapeutic agent in
patients for the treatment of SAP.
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APHPB-0385
SURGICAL MANAGEMENT OF
CHOLEDOCHOLITHIASIS – OUR
EXPERIENCE FROM A TERTIARY
CARE CENTRE
B. Santhanamuthukrishnan, R. Prabhakaran, A.
Amudhan, D. Benet, S. M. Chandramohan and D.
Kannan
Surgical Gastroenterology, Madras Medical College,
Chennai, India
Objectives: Operative outcome, recurrence rate of CBD
stones, and long-term bile duct complications of surgi-
cally managed CBD stones.
Methods: A retrospective review of 100 cases who
underwent treatment for CBD stones in our institution
from the period of April 2012 to March 2014 was con-
ducted. All modality of managements are studied.
Operative outcome, recurrence rate of CBD stones, and
long-term bile duct complications were analyzed.
Results: Total number of cases are 100. Out of which
44 patients underwent choledochoduodenostomy. Three
patients underwent LC + LCBDE. Thirty one patients
were underwent ERCP and followed by laparoscopic
cholecystectomy. Thirteen patients underwent open
cholecystectomy, CBD exploration and ‘T’ tube drain-
age. Four patients underwent OC + CBD exploration
and primary CBD closure. Laparoscopic cholecystec-
tomy followed by ERCP done for 2 patients. Hepatico
jejunostomy was done in 6 patients. Surgical site infec-
tion was developed in 24 pts, cholangitis in 12 pts.
ERCP induced pancreatitis in 3 pts, perforation in 2
pts. There are 7 deaths mainly due to cholangitis and
MODS. During the period of follow up none of our
patients developed recurrent CBD stones or other
major complications.
Conclusion: LC + LCBDE is treatment of choice for
uncomplicated CBD stones. Dilated CBD >15 mm or
impacted stones warrants drainage procedure. Cholan-
gitis is the main indication for two stage procedure.
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APHPB-0386
DECREASED PREOPERATIVE SERUM
TOTAL CHOLESTEROL PREDICTS
RESECTABILITY OF
HEPATOCELLULAR CARCINOMA
WITH NON-B NON-C LIVER
CIRRHOSIS
Y. Shirai, H. Shiba, T. Horiuchi, R. Iwase, K. Haruki,
Y. Fujiwara, K. Furukawa, Y. Futagawa and K.
Yanaga
Surgery, Jikei University School of Medicine, Tokyo,
Japan
Objectives: The leading causes of liver cirrhosis with
hepatocellular carcinoma (HCC) are hepatitis B and C
virus infection. Recently, patients with non-B non-C
HCC have increased. In patients with HCC with associ-
ated non-alcoholic fatty liver disease (NAFLD), dis-
crepancy of histopathological degree of liver damage
differ from preoperative liver function test including
indocyanine green retensuin at 15 min (ICGR15). In
patients with NAFLD, serum total cholesterol (TC)
level is high, in contrast to cirrhotic patients for whom
serum TC level is low. Therefore, preoperative serum
TC level may reflect hepatic reserve in patients with
non-B non-C HCC.
Methods: The study included 30 patients without hepa-
titis virus infection or history of alcohol abuse, who
underwent hepatic resection for HCC between 2000
and 2012 at Jikei University Hospital. We retrospec-
tively analyzed the relation between preoperative clini-
cal variables including serum TC level and histology of
the liver.
Results: Ten of 30 patients were diagnosed as histo-
pathologically liver cirrhosis. Preoperative ICGR15 in 2
of the 10 non-B non-C cirrhotic patients were normal
(<10%). In preoperative serum TC level, there were sig-
nificant differences between the patients with liver cir-
rhosis (median TC 165 mg/dL; range 105–204) and
without liver cirrhosis (median TC 189.5; range 143–
411; p = 0.039). Prothrombin time (p < 0.001), and
serum total bilirubin (p = 0.023) were also significantly
different by univariate analysis.
Conclusion: Preoperative serum TC may be a predictor
of liver cirrhosis in patients with non-B non-C hepato-
cellular carcinoma.
APHPB-0387
COMPARATIVE STUDY OF PURE
LAPAROSCOPIC VERSUS OPEN LEFT
HEMIHEPATECTOMY USING
MULTIVARIATE ANALYSIS
H. D. Cho, K. H. Kim, S. Hwang, C. S. Ahn, D. B.
Moon, T. Y. Ha, G. W. Song, D. H. Jung, G. C. Park
and S. G. Lee
Division of Hepatobiliary Surgery and Liver
transplantation, Department of Surgery, Ulsan
University and Asan Medical Center, Seoul, Korea
Objectives: The objective of this study was to compare
the results of pure laparoscopic left hemihepatectomy
(LLH) versus open left hemihepatectomy (OLH) in
both benign and malignant condition with multivariate
analysis.
Methods: From October 2007 to December 2013, LLH
(n = 63) and OLH (n = 125) which were performed by
a single surgeon in Asan Medical Center, Korea were
investigated. Patient demographics, preoperative data,
clinical perioperative outcomes, and tumor characteris-
tics in patients with malignancy were compared
between both groups. Moreover, multivariate analysis
of prognostic factors associated with early discharge,
complication was executed.
Results: The mean operative time was longer in LLH
group rather than the OLH group significantly
(248.89  53.50 min vs. 177.23  68.13 min, p < 0.0001).
But, the LLH group had a significantly shorter post
operative hospital stay than the OLH group
(9.53  3.30 days vs. 14.68  11.09 days, p < 0.0001).
Multivariate analysis of prognostic factors associated
with complication revealed that OLH had nearly 3
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times the risk than LLH (odd ratio = 2.876, 95% CI
1.093–7.571, p = 0.0324).
Conclusion: LLH, as laparoscopic major hepatectomy,
was safe and feasible procedure in selected patients.
There was no mortality and no case to be converted
open surgery due to major bleeding. LLH had
shorter hospital stay, less operative blood loss. In
multivariate analysis, LLH had less risk of complica-
tion. The authors suggest prudentially that LLH
seems to be a reasonable treatment option in selected
patients.
APHPB-0389
MULTIDISCIPLINARY TREATMENT IN
UNRESECTABLE BILIARY TRACT
CANCER – A MULTI-CENTER
RETROSPECTIVE ANALYSIS
F. Harada1, R. Matsuyama1, K. Yoshida2, S. Okawa3,
J. Tanaka4, T. Asakura5, K. Sugimori6, Y.
Kawaguchi7, T. Mine7 and I. Endo1
1Department of Gastroenterological Surgery, Yokohama
City University, Yokohama, Japan; 2Department of
Gastroenterological Surgery, Kitasato University East
Hospital, Sagamihara, Japan; 3Department of
Gastroenterology, Yokohama Cancer Center, Yokohama,
Japan; 4Digestive Disease Center, Showa University
Northern Yokohama Hospital, Yokohama, Japan;
5Department of Gastrointestinal Surgery, School of
Medicine, St. Marianna University, Kawasaki, Japan;
6Gastroenterological Center, Yokohama City University
Medical Center, Yokohama, Japan; 7Department of
Gastroenterology, Tokai University School of Medicine,
Isehara, Japan
Objectives: There is still no established evidence about
the treatment strategies for unresectable biliary tract
cancer. To clarify the current situation of multidisci-
plinary treatment for unresectable biliary tract cancer.
Methods: 318 consecutive patients with unresectable
biliary tract cancer, who had been treated at seven
institutions in Kanagawa prefecture, Japan between
1999 and 2008 were reviewed retrospectively.
Results: The unresectable factor were followed; Locally
advance: 102 cases (32.0%), Hematogenous metastasis:
46 cases (14.7%), Peritoneal dissemination: 30 cases
(9.6%). 198 cases (63.4%) received chemotherapy. The
most common regimen was gemcitabine alone followed
by gemcitabine combination therapy and S-1 alone.
The one-year-survival rate was 35% and median sur-
vival time (MST) was 10 months among all patients,
whereas among the locally advanced patients, the 1-
year-survival rate was 65% and MST was 12 months.
The patients with peritoneal dissemination had the
worst prognosis; the 1-year-survival rate was 7% and
MST was 5 months. Among 90 cases of hilar bile duct
cancer, the patients received chemoradiotherapy had a
significantly better prognosis than the patients received
chemotherapy alone (the 1-year-survival rate: 83% vs.
39%, MST: 19 vs. 11 months, p < 0.001).
Conclusion: Multidisciplinary treatment was effective
for the patients with locally advanced biliary tract can-
cer. The Patients with metastatic biliary tract cancer
still had a poor prognosis even with receiving multidis-
ciplinary treatment.
APHPB-0390
PROGRESSED SYSTEMIC
INFLAMMATORY RESPONSE IS A
PROGNOSTIC PREDICTOR IN
PANCREATIC CANCER
H. Taniguchi, S. Aoki, M. Mizuma, T. Abe, R. Okada,
H. Yoshida, F. Motoi, T. Naitoh, Y. Katayose and M.
Unno
Department of Surgery, Tohoku University Graduate
School of Medicine, Sendai, Japan
Objectives: Progressed systemic inflammatory response
syndrome (SIRS) is a predictive value independent of
clinical stages in advanced cancer. Recently the effect
of anti-inflammatory therapy has been reported. The
aim of this study is to examine influences of progressed
SIRS on preoperative nutrition status and long term
prognosis in pancreatic cancer.
Methods: 187 pancreatic cancer patients who under-
went surgery at our institute between 2003 and 2013
were divided by preoperative CRP into two groups,
normal group (NG < 1.0 mg/dL: n = 162) and elevated
group (EG ≥ 1.0 mg/dL: n = 25) and were analyzed
retrospectively.
Results: Age, sex, bile drainage, tumor location, serum
CA19-9 value, operative procedure and stage were insig-
nificant between both groups. Serum albumin (3.9 vs.
3.4 g/dL, p < 0.01), lymphocyte (1530 vs. 1288/lL,
p = 0.02), pre-albumin (24.5 vs. 16.1 mg/dL, p < 0.01),
transferrin (221 vs. 184 mg/dL, p = 0.01) considered as
indicators of preoperative nutritional status were signifi-
cantly low in EG. Severe complication (≥Clavien3b) was
higher (7.5 vs. 24.0%, p = 0.02) and adjuvant therapy
application was lower (83.0 vs. 58.3%, p = 0.01) in EG.
Overall survival (OS) and disease free survival (DFS)
were lower in EG (MST: 24.2 vs. 11.8, p = 0.01, median
DFS: 12.0 vs. 6.7, p = 0.08: month). Subgroup analysis in
node involvement, residual tumor status, NCCN resect-
ability and adjuvant therapy revealed poor OS in EG.
Conclusion: CRP is a fair preoperative prognostic fac-
tor in resected pancreatic cancer. Preoperative pro-
gressed SIRS related to poor nutrition status, is likely
to increase risks of infectious complications and adju-
vant therapy failure. Anti-inflammatory agents might
improve SIRS and nutrition status, leading to a better
prognosis.
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INVESTIGATION AND TREATMENTS
FOR BILE LEAKAGE AFTER PRIMARY
CLOSURE OF LAPAROSCOPIC
COMMON BILE DUCT EXPLORATION
Z. Pan, H. Hou and Z. Ji
Department of General Surgery, Zhongda Hospital
Southeast University, Nanjing, China
Objectives: Laparoscopic common bile duct explora-
tion (LCBDE) has become one of the main options for
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treating choledocholithiasis. Our objective was to assess
the short-term outcomes of patients undergoing laparo-
scopic primary closure of the common bile duct (CBD).
Methods: We retrospectively studied 50 consecutive
patients undergoing primary closure following LCBDE
between January 2012 and January 2014. Preoperative
MRCP and intraoperative choledochoscopy were per-
formed in all patients. All patients satisfied the follow-
ing conditions: incisional length of CBD is <10 mm,
the number of stones are not more than three and the
diameter is <10 mm, the bilirubin? 2.0 mg/dL, the age
is <70 years and basket extraction for removal of bili-
ary tract stone. Seven patients undergoing transcystic
duct exploration because of enlarged cystic duct. When
closing the incision of CBD, interrupted sutures was
applied by using 5-0 MONOCRYL sutures.
Results: No patient was converted to open surgery. In-
traoperative choledochoscopy didn’t found stone in one
case. The mean duration of the operation was
112.4 min and mean length of postoperative stay was
5.2 days. Postoperative bile leakage occurred in four
patients (8.0%) on postoperative Day 1 to Day 3. All
of the patients recovered after simple drainage without
reoperation. The minimal follow-up was 6 months.
There were no recurrences.
Conclusion: Primary closure of the CBD is safe and
feasible in selected patients. Application of choledo-
choscopy to ensure clearance of the CBD and careful
suturing are essential for primary closure. Placement of
drainage sustained 3 days postoperative may aid in the
prevention of bile leakage.
Transplantation
APHPB-0392
TECHNICAL KNACKS TO ENHANCE
LUMINAL PATENCY OF INTERPOSED
SYNTHETIC GRAFT IN LIVING DONOR
LIVER TRANSPLANTATION USING
MODIFIED RIGHT LIVER GRAFT
T. Lim, S. Hwang, G. Song, D. Jung, C. Ahn, D.
Moon, G. Kim, G. Park, B. Jung and S. Lee
Division of Hepatobiliary Surgery and Liver
Transplantation, Department of Surgery, Asan Medical
Center, Seoul, Korea
Objectives: Due to shortage of vein allograft, synthetic
grafts such as polytetrafluoroethylene (PTFE) have
been used for reconstruction of middle hepatic vein
(MHV) tributaries of right liver graft during living
donor liver transplantation. We previously reported the
merits of composite patch graft to reduce tissue reac-
tion and to facilitate end-to-side anastomosis. With
accumulation of surgical experience, we found that
unique location of V8 anastomosis close to the graft
right hepatic vein (RHV) often led to buckling trans-
formation of PTFE graft and subsequent luminal ste-
nosis and thrombosis.This study intended to assess the
efficacy of newly developed technical knacks to over-
come such buckling-associated patency complications.
Methods: There were two recent modifications as fol-
lows: when V8 was <1.5 cm apart from graft RHV, we
made unification venoplasty of RHV and V8; other-
wise, we made V8 composite patch long to provide
some redundancy working as a short side branch. Their
3-month patency rate was compared with that of his-
torical control group with conventional MHV recon-
struction.
Results: In 60 cases of control group with V8 anastomo-
sis located within 3 cm from graft RHV, 3-month patency
rate was 85% with 4 cases of early MHV stenting. Modi-
fied design was applied in 30 patients, in which no vascu-
lar complication in V8-RHV unification venoplasty group
(n = 5) and redundant V8 group (n = 25) showed
3-month patentcy rate of 96% with 1 case of early MHV
stenting (modification versus control: p = 0.09).
Conclusion: Our technical modification on V8 recon-
struction appears to be effective to improve the patency
of MHV reconstruction.
APHPB-0393
COMPARISON OF TECHNICAL
HANDLING AND LUMINAL PATENCY
BETWEEN INTERPOSED PTFE GRAFTS
WITH INTERRUPTED RINGS VERSUS
CONTINUOUS SPIRAL RINGS IN
LIVING DONOR LIVER
TRANSPLANTATION
T. Lim, S. Hwang, T. Ha, G. Song, D. Jung, C. Ahn,
D. Moon, G. Kim, G. Park and S. Lee
Division of Hepatobiliary Surgery and Liver
Transplantation, Department of Surgery, Asan Medical
Center, Seoul, Korea
Objectives: Due to shortage of vein allograft, synthetic
grafts such as polytetrafluoroethylene (PTFE) have
been used for reconstruction of the middle hepatic vein
(MHV) tributaries of right liver graft during living
donor liver transplantation. There are two types of
10 mm-sized ringed PTFE grafts available, in which
each has interrupted rings (GORETEX) or continuous
spiral rings (IMPRA).This study intended to compare
the technical handling and luminal patency according
to different types of outer rings of interposed PTFE
grafts.
Methods: A prospective case-controlled study was per-
formed with randomized allocation of PTFE grafts
with interrupted rings (n = 60) or continuous rings
(n = 30). We have used GORETEX graft for 5 years,
thus it became the control group.
Results: Regarding on handling feasibility, GORETEX
was superior to IMPRA for bench work because it has
a thinner vessel wall and thinner outer rings. In con-
trast, IMPRA was superior for implantation because
its spiral rings permits some flexibility in length adjust-
ment and more resistant to instrumental clamping. The
6-month luminal patency was 68.3% in GORETEX
group and 70% in IMPRA group (p = 0.97). No
noticeable complications including graft infection
occurred, but graft migration into the stomach
occurred in one case of GORETEX group.
Conclusion: Mid-term luminal patency rates of PTFE
grafts were similar regardless of types of outer rings.
GORETEX appears to be easier for handling, whereas
IMPRA has advantage of longitudinal flexibility.
We think that both material are worthy of clinical
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application for MHV reconstruction of right liver graft
during living donor liver transplantation.
APHPB-0394
INFLUENCE OF HEMATOPOIETIC
STEM CELL TRANSPLANTATION ON
LIVER IN ALCOHOLIC CIRRHOSIS
PATIENTS
G. Burganova1, S. Abdulkhakov1, A. Gumerova1, I.
Gazizov1, M. Titova1, A. Odintcova2 and A. Kiyasov1
1Morphology and General Pathology, Institute of
Fundamental Medicine and Biology, Kazan Federal
University, Kazan, Russia; 2Gastroenterology,
Republican Clinical Hospital, Kazan, Russia
Objectives: So far there is no effective antifibrotic treat-
ment in alcoholic liver cirrhosis (ALC). One of the
novel treatment options is using of autologous hemato-
poietic stem cells (HSC). Sinusoids capilliarization and
myofibroblasts activation are key events in liver fibro-
genesis. The purpose of the study was evaluation of the
effect of HSC autotransplantation on these processes in
patients with alcoholic cirrhosis.
Methods: The study was performed on liver biopsies of
12 patients with ALC taken before the injection of
autologous peripheral blood HSCs mobilized by GCSF
into celiac trunk, 3 and 12 months after the procedure.
Biopsies were stained immunohistochemically with anti-
bodies against CD34 and a-SMA. CD34 is absent in
endothelial cells of normal liver however it appears in
case of their capillarization. A-SMA is a marker of
myofibroblasts.
Results: Before transplantation we observed the great
number of CD34-positive cells predominantly in portal
areas as well as some positive cells in septa and in
parenchyma. A-SMA-positive myofibroblasts were
mainly localized in periportal zones and portal tract
infiltration areas. 3 months after transplantation the
number of CD34-positive cells and myofibroblasts
markedly decreased; remaining cells were located
mainly around portal tracts. 12 months after transplan-
tation the number of CD34 and a-SMA-positive cells
increased again but didn’t reach initial levels. The num-
ber of cells correlated with the severity of infiltration.
Conclusion: We suggest that transplantation of HSCs
in patients with ALC is safe and effective procedure
leading to decreasing of myofibroblasts number and
restoring of normal sinusoids’ structure. However this
procedure should be probably repeated in a year.
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APHPB-0395
COMPARATIVE STUDY OF TOTALLY
LAPAROSCOPIC LIVER RESECTION
FOR HEPATOCELLULAR CARCINOMA
BETWEEN ANTEROLATERAL AND
POSTEROSUPERIOR LESIONS
J. Y. Jang, H. L. Choi, W. H. Lee, H. K. Shin, Y. R.
Choi, J. Y. Cho, Y. S. Yoon and H. S. Han
Surgery, Bundhang Hospital, Seoul National University,
Seongnam, Korea
Objectives: Laparoscopic liver resection is usually lim-
ited to the anterolateral segments of the liver (AL; Seg-
ments II, III, V, VI, and the inferior part of segment
IV) compared with posterosuperior segments (PS; Seg-
ments I, VII, VIII, and the superior part of segment
IV). We evaluated the feasibility and long term out-
come of laparoscopic liver resection including PS seg-
ments.
Methods: We analyzed retrospectively the clinical data
of 230 patients who underwent laparoscopic liver resec-
tion for hepatocellular carcinoma from September 2003
to July 2014. Patients were classified into 2 groups
according to tumor location: group AL (n = 170) and
group PS (n = 60).
Results: There was no mortality or reoperation. The
predominant type of resection was a minor liver resec-
tion in group AL, and a major liver resection in group
PS (p = 0.038). The mean operative time in group PS
was greater than that in group AL (p < 0.001). Group
PS showed higher median blood loss (p = 0.001), more
frequent intraoperative transfusion (p = 0.002). There
were no differences in the conversion rate (p = 0.306),
rate of curative resection (p = 1.000), mean hospital
stay (p = 0.112), and rate of complications (p = 0.108)
between the 2 groups. There was no significant differ-
ence in 3-year overall survival (p = 0.160), and disease
free survival (p = 0.876).
Conclusion: Laparoscopic liver resection for hepatocel-
lular carcinoma located in PS is more difficult than in
AL. However, there was no difference in short and
long term outcome. The limitation according to tumor
location will be overcome with accumulation of experi-
ence and technical improvement.
APHPB-0396
SURGICAL RESECTION OF A
SOLITARY LYMPHNODE METASTASIS
FROM HEPATOCELLULAR
CARCINOMA: RESECTION OR
SYSTEMIC TREATMENT
I. Y. Park and H. J. Choi
Surgery, Bucheon St. Mary’s Hospital, The Catholic
University of Korea, Bucheon, Korea
Objectives: Hepatocellular carcinoma (HCC) is the fifth
most common solid tumor in the world, but the out-
comes after hepatic resection remain still unsatisfactory
due to recurrence. The most frequent site of extrahe-
patic metastases is the lung, followed by the adrenal
gland and bone. Lymph node (LN) metastases after
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HCC resection are uncommon and there is currently no
standard treatment. We describe the surgical resection
of a solitary LN metastasis from HCC.
Methods: A 58-year-old male patient was performed
left hepatectomy due to HCC. Intrahepatic recurrence
was found 6 months after hepatectomy. He received
TACE two times.
Results: In 4 months after the last TACE, and
13 months after hepatic resection, a single LN metasta-
sis was found in the PET scan. He had no jaundice and
Child A state. The tumor marker, AFP was 92.84 ng/
mL, and PIVKA-II was 8850 mAU/mL. Because there
was no other metastasis in the PET scan we decided
surgical resection of the LN.
Conclusion: LN metastases at distant sites without
metastases in the hepatoduodenal ligament are rela-
tively rare. Patients with a solitary metastasis from a
controlled intrahepatic tumor can be treated surgically,
and good outcomes have been reported. However, it is
still difficult to decide solitary LN metastasis from
hepatocellular carcinoma whether to be resected or to
be received systemic treatment.
APHPB-0397
LAPAROSCOPIC DISTAL
PANCREATECTOMY FOR INVASIVE
PANCREATIC DUCTAL
ADENOCARCINOMA
A. Cho, H. Yamamoto, O. Kainuma, H. Arimitsu, N.
Takiguchi, Y. Nabeya, T. Tonooka and F. Ishige
Gastroenterological Surgery, Chiba Cancer Center,
Chiba, Japan
Objectives: Minimally invasive surgery is a rapidly
evolving in the field of abdominal surgery, including
pancreatic region. Laparoscopic pancreatic resection
for benign or low-grade malignant lesions has been
recently proposed as the treatment option. However,
laparoscopic pancreatic resection for invasive pancre-
atic ductal adenocarinoma (PDAC) remains not univer-
sally accepted as an alternative approach for open
surgery because of the difficulty of oncologic resection
and a lack of consensus regarding the adequacy of this
approach. We describe our experiences with laparo-
scopic distal pancreatectomy (LDP) for PDAC.
Methods: From November 2009 to June 2014, nine
patients with PDAC underwent LDP at the Division of
Gastroenterological Surgery, Chiba Cancer Center,
Japan. Clinicopathological characteristics were retro-
spectively reviewed.
Results: The average operation time was 265.9 min
(range, 186–348 min), average estimated blood loss was
241.1 mL (range, 5–1010 mL). There was no conver-
sion to open. 2 patients had developed pancreatic fis-
tula (Grade A), which resolved spontaneously. In seven
of 9 patient (77.8%), R0 resection could be achieved,
but the remaining two patients showed R1 resection.
The mean numbers of retrieved lymph nodes were 18.3
(range, 2–40). The average postoperative hospital stay
was 15.6 days (range, 7–47 days). Median follow up
was 20.8 months (range, 3–36 months). Peritoneal
recurrence in 3 patients, Lymph nodes recurrence in 2
patients occurred respectively. Four of them died by
primary disease. The remaining 4 patients are alive
without recurrence.
Conclusion: LDP for PDAC can be feasible, safe, and
effective in highly selected patients. Clearly, a prospec-
tive, randomized study is needed to elucidate appropri-
ate indications and effects of the present procedure.
APHPB-0398
POSTOPERATIVE OUTCOMES AFTER
PURE LAPAROSCOPIC MAJOR
HEPATECTOMY: EXPERIENCE OF A
SINGLE CENTER
T. Nomi1, F. U. K .S. David1, G. Mehendran1, A.
Kenichiro1, S. Ogiso1 and Y. Nakajima2
1Department of Digestive Disease, Institut Mutualiste
Montsouris, Paris, France; 2Department of Surgery,
Nara Medical University, Nara, Japan
Objectives: Although laparoscopic major hepatectomy
(LMH) is developed in several specialized centers, data
regarding outcomes are limited. The aim of this study
was to evaluate the outcomes of pure LMH at a single
center for the first identification of risk factors for post-
operative complications.
Methods: Between January 1998 and March 2014, 183
patients underwent pure LMH. We analyzed demo-
graphic data, pathological variables, associated patho-
logical conditions, preoperative, intraoperative and
postoperative variables. The dependent variables stud-
ied were the occurrence of overall and major complica-
tions. Risk factors for complication were determined.
Results: The types of major hepatectomy included left-
sided hepatectomy in 40 (21.9%) patients, right-sided
hepatectomy in 135 (73.8%), and central hepatectomy
in eight (4.3%). The median operating time was
255 min (range: 100–540), and the median blood loss
was 280 mL (range: 10–4500). Complications occurred
in 100 patients (54.6%), and the 90-day all-cause mor-
tality rate was 2.7%. Liver-specific and general compli-
cations occurred in 62 (33.9%) and 38 (20.8%)
patients, respectively. Multivariate analysis identified
one independent risk factor for global postoperative
complications: intraoperative associated radiofrequency
ablation [Relative Risk (RR): 6.930, Confidence Inter-
val (CI); 1.494–32.143, p = 0.013]. There were two
independent risk factors for major complications: intra-
operative transfusion (RR: 2.504, CI; 1.006–6.233,
p = 0.049) and bilobar resection (RR: 2.469, CI; 1.004–
6.060, p = 0.049).
Conclusion: The correction of modifiable risk factors
(i.e. avoid as much as possible ablation or resection of
tumors in the remnant liver and intra-operative bleed-
ing) may reduce the incidence of complications after
LMH.
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APHPB-0400
ASSESSMENT OF SURGICAL
OUTCOME AFTER
PANCREATICODUODENECTOMY BY
JUNIOR SURGEONS
T. Horiuchi, H. Shiba, Y. Shirai, T. Sakamoto, R.
Iwase, K. Haruki, Y. Fujiwara, K. Furukawa, T. Iida,
Y. Futagawa and K. Yanaga
Surgery, School of Medicine, Jikei University, Tokyo, Japan
Objectives: Pancreaticoduodenectomy (PD) is one of
the most complicated procedures in the digestive sur-
gery. We retrospectively assessed the therapeutic out-
come after PD by junior surgeons.
Methods: This study included 252 patients, who under-
went pancreaticoduodenectomy between 2001 and 2012
at Jikei University Hospital. We retrospectively ana-
lyzed surgical outcomes, complications, mortality and
long-term survivals after PD by between junior sur-
geons as operating surgeon (post graduate year is
12 years or less) and senior surgeons (post graduate
year is more than 12 years).
Results: Among the study population, junior surgeon
group (post graduate year: 9.0 years; median, 6–12 years;
range) was 59 consisting of pancreatic cancer in 30, bile-
duct cancer in 12, ampullary cancer in 10, duodenal can-
cer in 1, and others in 7, and senior surgeon group (18.0,
13–34 years) was 193 consisting of pancreatic cancer in
76, bileduct cancer in 44, ampullary cancer in 36, duode-
nal cancer in 7, and others in 30. In univariate analysis,
operative time was significantly shorter in senior surgeon
group than that in junior surgeon group (583 vs. 512 min,
p = 0.001). Intraoperative blood loss (p = 0.70), postop-
erative hospital stay (p = 0.64), incidence of complications
(p = 0.32), mortality (p = 0.44) were comparable. Three-
year disease-free and overall survival rates in pancreatic
cancer were not statistical difference between junior and
senior surgeon group (p = 0.25, p = 0.53), and in bile duct
and ampullary cancer were also not statistical difference
in two groups (p = 0.87, p = 0.95), respectively.
Conclusion: PD by junior surgeons needs more opera-
tive time, but it may be performed safely under appro-
priate teaching.
APHPB-0401
TREATMENT STRATEGY FOR HCC
PATIENTS WITH ADVANCED AGE 80
OR MORE YEARS-OLD
K. Minami1, S. Ueno2, M. Sakoda1, S. Iino1, K.
Hiwatashi1, K. Maemura1, Y. Mataki1, H. Kurahara1,
H. Shinchi3 and S. Natsugoe1
1Digestive Surgery Breast and Thyroid Surgery,
Graduate School of Medical and Dental Sciences,
Kagoshima University, Kagoshima, Japan; 2Clinical
Oncology, Graduate School of Medical and Dental
Sciences, Kagoshima University, Kagoshima, Japan;
3School of Health Sciences, Kagoshima University
Faculty of medicine, Kagoshima, Japan
Objectives: In this study, results following several
interventions in HCC patients with 80 or more years-
old were compared with those with 65 or less years-old.
Methods: Between 1990 and 2005, total of 1797
patients with primary HCC underwent to initial treat-
ment such as hepatic resection (HR), ablation therapy,
or transarterial chemoembolization (TACE) in the
Kagoshima carcinoma-of-liver study group. Retrospec-
tive comparison was made between 62 patients equal to
or more than 80 years-old (Elderly group) and 851
patients equal to or <65 years-old (Youth group).
Results: Total of 225 patients (Elderly n = 10; Youth
n = 215) were treated by HR, 198 patients (Elderly
n = 8; Youth n = 190) by ablation, and 469 patients
(Elderly n = 42; Youth n = 427) by TACE.
Although patients treated by TACE showed poorer
survival than those received HR or ablation in Youth
group, no clear difference during the 3 treatment was
seen in Elderly group.
When comparing both groups according to the therapy,
the elderly patients showed poorer survival than the
youth in HR and ablation.
Multivariate comparisons about disease-free survival
(DFS) and overall survival in each group.
In DFS, size and the number of tumor were prognostic
factors for Youth group; liver damage for Elderly
group. HR was a good prognostic factor in both
groups. On the other hand, in overall survival, size and
the number of tumor, liver damage, were prognostic
factors for Youth group;none for Elderly group.
Conclusion: In Elderly HCC patients, Taken together
with complication and performance status, it should be
respected to employ treatment with lower invasiveness.
APHPB-0402
REDUCED DELAYED GASTRIC
EMPTYING AND ISOLATED LOOP
WITH RETROCOLIC
GASTROJEJUNOSTOMY
K. Palaniappan, R. Rajalingam, A. Bharathan, S.
Govil, S. Reddy and M. Rela
Institute of Liver Disease & Transplantation, Global
Hospitals Chennai, Chennai, India
Objectives: Delayed gastric emptying is a frequent
complication after pancreaticoduodenectomy. The inci-
dence of DGE is lower following ante-colic Vs retrocol-
ic gastrojejunostomy in studies published previously.
The present study was done to document the incidence
of DGE following a retrocolic gastroenteric reconstruc-
tion.
Methods: All patients underwent Classical pancreatico-
duodenectomy with isolated Pancreaticojejunostomy
and retrocolic gastroenteric anastomosis. Data were
prospectively recorded. Primary outcome was incidence
of DGE (ISGPS Definition). The secondary endpoint
were pancreatic fistula rate, re-intervention rate, bleed-
ing and hospital stay.
Results: Total of 94 patients underwent PD from Jan
2010–Aug 2014. Male : Female was 1.5 : 1. Age group
varied from 19–73 (Median age 55.6). All patients
underwent Isolated PJ with retrocolic gastroenteric
anastomosis. Primary DGE (without any intra-abdomi-
nal collection) was 6.3%. Grade A was in 5 patients
(83.3%), Grade B was seen in 1 patient (17.7%). No
patient had Grade C DGE. Pancreatic fistula rate was
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5.3%. Four patients underwent re-exploration for
bleeding, leak etc. Mortality rate was 3.2% (30 Day
mortality). Median lymph node retrieved was 22nodes
(9–34). On univariate analysis, only isolated loop PJ
and retrocolic GJ were significant (p < 0.05).
Conclusion: Incidence of DGE following isolated loop
Pancreaticojejunal with retrocolic gastroenteric recon-
struction is very low. ISGPS Classification for DGE
helps in grading and stratification of patients with
DGE.
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APHPB-0403
LIVER ABSCESS: A REVIEW OF
MANAGEMENT AND CLINICAL
OUTCOMES AT WESTERN HEALTH
N. Kohli, J. Choi, S. Chan and V. Usatoff
Upper Gastrointestinal Surgical Unit, Western Health,
Footscray, Vic., Australia
Objectives: To evaluate management and clinical out-
comes of patients with liver abscess(s) at Western
Health Footscray to improve the care of liver abscess
patients.
To determine the indicators towards non-conservative
management.
Methods: We conducted a retrospective review of
patients with liver abscess(s) over the past 5 years at
Western Health. ICD-10 coding was used to capture
patients with pyogenic or amoebic liver abscesses. A
database was formed using patient admission and clini-
cal details. Statistical signficance was considered with a
p-value of < 0.05.
Results: Sixty-five patients (43:22 male to female) with
median age 61 (50.75–72.00 Interquartile range; IQR).
Fourteen (22%) were successfully managed with antibi-
otic treatment. Radiologically guided percutaneous
drainage was performed in 41 (63%) cases with median
time to drainage of 5.5 (1–11 IQR) days. It was suc-
cessful in 32 of 41 cases (78%). Seven patients (11%)
underwent surgery, of which 3 had failed drainage. Sur-
gical predictive factors were found to be CRP of >100
on admission (Odds ratio 30.750, 95% CI 3.25–291.31,
p = 0.003). The median length of stay was 15 (10.5–
25.0 IQR) days. There were 3 deaths during this period
of which 2 were due to sepsis in context of liver
abscess.
Conclusion: This study demonstrates that management
with intravenous antibiotics and radiologically guided
percutaneous drainage is successful in majority of cases.
There were seven cases requiring surgery and a CRP
>100 was shown to be predictive for need of surgery.
Future studies, ideally long term prospective, would be
beneficial to further explore this area.
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APHPB-0404
SURGICAL OUTCOMES AFTER
LAPAROSCOPIC MAJOR
HEPATECTOMY FOR VARIOUS LIVER
DISEASES
S. H. Kang and K. H. Kim
Division of Hepatobiliary Surgery and Liver
Transplantation, Department of Surgery, Asan Medical
Cencer, Seoul, Korea
Objectives: Laparoscopic liver resection has been more
frequently performed than before, but expansion of
laparoscopic major hepatic resection is still limited pri-
marily due to the technical difficulties compared to
open surgery. The aim of this study was to describe
our experiences of 149 patients undergoing laparo-
scopic major hepatectomy for various liver diseases.
Methods: We reviewed a clinicopathological data of
149 patients who underwent laparoscopic major hepa-
tectomy between October 2007 and August 2014 at
Asan medical center.
Results: The mean age of the patients was 54 years
and mean BMI was 23.5. The mean operation time was
273 min and mean estimated blood loss was 325 mL.
The most common indications were Hepatocellular car-
cinoma (n = 56, 37.6%), followed by intrahepatic duct
stones (n = 50, 33.6%). We performed 96 left hepatec-
tomies, 33 right hepatectomies, 17 right posterior sec-
tionectomies, 2 right anterior sectionectomy and 1
central bisectionectomy. Only one patient was con-
verted to open because of major bleeding. Postopera-
tive complications occurred in 18 patients (12.1%) and
there were no deaths. The mean postoperative hospital
stay was 10 days. For patients with malignant tumors,
there were no positive resection margins.
Conclusion: We concluded that laparoscopy can be
safely and effectively applicable for major hepatectomy
after candidate selection. However, prospective ran-
domized studies with a great number of cases are
needed to confirm the role of laparoscopy in major
hepatic resection.
APHPB-0405
CHANGING INCIDENCE AND
SURVIVAL FOR BILIARY TRACT
CANCERS IN KOREA, 1999–2011
S. S. Han1, Y. J. Won2, J. Ha2, S. M. Woo1, K. W.
Jung2, W. J. Lee1 and S. J. Park1
1Center for Liver Cancer, National Cancer Center,
Goyang, Korea; 2The Korea Central Cancer Registry,
National Cancer Center, Goyang, Korea
Objectives: It has been reported that the incidence of
biliary tract cancers (BTC) changed in the western
countries. The aim of this report is to investigate the
incidence, relative survival rates and their trends on bil-
iary tract cancers in Korea.
Methods: The incidence of gallbladder cancer (GBC),
intrahepatic bile duct cancer (IBC), and extrahepatic
bile duct cancer (EBC) was estimated from cases diag-
nosed between 1999 and 2011 using the National Can-
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cer Incidence Database in Korea. Age-standardized
rates (ASR), annual percent change (APC) and male-
to-female rate ratios were calculated. Five-year relative
survival rates were estimated.
Results: Between 1999 and 2011, 70,584 patients were
diagnosed with BTC in Korea (male/female = 54.7/
45.3%; mean age, 68 years). The absolute incidence
cases of the three cancers increased: 3556 in 1999 to
7299 in 2011. The most common site was the IBC
(39.3%), followed by GBC (33.7%) and EBC (27.0%).
BTC occurred in males more often than in females
(male to female, 1.64:1). In IBC, the ASR increased
from 2.4 per 100,000 person-years in 1999 to 4.5 in
2011, and the APC was 6.6% (p < 0.001), while in
EBC and GBC, the incidence rates remained stable
over time. The 5-year relative survival rate improved
by year of diagnosis (1999–2004 to 2005–2009: GBC,
20.6% to 24.9%; IBC, 9.4% to 10.1%; EBC, 17.6% to
21.81%).
Conclusion: This study provides the first population-
based analysis of biliary tract cancers in Korea. Our
study showed incidence of IBC is increasing and the 5-
year relative survival rate of BTC improved.
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APHPB-0406
A RARE CASE OF BILE DUCT
ADENOMA MIMICKING A KLATSKIN
TUMOR IN UNUSUAL LOCATION
E. Park, C. Cho, Y. Koh, Y. Hur, H. Kim, C. Kim, D.
Park, S. Yoon and H. Kim
Hepatobiliary-Pancreatic Surgery, Chonnam National
University Hospital, Gwangju, Korea
Objectives: Adenoma of bile duct is an extremely rare
benign tumor. It can be found mostly in the ampulla
or in close proximity to the Vaterian system, and the
common bile duct (CBD). It can mimic malignant
extrahepatic tumors, because preoperative differentia-
tion between adenomas and malignant tumors is very
difficult.
Methods: A 75-year-old man who presented epigastric
pain and indigestion for 6 months was referred to our
hospital. He had no past medical history and no family
history. On physical examination, there were tenderness
on epigastric area. Abdominal computed tomography
(CT) scan and magnetic resonance imaging (MRI) scan
demonstrated 3 cm sized soft tissue tumor at bifurca-
tion of common hepatic duct and left intrahepatic bile
duct (IHBD) obstruction with marked IHBD dilata-
tion. Based on laboratory test and imaging investiga-
tions, preoperative diagnosis was thought be hilar
cholangiocarcinoma with left intrahepatic bile duct
invasion.
Results: Extended left hepatectomy, caudate lobec-
tomy, cholecystectomy, CBD resection was performed.
At laparotomy, there was 1.5 cm sized polypoid mass
at left IHBD bifurcation and there was no vascular
invasion. Pathologic examination of the resected speci-
men showed tubulopapillary adenoma and there was
no atypia and no dysplasia. The patient tolerated the
procedure well and was discharge 3 weeks following
surgery without any problems.
Conclusion: Bile duct adenoma is an rare benign
tumor, especially rising at hepatic duct. It should be
considered different diagnosis of hilar cholangiocarci-
noma, and it is important to make an effective plan for
treatment.
APHPB-0407
CALCULI REMOVAL AND
GALLBLADDER PRESERVATION FOR
CHOLECYSTOLITHIASIS BY ENDOLAP
TECHNIQUE
Z. Ji
Department of General Surgery, Zhongda Hospital
Southeast University, Nanjing, China
Objectives: To explore a new method and the value of
minimally invasive surgery for removal calculi and the
preservation of gallbladder by laparoscope combined
with the choledochoscope.
Methods: A retrospective analysis was conducted in
100 patients with cholecystolithiasis between January
2010 and September 2014, who underwent the mini-
invasive surgery for removing calculi and preserving
the gallbladder.
Results: 100 cases had gallstone taken out and the gall-
bladder was preserved perfectly without any complica-
tions. Yet the other 4 cases switched to the
laparoscopic cholecystectomy because of tiny stones
blocked in the cystic duct and submucosal stones. The
success rate was 96%. Follow-up included both clinical
assessment and ultrasound examination every 6 months
after operation. The patients with the preoperative
symptoms were symptom-free and the function of gall-
bladder was found to be well preserved. The overall
stone recurrence rate was 4.92% at a mean follow up
of 26 months (range, 6–40 months).
Conclusion: Using the laparoscope combined with the
soft choledochoscope for gallbladder preserving chole-
cystolithotomy, which not only can remove stones
clearly and preserve the function of gallbladder, but
also effectively avoid the various complications of cho-
lecystectomy. In our follow-up, gallbladder function
was not affected and the stones recurrence rate was
quite low.
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APHPB-0408
BENEFICIAL EFFECTS OF
PERIOPERATIVE CHEMOTHERAPY
FOR PANCREATIC CANCER
M. Kitago, O. Itano, M. Shinoda, Y. Abe, H. Yagi,
T. Hibi and Y. U. K. O. Kitagawa
School of Medicine, Keio University, Tokyo, Japan
Objectives: Aims: We retrospectively assessed the bene-
fits of 5-fluorouracil (5-FU)- and heparin-based portal
infusion chemotherapy (PI) combined with systemic
administration of mitomycin C (MMC) and cisplatin
(CDDP) for 4 weeks following surgery (PI4W). The
goal was to determine if this treatment prevented liver
metastasis and improved survival for patients with
potentially curative resection of pancreatic cancer.
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Methods: 263 patients who underwent pancreatectomy
from January 1985 to December 2013 were treated. Of
these cases, 50 patients received portal infusion with 5-
FU (250 mg/day) for 2 weeks (PI2W) following surgery
(1985–2001 Group A), while 94 patients received PI4W
therapy (250 mg/day of 5-FU with 2000 IU/day of hep-
arin for 4 weeks, 4 mg MMC on days 6, 13, 20, 27,
and 10 mg CDDP on days 7, 14, 21, 28) (2001–2013
Group B). The remaining 119 patients (Ct) without
adjuvant therapy during the perioperative period
divided Group A (n = 58) and Group B (n = 61).
Results: The cumulative overall survival rate in the
PI2W was significantly higher than those in Ct of
Group A. The cumulative overall survival rate in the
PI4W also was significantly higher than those in Ct of
Group B. Furthermore, in the PI4W group, the rate of
liver metastasis is lower than Ct.
Conclusion: PI therapy after surgery, especially PI4W,
could become a promising adjuvant therapy in patients
with potentially curative resection of pancreatic cancer.
APHPB-0409
LAPAROSCOPIC MANAGEMENT OF
PRIMARY COLORECTAL CANCER AND
SYNCHRONOUS COLORECTAL LIVER
METASTASIS
K. M. Ho, C. K. So, K. C. Cheng and Y. P. Yeung
Surgery, Kwong Wah Hospital, Kowloon, Hong Kong
China
Objectives: The aim of the current study was to review
our experience in simultaneous and staged resection of
the colon and liver in patients with synchronous colo-
rectal liver metastasis.
Methods: A review of a prospectively managed hepa-
tobiliary pancreatic database at Kwong Wah Hospital
identified 39 patients, who underwent surgery for syn-
chronous colorectal liver metastasis from January 2004
to April 2014. The demographics, clinicopathologic,
operative outcomes and complications of the simulta-
neous and staged resection groups were evaluated.
Results: Sixteen patients underwent simultaneous resec-
tion while 23 patients underwent staged resection. The
demographics, ASA class, T staging, site of the primary
tumor and the type of colectomy were comparable
between the two groups. Patients in the simultaneous
group had significantly fewer liver tumors and more
likely to undergo laparoscopic resection (13/16 vs. 8/23,
p = 0.004). More major liver resections were performed
as staged operation (2/16 vs. 12/23, p = 0.011). There
was no significant difference in the total blood loss,
transfusion rate and complication rates between the
two groups. The total hospital stay for the simulta-
neous and staged group was 16 days and 20 days
respectively (p = 0.083). The resection margins for the
liver metastasis and primary colonic tumor were com-
parable. There was no significant difference in the over-
all survival and disease free survival.
Conclusion: Simultaneous is as safe as staged resection
in the management of synchronous colorectal liver
metastasis, with insignificantly shorter overall hospital
stay. Simultaneous laparoscopic resection of primary
colon cancer and synchronous liver metastases is feasi-
ble in selected patients with limited liver disease.
APHPB-0411
ACINAR CELL CARCINOMA
PRESENTED FROM PANCREASE –
REPORT OF TWO RARE CASES
Y. Koh1, C. Cho1, Y. Hur1, C. Kim1, D. Park1, S.
Yoon1, E. Park2, H. Kim2 and H. Kim2
1General Surgery, Chonnam National University Hwasun
Hospital, Chonnam, Korea; 2General Surgery, Chonnam
National University Hospital, Gwangju, Korea
Objectives: Acinar cell carcinoma is a rare pancreatic
neoplasm. Because of its rarity, characteristics of this
disease have not been fully investigated. Herein, we
present two cases of acinar cell carcinoma of pancreas.
Methods: Case 1. A 60-year-old woman was referred to
our hospital for evaluation of pancreatic mass found on
CT scan. Abdominal CT and MRI showed a about 3 cm
sized well marginated non-enhancing round mass with
internal bleeding in pancreatic head. A preoperative diag-
nosis of solid pseudopapillary tumor was made, a pylorus
preserving pancreaticoduodenectomy was performed.
Case 2. A 51-year-old woman visited our hospital pre-
senting epigastric pain and poor oral intake. Abdomi-
nal CT and pancreas MRI showed lobulated enhancing
soft tissue mass and multiple conglomerated amorphic
cystic lesions around main duct of pancreas in body
and tail. A preoperative diagnosis of intraductal papil-
lary mucinous neoplasm was made, radical antegrade
modular pancraticosplenectomy was performed.
Results: Case 1. At laparotomy, a 3 9 3 cm sized brown
soft mass was found in pancreatic head. Microscopic find-
ings revealed invasive acinar cell carcinoma. The patient
discharged 17 days following surgery without any compli-
cations. 2 months following the surgery, multiple hepatic
metastases were found on follow up CT scan.
Case 2. At laparotomy, there were a 9 cm sized hard
mass in pancreas body and multiple conglomerated
lymph node around mass. Microscopic findings
revealed acinar cell carcinoma. The patient discharged
12 days following surgery without any complications.
Conclusion: Acinar cell carcinoma of pancreas is a rare
neoplasm showing a poor prognosis. To understand char-
acteristics of this disease, more large scaled study is needed.
APHPB-0413
CHEMICAL THROMBOPROPHYLAXIS
DECREASE THE RISK OF PULMONARY
EMBOLISM AND DID NOT INCREASE
THE RISK OF MAJOR HEMORRHAGE
AFTER HEPATOBILIARY-PANCREATIC
SURGERY
H. Hayashi, T. Morikawa, M. Mizuma, K. Nakagawa,
T. Okada, H. Yoshida, T. Naitoh, F. Motoi, Y.
Katayose and M. Unno
Surgery, Tohoku University Graduate School of
Medicine, Sendai, Japan
Objectives: Chemical thromboprophylaxis is thought to
decrease the risk of postoperative venous thromboem-
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bolism (VTE) and pulmonary embolism (PE), but some
surgeons hesitate to use them because of the increased
risk of postoperative hemorrhage especially after hepa-
tobiliary-pancreatic (HBP) surgery. The benefit and risk
of chemical thromboprophylaxis after HBP surgery is
still unclear.
Methods: From 2008 to 2013, 766 patients with HBP
malignancy underwent radical surgery in our institute.
376 (49.1%) patients received postoperative chemical
thromboprophylaxis and 390 (50.9%) patients did not
receive them. The rate and the risk of VTE, PE, and
hemorrhage were evaluated retrospectively.
Results: Administration of chemical thromboprophy-
laxis did not decrease VTE rate compared with non-
administrated patients (4.8% vs. 6.8%, respectively,
p = 0.2623), but PE rate was significantly high in non-
administration group (0.8% vs. 2.9%, p = 0.0434).
Logistic analysis showed age 70 or over significantly
increased the risk of VTE (p = 0.0065) and non-admin-
istration of chemical thromboprophylaxis significantly
increased the risk of PE (p = 0.0445). Postoperative
hemorrhage was occurred at significantly high rate in
administration group (26.9% vs. 10.5%, p = 0.0001).
Logistic analysis showed surgical site infection (SSI)
and male increased postoperative hemorrhage
(p = 0.0037 and p = 0.0181, respectively) and major
hemorrhage, which required blood transfusion or he-
mostasis with surgery or IVR technique (p < 0.0001
and p = 0.0055, respectively). Administration of chemi-
cal thromboprophylaxis also increased the risk of post-
operative hemorrhage (p < 0.0001), whereas it did not
increase the risk of major hemorrhage (p = 0.3940).
Conclusion: Administration of chemical thrombopro-
phylaxis after HBP surgery is safe and beneficial
because it did not increase the major hemorrhage risk
and decreases the risk of PE.
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APHPB-0414
SURGICALLY TREATED
DIAPHRAGMATIC PERFORATION
WITH/WITHOUT HERNIATION AFTER
RADIOFREQUENCY FOR
HEPATOCELLULAR CARCINOMA
S. Shiraiwa1, K. Okuda1, R. Kurumatsu2, H. Sato3, H.
Sakai1, M. Yasunaga1, H. Horiuchi1, T. Torimura2 and
Y. Akagi1
1Department of Surgery, Kurume University School of
Medicine, Kurume, Japan; 2Department of Medicine,
Kurume University School of Medicine, Kurume, Japan;
3Department of Surgery, Tobata Kyoritsu Hospital,
Kitakyusyu, Japan
Objectives: Diaphragmatic perforation and herniation
after radiofrequency ablation (RFA) for hepatocellular
carcinoma (HCC) have rarely been reported as thermal
injury of RFA. Only 9 cases are reported previously in
English literatures. However, we have experienced 5
cases of surgically treated late-onset diaphragmatic per-
foration with/without herniation after RFA in our
institution. We reviewed our 5 cases.
Methods: From January 2003 to December 2013, 5
patients of diaphragmatic perforation and herniation
after hepatic RFA for HCC were diagnosed and surgi-
cally treated in our institution. We investigated clinical
profiles and RFA procedures.
Results: All of cases had an underlying liver cirrhosis
and 4 of five patients showed Child-Pugh grade B or C.
The majority of tumors located at S4, S6 and S8 adja-
cent to the diaphragm. At the time of the onset, a coro-
nal thoracic CT image showed a right diaphragmatic
defect and/or herniated viscera in the right pleural cav-
ity. An average interval from RFA to the onset was a
12 months (5–21 m). All cases underwent laparotomy
and direct suture of the diaphragm defect and the
patients rapidly recovered uneventfully after surgery.
Conclusion: The late onset of diaphragmatic perfora-
tion with/without herniation consequent to thermal
injury of RFA is never considered to be rare complica-
tion. In hepatic RFA adjacent to diaphragm clinician
should consider several techniques to prevent thermal
injury of the diaphragm, and be aware of integrity the
diaphragm in imaging to achieve earlier diagnosis of
diaphragmatic defect postoperative follow up after
RFA. Immediate surgical treatment should be recom-
mended for diaphragmatic perforation.
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APHPB-0415
OUTCOMES OF RECURRED PATIENTS
AFTER CURATIVE RESECTION OF
INTRAHEPATIC
CHOLANGIOCARCINOMA
S. Park1, S. S. Han1, S. H. Kim1, S. D. Lee1, S. F.
Yun2, S. A. Lee1, Y. W. Kang1, M. Y. Lee1, S. M.
Woo1 and W. J. Lee1
1Center for Liver Cancer, National Cancer Center,
Goyang, Korea; 2Department of Surgery, Busan
National University Hospital, Busan, Korea
Objectives: The outcomes of recurred patients after
resection of intrahepatic cholangiocarcinoma are not
well known.
Methods: Between 2001 and 2013, 150 patients under-
went hepatic resection for intrahepatic cholangiocarci-
noma. We analyzed the recurrence pattern and its
outcomes after recurrence following resection of intra-
hepatic cholangiocarcinoma.
Results: The survival rates at 1, 3, and 5 year were
73%, 54%, and 36%, respectively. Recurrences devel-
oped in the 105 of 150 patients. The median time from
resection to recurrence was 7 months (range, 0–
48 month). According to the first recurrence sites, 41
patients had intra-hepatic recurrence only (IH group)
and 64 patients with extra-hepatic recurrence or with
both intra- and extrahepatic recurrence (EH group). In
the IH group, the median time to recurrence was
8 months (1–48). The median time from recurrence to
death was 27 months (0–99) and 1-, 3- and 5-year sur-
vival rates after recurrence were 73%, 38%, and 33%,
respectively. Seven patients of IH group have been dis-
ease-free for 8–78 months since they underwent TACE
(4), surgery (2), and RFA (1). In the 64 patients of the
EH group, the median time to recurrence was 6 months
(0~34). Thirty-three of 64 patients had both intra- and
extra-hepatic recurrences. In the EH group, the median
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time from recurrence to death was 5 months (range,
0–66 months) and 1-, 3- and 5-year survival rates since
recurrence were 30%, 6%, and 0%, respectively.
Conclusion: As compared with the EH group, the IH
group had better overall survival rates after recur-
rences. In some patients of the IH group, aggressive
local treatments gave chance for cure.
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APHPB-0419
SURGICAL MANAGEMENT OF
CHRONIC CALCIFIC PANCREATITIS –
OPTIONS AND OUTCOMES – SINGLE
CENTRE EXPERIENCE
P. Raju, R. Rajkumar, D. Benet, A. Amudhan, D.
Kannan and S. M. Chandramohan
Surgical Gastroenterology, Madras Medical College,
Chennai, India
Objectives: To analyze the various indications for sur-
gery, results of various surgical procedures in terms of
symptom relief and complications and outcome after
single layer pancreatico Jejunal anastomosis
Methods: Prospective study of 102 patients from
August 2010 to March 2014. Patients with suspected
malignancy were excluded from the study. Clinical pre-
sentations like pain (>90%), Steatorrhoea (8%), diabe-
tes mellitus (15%) and complications like Pseudocyst
(n = 8), Pancreatic ascites (n = 5), Biliary obstruction
(n = 11), Portal Hypertension (n = 3) and duodenal
obstruction were considered. Surgical options like
Frey’s procedure (n = 80), Longitudinal Pancreatico
Jejunostomy (n = 12), Izbecki procedure (n = 3) and
Distal pancreatectomy with splenectomy (n = 3) and
cystoenterostomy (n = 4) additional choledocho duode-
nostomy (n = 2) were used. Surgical reconstruction was
done by Pancreatico Jejunostomy in single layer for all
patients. Duration of surgery, estimated blood loss,
post operative stay, complications and mortality were
analysed
Results: Duration of surgery was 180 min (120–
240 min). Median blood loss was 300 mL. Average
post operative stay was 8 days. 1 patient had anasto-
motic leak. 10 patients had minor complications. There
was nil mortality. Pain relief observed in more than
90% for a minimum follow up period of 6 months.
Conclusion: Frey’s procedure has become the standard
of care for chronic pancreatitis. Presence of complica-
tions addressed properly will gives same outcome as
CCP without complications. Single layer anastomosis is
s viable technique and helps to reduce the cost and
duration of surgery.
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APHPB-0420
ANALYSIS OF SURGICAL TREATMENT
AND PROGNOSIS OF 91 PATIENTS
WITH PERIHILAR
CHOLANGIOCARCINOMA
X. Li, C. Jiao, K. Wang, A. Yao, S. Han, D. Wang, R.
Peng and X. Wang
Liver Transplantation Center, The First Affiliated
Hospital of Nanjing Medical University, Nanjing, China
Objectives: To evaluate the surgical treatment outcomes
and to determine the prognostic factors for survival in
patients with resectable perihilar cholangiocarcinoma.
Methods: We retrospectively analyzed a total of 91
consecutive patients who underwent resection for peri-
hilar cholangiocarcinoma at a single institution from
March 2004 to October 2013, and determined the fac-
tors that influence the prognosis with statistical meth-
ods.
Results: A total of 128 patients with perihilar cholangio-
carcinoma were treated, of whom 91 (71.1%) underwent
resection. For the patients underwent resection, 1, 3, 5-
year survival rates were 75.4%, 33.6%, 21.7% respec-
tively; and the median overall survival time was
22.5 months. Among the 24 (26.4%) patients with post-
operative complications, only 2 patients (2.2%) died of
hepatic failure and gastrointestinal hemorrhage. Univar-
iate analysis identified the following prognostic factors:
surgical margin (v2 = 62.95, p < 0.001); preoperative
serum Albumin (<35 g/L, v2 = 25.889, p < 0.001); hos-
pital day (≥30d, v2 = 25.889, p < 0.001); lymph node
metastasis (v2 = 33.824, p < 0.001); differentiation
degrees (v2 = 31.474, p < 0.001); TNM staging
(v2 = 55.665, p < 0.001). Multivariate analysis identified
positive surgical margin (HR = 4.716, p < 0.001) and
poorly differentiation degree (HR = 3.958, p < 0.001) as
independent poor prognostic factors.
Conclusion: Radical resection (R0) is the key to
improve the long-term survival rate for treatment of
perihilar cholangiocarcinoma. Aggressive surgical resec-
tion can improve R0 resection rate.
APHPB-0421
THE HAMMERSMITH LAPAROSCOPIC
PANCREATICOGASTROSTOMY
(HLPG): A NOVEL PANCREATIC
ANASTOMOSIS FOLLOWING CENTRAL
PANCREATECTOMY
T. Gall, M. Sodergren, A. Frampton, N. Habib, R.
Fan, M. Pai and L. Jiao
Surgery and Cancer, Imperial College London, London,
UK
Objectives: Central pancreatectomy (CP) is preferred to
distal pancreatectomy (DP) for the excision of benign
tumors at the neck or body of the pancreas, in order to
preserve pancreatic function and the spleen. However,
the pancreaticoenterostomy is technically difficult to
perform laparoscopically and the postoperative pancre-
atic fistula (POPF) rate is high. A novel laparoscopic
reconstruction of the pancreatic stump during CP is
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described, the Hammersmith Laparoscopic Pancreatic-
ogastrostomy (HLPG).
Methods: Four patients underwent HLPG and opera-
tive outcomes were reviewed prospectively.
Results: Two males and two females with a median age
of 49 years had a laparoscopic CP with HLPG. After a
median follow-up of 27.5 months, there was no mortal-
ity. One patient had a grade A postoperative pancreatic
fistula (POPF), which settled spontaneously without
intervention.
Conclusion: The HLPG is a safe and technically less
demanding method to reconstruct pancreatic drainage
laparoscopically. It is associated with a reduced POPF
rate.
APHPB-0422
A EXTREMLY RARE CASE OF LARGE
CELL NEUROENDOCRINE
CARCINOMA IN INTRAHEPATIC BILE
DUCT
H. Kim1, E. Park1, H. Kim1, C. Cho2, Y. Koh2, Y.
Hur2, C. Kim2, D. Park2 and S. Yoon2
1General Surgery, Chonnam National University
Hospital, Gwangju, Korea; 2General Surgery, Chonnam
National University Hwasun Hospital, Gwangju, Korea
Objectives: Large cell neuroendocrine carcinoma is a
high grade type of neuroendocrine tumor. Neuroendo-
crine carcinoma of biliary system are extremely rare.
Here in, we present a case of large cell neuroendocrine
carcinoma of intrahepatic bile duct.
Methods: A 53-year-old man visited our hospital pre-
senting right upper quadrant pain and jaundice. Abdo-
men CT and Cholangiogram MRI showed diffuse
heterogenous enhancing mass including from common
hepatic duct and left distal branch and dilatation of
both intrahepatic bile duct. Endoscopic retrograde cho-
langiopancreatography showed abruptly narrowing in
common hepatic duct and irregular narrowing in left
intrahepatic bile duct. Biopsy from left intrahepatic bile
duct showed reactive atypia. Preoperative diagnosis
was thought be intrahepatic cholangiocarcinoma or
klatskin tumor.
Results: We performed Left hepatectomy, caudate
lobectomy, common bile duct resection and routine
lymph node dissection. At laparotomy, there were
8 9 2.5 cm size friable polypoid mass from first order
branch of left intrahepatic bile duct and distal left int-
rahepatic bile duct. Microscopic finding revealed large
cell neuroendocrine carcinoma type cholangiocarcino-
ma. The patient discharged 23 days following surgery
without any complications.
Conclusion: Here in, we report a case of large cell neu-
roendocrine carcinoma of intrahepatic bile duct.
APHPB-0424
IMPORTANCE OF ONCOLOGICAL
NAVIGATION IN THE RADICAL
OPERATION FOR THE LOCALLY
ADVANCED PANCREATIC CANCER
M. Imamura, Y. Kimura, T. Ito, T. Kyuno, T.
Nobuoka, M. Meguro, T. Mizuguchi and K. Hirata
Department of Surgery, Surgical Oncology and Science,
School of Medicine, Sapporo Medical University,
Sapporo, Japan
Objectives: We analyzed the cases that performed radi-
cal operation after chemotherapy or chemoradiation
therapy (preoperative therapy) for locally advanced
pancreatic cancer and considered perivascular compe-
tent abrasion and importance of oncological navigation
that aimed at R0 resection.
Methods:
[Surgical procedure]:
1. The extent of resection accepts local extension
degree before the preoperative therapy.
2. Approach main vascular in the surgery begin-
ning, and make the frozen section diagnosis of
the vascular surrounding tissue.
3. In the case of cancer negative by frozen section
diagnosis, perform en bloc resection of invasion
organs, lymph nodes and nervous plexus.
Results: We performed 18 radical operations after the
preoperative therapy until May, 2014. Tumor site;
head/body and tail/multiple = 5/12/1 cases. Clinical
stage according to the UICC; IIB/III/IV = 5/12/1. Pre-
operative therapy; chemoradiation therapy/chemother-
apy = 17/1 cases. Combination anticancer drugs;
GEM/ TS1/others = 3/13/1 cases. Radical operative
method; PD/DP/TP = 5/11/1 cases. By oncological
navigation, one case was exploratory laparotomy. R0/
R1 resection = 15/1 cases. Effect of preoperative ther-
apy; pCR/down stage = 1/7 cases. Median survival
time; after preoperative therapy/postoperation = 32.1/
16.4 months.
Conclusion: The case that R0 resection was enabled is
present because preoperative therapy succeeded. At
present, the extent of resection in the radical operation
cannot but set it depending on local advance before the
preoperative therapy. In future, imaging diagnostic
methods corresponding to the tissue changes of the pre-
vious treatment and the accumulation of the periopera-
tive findings are expected. We regard oncological
navigation as important in the R0 resection.
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APHPB-0426
MULTIMODALITY APPROACH IN
PANCREATIC PSEUDOCYST
MANAGEMENT
M. Thiruvarul, A. Amudhan, D. Bennet, R.
Prabakaran, D. Kannan and S. M. Chandramohan
Surgical Gastroenterology, Madras Medical College,
Chennai, India
Objectives: We present our treatment experience with
pancreatic pseudocyst using multimodality approach
over the past 3 years.
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Methods: A total of 91 patients were treated for
pancreatic pseudocyst with either surgery or interven-
tions in our surgical gastroenterology Institute in Rajiv
Gandhi Government General Hospital in Chennai in
the past 3 years. They were retrospectively reviewed
and followed up.
Results: There were 65 (63.6%) men and 26 (36.4%)
women between 15 and 79-years-old (mean age
38.2 years). Among the 91 cases, 82 cases followed
acute pancreatitis and 9 cases followed chronic pancre-
atitis. Among the cases of acute pancreatitis 14 cases
followed biliary pancreatitis, 6 cases followed traumatic
panreatitis and 62 cases followed alcoholic pancreatitis.
Dominating symptoms in most patients were epigastric
pain, palpable mass, nausea, vomiting, fever and leuko-
cytosis, and persistent elevation of serum amylase.
Imaging studies, such as ultrasound, computed tomog-
raphy scan, and endoscopic retrograde cholangiopan-
creaticography,were helpful in establishing the
diagnosis. Operative procedures done for 38 cases -con-
sisted of external drainage (ED, 2 cases),internal drain-
age using cystojejunostomy (CJ, 14 cases)and
cystogastrostomy (CG, 12 cases) lap cystogastrostomy
(LCG 2 cases), cystojejunostomy with cholecystectomy
(3), cystogastrostomy with cholecystectomy (1), cys-
tojejunostomy with frey’s (1) modified stapled cystoga-
strostomy 2 cases and distal pancreatectomy (1 case).
Non surgical interventions (endoscopic and percutane-
ous drainage) done for 53 cases.
Conclusion: Surgical intervention, endoscopic drainage,
and percutaneous drainage are complementary rather
than competing alternatives both for simple and com-
plicated pseudocysts.
APHPB-0427
ROLE OF SURGERY IN PANCREATIC
ASCITES MANAGEMENT
M. Thiruvarul, A. Amudhan, D. Bennet, R.
Prabakaran, D. Kannan and S. M. Chandramohan
Surgical Gastroenterology, Madras Medical College,
Chennai, India
Objectives: Pancreatic ascites is a rare complication
and should be suspected in patients with chronic alco-
holism and pancreatitis presenting with ascites. The eti-
ology is likely from a pancreatic pseudocyst leakage or
due to ductal disruption. Our study is to emphasise the
role of surgery in pancreatic ascites management.
Methods: A total of 13 patients were treated for pan-
creatic ascites by surgery in our surgical gastroenterol-
ogy Institute in Rajiv Gandhi Government General
Hospital in the past 3 years. They were retrospectively
reviewed and followed up.
Results: Among the 13 cases, there were 9 men and 4
women between 15 and 79-years-old (mean age
38.2 years). Among the 13 cases 11 cases followed
chronic pancreatitis and 2 cases followed traumatic
pancreatitis. Dominating symptoms in most patients
were epigastric pain and abdominal distension, and
weight loss and persistent elevation of serum amylase
and ascitic fluid amylase. Imaging studies, such as
ultrasound, computed tomography scan, and endo-
scopic retrograde cholangiopancreaticography, MRCP
were helpful in establishing the diagnosis. Operative
procedures done for 13 cases – pancreatico jejunostomy
in 7 patients, distal pancreatectomy with splenectomy
and pancreaticojejunostomy in 4 cases, cysto gastrosto-
my done for 2 cases associated with pseudocyst. All the
13 patients were referred to us after failed endotherapy
by our medical gasteroenterology department. Percuta-
neous drainage was done for 3 patients pre operatively
to relieve symptoms. Mortality occurred in 2 patients.
Recurrence of symptoms occurred in one patient for
which endotherapy was done.
Conclusion: Surgery gave good results in patients who
were refractory to endotherapy.
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APHPB-0431
ERAS AFTER
PANCREATODUODENECTOMY
S. J. Park, S. S. Han, S. H. Kim, S. D. Lee, Y. W.
Kang, M. Y. Lee, J. H. Yu, S. M. Woo and W. J. Lee
Center for Liver Cancer, National Cancer Center,
Goyang, Korea
Objectives: Our institute established ERAS for pancre-
atoduodenectomy (PD) patients which includes conven-
tional ERAS and best supportive care program in
2011. The aim of this study is to analyze the efficacy of
ERAS program after PD.
Methods: Between 2011 and 2013, ERAS was applied
to 151 patients after PD. We evaluated the success rate
of each items in ERAS program and also analyzed the
intaked calories by patients after PD.
Results: Median hospital stay was 17 days (9–66). The
mortality was 2% and complication was in 43% (pan-
creas fistula 27%, delayed gastric emptying 9%, wound
infection 12%, bleeding 5%, etc). More than 40% of
PD patients have the preoperative or postoperative psy-
chological problems such as anxiety, depression or
insomnia. NG tube removal on postoperative day
(PoD) 1 was successful in 92% but reinsertion was
done in 10%. Drain removal on PoD 3 was successful
in 62% and successful foley catheter removal on PoD 2
in 85%. Oral diet was successfully started in 87% on
PoD 4 and for 64% of patients, no nutritional support
was needed from PoD 12. However median intaked cal-
ory was 125  85 Calories on PoD 4–5, 303  73 Cal-
ories on PoD 6–7, 533  118 Calories on PoD 8–
9 days, and 880  265 Calories on PoD 10-11.
Conclusion: ERAS after PD might be effective in
reducing hospital stay and cost. However ERAS after
PD should be set-up and applied considering the vari-
ous situations of each institute.
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APHPB-0434
CLINICOPATHOLOGIC DIFFERENCES
IN THE GALLBLADDER CANCER
ACCORDING TO THE PRESENCE OF
ANOMALOUS PANCREATICOBILIARY
DUCTAL UNION
J. Chang, J. Y. Jang, M. J. Kang, W. Jung, Y. C. Shin,
Y. R. Chang and S. W. Kim
Department of Surgery, Seoul National University
College of Medicine, Seoul, Korea
Objectives: Clinical significance of anomalous pancre-
aticobiliary ductal union (APBDU) on gallbladder can-
cer (GBC) was investigated.
Methods: Among 435 patients with GBC who under-
went surgery at Seoul National University Hospital
between 2000 and February 2014, 386 patients who
had identifiable data of APBDU were included for
analysis.
Results: Of the 386 patients, mean age was 64.1 years
and 53.1% (n = 205) were female. APBDU was identi-
fied in 67 (17.4%) patients of which 33 (49.3%) were
male and 34 (50.7%) were female. C-P, P-C, and com-
plex type were 46.3% (n = 31), 50.7% (n = 34), 3.0%
(n = 2), respectively. Only APBDU group had 17
patients with choledochal cyst (CC). For APBDU and
non-APBDU group, mean age (60.3 vs. 65.0,
p = 0.002) and R0 resection (73.1 vs. 58.9%, p = 0.040)
showed difference, while the proportion of female, pap-
illary morphology, well- or moderately differentiated
histology, and tumor less than stage II were compara-
ble. For CC and non-CC group with APBDU, papil-
lary morphology (75.0 vs. 36.4%, p = .045) and stage I
and II (68.8 vs. 39.0%, p = .042) showed difference.
Median overall survival (OS) of APBDU and non-AP-
BDU group was 20.6 and 22.5 months, respectively
(p = .618). Median OS of CC and non-CC group was
16.8 months and 20.7 months, respectively (p = 0.089).
Conclusion: APBDU was found in 17.4% of the
patients with GBC. Although APBDU is noted in
younger patients, clinicopathologic characteristics and
survival were comparable. For CC, papillary morphol-
ogy and early stage of the disease were more frequent
in CC group without survival difference. Prognostic
significance of APBDU and CC on GBC is limited.
APHPB-0435
ANALYSIS OF CLINICAL SPECTRUM
AND SHORT TERM OUTCOME OF
OBSTRUCTIVE JAUNDICE WITH
CARCINOMA GALL BLADDER
K. Chakaravarthi1, T. D. Yadav1, V. Gupta1, S. K.
Sinha2, V. Singh3, A. Lal4 and A. Das5
1General Surgery, PGIMER, Chandigarh, India;
2Gasteroenterology, PGIMER, Chandigarh, India;
3Hepatology, PGIMER, Chandigarh, India; 4Radio-
Diagnosis, PGIMER, Chandigarh, India;
5Histopathology, PGIMER, Chandigarh, India
Objectives: Carcinoma Gallbladder (CaGB) with jaun-
dice at presentation generally considered as advanced
disease, inoperable and poor prognosis. This study was
designed to analyze the spectrum of jaundice in patients
with CaGB.
Methods: CaGB with jaundice patients who received
treatment at the Post graduate institute of medical edu-
cation and research (PGIMER), Chandigarh, India
from December 2012 to May 2014 were recruited into
this study. The main outcome measured was the clinical
spectrum of jaundice in patients with CaGB focusing
on resectability, morbidity, mortality and short-term
outcome.
Results: 64 patients included in this study, in which the
mean age was 51 years and male : female ratio was
1 : 1.4. Mean value of jaundice was 16.7 mg% (3.5–
39.2).All the patients were had advanced diseases
according to cTNM classification. [Stage III (n = 4)
and Stage IV (n = 60)] Contiguous and Non-contigu-
ous liver infiltration was seen in 98% and 36% respec-
tively, Right hepatic artery and Main portal vein
involved in 20.3% and 12.5%,Metastatic left supra cla-
vicular lymph node seen in 9%. Four patients under-
went staging laparoscopy in which only one underwent
R0 resection (1.5%). Resected patient was survived
more than 1.5 years (577 days).The mean survival of
stage III and IV was 3 and 2 months respectively.
Conclusion: Jaundice at initial presentation in CaGB
invariably indicates the advanced stage of disease and
has dismal prognosis. However, our study indicates
that radical resection is still possible in CaGB with
jaundice in the absence of metastic or locally advanced
disease.
APHPB-0436
CLINICAL SIGNIFICANCE ACCORDING
TO THE PRECURSOR TYPE OF
AMPULLA OF VATER CANCER
J. Park, S. Youn, H. Lee, W. Kwon, J. Heo, S. Choi
and D. Choi
Department of Surgery, Samsung Medical Center, Seoul,
Korea
Objectives: Although ampullary cancer are rare disease,
it is considered to have a better prognosis than other
periampullary cancer. According to a recent study,
Intra-ampullary Papillary-Tubular Neoplasm (IAPN) is
mass-forming preinvasive neoplasm that occur specifi-
cally within the ampulla. The aim of this study were to
identify clinical outcome according to the precursor
type (IAPN and flat dysplasia) of ampullary cancer.
Methods: Patients who underwent pancreatoduodene-
tomy for ampullary cancer between February 2008 and
August 2014. We retrospectively collected data on clini-
cal records. 201 patients underwent curative resection.
Among them, precursor type has been reported 80
cases (IAPN 33 and flat dysplasia 47).
Results: The 1-year disease free survival rates of the 80
cases were 75.8%. And only one of IAPN was expired.
(DFS 22 months, OS 45 months). Univariate analysis
showed that TNM stage (p = 0.001), Lymphovascular
invasion (p = 0.02) and flat dysplasia (p = 0.054) signif-
icantly increased the risk of recurrence. However, mul-
tivariate analysis showed that TNM stage (p = 0.041)
were significantly increased the risk of recurrence. Also,
there was similar result in IAPN (p = 0.006) Further-
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more, the flat dysplasia type was found to be more
associated with advanced T stage (p = 0.013), regional
lymphnode metastasis (p = 0.0024), poor differentiation
(p = 0.003), lymphovascular invasion (p < 0.001) and
perineural invasion (p = 0.035) than IAPN type.
Conclusion: Advanced TNM stage was found to be
independent predictors of recurrence after curative
resection IAPN type ampullary cancer. It is considered
that furthermore study is needed.
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APHPB-0438
ACUTE BILIARY PANCREATITIS: A
PROSPECTIVE STUDY ON INCIDENCE
OF COMMON BILE DUCT STONES
AND ASSOCIATED CLINICAL
PREDICTORS
S. L. Jee, K. F. Lim, K. Raman and H. Singh
HPB Surgery, Selayang Hospital, Kuala Lumpur,
Malaysia
Objectives: To define the incidence of common bile
duct (CBD) stone in mild to moderate acute biliary
pancreatitis (ABP), and identify its clinical predictors.
Methods: 72 patients admitted with mild to moderate
ABP to Selayang Hospital from January 2013 to
August 2014 were studied prospectively. CBD stones
were diagnosed on either endoscopic retrograde cholan-
giopancreatography (ERCP) or intraoperative cholangi-
ogram (IOC). Preoperative ERCP was performed if
there was strong suspicion of CBD stones from labora-
tory parameters, transabdominal ultrasound (US) or
endoscopic ultrasound (EUS), and CBD stones were
cleared if identified. All patients underwent laparo-
scopic cholecystectomy with IOC. CBD stones discov-
ered on IOC were removed via surgical exploration or
postoperative ERCP.
Results: There were 31 male (43.06%) and 41 female
(56.94%) patients with ages from 18 to 75 years. 34
(47.22%) patients underwent preoperative ERCP. CBD
stones were detected in 36 patients (50%); on ERCP
(33 patients) and IOC (3 patients). Significant clinical
predictors are serum bilirubin (p = 0.012), CBD dilata-
tion (>8 mm) on US (p = 0.006) and EUS (p = 0.0001).
Age, gender, serum alkaline phosphatase, transaminases
(ALT, AST) and gamma glutamyltransferase are not
predictive. EUS is the best predictor with sensitivity
and specificity of 90% and 96% respectively.
Conclusion: The incidence of CBD stones in mild to
moderate acute biliary pancreatitis is high (50%).
Serum bilirubin, CBD dilatation on US or EUS are sig-
nificant clinical predictors.
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APHPB-0439
DETERMINATION OF RISK FACTORS
FOR PANCREATIC FISTULA AFTER
PANCREATICO-DUODENECTOMY
USING INTERNATIONAL STUDY
GROUP ON PANCREATIC FISTULA
(ISGPF) DEFINITION
K. W. Fong, C. N. Chong, Y. S. Cheung, J. Wong, K.
F. Lee and B. S. Lai
Surgery, The Chinese University of Hong Kong, Shatin,
Hong Kong, China
Objectives: Various definitions for pancreatic fistula
after pancreatico-duodenectomy exist in the literature,
making comparison of the risk factors difficult. We aim
to determine the risk factors for pancreatic fistula
under the International Study Group on Pancreatic
Fistula (ISGPF) classification in patients undergoing
pancreatico-duodenectomy.
Methods: A total of 143 pancreatoduodenectomies
were performed in the period of December 2000 to
April 2014 in a tertiary referral hospital. Pancreatic fis-
tula was evaluated by ISGPF definition. Multi-variate
analysis was used to identify the risk factors for pan-
creatic fistula.
Results: Pancreatic fistula occurred in 62 patients
(43%), most of the pancreatic fistula was grade A
according to ISGPF definition (84%). On multivariate
analysis, smoking (p = 0.023), soft pancreas (p = 0.042)
and pancreatic duct size <4 mm (p = 0.038) were inde-
pendent risk factors for the developing pancreatic fis-
tula. Only 8 patients (13%) had Grade B and 2
patients (3%) had grade C pancreatic fistula after sur-
gery. Patients with Grade B or Grade C pancreatic fis-
tula had longer hospital stay (p = 0.039).
Conclusion: ISGPF definition and grading systems are
applicable and correlate well with clinical course in
patients undergoing pancreatico-duodenectomy. Smok-
ing, soft pancreas and small duct size are risk factors
for developing post-operative pancreatic fistula.
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APHPB-0440
‘HEMOSUCCUS PANCREATICUS’ –
DIAGNOSTIC CHALLENGES AND
MANAGEMENT OPTIONS
J. G. Johnrose, A. Amudhan, T. Perungo, R.
Prabakharan, D. Bennet, D. Kannan and S. M.
Chandramohan
Institute of Surgical Gastroenterology, Madras Medical
College, Rajiv Gandhi Government General Hospital,
Chennai, Tamilnadu, India
Objectives: ‘Hemosuccus pancreaticus’ – is a rare and
life-threatening complication of pancreatitis. Patients
often present with obscure bleeding and there is signifi-
cant diagnostic and therapeutic dilemma.The aim of
this study is to analyze the mode of presentation and
to present diagnostic and therapeutic options in the
management of ‘ Hemosuccus- pancreaticus’.
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Methods: Data of patients diagnosed as Hemosuccus
Pancreaticus between March 2005 and March 2014 was
retrospectively reviewed from a prospectively main-
tained database.
Results: Twenty patients were diagnosed as Hemosuc-
cus Pancreaticus. Seventeen patients were males and
three were females (17 : 3). The presentation was with
overt GI bleed in 17 patients (85%), anemia in two
(10%) and epigastric pain in one patient (5%). Twelve,
six and two patients had associated chronic pancreati-
tis, tropical pancreatitis and acute pancreatitis respec-
tively. Bleeding through the ampulla could be identified
at UGI scopy in nine patients (45%). CT Angiography
was performed in 11 patients (55%).The arterial feeder
was splenic artery in 10(50%),GDA in 8(40%) and
pancreatico-duodenal vessels in 1(5%),hepatic artery in
one (5%). Coil embolisation of feeding vessels was
attempted in eleven (55%) and was succesfull in 11
(77.8%). 9 (45%) required surgery. The rebleeding rate
was 18% following embolisation which was treated by
re-embolisation in one and surgery in one. The mortal-
ity was 10%.
Conclusion: In a hemodynamically stable patient
Angio-embolisation offers better immediate control of
bleeding and is the preferred and safe initial treatment.
Surgical intervention is indicated in a patient with hem-
orrhagic shock, impending rupture failed embolisation
or if there is associated conditions which warrant defin-
itive surgery.
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APHPB-0441
SHORT-TERM OUTCOME OF
LAPAROSCOPIC RADIOFREQUENCY
ABLATION FOR HEPATOCELLUAR
CARCINOMA IN LIVER CIRRHOSIS:
THE SAFETY AND EFFICACY
B. G. Na, G. S. Choi, J. M. Kim, C. H. D. Kwon, J.
W. Joh, J. B. Park and S. J. Kim
Surgery, Samsung Medical Center, Seoul, Korea
Objectives: Radiofrequency ablation (RFA) has been a
legitimate treatment for primary and metastatic hepato-
cellular carcinoma (HCC) with liver cirrhosis. The lapa-
roscopic RFA has replaced percutaneous RFA in
HCCs that were considered to be infeasible because of
poor sonic window, adjacent organ and major vessels.
The aims of this study is to assess the clinical data and
short-term outcome to evaluate efficacy and safety of
laparoscopic RFA for HCCs with cirrhosis.
Methods: Between September 2009 to August 2014, 45
consecutive HCC patients with cirrhosis were treated
by laparoscopic RFA. Most patients had hepatitis B
(60%) and Child-Pugh class B status (90%). Median
age was 60 years (range, 49–84). The short-term out-
come was evaluated by radiologic images in 3-, 6-, and
9 months.
Results: Laparoscopic RFA was done in all patients
and 49 HCC nodules was completely ablated. There
was no procedure related morbidity and mortality. The
HCC nodules consisted of primary (n = 22), recurred
(n = 19) and metastatic lesions (n = 8). Median nodule
diameter was 17 mm (range, 8–40). The 19 (45%) nod-
ules were located in segment 8. Median time of RFA
was 14 min (range, 7–28), while total operative time
was 130 min (range, 63–303). The combined procedure
were adhesiolysis (n = 17), cholecystectomy (n = 2),
colorectal surgery (n = 1). The hospital stay was 5 days
(range, 3–22). The 3-, 6-, and 9-months disease-free sur-
vival rate was 97.2%, 83.2%, and 78.6% respectively.
Conclusion: Laparoscopic RFA is a safe and effective
therapeutic option for HCCs infeasible to percutaneous
RFA in patients with cirrhosis. The laparoscopic RFA
combines the advantage of clinical outcomes compara-
ble to those percutaneous RFA.
APHPB-0442
CURRENT STATUS OF LAPAROSCOPIC
HEPATECTOMY, AND OUR
TECHNIQUE FOR SAFETY OPERATION
K. Shibuya, K. Matsui, I. Yoshioka, S. Sekine, I.
Hashimoto, S. Hojo, R. Hori, T. Okumura, T. Nagata
and K. Tsukada
Department of Surgery & Science, University of
Toyama, Toyama-shi, Japan
Objectives: In about 10 years laparoscopic hepatec-
tomy is spreading in our country. Only partial resection
and lateral segmentectomy has been applied to national
insurance. But currently, many reports of laparoscopic
anatomical resection is increasing, because technical
improvement of laparoscopic hepatectomy has been
achieved via the development of surgical devices. We
also experienced cases of anatomical resection in recent
years. So now, we report our situation of laparoscopic
hepatectomy, and our technique for safety operation.
Methods: Laparoscopic hepatectomy was introduced in
our department from 2010. Initially, we used hybrid
approach at mobilization for right or left lobe. From
2012, pure laparoscopic approach has become possible
in all caeses with technical improvement. From 2013,
we introduced pre-coagulation technique by the
monopolar forceps using soft-coagulation with saline
dripping for all parenchymal dissection line.
Results: 47 patients who have performed laparoscopic
hepatectomy were identified between 2010 and 2014.
The mean age was 65.9 years (range 29–87), 33 were
men. There are 32 cases of HCC, nine cases of liver
metastasis, two cases of cholangiocellular carcinoma,
and four of the benign tumors. It was applicable for
partial resection in 37, subsegmentectomy in 3, segmen-
tectomy in 4, and lobectomy in 3. Tumor localization,
S1/S2/S3/S4/S5/S6/S7/S8: 2/6/6/10/5/9/6/7. The mean
tumor size was 2.4 cm diameter (range 1–4.6). The
mean operation time was 267.9 min. There was no
severe complication. After introduction of pre-coagula-
tion by soft-coagulation, intraoperative blood loss sig-
nificantly decreased (p = 0.0465).
Conclusion: Laparoscopic hepatectomy with pre-coagu-
lation by soft-coagulation is safe and useful.
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APHPB-0444
EXTENT OF RESECTION IN CYSTIC
NEOPLASM OF PANCREAS – A
SURGICAL CONUNDRUM
B. Saxena, K. Gharpure, H. Jain, H. Lokhandwala, R.
Singh and R. Joshi
General Surgery, BYL Nair Charitable Hospital and T
N Medical College, Mumbai, India
Objectives: Cystic neoplasms of pancreas can be
benign, potentially malignant or malignant and the
extent of resection remains a surgical conundrum. The
objective is to determine the accuracy of the decision
regarding the extent of resection.
Methods: 29 patients were analysed based on pre and
intra operative characteristics.
Results: Male to female ratio was 1 : 3.8 and average
age 45 years. Surgical decision was determined by gen-
der, size and location of tumour, serum tumour mark-
ers, imaging studies and intra-operative findings.
Subsequently, 17 patients underwent oncological resec-
tion and 12 patients enucleation.
On histopathology, 6 patients had mucinous cystadeno-
ma, 9 mucinous cystadenocarcinoma, 8 Gruber Frantz
tumour and 6 serous cystadenoma. All patients with
mucinous cystadenocarcinoma, 2 patients with mucin-
ous cyst adenoma and 6 patients with Gruber Frantz
underwent oncological resection along with enucleation
in all patients with serous cystadenoma and these deci-
sions were justified. Debatable however was enucleation
in 4 patients with mucinous cystadenoma and 2
patients with Gruber Frantz tumour. On further evalu-
ation all these 6 patients were females, had normal
serum tumour marker levels, tumour size was <4.5 cms
and location was in the head of pancreas.
Conclusion: In our series, the decision regarding extent
of surgery was accurate in 80% of patients. In 20%,
where the decision was debatable, justification is possi-
ble if suitable demographic and morphological features
are considered. Literature has shown that enucleation
may be justifiable in young patients, with tumour
located in the head of pancreas and which are easily
amenable to enucleation.
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APHPB-0445
SPONTANEOUS CHOLEDOCHO
DUODENAL FISTULA – AN UNUSUAL
CAUSE OF PNEUMOBILIA THAT
NEEDS ATTENTION
T. Perungo, S. M. Chandramohan, D. Kannan, D.
Benet, A. Amudhan, P. Raju, P. Selvarathinam, S.
Sugaprakash, S. Balakumaran and J. John Grifson
Surgical Gastroenterology, Madras Medical College,
Chennai, India
Objectives: Spontaneous Choledocho duodenal fistulae
are infrequently reported in literature. Diagnosing and
treating the underlying cause is important to prevent
recurrent cholangitis. Our aim is to analyze the out-
come after intervention for patients presenting with
choledocho duodenal fistula.
Methods: During the time period from January 2009 to
April 2014 eight patients (n = 8), 6 males and 2
females, were diagnosed to have Choledocho duodenal
fistula. The age group was between 29 and 68 years.
All patients presented with abdominal pain, three had
jaundice and four had history of recurrent abdominal
pain in the past. The average duration of symptoms
was 6 months.
The etiology was peptic ulcer disease in five patients,
choledocholithiasis in two and incidental in one with
associated chronic calcific pancreatits. Endoscopy
showed choledocho duodenal fistula in all patients
which was demonstrated in either CECT abdomen or
MRCP.
One patient was managed medically, one endoscopi-
cally and six patients underwent surgery – vagotomy
drainage, CBD exploration and drainage or Frey’s pro-
cedure according to the underlying etiology.
Results: All patients recovered well in the post op per-
iod. Orals were started on 4th POD. The average dura-
tion of hospital stay was 6 days. All patients are under
regular follow up and the one treated endoscopically
has recurrent symptoms.
Conclusion: Choledochoduodenal fistula per-se need
not be treated. The underlying cause is to be addressed
which gives good relief of symptoms.
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APHPB-0446
CHOLEDOCHAL CYSTS BEYOND
FIRST DEACDE: RARE BUT THERE!
K. V. Gharpure, B. Saxena, H. Jain, H. Lokhandwala,
R. Singh and R. M. Joshi
Department of General Surgery, B.Y.L Nair Charitable
Hospital and T.N.M. College, Mumbai, India
Objectives: Nearly 25% of choledochal cysts are
detected during infancy and 80% in the first decade.
20% are asymptomatic, have non-specific complaints
and maybe diagnosed incidentally or otherwise, beyond
the first decade. The objective is to review clinical man-
ifestations encountered with choledochal cysts diag-
nosed beyond first decade and to evaluate the post-
surgical outcomes.
Methods: 13 patients with age >10 years with choled-
ochal cysts who underwent surgery, were reviewed.
Results: Mean age was 37 years (range 15–64) with male
to female ratio of 1 : 3.3. Presentation varied from vague
abdominal pain in 6 patients, dyspepsia in 4, cholangitis
in 1 and 2 patients were diagnosed incidentally. 9
patients (69%) had cystic dilatations, 2 patients (15.3%)
had fusiform dilatation and 2 patients (15.3%) had both
intra and extra hepatic dilatations. All patients under-
went total cyst excision with Roux-en-Y hepaticojejunos-
tomy. Mean hospital stay was 5–7 days. The morbidity
was 7.6% and mortality 0%. Histopathology revealed
no malignancy. Mean follow up was 30 months.
Conclusion: Although rare beyond first decade, all
choledochal cysts need surgical intervention for fear of
complications like cholangitis, spontaneous rupture,
secondary biliary cirrhosis and malignant transforma-
tion. Cyst excision and Roux-en-Y hepaticojejunostomy
is the treatment of choice. Surgery is the mainstay for
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all patients of choledochal cysts even if asymptomatic,
given the potential for complications. The fact that sur-
gery is associated with low morbidity and mortality,
especially if the cyst is uncomplicated, makes it a feasi-
ble option.
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APHPB-0447
EVALUATION OF SURGICAL
RESECTION OF LYMPH NODE
METASTASES FROM
HEPATOCELLULAR CARCINOMA
S. Okubo, N. Gotohda, D. Takahashi, Y. Nakayama,
Y. Nishida, R. Okada, K. Kitaguchi, Y. Katoh, S.
Takahashi and M. Konishi
Hepato-Biliary-Pancratic Surgery, National Cancer
Center Hospital East, Kashiwa, Japan
Objectives: Lymph node metastases (LNs) from hepa-
tocellular carcinoma (HCC) seem to be rare. HCC with
LNs has been regarded as a systemic disease with poor
prognosis. The aim of this study is to evaluate the effi-
cacy of surgical resection of LN from HCC.
Methods: From 2000 to 2013, 56 patients diagnosed as
LNs from HCC without other extra-hepatic metastatic
lesions were evaluated. Clinicopathological data in
these patients were analyzed retrospectively.
Results: Patients characteristic are shown as follows;
median age: 69 years old, male/female: 46/10 cases (82/
18%), HBV(+)/HCV(+): 8/31 cases (14/55%), Child-
Pugh A/ B or C: 45/11 cases (80/20%), Pretreatment
history before treatment for LNs (yes/no): 35/21 cases
(63/37%), Intrahepatic lesions (yes/no): 44/12 cases (79/
21%), Number of LNs (single/multiple): 30 /26 cases
(54/46%), Time interval from initial treatment to treat-
ment for LNs (<1-year/ ≥ 1-year): 32/24 cases (57/
43%). Twenty-two patients (39%) underwent surgical
resection for LNs, 25 patients (45%) received systemic
chemotherapy, 9 patients (16%) received other treat-
ments. Median overall survival time (after treatment
for LNs) was 513 days. Patients with single LNs or no
intrahepatic lesions were good prognostic factors.
Conclusion: We should allow for surgical resection for
HCC patients with LNs if they had single LNs and no
intrahepatic lesions.
Transplantation
APHPB-0448
ANALYSIS AND STRATEGY FOR
PORTAL VEIN THROMBOSIS IN LIVER
TRANSPLANTATION
T. Onoe1, S. Shimizu2, K. Ishiyama2, K. Ide2, M.
Ohira2, H. Tahara2, Y. Saeki2, N. Tanimine2, T. Abe2
and H. Ohdan2
1Institute for Clinical Research, National Hospital
Organization Kure Medical Center/Chugoku Cancer
Center, Kure, Japan; 2Department of Gastroenterological
and Transplant Surgery, Institute of Biomedical and
Health Sciences Hiroshima University, Hiroshima, Japan
Objectives: Post-operative portal vein thrombosis
(PVT) could be crucial for prognosis of liver transplan-
tation. Therefore, it is very important to prevent portal
thrombosis after liver transplantation in order to secure
an enough blood flow of graft. In this study, we eluci-
dated the risk factors for post-operative portal throm-
bosis to establish a strategy for PVT.
Methods: Between 2002 and 2012, living donor or
deceased donor liver transplantation were performed in
181 patients. In those patients, we elucidated the risk
factors for post-operative PVT by using multivariate
analysis.
Results: Among 181 patients, 12 patients had post-
operative PVT (6.6%). One and 5 year survival rate of
patient with post-operative PVT was significantly lower
than those of patients without post-operative PVT
(58.3%, 50.0% and 85.1%, 74.6%, respectively). A
multivariate analysis of factors revealed that a presence
of pre-operative PVT and high donor age (≥50) were
significant risk factors for post-operative PVT
(p < 0.001 and <0.01, respectively). Next, we reviewed
our procedures for pre-operative PVT. We have per-
formed thrombectomy for grade 1-2 PVT and recon-
struction of portal vein for grade 3-4 PVT. Twenty-one
patients had pre-operative PVT (13 patients with grade
1, 6 patients with grade 2 and 2 patients with grade 3
PVT). Among them, 4 patients had re-PVT and all of
them were the patients with grade 2 PVT who under-
went thrombectomy.
Conclusion: Pre-operative PVT and high aged donor
are risk factors for post-operative PVT. An aggressive
portal vein reconstruction for grade 2 pre-operative
PVT might be useful for preventing re-PVT.
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APHPB-0449
MANAGEMENT OF CHRONIC
CALCIFIC PANCREATITIS WITH
SINISTRIAL PORTAL HYPERTENSION
IN A SINGLE CENTER EXPERIENCE – A
RETROSPECTIVE STUDY
R. Vellaisamy, S. Sankareswaran, R. Rajendran, A.
Anbalagan, B. Duraisamy, P. Raju, C. Servarayan
Murugesan and K. Devygounder
Institute of Surgical Gastroenterology, Madras Medical
College, Rajiv Gandhi Government General Hospital,
Chennai, India
Objectives: Left sided or sinistrial portal hypertension
is one of the vascular complications in Chronic calcific
pancreatitis patients. Combined Frey’s procedure with
splenectomy can be done in specialist pancreatic centers
without increasing mortality and morbidity.
Methods: This is retrospective study of 140 patients
with Chronic calcific pancreatitis between August 2010
to May 2014. Out of 140 cases 14 (10%) (10 Males, 4
females) had sinistrial portal hypertension. The average
age was 34.5 years.10 patients were alcoholics. One
patient had Jaundice, one had Upper GI bleeding and
3 had steatorrhoea. All had abdominal pain radiating
to back with pain score between 8–9. Two patients had
small duct disease. Out of 14 patients, 10 were treated
with Frey’s procedure and splenectomy, 2 were treated
with Lateral pancreaticojejunostomy and splenectomy
and 2 were treated with Izbiki procedure and splenec-
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tomy. One patient required Choledochodudenostomy
for jaundice along with Frey’s. Average duration of
surgery was 180 min with mean blood loss 216 mL. 9
patients required blood transfusion. The followup per-
iod was 3–45 months.
Results: The pain score was 1 in the immediate postop
in 12 patients. 2 patients had score between 2–3. They
were managed with analgesics. On the Long term fol-
lowup 2 patients required celiac plexus neurolysis for
Pain relief.
Conclusion: Concomitant splenectomy should be
strongly considered in patients undergoing operative
treatment of symptomatic chronic pancreatitis with
sinistral portal hypertension. Adding splenectomy to
the pancreatic procedure did not increase morbidity or
mortality.
APHPB-0450
HYPER-GIANT HEPATIC
HAEMANGIOMA – LEAVE ALONE OR
RESECT?
H. Jain, H. Lokhandwala, B. Saxena, K. V. Gharpure,
R. Singh and R. Joshi
General Surgery, BYL Nair Charitable Hospital and T
N Medical College, Mumbai, India
Objectives: Majority of hepatic haemangiomas are
<4 cm and asymptomatic and do not require treatment.
However, Giant (>4 cms) and hyper-giant Haemangio-
mas (>10 cms) are often symptomatic, with a risk of
spontaneous rupture leading to haemoperitoneum or
intravascular consumptive coagulopathy. Should these
be left alone or resected? Is surgery a safe and viable
option?
Methods: 10 patients with hepatic haemangioma hav-
ing at least one lesion >10 cm were analysed. Diagnosis
was made on imaging like ultrasonography and com-
puted tomography. Indication for surgery was abdomi-
nal pain and uncertainty of diagnosis. Nature of
surgery was based upon size and location of the hae-
mangioma.
Results: Mean age of these patients was 47.7 years
with female to male ratio of 4 : 1. Palpable lump in
abdomen was found in 80% and dull aching pain in
60%. 6 patients had left sided lesions and 3 patients
had bi-lobar involvement whereas 1 patient had a right
sided lesion. The average size was 16.5 cm (range 10–
35 cm). Liver resection was done in 5 patients and enu-
cleation in 4 patients. 1 patient was kept under obser-
vation as he was asymptomatic. All the operated
patients had an uneventful post-operative recovery with
no evidence of recurrence over a period of 2 years.
Conclusion: Hyper-giant haemangiomas are usually
symptomatic. Size is not a criterion for surgery. Sur-
gery is indicated in symptomatic patients or in cases of
diagnostic dilemma. Size and location of the lesion
determine whether these lesions should be enucleated
or resected with satisfactory results in both.
APHPB-0451
MANAGEMENT OF BRONCHOBILIARY
FISTULA A RARE ENTITY – REPORT
OF TWO CASES
R. Vellaisamy, S. Rajasekar, J. S. Jesudason, A.
Anbalagan, B. Duraisamy, P. Raju, C. Servarayan
Murugesan and K. Devygounder
Institute of Surgical Gastroenterology, Madras Medical
College, Rajiv Gandhi Government General Hospital,
Chennai, India
Objectives: Bronchobiliary fistula is an abnormal com-
munication between the biliary tree and airway. It pres-
ent with cough and bilioptysis .This article is to
demonstrate the diagnostic usefulness of HIDA scan
and role of ERCP in bronchobiliary fistula manage-
ment.
Methods: The study was between May 2013 to May
2014.
Results:
Case 1: A 39 year male admitted with bilioptysis and
dyspnoea. He underwent percutaneous catheter drain-
age followed by laprotomy for liver abscess 2 years
back. Within a month, relaprotomy was done with
external drainage and cholecystostomy. Since he devel-
oped external biliary fistula he was treated with fistu-
lojejunostomy later .On evlauation Fistula was
demonstrated by HIDA scan not by MRCP and
ERCP. He was treated with ERCP and biliary stenting.
Bilioptysis stopped in 10 days.
Case 2: A 35 year male, a case of hilar cholangiocarci-
noma with liver metastasis admitted with bilioptysis for
20 days. He underwent palliative PTBD with stent in-
ternalisation 4 months back. Fistula was demonstrated
by HIDA scan. He was treated with ERCP and Biliary
stenting. The bilioptysis has gradually reduced in
7 days.
Conclusion: Bronchobiliary fistula has to be suspected
in patients with bilioptysis who have undergone hepa-
tobiliary intervention. Fistula can be demonstrated by
HIDA scan. Before plan for major hepatectomy, ERCP
biliary stenting has to be attempted. Even in metastatic
disease, symptomatic relief has to be given for better
quality of life to the patient.
APHPB-0452
PRIMARY HEPATIC TUBERCULOSIS
MIMICKING INTRAHEPATIC
CHOLANGIOCARCINOMA: REPORT OF
TWO CASES
J. I. Park and Y. H. Park
Surgery, Inje University Haeundae Paik Hospital,
Busan, Korea
Objectives: Primary hepatic tuberculosis (TB) is very
uncommon even in countries with high prevalence of
tuberculosis.
Methods: We present two cases of patients who were
preoperatively misdiagnosed as intrahepatic cholangio-
carcinoma (ICC), and confirmed primary hepatic TB
by postoperative pathology.
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Results: Case 1: A 61 year-old male complained of
abdominal pain for 1 month. Abdominal CT revealed
multilobulated lesion measuring in 7 cm diameter in
segment 4 of the liver with focal peripheral intrahepatic
duct (IHD) dilatation, as well as extrahepatic invasion
to the hepatic flexure of colon. ICC was strongly sus-
pected, so that we performed Left hemihepatectomy
with segmental resection of transverse colon. Postoper-
ative pathology confirmed chronic granulomatous
inflammation with extensive necrosis. He took the anti-
TB medications for 9 months.
Case 2: A 77 year-old male was referred for a liver
mass on ultrasonography. CT scan showed well defined
mass in 3 cm diameter, but atypical dense lesion on
arterial phase in left lateral segment of the liver. MRI
revealed peripheral rim like enhancement and focal
peripheral IHD dilatation. We diagnosed with ICC, so
that we performed left lateral sectionectomy. Postoper-
ative pathology confirmed granulomatous inflammation
with extensive central necrosis. He took the anti-TB
medications for a year.
Conclusion: Primary hepatic TB is very uncommon and
lack of specific clinical manifestations and imaging fea-
tures, so it can be misdiagnosed. But, if the disease can
be confirmed by needle biopsy preoperatively, anti-TB
drug therapy can help to prevent unnecessary opera-
tion. Primary hepatic TB should be considered in the
differential diagnosis of solitary liver lesions.
APHPB-0453
BONE MORPHOGENETIC PROTEIN-4
INDUCES EXPRESSION OF
CONNECTIVE TISSUE GROWTH
FACTOR IN HEPATIC PROGENITOR
CELLS THROUGH SMAD DEPENDENT
SIGNALING
W. Wang, Z. Y. Ding, Y. M. Sun, Q. Lv, H. F. Liang,
J. P. Zhao, Y. A. Ni, W. X. Chen, Z. Zeng, B. X.
Zhang and X. P. Chen
Hepatic Surgery Centre, Tongji Hospital, Tongji
Medical College, Huazhong University of Science &
Technology, Wuhan, China
Objectives: In the present study, we sought to deter-
mine Bone Morphogenetic Protein-4 (BMP4) induces
connective tissue growth factor (CTGF) expression and
the signaling pathway related in Hepatic progenitor
cells (HPCs).
Methods: We carried out immunohistochemistry analy-
sis to confirm HPCs activation, BMP4 and CTGF
expression. We employed recombinant human BMP4
(rhBMP4) to determine the effects of BMP4 on CTGF
production in HPCs. We also designed small interfering
RNA targeting Smad1/5 (siSmad1/5) and detected
whether Smad1/5 knockdown affects rhBMP4-induced
CTGF expression.
Results: In this study, by immunostaining of human
liver sections, we confirmed that HPCs were activated
in the cirrhotic liver and secreted Bone Morphogenetic
Protein-4 (BMP4) and connective tissue growth factor
(CTGF). CTGF was an important inducer of liver
fibrosis. Besides, we used HPC cell lines LE/6 and WB-
F344 as in vitro models and found that BMP4 induced
secretion of CTGF in HPCs. Moreover, BMP4 signal-
ing was intracrine activated and contributed to autono-
mous secretion of CTGF in HPCs. Furthermore, we
found that BMP4 induced expression of CTGF was
mediated by BMP4 activated Smad signaling.
Conclusion: Taken together, our results provide evi-
dence for the role of HPCs in liver fibrosis and suggest
that the production of CTGF by BMP4 activated Smad
signaling in HPCs may be a therapeutic target of liver
fibrosis.
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APHPB-0454
SURVIVAL AFTER RESECTION OF
HEPATOCELLULAR CARCINOMA IN
CIRRHOTIC PATIENTS
M. Amer1, A. Sultan2, M. Abdel Wahab2, A. Fouad2
and M. El-Shobari2
1General Surgery, Mansoura University, Students’
Hospital, Mansoura, Egypt; 2Gastroenterology Surgical
Center, Mansoura University, Mansoura, Egypt
Objectives: Hepatocellular carcinoma (HCC) is one of
the world’s most common malignancies. It accounts for
more than 90% of all primary liver cancer. The aim of
this study is to evaluate the clinical and pathological
factors influencing the survival after resection of HCC
in cirrhotic patients.
Methods: The study was done on 175 patients with
liver cirrhosis underwent hepatic resection for HCC in
gastroenterology surgical center, Mansoura University,
Egypt.
Exclusion criteria::
1. Thrombosis of the main portal vein
2. Presence of extrahepatic metastatic deposits
3. Multifocal HCC involving both liver lobes
4. Child-Pugh B and C
All patients were followed up at 2 weeks interval in the
first 3 months and monthly thereafter using abdominal
ultrasound, alpha feto protein and abdominal com-
puted tomography if recurrence is suspected.
Results: Patients were 131 (75%) male and 44 (25%)
female with mean age of 54.8  9.8 years. Major hepa-
tic resection was done for 65 (37.1%) patients, segmen-
tectomy for 62 (35.4%) patients and localized resection
for 48 (27.4%) patients.
The median survival after surgical resection was
24 months. One year survival was 72%, 3 years sur-
vival was v42% while 5 years survival was 21%.
Factors which significantly predict the survival were
lymph nodes status, tumor differentiation, staging, cut
margin infiltration and vascular invasion.
Conclusion: Despite the resectability of HCC in cir-
rhotic patients, the over all survival remains dismal due
to high recurrence rate and the subsequent development
of liver cell failure.
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APHPB-0455
ADULT HEPATOBLASTOMA – A CASE
REPORT
B. Sathyamoorthy, R. Vellaisamy, S. Sankareshwaran,
A. Anbalagan, P. Raju, B. Duraisamy, K.
Devygounder and C. ServarayanMurugesan
Institute of Surgical Gastroenterology, Madras Medical
College, Rajiv Gandhi Government General Hospital,
Chennai, India
Objectives: Adult hepatoblastoma is a rare malignant
liver neoplasm. Surgery is the treatment of choice, but
recurrence is common even after complete resection. No
standard therapeutic strategy has been established so for.
Methods: A 14-year-old female presented with a rapidly
expanding right hypochondrial mass. Pain preceded the
appearance of the mass. Clinical examination revealed a
15 9 15 cm mass occupying the right hypochondrium
and epigastrium. 64 slice CECT Abdomen showed
15 9 11 9 9 cm multiseptated locuated mass lesion
involving right lobe of liver segment 5,6,7,8. Portal
Doppler study showed Right portal vein is displaced.
PET CT showed Activity noted in the liver, spleen, medi-
astinal nodes in the axilla and right side of neck sugges-
tive of lymphoma. USG guided biopsy done revealed
suspected Hepatic Adenoma with cholestasis. Preop
AFP was more than 30,000. With the preoperative diag-
nosis of ? Hepatic adenoma .The tumor was completely
resected off the inferior vena cava with Right hepatec-
tomy. The histopathological diagnosis was mixed he-
patoblastoma. Grossly the tumor was weighing about
2.5 kg. The postoperative course went smoothly.
Results: Hepatoblastoma is a rare malignant tumor of
the liver and usually occurs in the first three years of
life. Unusual that hepatoblastomas occur in adults. He-
patoblastoma is most often unifocal, responds well to
neoadjuvant chemotheraphy and resection is often pos-
sible. Early detection may lead to improved prognosis
and survival but they are often detected late.
Conclusion: We are presenting this case due to the rar-
ity of hepatoblastoma in adults and its preoperative
diagnostic difficulty and successful surgical treatment
with hepatectomy.
APHPB-0456
CYTOPLASMIC TRANSLOCATION OF
HIGH MOBILITY GROUP BOX 1
(HMGB1) IN ADJACENT
NONCANCEROUS TISSUE OF HUMAN
HEPATOCELLULAR CARCINOMA
(HCC) PROMOTES MALIGNANCY AND
PREDICT POOR PROGNOSIS
W. Yanjun1, L. Hui-fang2, Z. Bi-xiang2 and C. H. E.
N. Xiao-ping2
1Hepatic Surgery Center, The Second Affiliated Hospital
of Fujian Medical University, QuanZhou, China;
2Hepatic Surgery Center, Tongji Hospital, Tongji
Medical College, Huazhong University of Science and
Technology, Wuhan 430030, China
Objectives: High mobility group box 1 protein
(HMGB1) plays dual roles as both a nuclear protein
and a cytokine. In the cases of tumor, extracellular
HMGB1 plays a paradoxically dual effect, either as a
tumor promoter or inhibitor. However, few studies
about the role of extracellular HMGB1 in hepatocellu-
lar carcinoma (HCC) were reported. Hence, we investi-
gate the role of HMGB1 in HCC to further understand
the molecular pathogenesis of HCC.
Methods: In this study, we examined the HMGB1
expression in HCC and corresponding adjacent non-
cancerous specimens obtained from 155 patients by
immunohistochemistry, and in patients’ serum by
ELISA. HBx was transfected to a non-tumor liver cell
line, LO2, and its effect on HMGB1 was evaluated.
Results: Immunohistochemical study showed increased
cytoplasmic HMGB1 in 76.6% (119/155) adjacent non-
cancerous tissue samples compared to normal liver tis-
sues (0/18) and HCC tissues (27.1%). Cytoplasmic
HMGB1 overexpressed in adjacent noncancerous tis-
sues was significantly correlated with high hepatitis B
virus (HBV)-DNA load (p < 0.001) and high severity
of liver fibrosis (p < 0.01). High cytoplasmic HMGB1
levels also predict shorter disease-free (p = 0.006) and
overall survival (p = 0.016). LO2 cells transfected with
HBx secreted more HMGB1 compared to control
(p < 0.05). Extracellular HMGB1 treatment promoted
HCC cells migration and invasion with the involvement
of ERK1/2 activation.
Conclusion: This study indicated that HMGB1 cyto-
plasmic translocation in adjacent noncancerous tissue
of HCC promotes the tumor malignancy and predicts
poor prognosis, probably through activation of ERK
pathway. Targeting HMGB1 would be a novel thera-
peutic strategy of human HCC.
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APHPB-0457
INCIDENCE OF PANCREATIC FISTULA
AFTER DISTAL PANCREATECTOMY
AND ITS CLINICAL IMPLICATIONS
S. Samsudin, K. F. Lim, K. Raman and H. Singh
HPB Surgery, Hospital Selayang, Kuala Lumpur,
Malaysia
Objectives: To study the incidence of post-operative
pancreatic fistula (POPF) after elective distal pancrea-
tectomy (DP) and its impact on clinical outcomes.
Methods: A retrospective review was performed on 75
patients who underwent elective DP from 2001–2011 in
the HPB Surgery Department, Selayang Hospital. Data
was collected from patient records. POPF is defined
and graded based on International Study Group of
pancreatic Fistula (ISGPF) criteria (drainage output
after Day 3 of surgery with amylase content higher
than 3 times upper normal serum limit). Clinical out-
comes of length of hospital stay (LOS), readmission, in-
traabdominal abscess and mortality were analysed.
Results: POPF occurred in 50 pts (66.67%); Grade A
fistula (46 patients, 92%) and Grade B/C fistula (4
patients, 8%). 25 patients did not have POPF
(33.33%). Grade B/C fistulae resulted in significantly
longer LOS (37.5  17.3 days) than Grade A fistula
(15.3  9.4 days) or without fistula (14.3  12.6 days),
(p = 0.001). Intraabdominal abscess rates (100%) and
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hospital readmissions (50%) were also higher in Grade
B/C fistula as compared to Grade A fistula or without
fistula (p = 0.0001, 0.0323). Mortality rates (1 patient
with Grade B/C fistula died from a non-related cause)
were not significantly different (p = 0.1379). Patients
with Grade A fistula did not have significant difference
in outcomes from those without fistula (p > 0.05).
Conclusion: Incidence of POPF after DP is high.
Majority are Grade A fistulae which do not lead to sig-
nificant clinical outcome difference while Grade B/C
fistulae brings significant increase in morbidity.
Malignant HPB Diseases
APHPB-0458
OUR EXPERIENCE WITH SOLID
PSEUDO PAPILLARY NEOPLASM OF
PANCREAS
B. Sathyamoorthy, R. Vellaisamy, A. Anbalagan,
P. Raju, B. Duraisamy, K. Devygounder and C.
ServarayanMurugesan
Institute of Surgical Gastroenterology, Madras Medical
College, Rajiv Gandhi Government General Hospital,
Chennai, India
Objectives: Solid-pseudopapillary tumor of the pan-
creas (so-called Franz tumor) is a rare neoplasm of typ-
ically benign behavior, predominantly occurring in
young females .This study was designed to analyse clin-
icopathological characteristics of the rare disease, man-
agement strategy and outcome of this rare disease.
Methods: Total of 18 patients of solid-pseudopapillary
tumors of the pancreas (SPTPs) have been treated
between 1994 and 2013 .Out of 18, 17 patients were
female, 1 patient was male. Mean age of presentation
was 39 years of age. All under went thorough clinical
examinations, X Ray abdomen, CECT abdomen. Most
patients presented wih dyspepsia and abdominal pain
and abdominal lump. Regarding location of the
tumour, 8 presented as distal body and tail tumour, 6
at the head and 4 at the body. 8 patients were managed
with simple excision/enucleation of the tumour and 5
with distal pancreatectomy and splenectomy and 4 with
distal pancreatectomy and 1 patient managed with
whipples procedure.
Results: The clinical and radiological diagnosis was
confirmed by histological examination of the tumor. 2
Patients lost follow up .Neither short-term or long-term
surgical complications, nor metastases have been
recorded in the follow-up (mean-7 years).
Conclusion: Solid-pseudo papillary tumors of the pan-
creas are rare tumors. Despite rare presumptive diagno-
sis is possible, based on the fact that these tumors
particularly affect young females and radiological find-
ings show a tumor with solid and cystic parts. Radical
tumor resection is the therapeutic method of choice.
Although enucleation is discussed controversial it is a
viable option in very large encapsulated tumours in the
body.
APHPB-0461
SURGICAL OUTCOMES IN
HEPATOCELLULAR CARCINOMA
PATIENTS WITH PORTAL VEIN
TUMOR THROMBOSIS
D. Moon, S. G. Lee, Y. J. Lee, S. Hwang, K. H. Kim,
T. Y. Ha, G. W. Song, C. S. Ahn, D. H. Jung, G. C.
Park, T. H. Lim, W. H. Kang and S. H. Kim
Hepatobiliary Surgery and Liver Transplantation, Asan
Medical Center University of Ulsan College of Medicine,
Seoul, Korea
Objectives: The role of surgical resection and thromb-
ectomy for HCC with portal vein tumor thrombus
(PVTT) is controversial. This study aimed to evaluate
the effect of the extent of PVTT and curative resection
on the long-term outcomes of surgical treatment for
HCC.
Methods: A total of 227 patients with HCC and PVTT
underwent hepatic resection. The patients were divided
into 4 groups according to the level of PVTT: in PV1,
PVTT was located at subsegmental PV (25 patients), in
PV2, PVTT is located at sectional PV (58 patients), in
PV3, PVTT is located at right or left PV (116
patients), in PV4, PVTT extended into main PV (28
patients). In addition, PVTT patients were divided into
3 groups according to marginal status of resection: in
R0 (175 patients), in R1 (40 patients), in R2 (12
patients). We compared overall survival rates between
the groups.
Results: The cumulative 1-, 2-, 3-, and 5 year overall
survival rates were 61.3%, 45.5%, 37.3%, and 31.5%,
respectively. The overall survival rates between PV1, 2,
3, and 4 groups were not different, and the 5-year over-
all survival rate were 38.9%, 33.8%, 31.1%, and
29.4%, respectively. Meanwhile, the overall survival
rates between R0, 1, and 2 groups were significantly
different, and the 5-year overall survival rates were
36.9%, 19.2%, and 0%, respectively.
Conclusion: Hepatic resection with or without thromb-
ectomy for HCC with PVTT patients at our institution
yielded relatively better outcomes compared to the pre-
vious reports.
APHPB-0462
BORDERLINE RESECTABLE
PANCREATIC TUMORS: MULTIMODAL
APPROACH IMPROVES OUTCOMES
A. Mitra1, N. Shetty2, S. Patkar1, V. Ostwal3, R.
Engineer4, M. Goel1 and S. V. Shrikhande1
1GI and HPB Service Department of Surgical Oncology,
Tata Memorial Hospital, Mumbai, India; 2Department
of Radiology, Tata Memorial Hospital, Mumbai, India;
3Department of Medical Oncology, Tata Memorial
Hospital, Mumbai, India; 4Department of Radiation
Oncology, Tata Memorial Hospital, Mumbai, India
Objectives: Borderline Resectable Pancreatic Tumors
pose a management challenge. We aimed to assess the
impact of multimodality approach on outcomes of bor-
derline resectable (BR) pancreatic tumors.
Methods: Prospective database (January 2007–July
2014) was analyzed retrospectively. Pancreatic tumors
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were segregated into BR and locally advanced unresec-
table (LA) groups. The decision to operate upfront or
offer neoadjuvant therapy was based on predefined
radiologic criteria and on joint clinic decisions.
Results: There were 104 pancreatic tumors. 84 were
BR and 20 LA. In the BR group, 39 were treated with
neoadjuvant therapy and 38 underwent upfront resec-
tion. 7 were lost to follow-up without the start of treat-
ment and 3 after treatment. Amongst the neoadjuvant
therapy group, 22 were subjected to exploration and 17
not explored due to various reasons. Thus, of a total
60 (38 + 22) explorations, 50 were resected and 10 were
inoperable. R0 resection was achieved in 44/84
(52.4%). The median overall survival (OS) for BR
group (n = 74) was 31.8 months. The mean OS (med-
ian OS was not reached) for resected patients (n = 48)
was 53.2 months and for the unresected patients
(n = 26) it was 14.4 months (p = 0.000). Specifically for
adenocarcinomas, the median OS survival for the entire
cohort of BR tumors was 19.6 months; for the resected
(n = 32) vs. unresected (n = 23) it was 31.8 vs.
9.5 months (p = 0.002), respectively.
Conclusion: Multimodal approach in a dedicated refer-
ral centre greatly aids in attaining R0 resection in BR
pancreatic tumors in over 50% cases with survival ben-
efit comparable to resectable pancreatic tumors.
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APHPB-0464
COMMON BILE DUCT CALCULI – SRI
LANKAN EXPERIENCE
D. J. D. Jayasinghe, W. M. M. de Silva, T. Wijeratne,
B. D. Gamage and C. P. Punchihewa
University Surgical Unit, Colombo South Teaching
Hospital, Colombo, Sri Lanka
Objectives: This study describes demographic charac-
teristics of patients referred for endoscopic retrograde
cholangiography (ERCP) with suspected Common bile
duct (CBD) calculi and explore the association of CBD
calculi with concomitant pathologies of the biliary
tract. It evaluates the diagnostic and therapeutic value
of ERCP in suspected CBD calculi among a selected
population of patients in Sri Lanka.
Methods: This cross sectional study includes consecu-
tive, consented 200 patients referred for ERCP at Hep-
ato-biliary endotherapy unit, Colombo-south teaching
hospital, Sri Lanka from April 2013 to May 2014, with
suspected CBD calculi. Data was extracted using a
structured, pre-tested proforma and analyzed using
SPSS.
Results: CBD cannulation rate was 93% and 101
(54.3%) patients had CBD calculi. Majority with CBD
calculi were females (n = 62, 61.4%) and mean age at
presentation (46.6 years) was significantly lower than
males (56.5 years).
Commonest presentation was obstructive jaundice 85
(84.1%) while 13 (12.8%) had acute cholangitis. Most
calculi were found at distal CBD 54 (53.4%) and 11
(10.8%) had multiple calculi.
CBD strictures were associated with 17 (16.8%)
patients while 12 (11.8%) had Juxta-papillary duodenal
diverticuli and 18 (17.8%) had undergone a previous
cholecystectomy.
Majority required lithotripsy to clear the CBD with 84
(83.2%) had clearance at first attempt of ERCP. Acute
pancreatitis was the commonest post-ERCP complica-
tion 12 (11.8%) observed.
Conclusion: CBD calculi were present in half of the
patients who underwent ERCP for suspected calculus
disease. ERCP successfully achieved a CBD clearance
in majority of patients with CBD calculi.
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APHPB-0465
VALUE OF ALPHA FETO-PROTEIN IN
THE DIAGNOSIS OF
HEPATOCELLULAR CARCINOMA
(HCC) IN A DEVELOPING COUNTRY
N. Karunaratne, T. Samarasinghe, R. Jayawardena, T.
Wijeratne and A. Pathirana
Department of Surgery, Faculty of Medical Sciences,
University of Sri Jayewardenepura, Colombo, Sri Lanka
Objectives: AFP (alpha-fetoprotein) is a commonly
used tumour marker in the diagnosis of HCC. AFP lev-
els >400–500 ng/mL are considered diagnostic of HCC.
However the diagnosis is frequently made even with
lower levels. A significant percentage with HCC will
have AFP levels in the normal range. Evaluation of
AFP is not available in the government-funded hospi-
tals and is a costly investigation. Our study was con-
ducted to find the correlation between AFP levels and
the burden and possible aetiology of HCC in a cohort
of Sri Lankan patients.
Methods: Retrospective case note analysis of 113 con-
secutive patients with HCC presenting to a tertiary care
centre in Sri Lanka. Statistical analysis was done using
SPSS 20 software.
Results: The mean age was 62.8 years (range from 25 to
82) and only 21 were females. 64.3% had features of cir-
rhosis on imaging: with 41% belonging to Child’s A and
53.8% to Child’s B categories. AFP levels were within
normal limits in 48.8%. Twenty four percent were heavy
alcohol consumers. Cryptogenic cirrhosis was the possi-
ble commonest aetiological factor and only one patient
had a viral aetiology (positive for hepatitis B). There was
no statistically significant correlation of AFP levels with
the state of the liver (p = 0.84), tumour burden
(p = 0.36) or possible aetiology (p = 0.594).
Conclusion: AFP level does not appear to be useful in
the diagnosis of HCC, irrespective of the aetiology of
cirrhosis. A larger study would be necessary to confirm
our findings.
APHPB-0468
OUR INITIAL EXPERIENCE OF ALPPS
TECHNIQUE FOR COLORECTAL LIVER
METASTASES: CASE REPORT
W. F. Li, C. C. Wang and Y. J. Tseng
General Surgery, Chang Gung Memorial Hospital-
Kaohsiung Medical Center, Kaohsiung, Taiwan
Objectives: A patient with insufficient future liver rem-
nant (FLR) is excluded from surgical resection for the
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primary or secondary liver tumors because there is high
risk of post-hepatectomy liver failure. An innovative
surgical technique named associating liver partition and
portal vein ligation for staged hepatectomy (ALPPS)
has been developed recently. It is reported to increase
the FLR effectively and provide the chance of liver
resection for patients with initial unresctable liver
tumors. Our aim is to report our preliminary experi-
ence with ALPPS procedure.
Methods: We performed extended right hepatectomy
by ALPPS approach for 2 patients with colorectal liver
metastases in July 2013 and January 2014. The liver
volume, peri-operative complications and oncologic
outcomes were reported.
Results: The ALPPS was successfully performed in
these 47-year-old woman and 49-year-old man. The
pre-operative FLR volumes and FLR/total liver vol-
ume were 352 mL/22.0% and 349 mL/31.4%, respec-
tively. The intervals between two operations were 14
and 10 days. The post-operative FLR volumes were
511 and 552 mL, with a volume increase of 45% and
58%. Intra-abdominal infection, pleural effusion and
bile leak developed in the distinct patients. There was
not post-hepatectomy liver failure or post-operative
mortality. They presented intra-hepatic tumor recur-
rence 3 months and 2 months after operation.
Conclusion: The ALPPS approach induces significant
liver hypertrophy allowing major hepatectomy in our
patients otherwise considered unresctable. But, it
should be applied in selected case due to high morbid-
ity rate. And the oncologic outcome is needed to be
evaluated in further series.
APHPB-0469
SURVIVAL ANALYSIS FOLLOWING
CURATIVE RESECTION OF
HEPATOCELLULAR CARCINOMA
ACCORDING TO CAUSES OF
BACKGROUND LIVER PATHOLOGY
B. Jung1, S. Hwang1, S. Lee1, Y. Lee2, K. Kim1, C.
Ahn1, D. Moon1, T. Ha1 and G. Song1
1Division of Liver Transplantation and Hepatobiliary
Surgery, Asan Medical Cencer, Seoul, Korea; 2Division
of Hepatobiliarypancreatic Surgery, Asan Medical
Cencer, Seoul, Korea
Objectives: HBV infection is the most common back-
ground liver pathology in patients with HCC, but the
proportions of other causes are slowly increasing. This
study intended to evaluate the survival outcome of
HCC patients who underwent hepatectomy according
to the background liver pathology.
Methods: A retrospective review was undertaken for
724 HCC patients who underwent hepatectomy from
January 2000 to April 2012. The exclusion criteria
included CTP score >5, MELD score >7, ICG-
R15 > 10%, not R0 resection, HBV and HCV co-infec-
tion, and pT3b and pT4 on AJCC 7th staging system,
by which the background liver was regarded not cir-
rhotic and the primary tumor was locally controllable.
Results: Mean patient age was 51.5  10.0 years.
Background liver pathology was HBV in 611, HCV in
22 and alcoholic liver disease in 61. Preoperative treat-
ment was performed in 138. Preoperative AFP >20 ng/
mL and PIVKA-II >40 mAU/mL were 411 and 560.
Anatomical and non-anatomical resection were
performed in 546 and 178. Major hepatectomy was per-
formed in 229. No patient died of perioperative mortal-
ity within 1 month. Most patients with HBV viral
replication received antiviral treatment after surgery.
Patients proportions were pT1 in 544, pT2 in 162,
pT3a in 18. Overall 1-,3-,5- and 10-year survival rates
were 98%, 90%, 80% and 65% in pT1; 88%, 68%,
52% and 41% in pT2 (p = 0.000). Different
background liver pathology did not show any survival
difference in all-stage (p = 0.19), pT1 (p = 0.45) and
pT2 (p = 0.67) tumors.
Conclusion: This study revealed that the causes of
background liver pathology did not become indepen-
dent risk factor for HCC prognosis, probably due to
active antiviral treatment.
APHPB-0470
THE COMPARISON BETWEEN
NONINVASIVE FIBROSIS INDICES AND
INTRAOPERATIVE PORTAL VENOUS
PRESSURE FOR PREDICTING LONG-
TERM OUTCOME AFTER CURATIVE
RESECTION OF HEPATOCELLULAR
CARCINOMA
K. Natsuda, A. Soyama, M. Takatsuki, M. Hidaka,
I. Carpenter, A. Kinoshita, T. Kugiyama, T. Adachi,
A. Kitasato, T. Kuroki and S. Eguchi
Surgery, Nagasaki University Graduate School of
Biomedical Sciences, Nagasaki, Japan
Objectives: We reported the association between high
intraoperative portal venous pressure (PVP) and long-
term outcome after curative resection of hepatocellular
carcinoma (HCC). Although it is useful for predicting
patients’ survival, it is not possible to use for preopera-
tive evaluation. Recent studies show the efficacy of
noninvasive fibrosis indices such as APRI (AST/platelet
ratio index) and FIB4, those can be calculated by using
combinations of general liver function tests. We aimed
to examine the correlation between intraoperative PVP
and these indices, and also analyzed whether these indi-
ces can predict long-term outcome.
Methods: One-hundred and sixty-seven patients mea-
sured intraoperative PVP at the time of curative resec-
tion of HCC between 1992 and 2009 were enrolled.
Correlation between intraoperative PVP and noninva-
sive fibrosis indices was evaluated. All patients were
divided into three groups following previously reported
cut-off values; APRI: 0.5 and 1.5, FIB4: 1.45 and 3.25,
respectively. Overall survival (OS) and recurrence-free
survival (RFS) of each group was analyzed by Kaplan-
Meier method/log-rank test.
Results: APRI and FIB4 were significantly correlated
with intraoperative PVP (p < 0.001, respectively).
Long-term outcome of low-APRI group was signifi-
cantly better than that of medium-APRI group (OS:
p < 0.01, RFS: p = 0.03). There was no significant dif-
ference between medium and high-APRI groups. There
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was no significant difference among three groups
according to FIB4.
Conclusion: APRI and FIB4 might be alternative
markers of intraoperative PVP, and APRI was sug-
gested as a useful predictive factor after curative resec-
tion of HCC.
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APHPB-0471
NEEDLESCOPIC GRASPER ASSISTED
SINGLE INCISION LAPAROSCOPIC
BILE DUCT EXPLORATION IN
PATIENTS WITH FAILED ENDOSCOPIC
BILE DUCT STONE REMOVAL
K. Kim, C. An and J. Kim
Surgery, Uijong-Bu St. Mary’s Hospital, Uijongbu,
Korea
Objectives: Single incision laparoscopic surgery has
been reported to be safe and feasible in various clinic al
experiences. However, there are few reports about bile
duct stones so far. We present our early experience of
needlescopic grasper assisted single incision laparo-
scopic bile duct exploration (NSILBE). We hypothe-
sized that creating NSILBE protocol by adding a single
2 mm grasper at the level of mid-clavicular line would
restore triangulation while not contributing to patient
morbidity or jeopardizing the cosmetic outcome.
Methods: Between November 2011 and August 2014,
20 patients underwent NSILBE for biliary stone in sin-
gle institute by one surgeon. 20 patients with a mean
age 60.5 years (range 31–81) were identified. We used a
SILSTM (Covidien, Tyco health Medical) single-port
device for operation. Single port device was placed
through umbilicus. A (2 mm) needlescopic retractor
(Stryker, San Jose, CA, USA) was placed in the right
flank region directly through the abdominal wall for
retraction of the gallbladder infundibulum in an ante-
rior and cephalad direction. And snake retractor was
used for liver retraction.
Results: Patient all had a pathologic diagnosis of acute
gangrenous and chronic cholecystitis. Operative times
averaged 237.8 min (range 125–365 min). Postoperative
hospital stays averaged 3.7 days. There were no
instances of bile leak, soft tissue infection, abscess, her-
nia or bile duct injury. But two patients had a seroma
which was managed by sono-guided aspiration.
Conclusion: NSILBE is safe and feasible for removal of
bile duct stones. Liver retraction using a snake retrac-
tor is very useful in obtaining a critical view of safety.
Malignant HPB Diseases
APHPB-0473
FRESH FROZEN PLASMA
TRANSFUSION CRITERIA IN LIVER
RESECTION
S. Yamazaki, T. Takayama and M. Moriguchi
Digestive Surgery, School of Medicine, Nihon
University, Tokyo, Japan
Objectives: To establish transfusion criteria for use of
fresh frozen plasma (FFP) in liver resection.
Methods: Prospective study using a phase 1 dose
escalation, 3 + 3 cohort expansion design, modified for
FFP transfusion. We designated a serum albumin level
of 3.0 g/dL (step 1) as the starting limit for no transfu-
sion and reduced the level in 0.2 g/dL steps. Advance-
ment to the next step was permitted when the albumin
level equaled the target value for the previous step in 3
patients. The study continued until high-grade postop-
erative complications occurred without transfusion. If 1
of 3 patients developed Clavien-Dindo grade II or
higher complications, 3 more patients were added to
the same step.
Results: Of the 213 consecutive patients with liver can-
cer enrolled, 172 patients (80.8%) fulfilled the inclusion
criteria. Step progression proceeded until step 5 (albu-
min level, 2.2 g/dL) without high-grade complications,
but step 2 (albumin level, 2.8 g/dL) required 63 patients
to complete because 1 patient developed grade II com-
plications. Step progression was broken off at step 5 in
the 172nd patient because the postoperative day 2 albu-
min value did not fall below the step 4 level (2.4 g/dL),
defined as the goal limit. The overall operative morbid-
ity rate was 27.9%; the mortality rate was 0%. The
FFP transfusion rate was significantly reduced from
48.6% in a previous series involving 222 patients to
0.6% in the present study (p < 0.001).
Conclusion: In liver resection, FFP transfusion is not
necessary in patients with serum albumin levels higher
than 2.4 g/dL on postoperative day 2.
APHPB-0474
HEPATIC RESECTION FOR LARGE
HEPATOCELLULAR CARCINOMA
B. Kundil and S. Padman
Surgical Gadtroenterology, Pariyaram Medical College,
Kannur, India
Objectives: Treatment of Hepatocellular carcinoma
(HCC) remains a challenge, especially when the disease
presents at an advanced stage. The aim of this retro-
spective study was to determine the efficacy of liver
resection in patients who exceed University of Califor-
nia San Francisco (UCSF) criteria.
Methods: Between 2010 and 2014 may, 56 patients
with HCC underwent hepatectomy. Twenty-six of these
patients fulfilled UCSF criteria (group A) and 30 did
not (size > 8 cm) (group B). Disease-free survival and
overall survival rates were compared between the two
groups after resection.
Results: In all patients major or extended hepatecto-
mies were performed. One patient died in the postoper-
ative period (group B). Morbidity consisted of biliary
fistula (3%), pleural effusion 30% and pneumonia 3%.
Mean follow up 18 months. 6 patients in the group A
and 7 patients in group B developed recurrence. 3
patients in group A 4 in group B died in the follow up
due to worsening of liver function. Disease free survival
and overall survival are similar in both groups.
Conclusion: Surgical resection, if feasible, is suggested
in patients with large HCC and can be performed with
acceptable overall and disease-free survival and mor-
bidity rates.
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APHPB-0475
CORRELATION OF PHYSICAL
CHARACTERISTICS OF GALLSTONES
AND BILIARY ANATOMY IN
CAUSATION OF GALLSTONE
PANCREATITIS
S. Marwah, G. Yadav, S. Pandey, P. Singla and H.
Sharma
Surgery, Pt.BDSPGIMS Rohtak, Rohtak, India
Objectives: Gallstone disease is the most common pre-
ventable cause of pancreatitis. Gallstone migrating into
the biliary tract leading to obstruction and bile regurgi-
tation into pancreatic duct is considered to be one of
the mechanisms in causation of gallstone pancreatitis.
The present study was aimed to correlate of biliary
anatomy and physical properties of gallstones in causa-
tion of gallstone pancreatitis.
Methods: Prospective randomized study of 136 patients
of symptomatic gallstone disease undergoing elective
cholecystectomy over a period of 2 years. The study
group (30 cases) had gallstone pancreatitis and control
group (106 patients) had symptomatic gallstone disease
without pancreatitis. During surgery, biliary anatomy
was assessed by length, diameter, internal circumference
and level of insertion of cystic duct whereas gallstone
morphology was assessed by number and type of stones
with or without sludge and size of smallest and largest
gallstone.
Results: On univariate analysis, multiple gallstones,
diameter of the smallest gallstone ≤5 mm, irregular sur-
faced stones, sludge in gallbladder and cystic duct
diameter ≥5 mm were significant risk factors whereas
on multivariate analysis, diameter of the smallest gall-
stone ≤5 mm and cystic duct diameter ≥5 mm were
found to be significant risk factors in causation of gall-
stone pancreatitis (p < 0.05).
Conclusion: Both stone related (Small sized stones) and
pancreatobiliary anatomy (wide cystic duct) are signifi-
cant risk factors for causation of gallstone pancreatitis.
Such patients, even asymptomatic, should be offered
early surgery.
APHPB-0476
LAPAROSCOPIC HEPATECTOMY FOR
A HCC OF A PATIENT WITH ABSENCE
OF THE PORTAL BIFURCATION: A
CASE REPORT
Y. Kohira, K. Sakamoto, G. Honda, S. Kimura, M.
Honjyo, S. Kobayasi and M. Kurata
Surgery, Komagome Hospital, Tokyo, Japan
Objectives: Portal vein (PV) branches are one of the
most important anatomical landmarks during hepatec-
tomy, because anatomical variation of portal vein is
less than those of bile duct or hepatic artery. However,
because there are some rare dangerous anomalies of
PV, surgeons have to be careful about them.
Methods: Patient was 60s-year old male, who had
hepatocellular carcinoma related to chronic hepatitis C.
The tumor located at the caudal side of segment 4 and
compressed the hilar plate. Preoperative images
revealed anomaly of the PV branches; one was absences
of the left main PV with an alternative flow between
the right PV and the umbilical portion via the caudate
branches, and another one was absence of main P8
branch connecting to the anterior PV with an alterna-
tive flow between peripheries of P7 and P8 branches.
His liver function was affected; Child-Pugh was A but
ICG test (R15) was 27.2%.
Results: Laparoscopic partial hepatectomy was selected
and performed in order to avoid injuring to the com-
municating branch to the umbilical portion in the cau-
date lobe. Operative time was 267 min and blood loss
was 50 g.
Conclusion: The PV anomalies of this case can be
acquired one caused by compression by the tumor.
However, because the tumor did not compress strongly
and the communicating branch between segment 7 and
8 was well-developed, we believe that the PV anomalies
of this case was congenital. We achieved laparoscopic
hepatectomy for this patient safely by detecting the PV
anomalies with preoperative images and considering
about proper procedure carefully.
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APHPB-0477
ASSOCIATING LIVER PARTITION AND
PORTAL VEIN LIGATION FOR STAGED
HEPATECTOMY (ALPPS)
B. Kundil, S. Padman and S. A. B. U. Kadavil
Surgical Gadtroenterology, Pariyaram Medical College,
Kannur, India
Objectives: Associating liver partition and portal vein
ligation (PVL) has recently been described as a revolu-
tionary strategy to induce a rapid and large FLR vol-
ume increase. Aim is to describe early result of this
new approach for two patients with colorectal Bilobar
liver metastases.
Methods: Both patients were with synchronous liver
metastases. Both treated with chemotherapy before
liver resection.
Results: First patient with left colon growth with bi-
lobr liver metastases. She was treated with chemother-
apy 4 course, then taken up for laparoscopic left
hemicolectomy and metastatectomy of the left lobe and
ligation of right portal vein and partition of liver. After
3 weeks taken up for rt extended hepatectomy. Postop-
erative period was uneventful except for minor bile
leak. Other patient with rectosigmoid growth presented
with obstruction underwent anterior resection. He was
treated with chemotherapy 4 courses in the postopera-
tive period. He was then taken up for metastatectomy
in the left lobe, ligation of right portal vein and liver
partition. After 24 days he underwent right extended
hepatectomy. In the postoperative period he developed
biliary fistula, pleural effusion.
Conclusion: ALPPS is feasible and safe, with satisfac-
tory short-term results.
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APHPB-0478
REFRACTORY HYPOGLYCEMIA AS A
RARE CAUSE OF INITIAL
PRESENTATION IN PREVIOUSLY
UNDIAGNOSED HEPATOCELLULAR
CARCINOMA
J. Koong, E. S. Lim, P. S. Koh and B. K. Yoong
Surgery, University of Malaya, Kuala Lumpur, Malaysia
Objectives: Hypoglycemia presenting as the initial pre-
sentation in previously undiagnosed hepatocellular car-
cinoma (HCC) is extremely rare as it usually occur in
late stages of the disease. Association with insulin- like
growth factor 2 (IGF-2) has been a notable cause of
hypoglycemia in HCC. We report a case of probable
IGF-2 induced hypoglycemia associated with HCC pre-
senting as an acute emergency.
Methods: Literature review was done for this rare pre-
sentation.
Results: A 29 years old male presented to us with loss
of consciousness and blood glucose level was detected
at 1.3 mmol/L. There was a history of abdominal dis-
comfort with weight loss. Abdominal examination
revealed a palpable mass over the left liver lobe. Con-
trast enhanced computed tomography demonstrated a
left lateral lobe HCC measuring 17 9 11 9 18 cm.
Patient was also found to be Hepatitis B positive and
serum alpha feto protein was 79257 IU/mL. Hypogly-
cemia persisted despite continous dextrose infusion. A
serum insulin and IGF-1 level sent was low at 0.4 l/L
and 42 ng/mL respectively. Emergency left lateral hepa-
tectomy was performed with a segment 6 wedge resec-
tion for a lesion discovered on intra operative
ultrasound. Histopathological examination revealed a
moderately differentiated HCC. Post operative was
uneventful and hypoglycemia resolved.
Conclusion: IGF-2 induced hypoglycemia in HCC are
rare with only few reported in literature and even fewer
treated successfully by resection. The above case illus-
trated that hypoglycemia can be a presentation in HCC
albeit rare. Early and appropriate management is cru-
cial to ensure good overall outcome.
APHPB-0479
IMPROVEMENT IN CLINICAL
OUTCOME OF PATIENTS WITH
GALLBLADDER CANCER
J. Chang, J. Y. Jang, M. J. Kang, W. Jung, Y. C. Shin,
Y. R. Chang and S. W. Kim
Department of Surgery, Seoul National University
College of Medicine, Seoul, Korea
Objectives: Chronological changes in clinicopathologic
characteristics and survival outcomes of gallbladder
cancer (GBC) were investigated.
Methods: A total of 686 patients who consecutively
underwent surgery at Seoul National University Hospi-
tal between 1987 and 2014 were analyzed. Clinicopath-
ologic changes were explored according to the
treatment period (P), P1 (1987–2000, n = 249) and P2
(2001–2014, n = 437).
Results: Of the 686 patients, mean age was 63.3 years
and 52.3% (n = 359) were female. Stage I, II, III, and
IV were noted in 12.5%, 21.4%, 31.9%, and 20.7% of
patients, respectively. Proportion of extended cholecys-
tectomy (EC), cholecystectomy, pancreaticoduodenec-
tomy, and extended right hemihepatectomy were
42.1%, 32.4%, 5.0%, and 3.9%, respectively. R0 resec-
tion rate was 63.3%. Comparing P1 and P2, mean age
(61.2 vs. 64.6 years, p < 0.001), asymptomatic presenta-
tion (14.1 vs. 35.7%, p < 0.001), proportion of EC
(26.5 vs. 51.3%, p < 0.001), R0 resection (49.2
vs. 72.1%, p < 0.001), tumor below stage II (33.9 vs.
42.7%, p = 0.039), and the patients receiving adjuvant
chemotherapy (16.9 vs. 36.2%, p < 0.001) and radio-
therapy (8.4 vs. 24.9%, p < 0.001) were higher in P2.
Gender, elevated serum CA 19-9, combined gallbladder
stone, and N stage were comparable between the two
periods. Median survival (13.4 vs. 46.4 months, p < 0.001)
was better in P2, both in curative (p = 0.021) and palli-
ative (p = 0.013) groups. In curative resection group,
older age (p < 0.001), symptomatic presentation
(p < 0.001), perineural invasion (p = 0.012), and
advanced stage (p = 0.001) were independent poor
prognostic factors.
Conclusion: Earlier detection and optimal surgical
extent could improve the outcome of GBC over the
period. However, effective treatment strategy should be
developed for patients with poor prognostic factors.
APHPB-0480
THE CLINICAL USEFULNESS OF 18 F-
FLUORODEOXYGLUCOSE POSITRON
EMISSION TOMOGRAPHY/COMPUTED
TOMOGRAPHY (PET-CT) IN FOLLOW-
UP OF CURATIVELY RESECTED
PANCREATIC CANCER PATIENTS
W. Jung, J. Y. Jang, M. J. Kang, Y. R. Chang, J.
Chang, Y. C. Shin and S. W. Kim
Surgery, Seoul National University Hospital, Seoul, Korea
Objectives: The aim of this study was to evaluate the
clinical usefulness of PET-CT in comparison with CT,
and to explore the clinical potential of maximal stan-
dardized uptake value (SUVmax) in PET-CT as a met-
abolic biomarker.
Methods: Prospectively collected clinicopathologic fea-
tures including serum tumor marker, CT and PET-CT
results, recurrences and survival outcomes of 110
patients were reviewed.
Results: Overall recurrence rate was 76.4%. PET-CT
showed relatively higher sensitivity (84.5% vs. 75.0%)
and accuracy (84.5% vs. 74.5%) than CT. PET-CT in
combination with CT improved sensitivity (97.6%) and
accuracy (90.0%) than PET-CT alone. In terms of dis-
tant recurrences PET-CT showed higher sensitivity
(83.8% vs. 66.2%) and accuracy (87.2% vs. 76.4%) than
CT. PET-CT and CT had discordant results in 37
(33.6%) patients. There were 19 patients with false nega-
tive CT findings. Among these 19 patients, 11 had invisi-
ble lesion or suspected benign condition in CT, and the
other 8 had recurrences in uncovered area by abdominal
CT. Elevated SUVmax was not correlated with serum
CA19-9 (p = 0.288). The SUVmax was not correlated
with the survival outcome (p = 0.236). For these
patients, multiple site recurrence (HR 1.992, 95% CI
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1.197–3.316, p = 0.008) and CA19-9 > 37U/mL (HR
1.806, 95% CI 1.071–3.044, p = 0.027) were independent
risk factors of poor survival after multivariate analysis.
Conclusion: PET-CT in combination with CT improves
detection rate of recurrence after curative operation for
pancreatic cancers, especially for recurrences in uncov-
ered area with abdominal CT. More sensitive and prog-
nostic specific metabolic indicator other than SUVmax
is needed to improve the diagnostic value of PET-CT.
APHPB-0482
SURGICAL MANAGEMENT OF EXTRA
LARGE HCC
T. Lalisang
Surgery, FMUI/ Cipto Mangunkusumo Hospital,
Jakarta, Indonesia
Objectives: Large HCC referred to tumor more than
5 cm in diameter or involves two or more segments of
the liver, which is impact on the tumor recurrences and
remaining liver function should the resection be carried
out. The specificity of these extra large HCC cases
referred to the diameter of the tumor, which were more
than 10 cm.
As long as it is resectable and operable, the resection
can be done directly, aimed to obtain the better quality
of life. The strategy to have save resection is,
approached by pre operative TACE, Neo adjuvant
chemo-targeted therapy and preserving optimal Child-
Pough A liver function.
Methods: Retrogade case series.
Results: Since 2010, at Cipto Mangunkusumo Hospital
there were average 10 HCC cases were resected and
50% cases were extra large HCC during a year. This
has lead to the policy to a major liver resection. Pre-
operative TACE was done in all cases followed by the
resection in 2–3 weeks later. Anatomical resection with
optimal preservation of normal liver parenchyma and
in flow control was performed; even that the blood lost
were remain 1000–2000 mL. There were no operative
mortality, but the liver shut down found as the major
problem post-operatively. All the problems successfully
managed conservatively. Re-laparotomy found in one
case due to surgical bleeding. The survival was more
than 12 months on the most cases.
Conclusion: Resection was save on suitable large HCC
cases in order to provide a better quality of live.
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APHPB-0483
PANCREATIC FISTULA FOLLOWING
SURGERIES FOR NONPANCREATIC
PATHOLOGY
R. Vellaisamy, J. S. Jesudason, A. Anbalagan, B.
Duraisamy, P. Raju, C. Servarayan Murugesan and K.
Devygounder
Institute of Surgical Gastroenterology, Madras Medical
College, Rajiv Gandhi Government General Hospital,
Chennai, India
Objectives: To analyse the etiology, clinical presenta-
tion and management of pancreatic fistula following
surgeries done for Nonpancreatic pathology.
Methods: This is retrospective study between August
2013 to August 2014. Three patients with postoperative
pancreatic fistula were analysed. The surgeries they
have undergone were hepaticojejunostomy for Choled-
ochal cyst excision, Laprotomy and Excision for Retro-
peritoneal Benign cystic teratoma and Subtotal
colectomy + Distal pancreatectomy + splenectomy for
Splenic flexure growth.
S.
no Age Sex
Indication
and
Surgical
procedure
done
Time of
diagnosis
of
pancreatic
fistula
Duration of
Medical
management +
Percutaneous
drainage
Timing
of ERCP
1 28 F Choledochal Cyst
excision with
Hepaticojejunostomy
Pod 10 22 days Pod 22
2 32 F Laprotomy and
Excision for
Retroperitoneal
Benign cystic
teratoma
Pod 16 20 days on
treatment
–
3 50 F Subtotal colectomy
with distal
pancreatectomy and
splenectomy for
adenocarcinoma
of splenic flexure
Pod 7 28 days Pod 35
Results: All three patients were treated with percutane-
ous drainage and medical management. ERCP and
pancreatic duct stenting was done in 2 patients who did
not show improvement. Post ERCP the drain output
decresed in 11 and 40 days in 2 patients respec-
tively.The third patient was under treatment with per-
cutanous drainage with medical management.
Conclusion: Pancreatic fistula has to be kept in mind
inpatients undergoing biliary, splenic flexure of colon,
splenic and retroperitoneal surgeries. These Postopera-
tive pancreatic fistulae have to be managed conserva-
tively initially, if it fails ERCP and pancreatic duct
stenting have to be done.
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APHPB-0484
ASSOCIATION OF TUMOR BUDDING
WITH CLINICOPATHOLOGICAL
CHARACTERISTICS AND PROGNOSIS
IN PANCREATIC DUCTAL
ADENOCARCINOMA
K. Takizawa, M. Minagawa, K. Miura, M. Nagahashi,
J. Sakata, T. Kobayashi and T. Wakai
Digestive and General Surgery, Niigata University
Medical and Dental Hospital, Niigata, Japan
Objectives: Pancreatic ductal adenocarcinoma (PDAC)
is one of the most aggressive and lethal human malig-
nancies. Tumor budding, defined as the presence of de-
differentiated single tumor cells or small cell cluster at
the invasive front of carcinoma such as colorectal and
oesophageal, is a prognostic factor. The aim of this
study was to assess the prognostic impact of the tumor
budding in PDAC.
Methods: A total of 81 resected cases of PDAC was
examined. We defined tumor budding as an isolated
single cancer or a cluster composed of fewer than five
cancer cells. Whole-tissue sections were stained using a
pancytokeratin marker (AE1/AE3). Tumor budding
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was assessed in a microscopic field of 9200 and
counted. Cutoff points of the budding were determined
using v2 scores calculated with the Cox proportional
hazards regression model.
Results: Cutoff points of the budding were 13 or more
(v2 = 23.123, p < 0.001) in hematoxylin-eosin (H&E)
stained sections and 15 or more (v2 = 9.236, p = 0.002)
in sections with AE1/AE3 immunohistochemistry. High
grade budding evaluated with both standard H&E
(11.1% cases) and AE1/AE3 staining (43.2% cases)
correlated significantly with poor overall survival and
the histological grade. The cumulative 2-year survival
rates were 43.1% for patients with low grade budding
and 0% for patients with high grade budding stained
with standard H&E (p < 0.001). Multivariate analysis
revealed that the high grade budding, the histological
grade and the margin status were independent prognos-
tic factors.
Conclusion: The high grade budding is a strong and
independent prognostic factor.
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APHPB-0485
RUPTURED, LARGE INTRAHEPATIC
SUBCAPSULAR HEMATOMA AFTER
LAPAROSCOPIC CHOLECYSTECTOMY
J. Ryu, C. W. Chu, K. H. Yang, Y. M. Park and H.
Y. Lee
Surgery, Pusan National University Yangsan Hospital,
Yangsan-si, Gyeongnam, Korea
Objectives: The development of large subcapsular
hematoma after laparoscopic cholecystectomy (LC) an
infrequent complication and rarely reported. Fourteen
cases have been published with different etiologies
including use of NSAID’s like Ketololac during and
after surgery, hemangiomas or small iatrogenic lesions
aggravated by administration of ketorolac.
Methods: We report the case of a patient undergoing
LC developed the complication of a ruptured, large int-
rahepatic subcapsular hematoma. A 35 years old
woman was admitted because of symptomatic gall
stones with obstructive jaundice. MRCP showed papil-
litis due to passed stones, multiple gallstones. Medical
history was insignificant.
Results: She underwent LC. There was no compica-
tion. She was administered ketorolac 30 mg every 8 h
for 24 h. After 48 h, the patient had an episode of
RUQ pain. Blood test showed Hb of 6.6 g/dL. A CT
was checked and showed subcapsular hematoma of Rt.
liver and moderate amount of hemoperitoneum. She
underwent exploratory laparotomy and we found a
massive subcapsular hematoma of right liver and he-
moperitoneum. No iatrogenic lesions were found. The
hematoma wad drained we performed bleeding control
of hepatic surface. She recovered uneventfully. Follow-
up CT was performed 7 days after surgery and it
revealed no evidence of active bleeding. She was dis-
charged after 22 days.
Conclusion: The presence of an subcapsular liver hema-
toma after a LC is a rare complication few studied.
About the management: if the patient is stable the
hematoma can be observed or drained percutanously
with ultrasound guidance, and if instable laparotomy is
mandatory.
Transplantation
APHPB-0486
INDONESIA FIRST ADULT LIVING
DONOR LIVER TRANSPLANTATION IN
CIPTO MANGUNKUSUMO HOSPITAL
JAKARTA
T. Lalisang
Surgery, FMUI/Cipto Mangunkusumo Hospital,
Jakarta, Indonesia
Objectives: Nowadays, the liver transplantation
becomes the standard treatment of choice in end liver
diseases.
Report of the first Adult and Pediatric LDLT in Indo-
nesia.
Methods: Preliminary report.
Results: There were seven living donor LT were carried
out in 4 pediatric (male) and 2 adults (male). The pro-
gram commenced in December 2010, the team was sup-
ported by first affiliated Hospital Zhejiang University
LT team, Hangzhou China. In the last 3 pediatric
cases, the team was supported by NUSH Singapore LT
team. Management of LT in adult cases was the first
LT done in Indonesia. Indication of LT for pediatric
includes biliary atresia (2) and autoimmune liver dis-
ease (2), whileas in adult is HCC and hepatitis B. All
donors were genetically related and there was no opera-
tive complication found; as they live healthy back to
their routines and works following 2 weeks hospital-
ized. There were also no post–operative mortality, all
the children. The first adult case survived with a good
quality of life, but the other one died a year later due
to rejection. Prolonged ascetic and hyperspleenism were
noted as the most complication, which were success-
fully managed, conservatively. All the pediatric recipi-
ents received the left lateral lobe from adult donors,
and the adult received adult liver segment 5,6,7,8 with
preservation of the medial hepatic vein. The graft to
recipient ratio was 0.9% and 1%.
Conclusion: LDLT can be carried out with a good
result and more adult cases are required to pass the
learning curve.
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APHPB-0489
MANAGEMENT OF COLORECTAL
CANCER WITH SYNCHRONOUS LIVER
METASTASIS – EFFECT OF CLINICAL
RISK SCORE AND DIFFERENT
TREATMENT STRATEGY
Y. Cheung, K. Lee, M. Tang, E. Lo, R. Hung, H. Lok,
A. Fong, S. Chan, C. Chong, J. Wong and P. Lai
Department of Surgery, The Chinese University of Hong
Kong, Hong Kong, China
Objectives: To evaluate the impact of different surgical
strategy and clinical risk score on outcome of colorectal
cancer with synchronous liver metastasis.
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Methods: We performed a retrospective review for all
colorectal cancer with synchronous liver metastasis
receiving liver surgery in a teaching hospital from 2008
to 2013. Type of surgical treatment, timing of colorec-
tal and liver surgery and the tumor related factors were
reviewed. Memorial Sloan-Kettering Cancer Centre
Clinical Risk Score was used to stratify the severity of
liver metastasis with risk score 3 or above classified as
advanced metastasis. Survival analysis was performed
by log-rank test and Cox-regression in univariate and
multivariate analysis. Effect of staged versus combined
colorectal and liver resection on post-operative compli-
cations was evaluated with Chi-square test.
Results: Forty-two patients with synchronous liver
metastasis were included, of which 19 patients had
advanced metastasis. There was no significant prognos-
tic factor identified for overall survival. MSKCC clini-
cal risk score (p = 0.005) and type of liver surgery were
independent prognostic factors for disease-free survival.
Patients treated with radiofrequency ablation
(p = 0.025) were associated with a higher risk of local
recurrence as compared to hepatectomy alone. Staged
colorectal resection and liver surgery was associated
with lower post-operative complication (p = 0.026) as
compared to combined resection.
Conclusion: Use of radiofrequency ablation was associ-
ated with poorer disease-free survival in synchronous
liver metastasis. Staged resection had a comparable sur-
vival results and a lower post-operative complication
rate and thus should be considered in patients with
high operative risk or complex colorectal and liver
surgery.
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APHPB-0490
SURGERY FOR CHRONIC
PANCREATITIS IN CHILDREN OFFERS
CONSIDERABLE PAIN RELIEF: A
TERTIARY CENTER EXPERIENCE
V. Sivasubramaniam, M. Govindan, R. Palaniappan, J.
Sathyanesan, S. Perumal, R. Ramasamy, A.
Pitchaimuthu, K. Rajendran and K. Balaraman
Surgical Gastroenterology, Government Stanley Medical
College, Chennai, India
Objectives: Pain from chronic pancreatitis in children
and adolescents can lead to failure to thrive, malnutri-
tion, depression and disability. Surgical intervention
that improves pancreatic ductal drainage is a reason-
able treatment strategy for chronic pancreatitis in chil-
dren. The objective of this study is to document
considerable pain relief with surgery in children and
adolescents with chronic pancreatitis.
Methods: In our institution we treated 48 children and
adolescents with chronic pancreatitis from 2009 to 2013
over 4 years, almost all of them are idiopathic or tropi-
cal.
Results: Internal pancreatic fistulae were identified in 7
patients (ascites in 4 and pleural effusion in 3), pseudo-
cyst were observed in 4 patients. We observed endo-
crine (DM) and exocrine (steatorrhea) in 5 and 6
children respectively, splenic artery pseudo aneurysm
with bleed in 1 child, portal hypertension in 2 children
and biliary stricture in 1 child. 28 children were man-
aged conservatively, 14 of them developed recurrent
pain attacks and hence were subjected to surgery.
Totally 34 patients underwent surgery (Frey = 22,
LPJ = 10, distal pancreatectomy with LPJ = 1,
Berne = 1). IOUS was used for duct identification in 6
patients. Postoperative complications occurred in 7
patients (wound infection = 4, LRI = 1, Bleeding
requiring relaparotomy = 1, pancreatic leak = 1). There
was no mortality. Postoperative pain relief was
observed in all patients, 3 patients had readmissions for
pain attacks all of them had pain relief with oral anal-
gesics.
Conclusion: Surgery in children with chronic pancreati-
tis can be safe and feasible and offers symptomatic pain
relief in majority of patients.
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DIFFUSE TYPE HEPATOMA IN A
COHORT OF ALCOHOLIC AND
CRYPTOGENIC CIRRHOTICS
R. Siriwardana, M. A. Niriella, C. A. H. Liyanage, A.
S. Dassanayake, B. Gunathilake and H. J. De Silva
Surgery, North Colombo Liver Unit Faculty of
Medicine, Colombo, Sri Lanka
Objectives: Data on diffuse type hepatocellular carci-
noma (HCC) are rare. Incidence of HCC in Sri Lanka
is rising and majority are related to non alcoholic fatty
liver disease. The study was planned to compare nodu-
lar and diffuse type HCC.
Methods: Prospectively collected data of 227 patients
with HCC from July 2011 to July 2014 were analyzed.
Diffuse type cancer was defined as a tumour without
convex margin, diffusely infiltrating the hepatic paren-
chyma. There were 45 (20%) cases. The baseline liver
functions, etiology, treatment and the outcome were
compared with nodular type cancers.
Results: All cases except one were negative for infective
hepatitis. There was no difference in the age (63 vs.
62 years, p = 0.937) and gender. Low body mass index
(24 vs. 22, p = 0.009) and history of significant alcohol
intake (39% vs. 67%, p = 0.001) was associated with
diffuse type cancers. The baseline liver functions and
the clinical indicators of cirrhosis were similar in two
groups. Diffuse cancers had higher alpha feto protein
levels and higher incidence of major vascular invasion
(14% vs. 80%, p < 0.001). Large proportion (27% vs.
77%, p < 0.001) of diffuse cancers were not candidates
for active treatment. Overall survival was poor in dif-
fuse type (4.7 vs. 25 months, p < 0.001). None of the
prognostic factors or treatment had a significant impact
in the outcome of diffuse HCC.
Conclusion: Diffuse HCC are common in our cohort.
Alcohol consumption is a risk factor. These tumours
have a grave outcome irrespective of treatment.
© 2015 The Authors
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APHPB-0493
INTERNAL PANCREATIC FISTULAS –
AN ANALYSIS OF ALGORITHMIC
APPROACH AND COMPARISON OF
TREATMENT OPTIONS: EXPERIENCE
FROM A TERTIARY CARE CENTER
U. Muthuswamy, J. Sathyanesan, P. Senthilkumar, P.
Anbalagan, R. Kamalakannan, B. Kesavan, R. Ravi,
P. Ravichandran and G. Manoharan
Department of Surgical Gastroenterology, Stanley
Medical College, Chennai, India
Objectives: To assess optimal management strategies
and outcome, this study reviews and analyses the pat-
tern of presentation, management of internal pancreatic
fistula from a single tertiary care centre. This study also
aims at comparing the outcome of surgical treatment
with other treatment options and developing an algo-
rithmic approach.
Methods: Patients and Materials: An analysis of
patients who underwent treatment between March 2010
to March 2014 based on an institutional protocol was
performed. The end point was resolution of pancreatic
fistula, relief of symptoms and recurrence.
Results: Out of 38 patients, 22 had ascites 10 pleural
effusions and 6 presented with both conditions. Diag-
nosis was based on high amylase levels and albumin
content of exudates. Outcomes were analysed for
demographic variables, clinical variables. 36 patients
underwent initial conservative management. 17 patients
responded. Failure of conservative therapy was the
indication for endoscopic/surgical treatment in most
patients. 11 internal pancreatic drainage, 3 pancreatic
resection. 6 patients underwent Pseudocyst drainage
and 4 patients underwent endoscopic pancreatic duct
drainage. All these patients had relief of symptoms.
None had recurrence of ascites/effusion and none
required reoperation. One patient died of other cause.
Average time to resolution and morbidity were higher
with conservative approach. Nutritional status at
admission, background etiology, status of MPD were
significant factors in deciding treatment approach.
Conclusion: Despite Initial conservative approach,
selective early surgical approach is warranted to treat
pancreatic ascites and effusion in patients with severe
malnutrition and chronic pancreatitis. Internal pancre-
atic drainage was the ideal surgical treatment for
patients who did not respond to medical treatment.
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ADJUSTABLE LAPAROSCOPIC
RADIOFREQUENCY SURGICAL DEVICE
– LARA-K1: A NEW ATTITUDE TO
POSTERIOR SEGMENT LIVER
RESECTIONS
P. Vavra1, L. Karnik2, M. Skrobankova3, J. Palecek3,
P. Zonca1, J. Jurcikova4 and V. Prochazka4
1Department of Surgery, University Hospital Ostrava,
Ostrava, Czech Republic; 2Department of Robotic,
Faculty of Mechanical Engineering VSB – Technical
University of Ostrava, Ostrava, Czech Republic;
3Department of Surgery, Faculty of Medicine University
of Ostrava, Ostrava, Czech Republic; 4Department of
Vice-President for Science and Research, University
Hospital Ostrava, Ostrava, Czech Republic
Objectives: We have developed a new device, LARA-K1,
which after introduction into the abdominal cavity can
bend its long axis, allowing the application of radiofre-
quency energy in areas that are currently inaccessible
for laparoscopic surgery, such as posterior liver seg-
ments (IV, VII and VII).
Methods: The device is equipped with four telescopic
needle electrodes that coagulate tissue after delivery of
radiofrequency energy. Ex vivo testing was performed
in years 2012 and 2013 at the University Hospital
Ostrava on porcine liver tissue. The main goal of the
testing was to figure out, if the newly proposed elec-
trode layout is suitable for sufficient tissue coagulation
and creating a safety zone around tumors. We used a
laparoscopic simulator to evaluate the accuracy of the
device. We also monitored settings of power delivery,
time required for coagulation and adhesiveness of nee-
dle electrodes.
Results: During the ex vivo testing, material of needle
electrodes was improved to structural steel with special
coating which significantly decreased the adhesiveness.
We adjusted the power supply from 20W to 120W and
monitored the ablation time which varied from 110 to
10 s. Subsequently, optimal power delivery and time
for coagulation was determined.
Conclusion: This experimental study demonstrated the
feasibility and safety of the newly developed device.
Based on the ex vivo testing, LARA-K1 can create a
safety zone of coagulation. For further assessment of
the new device, we should perform an in vivo test.
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APHPB-0495
DIAGNOSTIC UTILITY OF PET-CT FOR
DIAGNOSIS OF PANCREATIC
ADENOCARCINOMA AND EARLY
INTRAEPITHELIAL NEOPLASIA
(PANIN). CASE–CONTROL STUDY OF
139 PATIENTS
F. Sanchez-Bueno1, R. Garcia1, J. De la Pe~na2, G.
Torres1, M. A. Claver3, L. Frutos3, E. Ortiz3, P. Gil1
and P. Parrilla1
1Surgery, Hospital Universitario Virgen de la Arrixaca,
Murcia, Spain; 2Pathology, Hospital Universitario
Virgen de la Arrixaca, Murcia, Spain; 3Nuclear
Medicine, Hospital Universitario Virgen de la Arrixaca,
Murcia, Spain
Objectives: Pancreatic ductal adenocarcinoma (PDA) is
a lethal disease with a 5-year survival rate of less 5%.
Surgical resection is the only curative treatment, but
due to its late clinical presentation very few patients
(15–25%) are candidates for curative resection. Thus,
early detection of noninvasive lesion (pancreatic intra-
epithelial neoplasia – panIN) and define early diagnos-
tic criteria of malignancy should be essential for early
treatment of this disease. The aim of this paper is to
determine the diagnostic utility of preoperative PET-
CT for early detection of ADP and early panIN
lesions.
Methods: Material and Methods: We studied the histo-
pathological features of ADP and different panIN
lesions (1, 2 and 3) in 139 surgical samples from
patients undergoing pancreatic resection in the period
from 2009 to 2012 in our hospital, comparing these
results with preoperative PET-CT and MDCT study.
Results: Histopathological analysis revealed that 71.2%
of patients with ADP had additional panIN lesions at
different stages. For tumor diagnosis in PET_TAC
maximum standard SUV 2.5 was used. Using this crite-
ria, the sensitivity of PET-CT for tumor diagnosis was
78% against 68% of MDCT. When we combine this
maximum tumor SUV with maximum normal pancre-
atic tissue from each patient SUV, the sensitivity of
PET-CT diagnosis for ADP increases to 92%. The sen-
sitivity of PET-CT using the same criteria for the diag-
nosis of lesions panIN was 96%.
Conclusion: A combination of studies of PET-CT in
tumor and non-tumor tissue of each patient can be a
very useful diagnostic tool not only for preoperative
diagnosis of ADP, but also for early panIN (1, 2 and
3) lesions.
APHPB-0496
PRE-OPERATIVE USE OF ANTIVIRAL
THERAPY IMPROVES PERIOPERATIVE
SURGICAL OUTCOMES IN PATIENTS
WITH HEPATITIS B VIRUS (HBV)-
RELATED HEPATOCELLULAR
CARCINOMA (HCC) UNDERGOING
MAJOR AND MINOR HEPATECTOMY
C. Chong1, G. Wong2, A. Fong1, S. Cheung1, J.
Wong1, K. Lee1, V. Wong2, H. Chan2 and P. Lai1
1Department of Surgery, The Chinese University of
Hong Kong, Shatin, Hong Kong, China; 2Department of
Medicine & Therapeutics, The Chinese University of
Hong Kong, Shatin, Hong Kong, China
Objectives: This study aims at evaluating the role of
pre-operative use of antiviral therapy in the improve-
ment of peri-operative surgical outcomes in patients
with HBV-related HCC undergoing hepatectomy.
Methods: Baseline characteristics, peri-operative
parameters and the use of antiviral therapy for all
patients with HBV-related HCC underwent major and
minor hepatectomy in an academic hospital were pro-
spectively collected from hepatectomy cohort and
reviewed.
Results: From 1999 to 2013, a total of 266 patients
received hepatectomy for HBV-related HCC and 149 of
them were on antiviral therapy before operation.
Patients’ demographics and tumor characteristics are
comparable between 2 groups. For the 105 patients
received major hepatectomy, the pre-operative antiviral
group was associated with a significantly lower overall
complication rate (p = 0.004), shorter total hospital
stay (p = 0.029) and less operative blood loss
(p = 0.009), despite a higher proportion of patients
with background cirrhosis (p = 0.026). There was no
significant difference in overall post-hepatectomy liver
failure rate (PHLF) between 2 groups (p = 0.757). For
the 161 patients received minor hepatectomy, there was
no significant difference in the overall complication
rate. However, the pre-operative antiviral group was
associated with a significantly lower incidence of pleu-
ral effusion (p = 0.024) and ascites (p = 0.015), lower
PHLF rate (p = 0.031) and shorter total hospital stay
(p = 0.002).
Conclusion: Pre-operative use of antiviral therapy
improves peri-operative surgical outcomes in patients
with HBV-related HCC underwent major hepatectomy
and minor hepatectomy and should be considered
before subjecting this group of patients to hepatec-
tomy.
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APHPB-0498
LAPAROSCOPIC SPLEEN-PRESERVING
DISTAL PANCREATECTOMY WITH
AND WITHOUT SPLENIC VESSEL
PRESERVATION – A COMPARATIVE
STUDY
S. Raveendran and B. Senadhipan
Department of Surgical Gastroenterology, Trivandrum
Institute of Digestive Diseases and Minimal Access
Surgery, Thiruvananthapuram, India
Objectives: This study is to compare the clinical out-
comes and potential spleen related morbidities of lapa-
roscopic spleen-preserving distal pancreatectomy
(LSPDP) with and without splenic vessel preservation
in patients with benign pancreatic lesions.
Methods: This is a retrospective analysis of all patients
who had undergone LSPDP in our institution during
the period Jan 2009- Jun 2014. Patients who underwent
LSPDP with Splenic Vessel Preservation (LSPDP-SVP)
were compared with those who underwent LSPDP with
Splenic Vessel Resection (LSPDP-SVR). The clinical
outcomes in terms of intra-operative parameters and
perioperative morbidities were compared.
Results: Of the 13 patients who underwent LSPDP,
SVP was done in 5 patients and SVR in 8 patients. The
mean operating time (210 vs. 180 min) and mean intra-
operative blood loss (250 vs. 160 mL) were significantly
lower in SVR group. No procedure was converted to
open, but one patient with attempted SVP was con-
verted to SVR because of accidental injury to splenic
vein. Mean postoperative hospital stay (7 vs. 8 days)
and general postoperative morbidities were similar in
both groups. But spleen related morbidities in the form
of significant splenic infarction was present in 2 (25%)
patients in SVR group and no patients in SVP group.
On a median follow up of 28 months (12–58 months) 2
patients in SVR group developed asymptomatic gastric
varices with no progression.
Conclusion: On comparison, LSDP-SVR is technically
easier but spleen related complications are more. The
short term benefits associated with the preservation of
the splenic vessels should lead to an increased prefer-
ence for LSPDP-SVP.
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APHPB-0499
PERIOPERATIVE SINGLE DOSE
ERTAPENEM PREVENTING SURGICAL
SITE INFECTION IN PATIENTS WITH
HEPATOCELLULAR CARCINOMA: A
RETROSPECTIVE STUDY
F. Xu1, C. Dai1, X. Bu1, C. Jia1 and S. Peng1
1Hepatobiliary and Splenic surgery, Shengjing Hospital
Of China Medical University, Shenyang, China
Objectives: Perioperative antibiotic prophylaxis is com-
monly believed to be effective in preventing postopera-
tive surgical site infection, but very few studies have
evaluated the usefulness of ertapenem prophylaxis after
liver resection. A retrospective study was conducted to
evaluate the role of ertapenem versus other standard
antibiotic prophylaxis in patients with hepatocellular
carcinoma undergoing hepatectomy.
Methods: This study was retrospectively analyzed the
clinical data of 118 patients with hepatocellular carci-
noma who underwent liver resection at our single cen-
ter between January 2012 and December 2013. The
patients were divided into ertapenem group (n = 54)
and nonertapenem group (n = 64). The ertapenem
group was only given a single dose ertapenem preoper-
ative half an hour as perioperative prophylaxis. The
nonertapenem group was given other antibiotics from
the preoperative half an hour until the temperature
back to normal for 3 days. Results and outcomes in
the two groups were compared.
Results: Groups were similar with respect to age (54.3
vs. 54.9, p > 0.05), gender and type of liver resection.
There were no significant differences between the two
groups in the incidence of surgical site infection (7.4%
vs 9.3%, p > 0.05), systemic inflammatory response
syndrome (12.1% vs 10.7%, p > 0.05), C-reaction pro-
tein on 3 days after surgery (64.9 mg/L vs. 58.3 mg/L,
p > 0.05) and the duration of postoperative hospital
stays (11.6 days vs. 12.4 days).
Conclusion: Postoperative antibiotic prophylaxis cannot
prevent surgical site infection after hepatectomy. The
patients with hepatocellular carcinoma given single
dose of ertapenem for perioperative prophylaxis suf-
fered low rates of surgical site infection, and needn’t
unnecessary and costly antibiotic prophylaxia postoper-
atively.
APHPB-0501
GROOVE PANCREATITIS VERSUS
PANCREAS CANCER: SEVEN CASES
F. Sanchez-Bueno1, G. Torres1, J. De la Pe~na2, M.
Fuster3, E. Ortiz2, R. Garcia1, P. Gil1, M. A. Claver4,
L. Frutos4 and P. Parrilla1
1Surgery, Hospital Universitario Virgen de la Arrixaca,
Murcia, Spain; 2Pathology, Hospital Universitario
Virgen de la Arrixaca, Murcia, Spain; 3Radiology,
Hospital Universitario Virgen de la Arrixaca, Murcia,
Spain; 4Nuclear Medicine, Hospital Universitario Virgen
de la Arrixaca, Murcia, Spain
Objectives: The Groove pancreatitis (PS) is an uncom-
mon clinical situation and radiologically can mimic car-
cinoma of the periampullary area. The objective of this
paper is to study a series of seven patients who under-
went surgery by pancreaticoduodenectomy (DPC), with
the diagnosis of pancreatic mass and subsequent ana-
tomopathological diagnosis of Groove.
Materials and Methods: During the last ten years,
seven patients who were operated on with the diagnosis
of pancreatic mass with high probability of pancreatic
ductal adenocarcinoma were resected by DPC. Postop-
erative histological confirmation was PS.
Results: Of the seven patients, six were male, with a
mean age of 51 years (range 39–70). Prior to surgery, six
patients had abdominal epigastric pain, two patients had
associated weight loss of more than 10 kilos in one
month, one for intractable vomiting and in another jaun-
dice was accompanied by progressive 12–15 mg/dL.
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CEA and Ca 19.9 were normal in all patients. Imaging
studies showed intrapancreaticas solid lesions in 5 of the
7 patients, and in the remaining two one papillary mass
of 5 and 6 cm, respectively, that caused stenotic in the
duodenal lumen. EUS neoplastic cells were negative for
all patients. Following the completion of the CPD, the
postoperative course was satisfactory in all seven
patients., Although one patient had frequent episodes of
recurrent acute pancreatitis with pseudocysts at five
years after the intervention.
Conclusions: The PS must be included in the differen-
tial diagnosis of pancreatic lesions, which may include
carcinoma of the periampullary area and other causes
of chronic pancreatitis.
Transplantation
APHPB-0502
THE IMPACT OF SPLENECTOMY ON
THE POSTOPERATIVE DEVELOPMENT
OF LABORATORY PARAMETERS IN
PATIENTS WITH LIVER TRANSPLANT
S. Hru?ovsk?1 and P. Hegyi1
1Internal Medicine Clinic, Slovak Medical University,
Bratislava, Slovakia
Objectives: Since 2008, our clinic, in cooperation with
the transplant surgical team, has performed fifty trans-
plant procedures on patients, out which seven patients
also underwent splenectomy. In order for us to achieve
some results in the given topic, we grouped together
patients who underwent both liver transplant and sple-
nectomy and those transplant patients who did not
undergo splenectomy. Since 2008, our clinic, in cooper-
ation with the transplant surgical team, has performed
fifty transplant procedures on patients, out which seven
patients also underwent splenectomy. In order for us to
achieve some results in the given topic, we grouped
together patients who underwent both liver transplant
and splenectomy and those transplant patients who did
not undergo splenectomy. The observation period: first
week, first three months and a year after liver trans-
plant. The aim of our work was to assess the develop-
ment of blood parameters in patients, who underwent
splenectomy at the same time as liver transplant proce-
dure.
Methods: Retrospective analysis.
Results: We found out that splenectomy significantly
prolonged the hospitalization of patients in the postop-
erative period in the surgical clinic.
Conclusion: The level of leukocytes and neutrophils sig-
nificantly increased from the second day until the third
month of liver transplant. Statistically, two weeks after
the liver transplantation the number of thrombocytes
significantly increased in the blood picture.
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APHPB-0503
TECHNICAL DEVELOPMENT OF A
NEW SEMI-SPHERICAL
RADIOFREQUENCY BIPOLAR DEVICE
(RONJA): EX VIVO AND IN VIVO
STUDY
P. Vavra1, M. Penhaker2, J. Jurcikova3, M.
Skrobankova4, J. Palecek4, M. Crha5, P. Delongova6,
N. Habib7, P. Ihnat1 and P. Zonca1
1Department of Surgery, University Hospital Ostrava,
Ostrava, Czech Republic; 2Department of Cybernetics
and Biomedical Engineering, Faculty of Electrical
Engineering and Computer Science VSB – Technical
University of Ostrava, Ostrava, Czech Republic;
3Department of Vice-President for Science and Research,
University Hospital Ostrava, Ostrava, Czech Republic;
4Department of Surgery, Faculty of Medicine University
of Ostrava, Ostrava, Czech Republic; 5CEITEC VFU,
University of Veterinary and Pharmaceutical Sciences
Brno, Brno, Czech Republic; 6Institute of Pathology,
University Hospital Ostrava, Ostrava, Czech Republic;
7Liver and Pancreas Surgery, Hammersmith Hospital
Imperial College London, London, United Kingdom
Objectives: Our aim was to develop a new semispheri-
cal surgical instrument for the bipolar multi-electrode
radiofrequency liver ablation. We tried to eliminate the
disadvantages of currently used instruments such as
ablation of healthy tissue, numerous needle punctures,
and therefore, longer operating procedure. We con-
ducted an ex vivo study on porcine liver tissue and an
in vivo study in order to assess its safety and feasibility
on a set of 12 domestic pigs. The main objective of the
testing was to find out if the newly constructed device
is suitable for sufficient tissue coagulation and for cre-
ating a safety zone around a tumor.
Methods: We created a model of the instrument by 3D
printing for the production of a prototype. Stainless
steel was used to produce the needle electrodes. The
new instrument RONJA has an asymmetrical electrode
layout, circle-shaped base, two wings with attached
needle electrodes and two connecting power wires
which power each wing separately. The ex vivo test was
then performed at the University Hospital Ostrava
using a standard radiofrequency generator. The in vivo
test was performed on a set of 12 pigs randomly
divided into two groups.
Results: Statistical analysis indicated that there were
not any significant differences between the groups of
pigs. The tested instrument RONJA performed the
operation with shorter ablation time in both liver lobes
and reduced the total operating time.
Conclusion: Further experimental studies are needed to
confirm these results before clinical application of the
method in the treatment of human liver malignancies.
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THE THERAPEUTIC EFFECTS OF
TRANSCATHETER ARTERIAL
CHEMOEMBOLIZATION AND LOCAL
REGIONAL THERAPY FOR
RECURRENT HEPATOCELLULAR
CARCINOMA
T. Zhen xiao1 and Z. H. Zhi wei1
1Hepatic surgery, Tongji Hospital Tongji Medical
College Hua Zhong University of Science and Tec,
Wuhan, China
Objectives: To compare the therapeutic effects of local
reginal therapy combined with or without transcatheter
arterial chemoembolization (TACE) for recurrent hepa-
tocellular carcinoma.
Methods: The study retrospectively collects 137
patients with recurrent hepatocellular carcinoma
(RHCC) from Jan 2008 to Dec 2010. They were
divided into three groups according to the different
treatments they received: TACE group (n = 52), local
reginal therapy (LRT) group (n = 31) and the combina-
tion group (n = 54). The overall survival (OS), time to
progression (TTP), length of hospital stay were ana-
lyzed.
Results: The average length of the hospital stay are
6.96 days, 5.81 days, and 9.44 days (p = 0.003) respec-
tively in TACE group, LRT group and combination
group. There is no mortality in 3 groups. 252 TACE
therapies and 165 LRT therapies have been carried out
in 137 patients. There are 2 (0.8%) patients who
received TACE treatment suffered hypoalbuminemia
and 2 (0.8%) suffered ascites, and for LRT therapy
there are 2(1.2%) patients suffered infection and 1
(0.6%) suffered hypoalbuminemia. The 1-,3-, and
5-year overall survival for the TACE group, LRT
group and the combination group were 65%, 39%,
17%, and 80%, 50%, 27%, and 85%,55%, 33%
respectively. The TTP of TACE group, LRT group and
combination group are 5.1 months, 7.3 months and
7.5 months respectively.
Conclusion: The combination of TACE and LRT was
safe and effective for RHCC, and could better prolong
the OS and TTP.
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TUBERCULOSIS MASQUERADING AS
BILIARY TRACT MALIGNANCY
N. Swamygowda1, V. K. Gunasekaran1, V.
Nanjegowda1, T. Gutti1 and V. Giriyappa1
1Surgical Gastroenterology, bangalore medical
collegeVictoria hospital, Bangalore, India
Objectives: Malignancy is considered to be the most
common cause of biliary stricture or mass in western
countries. It is prudent to differentiate benign lesions
from malignant ones so as to avoid unnecessary major
resections, that patient would undergo otherwise, to
reduce the morbidity. Even advanced imaging fails to
identify the nature of the lesion. We present our experi-
ence with tuberculosis (TB) of biliary tract which is
rare.
Methods: The records of patients operated for biliary
tract malignancy between 2008 and 2014 were retro-
spectively analysed from prospective database. In this
period 128 patients were operated with preoperative
diagnosis of biliary tract malignancy. Five patients (5/
128) had TB as their postoperative histopathology
diagnosis. Four patients had ceseating granulomas and
acid fast bacilli were demonstrated in a patient.
Results: Of 5 patients (4 men), 4 had biliary tract
tuberculosis and 1 had duodenal TB. The mean age of
presentation was 42 years (range 33–52). The most
common symptoms were abdominal pain (80%; 4/5)
and jaundice (80%; 4/5) followed by anorexia and
weight loss. Extrahepatic biliary obstruction was seen
in all patients. One (1/5; 20%) had evidence of old pul-
monary TB. All patients were diagnosed after surgery
and were started on ATT. One (1/5; 20%) patient
developed Grade A pancreatic leak which was managed
conservatively. No mortality seen. The median period
of follow up was 36 months (4–84 months).
Conclusion: In patients with atypical signs, TB should
be considered as a differential diagnosis, particularly in
endemic regions, and Intraoperative frozen section may
be considered to avoid unnecessary major resections.
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PRIMARY FOLLICULAR DENDRITIC
CELL SARCOMA OF THE LIVER OF
THE INFLAMMATORY
PSEUDOTUMOR-LIKE TYPE: A
REPORT OF ONE CASE AND A REVIEW
OF THE LITERATURE
F. Sanchez-Bueno1, R. Garcia1, A. Bas2, G. Torres1,
M. G. Lopez2, P. Gil1 and P. Parrilla1
1Surgery, Hospital Universitario Virgen de la Arrixaca,
Murcia, Spain; 2Pathology, Hospital Universitario
Virgen de la Arrixaca, Murcia, Spain
Objectives: Follicular dendritic cell sarcoma (FDCS) of
the liver is an uncommon pathologic entity, and only
16 cases have been reported previously. The aim of this
paper is to report a new case of primary FDCS of the
liver with a review the relevant medical literature.
Methods: We report the case of a 47-year-old woman
with a painful mass located in the epigastrium. The
abdominal ultrasound showed a mass that was con-
firmed by a CT scan as a large tumor mass in the left
liver lobe. Given the findings, the patient underwent
left hepatectomy.
Results: The surgical specimen measured 19 cm in
diameter, and the histology showed a well-circum-
scribed solid tumor composed of spindle cells and
numerous inflammatory cells, predominantly lympho-
cytes and plasma cells in a diffuse growth pattern. An
immunohistochemical study revealed a high proportion
of T-phenotype lymphocytes and a lower proportion of
B-cell phenotype lymphocytes. The tumor population
showed positivity for CD45, CD68, CD23 and EBER.
The result for CD21 was negative.
Conclusion: In conclusion, the inflammatory pseudotu-
mour (IPT)-like variant of FDCS of the liver is consid-
ered a separate entity, with different clinical,
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pathological and immunophenotypic features than
those of the classic FDCS. Therefore, it is crucial to
successfully integrate clinical, histological and immuno-
phenotypic data for the correct diagnosis of this rare
tumor.
APHPB-0507
RELATIONSHIP OF SERUM ALPHA
FETO-PROTEIN AND VIRAL HEPATITIS
WITH HEPATOCELLULAR
CARCINOMA IN A MULTI-ETHNIC
POPULATION: A SINGLE INSTITUTION
REVIEW
A. Zambri1, J. Koong1, P. Koh1 and B. Yoong1
1Hepato-pancreato-biliary Unit, University Malaya
Medical Centre, Kuala Lumpur, Malaysia
Objectives: The use of alpha feto-protein (AFP) mea-
surement is still widely practised in the management of
patient with HCC in this region although not recom-
mended as a diagnostic and screening tool due to its
low specificty and sensitivity in recent literature. This
study aim to look into the relationship between AFP
and viral hepatitis with HCC treated in a single institu-
tion practice on a multi-ethnic population.
Methods: A retrospective analysis of patients with
HCC from 2011 to 2013 was reviewed. Their demo-
graphics and clinicopathological data were obtained.
The viral hepatitis status and serum alpha feto-protein
in patients with HCC were analyzed.
Results: 81 patients with hepatocellular carcinoma were
identified during study period. It is most common in the
ethnic Chinese group (58%) followed by the Malays and
Indians with a median age of 61.9 years. The incidence
of viral hepatitis was 43.2% (n = 35) where majority
were Hepatitis B (85.7%, n = 30). Our study also showed
that only 42% (n = 34) of HCC patients showed signifi-
cantly raised AFP levels (>200 ng/mL). Of these raised
AFP levels only 12 had positive Hepatitis B with the rest
(n = 22) being negative for Hepatitis B which was found
to be not significant (p = 0.782). Patient with Hepatitis
C and HCC did not show raised AFP levels interestingly.
Conclusion: Serum AFP level was comparable in both
HCC patients with known viral and non-viral hepatitis
as it did not show any significant difference in a multi-
ethnic population, which conforms to most literatures.
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APHPB-0508
BILE REFLUX AND DELAYED GASTRIC
EMPTYING AFTER RETROGASTRIC
RETROCOLIC GASTROJEJUNOSTOMY
IN WHIPPLE PROCEDURE
R. C. Siriwardana1, A. Rajapaksha1, S. K. Liyanage2
and S. J. S. Hewavisenthi2
1Department of Surgery, Faculty of Medicine University
of Kelaniya, Colombo, Sri Lanka; 2Department of
Pathology, Faculty of Medicine University of Kelaniya,
Colombo, Sri Lanka
Objectives: With increasing survival following Whipple
surgery, quality of life in long term surviving patients
has been an important issue. Delayed gastric emptying
and bile reflux are important long term complications.
Objectives: As the standard practice we perform retrog-
astric retrocolic gastrojejunostomy. Study was designed
to assess the microscopic features and clinical symp-
toms following Whipple procedure.
Methodology: All patients who have undergone Whip-
ple procedure in a tertiary care surgical unit from 1/6/
2012 to 1/6/2014 who were off any adjuvant therapy
for last 3 months were selected. Patients underwent
orogastrodudenoscopy and multiple biopsies were
taken. Specimens were fixed and stained in Haemotoxy-
lin-Eosin and Giemsa stains. Two pathologists individ-
ually reported histological findings using a standard
visual scale (‘The Sydney system’). Bile reflux index
was calculated using the standard formula.
Nepean Dyspepsia Index-short form (NDI-SF) was
used to clinically assess the severity of functional dys-
pepsia. This was compared with endoscopic and micro-
scopic findings.
Results: Fifteen patients, 5 males and 10 females were
included in the study. Median age was 48 years (range
21–66 years)
Endoscopic findings revealed 12 out of 15 patients
(80%) had macroscopically detectable bile reflux
(66.7% yellowish bile, 13.3% greenish bile).
Mean NDI score was 23.9 and 12 patients had an NDI
score of 15 or more. Duration after surgery was not
significantly associated with NDI score (p = 0.92).
Conclusion: Fifteen patients, 5 males and 10 females
were included in the study. Median age was 48 years
(range 21–66 years).
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APHPB-0509
OUTCOMES OF EMERGENCY LIVER
RESECTION FOR SPONTANEOUSLY
RUPTURED HEPATOCELLULAR
CARCINOMA: SINGLE CENTRE
EXPERIENCE
H. Lok1, K. F. Lee1, P. Lai1, J. O. H. N. Wong1, S.
Cheung1 and C. Chong1
1Surgery, Prince of Wales Hospital, Hong Kong, Hong
Kong China
Objectives: Spontaneous rupture is a life threatening
complication of hepatocellular carcinoma (HCC) and is
associated with poor prognosis. Transarterial emboliza-
tion (TAE) is effective in achieving hemostasis in cases
of ruptured HCC. However, emergency liver resection
has important role as salvage procedure when TAE
failed or contra-indicated and as staged procedure after
initial hemostasis achieved.
Methods: Patients underwent emergency liver resection,
either as one stage or staged procedure, were reviewed
in terms of patient demographics, pre-rupture HCC
status, operative details, complication profiles and sur-
vival.
Results: From 2006 – 2014, 9 patients (9 male, median
age 57, range 30 – 82) underwent emergency liver resec-
tion for spontaneous ruptured HCC. 5 (56%) patients
had liver cirrhosis (Childs’ A). 8 patients did not have
known diagnosis of HCC before presentation as rup-
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tured HCC and the remaining patient has newly diag-
nosed, treatment-na€ıve HCC.
Three patients had emergency liver resection without
preceding angiogram. 3 patients had emergency salvage
liver resection after failed hemostasis by TAE. 3
patients had staged liver resection after hemostasis
achieved with TAE. Median operative time was
218 min (range: 90 – 295) and median blood loss was
2042 mL (range: 650 – 6074).
Median follow-up duration was 20 months. There was
no 30-days mortality. Two cases of morbidities were
recorded (1 pleural effusion, 1 post-op haemorrhage
necessitate re-laparotomy on day 0). Estimated median
survival by Kaplan-Meier analysis was 28 months.
Conclusion: Emergency liver resection for ruptured
HCC has acceptable outcome in selected patients.
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APHPB-0510
CHANGING TRENDS IN OUTCOME OF
BILIARY VERSUS NON-BILIARY
PANCREATITIS: DO WE NEED TO
CHANGE OUR MANAGEMENT? AN
AUDIT AT A TERTIARY CARE
HOSPITAL FROM SOUTH ASIA
A. Jiwani1 and M. Khan1
1Department of Surgery, Aga Khan University Hospital,
Karachi, Pakistan
Objectives: The objective of our study was to audit our
experience at Aga Khan University Hospital with a
view to summarize the difference between clinical out-
comes of biliary vs. non-biliary acute pancreatitis.
Methods: Of 351 adult patients who presented to
AKUH between Jan 2009 and Dec 2013 with acute
pancreatitis were included in the study. The data were
retrospectively collected on a designed performa.
Depending on the underlying etiology, the patients with
biliary pancreatitis were compared with non-biliary
type in terms of age, gender, co-morbid conditions,
severity of the disease, need for intervention (s), need
for ICU, length of hospital stay, morbidity, and mor-
tality. Mean and standard deviation were used for con-
tinuous variables and chi square test was used for
statistical analysis of categorical data.
Results: The proportion of biliary vs. non-biliary pan-
creatitis was similar in our study. Non-biliary acute
pancreatitis was more common in younger age (62.4%;
p = 0.003) and males (60.7%; p = 0.001), as compared
to biliary group. The proportion of patients with severe
pancreatitis (p = 0.052), organ failure (p = 0.076),
infected pancreatic necrosis (0.067), and need for surgi-
cal intervention (p = 0.06) was comparable in the two
groups. The need for ICU stay (p = 0.042), and overall
mortality rate (1.73% vs. 9.8%, p = 0.002) was higher
in the non-biliary group
Conclusion: Non-biliary acute pancreatitis was as com-
mon as biliary pancreatitis in our population, but
seems to have higher mortality. The work up for non-
biliary pancreatitis needs to be standardized.
APHPB-0512
LONG TERM RESULTS AND QUALITY
OF LIFE AFTER BILIARY
RECONSTRUCTION FOR BILE DUCT
INJURIES
A. Sultan1 and M. Shobary1
1Digestive surgery, gastro-enterology surgical center,
Mansoura, Egypt
Objectives: Biliary enteric anastomotic stricture
(BEAS) is reported to range from 2 to 25%. This is the
most important complication with serious consequences
as recurrent cholangitis and secondary biliary cirrhosis.
Methods: A retrospective study of patients who under-
went biliary enteric anastomosis (BEA) for the treat-
ment of bile duct injuries (BDI) in the Gastro-
enterology Surgical center, Mansoura University,
Egypt, between January 1992 and December 2007. The
primary outcome was the development of BEAS as
classified by Terblanche et al, 1990. MRCP was the
method of choice for evaluating the anastomosis when
required.
Results: 171 patients were eligible for the study. 156
(91.2%) followed open cholecystectomy while 15
(8.8%) followed laparoscopic cholecystectomy. Radio-
logical or surgical interventions preceded biliary recon-
struction in 107(62.6%) patients. 119(69.6%) patients
underwent hepaticojejunostomy, while 52 (30.4%)
patients underwent Hepp Couinaud operation. Long
term follow up was obtained in 120(70.2%) patients
with a mean follow up period of 13747 months.
Anastomotic stricture was detected in 14(11.6%)
patients. 4 patients were managed surgically, 2 patients
improved on percutaneous dilatation while conservative
treatment was employed in 8 patients. One patient
(0.8%) reported cholangitis with no evidence of anasto-
motic stricture on MRCP. The outcome was excellent
in 74(61.7%), good in 31 (25.8%), fair in 8(6.7%) and
7 (5.8%) patients.
Conclusion: Hepaticojejunostomy for BDI is safe with
good overall long term results.
Malignant HPB Diseases
APHPB-0513
PANCREATICODUODENECTOMY IN
MANAGEMENT OF PERIAMPULARY
TUMOR: SURVIVAL, MORBIDITY AND
MORTALITY. A SINGLE TEAM
INDONESIAN EXPERIENCE
T. Lalisang1 and T. Lalisang1
1Surgery, FMUI/ Cipto Mangunkusumo hospital,
Jakarta, Indonesia
Objectives: Report the first and largest series of pan-
creatico-duodenectomy (PD) 0n periampulary (PT) in
Indonesia.
Methods: Case series, retrograde.
Results: Hundred forty four malignant PT, 7 benignm
and 1 recurrent colon cancer were resected, on 84 male,
mean age 51 years. The location were 40% pancreatic
head, 38% Vateri, 14% duodenum. 4% benign tumor,
mostly indicated adenocarcinomas, with addition signet
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ring cell, LM, GIST, and adenosquamouscarsinoma.
Pathology staging 21.5% stage I, 49.5% stage II, and
25.7% stage III.
Preoperative average of albumin 3.42 mg/dL and total
bilirubin 7.13 mg/dL. Preoperative biliary decompres-
sion were performed in 93 cases and mostly using endo-
scopic stent or open cholecystostomy
PPPD, classic Whipple and total pancreatectomy, were
carried out 63.8% (98/155), 34% (54/155) and 1.9%
(3/155) consecutively. The mean operative time were
439.1 min, blood lost, 777.4 mL and relaparotomy in
14.3%.
The resection load were 10–15 cases/yearly with opera-
tive overall death 18.35 which decrease to 13.8%.from
33% when started. COD 58.6% due to were sepsis with
MOF and ARDS, postoperative bleeding in 6 cases.
One case died following aspiration. Overall morbidity
were 48.7%, consist of post-operative bleeding 14.4%
and 16.1% pancreatic/bile leak.
There were 126 survivors, and the overall survival was
14, 4 months, there are a couple survive till now
(96 months). Lost of follow up 21 cases.
Conclusion: Selection is important, survival become
better, due to resection rate increase more than 10 cases
per annually.
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APHPB-0514
PERCUTANEOUS DRAINAGE OF
NECROTIZING PANCREATITIS. A CASE
SERIES AND LITERATURE REVIEW
V. Leow1, K. Mannierajah2, C. Tee2, V. Letchumanan2
and M. K Subramaniam2
1HPB Unit Division of Surgery Department of General
Surgery, Advanced Medical and Dental Institute AMDI
Science University of Malaysia USM and Sultanah
Bahiyah Hospital, Penang, Malaysia; 2HPB Unit
Division of Surgery Department of General Surgery,
Advanced Medical and Dental Institute (AMDI) Science
University of Malaysia (USM) and Sultanah Bahiyah
Hospital, Kedah, Malaysia
Objectives: The management of necrotizing pancreatitis
has changed over the years. More and more institutions
have advocated a less invasive method in managing this
disease entity. This case series aimed to support the use
of interventional radiological method in the treatment
of pancreatic necrotic collection.
Methods: This was a case series involving 17 patients
diagnosed with necrotizing pancreatitis from the year
2013 to 2014. The study subjects were in house patients
and some referral from nearby hospitals. Study param-
eters such as patient demographic profiles, clinical find-
ings, laboratory results, imaging and treatment
modalities have been recorded. The patients were still
being follow up. Descriptive statistical analysis was per-
formed.
Results: The age of the study subjects were ranged
between 17 and 72 years old. Majority of them were
male. More than 80% of the necrotizing pancreatitis
was secondary to gallstone pancreatitis. The common-
est clinical findings were tender upper abdomen and
vomiting. Deranged ALP and ALT were seen as well.
A total of 17 cases were collected during this study per-
iod. All patients underwent abdominal ultrasonography
and computed tomography of the hepatobiliary system.
Six cases underwent percutaneous drainage successfully
and all were later discharged well.
Conclusion: We believe majority of necrotizing pancre-
atitis can be managed with percutaneous drainage.
Necrosectomy should be reserved for cases where
drainage failed.
APHPB-0518
BILE REFLUX AND QUALITY OF LIFE
AFTER RETROGASTRIC RETROCOLIC
GASTROJEJUNOSTOMY IN WHIPPLE
PROCEDURE
A. Rajapaksha1, R. C. Siriwardana2, S. K. Liyanage3
and S. J. S. Hewavisenthi3
1Department of Surgery, Faculty of Medicine University
of Kelaniya, Colombo, Sri Lanka; 2Department of
Surgery, Faculty of Medicine University of Kelaniya,
Colombo, Sri Lanka; 3Department of Pathology, Faculty
of Medicine University of Kelaniya, Colombo, Sri Lanka
Objectives: With increasing survival following Whipple
surgery, quality of life in long-term survivors has
become an important issue. As the standard practice,
we perform retrogastric retrocolic gastrojejunostomy.
Study was designed to assess the macro and micro-
scopic bile reflux and clinical symptoms of dyspepsia
following Whipple procedure.
Methods: All patients who had undergone Whipple
procedure from June 2012 to June 2014 were included.
Patients with recurrence and ones who had chemother-
apy within last three months were excluded. Included
patients (n = 15) underwent orogastrodudenoscopy and
multiple biopsies were taken. Specimens were reported
using ‘The Sydney system’. Bile reflux index was calcu-
lated using a standard formula. Nepean Dyspepsia
Index-short form (NDI-SF) was used to clinically
assess the severity of functional dyspepsia.
Results: There were 5 males and 10 females with a
median of 48 years (range 21–66). Endoscopically 12/15
(80%) had macroscopic bile reflux (66.7% yellowish
bile lake, 13.3% greenish bile lakes). None had stromal
ulcers or macroscopic inflammation. Mean NDI score
was 23.9(2.27) and 12 had NDI score of 15 or more.
Males had a mean score of 25.6 and females had a
mean score of 23 (no significant difference p = 0.605).
Mean histological score was 10.87. Duration after sur-
gery was not significantly associated with NDI score
(p = 0.92). There was no significant relationship
between macroscopic appearance of reflux and NDI
score (p = 0.233) or histological severity (p = 0.285).
Conclusion: Bile reflux after retrocolic retrogastric gas-
trojejunostomy is very common and its significantly
affecting the quality of life of these patients. Severity of
symptoms did not significantly correlate to endoscopic
findings or histologically severe bile reflux.
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APHPB-0519
FEASIBILITY TO
PANCREATICOJEJUNOSTOMY FOR
CHRONIC PANCREATITIS
T. Saito1, M. Watanabe1, K. Asai1, H. Matsukiyo1, T.
Niitsuma1, M. Kujiraoka1, Y. Saida1 and S. Kusachi1
1Surgery, Toho University Ohashi Medical Center,
Tokyo, Japan
Objectives: To evaluate the feasibility of pancreaticojej-
unostomy for chronic pancreatitis complicating pancre-
atolithiasis.
Methods: Patients who underwent pancreaticojejunos-
tomy for pancreatolithiasis to decompress the pancre-
atic duct from 2008 to 2014 were included. We
analyzed the short-term outcomes after pancreaticojej-
unostomy in these patients.
Results: Thirteen patients underwent pancreaticojejun-
ostomy for chronic pancreatitis; 4 underwent cholan-
gioduodenostomy for biliary stricture at the lower
biliary duct and 1 underwent distal pancreatectomy
and splenectomy for a retention cyst. Eleven patients
were man, and 2 were woman. The cause of chronic
pancreatitis was alcohol-related in 11 and idiopathic in
2 patients. The median follow-up period was 328 days
(range: 17–2190 days). The mortality rate was 0%. The
rate of Clavian 3 and 4 complications was 0%. Long-
term postoperative pain control was good in twelve
patients but one patient underwent endscopic pancre-
atic stenting for abdominal pain due to delayed stric-
ture of pancraticojejunostomy. The International Study
Group on Pancreatic Fistula grade B and C fistula rate
was 0%. The median operative time was 320 min
(range: 219–488 min). The median volume of bleeding
was 185 mL (range: 15–615 mL).
Conclusion: It is feasible and available that pancreat-
icojejunostomy is few perioperative complications and
pain control is good for chronic pancreatitis complicat-
ing pancreatolithiasis.
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APHPB-0520
5-AMINOLEVULINIC ACID-INDUCED
FLUORESCENCE RELATES TO THE
GEMCITABIN CLEARANCE IN
PANCREATIC CANCER
M. Minagawa1, K. Takizawa1, K. Miura1, J. Sakata1,
T. Kobayashi1 and T. Wakai1
1Digestive and General Surgery, Niigata University
Medical and Dental Hospital, Niigata, Japan
Objectives: 5-Aminolevulinic acid (5-ALA) is known as
a fluorescence agent in malignant tumors. We have
been testing 5-ALA-induced fluorescence in pancreatic
cancer patients. We report the preliminary results con-
cerning the relationship between 5-ALA fluorescence
and tumor progression in pancreatic cancer.
Methods: 5-ALA was orally administered to 16
patients with pancreatic cancer 2 h before surgery.
Tumors were resected in 11 patients. Three patients
were performed bypass surgery because of peritoneal
dissemination, and postoperatively given chemotherapy
with gemcitabine and S-1 (GS). The pattern of 5-ALA-
induced fluorescence was evaluated in a resected speci-
men, or by intraoperative observation of a main tumor.
The fluorescence pattern was scored as following;
grade-0: no fluorescence, 1: fluorescence in spotted or
small area, 2: fluorescence in the whole area of tumor.
Results: There were six patients in grade-0 or 1 group
and four patients in grade-2 group. While four patients
(66.6%) developed tumor recurrence in grade-0 or 1
group after postoperative chemotherapy, there was no
recurrence in grade-2 group within two years after sur-
gery. Among unresectable patients, two patients with
grade-2 fluorescence only had a partial response to GS
chemotherapy. Our data indicate the possibility that
the pattern of 5-ALA-induced fluorescence may reflect
the clearance of gemcitabine in cancer cells. This result
supports previous reports that the 5-ALA metabolic
pathway in cancer cells uses the same transporter mole-
cule as a gemcitabine clearance.
Conclusion: 5-ALA-induced fluorescence correlates
with tumor progression. Evaluation of 5-ALA-induced
fluorescence may become a novel tool to predict the
effect of gemcitabine in pancreatic cancer patients.
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APHPB-0521
BILE REFLUX AND QUALITY OF LIFE
AFTER RETROGASTRIC RETROCOLIC
GASTROJEJUNOSTOMY IN WHIPPLE
PROCEDURE
R. C. Siriwardana1, R. Rajapaksha1, S. K. Liyanage2
and S. J. S. Hewavisenthi2
1Department of Surgery, Faculty of Medicine University
of Kelaniya, Colombo, Sri Lanka; 2Department of
Pathology, Faculty of Medicine University of Kelaniya,
Colombo, Sri Lanka
Objectives: With increasing survival following Whipple
surgery, quality of life in long-term survivors has
become an important issue. Delayed gastric emptying
and bile reflux are common long-term complications.
As the standard practice, we perform retrogastric retro-
colic gastrojejunostomy. Study was designed to assess
the macro and microscopic bile reflux and clinical
symptoms of dyspepsia following Whipple procedure.
Methods: All patients who had undergone Whipple
procedure from June 2012 to June 2014 were included
(N = 21). Patients with recurrence and ones who had
chemotherapy within last three months were excluded.
Included patients (n = 15) underwent orogastrodude-
noscopy and multiple biopsies were taken. Specimens
were reported using ‘The Sydney system’. Bile reflux
index was calculated using a standard formula. Nepean
Dyspepsia Index-short form (NDI-SF) was used to
clinically assess the severity of functional dyspepsia.
Results: There were 5 males and 10 females with a
median age of 48 years (range 21–66). Endoscopically,
12/15(80%) had macroscopic bile reflux (66.7% yellow-
ish bile lake, 13.3% greenish bile lakes). None had sto-
mal ulcers or macroscopic inflammation. Mean NDI
score was 23.9 (SD  2.27) and 12 had NDI score of
15 or more. Males had a mean score of 25.6 and
females had a mean score of 23 (p = 0.605). Mean Bile
reflux index was 10.87. Duration after surgery was not
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significantly associated with NDI score (p = 0.92).
There was no significant relationship in NDI with mac-
roscopic appearance of reflux (p = 0.233) or bile reflux
index (p = 0.285).
Conclusion: 80% of patients had significant dyspeptic
symptoms even with retrocolic retrogastric anastomosis.
Though there was macroscopic bile reflux, there were
minimal microscopic changes in them.
APHPB-0522
HEPATIC INFLAMMASOME
ACTIVATION PLAYS A DOMINANT
ROLE IN THE HEPATOTOXIC EFFECT
OF BILE ACIDS
R. Tao1, X. Q. Liu1 and T. R. Billiar2
1Hepatobiliary-Pancreatic Surgery, Zhejiang Provincial
People’s Hospital, Hangzhou, China; 2Surgery,
University of Pittsburgh Medical Center, Pittsburgh,
USA
Objectives: Cholestasis is commonly resulted from cho-
ledocholithiasis, hepatobiliary-pancreatic (HBP) malig-
nancies, certain liver diseases amongst other etiologies.
It can cause significant hepatic injury and substantially
increases morbidity and mortality. Although earlier
studies indicated bile acid (BA)-induced apoptosis as
the main mechanism of cholestatic liver injury (CLI),
recent work have shed light on BA-induced sterile
inflammation in the pathogenesis of CLI. We hereby
explore the role of inflammasome activation in BA-
induced hepatic injury and evaluate its value as a
potential therapeutic target.
Methods: WT mice and mice with deficiency of the key
participants in inflammasome activation were subjected
to bile duct ligation (BDL); isolated hepatocytes and
Kupffer cells were subjected to various BA stimulation;
inflammasome activation within the liver tissue or cer-
tain types of cells as well as liver injury were examined.
Results: In both in vivo and in vitro models, western
blot and immunohistochemical staining showed a time-
dependent increase in the NACHT, LRR and PYD
domains-containing protein 3 (NALP3) expression and
Caspase 1 cleavage, along with increased expression of
the pro-inflammatory cytokines IL-1b, IL-18 and IL-
33. Both NALP3/ and Caspase 1/ mice as well as
mice with hepatocyte-specific deficiency of the high-
mobility group box-1 (HMGB-1) showed markedly
ameliorated cholestasis-induced hepatic injury com-
pared to wild type controls 3 and 5 days after BDL.
Conclusion: Our preliminary data support a central
role of inflammation in the pathogenesis of CLI. Tar-
geting the key components of the inflammasome or
inhibition of inflammasome activation (eg, omega-3
fatty acids) may be considered as novel therapeutic
means in the management of cholestasis.
APHPB-0523
BILE DUCT INJURY WITH
SECONDARY BILIARY CIRRHOSIS:
SHORT TERM OUTCOME OF
BILIOENTERIC ANASTOMOSIS
N. Agrawal1, A. Kidambi Seshadri1, A. Arora1, K. G S
Bharathy1, S. Kumar1 and T. K. Chattopadhyay1
1HPB Surgery, Institute of Liver and Biliary Sciences,
New Delhi, India
Objectives: To analyze short term outcome of bile duct
repair in patients of bile duct injury with secondary bil-
iary cirrhosis.
Methods: Data was collected retrospectively from a
prospectively maintained database from Jan 2010 till
May 2014. Patients with confirmed diagnosis of postc-
holecystectomy bile duct injury with secondary biliary
cirrhosis were included.
Results: There were five patients. The median age was
46 years. Three patients were Child Turcot Pugh (CTP)
A and two were CTP B. The median MELD score was
10 (6–10). All patients had cholangitis, four had jaun-
dice and two had ascites preoperatively. All patients
underwent a Roux-en-Y Hepaticojejunostomy of which
one was a re-do procedure. Mean duration of surgery
was 272 (240–420) min and mean blood loss was 274
(70–550) mL. One patient required blood transfusion.
Major morbidity (Clavien Dindo grade ≥ 3) occurred in
two patients. Transient worsening of hepatic function
occurred in two patients; both were CTP B. There was
no mortality. Mean hospital stay was 11.4 days overall
and 14.5 days in those who decompensated.
Conclusion: Bilio-enteric anastomosis in patients of
postcholecystectomy bile duct injury with secondary
biliary cirrhosis (CTP A and B) can be done safely with
acceptable morbidity.
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APHPB-0524
ADJUSTABLE LAPAROSCOPIC
RADIOFREQUENCY SURGICAL DEVICE
– LARA-K1: A NEW ATTITUDE TO
POSTERIOR SEGMENT LIVER
RESECTIONS
P. Vavra1, L. Karnik2, M. Skrobankova3, J. Palecek3,
J. Jurcikova4, V. Prochazka4, P. Ihnat1 and P. Zonca1
1Department of Surgery, University Hospital Ostrava,
Ostrava, Czech Republic; 2Department of Robotic,
Faculty of Mechanical Engineering VSB – Technical
University of Ostrava, Ostrava, Czech Republic;
3Department of Surgery, Faculty of Medicine of the
University of Ostrava, Ostrava, Czech Republic;
4Department of Vice-President for Science and Research,
University Hospital Ostrava, Ostrava, Czech Republic
Objectives: We have developed a new device, LARA-
K1, which after introduction into the abdominal cavity
can bend its long axis, allowing the application of ra-
diofrequency energy in areas that are currently inacces-
sible for laparoscopic surgery, such as posterior liver
segments (IV, VII and VIII).
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Methods: The device is equipped with four telescopic
needle electrodes that coagulate tissue after delivery of
radiofrequency energy. Ex vivo testing was performed
in years 2012 and 2013 at the University Hospital Os-
trava on porcine liver tissue. The main goal of the test-
ing was to figure out, if the newly proposed electrode
layout is suitable for sufficient tissue coagulation and
creating a safety zone around tumors. We used a lapa-
roscopic simulator to evaluate the accuracy of the
device. We also monitored settings of power delivery,
time required for coagulation and adhesiveness of nee-
dle electrodes.
Results: During the ex vivo testing, material of needle
electrodes was improved to structural steel with special
coating which significantly decreased the adhesiveness.
We adjusted the power supply from 20 W to 120 W
and monitored the ablation time which varied from 110
to 10 s. Subsequently, optimal power delivery and time
for coagulation was determined.
Conclusion: This experimental study demonstrated the
feasibility and safety of the newly developed device.
Based on the ex vivo testing, LARA-K1 can create a
safety zone of coagulation. For further assessment of
the new device, we should perform an in vivo test.
APHPB-0525
TECHNICAL DEVELOPMENT OF A
NEW SEMI-SPHERICAL
RADIOFREQUENCY BIPOLAR DEVICE
(RONJA): EX VIVO AND IN VIVO
STUDY
P. Vavra1, M. Penhaker2, J. Grepl2, M. Skrobankova3,
J. Palecek3, M. Crha4, P. Ihnat1, J. Jurcikova5, N.
Habib6 and P. Zonca1
1Department of Surgery, University Hospital Ostrava,
Ostrava, Czech Republic; 2Department of Cybernetics
and Biomedical Engineering, Faculty of Electrical
Engineering and Computer Science VSB – Technical
University of Ostrava, Ostrava, Czech Republic;
3Department of Surgery, Faculty of Medicine of the
University of Ostrava, Ostrava, Czech Republic;
4CEITEC VFU, University of Veterinary and
Pharmaceutical Sciences Brno, Brno, Czech Republic;
5Department of Vice-President for Science and Research,
University Hospital Ostrava, Ostrava, Czech Republic;
6Liver and Pancreas Surgery, Hammersmith Hospital
Imperial College London, London, United Kingdom
Objectives: Our aim was to develop a new semispheri-
cal surgical instrument for the bipolar multi-electrode
radiofrequency liver ablation. We tried to eliminate the
disadvantages of currently used instruments such as
ablation of healthy tissue, numerous needle punctures,
and therefore, longer operating procedure. The main
objective of the in vivo testing was to find out if the
newly constructed device is suitable for sufficient tissue
coagulation and for creating a safety zone around a
tumor.
Methods: We created a model of the instrument by 3D
printing for the production of a prototype The new
instrument RONJA has an asymmetrical electrode lay-
out, circle-shaped base, two wings with attached needle
electrodes and two connecting power wires which
power each wing separately. The ex vivo test was then
performed at the University Hospital Ostrava using a
standard radiofrequency generator.
The in vivo test was performed on a set of 12 pigs ran-
domly divided into two groups. Study was approved by
the expert committee on animal welfare of the Veteri-
nary and Pharmaceutical University Brno according to
the law on the protection of animals.
Results: Statistical analysis indicated that there were
not any significant differences between the groups of
pigs. The tested instrument RONJA performed the
operation with shorter ablation time in both liver lobes
and reduced the total operating time. The depth of the
tissue coagulation was on average 4 mm larger using
the newly tested instrument.
Conclusion: Further experimental studies are needed to
confirm these results before clinical application of the
method in the treatment of human liver malignancies.
Transplantation
APHPB-0526
TREATMENT OF EARLY DUCT TO
DUCT STRICTURES IN LIVER
TRANSPLANT RECIPIENTS
K. Kobryn1, W. Patkowski1, S. Koziel1, M. Grat1 and
M. Krawczyk1
1General Transplant and Liver Surgery, Warsaw
Medical University, Warsaw, Poland
Objectives: One of the potential early complications of
liver transplantation are strictures of end to end anas-
tomosis of the bile duct. In this retrospective cohort
study we analyzed endoscopic treatment of bile duct
strictures in liver transplant recipients.
Methods: From January 2011 to December 2013 507
patients underwent liver transplants (LT) at our Center.
51 ERCP with implantation of bile stents in 34 patients
were carried out due to end to end bile duct anastomo-
sis strictures. Methods of balloon dilation (BD) and
use of plastic stents (PS) and covered self-expandable
metal stents (SEMS) were applied. As an early period
of biliary complications we established a cut-off point
of 0–3 months post transplantation.
Results: BD was conducted in 10 patients, followed by
implantation of PS, with re-stenting after 3–4 months.
SEMS was applied in 9 patients during this period
overall. The remaining group of 15 patients was treated
with PS. 2 patients died from reasons unrelated to the
analyzed complications. 7 patients after 8–12 months
didn’t require further stenting.
Conclusion: Biliary complications accompany every
transplant center (ranging from 5–40%). For early bili-
ary duct to duct anastomosis strictures endoscopic ret-
rograde cholangiopancreatography is the primary
treatment. Often the need of repetitive covered self-
expandable metal stent implantation is inevitable, thus
reduces the number of surgical interventions, prolongs
graft survival and shortens hospitalization.
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APHPB-0528
SYSTEMATIC REVIEW AND META-
ANALYSIS OF SURGICAL TREATMENT
FOR LIVER HEMANGIOMA
T. Yang1, X. Huang1, H. Zhang1, J. H. Lu1, M. C.
Wu1 and F. Shen1
1Department of Hepatic Surgery, Eastern Hepatobiliary
Surgery Hospital, Shanghai, China
Objectives: Consensus on the management of liver
hemangioma, especially on surgical indication and
operating method, is controversial. The aim of the
study is to provide a systematic review and meta-analy-
sis on surgical treatment for liver hemangioma, regard-
ing its surgical indications and approaches.
Methods: A systematic review was performed with all
studies published from 2000 to 2013 using MEDLINE,
Embase, and the Cochrane Library. All data regarding
surgical indications, approaches, morbidity, mortality
and follow-up were analyzed.
Results: Twenty-four studies were analyzed and a total
of 977 patients with liver hemangioma in these studies
underwent surgical treatment. Tumor size ranged from
0.2 to 46 cm. Reported surgical indications mainly
include presence of symptoms, uncertain diagnosis,
rapid enlargement, patient request, prophylactic surgery
for giant lesions and occurrence of life-threatening
complications like Kasabach-Merritt syndrome. Enucle-
ation was adopted by 13 studies with 519 patients,
while open hepatic resections, either anatomical or
non-anatomical ones, were adopted by 21 studies with
458 patients. Detailed comparisons of the two
approaches were conducted in only 4 studies. Overall
postoperative morbidity and mortality was 14.1% and
0.2%, respectively.
Conclusion: Surgical Indication for liver hemangioma
far from well defined by now, a worldwide consensus is
mandatory. Surgical treatment, either enucleation or
hepatic resection, was reserved as a safe and effective
option for severe liver hemangioma. Minimally invasive
approaches may be optimal alternatives, pending fur-
ther studies and supportive evidence.
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APHPB-0530
MINIMALLY-INVASIVE
PANCRETICODUODENECTOMY IN
PERI-AMPULLARY MALIGNANCY: THE
INITIAL NATIONAL UNIVERSITY
HOSPITAL OF SINGAPORE
EXPERIENCE
C. W. B. Tay1, S. K. Y. Chang1, A. W. C. Kow1, S. G.
Iyer1 and K. Madhavan1
1Department of Surgery, Nation University Healthy
System, Singapore, Singapore
Objectives: Minimally-invasive pancreaticoduodenecto-
my (MIPD) is a highly complex surgical procedure.
Latest evidence has shown it has many advantages over
open pancreaticoduodenectomy, such as post-operative
complication rates, less intra-operative blood loss,
shorter hospital stays, higher number of harvested
lymph nodes. However, the procedure requires advance
laparoscopic skills, hence only few centers in the world
offer it as treatment for peri-ampullary malignancy.
We report the initial experience of MIPD performed
for peri-ampullary malignancy in National University
Hospital of Singapore.
Methods: We analyzed all laparoscopic-assisted pan-
creaticoduodenectomy performed from year 2011 –
2014. Patient characteristics, pre-, intra-, and post-oper-
ative data, as well as oncological information were
studied.
Results: 11 cases of laparoscopic-assisted pancreatico-
duodenectomy were studied, 6(55%) were females,
median age and BMI were 51(range: 37–77) and 24
(range: 20 – 30) respectively. Indications for surgery
were: ampullary cancer (n = 8, 73%), head of pancreas
cancer (n = 2, 18%), distal cholangiocarcinoma (n = 1,
9%). Median preoperative computed tomography (CT)
tumour, bile duct and pancreatic duct sizes were
18 mm (range: 1–31), 10 mm (range: 1–20) and 4 mm
(range: 1–15), respectively.
Median operative time was 481 min (range: 306–597)
and median blood loss was 600 mL (range: 300–1000).
1 case (9%) required premature conversion due to
inadvertent duodenal injury.
Median length of hospitalization was 8 days (range: 6–
21). 3 patients (27%) developed post-operative pancre-
atic fistula and 2 patients (18%) had delayed gastric
emptying. Median lymph node harvested was 15(4 –
31). All cases achieved negative margin status.
Conclusion: In our experience, MIPD is feasible and
safe in selected patients. Larger number, randomized
controlled trial will help to further evaluate the advan-
tages of MIPD.
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APHPB-0531
COMBINED-LAPAROSCOPIC VERSUS
OPEN SPLENECTOMY AND
ESOPHAGOGASTRIC
DEVASCULARIZATION FOR PORTAL
HYPERTENSION DUE TO LIVER
CIRRHOSIS
L. E. I. Zhang1, W. Zhang1 and X. Chen1
1Hepatic Surgery Center, Tongji Hospital Tongji
Medical College Huazhong University of Science and
Tech, Wuhan, China
Objectives: This study was conducted to compare the
feasibility, safety and effectiveness of the combined-lap-
aroscopic splenectomy and esophagogastric devascular-
ization (C-LSED) with those of open surgery (OSED)
in patients with portal hypertension due to liver cirrho-
sis.
Methods: From February 2011 to February 2014, 68
patients with portal hypertension were diagnosed with
serious gastroesophageal varices and/or hypersplenism
in our center. 30 patients underwent C-LSED and 38
patients received OSED. Results and outcomes were
compared retrospectively.
Results: No patients of C-LSED group required an in-
traoperative conversion to open surgery. Compared
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with OSED group, significantly shorter operating time,
less blood loss, lower transfusion rates, shorter postop-
erative hospital stay, lower rates of complications were
found in C-LSED group (p < 0.05). No death and reb-
leeding were documented in both groups during the fol-
low-up periods of six months. Postoperative endoscopy
revealed that the patients with varices in both groups
improved significantly from severe to mild, and in a
part of cases, the varices disappeared.
Conclusion: The final results suggest that the C-LSED
technique is superior to open procedure, which brings
about slightly invasive, simplified operative procedure,
significantly shorter operating time, less intraoperative
bleeding and lower complication rates. And C-LSED
offers comparable medium-term effects to OSED
approaches.
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APHPB-0532
ACCURATE PREOPERATIVE
DISCRIMINATION OF SMALL
INTRAHEPATIC
CHOLANGIOCARCINOMA AND
HEPATOCELLULAR CARCINOMA IN
CIRRHOTIC LIVERS WITH
MULTIPHASE DYNAMIC MAGNETIC
RESONANCE IMAGING: A
PROSPECTIVE COHORT STUDY
L. Wu1, B. I. N. Huang1 and H. Cheng1
1Interventional radiology, Eastern hepatobiliary surgery
hospital, Shanghai, China
Objectives: The discrimination of hepatocellular carci-
noma (HCC) and ICC remains a critical and also chal-
lenging issue because the prognosis and treatment of
both entities differ markedly. The aim of this study was
to validate prospectively the accuracy of magnetic reso-
nance (MR) in a cohort of patients with focal liver
lesions (FLLs) in the existence of cirrhosis.
Methods: Between January 2009 and January 2013, a
prospective cohort of 704 patients carrying FLLs
underwent partial hepatectomy and results of patholog-
ical examinations were obtained for all of them. The
clinico-radiologic-pathologic results were comprehen-
sively analyzed.
Results: The preoperative diagnoses of 563 of the 704
lesions (80.0%) were confirmed. Nine lesions of ICCs
(12.7%) and 484 lesions of HCCs (79.1%) displayed
contrast washout at delayed phases (p < 0.001).
Conclusion: The accurate discrimination of small ICCs
from HCCs in the setting of hepatitis B virus (HBV)
related cirrhosis by MR imaging still needs improve-
ment. The non-invasive diagnostic criteria of HCCs
may need to be reevaluated in small FLLs no more
than 30 mm in diameter in the setting of HBV-related
cirrhosis.
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APHPB-0533
LAPAROSCOPIC CHOLECYSTECTOMY
TO TORSION OF THE GALLBLADDER,
COMPARISON TO OPEN
CHOLECYSTECTOMY: A SINGLE-
INSTITUTION EXPERIENCE
T. Noda1, H. Hatano1, J. Shimizu2 and K. Dono1
1Surgery, Toyonaka Municipal Hospital, Toyonaka,
Japan; 2Surgery, Osaka Rosai Hospital, Sakai, Japan
Objectives: The gallbladder torsion is one subtype of
acute cholecystitis and preoperative diagnosis was diffi-
cult. However, there are few reports of a series of the
torsion due to the low incidence. The objectives of this
paper are to identify the important finding for preoper-
ative diagnosis, and to investigate the differences
between the clinical outcome of laparoscopic and open
cholecystectomy.
Methods: Between 2005 and 2011, a total of 172
patients were diagnosed as acute cholecystitis in our
surgical department. Six patients were diagnosed as
gallbladder torsion and treated an emergency cholecys-
tectomy, laparoscopic cholecystectomy in four and
open in two. We retrospectively analyzed the clinical
and radiological finding of the patients and investigate
the surgical outcome.
Results: The rotation of the gallbladder fundus was
shown in four cases. In only one case, a twisting of the
cystic artery was observed as a ‘whirl sign’. The length
of hospital stay in the patients receiving laparoscopic
cholecystectomy was shorter than that in the patients
with open cholecystectomy.
Conclusion: The presence of excessive gallbladder swell-
ing and rotation of the fundus was important key to
suspect the gallbladder torsion. The laparoscopic chole-
cystectomy should be considered as the first choice for
the patients of gallbladder torsion.
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APHPB-0534
TRANSCRIPTION FACTOR MAML3
CAN BE A NEW THERAPEUTIC
TARGET FOR PANCREATIC CANCER
THROUGH HEDGEHOG SIGNALING
PATHWAY
A. Yamasaki1, H. Onishi1 and M. Katano1
1Cancer therapy and research, Kyushu University,
Fukuoka, Japan
Objectives: We have reported that the Hedgehog (Hh)
signal which is one of the morphogenetic signal systems
is activated in a pancreatic cancer with a hypoxic envi-
ronment, and participates in cancer malignant alter-
ation. Goal of this study is to find a new target and
develop a new remedy for pancreatic cancer.
Methods: 1) Hypoxic condition in pancreatic cancer
tissues were analyzed by Immunohistochemistry (CA9)
of the pancreatic cancer resected specimen.
2) We cultured pancreaatic cancer cell lines under
Normoxic and Hypoxic condition. We analyzed the in-
flunence of Hypoxic condition on pancreatic cancer
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cells about proliferation, invasion and mRNA expres-
sion.
3) We silenced Mastermind-like 3 (MAML3) gene,
transcription factor of Notch signal, by the low mole-
cule interference RNA method.
Results: Cancer cells in pancreatic cancer tissue had
high CA-9 intensity compared with the adjacent tissue.
In hypoxic condition, Invasion ability of pancreatic
cancer cell lines were accelated, and Smoothened
(SMO) and MAML3 mRNA expressions were also acc-
elated. Silenced MAML3 intentionally reduced the pro-
liferation and invasion ability and SMO mRNA
expression of pancreatic cancer cells.
Conclusion: MAML3 was involved malignant alter-
ation and Hh signal of pancreatic cancer in hypoxic
environment, and was suggested to be a new therapeu-
tic target.
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APHPB-0536
SURGICAL OUTCOME OF
LAPAROSCOPIC CHOLECYSTECTOMY
FOR ACUTE CHOLECYSTITIS
PROGRESSING MORE THAN 72 H
AFTER THE ONSET
G. Shinke1, T. Noda1, H. Hisanori1, J. Shimizu2, A.
Takata1, M. Hirota1, T. Tanida1, T. Komori1, S.
Morita1, H. Imamura1, T. Iwazawa1 and K. Dono1
1Department of Surgery, Toyonaka Municipal Hospital,
Osaka, Japan; 2Department of Surgery, Osaka Rosai
Hospital, Osaka, Japan
Objectives: Early cholecystectomy is recommended for
patients with acute cholecystitis within 72 h after the
onset on Tokyo Guidelines 2013. Cholecystectomy for
acute cholecystitis progressing more than 72 h is sup-
posed to be difficult, and the guidelines state that the
gallbladder drainage is recommended. We retrospec-
tively analyzed the surgical outcome of laparoscopic
cholecystectomy for acute cholecystitis progressing
more than 72 h after the onset.
Methods: From May 2005 to July 2013, 220 patients
underwent laparoscopic cholecystectomy in Toyonaka
Municipal Hospital. We compared the clinical features
and surgical outcomes of 29 patients progressed more
than 72 h after onset with 191 patients within 72 h
after onset.
Results: Of the 29 patients, 10 patients received chole-
cystectomy from 72 h to 96 h. 13 patients from 96 h to
one week and 6 patients after one week. There was no
statistical significance between two groups about gen-
ders, years and severity of acute cholecystitis. Conver-
sion to open surgery occurred more frequently in group
after 72 h (17.2% to 2.6%). In that group, blood loss
and operation time significantly increased. However,
postoperative complications and hospital stay were not
different between two groups. In patients from 72 to
96 h, laparoscopic cholecystectomy was performed in
all ten patients and conversion to open surgery was not
observed.
Conclusion: Laparoscopic cholecystectomy for acute
cholecystitis progressing more than 72 h was more diffi-
cult and conversion rate was high. The data indicates
that laparoscopic cholecystectomy within 96 h in
patient progressing more than 72 h might be safe and
feasible.
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APHPB-0540
CASE CONTROLLED STUDY ON
SIMULTANEOUS HEPATECTOMY AND
SPLENECTOMY OR HEPATECTOMY
ALONE IN PATIENTS WITH CHRONIC
HEPATITIS B-RELATED
HEPATOCELLULAR CARCINOMA AND
PORTAL HYPERTENSION
Q. Wang1, H. P. Luo1 and B. X. Zhang1
1Hepatic Surgery Centre, Tongji Hospital, Wuhan,
China
Objectives: We investigated the outcomes of simulta-
neous splenectomy and hepatectomy (SPH) or hepatec-
tomy alone (HA) in patients with hepatitis B-related
hepatocellular carcinoma and portal hypertension
(HBV-HCC/PH), aiming to evaluate whether splenec-
tomy could improve outcomes of these patients.
Methods: We carried out a retrospective case control
study on 171 HBV-HCC/PH patients. Cases that ful-
filled the following criteria were enrolled in the study: ?
platelet counts ranging from 50 9 109/L to 80 9 109/L,
white blood cell count >2.0 9 109/L; ?without esopha-
geal varices or the varices being ≤ F2; ?receiving SPH
or HA. There were 57 cases in SPH group and 114
cases in HA group.
Results: The perioperative clinical characteristics of the
2 groups were not statistically different. Compared to
the HA group, the SPH group patients had transiently
improved postoperative liver function and long-term
ameliorated thrombocytopenia, but suffered from higher
rates of major postoperative complication. Splenectomy
had no effect on tumor free or overall survival.
Conclusion: In patients with HBV-HCC/PH, splenec-
tomy was associated with transiently improved liver
function and increased major postoperative complica-
tions. It was not necessary in those with mild pancytop-
nia and less than F2 esophageal varices.
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APHPB-0541
THE CHANGE OF MAIN PANCREATIC
DUCT ON PREOPERATIVE IMAGING IS
AN INDEPENDENT PREDICTOR OF
LYMPH NODE METASTASES OF
PANCREATIC NEUROENDOCRINE
TUMORS
Y. Nanno1, I. Matsumoto2, A. Ueta1, J. Ishida1, T.
Goto1, S. Asari1, H. Toyama1, T. Ajiki1, T.
Fukumoto1 and Y. Ku1
1HBP surgery, Kobe University Graduate School of
Medicine, Kobe, Japan; 2HBP surgery, Kinki University
Faculty of Medicine, Osaka, Japan
Objectives: Pancreatic neuroendocrine tumors (PNETs)
are potentially malignant, and presence of lymph node
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(LN) metastases is a major concern when considering
the management of tumor. The size of tumor has been
believed as a predictor of LN metastases, however,
other preoperative parameters are still not understood.
In this study, we designed a single center retrospective
study to investigate whether a stenosis or obstruction
of main pancreatic duct (MPD) was a preoperative pre-
dictor for LN metastases.
Methods: Consecutive patients with PNET between
2003 and 2013 at Kobe University Hospital were retro-
spectively reviewed. A presence or absence of the
change of MPD was evaluated with clinical data
(including gender, age, tumor size, number of mass,
location, and a type of tumor) by uni- and multivariate
analysis to determine clinical relevance with LN metas-
tases.
Results: Fifty-four patients were enrolled in the analy-
sis. A median tumor size was 20 mm (range: 0.8–156),
and there were 37 non-functioning tumors, 12 insulino-
mas, 4 gastrinomas, and 1 glucagonomas. LN metasta-
ses were positive in 20 (37%) patients, and the change
of MPD was present in 24 (44%) patients, respectively.
At multivariate analysis, the change of MPD remained
as an independent risk factor of LN metastases
(p = 0.037) as well as tumor size (≥15 mm, p = 0.048),
and type of hormonal production (non-insulinomas,
p = 0.020).
Conclusion: The change of MPD on preoperative imag-
ing was identified as an independent predictive factor
of LN metastases in PNETs.
APHPB-0542
REDEFINING THE GUIDELINES FOR
RESECTION OF HEPATOCELLULAR
CARCINOMA
Y. X. Koh1, P. K. H. Chow2, W. K. Lye3 and J. C.
Allen3
1Department of General Surgery, Singapore General
Hospital, Singapore, Singapore; 2Department of Surgical
Oncology, National Cancer Centre, Singapore,
Singapore; 3Department of Biostatistics, Duke-NUS
Graduate Medical School, Singapore, Singapore
Objectives: Large solitary lesions and multifocal lesions
presents a significant disease burden, accounting for
over 40% of resected HCC. The long term outcomes of
resection for such intermediate or advanced HCC
remain unclear. There is no current data that defines
the optimal size of solitary HCC and the number of
nodules of multifocal HCC that might benefit from sur-
gical resection
We hypothesize that the long term survival of resection
for HCC is associated with size (especially in solitary
lesions) and the number of lesions (in multifocal HCC).
The aim of our study was to determine the overall sur-
vival (OS) and disease free survival (DFS) in stratified
by size in single lesion HCC and by number of lesions
in multi-focal HCC and define the size and number at
which outcomes are similar to that of lower morbidity
loco-regional therapy.
Methods: This is a retrospective analysis of the long
term outcomes of surgical resection for hepatocellular
carcinomas carried out by the combined services of the
Singapore General Hospital and the National Cancer
Centre Singapore from 2000 – 2014
Exclusion criteria: Patients who at the time of with
macrovascular invasion, lymph node metastases and
extrahepatic metastatic disease will be excluded.
The remaining patients will be divided into 2 groups
namely those with solitary lesions and those multifocal
lesions. The 5 year overall survival and disease free sur-
vival will be analyzed according to the size of solitary
lesions and the number of nodules for multifocal lesions.
Results: Pending.
Conclusion: Pending.
APHPB-0545
AN INITIAL EXPERIENCE OF THE
UPPER MIDLINE INCISION FOR
VARIOUS LIVER RESECTIONS IN A
LOW VOLUME CENTER
Kim1 and K. Her1
1Surgery, JNUH, Jeju, Korea
Objectives: The upper midline incision (UMI) for vari-
ous liver resections has been recently introduced. This
study is to report an initial experience of the UMI in a
low volume center (annual number of a total liver
resection in an institution ≤10) above the umbilicus for
various liver resections using a conventional open-sur-
gery technique.
Methods: A retrospective study based on a prospec-
tively collected database of 6 liver resections performed
by a single surgeon was conducted to report initial clin-
ical outcomes of the UMI.
Results: From March to July 2014, this incision was
used successfully in 6 liver resections (66.7%) in 9
patients who underwent liver resection irrespective of
their previous history of abdominal operations. 3 cases
were major resection (2 right hemihepatectomies and 1
left hemihepatectomy). The median operating time was
174 min (range: 91–244 min). The median postoperative
hospital stay was 9.5 days (range: 8–10 days). All 6
patients fully recovered and returned to their previous
level of activity. Over a median follow-up of 4.3 months
(range: 1.8–6.1 months), 3 complications (50%) devel-
oped; 1 seroma, 1 bile leak and 1 wound infection.
Conclusion: The UMI can be used in conventional
open surgery in various liver resections with acceptable
complications in a low volume center.
Transplantation
APHPB-0546
SUPPLY OF PROBIOTICS REDUCES
POSTTRANSPLANT EARLY INFECTION
RATES AFTER LIVER
TRANSPLANTATION: A SINGLE
CENTER OBSERVATIONAL CROSS-
SECTIONAL STUDY
Kim1, S. D. Lee2 and S. H. Kim2
1Surgery, JNUH, jeju, Korea; 2Center for Liever
Cancer, National Cancer Center, Goyang, Korea
Objectives: Bacterial infections frequently occur early
(within on months) after liver transplantation (LT) and
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main cause of posttransplant death. Recently, there are
several reports about that probiotics can reduce post-
operative infections in patients undergoing colorectal
resection for cancer.Now, our aim is to investigate
whether the posttransplant outcomes can be better in
patients receive supply of probiotics following LT.
Methods: An observational cross-sectional study was
undertaken in 381 LT recipients. Comparison was
made between one group (A) receiving a probiotics and
another group (B) did not. One hundred thirty patients
belonged to group A and 251 patients belonged to
group B. Probiotics was given in group A on the post-
operative day 1 and continued until the first day of a
clinic visit. Early infection rate (within one month),
duration of antibiotic therapy, noninfectious complica-
tions and one year mortality rate were recorded.
Results: The incidence of posttransplant bacterial infec-
tions within 30 days was significantly reduced [group A
(2.3%) versus group B (7.2%); p = 0.049]. However,
there was no significant difference in 1 year mortality
rate. Posttransplant supply of probiotics reduces bacte-
rial infection rates following LT. Multicenter random-
ized prospective study is required to concrete our
findings
Conclusion: Posttransplant supply of probiotics reduces
early bacterial infection rates following LT. Multicenter
randomized prospective study is required to confirm
our findings.
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APHPB-0548
FEASIBILITY AND OUTCOMES OF
LAPAROSCOPIC ENUCLEATION FOR
PANCREATIC NEOPLASMS
J. Chung1, S. Jang1, K. Kim1, O. Lee1 and H. Kim1
1Surgery, Soonchunhyang University, Bucheon, Korea
Objectives: With the advancement of laparoscopic tech-
niques and instruments, laparoscopic approach for the
pancreatic lesions has become an increasingly used pro-
cedure. But, there are few limited studies about laparo-
scopic enuleation (LE) for the pancreatic lesions.
Therefore, the purpose of this study was to present our
experience and to evaluate the clinical outcome of LE
for pancreatic benign or borderline malignant tumors.
Methods: Between May 2005 and December 2011, 11
patients who underwent LE were analyzed. Candidates
for LE had following criteria: (1) benign or borderline
malignant pancreatic tumor, (2) no involvement of
main pancreatic duct, and (3) outwardly growing tumor
with small tumor bed.
Results: All 11 patients (10 women and 1 man with a
mean age of 43.1  11.9 years) who underwent LE
were completed laparoscopically without conversion.
The mean diameter of tumor was 4.0  3.3 cm and all
cases had benign tumors at the final pathologic diagno-
sis. One patient (9%) developed pancreatic fistula and
mean postoperative hospital stay was 5.5  1.7 days.
During follow-up period (mean; 44.3  23.9 months),
all patients were alive with no recurrence or new onset
of diabetes.
Conclusion: LE is a safe and effective procedure, and
should be considered as a treatment option for pancre-
atic lesions which do not involve the main pancratic
duct and have an outgrowing aspect with small tumor
bed.
APHPB-0549
FEASIBILITY AND OUTCOMES OF
LAPAROSCOPIC LIVER LEFT LATERAL
SECTIONECTOMY: COMPARISON
WITH OPEN LIVER LEFT LATERAL
SECTIONECTOMY
J. Chung1, K. Kim1, O. Lee1, S. Jang1 and H. Kim1
1Surgery, Soonchunhyang University, Bucheon, Korea
Objectives: With the advancement of laparoscopic tech-
niques and instruments, laparoscopic approach for the
hepatic lesions has become an increasingly used proce-
dure. Laparoscopic left lateral sectionectomy (LLS) for
the left liver lesions is increasingly performed. But,
there are few limited studies about the outcomes of the
laparoscopic surgery compared with open surgery. The
aim of this study was to evaluate the clinical outcomes
of laparoscopic LLS and compare it to that of open
LLS.
Methods: From November 2008 to November 2013, 46
consecutive patients (24 laparoscopic LLS patients and
22 open LLS patients) who underwent elective left lat-
eral sectionectomy were recruited into the current
study.
Results: There were no significant differences in opera-
tion time, transfusion, blood loss, mortality, and recur-
rence between the two groups. Compared to open LLS,
laparoscopic LLS had earlier time to oral intake
(1.8  0.9 vs. 3.0  1.3 days; p = 0.001) and shorter
postoperative hospital stay (10.5  7.2 vs.
14.9  5.7 days; p = 0.027).
Conclusion: Laparoscopic LLS is a safe procedure and
should be considered as an alternative treatment option
for conventional open LLS in liver disease.
Malignant HPB Diseases
APHPB-0550
EXPRESSION AND SIGNIFICANCE OF
CHEMOKINE RECEPTOR CCR7 AS A
PROGNOSTIC FACTOR IN HILAR
CHOLANGIOCARCINOMA
Y. Cheng1 and K. Ou1
1Hepatobiliary Surgery, Binzhou Medical University
Hospital, Binzhou, China
Objectives: Chemokine receptor CCR7 and Vasculo-
genic mimicry (Vm) play important role in the migra-
tion and invasion of cancers. This study investigate
expression CCR7 and Vm in hilar cholangiocarcinoma
tissue and relationship with clinical pathological param-
eters, and their prognosis in hilar cholangiocarcinoma.
Methods: CCR7 and Vm was tested by immunohisto-
chemical and PAS dual staining method respectively
for 63 patients with hilar cholangiocarcinoma receiving
surgery and 20 normal bile duct specimens, and had
correlation test with clinical pathological parameters.
The relationship between them and survival time of
patients were retrospectively analysized.
© 2015 The Authors
HPB © 2015 Americas Hepato-Pancreato-Biliary Association HPB 2015, 17 (Suppl. S2), 25–266
184 Poster Abstracts
Results: CCR7 expression was positive in 50 (79.4%)
hilar cholangiocarcinoma, only 2 (10%) of normal bile
duct. Vm was positively expressed in 25(39.7%) hilar
cholangiocarcinoma specimens, and zero in normal
specimens; CCR7 and Vm had a positive correlation
(r = 0.810, p < 0.05), Expression of CCR7 and Vascul-
ogenic mimicry were relevant to lymph node metastasis
and differentiation (p < 0.05), but not to age, gender,
tumor size, histological types and liver resection
(p > 0.05). univariate analysis showed CCR7/Vm/
lymph node metastasis/ differentuation were related
with survival rate; whereas in multivariate analysis
showed that CCR7 expression was an independed prog-
nostic factor.
Conclusion: CCR7 expression obviously correlates with
Vm expression, and were relevant to lymph node metas-
tasis and differentiation, but just CCR7 are a valuable
prognostic factor for hilar cholangiocarcinoma.
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APHPB-0551
CAN EARLY ESTIMATION OF DRAIN
FLUID AMYLASE PREDICT
POSTOPERATIVE PANCREATIC
FISTULA IN PATIENTS WITH
CHRONIC PANCREATITIS? A PILOT
STUDY
K. Raja1, B. Pottakkat1, K. Gaurav1 and V. Kate1
1Surgical Gastroenterology, Jipmer, Pondicherry, India
Objectives: Pancreatic fistula (PF), a major cause of
morbidity is less common after surgery for chronic pan-
creatitis compared to pancreatic malignancies. Hence,
early prediction of post-operative PF can facilitate
early drain removal and its related morbidity in
patients with low risk of PF. This pilot study was con-
ducted to determine whether early estimation of drain
fluid amylase on post-operative day 1 (DFA1) can pre-
dict pancreatic fistula following surgery for chronic
pancreatitis
Methods: All patients who underwent Frey’s procedure
for chronic pancreatitis from September 2013 to
August 2014 were included. Abdominal drain was rou-
tinely placed near the pancreatico-jejunostomy, serum
and drain fluid amylase (DFA) was estimated on post-
operative day 1 and 3. PF was defined as per Interna-
tional study group on pancreatic fistula (ISGPF) defini-
tion. DFA1 was considered elevated if it was raised
three times the serum value.
Results: Twenty one patients were included in this pilot
study. Majority were males (M: F = 19:2) and alcohol
ingestion was the most common etiology. Clinical
endocrine and exocrine deficiency was present in seven
and three patients respectively. Of the nine patients
who had elevated DFA1, five patients had PF (Grade
A-4, Grade B-1; Positive predictive value-55.6%). Of
the remaining 12 patients who had normal DFA1, none
had PF (Negative predictive value- 100%). Sensitivity,
specificity and accuracy of DFA1 to predict PF were
100%, 75.0% and 81.0% respectively.
Conclusion: Results of this pilot study suggest that ele-
vated DFA1 is highly sensitive in predicting PF in
patients with chronic pancreatitis. A prospective study
with large sample size is required to substantiate these
findings.
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APHPB-0553
USEFULNESS OF MULTI-THREE
DIMENSIONAL COMPUTED
TOMOGRAMS FUSED WITH MULTI-
PLANAR PRECONSTRUCTION IMAGES
AND PERORAL CHOLAMGIOSCOPIC
FINDINGS IN CHOLANGIOSCOPIC
FINDINGS IN HILAR
CHOLANGIOCARCINOMA
C. Takishita1, Y. Nagakawa1, Y. Hosokawa1, Y.
Sahara1, T. Nakajima1, Y. Hijikata1, H. Osakabe1, B.
Kyo1, K. Kasuya1 and T. Akihiko1
1Gastrointestinal and Pediatric Surgery, Tokyo medical
university hospital, Tokyo, Japan
Objectives: Multi-planar reconstruction (MPR)images
are useful for assessing the degrees of horizontal and
vertical extension of cholangiocarcinoma; but it’s diffi-
cult to ascertain the range of extensive superficial duc-
tal spread. However peroral cholangioscopy (POCS) is
used for diagnosing superficial ductal spread and map-
ping biopsy. Therefore, we’ve developed a novel tech-
nique to fuse conventional 3D-CT images with
MPRimages and POCS findings.
Methods: MPRimages were created using the Synapse
Vincent volume analyzer (Fujifilm). The range of can-
cer extension was assessed on MPRimages, plotted, and
fused onto cholangiographic CTimages to create multi-
3DCTimages. The results of biopsy performed under
POCS for assessment of the range of superficial exten-
sion of cancer were compared with virtual endoscopic
findings and the obtained findings were marked on the
multi-3DCTimages. A bile duct resection line was
designed based on these images.
Results: Multi-3DCTimages were created for 13
patients with hilar cholangiocarcinoma. Of 10 patients
underwent POCS, superficial spread was observed in
two. Resection was performed in 12 patients. In 2
cases, the margin of the intrahepatic bile duct was posi-
tive, resulting in 83.3% diagnostic accuracy for hori-
zontal spread. In all patients, the estimated number of
bile ducts was the same of the actual resections. R0
was achieved in 10 patients (83.3%).
Conclusion: The bile duct resection line for hilar cho-
langiocarcinoma should be designed based on the
degree of cancer extension and an understanding of the
branching pattern of the bile duct and three-dimen-
sional relationship between the portal vein and arteries.
This novel technique using multi-3D CTimages was
useful for not only undestanding three-dimensional
relationship but diagnosing extension of hilar cholan-
giocarcinoma.
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APHPB-0554
IS CHOLEDOCHODUODENOSTOMY
THE IDEAL BILIARY-ENTERIC
DRAINAGE PROCEDURE FOR BENIGN
BILIARY TRACT DISEASES WHEN
COMPARED WITH
CHOLEDOCHOJEJUNOSTOMY? A
COMPARATIVE ANALYSIS OF UTILITY
AND OUTCOMES
R. Mohan1, S. A. Naik1, S. B. Mashal1 and M. Achar1
1Department of Surgery, SDM College of Medical
Sciences & Hospital, Dharwad, India
Objectives: To assess the utility and outcomes follow-
ing Choledochoduodenostomy as biliary-enteric drain-
age procedure for benign biliary tract disease in
comparison with Choledochojejunostomy.
Methods: We retrospectively analysed and compared
outcomes of 28 Choledochoduodenostomy procedures
[25 side-to-side Choledochoduodenostomy, 2 side-to-
side Hepaticoduodenostomy, 1 end-to-side Choledocho-
duodenostomy], with outcomes of 21 Roux-en-Y Chol-
edochojejunostomy procedures done during January
2004 to December 2013, for benign biliary tract dis-
eases. The indications for Choledochoduodenostomy
were CBD stones [n = 11], retained CBD stones
[n = 9], recurrent CBD stones [n = 5], and benign ter-
minal CBD stricture [n = 3]. In all patients there was
prior history of ERCP and procedure [n = 17] or
attempt at ERCP [n = 11]. The operative steps were
exposure of the entire length of extra-hepatic biliary
system, complete mobilisation of duodenum, longitudi-
nal choledochotomy of 20 mm, bile duct exploration,
intra-operative cholangiography, longitudinal duoden-
otomy of 20 mm and single layer Choledochoduodenal
anastomosis using 3–0 Polygalactin, pre-placed inter-
rupted sutures. All patients underwent follow-up liver
function tests, abdominal ultra-sonography and endos-
copy.
Results: Mean age was 57 [range 29–81 years] with
median age of 59. 2 patients had anastomotic leak with
intra-abdominal abscess formation which was managed
conservatively, with subsequent stricture formation,
managed endoscopically. There was no mortality. No
patient developed features of cholangitis or hepatic
abscesses attributable to the ‘Sump syndrome’.
Conclusion: Choledochoduodenostomy has low proce-
dure related morbidity with outcomes similar to Roux-
en-y Choledochojejunostomy, and does not result in
‘Sump syndrome’. It is simpler to construct, maintains
good long term patency and is accessible endoscopi-
cally. It is a safe and effective procedure for biliary-
enteric drainage in benign biliary tract disease.
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APHPB-0555
A CASE OF DOUBLE CANCERS
(INTRAHEPATIC BILE DUCT
CARCINOMA AND HEPATOCELLULAR
CARCINOMA), DEVELOPED AFTER
SVR OF HCV CHRONIC HEPATITIS
TREATED INTERFERON
K. Tazawa1, S. Kawai1, Y. Tsuchiya1, F. Yamagishi1
and K. Tsukada2
1Department of Suregry, Itoigawa General Hospital,
Itoigawa, Japan; 22nd Department of Suregry, Toyama
University Hospital, Toyama, Japan
Objectives: The patient was a 81-year-old man. SVR was
obtained after interferon therapy of chronic hepatitis C.
In one year later, he underwent a partial resection of the
caudal lobe. Pathologically, moderately differentiated
hepatocellular carcinoma (HCC, 21 mm), T1N0M0,
stage I. Background liver showed mild chronic inflamma-
tion with fibrosis. In eight years later from the resection,
a echography revealed a new nodular lesion measuring
22 mm, with mosaic fegure, was located in the right lobe
(S5/S8). The lesion was suspected recurrence of HCC.
Methods: Blood examinations were within normal lim-
its. A serum level of AFP was 4.4. According to CT,
the tumor showed poor contrast effect in the portal
vein phase and late phase, because of central necrosis
of the tumor. Neither ascites nor varicosed vein was
noted. Preoperative diagnosis of the tumor was recur-
rence of HCC and he underwent a partial resection
(S5/S8). The postoperative course was good.
Results: In the tumor, microscopically, atypical epithe-
lial cells were located in the liver with papillary and
cubic-like figures. The atypical nuclear pleomorphism,
mitotic figures were noted and plasma cells, and neu-
trophils infiltrated in the portal triads. Immunohisto-
chemistry, the tumor cells are negative for, CD10, AFP
hepatocyte, and positive for CK7, CK19, CK20, EMA
and EpCAM. The tumor was recognized as an extrahe-
patic tumor, was clinically diagnosed with intrahepatic
bile duct carcinoma. Background liver tissue was mild
fibrosis and expansion of the portal area.
Conclusion: HCC and Intrahepatic carcinoma arising
from chronic hepatitis after SVR of interferon therapy
were very rare and additional discussion followed by
the literature was reported.
Transplantation
APHPB-0556
BONE MESENCHYMAL STEM CELLS
WITH HEPATOCYTE GROWTH
FACTOR LOADED COLLAGEN-
CHITOSAN SCAFFOLD AS A MODEL
FOR HEPATIC TISSUE ENGINEERING
S. Zheng1, X. Xu1 and C. Zhong1
1Department of Surgery First Affiliated Hospital School
of Medicine Zhejiang University, Division of
Hepatobilitary and Pancreatic Surgery, Hangzhou, China
Objectives: Bone marrow stromal cells (BMSCs) are
particularly attractive candidates for future clinical
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applications of stem cell-based therapy for liver disease.
This study was undertaken to evaluate the therapeutic
potential and mechanism of BMSCs on hepatocyte
growth factor (HGF) loaded Collagen-Chitosan scaf-
fold (CCs) in liver tissue engineering.
Methods: Alkaline phosphatase and glucogen staining,
7-alpha hydroxylase and albumin concentration were
used to evaluate cell differentiation. Using in vitro
release tests and in vivo implantation tests, the effective-
ness of liver tissue regeneration was appraised. Addi-
tionally, gene expression profiles, transcription and
translation levels of the key proteins such as retinol
binding protein 2 (RBP2) were examined.
Results: Based on the above analysis, we found
BMSCs-HGF-CCs was effective to stimulate hepatic
regeneration. RBP2 as a key protein has changed sig-
nificantly after differentiation. In the in vivo results of
hematoxylin eosin staining, liver regeneration is obvi-
ous.
Conclusion: Together, these results suggest that HGF
composed of CCs could provide a suitable support for
BMSCs growth and differentiation, which is a promis-
ing method for the development of a tissue-engineered
liver.
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APHPB-0557
CLINICAL OUTCOME FOR
PARENCHYMA-SPARING
PANCREATECTOMY (PSP) IN
PANCREATIC BENIGN NEOPLASM
J. Park1, S. Youn1, H. Lee1, W. Kwon1, J. Heo1, S.
Choi1 and D. Choi1
1Department of Surgery, Samsung Medical Center,
Seoul, Korea
Objectives: As an alterative surgical procedure, paren-
chyma-sparing pancreatectomy (PSP) can preserve nor-
mal pancreatic parenchyme. Pancreatic benign
neoplasm do not necessarily require extensive pancre-
atic resections to achieve surgical cure. This study
aimed to evaluate clinical outcome after PSP.
Methods: Patients who underwent PSP (enucleation
and central pancreatectomy (CP)) for pancreatic neo-
plasm included cystic lesions, IPMN and neuroendo-
crine turmors of low and moderate grade between 2000
and 2013. We retrospectively collected data on clinical
records
Results: A total of 75 patients underwent PSP. A clini-
cally significant complication was reported 25 patient
(33.3%, enucleation 13 patients, CP 12 patients). Of
those, pancreatic fistula was reported in 11 patients
(14.7%, enucleation 6 patients, CP 5 patients). Four
elderly patients developed non insulin dependent diabe-
tes mellitus. At a median follow up of 26 months no
patient developed recurrent tumor and no mortality.
Conclusion: PSP is effective for select pancreatic benign
neoplasm. It can be carried out with good results and
no mortality. It should be considerd the procedure. It
is to preserve pancreatic parenchyme and oncologically
feasible for pancreatic neoplasm.
APHPB-0559
EVALUATION OF THE EFFICACY AND
SAFETY OF LAPAROSCOPIC
SPLENECTOMY PLUS PERICARDIAL
DEVASCULARIZATION ON PATIENTS
WITH PORTAL HYPERTENTION
W. Wenjing1, T. Yong1, Z. Yu1, C. Qing1 and W.
Chidan1
1Hepatobiliary surgery, Union Hospital Tongji Medical
College Huazhong University of Science and Techn,
Wuhan, China
Objectives: To evaluate the efficacy and safety of lapa-
roscopic splenectomy plus pericardial devascularization
(LS) on patients with liver cirrhosis and portal hyper-
tention by comparing the clinical effects of LS with
open splenectomy plus pericardial devascularization
(OS).
Methods: Retrospectively analyse the clinical data of
103 cases of LS and 110 cases of OS on patients with
portal hypertention from January 2010 to May 2014 in
our medical center.
Results: The operations of the two groups were suc-
cessfully fullfilled with no perioperative deaths, and all
patients recovered and were discharged from hospital
with no complications in the six months of postopera-
tive follow-up. In the LS group, 2 cases converted to
laparotomy (conversion rate 1.9%). The average time
for an LS operation was longer than that needed for
an OS operation (344.16 min vs. 241.73 min,
p = 0.027). In terms of blood loss (793.25 mL vs.
914.54 mL, p = 0.009) and total abdominal drainage
(834.1 mL vs. 1008.1 mL, p = 0.016), the LS operation
also outperforms the OS operation. The average time
of bowel function recovery (42.66 h vs. 56.25 h,
p = 0.011) and postoperative hospitalization (7.5 days
vs. 8.93 days, p = 0.043) is much less in the LS group
than in the OS group. There are no significant differ-
ences between the two groups in terms of liver func-
tion, incidence of complications and average weight of
excised spleen (p > 0.05). And the incidence of postop-
erative complications (p > 0.05) has no statistical signif-
icance.
Conclusion: Clinical effects of LS are better than OS. It
is a safe and feasible procedure for portal hypertension.
APHPB-0560
LAPAROSCOPIC VERSUS OPEN
SURGERY FOR MIRIZZI’S SYNDROME:
A COMPARATIVE STUDY
H. Nag1, V. Bg2 and A. M. I. T. Dangi2
1G I SUrgery, G B Pant Hospital, Delhi, India; 2G I
Surgery, G B Pant Hospital, Delhi, India
Objectives: To compare outcomes of laparoscopic and
open surgery for Mirrizi’s syndrome (MS).
Methods: Retrospective analysis of prospectively col-
lected data of patients with MS who were treated by a
single surgical team from December 2009 to August
2014. On intention to treat basis, patients were divided
into laparoscopic group (LG) and open group (OG).
Both the groups were compared by using appropriate
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statistical methods and P≤0.05 (two sided) was consid-
ered significant.
Results: Out of total 43 patients, 27 patients were in LG
and 16 patients were in OG. Rate of conversion in LG
was 33.3% (9/27). Mean operative time in both the
groups was not different (p = 0.15) but median blood
loss was higher in OG (p = 0.004). Patient in OG had
longer postoperative hospital stay (p = 0.039) and higher
rate of non major complications (p = 0.02). Mean follow
was not different among both the groups (p = 0.2) and
there were no late complications and mortality.
Conclusion: Laparoscopic surgery for patient with Mir-
rizi’s syndrome is not inferior than open surgery how-
ever randomized trials are necessary for confirmation.
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APHPB-0561
CONVENTIONAL D1P (N1) AND
EXTENDED D2P (N2)
LIMPHADENECTOMY IN WIPPLE
PROCEDURE – COMPARATIVE
ANALYSIS
M. Zagriichuk1, A. Usenko1, M. Nychytaylo1, A.
Lytvin1, A. Goman1 and V. Prysyagnyuk1
1Laparoscopyc surgery, National Institute of Surgery
and Transplantology NAMS named after A.A.Shalimov,
Kiev, Ukraine
Objectives: Compare outcomes after pancreatoduoden-
ectomy in patients with N1 (D1p) and N2 D2p limpha-
denectomy. N1 (D1p) limphadenectomy include:
13a,13b,17a,17b,5,6,8a,12b2,14a,14b limph nodes. N2
(D2p) limphadenectomy include: N1
(D1p)+6,8a,8p,12a1,12a2,12b1,12b2,12p1,12p2,12 h,12-
c,14a,14b,14c,14d,14v limph nodes.
Methods: From 2010 to 2014 56 patients on ductal
adenocarcinoma were treated. Age – 53  1.8 years. 21
(37.5%) undergone standart Wipple procedure with
D1p limphadenectomy (N1 region) – group I. 35
(62.5%) D2p limphadenectomy was added (N2 region)
– II group. In group I 12 (57.1%) were stage I pancre-
atic cancer (T1aN0M0) and 9 (42.9%) – stage II.
Among them 7 (33.3%) were T1aN1M0 grade and 2
(9.5%) T1bN1M0 grade. From II group 18 (51.4%)
have stage II – T1aN1M0, 9 (25.7%) stage II
T1bN1M0 and 8 (22.9%) stage III with – T2
(TS3S1RP0PV0A0DU1CH2)N1M0.
Results: In group I operative time was
280.4  22.5 min. Blood loss 320.4  48.5 mL, mortal-
ity rate 6.4%. Bleeding in 2 (9.5%), partial failure of
pancreaticojejunoctomy in 4 (19%), hepaticojejunosto-
my in 1 (4.8%). 1-year survival rate 80.9%, 2-year
38.1%, tree year 4.8%. In group II operative time was
338.4  33.9 min. Blood loss 428.4  29.9 mL, intra-
operative mortality 7.9%. Bleeding in 4 (11.4%), par-
tial failure of pancreaticojejunoctomy in 5 (14.2%)
hepaticojejunostomy in 3 (8.5%). 1-year survival rate
89.6%, 2-year 67.3%, tree year 25.8%. Lethality 0%.
Conclusion: D2p (N2 region) limphadenectomy didn’t
significantly affect main operative criteria’s compare to
traditional Wipple procedure. However, steady increas-
ing in long term survival rate were admitted. Obvi-
ously, bigger number of observation is needed to
perform deep statistically appropriate research. D2p
(N2) regional limphadenectomy is feasible and safe in
carefully selected patients.
APHPB-0562
PROGNOSTIC FACTORS FOR LONG-
TERM SURVIVAL AND ADJUVANT
CHEMOTHERAPY FOR PATIENTS
WITH DISTAL BILE DUCT CANCER
I. Yoshioka1, K. Matsui1, K. Shibuya1, S. Sekine1, H.
Kojima1, M. Moriyama1, I. Hashimoto1, S. Hojo1, T.
Okumura1, T. Nagata1 and K. Tsukada1
1Department of Surgery and Science, University of
Toyama, Toyama, Japan
Objectives: Radical resection for treatment of distal
bile duct cancer is potentially curative, but the progno-
sis remains dismal. Adjuvant chemotherapy improves
disease-free survival and overall survival of patients in
various malignancies. However, benefits of adjuvant
chemotherapy in bile duct cancer are controversial. The
aim of this study was to identify main prognostic fac-
tors and to determine whether adjuvant chemotherapy
provides improved overall survival in distal bile duct
cancer patients following resection.
Methods: Between 1999 and 2013, a total of 38
patients with distal bile duct cancer underwent surgical
resection in our institute. We analyzed the actual sur-
vival outcome and prognostic factors after resection,
which included pancreatoduodenectomy (n = 30), bile
duct resection (n = 7) and hepatopancreatoduodenecto-
my (n = 1). Ten patients were administered S-1 with
gemcitabine as adjuvant chemotherapy and the effect
was investigated respectively.
Results: There was no operative mortality. The 1-, 3-,
and 5-year survival rates of all resection cases were
92.3%, 44.2% and 33.3%, respectively. UICC-TNM
stage, depth of invasion, resection margin involvement
and the surgical procedure had no significant prognostic
impact. Lymph node metastasis was significant prognostic
factor (p = 0.003). Adjuvant chemotherapy (GEM with
S-1 therapy) had only marginal significance (p = 0.06).
Conclusion: Lymph node metastasis is a useful prog-
nostic factor for predicting and adjuvant chemotherapy
using GEM with S-1 showed the potential of contribut-
ing to prolonged over-all survival in resected distal bile
duct cancer.
APHPB-0563
PRIMARY ADENOCARCINOMA OF THE
MINOR DUODENAL PAPILLA WITH
MASS-FORMING CHRONIC
PANCREATITIS
K. Suzumura1, S. Hai1, T. Hirano1, Y. Asano1, T.
Okada1, Y. Iimuro1, N. Uyama1, I. Nakamura1, Y.
Kondo1, H. Kosaka1, H. Sueoka1, A. Yada1, K.
Ohashi1, T. Okamoto1, A. Kurimoto1 and J. Fujimoto1
1Surgery, Hyogo College of Medicine, Nishinomiya, Japan
Objectives: A 70-year-old male was treated for gastric
ulcers. Follow-up upper gastrointestinal endoscopy
revealed an irregular, elevated tumor in the second
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portion of the duodenum. On pathology of a biopsy
specimen, a diagnosis of adenocarcinoma was made,
and the patient was admitted to our hospital.
Methods: Computed tomography showed an irregular
mass in the pancreatic head and dilatation of the main
pancreatic duct and bile duct. Pancreatic head carci-
noma with infiltration of the duodenum was diagnosed,
and pylorus-preserving pancreaticoduodenectomy was
performed.
Results: A histopathological examination of the
resected specimen showed moderately differentiated
adenocarcinoma in the minor duodenal papilla and
chronic pancreatitis in the pancreatic head. Therefore,
primary adenocarcinoma of the minor duodenal papilla
with mass-forming chronic pancreatitis was diagnosed.
Currently, the patient is alive without recurrence
17 months after the surgery.
Conclusion: Primary adenocarcinoma of the minor
duodenal papilla is extremely rare. We herein report
this case with a review of the literature.
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APHPB-0564
CLINICAL AVAILABILITY OF
PREOPERATIVE PTGBD IN ACUTE
CHOLECYSTITIS
K. Kwon1 and S. Bae1
1Surgery, NHIC Ilsan hospital, Goyang, Korea
Objectives: Definite treatment of acute cholecystitis is
cholecystectomy, especially laparoscopically in recent.
But there were still high complication and mortality
rates especially in old and critically ill patients. So
PTGBD (percutaneous transhepatic gallbladder drain-
age) can be a bridge procedure to reduce postoperative
complication and mortality and increase the chance of
laparoscopic cholecystectomy.
Methods: We had 21 PTGBD cases in acute cholecysti-
tis from 2012.01.01. to 2012.12.31. General characteris-
tics, preoperative diagnostic criteria, severity
assessment, treatment and its results, postoperative
complication and mortality rate were analyzed.
Results: According to T13 diagnostic criteria, all 21
cases were definite acute cholecystitis. According to
T13 severity assessment, Grade I was 3(14.3%), Grade
II 13(61.9%) and Grade III 5(23.8%). Cholecystectomy
was performed in 16 cases (76.2%) including total lapa-
roscopically in 11 cases, open converted in 3 cases and
initially open in 2 cases. 3 cases (18.8%) were not
improved by PTGBD and received emergent operation.
5 cases (23.8%) were improved by conservative treat-
ment only, in that 4 cases refused operation and 1 case
was follow up loss. The average interval between
PTGBD and operation was 5.3 days and mean hospital
stay was 7.1 days. There were no differences of hospital
stay between Grades of acute cholesystitis in laparo-
scopic cholecystectomy. Postoperative complication rate
was 18.8% and mortality rate was 4.8% but there were
no mortality and complications related PTGBD.
Conclusion: PTGBD can be a bridge procedure for
acute cholecystitis especially in old and critically ill
patients to reduce postoperative complication and mor-
tality rates and increase the chance of laparoscopic cho-
lecystectomy.
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APHPB-0565
RECENT ADVANCEMENTS AND
PERSPECTIVES OF DONOR
OPERATION IN LIVING DONOR LIVER
TRANSPLANTATION: SINGLE-CENTER
EXPERIENCE OF 886 PATIENTS IN 13
YEARS
K. S. Suh1, S. W. Suh1, N. J. Yi1, K. W. Lee1, J.
Jeong1 and H. Kim1
1Surgery, Seoul National University College of
Medicine, Seoul, Korea
Objectives: To address the past, present, and future of
donor surgery for living donor liver transplantation
(LDLT).
Methods: A total of 886 donor hepatectomies between
January 1999 and December 2012 at a single center
were investigated. Three groups were divided: the initial
period (1999–2004, n = 239); the primary usage of right
liver with middle hepatic vein reconstruction (2005–
2010, n = 422); and the exclusively using right liver
with standardized protocol, preoperative donor diet
program, steatosis evaluation by magnetic resonance
spectroscopy, no systemic heparin administration and
central venous pressure monitoring, exact mid-plane
dissection, and incremental application of minimal inci-
sions (2011–2012, n = 225). The selection of donors
and clinical outcomes were compared.
Results: The proportion of patients older than 50 years
increased (2.5% vs. 4.7% vs. 8.9%), whereas a remnant
liver volume ≤ 30%(6.5% vs. 13.9% vs. 6.3%) and mac-
rosteatosis ≥ 10%(7.9% vs. 11.1% vs. 4.4%) decreased
in recent period. Operative time (292.7 vs. 290.0 vs.
272.8, mins), hospital stay (12.4 vs. 11.2 vs. 8.5, days),
and overall morbidity rate (26.4% vs. 13.3% vs. 5.8%)
including major complications, more than grade III
(1.7% vs. 1.9% vs. 0.9%) and biliary complications
(7.9% vs. 5.0% vs. 0.9%) were markedly reduced
recently. No intraoperative transfusion required. There
was no case of irreversible disability or mortality.
Conclusion: Recently, donor surgery has been stan-
dardized with a large volume of experience, and it has
a minimal risk. However, a constant evaluation of our
experience is critical to our preparedness for any
unavoidable crisis.
APHPB-0566
SYNERGISTIC EFFECTS OF
METFORMIN IN COMBINATION WITH
RAPAMYCIN ON HEPATOCELLULAR
CARCINOMA CELL LINES
K. W. Lee1, S. W. Suh1, J. Jeong1, H. Kim1, N. J. Yi1
and K. S. Suh1
1Surgery, Seoul National University College of
Medicine, Seoul, Korea
Objectives: Several studies have shown that metformin
had an anti-tumor effect on several cancers, including
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hepatocellular carcinoma (HCC). After liver transplan-
tation (LT), immunosuppression is needed to avoid
rejection and graft loss, however, it can stimulate HCC
recurrence and progression. The aim of this study was
to evaluate interactions between metformin and immu-
nosuppressive agents for antitumor activity.
Methods: Antiproliferative effects were assessed using
HCC cell line as HepG2, Hep3B, Huh7. Metformin
(10 mM/L) and several immunosuppressive agents such
as Sirolimus (5 ng/mL), Tacrolimus (5 ng/mL), and
MMF (500 ng/mL) were evaluated. Cell viability was
determined using a standard colorimetric 3-(4 5-dim-
ethylthiazol-2-yl)-2 5-diphenyltetrazolium bromide
(MTT) assay after 48 h. Western blot analysis were
performed to investigate protein levels in HCC cells.
Results: Metformin and Sirolimus itself had antitumor
effect in all of the HCC cell lines (73% and 66%,
HepG2; 84% and 73%, Hep3B; 77% and 66%, Huh7).
They also had significant synergistic antiproliferative
effect in all of the HCC cell lines (68%, HepG2; 57%,
Hep3B; 63%, Huh7), however, there was no synergistic
effect with other immunosuppressive agents. In addi-
tion, combination of metformin, sirolimus and MMF
showed some synergistic antiproliferative effect in
Hep3B and Huh7 HCC cell lines (53%, Hep3b; 53%,
HuH7).
Conclusion: Metformin had synergistic interactions
with Sirolimus in terms of antitumor effects for HCC
cell lines.
These results may provide a foundation for further
studies to evaluate combination therapies for patients
with HCC who underwent LT in clinical era.
Malignant HPB Diseases
APHPB-0567
SERUM BILIRUBIN AND CA 19-9
LEVELS AS PREDICTORS OF
MALIGNANCY IN OBSTRUCTIVE
JAUNDICE
L. Hozefa1, J. A. I. N. Hitesh1, J. Saurabh1, H.
Hunaid1, S. Rajinder1 and J. Rajeev1
1GENERAL SURGERY, B.Y.L Nair Charitable
Hospital and T.N.M. Collge, Mumbai, India
Objectives: Obstructive jaundice due to malignant
pathology is associated with high bilirubin levels. How-
ever, malignant pathologies can present with low biliru-
bin levels in the early stages and benign pathologies
with high levels, if associated with cholangitis. CA 19-9
is also an inaccurate predictor of malignancy. This
study examined the accuracy of bilirubin levels and CA
19-9, in order to predict malignancy as a cause of
obstructive jaundice.
Methods: Bilirubin levels in a total of 900 patients with
obstructive jaundice and CA 19-9 levels in 649 of these
patients suspected to have malignancy on clinical evalu-
ation or imaging, were analyzed. Values of bilirubin in
isolation and in combination with CA19-9 were used
for co relation.
Results: Bilirubin levels at cut off values of 3, 7, 11, 15
and 19 mg% were evaluated for sensitivity and specific-
ity to establish the diagnosis of malignancy. Level
>7 mg% provided the optimum sensitivity and specific-
ity for malignancy (71.9% and 84.9%, respectively)
while a level >19 mg% achieved specificity of 99.1%.
Sensitivity and specificity of CA 19-9 in isolation was
70.9% and 78.3% respectively, at a cut-off value of
37 U/mL. When both levels were combined, sensitivity
and specificity increased to 87.9% and 91.3% respec-
tively.
Conclusion: In patients with obstructive jaundice, bili-
rubin levels and CA 19-9 are not always specific or sen-
sitive for diagnosis of malignancy. Our study shows
that if bilirubin levels exceed 7 mg% the diagnosis is
more likely to be malignancy and the diagnostic yield
improves significantly if serum bilirubin and CA 19-9
are used in combination.
Transplantation
APHPB-0568
ANIMAL MODEL OF LIVING DONOR
LIVER TRANSPLANT IN SWINE
WITHOUT USING VENOVENOUS
BYPASS
Y. Wu1, M. Hung1, S. Huang1, H. Wong1, H. Wu1 and
M. Huang1
1Surgery, Show Chwan Memorial Hospital, Changhua,
Taiwan
Objectives: A model of living donor liver transplant
(LDLT) was developed to investigate the home-made
internal shunt (IS), which could be useful in the liver
transplantation.
Methods: Two swines were prepared around 25 kg,
including one for donor and the other for recipient.
The donor liver was dissected and the right partial
graft was taken for the recipient. The upper end of
inferior vena cava (IVC) was anastomosed first with
artificial vessel, 15 mm in diameter. Home-made IS was
used for reducing the portal occlusion time less than
30 min during anhepatic phase. Then anastomosed the
low end of IVC with distal end of artificial vessel. The
3rd arm of IS was inserted to the artificial vessel for
draining venous flow of low body. The hepatic vein of
partial liver graft was anastomosed the artificial vessel.
Thereafter, the portal vein anastomosis was completed.
Finally completion of hepatic artery and bile duct was
done.
Results: The vital sign of both swines were stable with-
out blood transfusion after LDLT.
Conclusion: Home-made IS without VV bypass could
be designed for reducing portal occlusion time. Then
the swine would be survived after operation. This ani-
mal model of LDLT is feasible in swine.
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APHPB-0569
LAPAROSCOPIC PANCREATIC
SURGERY: A SINGLE SINGAPOREAN
INSTITUTION EXPERIENCE
P. Toonson1 and W. Woon1
1General Surgery, Tan Tock Seng Hospital, Singapore,
Singapore
Objectives: We sought to firstly determine whether
laparoscopic pancreatic surgery is being carried out
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efficaciously in our hospital, and secondly to identify
barriers preventing totally laparoscopic pancreaticoduo-
denectomy (LPD).
Methods: Utilising our institution’s pancreatic data-
base, all pancreatectomies between 2008 and 2014 that
were attempted laparoscopically were analysed. Specifi-
cally assessed were resection margin, blood loss, opera-
tive time, conversion rate, length of stay and pancreatic
fistula.
Results: 52 pancreatic resections were attempted lapa-
roscopically. 10 patients had advanced disease prevent-
ing resection. 28 DP and 12 PD were performed either
totally laparoscopic or lap-assisted. 2 enucleations were
performed. Of the 28 LDP: 5 (18%) were converted to
open due to bleeding or difficulty with dissection. 5
(18%) were for malignancies. The incidence of fistula
(Grade B and C) was 14%; the median blood loss was
150 mL; median operation time was 295 min; and
mean length of stay was 6 days. Of the 12 LPD, 8 were
completed hybrid and 4 were converted to open due to
bleeding or difficulty with the dissection. Mean blood
loss for LPD was 300 mL, median operation time was
677 min and median length of stay was 9 days. 2 posi-
tive resection margins were encountered for both proce-
dures; 1 during DP for IPMN; and another during PD
for cholangiocarcinoma.
Conclusion: LDP is performed safely in our institution
for both benign and malignant disease. LPD however
remains challenging. The major limitations encountered
were difficulty with resection associated with bleeding or
concern regarding an R0 resection, or with the recon-
struction phase, particularly the pancreatic anastomosis.
Benign HPB Diseases
APHPB-0571
RESEARCH OF RADIO FREQUENCY
ABLATION ASSISTED SPLEEN-
PRESERVATION TECHNIQUE FOR
SPLENIC INJURY
W. Zhang1
1Department of Hepatobiliary Surgery, Yue Bei people’s
Hospital, Shao Guan, China
Objectives: To investigate the value of the research of
radio frequency ablation assisted spleen-preservation
technique for splenic injury.
Methods: From Oct 2008 to June 2014, we colletcted
152 cases of splenic traumatic rupture that were imple-
mented the spleen-preserving surgery using radiofre-
quency ablation. Conventional open celiac and
exploration, then use a radiofrequency electrode to stop
the bleeding of ruptured spleen or Splenic partly resec-
tion.
Results: 147 in 152 cases radio frequency ablation
assisted splenic-preserving splenorrhaphy operation
were successful. Protect spleen and success rate of
96.7%
Operation time is 124.2  44.3 min, hospital stays was
11.2  3.6 day. Celiac drainage tube drainaged out 10–
120 mL light red liquid in the first day after operation,
5–25 mL in the next two days and all were removed in
the third day. No case of subphrenic abscess or postop-
erative hemorrhage etc complications appeared. There
weren’t effusion around the spleens, no necrosis of the
spleens exist, and immune examinations showed normal
splenic function after 6 month.
Conclusion: Radiofrequency ablation assisted spleen-
preserving splenorrhaphy operation was simple, easy to
popularize, reduced the difficulty of preserving spleen
surgery. We predict it will become the future gold stan-
dard technique of spleen-preserving surgery.
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APHPB-0573
EXPRESSION AND SIGNIFICANCE OF
B7-H4 AND HBX IN HBV RELATED
HEPATOCELLULAR CARCINOMA
H. P. Yao1, S. S. Li1, Y. Qian1, Z. G. Wu1 and N. P.
Wu1
1State Key Laboratory for Diagnosis & Treatment of
Infectious Diseases, the First Affiliated Hospital College
of Medicine Zhejiang University, Hangzhou, China
Objectives: Hepatitis B virus (HBV) is a major public
health problem, and Hepatitis B virus-related hepatoce-
lular carcinoma (HBV-HCC) has an extremely poor
prognosis due to a lack of effective treatments. B7-H4
is a novel member of the B7 superfamily that are
actively involved in regulating the pathogenesis of
tumors. However, the intrahepatic expression of B7-H4
in HBV-HCC patients has not been described. In this
study, we investigated the expression and clinical signif-
icance of B7-H4 and Hepatitis B Virus X (HBx) pro-
tein in HBV-HCC.
Methods: The expression of B7-H4 in the human HCC
cell lines HepG2 and HepG2215 was detected by wes-
tern blotting, flow cytometry and immunofluorescence
analysis. The expression of B7-H4 and HBx in 83
HBV-HCC was detected by immunohistochemistry,
and the relationship with clinicopathological features
was analyzed.
Results: B7-H4 was significantly up regulated in
HepG2215 cells than in HepG2 cells. The positive rates
of B7-H4 and HBx in 83 HBV-HCC tissues were
68.67%(57/83)and 59.04%(49/83) respectively. The
expression of HBx was correlated with TNM staging.
The expression of B7-H4 was positive correlated with
HBx (rs = 0.388, p < 0.01). The expression level of B7-
H4 in HBx-positive HBV-HCC tissues was substan-
tially higher than that in HBx-negative HBV-HCC tis-
sues, which was negative related to tumor TNM stage.
Conclusion: The higher expression of HBx and B7-H4
were correlated with tumor progression of HBV related
hepatocelular carcinoma. B7-H4 may be an effect mole-
cule in HBV related hepatocarcinogenesis.
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APHPB-0574
ASSOCIATING LIVER PARTITION AND
PORTAL VEIN LIGATION FOR STAGED
HEPATECTOMY FOR HCC —SIX
CASES REPORT
K. Ma1, S. Zheng1, X. feng1, J. I. A. N. Chen1, J. U.
N. Yan1, Z. Yan1 and P. I. N. G. Bie1
1Hepatobiliary surgery, Southwest HospitalThird
Military Medical University, Chongqing, China
Objectives: To study the safety and efficacy of associat-
ing liver partition and portal vein ligation for staged
hepatectomy (ALPPS) for HCC patients.
Methods: The clinic datas of 6 HCC patients who
underwent associating liver partition and portal vein
ligation for staged hepatectomy (ALPPS) from October
2013 to July 2014 was analyzed respectively. Operative
process can be divided into two steps, the first opera-
tion is liver split and portal vein ligation with the con-
ventional methods, then second operation will be done
at least 2 weeks after first operation and the remaining
volume of liver is greater than 40%, the liver that need
resected wil be moved out. Surgical techniques and
treatment response were retrospectively reviewed. 4
male and 2 Famle of patients and aging from 28 to
66 years with a mean of (49.5  13.9) years. 4 of the 6
patients were infected with hepatitis B virus and had
liver cirrhosis. Residual liver volume ratio after first
hepatic resection less than 30%.
Results: The first surgical time and second surgical
time was 195–385 min and 210–485 min, with a mean
of 297.7  67.7 min and 331.2  100.8 min respec-
tively. The bleeding in first surgical and second surgical
was 200–600 mL and 100–1200 mL, with a mean of
376.7  141.7 mL and 683.3  444.6 mL respectively.
The hospital stay was 32–77 days, with a mean of
(55.2  18.6) days. 4 medical complications and no
postoperative death happend. 5 patients were cured
and discharged, 1 patient still in the hospital.
Conclusion: Associating liver partition and portal vein
ligation for staged hepatectomy (ALPPS) for HCC pa-
tientgs is safe and effective.
APHPB-0575
CLINICAL APPLICATION OF
NAVIGATION SURGERY USING
AUGMENTED REALITY IN HEPATO-
BILIARY PANCREATIC SURGERY
T. Okamoto1, J. Yasuda1, F. Suzuki1, N. Funamizu1,
S. Fujioka1, S. Onda2, K. Yanaga2, N. Suzuki3 and M.
Hattori3
1Surgery, The Jikei University Daisan Hospital, Tokyo,
Japan; 2Surgery, The Jikei University Shool of
Medicine, Tokyo, Japan; 3High Dimensional Medical
Imaging, The Jikei University Shool of Medicine, Tokyo,
Japan
Objectives: We have developed a system of augmented
reality-based navigation surgery (AR-based NS) for he-
patobiliary and pancreatic surgery (HBP-S) for better
comprehension of anatomy, sharing information and
education. This paper presents our outcomes and
current problems.
Methods: Three-D reconstructed images from CT were
created by segmentation. In the operating room, initial
registration was performed by using the optical loca-
tion sensor. Reconstructed images were superimposed
onto the real organs in the monitor display. Twenty-
four patients underwent HBP-S using the AR-based
NS. The purposes for the use of this system were to
determinate the location of lesions and resection line in
13 (including 5 L with aparoscopic procedures), early
ligation of the inferior pancreaticoduodenal artery
(IPDA) in 10, and prevention of injuries of vessels or
organs in one patient. The feasibility, safety and useful-
ness were assessed.
Results: The position of each organ in reconstructed
image almost corresponded with that of the actual
organ. The mean registration error was approximately
5 mm. Intraoperative information provided us with
useful navigation. In particular, the early identification
and ligation of the IPDA were made easier. However,
AR-based NS for the liver remained a prolem due to
organ deformity. As to laparoscopic operations, there
seemed several obstacles such as organ shifting by
pneumoperitoneum or positition changes to achieve
accurate navigation as in an open surgery.
Conclusion: In spite of some problems to implement
these in routine surgery, AR-based NS has features
that offer surgeons visually vivid and easily comprehen-
sible images. This technology might contribute to
improve surgical quality, training, and education.
APHPB-0576
INCIDENCE OF PYOGENIC LIVER
ABSCESS ASSOCIATED WITH
MALIGNANCY
P. J. Toonson1, Z. J. Lo1, S. P. Junnarka1, J. K. Low1
and W. W. Woon1
1General Surgery, Tan Tock Seng Hospital, Singapore,
Singapore
Objectives: To assess the incidence of underlying malig-
nancy associated with liver abscess and to determine
which unrecognised cancers are most likely to cause
pyogenic liver abscess.
Methods: Our hospital’s retrospective pyogenic liver
abscess (PLA) database was utilised to provide sub-
group analysis of liver abscesses associated with malig-
nancy.
Results: Over the past 10 years, there were 741 PLA
with an incidence of 86/100,000 admissions. While 462
(62%) were cryptogenic, 55 (7%) were associated with
synchronous malignancies. Of these, 30 were hepato-
pancreaticobiliary (HPB) cancers (9 pancreatic, 5 hepa-
tocellular carcinoma, 5 cholangiocarcinoma, 6
gallbladder, 5 ampulla) and 16 were colorectal cancers.
Of the 55 PLA patients with synchronous malignancies,
27 (49%) were subsequently found to have cancer fol-
lowing their admission with PLA. 8 previously
unknown colorectal cancers were determined by colo-
noscopy either during index admission or as an outpa-
tient. 11 HPB cancers were subsequently diagnosed
during index admission or by serial imaging.
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Conclusion: The incidence of PLA is high in our
Singaporean institution. 7% of PLA were associated
with an underlying malignancy. HPB and colorectal
cancers were more likely to result in PLA. Serial imag-
ing and tumour markers for HPB malignancies is
recommended for cryptogenic PLA. As only 8 of 741
PLA resulted from previously unknown colorectal can-
cer, routine screening colonoscopy is not recommended
for cryptogenic PLA without other risk factors for
colorectal cancer.
APHPB-0577
PRIMARY SQUAMOUS CELL
CARCINOMA OF LIVER: REPORT OF 4
CASES AND REVIEW OF THE
LITERATURES
X. F. Zhang1, K. Wang2, X. M. Liu1 and Y. Lv1
1Department of Hepatobiliary Surgery, First Affiliated
Hospital of Medical College Xi’an Jiaotong University,
Xi’an, China; 2Department of Clinical Pathology, First
Affiliated Hospital of Medical College Xi’an Jiaotong
University, Xi’an, China
Objectives: Primary squamous cell carcinoma (SCC) of
liver is rare, and its prognosis is extremely poor. This
study aims at reviewing the clinical data of all patho-
logically proved liver cancer in our institute, and to dis-
cuss the clinical presentation, diagnosis, treatment and
prognosis of our cases of SCC and the literatures
reported previously
Methods: All the patients undergoing surgery or biopsy
of liver from 2002 to 2013 in our hospital were
reviewed, and all the liver tissues were examined patho-
logically.
Results: From January 2002 to October 2013, 2210
cases of liver cancer were diagnosed pathologically in
our hospital. Amongst, four cases (0.2%) were diag-
nosed as primary SCC of liver. All were negative for
HBV infection, but present with liver cyst and/or he-
patolithiasis. Two patients underwent radical resection,
but died of tumor recurrence 18 and 9 months postop-
eratively. One patient received laparotomy and alcohol
and fluorouracil injection, but died 4 months postoper-
atively. The last patient received only biopsy and che-
motherapy, and finally died of tumor metastasis
6 months later. From 1970 to 2014, 30 case reports
have been published in English, and amongst, 18
patients presented with liver cyst, 6 with hepatolithiasis,
1 with both combined and 3 without any apparent liver
disease. Radical hepatectomy remains the optimal treat-
ment for the patients, with the median survival time of
17 months (2–84 months).
Conclusion: Primary SCC seems to be mostly origi-
nated from liver cyst or hepatolithiasis. Radical surgery
should be firstly recommended, although the prognosis
might be unfavorable.
APHPB-0579
CIGARETTE SMOKING INCREASES
RISK OF EARLY MORBIDITY AFTER
HEPATIC RESECTION IN PATIENTS
WITH HEPATOCELLULAR
CARCINOMA
X. F. Zhang1, C. Liu1 and Y. Lv1
1Department of Hepatobiliary Surgery, First Affiliated
Hospital of Medical College Xi’an Jiaotong University,
Xi’an, China
Objectives: Cigarette smoking is an important risk fac-
tor for the development of postoperative pulmonary
complications after major surgical procedures. The
objective of this prospective study was to investigate
whether preoperative smoking has any impact on early
morbidity after liver resection for hepatocellular carci-
noma (HCC).
Methods: We enrolled 425 consecutive patients under-
going partial hepatectomy for HCC, recording smoking
and drinking habits, biochemical tests, tumor status,
operation data, and any postoperative complications
occurring before discharge from the hospital. The risk
factors promoting postoperative complications were
analysed by univariate and multivariate methods.
Results: The overall morbidity rate was 40% (170 of
425). There were 166 smokers (39%). There were 12
potential risk factors increasing postoperative overall
morbidity by univariate analysis (all p < 0.05). Only
liver cirrhosis (Risk Ratio (RR) 4.5, 95% confidence
interval (CI) 2.2–9.1), smoking status (RR 3.0, 95% CI
1.7–5.1), PY of smoking (RR 2.1, 95% CI 1.1–3.9) and
preoperative platelet count (RR 1.5, 95% CI 1.3–1.9)
were identified as independent risk factor promoting
postoperative morbidity by multivariate analysis (all
p < 0.05). When analysed by each complication, liver
failure, bile leakage, intractable ascites, chest infection
and wound infection were more frequently occurred in
smokers than non-smokers.
Conclusion: Cigarette smoking is an independent risk
factor for the development of liver-related and infec-
tious complications in patients undergoing partial hepa-
tectomy for HCC.
APHPB-0580
BILATERAL OVARIAN METASTASIS
FROM COMMON BILE DUCT
CARCINOMA WITH CHOLEDOCHAL
CYST MASQUERADING AS A PRIMARY
OVARIAN NEOPLASM
S. Lee1, S. Suh1 and Y. Choi1
1Department of Surgery, Chung-Ang University, Seoul,
Korea
Objectives: We present an unusual case of metastatic
carcinoma of the common bile duct (CBD) cancer orig-
inated from choledochal cyst. 60-year-old woman was
admitted for the investigation of abdominal distension
which had lasted for 1 week
Methods: One and half year ago, the patient had
undergone operations for choledochal cyst that
included choledochal cyst excision, Roux-en Y hepati-
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cojejunostomy and cholecystectomy. CT scans of the
abdomen revealed papillary mass in the remnant distal
CBD and enlargement of both ovaries with huge
amount of ascites. An explorative laparotomy disclosed
no peritoneal seeding with resectable cholangiocarcino-
ma and bilateral ovarian mass. Pylorus-preserving pan-
creatoduodenectomy and bilateral salphingo-
oophorectomy with hysterectomy were performed.
Results: Histologically, it was a well-differentiated ade-
nocarcinoma, which extended to the pancreas with peri-
neural invasion and regional lymph node metastasis
while all surgical margins were free of tumor. Both
ovarian masses were consistent with metastatic adeno-
carcinoma from CBD. The patient received six cycles
of postoperative adjuvant systemic chemotherapy,
dying after 10 month due to progression of tumor and
pulmonary embolism.
Conclusion: Ovarian metastases represent 10% of all
ovarian malignancies. Most of these tumors originate
in the digestive tract and cholangiocarcinoma is rare
neoplasm that rarely involves the ovary.
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APHPB-0581
RISK OF DEVELOPMENT OF BILIARY
MALIGNANCY AFTER CYST EXCISION
FOR CHOLEDOCHAL CYST
S. Lee1, Y. Choi1 and S. Suh1
1Department of Surgery, Chung-Ang University, Seoul,
Korea
Objectives: The aim of this study was to elucidate the
risk of subsequent biliary malignancy in patients under-
going cyst excision for congenital choledochal cysts.
Methods: Electronic searches of the MEDLINE (Pub-
Med) database between 1970 and 2011 were performed
to identify to identify relevant articles. searched both
English and Japanese language literature.
Results: Of 58 cases were identified and among them,
data of site of malignancy can be available in 54 cases.
According to Todani’s classification, 24 of 41 patients
(59%) were classified into type IVa and 17 (42%) were
into type I. The most common site of involvement in
54 cases was the hepatic duct, at or near the choledo-
cho-enteric anastomosis (43%) followed by the intrahe-
patic duct (41%) and distal choledochus (17%). The
time between cyst excision and cancer detection ranged
from 1 to 32 years (mean, 10.4 years). 20 patients
(37.4%) gave a medical history of cholangitis or he-
patolithiasis after choledochal cyst excision. It seems
that post-operative or pre-existed stenosis of bile duct,
bile stasis caused by stenosis, and repeated chronic
inflammation of the epithelium might induce carcino-
genesis.
Conclusion: Initially, complete excision of the dilated
bile duct at the level of confluence with the pancreatic
duct and wide anastomosis with free drainage of bile
should be performed. Thereafter, life-long regular fol-
low-up through tumor marker such as serum level of
CA19-9 and imaging modalities such as computed
tomography or ultrasonography for early detection of
subsequent biliary malignancy after cyst excision
should be done.
APHPB-0582
EXPERIENCE ON ALPPS
(ASSOCIATING LIVER PARTITION AND
PORTAL LIGATION FOR STAGED
HEPATECTOMY) IN HCC PATIENTS –
CASE SERIES
J. Wong1, S. Y. Kok1, C. F. Lau1, T. L. Tam1, T. P.
Fung1 and S. H. Lam1
1Surgery, United Christian Hospital, Hong Kong, Hong
Kong China
Objectives: ALPPS could induce a rapid future liver
remnant (FLR) hypertrophy. However, the effect in
HCC patients with diseased liver was unclear.
Methods: Three HCC patients underwent ALPPS in
our center. Operations included the ligation of right
portal vein together with liver partition along the Cant-
lie line with anterior approach.
Results: 1. 64 years old man suffered from hepatitis B
related HCC. CT volumetry showed the FLR was
396 cm3 and FLR/ estimated total liver volume (eTLV)
was 24.7%. CT volumetry 6 days after ALPPS revealed
the increase in FLR to 596 cm3 (FLR/eTLV = 37.1%);
ie: 50.5% increase in FLR. Right hepatectomy was per-
formed on POD 7 without mortality. Pathology con-
firmed cirrhosis (Ishak’s stage 6/6).
2. 69 years old woman suffered from hepatitis B related
HCC. CT volumetry showed the FLR was 310 cm3
(FLR/eTLV = 24.7%). CT volumetry 7 days after AL-
PPS revealed the increase in FLR to 480 cm3 (FLR/
eTLV = 38.2%); ie: 54.8% increase in FLR. Right hep-
atectomy was performed on POD 10 without mortality.
Pathology showed bridging fibrosis (Ishak’s stage 4/6).
3. 70 years old man suffered from alcoholic liver dis-
ease and HCC. CT volumetry showed the FLR after
right hepatectomy was 271 cm3 (FLR/eTLV = 20%).
CT volumetry 7 days after ALPPS revealed the increase
in FLR to 524 cm3 (FLR/eTLV = 38.7%); ie: 93%
increase in FLR. Right hepatectomy was performed on
POD 9 without complication. Pathology showed bridg-
ing fibrosis (Ishak’s stage 3/6).
Conclusion: ALPPS could induce a rapid increase in
the FLR even in HCC patients with background liver
disease.
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APHPB-0583
THE ‘CRITICAL VIEW OF SAFETY’ IN
LAPAROSCOPIC CHOLECYSTECTOMY:
A COMPASS FOR NAVIGATING
THROUGH TROUBLED WATERS
D. K. Manatakis1, N. Stamos1, C. Agalianos1, I.
Terzis1, I. D. Kyriazanos1 and D. Davides1
11st Surgical Department, Athens Naval and Veterans
Hospital, Athens, Greece
Objectives: Bile duct injuries during laparoscopic chole-
cystectomy still remain a major source of post-opera-
tive morbidity and mortality, severely affecting quality
of life. We present our experience with the critical view
of safety (CVS) technique and an analysis of iatrogenic
bile duct injuries.
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Methods: After Research Ethics Committee approval,
a retrospective analysis of prospectively collected data,
between January 2012 and September 2014, was per-
formed, on elective laparoscopic cholecystectomies, rea-
sons for conversion to the open approach, number and
type of bile duct injuries and their management.
Results: Of 304 elective laparoscopic cholecystectomies,
14 (4.6%) were converted to the open approach, due to
difficulty in positive identification of anatomic struc-
tures in the triangle of Calot. The critical view of safety
was feasible in 284 (93.4%) patients, while in 2 (0.7%)
cases a partial cholecystectomy was performed and in 4
(1.3%) cases the operation was completed after retro-
grade dissection of the gallbladder. No major bile duct
injuries (Strasberg types B-E) were observed. Two
patients (0.7%) were admitted post-operatively due to
biloma and bile leakage from the cystic duct stump
(Strasberg type A), which was successfully treated with
ERCP and stenting.
Conclusion: Although the CVS technique does not
eliminate technical skills errors, it does contribute to
avoid anatomic errors. In those cases where this techi-
que is not possible, the alternatives of retrograde chole-
cystectomy, partial cholecystectomy or intraoperative
cholecystostomy should be examined, or the operation
should be converted to the open approach. The CVS
technique is safe and feasible, easily reproducible and
time-sparing.
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IMPLEMENTATION OF AN ENHANCED
RECOVERY PROTOCOL IN
PANCREATIC SURGERY –
PRELIMINARY RESULTS
D. K. Manatakis1, N. Moustakis1, C. Agalianos1, I.
Terzis1, I. D. Kyriazanos1 and D. Davides1
11st Surgical Department, Athens Naval and Veterans
Hospital, Athens, Greece
Objectives: Enhanced recovery (ERAS) protocols have
been shown to reduce the systemic inflammatory
response to surgical trauma, thus improving periopera-
tive care and accelerating postoperative recovery. We
present our initial experience of an ERAS protocol in
pancreatic surgery.
Methods: Between October 2012 and July 2014, 20
patients undergoing pancreatectomy for malignant neo-
plasms (9 pancreaticoduodenectomies, 9 distal and 2
total pancreatectomies) consented and were enrolled in
an ERAS protocol, which included preoperative (patient
counseling, minimal fasting, no anxiolytic premedica-
tion), intraoperative (thoracic epidural analgesia, active
prevention of hypothermia) and postoperative (antimi-
crobial chemoprophylaxis, thromboprophylaxis, antie-
metics, early mobilization and pulmonary toilet)
interventions.
Results: Perioperative mortality was 0%, while total
morbidity was 65% (medical 10%, surgical 55%), with
major morbidity (Clavien-Dindo category ≥III) being
15%. Thirty-day readmission rate and reoperation rate
were 10% and 5% respectively. Ten patients (50%)
were discharged within 8 days (median 8.5 days, range
7–32 days).
Conclusion: Despite a relatively high morbidity rate,
most complications were mild and managed conserva-
tively. Mortality, readmission and reoperation rate, as
well as total hospital length of stay are comparable to
larger series from specialized pancreatic surgery centers.
Fast-track protocols in pancreatic surgery are promis-
ing and require in-depth evaluation with randomized
trials.
Benign HPB Diseases
APHPB-0586
INTRADUCTAL PAPILLARY
MUCINOUS NEOPLASM (IPMN)
MIMICKING CHRONIC PANCREATITIS:
A CASE DISCUSSION
C. Tay1, S. K. Y. Chang1, S. G. Iyer1, A. W. C. Kow1
and K. Madhavan1
1Surgery, NUHS, Singapore, Singapore
Objectives: We report a case of intraductal papillary
mucinous neoplasm (IPMN) mimicking chronic pancre-
atitis in a South East Asian gentleman.
Methods: -
Results: Mr. D is a 51 year old man, who first pre-
sented with acute pancreatitis in year 2006, which was
thought to be gallstone-related, and underwent laparo-
scopic cholecystectomy subsequently. He is a hepatitis
B carrier, ex-smoker and non-alcohol consumer. His
mother had pancreatic tail cancer.
He then represented himself with steatorrhoea in year
2014, he denied abdominal pain or weight loss. Labora-
tory tests revealed elevated serum lipase and amylase.
Magnetic resonance imaging (MRI) of the pancreas
revealed irregularly dilated main pancreatic duct, espe-
cially in the proximal body region and some of the side
branches. A tubular filling defect was noted in the
proximal pancreatic body. No calcification or paren-
chymal masses in the pancreas was seen.
He was planned for Puestow’s pancreaticojejunostomy
in view of the above finding to relieve his symptoms
and prevent malignant transformation in the pancreas.
Intraoperatively, the pancreas felt to be firm with no
mass. Upon opening of the main pancreatic duct, we
discovered mucinous material and a small intraductal
polypoidal lesion in the pancreatic body, frozen section
showed mucinous epithelium with papillary architec-
ture.
In view of the high possibility of IPMN, we performed
distal pancreatectomy. Histology report revealed IPMN
with intermediate grade dysplasia, with tumour
involves the main pancreatic duct and its branches. The
surrounding pancreatic parenchyma shows features of
chronic pancreatitis. He had uneventful recovery after
surgery.
Conclusion: This interesting case highlights the rare
manifestation of IPMN.
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APHPB-0587
THERAPEUTIC MANAGEMENT AND
OUTCOME OF PATIENTS WITH
POSTPANCREATECTOMY
HEMORRHAGE: A SINGLE-CENTER
EXPERIENCE IN 35 PATIENTS
S. Asari1, H. Toyama1, I. Matsumoto2, T. Goto1, T.
Ajiki1, M. Kido1, T. Fukumoto1 and Y. Ku1
1Surgery, Kobe University Graduate School of Medicine,
Kobe, Japan; 2Surgery, Kinki University Faculty of
Medicine, Osaka, Japan
Objectives: The aims of this study were to analyze the
incidence and outcome of PPH, and to study the effi-
cacy of endovascular procedure as well as endoscopic
and surgical procedures as a treatment.
Methods: All patients undergoing standard pancreatic
resection for pancreatic, distal biliary duct, periampul-
lary or duodenal tumors performed at Kobe University
Hospital between January 2003 and December 2013
were included.
Results: The overall incidence of PPH was 6% (35 of
553 patients). Early hemorrhage was extraluminal in 6
(17%) of the 35 patients. Late hemorrhage was intralu-
minal and extraluminal in 5 (17%) and 24 (83%) of the
29 patients, respectively. Of the 28 patients excluding a
dead patient by hemorrhage shock, 17 (57%), 3 (10%),
3 (10%) and 5 (17%) patients underwent interventional
radiology (IR), surgery, endoscopy and observational
monitoring, respectively. Pancreatic fistula of grade B/
C predominantly occurred in the late group compared
with the early group (57% vs. 6%, p = 0.106). PPH
occurred a total of 44 times in the 28 patients excluding
7 patients without any intervention. The mortality rate
among those with PPH was 20% (7 of 35): IR, 16% (3
of 19); surgery, 33% (2 of 6); endoscopy, 0% (0 of 3).
Conclusion: IR resulted in a higher rate of emergent
hemostasis and survival in the PPH patients. To man-
age the patients with lower mortality, it is important to
continually monitor the patients, especially those with
severe pancreatic fistula, in the hospital after successful
hemostasis because multiple bleedings occasionally
occur in the patients.
APHPB-0590
EXPRESSION ANALYSIS OF IPS CELL-
INDUCTIVE GENES IN
HEPATOCELLULAR CARCINOMA BY
TISSUE MICROARRAY
K. Matsui1, K. Shibuya1, I. Yoshioka1, S. Sekine1, T.
Okumura1, T. Nagata1 and K. Tsukada1
1Surgery and Science, Toyama University, Toyama,
Japan
Objectives: The transcription factor NANOG, which
play an important role in ES cells and Octamer-binding
transcription factor 4 (OCT4), Kruppel-like factor 4
(KLF4), c-MYC are iPS cell-inductive genes to be asso-
ciated with malignant transformation and tumor
growth in various cancers. The purpose of this study
was to determine the significance of NANOG, KLF4,
OCT4, c-MYC in hepatocellular carcinoma.
Methods: Between 1999 and 2011, 100 patients with
hepatocellular carcinoma patients receiving operation
were selected. We examined the immunohistochemical
expression levels of the four genes by using tissue
microarray (TMA) in 100 hepatocellular carcinoma
patients.
Results: There was no relationship between the expres-
sion of the four genes and TNM factors of the patients.
Patients with high expression of KLF4 had poor dis-
ease-free survival (DFS) rates than those with low
expression of KLF4 (p = 0.04). In contrast, patients
with high expression of NANOG had better overall
survival rates than those with weak expression of NA-
NOG (p = 0.09). There was no obvious correlation to
prognosis and expression for OCT4 and c-MYC.
Conclusion: High expression of KLF4 is an indicator
of a poor prognosis for hepatocellular carcinoma,
whereas NANOG is a favorable prognostic indicator.
Our data suggest that KLF4 and NANOG may be a
useful of prognostic marker in patients with hepatocel-
lular carcinoma.
APHPB-0592
INCIDENCE, MANAGEMENT AND RISK
FACTORS OF BILE LEAKAGE AFTER
HEPATECTOMY FOR
HEPATOCELLULAR CARCINOMA
S. Hai1, Y. Iimuro1, T. Hirano1, T. Okada1, Y.
Asano1, N. Uyama1, K. Suzumura1, I. Nakamura1, Y.
Kondo1, H. Kosaka1, H. Sueoka1, A. Yada1, K.
Ohashi1, T. Okamoto1, A. Kurimoto1 and J. Fujimoto1
1Department of Surgery, Hyogo College of Medicine,
Nishinomiya, Japan
Objectives: Despite of advances in surgical techniques
and perioperative management, the postoperative mor-
bidity rate is still high; especially bile leakage is a clini-
cally problematical.
Methods: Clinical data from 538 patients who under-
went hepatectomy for hepatocellular carcinoma without
biliary anastomoses in our department were reviewed
retrospectively. Management and risk factors for bile
leakage were investigated.
Results: Postoperative bile leakage occurred in 25 of
538 patients (4.6%). Two of these patients died due to
hepatic failure after operation, but no patients died of
postoperative bile leakage. Bile leakage healed sponta-
neously in 12 of 25 patients (48.0%), but the remaining
13 patients required some form of additional treatment
such as percutaneous drainage in 8 patients, and endo-
scopic nasobiliary biliary drainage (ENBD) in 10 pat-
iens. Reoperation was performed in one patient, in
whom intractable biliary fistula and bronchobiliary fis-
tula occurred after limited hepatic resection under tho-
racoabdominal approach, because the bile leakage
failed to heal by continuous abdominal drainage,
ENBD, or ethanol injection therapy to ablate the
biliary fistula. Patients with bile leakage needed signifi-
cantly longer postoperative hospital care than the
patients without bile leakage (median: 53 vs. 22 days)
(p < 0.0001). By multivariate analysis, operation time
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(480 m≤), left medial sectionectomy and right anterior
sectionectomy were shown significantly as risks for
postoperative bile leakage after hepatectomy for hepa-
tocellular carcinoma.
Conclusion: Bile leakage develops most commonly after
left medial sectionectomy or right anterior sectionecto-
my and often restults to be intractable. Therefore, we
should perform an appropriate treatment such as inter-
ventional procedures and surgical treatment for postop-
erative bile leakage.
APHPB-0593
DIFFERENCES IN OUTCOMES
BETWEEN HEPATITIS B AND C
PATIENTS AFTER SURGICAL
RESECTION FOR HEPATOCELLULAR
CARCINOMA IN AN ASIAN CENTRE
E. W. C. Eu1, J. W. H. Leong1, J. C. Allen2, P. C.
Cheow3, C. Y. Chan3, B. K. P. Goh3, V. T. W. Lee3,
A. Y. F. Chung3, L. L. P. J. Ooi3 and P. K. H. Chow4
1Department of General Surgery, Singapore General
Hospital, Singapore, Singapore; 2Centre for Quantitative
Medicine, Duke-NUS Graduate Medical School,
Singapore, Singapore; 3Department of Hepato-
Pancreato-Biliary and Transplant Surgery, Singapore
General Hospital, Singapore, Singapore; 4Department of
Surgical Oncology, National Cancer Centre, Singapore,
Singapore
Objectives: Curative treatment for Hepatocellular Car-
cinoma (HCC) has been largely surgical, with resections
more common than transplantation due to donor organ
shortages. Reported resection outcomes appear to dif-
fer globally. We hypothesize that differences in etiology
give rise to different molecular mechanisms and result
in different clinical outcomes after resection, and aim
to compare Disease-Free Survival (DFS) and Overall
Survival (OS) for Hepatitis B Virus (HBV) and Hepati-
tis C Virus (HCV) HCC after potentially curative resec-
tion.
Methods: We retrospectively analysed 712 patients who
underwent surgical resection for HCC at our centre
between January 2000 to September 2013. Excluded
were patients who were either both positive or negative
for Hep B and C, and those where surgery was for pal-
liation (e.g. ruptured HCC, invasion of adjacent
organs). 437 resected patients met the study criteria, of
which 352 had single nodule HCC. Approval was
obtained from the Centralized Institutional Review
Board.
Results: DFS was shorter in HCV patients than HBV
(15.4 months vs. 25.4 months, p = 0.007) in the overall
cohort (n = 437) as well as in those with single nodule
HCC (n = 352) (15.8 months vs. 31.2 months,
p = 0.006). OS was shorter in HCV patients in the
entire cohort (78.1 months vs. 93.1 months, p = 0.253)
as well as in patients with single nodule HCC
(91.6 months vs. 101.9 months, p = 0.44).
Conclusion: DFS and OS between HBV- and HCV-
associated HCC were significantly different, with poor
survival demonstrated in patients with HCV. This sug-
gests that the etiology of HCC is an important consid-
eration in the approach to the management of HCC.
APHPB-0594
HEPATIC METASTASES SECONDARY
TO COLORECTAL CARCINOMA IN
THE ASIAN POPULATION IS NOT AS
COMMON AS WE THINK!
N. Wee1, S. P. Junnarkar1 and W. L. W. Woon1
1General Surgery, Tan Tock Seng Hospital, Singapore,
Singapore
Objectives: Colorectal cancer is the world’s commonest
malignancy, with more than 500,000 deaths internation-
ally every year. Without treatment, life expectancy for
patients with metastatic disease is less than a year.
Today, as clinical technology improves, we can offer
more surgical options for liver metastases. There is a
paucity of data on the incidence of hepatic metastases
in colorectal cancer patients locally. This study looks at
the incidence of hepatic metastases in Asian patients
undergoing treatment in a tertiary hospital.
Methods: A retrospective study of 736 patients, diag-
nosed over 3 years with colorectal carcinoma in our
institution was reviewed. Data was collected on the
incidence, severity of comorbidities and length of time
from diagnosis to intervention, and correlated with sur-
gical and conservative treatment methods, postopera-
tive complications and length of stay. Data obtained
was analyzed using the IBM Statistical Product and
Service Solutions (SPSS) method.
Results: Of 736 patients were recruited, ranging from
33 to 98 years old. Our study showed approximately
13.04% of patients with colorectal cancer developed
metastases, 93.74% involving the liver. Among those
who developed liver metastases, 45.83% were synchro-
nous and 54.17% were metachronous. Our study shows
only 15.63% of liver metastases were resectable. The
remaining patients were treated with systemic chemo-
therapy and locoregional therapy.
Conclusion: Our study showed the incidence of hepatic
metastases in colorectal cancer is not as common in
Asia as compared to western figures, even though
metastases was most often to the liver. Being Asian
may have certain ‘protective factors’ in reducing inci-
dence of liver metastases in colorectal cancer.
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APHPB-0597
REAPPRAISAL OF PERCUTANEOUS
APPROACH FOR ENDOSCOPIC
INACCESSIBLE COMMON BILE DUCT
STONES/ REPORT OF A CASE
M. Watanabe1, Y. Ichimura1, T. Takagaki1 and S.
Iitsuka1
1Department of Surgery, Moriya Daiichi General
Hospital, Moriya, Japan
Objectives: For the treatment of CBD stones, endo-
scopic sphincterotomy has become the major procedure
these days. In the case of endoscopy inaccessible papilla
such as post-gastrectomy, surgical treatment may be a
standard treatment. Besides with advances of laparo-
scopic surgery technique, laparoscopic choledocholith-
otomy is increasing for the treatment of CBD stones.
However, patients with critical condition for surgery
© 2015 The Authors
HPB 2015, 17 (Suppl. S2), 25–266 HPB © 2015 Americas Hepato-Pancreato-Biliary Association
Poster Abstracts 197
and anesthesia should be considered another treatment
further more. Percutaneous papillary balloon dilation
for bile duct stone removal (PPBD) should be consid-
ered as alternative treatment of such case.
Methods: A 57 years old male had a history of subto-
tal gastrectomy (Roux en Y reconstruction) 3 years
previously. He visited our hospital with right upper
quadrant pain and nausea. Abdominal ultrasonography
and CT showed CBD stone of 10 mm in diameter. He
was admitted with the diagnosis of cholangitis and had
antibiotics therapy. Operation was considered the case
with difficulty due to severe intraperitoneal adhesion.
In addition since the patient did not hope to have oper-
ation, we decided to have PPBD treatment to this case.
Results: A percutaneous transhepatic cholangiodrai-
nage (PTCD) was placed for CBD obstruction initially.
He was discharged 4 days later, and readmitted to hos-
pital for CBD stone removal. Percutaneous transhepat-
ic route was dilated with 10Fr dilator, then wire-guided
balloon dilation to the papilla was performed. After
dilation of papilla, CBD stone was pushed out to the
duodenum by retrieval balloon. PTCD was removed
7 days later, and he was discharged at 9 hospital days.
Conclusion: In the case of CBD stones with endoscopic
inaccessible papilla, PPBD treatment can be a alterna-
tive treatment to surgery.
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APHPB-0599
176 LIVER RESECTIONS: EXPERIENCE
FROM TATA MEMORIAL CENTRE
M. Goel1, A. Mitra1, S. Patkar1 and S. V. Shrikhande1
1GI & HPB Service Department of Surgical Oncology,
Tata Memorial Hospital, MUMBAI, India
Objectives: Analyze evolution of liver resections in
HPB oncology unit.
Methods: Retrospective analysis of prospective data-
base (February 2009 – August 2014). All cases were
imaged by triphasic CT scan or MRI. Future liver rem-
nant was calculated using Myrian software. HCCs were
staged with Child’s score and BCLC. Hypotensive
anaesthesia and vascular occlusive techniques were not
used. Hanging manoeuvre and focus clysis with water-
jet dissection was employed.
Results: Of 192, 176 (92%) (M = 108, F = 68, median
age 54 years) were resected. Anatomical resections were
127 (72%) and major (≥3 segments) were 93 (52.8%).
Indications were HCC (71), colorectal metastasis
(CRLM) (38), cholangiocarcinomas (14) and others
(53). Cirrhotic resections were 51(28.9%). Median
tumour size was 6 cm (0.7–30). Median loss was
1000 mL overall and 1500 mL for major hepatectomy.
Median hospital stay was 8 days (3–44). Postoperative
morbidity and mortality was 28.9% and 5.1% respec-
tively. Postoperative liver insufficiency and bile leaks
occurred in 5.1% and 6.2% respectively. Haemorrhage
requiring packing / re-exploration was in 4 patients.
Major hepatectomy for tumors >10 cm (n = 34) vs. ≤
10 (n = 59) resulted in higher median blood loss
(2000 mL vs. 1300 mL; p = 0.02) but did not result in
increased morbidity (32.4% vs. 37%; p = 0.63).
Conclusion: Main indication for liver resection was
HCC and not CRLM as in the West. Despite increased
blood loss following major hepatectomy, there was no
added morbidity irrespective of tumour size. This possi-
bly represents the largest series of liver resections
(excluding gall bladder cancer) to be presented from
India till date.
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APHPB-0600
SAFE ALTERNATIVES TO ‘CRITICAL
VIEW OF SAFETY’ TECHNIQUE IN
LAPAROSCOPIC CHOLECYSTECTOMY
D. K. Manatakis1, G. Sotiropoulos1, C. Agalianos1, I.
Terzis1, I. D. Kyriazanos1 and D. Davides1
11st Surgical Department, Athens Naval and Veterans
Hospital, Athens, Greece
Objectives: Since January 2012, we have been routinely
applying the critical view of safety (CVS) technique in
all laparoscopic cholecystectomies. The aim of the pres-
ent study is to explore equally safe alternative options,
when the CVS can not be obtained, in order to avoid
bile duct injuries.
Methods: After Research Ethics Committee approval,
a retrospective analysis of laparoscopic cholecystecto-
mies, between January 2012 and September 2014, was
performed, emphasizing on those cases where the CVS
could not be achieved, their intraoperative management
and the alternatives used.
Results: Of 304 laparoscopic cholecystectomies per-
formed, the CVS technique was feasible in 284 (93.4%)
cases. In 2 (0.7%) patients, a partial cholecystectomy
was performed, 4 (1.3%) cases were performed with
retrograde dissection of the gallbladder and 14 (4.6%)
were converted to the open technique. No vasculobilia-
ry injuries were observed. Two patients (0.7%) were re-
admitted postoperatively due to bile leakage from the
cystic duct stump (Strasberg type A) and were managed
successfully by ERCP and stenting.
Conclusion: To minimize biliary injuries, laparoscopic
cholecystectomy technique should be standardized and
the CVS should be obtained in every patient, regardless
of difficulty. In those cases where this is impossible, the
surgeon must consider equally safe alternative options,
i.e. partial cholecystectomy, retrograde cholecystec-
tomy, cholecystostomy, intraoperative cholangiography
or finally to convert the operation to the open
approach. Ligating and transecting any structures with-
out prior positive identification should be absolutely
discouraged.
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APHPB-0601
A RETROSPECTIVE STUDY ON THE
ASSOCIATION OF THE SEVERITY OF
ACUTE CHOLECYSTITIS AND POST
OPERATIVE MORBIDITIES AFTER
CHOLECYSTECTOMY AT THE
NATIONAL KIDNEY AND TRANSPLANT
INSTITUTE
M. Tulaylay1, J. Merced1, E. Ragaza1 and C. Teh1
1Department of Surgery, National Kidney and
Transplant Institute, Quezon CIty, Philippines
Objectives: The purpose of this study was to determine
the severity of acute cholecystitis and subsequently
associating it with the post cholecystectomy morbidi-
ties.
Methods: The study was able to gather 171 patients
diagnosed with acute cholecystitis, ICD code K81.0,
from January 1, 2007 to December 31, 2012 using the
inclusion and exclusion criteria. Using Tokyo Guide-
lines 2013, the severity of the acute cholecystitis was
determined. The severity of the acute cholecystitis com-
pared with the postoperative morbidities and the opera-
tion performed were tabulated. All data were analyzed
using SPSS software version 22.0
Results: The age group with the most number of
patients who underwent cholecystectomy was greater
than 60 years old, under the BMI classification of
obese type 1, corresponding to about a third of the
population, with equal distribution between both sexes.
Nonrenal cases corresponded to 94.7%, while the
remaining 5.3% corresponded to renal cases. Based on
the criteria set forth by the Tokyo Guidelines 2013,
grade 2 or moderate severity of acute cholecystitis cor-
responds to 90.6% of cases. Grades 1 and 3 severities
corresponded to 2.9% and 6.4%, respectively. Postop-
erative morbidities encountered were bleeding, bloated-
ness, fever, headache, pain and wound infection. Pain
had the highest rate postoperative complication, which
was 12.1%. The rest were less than 5%. The rate of
conversion from laparoscopic to open cholecystectomy
was 7.6%.
Conclusion: Low rates of postoperative complications
we observed even at different grades of severity. Lapa-
roscopic cholecystectomy yielded slightly less complica-
tions than open cholecystectomy, making it the
procedure of choice for the management of acute chole-
cystitis in our institution.
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APHPB-0602
PHASE I/II STUDY OF SORAFENIB IN
COMBINATION WITH INTERMITTENT
HEPATIC ARTERIAL INFUSION
CHEMOTHERAPY USING CISPLATIN
FOR UNRESECTABLE ADVANCED
HEPATOCELLULAR CARCINOMA
WITH PORTAL VEIN TUMOR
THROMBUS
M. Ishizaki1, M. Kaibori1, K. Matsui1, H. Iida1, T.
Sakaguchi1, H. Matsushima1, R. Nakatake1 and M.
Kon1
1Surgery, Kansai Medical University, Hirakata, Japan
Objectives: Our purpose in the study was to ascertain
the feasibility of a combination therapy with sorafenib
and hepatic arterial infusion therapy (HAIC) using cis-
platin (CDDP) for unresectable advanced HCC
included portal vein tumor thrombus.
Methods: Phase I study: Soraenib was administered
continuously, whereas CDDP was given on day1, 8,
and 15. The dose of sorafenib was escalated in two
steps from 400 to 800 mg/body, whereas the dose of
CDDP was escalated in three steps from 20 to 25 and
30?mg/m2. We estimate the dose-limiting toxicity
(DLT) and the maximum tolerated dose (MTD) of this
therapy, to determine the recommended dose (RD).
Phase II study: Thirty-five patients with unresectable
HCC received this therapy under RD, and the efficacy
and safety were assessed.
Results: Phase I study: 15 patients with unresectable
advanced HCC have been enrolled. None of the
patients treated with sorafenib 400 mg and CDDP 20?
mg/m2 experienced DLT. Three of three patients treatd
with sorafenib 800 mg and CDDP 20?mg/m2 experi-
enced DLTs. None of the patients treated with sorafe-
nib 400 mg and CDDP 25?mg/m2 experienced DLT.
One of six patients treated with sorafenib 400 mg and
CDDP 30?mg/m2 experienced thrombocytopenia. Phase
II study: 35 patients with unresectable advanced HCC
have been enrolled. The clinical response were rated as
9 partial response (PR), 18 stable disease (SD), and 8
progressive disease (PD).
Conclusion: In this study, RD of this therapy was so-
rafenib 400 mg/body and CDDP 30?mg/m2. Sorafenib
in combination with intermittent HAIC using CDDP
for unresectable advanced HCC was expected to be
safe and effective treatment.
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APHPB-0603
ROLE OF GADOXETIC ACID-
ENHANCED MRI IN THE
MANAGEMENT OF HCC PATIENTS –
THE SURGEONS PERSPECTIVE
C. F. Lau1, J. Wong1, S. Y. Kok1, T. L. Tam1, T. P.
Fung1, S. H. Lam1, T. Loke2 and C. S. Chan2
1Surgery, United Christian Hospital, Hong Kong, Hong
Kong China; 2Radiology, United Christian Hospital,
Hong Kong, Hong Kong China
Objectives: Gadoxetic acid-enhanced MRI has shown
to be accurate in the diagnosis of early HCC. The
objectives of this study is to evaluate the clinical impact
of Gadoxetic acid-enhanced MRI on the management
of HCC patients.
Methods: From January 2011 to July 2014, total 73
patients suffered from HCC with doubtful findings on
the CT scans were subjected to Gadoxetic acid-
enhanced MRI. The median interval between two scans
was 7 weeks. The clinical outcome on these patients
were analyzed.
Results: Total 73 patients (M:F = 10:63) were included
for analysis. The mean age was 62 years old and 71%
of patients were hepatitis B carrier. 29 patients suffered
from recurrent HCC and the mean AFP level was
353 ng/mL. The CT findings from all these patients
were either indeterminate on the diagnosis of HCC or
inconclusive on the actual number of HCC. The addi-
tional Gadoxetic acid-enhanced MRI has changed the
clinical management in 54 (73.9%) patients. It con-
firmed the diagnosis of HCC in 37 patients and exclude
other indeterminate lesions in 3 patients. Besides, a
total number of 79 additional HCC was found in 21
patients. Among the 79 lesions, 37 (46.8%) lesions were
small than 1 cm in size and 22 (27.8%) lesions were
between 1 and 2 cm in size. As a result, 17 patients
required change of management to TACE or systematic
therapy.
Conclusion: Gadoxetic acid-enhanced MRI was useful
in the management of HCC patients with doubtful CT
finding. It could change the clinical management in
73.9% of patients.
APHPB-0604
CLINICOPATHOLOGICAL
PREDICTORS OF OUTCOME
FOLLOWING LIVER RESECTIONS FOR
HEPATOCELLULAR CARCINOMA; A
SOUTH EAST ASIAN EXPERIENCE
G. Bonney1, D. Mirza1, A. Kow2, S. Iyer2, S. Chang2
and K. K. Madhavan2
1Hepatobiliary and Liver Transplantation Surgery,
Queen Elizabeth Hospital, Birmingham, United
Kingdom; 2Hepatobiliary and Liver Transplantation
Surgery, National University Hospital, SIngapore,
Singapore
Objectives: The surgical management of Hepatocellular
Carcinoma (HCC) remains challenging; with resections
frequently difficult in cirrhotics and transplants requir-
ing the use of a scarce resource. In a European series,
we have previously described a biological marker
(Alphafetoprotein to total tumour volume; AFP:TTV)
to predict disease recurrence following resections. The
aim of this study was to analyse clinico-pathological
predictors of outcomes following liver resection for
HCC in a South East Asian series and validate this
prognostic biomarker.
Methods: A retrospective analysis of all patients under-
going liver resections between Jan 1998 and Dec 2013
in a Singaporean centre was undertaken. Patient demo-
graphics, biochemical variables as well as pre-operative
alpha-fetoprotein (AFP) was collated. Pathological data
including no of tumours, tumour size (s), vascular inva-
sion and resection margins were analysed. Clinico-pa-
tholocial predictors of disease free and overall survival
were analysed.
Results: In the study period, a total of 149 patients
underwent resections for HCC with complete follow-up
data. With a median age of 62 years, 58% of resections
were performed on cirrhotics with 65% of patient hav-
ing viral hepatitis. Resection margin positivity and vas-
cular invasion were the only significant predictors of
overall survival (p = 0.03 and 0.04 respectively).
Tumour grade, resection margins, vascular invasion
and a AFP:TTV ratio>0.3 predicted disease free sur-
vival (p = 0.04, 0.03, 0.03 and 0.04 respectively).
Conclusion: We present here clinicopathological predic-
tors of overall and disease free survival for patients
undergoing resections for HCC. This data validates, in
a transcontinental series, the predictive utility of the
AFP:TTV ratio previously described.
APHPB-0605
WHERE ARE THE ‘MISSING’
METASTASES? – ROLE OF GADOXETIC
ACID-ENHANCED MRI IN THE
MANAGEMENT OF COLORECTAL
LIVER METASTASIS
S. Y. Kok1, J. Wong1, C. F. Lau1, T. L. Tam1, T. P.
Fung1, S. H. Lam1, T. Loke2 and C. S. Chan2
1Surgery, United Christian Hospital, Hong Kong, Hong
Kong China; 2Radiology, United Christian Hospital,
Hong Kong, Hong Kong China
Objectives: Gadoxetic acid-enhanced MRI has shown
to be accurate in the diagnosis of early colorectal liver
metastasis. The objective of this study is to evaluate the
clinical impact of Gadoxetic acid-enhanced MRI on the
management of patients with colorectal liver metastasis.
Methods: From August 2011 to July 2014, a total 10
patients suffered from colorectal liver metastasis were
subjected to both PET/CT scan and Gadoxetic acid-
enhanced MRI assessment. The median interval
between the scans was 6 weeks. The clinical outcome
on these patients were analyzed.
Results: Total 10 patients (M:F = 7:3) were included
for analysis. The mean age was 64 years old and the
mean CEA level was 16.8 mg/L. PET/ CT scan showed
solitary liver metastasis in 5 patients and one patients
with two liver metastases. Indeterminate lesions were
present in 6 patients. The additional Gadoxetic acid-
enhanced MRI has changed the clinical management in
7(70%) patients. It confirmed the diagnosis of colorec-
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tal liver metastasis in one patient and additional metas-
tases were found in 8 patients. Total 37 additional
metastases were detected by MRI and 31(83.8%) of
these lesions were smaller than 1 cm in size. As a
result, 4 patients switched to systemic chemotherapy, 1
patient switched to right hepatectomy and 1 patient
switched to open radiofrequency ablations.
Conclusion: Gadoxetic acid-enhanced MRI was useful
in the management of patients with colorectal liver
metastasis. It could detect the small metastasis which
was not detected on the PET/CT scan, and hence chan-
ged the clinical management.
Benign HPB Diseases
APHPB-0606
FACTORS AFFECTING THE
OUTCOMES OF SURGICAL
MANAGEMENT OF POST
CHOLECYSTECTOMY BILE DUCT
STRICTURES
V. Sivasubramaniam1, K. Balaraman1, A.
Pitchaimuthu1, S. Perumal1, K. Rajendran1, R. A. V. I.
Ramasamy1, J. Sathyanesan1, R. Palaniappan1 and M.
Govindan1
1Surgical gastroenterology, Government stanley medical
college, Chennai, India
Objectives: 1. To evaluate the clinicopatholgical factors
influencing surgical outcomes following biliojejunosto-
my for bile duct injury following cholecystectomy
2. To evaluate the factors affecting the perioperative
outcomes following hepatojejunostomy for various
types of post cholecystectomy bile duct injury
Methods: Collection of clinicopathological data of post
cholecystectomy bile duct injury, demographic details,
presenting symptoms and signs, investigations, opera-
tive details, salvage procedures, complications and fol-
low-up of the concerned cases at our institute. Factors
were analysed by using SPSS 16
Results: Of the 46 patients analysed, patients with lar-
ger bile duct dilatation had better outcomes than with
smaller duct size (p = 0.0398). No associations identi-
fied between short-term postoperative complications
and any of the perioperative variables examined: sex
(p = 0.76), age (p = 0.13), bile leak ((p = 0.13), hospital
of origin (p = 0.63), jaundice (0.793).
Conclusion: Of the 46 patients studied by univariate
and multivariate analysis only bile duct dilatation is the
factor which affects the outcome of post cholecystec-
tomy bile duct strictures. Other factors were not statis-
tically significant
APHPB-0607
XANTHOGRANULOMATOUS
CHOLECYSTITIS MASQUERADING AS
GALLBLADDER CANCER: CAN IT BE
DIAGNOSED PREOPERATIVELY?
S. Murugesan1, S. Jeswanth1, P. Senthil Kumar1,
R. Ravi1, R. Kamalakannan1, P. Anbalagan1,
B. Kesavan1, P. Ravichandran1 and G. Manoharan1
1Surgical Gastroenterology, Stanley medical college,
Chennai, India
Objectives: To determine the preoperative characteris-
tics of Xanthogranulomatous cholecystitis (XGC) that
could potentially aid in an accurate diagnosis of XGC
masquerading as gallbladder cancer (GBC)
Methods: An analysis of prospectively collected data-
base of patients operated with a preoperative diagnosis
of GBC between Jan 2008 and Dec 2012 was con-
ducted to determine the clinical and radiological fea-
tures which could assist in the preoperative diagnosis
of XGC.
Results: Out of 77 patients with resectable disease who
underwent radical cholecystectomy, 16 were reported as
XGC on final histopathology (Group A), while 60 were
GBC (Group B). One patient had GBC associated with
XGC and was excluded from the analysis. The inci-
dence of abdominal pain and acute cholecystitis were
significantly higher in Group A, anorexia and weight
loss was higher in Group B (p < 0.001). Cholelithiasis,
choledocholithiasis was more common in Group A. On
CT of the abdomen, diffuse gallbladder wall thickening,
continuous & homogenous mucosal line enhancement
and submucosal hypoattenuated nodules or bands
(p < 0.001) were the significant findings in Group A
(p < 0.001). CT findings on retrospect, revealed atleast
one of these findings in 68.7% (11/16) cases
Conclusion: Differentiating XGC from GBC is a diag-
nostic conundrum. Making this distinction preopera-
tively or intraoperatively is difficult and a definitive
diagnosis still necessitates a histopathological examina-
tion. An accurate preoperative diagnosis requires an
integrated review of clinical and characteristic radiolog-
ical features, the presence of which may help avoid rad-
ical resection and avoidable morbidity in selected cases.
Malignant HPB Diseases
APHPB-0609
INCIDENTAL GALL BLADDER
CANCERS: ARE THEY TRULY
INCIDENTAL?
S. Murugesan1, S. Jeswanth1, P. Senthil Kumar1, R.
Ravi1, R. Kamalakannan1, P. Anbalagan1, B.
Kesavan1, P. Ravichandran1 and G. Manoharan1
1Surgical Gastroenterology, Stanley medical college,
Chennai, India
Objectives: To ascertain the true incidence of Inciden-
tal Gallbladder cancer (IGBC), we aimed to seek and
analyse features suggestive of GBC on preoperative
imaging and intraoperative findings in patients diag-
nosed as having IGBC.
Methods: The study was conducted on 79 patients of
IGBC managed in our department over a ten year per-
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iod (2003–2012). Review of clinical findings, preopera-
tive imaging and operative notes were done to ascertain
any suspicion of malignancy-in-retrospect.
Results: Of the 79 patients, Ultrasound abdomen
showed diffuse thickening, not suspicious of malig-
nancy in 5 patients, and diffuse suspicious thickening
was seen in 4 patients. Focal thickening suspicious of
malignancy was present in 24 patients. Preoperative
CT/MRI was done in 9 patients for suspicion of malig-
nancy. In 5 patients, difficult Cholecystectomy was
encountered due to dense / inflammatory adhesions. In-
traoperative findings showed focal thickening of the
gallbladder and a gallbladder mass in 9 and 17 patients
respectively. On overall analysis, 37 patients had preop-
erative imaging or intraoperative findings suggestive of
malignancy, which was either a missed GBC or an
unsuspected/unexpected GBC. In 42 (53.2%) patients,
there was no evidence suggestive of malignancy and
was an unanticipated diagnosis.
Conclusion: Conclusion: Our study highlights a poten-
tial and not-so-rare pitfall of Laparoscopic Cholecys-
tectomy. A greater awareness of this clinical entity
along with a high index of suspicion and a low thresh-
old for conversion to open procedure, especially in
endemic areas may avert avoidable patient morbidity
and mortality.
APHPB-0610
FEASIBILITY OF IMPLEMENTING
FAST-TRACK SURGERY IN
PANCREATICODUODENECTOMY
WITH PANCREATICOGASTROSTOMY
FOR RECONSTRUCTION – A
PROSPECTIVE COHORT STUDY WITH
HISTORICAL CONTROL
S. Murugesan1, S. Jeswanth1, P. Senthil Kumar1, R.
Ravi1, R. Kamalakannan1, P. Anbalagan1, B.
Kesavan1, P. Ravichandran1 and G. Manoharan1
1Surgical Gastroenterology, Stanley medical college,
Chennai, India
Objectives: To analyse the feasibility of implementing
fast track rehabilitation protocol in pancreaticoduoden-
ectomy (PD) with pancreaticogastrostomy, using histor-
ical control for comparison.
Methods: Between April 2012 and December 2012,
twenty patients who underwent PD (with pancreaticog-
astrostomy) were managed by a fast-track rehabilita-
tion protocol. These patients were compared with an
equal number of historical controls treated according
to the traditional protocol.
Results: Patients in the fast track group were able to
tolerate liquid (p = 0.0005) and solid diet (p = 0.0001)
earlier, and they passed stools earlier (p = 0.02).
Delayed gastric emptying (DGE) was significantly
reduced in the fast track group (p = 0.02). There was
no difference in the rates of pancreatic fistula (PF),
post pancreatectomy haemorrhage (PPH) and mortality
between the two groups. Length of hospital stay was
reduced in the fast track group (median 14 vs. 18.5,
p = 0.007).
Conclusion: Fast track programme appears to be feasi-
ble in PD, even with pancreatico-gastric anastomosis. It
is associated with early recovery, reduced DGE and
reduced hospital stay.
APHPB-0611
DEFERASIROX SHOWS IN VITRO AND
IN VIVO ANTICANCER EFFECTS ON
HUMAN PANCREATIC CANCER CELL
LINES
H. Harima1, S. Kaino1, S. Shinoda1, M. Kawano1, S.
Suenaga1, K. Fujisawa1, N. Yamamoto1, T. Yamasaki2
and I. Sakaida1
1Gastroenterology & Hepatology, Yamaguchi University
School of Medicine, Ube, Japan; 2Oncology and
Laboratory Medicine, Yamaguchi University School of
Medicine, Ube, Japan
Objectives: Iron is essential for cell proliferation and
viability. Therefore, iron depletion by a chelator can be
used as a new strategy for cancer therapy. Deferasirox
is a new oral iron chelator, and no reports have
described its effects on pancreatic cancer cells. This
study aimed to elucidate the in vitro and in vivo activity
of DFX against pancreatic cancer cells.
Methods: In vitro, three human pancreatic cancer cell
lines (BxPC-3, Capan-2, SW 1990) were treated with
DFX. The cell proliferation was evaluated by the MTT
assay, and the cell cycle progression and apoptosis were
analyzed by flow cytometry. The role of caspases in the
DFX-induced apoptosis was investigated using a lumi-
nescent assay. In vivo, a BxPC-3 xenograft pancreatic
cancer model in mice was established. The mice were
gavaged with DFX or vehicle alone for treatment.
Results: The MTT assay showed that DFX had con-
centration-dependent cytoxic effects. The cell cycle
analysis showed that a low concentration of DFX
increased the S phase fraction, while a high concentra-
tion of DFX increased the sub-G1 fraction. The induc-
tion of apoptosis was also confirmed by Annexin V
and PI staining. The caspase 3/7 activities were
increased in a concentration-dependent manner by
DFX. When DFX was orally administered to mice on
alternate days at 80 mg/kg for three weeks, significant
tumor growth suppression was observed compared with
that in mice gavaged with the vehicle alone (p < 0.05).
Conclusion: We demonstrated that DFX is an orally
effective agent that had activity against pancreatic can-
cer cells.
APHPB-0612
PURE LAPAROSCOPIC ANATOMICAL
LIVER RESECTION WITH UPFRONT
TRANSECTION OF THE TUMOR-
BEARING PORTAL PEDICLE
S. Ei1, O. Itano1, Y. Abe1, M. Shinoda1, M. Kitago1,
T. Hibi1, H. Yagi1 and Y. Kitagawa1
1Surgery, Keio University, Tokyo, Japan
Objectives: Preoperative simulation using 3D imaging
provides accurate information required for pure laparo-
scopic anatomical liver resection, to isolate and divide
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the tumor-bearing portal pedicle before liver parenchy-
mal dissection. The aim of this study was to validate
the safety and feasibility of our surgical approach.
Methods: From March 2013 to May 2014, 68 patients
underwent laparoscopic liver resection at our institu-
tion. Of these, anatomical hepatectomy with upfront
tumor-bearing glissonean transection was performed in
11 cases. Their short-term outcomes were retrospec-
tively collected and analyzed.
Results: Mae: female = 9: 2, age 63 (54–73). Median
operative time, 577 min; estimated blood loss, 433 mL.
The tumor was located in left lateral sector in 2, Couin-
aud’s S5 in 3, S6 in 1, S7 in 1, S8 in 3, and caudate
lobe in 1. In all cases, the tumor-bearing portal pedicle
was identified by preoperative 3D imaging and was
transected safely preceding liver parenchymal dissection
using pure laparoscopic approach. <Case presentation>
A 3.5 cm-colorectal liver metastasis was found in S8 in
a 58-year-old man with history of partial liver resection
for prior metastases. Pure laparoscopic right anterior
sectionectomy was safely performed as planned by
meticulous preoperative simulation, paying extreme
caution to the displacement of portal pedicles by previ-
ous surgery and growth of the tumor in close proxim-
ity.
Conclusion: Pure laparoscopic anatomical liver resec-
tion with upfront tumor-bearing glissonean transection
is safe and feasible with the use of detailed preoperative
simulation using 3D imaging.
APHPB-0613
SURGICAL STRATEGY FOR PT2
GALLBLADDER CANCER
R. Matsuyama1, R. Mori1, T. Kumamoto1, K. Takeda1
and I. Endo1
1Gastroenterological Surgery, Yokohama City
University, Yokohama, Japan
Objectives: Advanced gallbladder cancer (GBC) is still
a lethal disease in all over the world. The aim of this
study is to clarify the therapeutic efficacy of anatomical
hepatectomy and EBDR for pT2 GBC.
Methods: Of 108 patients with GBC who underwent
surgical resection from 1992 to 2012, 41 patients were
identified as having histologically proven pT2 GBC.
Relationship between clinico-pathological factors and
long-term outcome were retrospectively analyzed.
Results: The 5-year survival rate for pT2 GBC was
70.4%. Absence of lymph node metastasis, lymphatic
invasion and venous invasion and curative resection
were significantly favorable factors by univariate analy-
sis. The 5-year survival rate was 85.6% for the pN0
patients, 64.2% for the patients with 1 or 2 metastatic
lymph nodes and 33.3% for the patients with more
than 3 metastatic lymph nodes. The 5-year survival rate
was 72.2% for the 15 patients with anatomical hepatec-
tomy, and 72.2% for the 23 patients without anatomi-
cal hepatectomy. When restricting the patients without
lymph node metastasis, The 5-year survival rate was
77.8% for the 9 patients with EBDR, and 85.7% for
the 8 patients without EBDR.
Conclusion: There is no positive therapeutic effect in
an anatomical hepatectomy and an EBDR in the surgi-
cal treatment of pT2 GBC. The number of lymph node
metastasis is powerful predicting factor for the survival.
In the treatment of pT2 GBC patients, radical resection
to achieve curative resection including surgical margin
and lymph nodes contributes to a better prognosis.
APHPB-0615
CLINICAL VALUE OF BILE ACID
RECEPTOR TGR 5 OVER EXPRESSION
IN GALLBLDDER CANCER
K. Kim1, J. Han1, C. An1 and J. Kim1
1Surgery, Uijong-Bu St. Mary’s Hospital, Uijongbu,
Korea
Objectives: TGR 5 is a plasma membrane bound, G-
protein coupled receptor for bile acids. It has been
detected in a various tissues, especially in biliary tree.
There have been some reports that TGR 5 expression
is related with the development of cancer however,
almost all of it was for knockout mice. In this study,
we determined the relationship between the strength of
TGR 5 expression and gallbladder cancer.
Methods: We retrospectively reviewed the medical
records and immunohistochemistry assessment of 30
patients who underwent radical cholecystectomy for
gallbladder cancer at our hospital between July 2004
and April 2013. And then, we compared it to the
patients who underwent cholecystectomy for benign
gallbladder disease, such as gallbladder stone or benign
polyps. We analyzed the staining pattern and strength
for TGR 5 as intensity and extent, then we categorized
it as three groups: weak, moderate and strong staining.
Results: The overall strength of TGR 5 staining was
significantly higher in the gallbladder cancer group
(p = 0.001). In gallbladder cancer group, strong TGR 5
staining was present in 50% and weak staining was
only in 6.7%. However, in benign gallbladder disease
group, weak TGR 5 staining was observed in 25.9%
and strong staining was only in 18.5% (p = 0.002).
There was no significant differentiation between the
strength of TGR 5 expression and cancer cell differenti-
ation (p = 0.309).
Conclusion: We concluded that TGR 5 is much more
expressed in gallbladder cancer than normal gallbladder
mucosa. Further study is needed about the role of
TGR 5 in gallbladder cancer.
Transplantation
APHPB-0617
INDOCYANINE GREEN CLEARANCE IS
A USEFUL TOOL FOR ASSESSING
BRAIN DEAD DONOR LIVER
FUNCTION
L. F. Lau1, R. Jones1, G. Riddiough1, G. Starkey1, M.
A. Fink1, B. Z. Wang1, C. Christophi1, J. Lokan2, K.
Asadi2 and V. Muralidharan1
1Surgery, Austin Health, Heidelberg, Australia;
2Pathology, Austin Health, Heidelberg, Australia
Objectives: Donor liver quality is a critical factor
which determines outcome following liver transplanta-
tion. Current assessment is largely subjective. This
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study aims to assess the feasibility and use of indocya-
nine green clearance (ICG) in the objective quantifica-
tion of donor liver function for transplantation.
Methods: Potential brain-dead liver donors were
recruited. ICG clearance was performed prior to organ
retrieval and compared to histopathology, surgeon
assessment of macrosteatosis and donor risk index
(DRI). Primary outcome parameters were early allo-
graft dysfunction and post-operative mortality.
Results: Fifteen brain dead donors were recruited for
this study. There were three patients with early allo-
graft dysfunction and one post-operative mortality fol-
lowing a prolonged 70 day ICU stay. In the patient
that died, the ICG clearance of the donor liver at the
time of organ retrieval was significantly lower com-
pared to the other donor livers (9 vs. median 28.5,
range 17.1–46.3%/min). Correspondingly, the DRI was
also the lowest in this donor (2.1 vs. median 1.53, range
1.1–2.0). Surgeon assessment and degree of macrostea-
tosis on histopathological examination did not predict
to outcome.
Conclusion: ICG assessment of donor liver function is
feasible and practical. It may be incorporated with little
interruption into the current organ retrieval process
and provides an objective quantification of donor liver
function. There is early evidence that this is better than
surgeon macroscopic or histological assessment and
may be a useful adjunct to the DRI. Further studies
are required to establish an ideal cut-off level for its
use in donor liver assessment for transplantation.
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APHPB-0618
SURVIVAL RATES AND RISKS OF
COMPLICATIONS OF
HEPATOCELLULAR CARCINOMA
FOLLOWING TRANS ARTERIAL
CHEMOEMBOLIZATION- A SINGLE
CENTRE EXPERIENCE
I. Maduka1, S. Junnarkar1, V. Shelat1, W. Woon1 and
J. K. Low1
1General Surgery, Tan Tock Seng Hospital, Singapore,
Singapore
Objectives: For operable hepatocellular carcinomas
(HCC); resection, transplantation and thermo ablation
(for <3 cm lesions) are curative options. For inoperable
lesions, which do not satisfy, transplant criteria, trans
arterial chemoembolization (TACE) or selective inter-
nal radiation therapy (SIRT) remains the primary
mode of treatment. TACE is shown to improve sur-
vival. TACE is not free from morbidity and ‘post
TACE syndrome’ is a common complication. Our aim
of the study was to analyse survival rates and risk fac-
tors for side effects in patients undergoing TACE for
HCCs.
Methods: A retrospective study was carried out and
306 TACE sessions in 149 patients done from 2001 to
2013 were included in the study.
Results: Out of the complications reported post TACE
fever was the commonest documented complication
noted with 83(27.12%) reported cases post procedure.
Tumour size (<5 cm) had a lower risk of complications
compared to larger tumours (p < 0.05). Unifocal
disease compared to multifocal disease and Child’s A
status compared to Child’s B status and patients under-
going <2 TACE sessions compared to >2 sessions had
a lower risk of complications (p < 0.05).
The analyzed survival rates at 12 months, 24 months
and 36 months were 61%, 35% and 24%.
Conclusion: Smaller tumour size, unifocal disease and
absence of liver failure were associated with a lower
risk of side effects following the procedure. The relative
risk of side effects increases with each session of TACE
in a single patient.
Primary tumour size and Child-Pugh classification were
found to be significant factors, which influence the
survival.
APHPB-0619
SHORT AND MIDDLE TERM
OUTCOMES AFTER LAPAROSCOPIC
VERSUS OPEN LIVER RESECTION FOR
HEPATOCELLULAR CARCINOMA
S. Nakahira1, Y. Takeda2, Y. Katsura2, T. Kato2, N.
Hatanaka1 and S. Tamura2
1Department of Digestive Surgery, National Hospital
Organization Kure Medical Center, Kure, Japan;
2Department of Digestive Surgery, Kansai Rosai
Hospital, Amagasaki, Japan
Objectives: The aim of this study was to analyze the
perioperative results and survival outcomes of LLR
versus open liver resection (OLR).
Methods: Between June 2010 and May 2013, 104
patients underwent pure laparoscopic liver resection
(PLLR) for HCC at our hospital. Historical control
patients (n = 82) who received OLR for HCC between
January 2004 and March 2010 were included for com-
parison.
Results: The patient age was elder in the PLLR group
than the OLR group (71.6 vs. 68.6). No significant dif-
ferences were noted between the PLLR and OLR
groups with respect to patient gender or liver damage.
The intraoperative blood loss was lower in the PLLR
group than the OLR group (143.9 mL vs. 1226.6 mL).
With the PLLR compared with the OLR group, opera-
tion time was 295.4 min vs. 203.0 min (p < 0.0001) and
hospital stay was 14.4 days vs. 15.5 days (p = 0.5992).
AST on the POD1 was 467.0 IU/L versus 396.9 IU/L
(p = 0.2558), ALT was 336.9 IU/L versus 304.4 IU/L
(p = 0.5223), total bilirubin was 0.89 mg/dL vs.
1.18 mg/dL (p = 0.0002), WBC was 9151/lL versus
11585/lL (p < 0.0001), and CRP was 0.97 mg/dL vs.
2.80 mg/dL (p < 0.0001). The surgical margins were
similar in the two groups. The 1 year disease-free sur-
vival at 1 year of stage I, II, III HCC were 83.1% ver-
sus 78.9% (p = 0.6899), 73.7% versus 79.2%
(p = 0.6114), and 67.9% versus 43.5% (p = 0.2181) for
PLLR and OLR, respectively.
Conclusion: Compared with OLR, LLR for HCC is
associated with less blood loss and lower systemic influ-
ence with no compromise in survival.
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APHPB-0620
THE MANAGEMENT OF FAILURE OF
RADIOLOGICAL INTERVENTIONAL IN
PATIENTS WITH PORTAL VEIN
THROMBOSIS AFTER LIVING DONOR
LIVER TRANSPLANTATION- CASE
REPORT AND LITERATURE REVIEW
Y. Cheng-Hsi1, L. I. N. Yu-Hung1, L. I. Wei-Feng1, L.
I. N. Ting-Lung1, Y. O. N. G. Chih-Chuan1, L. I. N.
Chin-Che1, W. A. N. G. Shih-Ho1, W. A. N. G. Chih-
Chi1 and C. H. E. N. Chao-Long1
1General Surgery, Kaohsiung Chang Gung Memorial
Hospital, Kaohsiung, Taiwan
Objectives: Portal vein thrombosis (PVT) after living
donor liver transplantation (LDLT) was a rare compli-
cation. It would cause clinical complications of variceal
bleeding, ascites, and graft dysfunction. Managements
of PVT include thrombectomy of portal vein (PV) with
stent and splenic artery embolization (SAE). Shunt
between portal branch and systemic circulation is an
alternative procedure after failure of radiological inter-
vention failed. We report two cases with frequent he-
matemesis and tarry stool due to total occlusion of PV
treated by porto-systemic shunt.
Methods: Two cases of PVT after LDLT were treated
meso-femoral shunt in Kaohsiung Chang Gung Memo-
rial Hospital. The clinical course and complications
were reviewed.
Results: Thirty-three year old male patient developed
variceal bleeding due to PVT after LDLT. The SAE
were performed but failed. Repeated esophageal vari-
ceal bleeding was still noted. He received meso-femoral
shunt with Gortex graft (0.8 cm) between inferior mes-
enteric vein and femoral vein. The second patient,
12 year-old boy; has PVT due to occlusion of PV trea-
ted with SAE. Repeated bleeding was noted and trea-
ted with meso-femoral shunt. The shunt was occluded
on post-operative day 3. He received splenectomy with
proximal spleno-renal shunt. Both patients recover
smoothly and do not have variceal bleeding at present
follow-up.
Conclusion: Porto-systemic shunt is the alternative pro-
cedure to failure of PV stent for PVT after LDLT.
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APHPB-0622
SPONTANEOUS BILE PERITONITIS IN
PANCREATIC HEAD TUMOR: REPORT
OF A CASE
K. Her1
1Surgery, University of Jeju College of Medicine, jeju,
Korea
Objectives: Bile peritonitis without trauma is rare even
in adults. Most common underlying diseases of these
rare conditions were CBD stones and/or intrahepatic
duct stones. Pancreatic tumor as a cause of spontane-
ous bile peritonitis is very rare. Here we report the bile
peritonitis secondary to pancreatic head tumor.
Methods: A 82-year-old male patient presented with
general weakness and chilling. Initially the patient was
jaundiced, body temperature was 38.5? and SBP was
60 mmHg checked. Anti-shock resuscitation and empir-
ical antibiotics were started without delay. A poorly
enhancing mass (2.3 cm) in uncinate process of pan-
creas with distal CBD obstruction was shown on fol-
lowing abdominal CT. PET-CT suggested the lesion as
a malignant tumor.
Results: On 4th admission day, abdominal distension
developed and progressed with tenderness. Chemistry
showed extremely high level of bilirubin in aspirated
ascites. Percutaneous ascites drainage was done for two
days and drainage amount reached up to 4 L. Endo-
scopic retrograde cholangio-pancreatography showed
no definite leakage of contrast both in intra- and extra-
hepatic biliary system. A double pigtail stent was
inserted into bile duct for the biliary drainage. Percuta-
neous ascites drainage was removed without problems.
No further surgery was allowed because of patient
refused it.
Conclusion: Although extremely rare, it is possible that
bile duct can be perforated spontaneously in the
patients of obstructing periampullary tumor. High sus-
picion of spontaneous biliary leakage is essential when
acsites is progressing in periampullary tumor patients.
This report shows extraordinary case that bile leaked
spontaneously and sealed by itself in pancreatic tumor.
Transplantation
APHPB-0624
ONE CASE THAT CAUSED THE
PNEUMOCOCCAL SEPSIS AFTER
SPLENECTOMY BY LIVING DONOR
LIVER TRANSPLANTATION
G. Nakayama1, K. Takeda1, Y. Honma1, Y. Oota1, R.
Mori1, T. Kumamoto1, R. Matsuyama1, I. Endou1 and
N. Gakuryu1
1Surgeon of gastroenterology, Yokohama City
University, Yokohama, Japan
Objectives: Overwhelming postsplenectomy infection
(OPSI) is a serious condition that causes severe infec-
tion after surgery and its mortality is 50–75%.
Methods: The patient was a 27-year-old man. He
underwent living donor liver transplantation (LDLT)
because of biliary atresia. The donor was his mother
and blood type combination was incompatible. There-
fore, preoperative administration of Rituximab and in-
traoperative splenectomy were performed. Biliary
anastomotic stricture appeared 3 months after LDLT
and plastic stent had been inserted.
Results: He was referred to the chief complaint of fever
of 39 degrees and septic shock the second year after
LDLT. S. pneumoniae (PSSP) has been detected from
bile culture and blood culture. Abdominal CT revealed
intrahepatic bile duct dilatation of the posterior seg-
ment. He was diagnosed as OPSI accompanying liver
abscess and septic shock. PTCD was inserted into the
bile duct of the posterior segment immediately after
hospitalization. Endotoxin adsorption therapy and anti-
biotics of DRPM and VCM in the initial treatment
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were performed. After had that, septic shock was
recovered immediately.
Conclusion: OPSI the present case had been merged
acute cholangitis and sepsis, liver abscess. I want to
report a discussion of the literature of slightly fewer
reported cases of OPSI after liver transplantation by
Japan.
APHPB-0625
EMERGENCY ADULT LIVING DONOR
LIVER TRANSPLANTATION USING
ABO-INCOMPATIBLE DONOR FOR
ACUTE LIVER FAILURE
M. Shinoda1, O. Itano1, H. Obara1, M. Kitago1, T.
Hibi1, Y. Abe1, H. Yagi1, K. Matsubara1, Y. Yamada1,
A. Fujino1, K. Hoshino1, T. Kuroda1, M. Tanabe2 and
Y. Kitagawa1
1Surgery, Keio University School of Medicine, Tokyo,
Japan; 2Hepato-Biliary-Pancreatic Surgery, Tokyo
Medical and Dental University, Tokyo, Japan
Objectives: Outcomes of emergency adult ABO blood
type incompatible (ABOI)-living donor liver transplan-
tation (LDLT) for acute liver failure (ALF) have not
been well reported so far. We assessed the outcome of
emergency ABOI-LDLTs for ALF in our hospital.
Methods: We have performed 130 cases of adult LDLT
since 1998. There have been 3 cases of emergency adult
ABOI-LDLT after introduction of rituximab (cases 1,
2, and 3). Our current protocol for elective ABOI-
LDLT is as follow: 1) systemic immunosuppression, 2)
PE and splenectomy, 3) rituximab 1–3 weeks prior to
surgery, and 4) postoperative portal infusion. In emer-
gent cases, we attempted to employ the protocol above
as much as possible.
Results: There was no significant difference of 5-year
survival rate between the groups of non-ABOI
(n = 101) and ABOI (n = 29). In the emergent ABOI
cases, blood type of fresh frozen plasma used for PE
was preoperatively converted to type AB, resulting on
the successful reduction of anti-donor blood type anti-
body titers. Rituximab was administered on 0 and 1
POD, -2 and 1 POD, and 1POD in case 1, 2, and 3,
respectively. Rates of CD19 and CD20 positive lym-
phocytes in spleen were higher in the emergent ABOI-
LDLT than those in elective ABOI-LDLT on the oper-
ation day. No antibody mediated rejection occurred in
the 3 cases of ABOI-LDLT. The 3 cases are alive for 8,
7, and 2 years, respectively.
Conclusion: Although timing of rituximab administra-
tion was modified, emergency adult ABOI-LDLTs for
ALF were successfully performed employing our cur-
rent protocol.
Malignant HPB Diseases
APHPB-0626
IMPACT OF CHEWING GUM ON
DELAYED GASTRIC EMPTYING
FOLLOWING
PANCREATICODUODENECTOMY
U. M. Muthuswamy1, S. Jeswanth1, P. Senthilkumar1,
R. Ravi1, R. Kamalakannan1, P. Anbalagan1, B.
Kesavan1, P. Ravichandran1 and G. Manoharan1
1Department of Surgical Gastroenterology, Stanley
medical college, Chennai, India
Objectives: Gum chewing is known to accelerate gastric
emptying. The aim of this prospective study was to
analyse the feasibility of implementing chewing gum
protocol in patients undergoing Pancreaticoduodenec-
tomy (PD), using historical control as comparison
Methods: Between April 2014 and August 2014, 20
patients who underwent PD were managed by chewing
gum protocol. Patients chew sugarless gum for 30 min
three times a day from the 1st POD. These patients
were compared with an equal number of matched his-
torical controls treated according to the traditional pro-
tocol. Overall time to pass flatus, time to first bowel
movement, delayed gastric emptying (DGE), length of
hospital stay were compared. We also investigated the
physiologic effect of chewing gum on gastric motility
using an ElectroGastroGram (EGG) analysis in the
study group
Results: DGE was significantly reduced in the chewing
gum group (7 vs. 15, p = 0.02). Patients in the chewing
gum group were able to tolerate liquid (p = 0.0005)
and solid diet (p = 0.0001) earlier, and they passed
stools earlier (p = 0.02). Length of hospital stay was
also reduced (median 14 days vs. 18.5 days, p = 0.007).
There were no differences in the morbidity and mortal-
ity between the two groups. EGG analysis also showed
an increase in gastric motility during gum chewing in
the study group
Conclusion: Chewing gum protocol is associated with
early recovery of bowel function, reduced DGE and
reduced hospital stay in PD, even with pancreatico-gas-
tric anastomosis. This protocol can be introduced easily
with no increase in costs, adverse events. Further
research would clarify this effect.
APHPB-0627
THE EVOLUTION OF TWO-STAGED
LIVER RESECTION
J. T. Li1, S. Y. Peng1, D. F. Hong2, Y. B. Liu3, H. O.
N. G. Yu4 and X. J. Cai4
1Surgery, Second Affiliated Hospital Zhejiang University
School of Medicine, Hangzhou, China; 2Surgery, the
people’s hospital of Zhejiang Province, Hangzhou,
China; 3Surgery, Xinhua Hospital of Shanghai Jiaotong
Univerity, Shanghai, China; 4Surgery, Sir Run Run
Shaw Hospital, Hangzhou, China
Objectives: This study reports different ways we used
to increase the volume and function of the potential
liver remnant and the results.
Methods: A serious of different ways was used as the
first stage. TAE was used since 1987; PVE since 1998,
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PVE+HAE was used for HCC with PVTT in 2005(case
1). RHAL+chemotherapy through RHA catheter was
used for a patient with a huge HCC situated at seg-
ment VIII in 1987(case 2). PVE was used for a patient
with a huge HCC situated at the caudate lobe (case 3)
In 2014 we adopt ALPPS with an interesting modifica-
tion—using liver hanging tape as a tourniquet to
replace liver parenchyma transection Both stage were
carried out under laparoscopy.
Results: Case 1 has been surviving for 9 years. Case 2
for 27 years. Case 3 for 14 years. Regarding ALPPS,
The patient recovered uneventfully without bile leak-
age. He was up and about on day 1 both after the two-
stage operations.
Conclusion: The evolution of two-staged liver resection
reflects the gradual progress in liver surgery. Currently
there have been a great variety ways of two-staged liver
resection that a surgeon can chose to treat different
patients. In situ splitting of the liver was supposed to
be the major cause of the high occurrence rate of bili-
ary leakage. Using liver hanging tape as a tourniquet
that we call it round-the-liver ligation to replace liver
splitting is good for avoiding the complication, Round-
the-liver ligation to replace liver splitting is conducive
to ALPPS.
APHPB-0628
FAVORABLE PROGNOSTIC FACTORS
AFTER RESECTION OF PANCREATIC
CANCER
T. Takahashi1, R. Matsuyama1, R. Mori1, Y.
Homma1, Y. Ota1, T. Kumamoto1, K. Takeda1 and I.
Endo1
1Gastroenterological Surgery, Yokohama City University
Graduate School of Medicine, Yokohama, Japan
Objectives: The purpose of this study was to identify
prognostic factors related to long-term survival after
resection of pancreatic ductal adenocarcinoma
(PDAC).
Methods: Between September 1991 and December
2012, 271 patients underwent a pancreatic resection for
invasive ductal carcinoma. Clinicopathological factors
of the patients with 5-year disease free survival (15
patients) were compared with that of the patients who
died of cancer within 3 years (142 patients).
Results: Univariate analyses revealed that a tumor size
<3 cm (p = 0.018), a negative venous invasion
(p = 0.007), a preoperative CA19-9 concentration?
37 U/mL (p = 0.042), a preoperative SPAN1 concen-
tration? 30 U/mL (p = 0.002), a preoperative peripheral
lymphocyte counts>1300 (p = 0.004), and a peripheral
lymphocyte counts on 1 postoperative month>1300
(p = 0.02) were significant favorable factors. Using
these significant factors identified by univariate analy-
sis, multivariate analysis revealed that a preoperative
peripheral lymphocyte counts>1300 (95%CI: 1.197–
189.409, p = 0.036, HR = 15.06), a preoperative CA19-
9 concentration?37 U/mL (95%CI:2.674–408.163,
p = 0.008, HR = 4.17) and a negative venous invasion
(95%CI:1.314–194.334, p = 0.03, HR = 16.13)were the
independent favorable prognostic factors.
Conclusion: Preoperative higher lymphocyte counts,
lower CA19-9 level and without venous invasion
related to the long-term survival for patients with
PDAC. It is suggested that the survival outcome might
be improved by modification of peripheral lymphocyte
counts in preoperative period.
APHPB-0629
SARCOMATOID CARCINOMA OF
GALLBLADDER: A RARE CLINICAL
ENTITY
D. R. Kulkarni1, S. Mistry1, R. Hegde1, V. Yadav1
and S. Borade1
1General Surgery, Dr. R.N.Cooper Hospital, Mumbai,
India
Objectives: Sarcomatoid carcinoma of Gallbladder is a
rare malignancy of the gall bladder with reported inci-
dence of less than 1%. We report this case for its rarity
and review the literature to highlight 1) the limitations
of advanced imaging techniques to diagnose this
pathology preoperatively, 2) the importance of immu-
nohistochemistry in final diagnosis, 3) the need of a
radical R0 resection and 4) poor overall prognosis.
Methods: We report a 75-year-old gentleman, who pre-
sented to us with pain in right hypochondrium. Imag-
ing studies (USG, CT scan, MRI, EUS) suspected
gallbladder cancer versus chronic calculus cholecystitis.
A radical cholecystectomy, S4b, 5 liver resection, extra-
hepatic bile duct resection and Roux-en-Y hepaticojej-
unostomy was done based on intraoperative findings &
R0 resection was achieved
Results: Histopathology revealed epithelial & mesen-
chymal components and IHC was positive for cytoker-
atin confirming diagnosis of sarcomatoid cancer. All
margins were negative & none of the lymph nodes were
positive.
Conclusion: Sarcomatoid cancer is very rare malig-
nancy of gall bladder. It is nearly impossible to suspect
it preoperatively with available imaging techniques. A
diligent histopathology examination and immunohisto-
chemistry is vital for a correct diagnosis. A radical R0
resection is the only chance to long-term survival.
However even with R0 resection the results are dismal.
So far there is no role for chemo or radiotherapy.
APHPB-0630
SIGNIFICANCE OF ENDOSCOPIC
TRANSGASTRIC DRAINAGE FOR
POSTOPERATIVE PANCREATIC
FISTULA
J. Yamamoto1, R. Mori1, R. Matsuyama1, Y. Ota1, Y.
Honma1, T. Kumamoto1, K. Takeda1, K. Hosono2, K.
Kubota2 and I. Endo1
1Gastroenterological Surgery, Yokohama City
University, Yokohama, Japan; 2Gastroenterology and
Hepatology, Yokohama City University, Yokohama,
Japan
Objectives: Endoscopic transgastric drainage (ETGD)
has been a useful modality to decompress pancreatic
pseudocysts. However, it is unclear whether ETGD is
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effective for postoperative pancreatic fistula (POPF)
after pancreatic surgery. We reported our experience of
ETGD for POPF.
Methods: 154 patients who underwent pancreatectomy
in April 2009 to March 2014 were analyzed retrospec-
tively in our department. EUS-guided ETGD was per-
formed. Nasal drainage tube is used for first drainage,
and nasal tube is exchanged to internal drainage tube,
if prolonged drainage is expected.
Results: Of 44 patients (28.6%) were suffered from
POPF of GradeB / C. In 16 patients of them, puncture
to fluid collection was performed after removal of the
drainage catheter. 4 patients of them (25%) underwent
ETGD because percutaneous puncture route could not
be found out. All 4 patients underwent distal pancrea-
tectomy for pancreatic cancer. ETGD was performed
at a median time of 19th postoperative day and started
meal at a median time of 16 days after ETGD. One
patient required additional drainage because decom-
pression of fluid collection could not be achieved by
the initial drainage. There was no ETGD-related com-
plication. The patients discharged from our hospital at
a median time of 36 days after ETGD and the drainage
tubes were removed at a mean time of 49 days after
ETGD.
Conclusion: ETGD for POPF after distal pancreatec-
tomy can be performed safely. This treatment seems
useful for POPF, especially in the patients with difficult
percutaneous drainage.
APHPB-0631
SURGICAL OUTCOMES AFTER
HEPATOPANCREATODUODENECTOY
ACCORDING TO THE EXTENT OF
HEPATECTOMY
H. Lee1, J. S. Heo1, J. Y. Park1, S. Youn1, W. Kwon1,
S. H. Choi1 and D. W. Choi1
1Surgery, Samsung Medical Center Sungkyunkwan
University School of Medicine, Seoul, Korea
Objectives: The aim of this study is to analyze the sur-
gical outcomes after hepatopancreatoduodenectomy
according to the extent of hepatectomy and diagnosis.
Methods: From January 2000 to December 2013, we
reviewed medical records of 45 patients who underwent
hepatopancreatoduodenectomy. The patients were
divided according to the extent of surgery and diagno-
sis. Hemihepatectomy and trisectionectomy were
defined as the major hepatectomy. The patients were
divided into cholangiocarcinoma group and other
malignancy group.
Results: The 35 patients underwent major hepatectomy
with pancreatoduodenectomy and ten patients under-
went minor hepatectomy. There were four cases
(11.4%) of in-hospital mortality in major hepatectomy
group although no mortality in minor hepatectomy
group. The 24 of 25 patients with cholangiocarcinoma
and 11 of 20 patients with other malignancy underwent
major hepatectomy (p = 0.001). After median follow-up
of 18 months, the survival of cholangiocarcinoma
group was better than other malignancy group after he-
patopancreatoduodenectomy (p = 0.002). The median
survival time was 45 months in cholangiocarcinoma
group although 21 months in other malignancy group.
Conclusion: Major hepatectomy with pancreatoduoden-
ectomy is associated with high mortality rate. However,
hepatopancreatoduodenectomy enables long term sur-
vival in the patients with cholangiocarcinoma.
APHPB-0632
THE GLASGOW PROGNOSTIC SCORE
TO PREDICT THE LONG TERM
SURVIVAL AND PROGNOSIS IS A
MORE PREDICTABLE FACTOR IN
LOCALLY ADVANCED PANCREAS
CANCER
E. Jun1, S. Kim1, K. Song1, J. Lee1, D. Hwang1, J.
Hwang2, D. Lee1, J. Lee1, S. Shin1, H. Kim1, K. Park1
and Y. Lee1
1Division of Hepatobiliary and Pancreatic Surgery, Asan
Medical Center, Seoul, Korea; 2Department of Surgery,
Hallym University Medical Center, Seoul, Korea
Objectives: Pancreatic ductal adenocarcinoma (PDAC)
is one of the most lethal and aggressive malignancies.
Prognosis prediction after curative resection for PDAC
is crucial but remains a challenge. The Glasgow Prog-
nostic Score (GPS) was composed of both CRP and
albumin had independent prognostic value in various
cancers. Our aim was to retrospectively evaluate the
prognostic value of the GPS in resected PDAC.
Methods: From Jan 2005 to Dec 2012, the medical
records of 872 patients who underwent pancreaticoduo-
denectomy and distal pancreatectomy for PDAC in a
single center were retrospectively reviewed. To clarify
the value of GPS, various factors among patients was
compared. Kaplan–Meier methodology was used to
evaluate the potential prognostic effects.
Results: In patients with low and high GPS, a signifi-
cant difference in overall survival (OS) was detected.
First, GPS ≥1 predicted poorer overall survival (OS)
compared with GPS < 1, in all stage. (median OS, 17
and 22, respectively; p = 0.001). Second, we compared
the value of GPS by TNM stage. In stage 1, there are
no differences between GPS score. (p = 0.117) How-
ever, more than stage 2, the OS was more dependent
on GPS. GPS≥1 and GPS < 1 represented the OS
(respectively 17.3 and 20.5; p = 0.009)
Conclusion: To predict the prognosis for PDAC
patients, we have retrospectively validated the signifi-
cance of preoperative GPS. Preoperative GPS could be
one of the important determinants of overall survival
in PDAC patients with a variety of clinical scenarios.
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APHPB-0633
ENLIGHTENMENT OF SLENDER
(NEEDLE TYPE) FLEXIBLE DEVICE TO
CONTROL ORGANS ESPECIALLY FOR
A LAPAROSCOPIC HEPATECTOMY
H. Ikoma1, R. M. Morimura1, T. K. Kosuga1, H. K.
Konishi1, Y. M. Murayama1, S. K. Komatsu1, A. S.
Shiozaki1, Y. K. Kuriu1, M. N. Nakanishi1, E. O.
Otsuji1, D. I. Ichkawa1, H. F. Fujiwara1, K. O.
Okamoto1 and T. O. Ochiai1
1Surgery, Kyoto Prefectural University of Medicine,
Kyoto, Japan
Objectives: In a laparoscopic surgery, it is important to
secure an operating field. Various handiworks were
made at the tip of devices to control organs more easily
and safety. However, since the size at the tip of a
device is limited by the diameter of the lumen of the
trocar which approaches an intraabdominal, no device
with sufficient effect has been made yet. Then, I
enlightened a new device to control organs especially
liver.
Methods: The product made from a stainless with the
flexible tip coated with the silicon and slender body
such as needle (1.5–3.5 mm). (Patent pending in japan).
The tip can be transformed suited to organ control
freely with maniphalanxes, and can hold the form. So
the transformation of the tip is performed in manual in
the state where I derived outside of the abdomen from
an umbilicus wound. Then the tip was taken back to
the intrabdomen via the umbilicus wound.
Results: Making up the tip to adjust it freely by the
preference of the operator by hand was easy. The per-
formance of this new device for retracting organs was
good and safety as a result of the use in the animal lab-
oratory and the living body.
Conclusion: This device gained atraumatic shape by the
flexibility in opposition to the fine body like a needle.
Since it is furthermore slender body, and there is little
parietal destruction, a supplemental of a device is easy.
A new suggestion is made as for this device to an
development of the laparoscopic surgery in hepato-bill-
aly-pancreatic surgery.
APHPB-0635
MOST ACCURATE POST OPERATIVE
DAY DRAIN AMYLASE LEVEL IN
PREDICTING POST OPERATIVE
PANCREATIC FISTULAS
E. L. S. Tang1, C. W. T. Huey1, S. P. Junnarkar1, J.
K. Low1 and W. L. W. Woon1
1Hepato-Pancreato-biliary Surgery Service Department
of General Surgery, Tan Tock Seng Hospital, Singapore,
Singapore
Objectives: To establish which post operative day drain
amylase level is most predictive in identifying post
operative pancreatic fistulas.
Methods: A retrospective study of 186 consecutive
patients who underwent pancreatic resection in a single
institution from 2006 to 2013 was performed. Drain
amylase levels were routinely measured for all pancre-
atic resections. The International Study Group of Pan-
creatic Fistula (ISGPF) definition of post operative
pancreatic fistula (POPF) of drain amylase levels on or
after post operative day (POD) 3, greater than 3 times
the serum amylase activity, was employed. The ISGPF
grading of clinical severity was also used in grading the
pancreatic fistulas.
Results: 43.4% (82 out of 189) of patients who under-
went pancreatic resection had a biochemical POPF.
38.6% had clinically insignificant pancreatic fistulas
(Grade A), 4.23% required percutaneous drainage
(Grade B), while 0.53% had severe clinical sequelae
from the pancreatic fistula (Grade C).
Drain amylase from post operative day 1 was the most
accurate in picking up pancreatic fistulas (61.0%), fol-
lowed by POD day 3, which picked up 51.2% of pan-
creatic fistulas. Subgroup analysis of the drain amylase
levels according to the ISGPF classification revealed
POD 1 drain amylase to be most accurate for Grade A
fistulas, POD 1 and 3 to be just as accurate for Grade
B fistulas, and POD 3 to be most accurate for Grade C
fistulas.
Conclusion: Drain amylase levels from POD 1 was
most predictive in identifying post operative pancreatic
fistulas.
APHPB-0636
HILAR CHOLANGIOCARCINOMA:
RESULTS OF SURGERY IN 126
PATIENTS
G. M. Sebastian1, A. Yadav1, A. Venugopal1, M.
Subramaniaiyer1 and H. Ramesh1
1Surgical Gastroenterology & Liver transplantation,
Lakeshore hospital and research centre, Cochin, India
Objectives: To compare outcomes of resection in hilar
cholangiocarcinomas and specifically study the survival
among patients who underwent direct surgery versus
those who underwent biliary drainage preoperatively.
Methods: There were 136 patients (75 male, 51 female)
with age range 25–81 years (median 57). Sixty nine
patients had significant comorbid illness, and bilirubin
levels ranged from 1.6 to 21.6 mgs%. 23 patients
underwent preoperative biliary drainage, and 9 patients
underwent preoperative portal vein embolization.
Patients underwent bile duct resection alone (n = 26),
hepatic resection (more than 3 segments; n = 66), and
parenchyma conserving liver resection (n = 44). The
following was analysed: a) mortality and overall sur-
vival, b) mortality and survival following different
types of resection, c) outcomes following patients who
were drained preoperatively versus those not drained
and operated directly
Results: Mortality occurred in 7 cases. Factors affect-
ing mortality included bleeding, intraoperative hyper-
tension, and vascular resection. Bilirubin levels did not
influence mortality. 1 year survival was 81%, 3 year
survival 63% and 5 year survival 32%. Survival was
significantly improved in the RO resection group. 36
patients had R1 resection. Survival was poorer among
patients who had preoperative biliary drainage.
Conclusion: Most hilar cholangiocarcinomas present
with Stage 3 disease, and early surgery may represent
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the only chance for prolonging survival and improving
quality of life.
APHPB-0637
THE IMPACT OF FDG-PET WITH
CONCURRENT NON-CONTRAST CT
SCANNING (PET/CT) ON THE
MANAGEMENT OF OPERABLE
PANCREATIC, AMPULLARY OR
DISTAL BILE DUCT CANCER
D. Kilburn1, M. Burge2, N. O’Rourke1, R. Bryant1, A.
Francesconi2, K. Houston2, D. Wyld2, M. Eastgate2,
R. Finch1, L. Nathanson1, G. Hopkins1, P. Thomas2
and D. Macfarlane2
1General Surgery, Royal Brisbane and Women’s
Hospital, Brisbane, Australia; 2Radiology, Royal
Brisbane and Women’s Hospital, Brisbane, Australia
Objectives: The role of Fluorodeoxyglucose (FDG)
Positron Emission Tomography (PET/CT) scanning in
operable pancreas cancer is unclear. We therefore
wanted to investigate the impact of PET/CT on man-
agement, by incorporating it into routine work-up.
Methods: This was a single institution prospective
study. Patients with suspected and potentially operable
pancreas, distal bile duct or ampullary carcinomas
underwent PET/CT in addition to routine work-up.
The frequency that PET/CT changed the treatment
plan or prompted other investigations was determined.
The distribution of standard uptake values (SUV)
among primary tumours, and adjacent to biliary stents
was characterised.
Results: Fifty six patients were recruited. The surgical
plan was abandoned in 9 (16%) because PET/CT iden-
tified metastases, but in 4 other patients metastases
were missed. 7 patients were inoperable at surgery
which was not predicted by PET/CT. In 10 patients,
there was unexpected FDG uptake resulting in 7 addi-
tional investigations, of which 2 were deemed useful.
Primary tumour FDG uptake is frequently normal or
only mildly elevated and may be highest around the bil-
iary stent. PET/CT detected metastases in 5 patients
whose primary tumours demonstrated only mild to
moderate avidity (SUV < 5).
Conclusion: PET/CT in potentially operable pancreas
cancer has limitations. However, due to its ability to
detect metastases, PET/CT scanning is a useful tool in
the selection of such patients for surgery.
APHPB-0640
DELAYED GASTRIC EMPTYING AFTER
PANCREATICODUODENECTOMY. RISK
FACTORS, PREDICTORS OF SEVERITY
AND OUTCOME. A SINGLE CENTER
EXPERIENCE OF 588 CASES
M. El Sorogy1 and A. El Nakeeb1
1General Surgery Mansoura Faculty of Medicine,
Gastroenterology surgical center Mansoura University,
Mansoura, Egypt
Objectives: Delayed gastric emptying (DGE), a com-
mon complication after pancreaticoduodenectomy (PD.
This study was carried to identify the incidence and
risk factors for development of DGE after PD in a
high volume center and comparing outcome of primary
and secondary DGE.
Methods: Between 2001 and 2014, 588 patients under-
went PD for various pathologies. The incidence and
associated variables of DGE (identified according to
the International Study Group of Pancreatic Surgery)
were retrospectively analyzed.
Results: DGE occurred in 105 (17.9%) of the 588
patients. 43 patients (7.3%) were grade A, 53 patients
(9%) grade B and 9 patients (1.9%) were grade C. In
72 (12.2%) patients DGE was associated with other
postoperative complications (secondary DGE) while
primary DGE occurred in 33 patients (6.5%). BMI
above 25 0.0001, diabetes (0.0001), preoperative ERCP
(0.005), pancreatic duct diameter less than 3 mm 0.02,
PG reconstruction 0.4, retrocolic gastrojejunostomy
(0.0001), presence of complication 0.0001, pancreatic
leakage (0.0001), collection and bile leakage (0.005)
were significantly associated with DGE. Primary DGE
not associated with any other complication and amount
of Ryle was more in secondary DGE, resume oral
intake more earlier than in secondary DGE 0.02, hospi-
tal stay was significantly longer in secondary DGE
(0.02).
Conclusion: DGE is strongly linked to secondary post-
operative complications especially pancreatic leakage.
However, 6.5% of the patients had DGE with no obvi-
ous cause. Although the International Study Group of
Pancreatic Surgery classifies DGE according its degree,
the etiology of DGE (primary or secondary) should be
clarified for proper management.
APHPB-0641
SURVIVAL OUTCOMES AFTER
LAPAROSCOPIC TWO-STAGE
HEPATECTOMY FOR BILOBAR
COLORECTAL LIVER METASTASES
D. Kilburn1, A. Chiow1, J. Lewin1, D. Cavallucci1, L.
Nathanson1, R. Bryant1 and N. O’Rourke1
1General Surgery, Royal Brisbane and Women’s
Hospital, Brisbane, Australia
Objectives: This report describes the technical aspects
and outcomes of a laparoscopic approach in planned
two-stage liver resections for patients with bilobar colo-
rectal cancer (CRC) liver-only metastases.
Methods: This is a retrospective review of our database
examining consecutive patients who underwent an ini-
tial first-stage laparoscopic liver resection for CRC
metastases, with a planned second-stage resection from
2007 to 2013.
Results: Seven patients underwent an initial laparo-
scopic first stage with concurrent right portal vein liga-
tion (RPVL) in two patients. Median operating time
was 100 (60–170) min with a median blood loss of 100
(50–400) mL. Median length of stay was 3 (2–5) days.
The remaining five patients required post-operative
right portal vein embolization (RPVE). All patients
had significant hypertrophy of the future liver remnant
(FLR) (future liver remnant volume (FLRV) >25%)
and six patients subsequently had a successful open
© 2015 The Authors
HPB © 2015 Americas Hepato-Pancreato-Biliary Association HPB 2015, 17 (Suppl. S2), 25–266
210 Poster Abstracts
right hepatectomy with one attempted laparoscopically
converted to open. Two patients had prolonged bile
leaks after the second procedure.
Three patients remained disease free, with median fol-
low-up of 34 (13–80) months. One patient had disease
progression following RPVE precluding performance of
second stage.
Conclusion: Laparoscopic first-stage resection of
tumours in the left liver can be safely combined with
RPVL/RPVE to achieve adequate hypertrophy of the
FLR, allowing subsequent right hepatectomy.
APHPB-0642
LAPAROSCOPIC RESECTION OF
HEPATOCELLULAR CARCINOMA: THE
BRISBANE EXPERIENCE
D. Kilburn1, A. Chiow1, D. Cavallucci1, L.
Nathanson1, R. Bryant1 and N. O’Rourke1
1General Surgery, Royal Brisbane and Women’s
Hospital, Brisbane, Australia
Objectives: This series was designed to report the tech-
nical aspects and outcomes of laparoscopic liver resec-
tion for hepatocellular carcinoma (HCC).
Methods: This is a retrospective and prospective review
of consecutive patients who underwent laparoscopic
liver resection for HCC from 1999 to 2014. We analy-
sed the surgical techniques based on the site of tumour,
looking at pre/operative details, pathology, and 1, 3
and 5-year survival/disease free survival.
Results: 29 patients underwent a total of 32 operations
and 43 HCCs were resected. Of these 32 operations, 31
were pure laparoscopic and 1 was hand-assisted lapa-
roscopy (HALS). 19 patients had cirrhosis (18 Child’s
A).
There were 5 major anatomic, 19 minor anatomical,
and 8 minor non-anatomical resections. Of these, about
35% were left lateral sectionectomies. There were 8
dome lesions in the series that were resected in 5 lapa-
roscopic +/- transthoracic procedures.
Mean blood loss was 350 mL and mean operative time
was 145 min. The mean length of stay was 5 days.
There were 2 postoperative complications (Clavien-Din-
do grade 1) and 1 post-operative death. R0 rate was
94%. Actuarial rates of overall survival at 1, 3 and
5 years were 95%, 80% and 76% respectively. 5-year
disease free survival was 61%.
Conclusion: Laparoscopic liver resection of HCC is fea-
sible in selected patients, including patients with cirrho-
sis. Good survival rates can be achieved with the use of
various surgical techniques. We suggest a combined
laparoscopic/transthoracic approach for lesions in seg-
ment 7 and 8.
Transplantation
APHPB-0643
MULTI-MODALITY APPROACH TO
PORTAL VEIN THROMBOSIS AFTER
LIVER TRANSPLANT IN A YOUNG
PATIENT WITH EXTENSIVE
PORTOSYSTEMIC SHUNT
C. W. Tay1, S. K. Y. Chang1, S. G. Iyer1, A. W. C.
Kow1 and K. Madhavan1
1Surgery, NUHS, Singapore, Singapore
Objectives: We report a case of portal vein thrombosis
after cadaveric liver transplant managed successfully
with the combination of surgery, catheter-directed
thrombolysis and medical treatment.
Methods: -
Results: Miss Z is a 15 year old lady who suffered
from autoimmune liver cirrhosis, with severe portal
hypertension and portosystemic shunt on CT scan. She
received a cadaveric liver transplant; unfortunately she
developed portal vein thrombosis (PVT) during the
transplant and required thrombectomy and ligation of
a large coronary vein.
Doppler ultrasound of the transplanted liver showed
extensive reformation of thrombus in the portal vein,
she was brought back for relook laparotomy, thromb-
ectomy and shunt ligation. She was started on intrave-
nous heparin infusion.
A repeat Doppler ultrasound on post op day 2 again
revealed thrombus in the portal vein. A relook laparot-
omy was performed and angiography catheter was
inserted via inferior mesenteric vein and catheter-direc-
ted thrombolysis with recombinant tissue plasminogen
activator infusion was commenced. Her abdomen was
temporarily closed and rTPA infusion was continued
for 8 h. A check portovenogram was performed
showed significant improvement of portal blood flow
and thrombus.
On POD 3, on-table portovenogram showed good por-
tal blood flow and a new splenorenal shunt was opened
up. The splenorenal shunt was ligated, and abdomen
was closed definitely after confirmation of good portal
blood flow. She was given anticoagulant for 4 weeks,
check CT liver showed complete resolution of throm-
bus after 20 days.
Conclusion: Our case highlighted PVT can be easily
developed in patient with extensive portosystemic
shunts and this should be managed with multi-modality
approach.
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APHPB-0644
THE PROGNOSTIC FACTORS FOR
RECURRENCE AFTER RESECTION OF
INTRAHEPATIC
CHOLANGIOCARCINOMA
H. Sueoka1, T. Hirano1, Y. Iimuro1, T. Okada1, Y.
Asano1, N. Uyama1, K. Suzumura1, S. Hai1, I.
Nakamura1, Y. Kondo1, H. Kosaka1 and J. Fujimoto1
1Surgery, Hyogo College of Medicine, Nishinomiya, Japan
Objectives: Intrahepatic cholangiocarcinoma (ICC) is
fetal disease because of early invasion and widespread
metastasis. Complete surgical resection is the only treat-
ment to cure the patients however, prognosis is extremely
poor. We investigated the outcomes of surgical treatment
of ICC in our institution, and analyzed the prognostic fac-
tors affecting recurrence of ICC using statistical analysis.
Methods: We totally treated 55 patients in the period
January 2004 to December 2013. We performed opera-
tions for 49 patients, and 42 cases were achieved cura-
tive resection. We considered prognostic factors of
recurrence with significant difference in univariate and
multivariate analysis.
Results: 1-year, 3-years and 5-years overall survival rate
were 85%, 38% and 33% in the patients with curative
operation. The median survival time of patients under-
went curative resection was 26 months, while that of
patients received non-curative operation was only
5 months. After curative resection, 32 patients suffered
recurrence at a median time of 10 months and most
(70%) of recurrences were seen within 12 months after
operations. Univariate and multivariate analysis showed
that tumor number and regional lymph node metastasis
were prognostic factors for recurrence (p < 0.01). Portal
vein (PV) invasion, tumor number and regional lymph
node metastasis were significantly higher in the recurrent
group within 6 months after operation.
Conclusion: Multiple tumor and regional lymph node
metastasis were predictive factors for recurrence in
ICC. However, vascular invasion was not shown as a
predictive factor for recurrence in our study, the
patients with PV invasion suffered early recurrence
after operation.
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APHPB-0645
PREDICTING THE NEED FOR
OPERATIVE COMMON BILE DUCT
EXPLORATION (CBDE) DESPITE
ATTEMPTED ENDOSCOPIC
RETROGRADE
CHOLANGIOPANCREATOGRAPHY
(ERCP) WITH REMOVAL OF STONES
S. H. J. Wong1, C. J. Simon2 and Y. L. Cheah2
1General Surgery, National Healthcare Group-Alexandra
Health Pte Ltd Residency, Singapore, Singapore;
2Department of Surgery, Khoo Teck Puat Hospital,
Singapore, Singapore
Objectives: Unsuccessful ERCP stone clearance occurs
in a significant minority of patients with choledocho-
lithiasis. The aim of this study is to identify risk factors
associated with the need for CBDE despite attempted
endoscopic clearance.
Methods: 602 patients who underwent ERCP for chole-
docholithiasis in a single institution from 2010 to 2014
were analyzed. Patients who had subsequent surgery
confirming successful ERCP clearance (control) were
compared against 2 groups; patients with documented
ERCP clearance but found to have choledocholithiasis
during surgery (Group A), and patients with failed
ERCPs necessitating CBDE (Group B). Mean follow-
up period was 20 months. Clinical, endoscopic, and
operative data were reviewed.
Results: Of 223 patients were included in the study
(118 female; mean age 56 years). Thirty-eight (17%)
patients (16 in Group A, 22 in Group B) required oper-
ative CBDE despite attempted endoscopic clearance.
For patients in Group A, only the presence of Mirizzi’s
syndrome (25 vs 4.3%; p < 0.05) significantly predicted
the need for operative CBDE. Notable factors which
did not predict need for CBDE in this group included
GGT levels, stone size, and duration between ERCP
and surgery. Group B patients underwent 2.2 (average)
ERCPs prior to surgery. Factors significantly
(p < 0.05) associated with failed ERCP clearance
(Group B) were Mirizzi’s syndrome (27.3 vs. 4.3%),
post-gastrectomy anatomy (13.6 vs. 0%), presence of
large (>10 mm) CBD stones (50 vs. 14.6%) and dilated
CBD (95.5 vs. 73.5%).
Conclusion: Patients with Mirizzi’s syndrome require
CBDE despite the outcome of ERCP. Earlier CBDE
should be considered in fit patients with multiple risk
factors for ERCP failure.
APHPB-0646
MANAGEMENT FLOWCHARTS AND
CARE BUNDLES OF ACUTE
CHOLANGITIS AND CHOLECYSTITIS:
TOKYO GUIDELINES 2013
M. Yoshida1, T. Takada2, F. Miura2, K. Okamoto3, T.
Mayumi4, M. Yokoe5, H. Gomi6 and S. Kiriyama7
1Surgery and Hemodialyis, International University of
Health and Welfare Kaken hospital, Chiba, Japan;
2Surgery, Teikyo University School of Medicine, Tokyo,
Japan; 3Surgery, Kitakyushu Municipal Yahata
Hospital, Kitakyushu, Japan; 4Emergency Medicine,
University of Occupational and Environmental Health,
Kitakyushu, Japan; 5General Internal Medicine, Nagoya
Daini Red Cross Hospital, Nagoya, Japan; 6Center for
Clinical Infectious Diseases, Jichi Medical University,
Tochigi, Japan; 7Gastroenterology, Ogaki Municipal
Hospital, Ogaki, Japan
Objectives: Tokyo Guidelines 2007 for the management
of acute cholangitis and cholecystitis was published,
but clinical medical treatments have been marked
developed all over the world. Management flowcharts
of guidelines are proposed to allow clinicians to grasp,
at a glance, the outline of the management strategy of
the disease. The care bundles are designed to be easily
achievable and sustainable both to implement and to
audit.
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Methods: We revised management flowcharts and
adopted the world’s first care bundles for acute cholan-
gitis and cholecystitis in the updated Tokyo Guidelines
2013 (TG13).
Results: Flowcharts and bundles are all showed in fig-
ures and tables of TG13. Care bundles showed 10–11
items or procedures strongly recommended in clinical
practice. Management flowcharts showed management
flows of acute cholangitis and cholecystitis as three
severity grades; Mild (grade I), Moderate (gradeII) and
Severe (gradeIII).
Conclusion: Revised management flowcharts and care
bundles of acute cholangitis and cholecystitis are hoped
to enhance the understandings and implementations of
TG 13. The Flowcharts, Bundles, all TG13 guidelines
and mobile applications (iOS, Android) are available
via http://www.jshbps.jp/en/guideline/tg13.html.
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APHPB-0647
RUPTURED HEPATOCELLULAR
CARCINOMA (HCC) – OUTCOMES OF
A MULTIDISCIPLINARY APPROACH IN
AN INDIAN TERTIARY CARE CENTER
M. Govindhan1, M. Uma Maheshwaran1, R. Ravi1, P.
Senthilkumar1, R. Kamalakannan1, B. Kesavan1, P.
Anbalagan1, S. Jeswanth1 and P. Ravichandran1
1Surgical gastroenterology & liver transplantation,
Government stanley medical college, Chennai, India
Objectives: The aim of this study is to report a single
center experience of patients with ruptured HCC and
To analyze the outcome of ruptured HCC and the role
of non-operative and operative interventions.
Methods: Between 2004–2013 total of 30 Patients pre-
sented with Spontaneous rupture of HCC. We analyzed
the Variables like clinical presentation, treatment strate-
gies and survival outcome.
Results: Out of 30 patients, 22 were males and 8 females
with median age of 48 years. Median tumor size was
7.5 cm (range 4–14). Liver was cirrhotic in 13(43.4%),
non-cirrhotic in 17 (56.6%) and HCC was multifocal in
8 (26.6%) patients. Procedures like Definitive resection
was performed in 18 (60%) and hemostatic interventions
in 12 (40%), angiographic embolization in 8 and surgical
hemostasis in 4 patients. Definitive resections were Rt
hepatectomy (3), left hepatectomy (4), lateral segmentec-
tomy (5), non-anatomical resection (6). Mean hospital
stay was 14 days. Incidence of complications –morbidity
8 (26.6%), mortality in 10 (33.3%). Patients were fol-
lowed up for upto 10 years and was observed that
patients with cirrhosis had Less than 3 year survival,
Non-cirrhotic patients had improved survival.
Conclusion: Rupture of HCC is a life threatening event
and requires a multidisciplinary approach. Primary he-
mostasis, followed by emergency or staged hepatic
resection, is the treatment of choice. Angioembolization
is useful for non-resectable tumors and resectable
tumors with poor performance status. Definitive resec-
tion is the primary modality for preserved patients with
resectable lesions. Patients who had no underlying liver
disease had better prognosis.
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APHPB-0648
DOES RADICALITY OF FREY
PROCEDURE FOR CHRONIC
PANCREATITIS INFLUENCE THE LATE
RE-INTERVENTION RATE AFTER
SURGERY?
G. M. Sebastian1, A. Yadav1, M. Subramaniaiyer1, A.
Venugopal1 and H. Ramesh1
1Department of Surgical Gastroenterology & Liver
Transplantation, Lakeshore hospital and research centre,
Cochin, India
Objectives: There is a paucity of data on late re-inter-
ventions after Frey Procedure for chronic pancreatitis.
Aim: To determine if extent of head coring influences
rates of re-intervention after Frey procedure.
Methods: Study design: Retrospective analysis. Patients
and Methods: The data of 500 patients in 3 groups
(A = 105, B = 192 and C-203) treated over different
time periods and increasing radicality of head coring
were analysed to determine re-intervention rates and
outcomes after re-intervention.
Results: Of 70 re-interventions were required in 53
patients. 56 of these occurred in the first 4 years after
surgery. Reinterventions were significantly more fre-
quent in group A (30/105; 29%), and B (18/192
patients; 9%) than in C (5/203; 2%). Pancreatic reinter-
ventions were endoscopic in 45 and surgical in 25 cases.
Reinterventions included endoscopic biliary stenting
(n = 27), pancreatic stenting (n = 8), choledochoduode-
nostomy (n = 3), repeat Frey procedure (n = 8), Whip-
ple resection (n = 6), endoscopic pseudocyst drainage
(n = 12), and tail abscess drainage (n = 2). There was
no mortality. Overall, 51 out of 53 patients are well
after reintervention over long-term follow up.
Conclusion: Increased radicality of head coring
decreased the number of re-interventions after Frey
procedure. Outcomes after such reintervention were
good in most cases. The majority of interventions
occurred within 4 years after surgery.
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APHPB-0649
T2N0M0 PERI-AMPULLARY CANCERS,
DO THEY NEED ADJUVANT
CHEMOTHERAPY?
V. Ostwal1, C. Harris1, M. Goel1 and S. Shrikhande1
1Medical oncology GI, TATA Memorial Hospital,
Mumbai, India
Objectives: Surgery is the only modality that offers
cure for periampullary adenocarcinoma. However, sur-
gery alone results in failure in 60% of patients. Pro-
spective trials have shown survival benefit with
adjuvant chemotherapy, especially in patients with
nodal positivity and higher tumor stage. We sought to
determine the role of adjuvant chemotherapy in early
stage tumors with uninvolved nodes.
Methods: A retrospective analysis of the prospectively
maintained database of patients operated upon for pe-
riampullary tumors at a tertiary referral centre from
2007 to 2014 was performed. Patients with T2N0
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tumors (AJCC 2010) were studied for adverse risk fac-
tors, adjuvant therapy received, if any, and the sur-
vival. Adjuvant chemotherapy was considered as per
the discretion of treating physician.
Results: A total of 392 pancreatoduodenectomies were
performed during the study period, of which 112
patients had T2N0 disease. Follow up data was avail-
able for 99 patients, with a median follow up of over
22 months (1–90). 23 patients received adjuvant chemo-
therapy (Gemcitabine or capecitabine based), while 85
were observed. The overall 5-year survival was 63% in
the observed group and 67% in the group which
received chemotherapy (O.76), with the 5-year disease
free survival being 64% and 68% respectively
(p = 0.86)
Conclusion: Adjuvant Chemotherapy does not have
clear benefit in T2N0 peri-ampullary adenocarcinoma.
However, this needs further confirmation in prospective
trials with careful patient selection.
APHPB-0650
THERAPEUTIC STRATEGY FOR
HEPATOBILIARY AND PANCREATIC
DISEASE COMORBID
CARDIOVASCULAR DISEASE
REQUIRING ANTITHROMBOTIC
THERAPY
Y. Ota1, R. Mori1, R. Matsuyama1, K. Miyake1, F.
Asano1, Y. Sawada1, Y. Honma1, T. Kumamoto1, K.
Takeda1 and I. Endo1
1Gastroenterological Surgery, Yokohama City University
Graduate School of Medicine, Yokohama, Japan
Objectives: The patients receiving hepatobiliary and
pancreatic (HBP) surgery with cardiovascular disease
requiring antithrombotic therapy is increasing. In this
study, perioperative factors and complications of HBP
surgery were evaluated for patients requiring anti-
thrombotic therapy.
Methods: From January 2009 to June 2014, patients
underwent HBP surgery were retrospectively investi-
gated.
Results: Forty-two of 928 (4.5%) cases had comorbid
cardiovascular disease. There were 38 male and 4
female an average age of 72 year-old. HBP disease were
biliary tract (n = 18), liver (n = 17), pancreas (n = 7).
Medication includes anti-platelet drug (n = 34), anti-
clotting drug (n = 12), both (n = 4).
Patients were divided according to postoperative hepar-
inization (H group; n = 26 vs. Non-H group; n = 16).
Preoperative drug holiday was shorter in H group
(p < 0.001). On the other hand, there were no differ-
ence in operating time, amount of bleeding, blood
transfusion, interruption period of antithrombotic ther-
apy, Clavien-Dindo grade >IIIa postoperative morbid-
ity, postoperative hospital stay. There were two cases
of bleeding incidence in H group and one thromboem-
bolism in Non-H group meanwhile there were no dif-
ference and no hospital mortality.
One case diagnosed as having HCC and angina simul-
taneously, underwent cardiac stent placement before
surgery. Two cases required continuous anti-platelet
drug administration due to a short-period after place-
ment of drug eluting stents at the time of diagnosis.
Both cases underwent surgery at 6 months after stent
placement. Neither thrombotic nor bleeding complica-
tions were occurred in these cases.
Conclusion: HBP surgery which comorbid cardiovascu-
lar disease could be enforced relatively safe. However,
timing of surgery should be carefully considered in case
shortly after coronary stent placement.
APHPB-0651
INVESTIGATION OF PROGNOSTIC
FACTORS AND MANAGEMENT
STRATEGY OF NON-FUNCTIONING
PANCREATIC NEUROENDOCRINE
TUMORS
S. Youn1, H. Lee1, J. Y. Park1, J. S. Heo1, S. H.
Choi1, D. W. Choi1 and W. Kwon1
1Surgery, Samsung Medical Center Sungkyunkwan
University School of Medicine, Seoul, Korea
Objectives: Various factors have been reported as prog-
nostic factors of non-functioning pancreas neuroendo-
crine tumors (NF-pNETs) but controversies persist.
Furthermore, consensus on management strategy have
not been reached. We aimed to further investigate the
prognostic factors using a large single-center cohort to
help determine the management strategy of NF-pNET.
Methods: 172 consecutive NF-pNET patients who
underwent surgery between 1995 and 2014 were identi-
fied. These patients were retrospectively analyzed for
clinical characteristics and outcomes.
Results: The 5-year overall survival (OS) and disease-
free survival rates were 85.6% and 75.4%, respectively.
In univariate analysis, Age < 40 (p = 0.047), asymp-
tomatic tumor (p < 0.001), T1/2 (p < 0.001), no lymph
node (LN) metastasis (p < 0.001), no distant metastasis
(p < 0.001), size < 2 cm (p < 0.001), lower WHO grade
(p < 0.001) were significantly associated with better OS.
Through multivariate analysis, asymptomatic (HR 4.11
(1.38~12.28), p = 0.011) and lower WHO grade (G2,
HR 11.06(1.44~84.99), p = 0.021; G3, HR 125.09
(14.42~1085.43), p < 0.001) were identified as indepen-
dent prognostic factors for OS. Lower WHO grade was
significantly associated with age < 40 (p = 0.003), dis-
tally located tumor (p = 0.016), lower T stage
(p < 0.001), no LN metastasis (p < 0.001), no distant
metastasis (p = 0.003), and size < 2 cm (p < 0.001).
Conclusion: Asymptomatic tumor and lower WHO
grade were found to be independent prognostic factors
for OS in NF-pNET. But because WHO grade can be
determined through pathologic examination, other fac-
tors associated with lower WHO grade may be used to
predict lower grade. Therefore, young (age < 40)
asymptomatic patients with small NET (size < 2 cm)
and without evidence of LN or distant metastasis on
image study may be considered for observation rather
than immediate surgical resection.
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APHPB-0653
THE SIGNIFICANCE OF 2 CM AND THE
VALUE OF IMAGING STUDIES IN
DETERMINING THE MANAGEMENT
OF NON-FUNCTIONING PANCREATIC
NEUROENDOCRINE TUMOR
S. Youn1, H. Lee1, J. Y. Park1, J. S. Heo1, S. H.
Choi1, D. W. Choi1 and W. Kwon1
1Surgery, Samsung Medical Center Sungkyunkwan
University School of Medicine, Seoul, Korea
Objectives: The enhanced accessibility of diagnostic
imaging studies have led to an increase in the incidental
detection of small non-functioning pancreatic neuroen-
docrine tumors (NF-pNETs). Currently, 2 cm is a
widely used reference in determining the need for more
aggressive treatment. We aimed to re-analyze the impli-
cation of 2 cm as reference and the value of imaging
studies in determining the management plan of
NF-pNET.
Methods: 172 consecutive NF-pNET patients who
underwent surgery between 1995 and 2014 were identi-
fied. Clinical characteristics, imaging study results and
outcome of these patients were retrospectively ana-
lyzed.
Results: Tumors with size≥2 cm in preoperative imag-
ing were associated with T3 (HR 9.5 (3.21~28.15),
p < 0.001), and lymph node metastasis (HR 4.94
(1.63~14.95), p = 0.002). The distributions of WHO
grade in tumors < 2 cm were 79.7%, 20.3%, 0% for
G1, G2, G3, respectively. In contrast, the distributions
in tumors ≥2 cm were 34.%, 53.4%, 12.6% for G1,
G2, G3, respectively. The 5-year overall survival and
disease free survival rates of NF-pNET < 2 cm were
94.0% and 89.3%, respectively. They were significantly
higher than those with ≥2 cm (80.7% and 68.%, respec-
tively; p < 0.001). In particular, there were no mortality
or recurrence in 16 patients with tumors <1 cm. The
grossly measured size and the size evaluated by the
imaging modalities (CT, MRI, EUS) showed excellent
correlation (R = 0.958, p < 0.001).
Conclusion: Of 2 cm remains to discriminate NF-
pNETs with benign and malignant behavior fairly well.
And the current imaging modalities seem to accurate in
determining the size of NF-pNETs. Therefore, ‘Wait
and See strategy’ with short term follow up with imag-
ing study may be applicable in well-selected patients,
especially in patients with tumor <1 cm.
APHPB-0654
LAPAROSCOPIC LIVER RESECTION,
INITIAL EXPERIENCE FROM A SINGLE
TEAM IN JAKARTA
M. Mayasari1 and T. J. M. Lalisang1
1Surgery, Cipto Mangunkusumo Hospital, Jakarta
Pusat, Indonesia
Objectives: To report a case series of initial experience
in laparoscopic liver resection from a single team in
Jakarta.
Methods: From 2012 to 2014, data on all laparoscopic
liver resection were collected. The team consist of aca-
demic surgeons, practicing in the local university hospi-
tal as well as private hospital. Data on indication,
length of surgery, tumor diameter, blood loss, post
operative hospital stay, and long term follow up were
collected and analyzed.
Results: From 2012 to 2014 there were 4 cases of lapa-
roscopic liver resection performed. All were done for
malignancies, 3 for HCC and 1 for metastatic breast
cancer. All tumor diameter were under 5 cm. Types of
resection were either segmentectomy or wedge, all
turned out to be of free margin. All cases recovers
uneventfully. Follow up were done from 1 month to
1 year post operatively. No recurrence were found dur-
ing the follow up.
Conclusion: Although laparoscopic liver resection was
not yet a standard care in Jakarta, the initial report
showed promising result, even for malignant lesion.
Expanding the indication to a larger size tumor and
wider resection could include more cases in the future.
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DIAGNOSTIC VALUE OF DOUBLE
MICROTRANSDUCER MANOMETRY
ON SPHINCTER OF ODDI
DYSFUNCTION
S. Takahata1, T. Othsuka1 and M. Tanaka1
1Department of Surgery and Oncology, Kyushu
University Hospital, Fukuoka, Japan
Objectives: Sphincter of Oddi dysfunction (SOD) is a
functional disorder of sphincter of Oddi (SO) has
repeated upper abdominal pain after cholecystectomy
without any organic abnormality. Endoscopic sphincter
of Oddi manometry (SOM) is a standard diagnostic
tool for SOD. Patients with high basal pressure are
diagnosed as SO stenosis, and with other manometric
abnormal findings as SO dyskinesia. As a treatment of
SOD, endoscopic sphincterotomy (ES) is effective for
SO stenosis, however, efficacy of ES on SO dyskinesia
is controversial. We have developed double microtrans-
ducer manometry (DMM) enables long term pressure
measurement in bile duct and duodenum and repot its
efficacy for diagnosis of SOD.
Methods: Consequent 20 patients suspected for SOD
were enrolled. Standard SOM and DMM were per-
formed. Diagnostic value of DMM was evaluated and
compared with those of SOM
Results: One patient was diagnosed as non-SOD with
negative results by SOM and DMM. Six patients were
diagnosed as SO stenosis with high basal pressure
revealed with SOM. ES was effective in 4 out of 6
patients. Other 13 patients diagnosed as SOD by SOM
and/or DMM underwent ES. ES was effective in 10
patients (77%). Comparing diagnostic value, DMM
showed high accuracy (70%vs. 50%) and sensitivity (93
vs. 50%), but low specificity (17 vs. 50%) compared
with SOM.
Conclusion: Long term pressure measurement by
DMM is effective diagnostic tool for SOD.
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APHPB-0657
THE ENHANCED RECOVERY
PROGRAMME DOES NOT INFLUENCE
FITNESS FOR ADJUVANT
CHEMOTHERAPY OR COMPLETION
OF CYCLES IN PATIENTS WITH
PANCREATIC CANCER
S. Kotecha1, A. Khan1, A. Chan1, E. Atkinson1, J.
Thomas1, C. Harris1, D. Chang1, A. Kausar1 and D.
Subar1
1General Surgery-Department of HPB surgery, East
Lancashire Hospital Trust, Blackburn, United Kingdom
Objectives: The enhanced recovery programme (ERP)
for pancreaticoduodenectomy (PD) has been reported
to decrease length of hospital stay without affecting
morbidity or mortality while improving quality of life.
Survival is improved by adjuvant chemotherapy.
The aim of this study was to assess the effect of ERP
on ability to have chemotherapy and the completion of
six cycles of chemotherapy in patients having pancreati-
coduodenectomy for pancreatic adenocarcinoma.
Methods: This is a retrospective study of patients who
had whipple’s procedure for adenocarcinoma of the
head of the pancreas. Demographic and clinical data
including age, sex, number of comorbidities, BMI,
weight change from pre-operatively to pre chemother-
apy, type and number of complications and post-opera-
tive length of stay was assessed.
Results: The mean age was 64.6 years. The male to
female ratio was 63:52. 42 patients had ERP and 78
did not. ERP did not influence the number of patients
proceeding to chemotherapy (p = 0.137) or those who
had 6 or more cycles (p = 0.422). LOS (p = 0.035) and
more than 1 comorbidity (p = 0.015) affected those
who progressed to chemotherapy. Time to chemother-
apy affected the completion of 6 or more cycles of che-
motherapy (p = 0.024).
Conclusion: ERP does not does not affect patients’
suitability for chemotherapy nor their ability to com-
plete 6 or more cycles.
APHPB-0658
LOCOREGIONAL THERAPIES FOR
COLORECTAL LIVER METASTASES:
EXPERIENCE FROM REGION OF LOW
ENDEMICITY
S. Patil1, S. Kulkarni1, N. Shetty1, A. Polnaya1, S.
Shikhande2, M. Goel2, V. Bakare1, A. Saklani2, S.
Mehta3 and V. Ostwal4
1Interventional Radiology Department of Radiodiagnosis,
TATA Memorial Hospital, Mumbai, India; 2Surgical
Oncology, TATA Memorial Hospital, Mumbai, India;
3Medical Gastroenterology, TATA Memorial Hospital,
Mumbai, India; 4Medical oncology, TATA Memorial
Hospital, Mumbai, India
Objectives: To evaluate role of various interventional
radiological procedures in treatment of colorectal liver
metastases.
Methods: 72 consecutive patients of colorectal liver
metastasis which underwent locoregional interventional
therapies including radiofrequency ablation, transarteri-
al chemo & radioembolisation and Portal vein emboli-
sation between January 2010 till August 2014.
Results: Of 54 patients underwent 76 sessions of RFA
& 15 patients underwent Transarterial chemoembolisa-
tion using drug eluting beads either prior or after the
RFA. Median follow up was 476 days. 7 patients had
synchronous primary at the time of RFA. 11/54
patients with extrahepatic disease & 22 patients of liver
limited disease received post RFA chemotherapy. Mean
DFI was 176 days with Median DFI = 167days (Range
43–581 days). Median survival using Kaplan Meier was
457 days. 41/47 (87.2%) patient had complete ablation
of the lesion while 7 patient underwent either TACE or
repeat RFA for residual lesion. 72.5% (29/40) patients
remained in complete response after 6 weeks. 2 out of
52 patients underwent transarterial radioembolisation
for disease progression. 13 patients with disease pro-
gression on chemotherapy underwent 19 sessions of
TARE. Overall response (CR+PR) rate of 82.3% was
observed at 3 months with Median survival patients of
404 days +/175 days. We treated a patient with Portal
vein embolisation as bridge to surgery who had inade-
quate Future Liver remnant. 3 patients underwent
TACE as bridge to surgery.
Conclusion: Liver-directed interventional modalities of
treatment are effective in management of unresectable
colorectal liver metastasis by prolonging survival &
providing good palliation.
APHPB-0659
LIVER DIRECTED THERAPIES IN
MANAGEMENT OF COLORECTAL
LIVER METASTASIS (CRLM):
EXPERIENCE FROM TATA MEMORIAL
CENTRE
S. Patkar1, M. Goel1, S. Patil2, A. Polnaya2, N.
Shetty2, S. Kulkarni2 and S. V. Shrikhande1
1Surgical Oncology, Tata Memorial Centre, Mumbai,
India; 2Radiology, Tata Memorial Centre, Mumbai,
India
Objectives: Data from Asia Pacific region on liver
directed therapies in management of CRLM is sparse.
Methods: Retrospective analysis of prospective data-
base (November 2009–August2014). Patients offered
liver directed therapy i.e. surgery, radiofrequency abla-
tion (RFA), transarterial chemo (TACE)/radio-emboli-
sation (TARE) were included.
Results: Of 98 patients, surgery alone was performed
in 30 patients, Surgery + RFA in 4, Surgery + TACE
in 3 and Surgery + RFA and TACE in 3. RFA was
performed in 47 (along with TACE in 15 and TARE in
2) and only TARE in 11 patients. Synchronous resec-
tion of the primary and liver lesion was performed in 1
patient. Systemic chemotherapy was administered to 17
patients prior to surgery. One patient required portal
vein embolisation. 4 patients were inoperable (2 each of
peritoneal and bilobardisease). Median loss was
1405 mL. Median hospital stay was 8 days (3–20).
Postoperative morbidity was 10%with no mortality.
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Postoperative liver insufficiency and bile leaksoccurred
in 2.5% and 5% respectively.1 patient required packing
for haemorrhage control.
40/47 (85.1%) patients who underwent RFA had com-
plete ablation while 7 underwent either TACE or repeat
RFA for residual lesion. 29 patients had complete
response after 6 weeks treatment while 4/54 patients
(7.8%) had lesion recurrence. 2 underwent TARE for
disease progression. Overall response (CR+PR) rate
was 82.3% at 3 months follow up.
Conclusion: CRLM are increasingly diagnosed in the
Indian subcontinent. Our series highlights the crucial
role of multidisciplinary care in management of
CRLM.
APHPB-0660
THE IMPACT OF TRANSARTERIAL
CHEMOEMBOLIZATION FOR
ADVANCED STAGE
HEPATOCELLULAR CARCINOMA: A
SINGLE CENTER EXPERIENCE
N. Tongsiri1 and S. Sabwongcharoen1
1Surgery, Rajavithi Hospital, Bangkok, Thailand
Objectives: 1. To study survival of hepatocellular carci-
noma (HCC) patients with Barcelona Clinic Liver Can-
cer (BCLC) stage C who received Transarterial
Chemoembolization (TACE) in Rajavithi Hospital,
Thailand
2. To study complication of TACE in BCLC stage C
patients.
Methods: Descriptive retrospective study, the data
from patient record since 2008 to 2012 was collected.
The general information of the patients, procedural-
related complications, and cause of death were pre-
sented with descriptive statistics. Survival was analysed
with Kaplan-Meier method.
Results: In 5-year period, there were 396 patients who
were performed TACE in Rajavithi Hospital, 57 cases
were classified as BCLC stage C, however only 44 cases
had complete patient records. The mean age of the
patients is 56.3 year (range from 30 to 75 year), 36 cases
(81.8%) are male, 26 cases (59.1%) have hepatitis B
infection, and 35 cases (79.5%) are Child-Pugh A. The
median survival is 7.1 months and procedural-related
complications are found in 40 cases (90.9%), but these
complications were controllable with medication and
conservative management. The most common complica-
tion is post-embolization syndrome which occurred in 39
patients (88.6%). Liver failure occurred in 8 cases
(18.2%) and responsible for 3 deaths (6.8%).
Conclusion: TACE in HCC with BCLC stage C in Raj-
avithi Hospital is effective and safe in comparison with
previous studies, and it may be suitable for patients
who cannot access to Sorafenib.
APHPB-0661
IMPACT OF POSTOPERATIVE
COMPLICATIONS ON RECURRENCE IN
LIVER RESECTION FOR COLORECTAL
METASTASES
M. Levy1, V. Visokai1, L. Lipska1, M. Mracek1 and J.
Simsa1
1Surgical Department, Charles University and Thomayer
Hospital, Prague 4, Czech Republic
Objectives: Liver metastases will appear approximately
in 40% of patients with colorectal carcinoma. Surgery
remains the only option for curative radical treatment
for liver metastases for colorectal carcinoma. Aim of
our study was to evaluate the impact of postoperative
complications following radical surgery for colorectal
cancer metastases on disease free interval.
Methods: There were 185 liver resections in 155 patiens
operated for CRLM between 1996 and 2012 at our sur-
gery. Fifty two patients were operated for metachro-
nous, 103 patients for synchronous liver metastases, 80
of these operated simultaneously with colon or rectum
resection. Postoperative complications occurs in 37
operations.
We identified minor complications (Clavien-Dindo clas-
sification I, II): wound abscess, pneumonia, postopera-
tive bowel obstruction and other in 22 patients
(59.5%), moderate complications (Clavien-Dindo III):
intraabdominal abscess, colon anastomotic leakage,
severe bleeding in 8 patients (21.6%), and severe septic
complications: sepsis, peritonitis, liver failure in 7
patients (18.9%).
Results: Median follow up was 2.1 year. Significantly
worse disease-free interval was found in patients with
severe septic complications. Other, less serious compli-
cations also increase the risk of recurrence, but not sta-
tistically significantly. In all patients, in contrary to
simillar study in colon cancer resection, there is no sta-
tistical significancy in reccurency in liver between
patients with and without postoperative complications.
Conclusion: Severe septic complications has an adverse
effect on the further course of the disease in terms of
relapse. In addition, serious complications increases
postoperative mortality, prolong hospitalization,
increase the cost of treatment.
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APHPB-0662
SURGICAL RESECTABILITY AFTER
NEO-ADJUVANT FOLFIRINOX FOR
BORDERLINE OR LOCALLY
ADVANCED PANCREATIC
ADENOCARCINOMA
M. Alline1, P. E. Colombo1, F. Quenet1, M. Jarlier2, F.
Portales3, C. Llacer4, J. M. Fabre5, M. Ychou6 and P.
Rouanet1
1Surgical Oncology, Montpellier Cancer Institute,
Montpellier, France; 2Biostatistics, Montpellier Cancer
Institute, Montpellier, France; 3Oncology, Montpellier
Cancer Institute, Montpellier, France; 4Radiotherapy,
Montpellier Cancer Institute, Montpellier, France;
5Surgery, Montpellier Universitary Hospital,
Montpellier, France; 6Surgery, Montpellier Cancer
Institute, Montpellier, France
Objectives: FOLFIRINOX has already demonstrated
its efficiency in metastatic pancreatic cancer (PC). This
combination need to be assessed in a neoadjuvant situ-
ation for locally advanced non metastatic PC.
Methods: From 2009 to 2013, 31 patients with border-
line or locally advanced PC received a neoadjuvant
treatment with FOLFIRINOX (so as to get them to a
resectable situation). According to the tumoral
response, chemoradiotherapy with gemcitabine was
done. The primary analysis endpoint was the resecabili-
ty rate. Pathologic response, chemotherapy’s toxicity
and surgical morbidity were also evaluated.
Results: Among the 31 PC, 17 were borderline resect-
able and 14 locally advanced according to NCCN clas-
sification. 16 (52%) received complete chemotherapy
with a median of 4 cycles. Toxicity lead to treatment
modification or interruption for 9 patients (29%).
Grade 3–4 toxicity occurred in 7 patients (24%). 22
patients (71%) underwent chemoradiotherapy after
FOLFIRINOX chemotherapy. 13 patients (42%) had
disease progression under treatment whereas 18
patients with objective radiologic response or at least
stable disease were surgically explored with a resection
completed in 13 cases (42%). Surgical morbidity was
controlled with grade 1–2 complications for 9 patients
(69%) and no mortality. 11 patients (35%) demon-
strated a significant pathologic response. Resected
patients had a global survival median of 36 months.
Conclusion: FOLFIRINOX in a neoadjuvant setting
seems feasible with limited morbidity in locally
advanced PC with encouraging resecability and patho-
logic response rates. Resected patients’ survival is
promising but need to be confirmed in larger series.
APHPB-0663
SIMULTANEOUS LAPAROSCOPIC
RESECTION OF COLORECTAL
CANCER AND LIVER METASTASES-
INITIAL EXPERIENCE
N. Belev1, M. Slavchev1, N. Shopov1, P. Rusev1,
S. Popov1 and P. Krastev1
1Surgical Department, MPHAT-Eurohospital, Plovdiv,
Bulgaria
Objectives: Synchronous liver metastases (SLMs) are
found in 15–25% of patients at the time the presenta-
tion with colorectal cancer, which is limited to the liver
in 30%. Surgical resection is the most effective and
potential curative therapy for metastatic colorectal car-
cinoma (CRC) to the liver. Simultaneous resection of
primary CRC and synchronous liver metastases is sub-
ject of debate with respect to morbidity in comparison
to staged resection. Minimally invasive laparoscopic
surgery improves postoperative recovery, diminishes
postoperative pain, reduces wound infections, shortens
hospitalization, and yields superior cosmetic results,
without compromising oncological outcome. The aim
of this study is therefore to evaluate our initial experi-
ences of simultaneous laparoscopic resection of primary
CRC and SLM.
Methods: Currently, laparoscopic resection of primary
CRC is performed in more than 53% of all patients in
our surgical department. 18 patients with primary CRC
and a clinical diagnosis of SLM underwent combined
laparoscopic colorectal and liver surgery. 6 of them
underwent laparoscopic colorectal resection combine by
major laparoscopic liver resection.
Results: Surgical approach was total laparoscopic (17
patients) or hand-assisted laparoscopic (1 patients). The
incision created for the extraction of the specimen var-
ied between 5 and 8 cm. Median operation time was
245 (range 150–320) min with a total blood loss of 600
(range 200–750) mL. Postoperative hospital stay was
7 day (5–12). An R0 resection was achieved in all
patients.
Conclusion: Simultaneous laparoscopic colorectal and
liver resection appears to be save and feasible in
selected patients with CRC and SLM, with satisfying
short-term results.
APHPB-0664
HEREDITARY HEPATOBLASTOMA-
SURGICAL VIEW OF THE TREATMENT
N. Belev1, V. Tashev2, D. Mitkovsky2, P. Tashev3,
E. Moshecov2 and P. Stefanova2
1Surgical Department, MPHAT-Eurohospital, Plovdiv,
Bulgaria; 2Clinic of Child Surgery, University Hospital-
‘S.George’, Plovdiv, Bulgaria; 3Clinic of Child Surgical
Department, University Hospital-‘S.George’, Plovdiv,
Bulgaria
Objectives: Hepatoblastomas (HB) are rare pediatric
neoplasms, comprising 1% of pediatric malignancies.
Till 1970s, surgery was the primary modality of treat-
ment of HB. 60% of the patients present in an unresec-
table stage. Surgical resection after neoadjuvant
chemotherapy (NCh)could be done in 87% of the cases
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whereas historically only 30% of the cases were opera-
ble upfront. Orthotopic Liver transplant is an effective
treatment for unresectable HB with survival rates of
82% .
Methods: Seven children were operating between 2008
and 2014s. in our department. The clinical presenta-
tions, chemotherapy tolerance and response, surgical
procedure undertaken, and complications were analysed
retrospectively. All the patients had elevated AFP levels
and pathological confirmation was done. Median age
of the population was 12 months (6–18 months).
Results: Five patients were treated with NCh incorpo-
rating cisplatin and adriamycin. Patients were routinely
reassessed after three cycles for surgical resection. If the
tumor was found to be inoperable, patient was given
one more cycle of chemotherapy. Postoperatively, two
to three cycles of chemotherapy were given to a total
of six cycle. Chemotherapy was well tolerated without
morbidity or mortality. Primary surgery was done in
tow patients. Major hepatic resection were performing
in four children. Morbidity rate was 14% (1 patients
with low debit biliary fistula). 3 years survival was
86%.
Conclusion: Treatment of HB with multidisciplinary
approach was well tolerated. Surgical morbidity was
also less if resection was performed after neoadjuvant
chemotherapy. Combined modality treatment is now
the standard of care in HB.
Benign HPB Diseases
APHPB-0666
LAPAROSCOPIC APPROACH OF
SURGICAL TREATMENT FOR
HEPATOLI
S. Huang1, M. Hung1, H. Wong1, H. Wong1, H. Wu1
and Y. Wu1
1Surgery, Showchwan Memorial Hospital, Taichung,
Taiwan
Objectives: The aim of the current study was to evalu-
ate our experiences with laparoscopic surgery for treat-
ing hepatolithiasis.
Methods: The patients who underwent a laparoscopic
surgical approach for the hepatolithiasis were collected
since 2 years ago. Data were collected and analyzed
retrospectively.
Results: Five patients underwent laparoscopic surgery
by left hepatectomy (LLH) and common bile duct
exploration (LCBDE). Two of them underwent CBD
excision with Roux-en Y anastomosis in addition to
the LLH. The mean operative time for LLH and
LCBDE was 240.2  58.1. The postoperative hospital
stay was from 5 to 14 days. Neither patient needed
conversion to open surgery, nor operative mortality
was shown.
Conclusion: In selected patients with hepatolithiasis,
laparoscopic approach could be an effective and feasi-
ble option.
Transplantation
APHPB-0667
RECENT SELECTION CRITERIA OF
PATIENTS FOR LIVING DONOR LIVER
TRANSPLANTATION – THE IMPACT
OF DONOR AGE ON RECIPIENT
SURVIVAL
F. Yusuke1, Y. Fujita1, M. Shinoda1, O. Itano1, H.
Obara1, T. Hibi1, K. E. N. Hoshino1, T. Kuroda1 and
Y. U. K. O. Kitagawa1
1Department of Surgery, Keio University School of
Medicine, Tokyo, Japan
Objectives: Selecting appropriate recipient and donor is
important for better recipient outcome in living donor
liver transplantation (LDLT). Older donors are some-
times considered to be marginal. In this study, we ana-
lyzed risk factors for recipient’s survival focusing on
donor age.
Methods: We have performed 125 cases of adult LDLT
since 1998. We analyzed if there is a difference of reci-
pient survival between older and younger donors to
define the age of ‘old donor’. In the analysis, older
donor was defined as above 40, 45, 50, 55, and 60 years
old. Then, we assessed if the following variables are
risk factors for recipient’s survival; recipient age, gen-
der, and diseases, donor age, graft-to-recipient weight
ratio (GW/RW), ABO blood type incompatibility, bili-
ary reconstruction, and MELD score.
Results: In donor age-specific analysis, survival rate of
the group in donor age?45 was significantly lower than
donor age < 45 (5-year survival rate 66% vs 82%,
p < 0.05). A multivariate analysis showed that donor
age?45, HCV positive recipient, GW/RW < 0.8, hepati-
cojejunostomy are risk factors for recipient survival
(p < 0.05). Recipients with multiple risk factors showed
worse 5-year survival than those with no factor (100%,
85%, 58%, and 33% in 0, 1, 2, and 3 factors, respec-
tively).
Conclusion: Donor age is a significant risk factor for
recipient survival. Since the donor source are limited in
LDLT, we should carefully select donor and recipient
avoiding overlap of the risk factors.
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APHPB-0668
A CASE REPORT OF LIVER
METASTASIS OF THE COLON WITH
HIGH SERUM ALPHA-FETOPROTEIN
AND PIVKA-II LEVEL
J. D. Yang1, S. I. Bae1, S. E. Hwang1, J. H. Lee1, H.
C. Yu1 and B. H. Cho1
1Surgery, Chonbuk National University, Jeonju, Korea
Objectives: We report a case of 63-year-old man in
whom liver metastasis of sigmoid colon cancer was pre-
sented with a marked elevation of serum alpha-fetopro-
tein (AFP) and PIVKA-II.
Methods: He was transferred to our hospital for sig-
moid colon cancer with multiple liver masses. Abdomi-
nal computed tomogram revealed two low-density
masses in the liver. Preoperative CEA and AFP level
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were normal range. We performed combined operation
of colon and liver - anterior resection, wedge resection.
Results: The biopsies revealed moderately differenti-
ated adenocarcinoma. After six cycle FOLFOX chemo-
therapy during 4 months, multiple liver metastasis by
abdominal CT and high serum AFP (3599 ng/mL) and
PIVKA-II (1570 mAU/mL) level were detected. How-
ever, the possibility of combined hepatocellular carci-
noma could not be ruled out due to serum AFP and
PIVKA-II elevation. The liver biopsies revealed adeno-
carcinoma with neuroendocrine differentiation using an
immunohistochemical staining.
Conclusion: This case represents a very rare case of
colon cancer with a marked elevation of serum AFP
and PIVKA-II.
Transplantation
APHPB-0670
USEFULNESS OF CIRCULATING
BLOOD VOLUME EVALUATION AFTER
LIVER TRANSPLANTATION BY USING
STROKE VOLUME VARIATION (SVV)
K. Takeda1, T. Kumamoto1, G. Nakayama1, F.
Asano1, Y. U. Sawada1, Y. U. K. I. Honma1, Y.
Ohta1, R. Mori1, R. Matsuyama1 and I. Endo1
1Gastroenterlogical Surgery, Yokohama City University,
Yokohama, Japan
Objectives: Perioperative aggressive fluid loading and
dehydration are harmful in patients undergoing liver
transplantation (LT). Stroke volume variation (SVV) is
a sensitive functional preload index for evaluating
responsiveness to volume loading in patients during
major surgery. However, there were few papers that
reported the use experience of SVV after LT recipients.
Methods: Patients and method: Sixty patients under-
went LDLT in our institute. Of these, in the former 52
cases, only central vein pressure (CVP) was used to
guide fluid management (Conventional group). In the
recent 8 patients, SVV was also monitored as circulat-
ing blood volume on addition to CVP (SVV group).
The boundary of fluid management of CVP and SVV
was 10 mmHg and 10%, respectively. In SVV group,
the transient of SVV and CVP was compared. The
postoperative change of PaO2/FiO2 ratio between SVV
group and the conventional group was also compared.
Results: In SVV group at the diuretic phase, SVV was
<10% in all cases (100%). However, CVP was more
than 10 mmHg in only 4 cases (50.0%). Between SVV
and conventional group, the minimum degree of PaO2/
FiO2 ratio in SVV group was higher than that of the
Conventional group significantly (SVV and Conven-
tional group = 296.2  106.0 and 205.6  98.9 days,
respectively, p = 0.019).
Conclusion: Postoperative fluid management using SVV
is useful especially after in LT.
Malignant HPB Diseases
APHPB-0671
DIAGNOSTIC ADVANTAGE OF EOB-
MRI OVER CT FOR DETECTION OF
LIVER METASTASIS IN PATIENTS
WITH POTENTIALLY RESECTABLE
PANCREATIC CANCER
T. Ito1, T. Sugiura1, Y. Okamura1, Y. Yamamoto1, R.
Ashida1, S. Uemura1, T. Miyata1 and K. Uesaka1
1Division of Hepato-Biliary-Panceatic Surgery, Shizuoka
Cancer Center Hospital, Sunto-Nagaizumi, Japan
Objectives: To evaluate the diagnostic value of gadolin-
ium ethoxybenzyl diethylenetriamine pentaacetic acid
enhanced magnetic resonance imaging (EOB-MRI) for
the detection of liver metastasis in patients with poten-
tially resectable pancreatic cancer (PC) assessed by mul-
tidetector CT (MDCT) and ultrasonography.
Methods: Between 2008 and 2013, potentially resect-
able PC was diagnosed in 258 patients on the basis of
the MDCT and ultrasonography findings. Among
them, 144 patients in whom EOB-MRI was subse-
quently performed were enrolled. Even if possible
lesions (PLs) for liver metastases were detected by
EOB-MRI, all patients underwent laparotomy and PLs
were investigated during surgery.
Results: A total of 23 PLs were detected by EOB-MRI
in 11 patients. Of these lesions, 15 were confirmed as
liver metastases during surgery, three were occult
metastases which were not detected during surgery but
postoperatively confirmed as liver metastases by CT
within four months after surgery, and 5 were false posi-
tive lesions (2 hemangiomas and 3 abscesses). During
surgery, 7 metastatic lesions of the liver were newly
found which were not detected by EOB-MRI (false
negative lesions).
Conclusion: EOB-MRI could detect 15 metastatic and
three occult metastatic lesions of the liver in 144 poten-
tially resectable pancreatic cancer patients. Thus, EOB-
MRI is more useful for detecting liver metastasis from
pancreatic cancer than MDCT, but caution should be
paid for false positive lesions such as minute hemangio-
mas and abscesses.
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APHPB-0672
YTTRIUM-90 SELECTIVE INTERNAL
RADIATION THERAPY CONFERS
SIMILAR AND POTENTIALLY BETTER
SURVIVAL OUTCOMES TO LIVER
RESECTION (LR) IN
HEPATOCELLULAR CARCINOMA
(HCC) WITH PORTAL VEIN TUMOR
THROMBOSIS (PVTT)
Y. Y. B. Chin1, C. F. S. Teo1, P. K. H. Chow2, Y. X.
Koh2, K. C. Lim3 and J. C. Allen4
1Yong Loo Lin School of Medicine, National University
of Singapore, Singapore, Singapore; 2General Surgery,
Singapore General Hospital, Singapore, Singapore;
3Diagnostic Radiology, Singapore General Hospital,
Singapore, Singapore; 4Centre for Quantitative
Medicine, Duke-NUS, Singapore, Singapore
Objectives: Liver Resection (LR) remains controversial
for HCC with PVTT due to poor outcomes but is often
carried out on the basis of no viable alternative ther-
apy. Recently, Yttrium-90 Selective Internal-radiation
(Y90) has been shown to prolong survival in PVTT.
Hence, this study aims to compare the survival out-
comes of Y90 Versus LR for HCC with PVTT.
Methods: A retrospective matched study to analyze the
overall-survival of HCC patients with macroscopic
PVTT who have undergone LR compared to Y90
based on the intention-to-treat principle.
Stratification was done according to the PVTT-classifi-
cation proposed by Jie Shi et al (2010). Each PVTT
type was then matched and compared according to
tumor burden (solitary or multifocal lesions).
Excluded were metastatic-HCC or isolated microscopic-
vascular invasion.
Results: Between October 2000 to August 2013, 115
patients underwent Y90 and 785 underwent LR of
which 79 patients in total fulfilled the above criteria.
Patient profiles between the two groups (LR V Y90)
were significantly different; the Y90 group had greater
tumor burden (solitary HCC 6 vs. 26 (Y90,LR), multi-
focal 31 vs. 16 (Y90,LR)) and more advanced PVTT-
disease.
However Y90 conferred similar survival-outcomes to
LR. Additionally, Y90 showed a trend towards better
survival (21.7 months vs. 13.1 months) in PVTT2-soli-
tary lesion (p = 0.6947) and (24.4 months vs.
5.0 months) PVTT2-multifocal lesions (p = 0.7571),
although p-values did not reach statistical significance.
When comparing tumor burden, Y90 showed better
median survival in solitary lesions (Y90-21.7 months
vs. LR-20.5 months, p-value 0.4269).
Conclusion: Y90 is a viable alternative to LR in HCC
patients with PVTT; conferring similar and potentially
better survival-outcomes. A prospective study is war-
ranted.
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APHPB-0675
INTRA-OPERATIVE INDOCYANINE
GREEN VISUALISATION IN
LAPAROSCOPIC CHOLECYSTECTOMY
– EARLY EXPERIENCE IN A TEACHING
HOSPITAL
A. Chia1, S. Z. Lim1 and P. K. Chow2
1General Surgery, Singapore General Hospital,
Singapore, Singapore; 2Hepato-Pancreato-Biliary and
Transplant Surgery, Singapore General Hospital,
Singapore, Singapore
Objectives: Laparoscopic cholecystectomy (LC) is one
of the most commonly performed surgical procedures,
carried out through either multiple ports or a single
port. It is a surgical procedure taught to all surgical
residents. Bile duct injury remains a potentially serious
complication, most frequently caused by failure to
clearly delineate the anatomy of the extrahepatic bile
ducts. Indocyanine green (ICG) can be used to visualize
of the biliary tree to enhance safety through fluores-
cence of the structures by near infra-red (NIR) wave-
length of 700–900 nm.
This study aims to determine the feasibility of using
ICG to visualize the extra-hepatic biliary tree during
LC.
Methods: This was a single-institution prospective
observational study. ICG was injected intravenously at
induction of anaesthesia. A NIR laparoscopic camera
was used intermittently during the operation to identify
the fluorescing extra-hepatic ducts upon reaching the
Calot’s triangle. Successful recognition of the cystic and
common bile ducts under the fluorescence mode of the
laparoscopic camera was recorded.
Results: Twelve consecutive patients undergoing LC
were studied. The use of ICG coupled with a laparo-
scopic camera capable of fluorescence mode allowed
clear identification of the cystic duct and CBD in all
patients. None of the patients suffered adverse effects
as a consequence of ICG use.
Conclusion: Intra-operative use of ICG in LC offers an
effective means of enhancing safety. Routine use of
intra-operative ICG can reduce the risk of bile duct
injury arising from misidentification of the critical
structures and is useful in the training of surgical resi-
dents and in single port LC.
Malignant HPB Diseases
APHPB-0676
PTPN11 PROMOTES LIVER CANCER
PROGRESSION AND PREDICTS POOR
PROGNOSIS OF PATIENTS
J. Ding1, T. Han1, D. Xiang1, W. Sun1, G. Feng2 and
H. Wang1
1International Cooperation Laboratory on Signal
Transduction, Eastern Hepatobiliary Surgery Hospital,
Shanghai, China; 2Department of Pathology, University
of California San Diego, Shanghai, China
Objectives: The complexity of hepatocarcinogenesis is
underscored by the recent revelation of tumor-suppress-
ing effect for a number of classical tumor-promoting
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molecules. In particular, we have shown that PTPN11,
a tyrosine phosphatase previously shown to be pro-leu-
kemogenic, suppresses the initiation of hepatocellular
carcinoma (HCC). However, role of PTPN11 in HCC
progression remains obscure.
Methods: PTPN11 expression was determined in
human HCC using real-time PCR, immunoblotting and
immunohistochemistry. Clinical significance of PTPN11
expression was analyzed in 301 HCC tissues with clinic-
o-pathological characteristics and follow-up informa-
tion. Short hairpin RNA was utilized to investigate the
function of PTPN11 in hepatoma cell behavior. Role
of PTPN11 in HCC progression was monitored
through nude mice xenograft assay. Kinase activity
assay and co-immunoprecipitation were used for mech-
anism analysis.
Results: Elevated expression of PTPN11 was detected
in 65.9% (394/598) of human HCCs, and its levels were
even higher in metastasized foci. Overexpression of
PTPN11 correlated well with the malignant clinico-
pathological characteristics of HCC and predicted the
poor prognosis of patients. Interference of PTPN11
expression suppressed the proliferation of hepatoma
cells in vitro and inhibited the growth of HCC xeno-
grafts in vivo. Downregulation of PTPN11 attenuated
the adhesion and migration of hepatoma cells and
diminished metastasized HCC formation in mice. Our
data demonstrated that PTPN11 promotes HCC
growth and metastasis by coordinately activating Ras/
Raf/Erk pathway and PI3-K/Akt/mTOR cascade.
Conclusion: PTPN11 has dual roles in liver cancer,
either suppressing HCC initiation or promoting HCC
progression. This notion could be extended to other
key HCC-associated molecules.
Malignant HPB Diseases
APHPB-0682
TOTALLY LAPAROSCOPIC
ASSOCIATING LIVER TOURNIQUET
AND PORTAL LIGATION FOR STAGED
HEPATECTOMY USING THE
ANTERIOR APPROACH TECHNIQUE
FOR HEPATOCELLULAR CARCINOMA
WITH HEPATITIS B CIRRHOSIS
Y. Zhang1, H. Yang1, Y. Chen1 and T. A. O. Lu1
1Department of Hepatobiliary-Pancreatic Surgery,
Sichuan Academy of Medical Sciences (Sichuan
Provincial People’s Hospital), Chengdu, China
Objectives: To investigate the application value of
totally laparoscopic associating liver tourniquet and
portal ligation for staged hepatectomy (ALTPS) using
the anterior approach technique for hepatocellular car-
cinoma (HCC) with hepatitis B cirrhosis.
Methods: In September,2014, a patient, whose body
wight (BW), tatal liver volume (TLV) and standard
liver volume (SLV) were 61 kg,1330.31 mL and
1036.01 mL respectively,suffered cirrhotic hepatocellu-
lar carcinoma in the right liver scheduled for two-stage
liver resection, in whom the future liver remnant (FLR)
was considered too small (FLR/TLV:22.7%,FLR/
SLV:29.1%,FLR/BW:0.49%). In the first stage, using
laparoscopic technique, a tourniquet was placed around
the parenchymal transection line on the Cantlie’s line
via an anterior approach through retrohepatic tunnel
for staged right hepatectomy, and the right portal vein
was ligated. In the second stage, laparoscopic right
hemihepatectomy was carried out 10 days after the
first-stage operation.
Results: TThe FLR on postoperative day (POD) 4 of
the first stage increased from 301.48 to 496.45 mL
(FLR/TLV:37.9%,FLR/SLV:47.9%,FLR/BW: 0.81%),
with a 64.67% hypertrophy. And the FLR on POD 8
of the first stage increased to 510.96 mL (FLR/
TLV:38.9%,FLR/SLV:49.3%,FLR/BW:0.84%), with a
69.48% hypertrophy. No serious complication hap-
pened. The patient was discharged 7 days after the sec-
ond stage. Until follow-up on POD 60, no tumor
recurrened.
Conclusion: As a effective, safe, simple and ‘non-touch’
technique, which could provide a less aggressive modifi-
cation of the ALPPS procedure with more oncological
efficacy, the laparoscopic anterior approach ALTPS
could achieve sufficient hypertrophy of the FLR in sev-
eral days. A proper expansion of the indications for the
procedure is safe and feasible in HCC patients with
cirrhosis.
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APHPB-0683
INCREASED PREVALENCE OF
GALLBLADDER & PANCREAS AND
LOWER GI TRACT ABNORMALITIES IN
PATIENTS WITH PRIMARY BILIARY
CIRRHOSIS
M. Basaranoglu1, M. Yuksel1, M. Ozdemir2, A. A.
Erbag3, G. Nessar4, N. Turhan5, O. Coskun6, A.
Aksoy6 and Z. Bilge6
1Gastroenterology, Bezmialem University, Istanbul,
Turkey; 2Radiology, Turkiye Yuksek Ihtisas Hospital,
Istanbul, Turkey; 3Surgical Oncology, Turkiye Yuksek
Ihtisas Hospital, Ankara, Turkey; 4Gastrointestinal
Surgery, Turkiye Yuksek Ihtisas Hospital, Ankara,
Turkey; 5Pathology, Turkiye Yuksek Ihtisas Hospital,
Ankara, Turkey; 6Gastroenterology, Turkiye Yuksek
Ihtisas Hospital, Ankara, Turkey
Objectives: It was reported that involvement of the
gallbladder (GB)&pancreas and lower gastrointestinal
(GI) tract is rare in patients with primary biliary cir-
rhosis (PBC). Our aim was to find the prevalance of
these involvements.
Methods: We evaluated our PBC clinic’s records. We
used US to show GB and pancreas abnormalities.
Lower GI tract abnormalities were evaluated by colo-
noscopy and rectoscopy. Patients with recent onset dys-
pepsia were used as a control group.
Results: Of the 82 patients with PBC, 62 had docu-
mented US results. There were 61 patients as a control
group. 8.1% in PBC and 8.1% in control were male
(p > 0.05). Gallbladder polip, 1.6% in PBC vs. 4.9% in
controls (p > 0.05); gallbladder sludge&stone, 14.5% in
PBC vs. 9.8% in controls (p > 0.05); gallbladder opera-
tion, 22.6% in PBC vs. 9.8% in controls (p = 0.05);
gallbladder wall tickness, 6.5% in PBC vs. 1.6% in
controls (p > 0.05); all gallbladder abnormalities 43.5%
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in PBC vs. 26.2% in controls (p < 0.05); pancreas
abnormalities 6.5% in PBC (p < 0.05) and one was
dead due to liver impairment. Lower GI tract examina-
tion showed colon polyps (up to 15 mm) were found in
5 patients as follows: 3 with such as adenomatous, tub-
ulovillous and inflammatory. Ileum biopsies showed
normal ileum mucosa in all 5 patients.
Conclusion: Our results showed that GB and pancreas
abnormalities are not frequent, but also not rare in
patients with PBC. Although the colon adenomatous
polyps occurence was increased in PBC, none of the
patients had IBD.
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APHPB-0684
EMPLOYMENT OF DIGITAL GENE
EXPRESSION PROFILING TO
IDENTIFY POTENTIAL PATHOGENIC
AND THERAPEUTIC TARGETS OF
FULMINANT HEPATIC FAILURE
E. Chen1, H. Tang1, D. Y. Gong1 and L. Bai1
1Center of Infectious Diseases, West China Hospital of
Sichuan University, Chengdu, China
Objectives: To investigate the precise gene expression
profile and their interactions association with FHF.
Methods: We detected the digital gene expression pro-
file (DGEP) by high-throughput sequencing in normal
and FHF mouse liver, and the candidate genes and
potential targets for FHF therapy were verified. And
the FHF mouse model was induced by D-Galactos-
amine (GalN)/lipopolysaccharide (LPS).
Results: Totally 12,727 genes were detected, and 3551
differentially expressed genes (DEGs) were obtained in
FHF mouse liver. In FHF mouse liver, many of those
DEGs were identified as differentially expressed in met-
abolic process, biosynthetic process,response to stimu-
lus and response to stress, etc. Similarly, pathway
enrichment analysis in FHF mouse liver showed that
many significantly DEGs were also enrichedin meta-
bolic pathways, apoptosis, chemokine signaling path-
ways, etc. Considering the important role of nuclear
factor-kappa B (NF-jB) in metabolic regulation and 16
delicate balance between cell survival and death, several
DEGs involved in NF-jB pathway were selected for
experimental validation. As compared to normal con-
trol, NF-jBp65 and its inhibitory protein IjBa were
both significantly increased, and NF-jB targeted genes
including tumor necrosis factor a (TNFa), inducible
nitric oxide synthase (iNOS), interleukin-1b, chemokin-
es CCL3 and CCL4 were also increased in hepatic tis-
sues of FHF. In addition, after NF-jB was successfully
pre-blocked, there were significant alteration of hepatic
pathological damage and mortality of FHF mouse
model.
Conclusion: This study provides the globe gene expres-
sion profile of FHF mouse liver, and demonstrates the
possibility of NF-jB gene as a potential therapeutic
target for FHF.
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APHPB-0685
CD47 BLOCKADE REDUCES ISCHEMIA
REPERFUSION INJURY AND
IMPROVES SURVIVAL IN A RAT LIVER
TRANSPLANTATION MODEL
Z. Xiao1 and W. Chapman2
1Hepatic Surgical Center, Tongji Hospital, Wuhan,
China; 2Transplantation Deaprtment, Washington
University, Saint Louis, USA
Objectives: Orthotopic liver transplantation (OLT)
remains the standard treatment option for non-respon-
sive liver failure. Given that ischemia reperfusion injury
(IRI) is an important impediment to the success of
OLT, new therapeutic strategies are needed to reduce
IRI. We try to investigate whether blocking the CD47/
TSP-1 inhibitory action on NO signaling using a mono-
clonal antibody specific to CD47 (CD47mAb400)
reduces IRI in liver grafts.
Methods: Syngeneic OLT was performed using Lewis
rats. Control IgG or CD47mAb400 was administered
to the donor organ at procurement or to both the
organ and the recipient at the time of transplant.
Serum transaminases, histological changes of the liver
and animal survival were assessed. Oxidative stress,
inflammatory responses and hepatocellular damage
were also quantified.
Results: A significant survival benefit was not achieved
when CD47mAb400 was administered to the donor
alone. However, CD47mAb400 administration to both
the donor and recipient increased animal survival after.
The CD47mAb400 treated group showed lower serum
transaminases, bilirubin, oxidative stress, TUNEL
staining, caspase-3 activity and proinflammatory cyto-
kine expression of TNF-a, IL-1b and IL-6.
Conclusion: CD47 blockade with CD47mAb400 admin-
istered both to the donor and the recipient reduced
liver graft IRI in a rat liver transplantation model. This
may translate to decreased liver dysfunction and
increased survival of liver transplant recipients.
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A PROSPECTIVE EVALUATION OF
LAPAROSCOPIC CHOLECYSTECTOMY
AS DAY-CASE SURGERY (DCLC) IN
QUEEN ELIZABETH HOSPITAL SABAH
– A FEASIBILITY STUDY
W. Ooi1, S. Sharifuddin2 and R. Jarmin3
1General Surgery, Hospital Queen Elizabeth 1, Kota
Kinabalu, Malaysia; 2Hepatobiliary Unit, Hospital
Queen Elizabeth 1, Kota Kinabalu, Malaysia;
3Hepatobiliary Unit, Universiti Kebangsaan Malaysia,
Kota Kinabalu, Malaysia
Objectives: This study aimed to examine the feasibility
of introducing Laparoscopic Cholecystectomy as day-
case surgery in our centre by measuring successful same
day discharges,conversion rate,readmission rate and
analyzing factors leading to overnight admission rate;
hemorrhage,bile leak, pain, post-op nausea/vomiting,
© 2015 The Authors
HPB 2015, 17 (Suppl. S2), 25–266 HPB © 2015 Americas Hepato-Pancreato-Biliary Association
Poster Abstracts 223
social-economic and technical factor;Education level
and Number of surgical ports and patient satisfaction.
Methods: This is a prospective observational cohort
study conducted over 1 year. Surgery was performed
by single surgeon. Upon discharge they were reviewed
in clinic in 1 week and 6 weeks time. Patient satisfac-
tion survey was conducted and all data recorded from
case notes. Analysis was done using SPSS software.
Results: Thirty patients were recruited with inclusion
rate of 20%. Female accounted for 63% and median
age was 40. 18 of patient were from within Kota Ki-
nabalu while the remaining from district. 90% had sec-
ondary or lower education level. Symptomatic
cholelithiasis make up 76% of the diagnosis. Conver-
sion rate was 10%. The mean operating time for all
patients was 52.3 min (SD 22.71) meanwhile the oper-
ating time for successful LC surgery was 48.3 min (SD
14.57). There were no readmissions for complications
nor operative complications during the study. Total of
12 patients had pain & vomiting post-operatively and 1
patient had acute urinary retention. There were no
post-operative complications such as bleeding, bile leak
or SSI. 83% of the patient was successfully discharge
on the same day.
Conclusion: DCLC is a safe, highly successful surgery
and it is feasible to be performed in our instituition in
Sabah state.
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APHPB-0687
MOST LIVER RELATED DEATHS IN
INDIA ARE CAUSED BY ALCOHOL: AN
AUDIT OF LIVER MORTALITY FROM
TERTIARY CARE CENTER IN NORTH
INDIA
A. Kumar1, V. Gupta1, P. Sharma1 and A. Arora1
1Gastroenterology, Sir Ganga Ram Hospital, New Delhi,
India
Objectives: Alcohol, hepatotropic viruses, and non-
alcoholic steatohepatitis (NASH) are the most impor-
tant causes of liver related deaths. The distribution of
these causes among Indian patients dying of liver dis-
ease is unknown. This information will help in priori-
tizing healthcare efforts in preventing liver related
deaths in India.
Methods: Records of all consecutive patients who had
died due to liver-related causes from Nov 2010 to Oct
2014 were analyzed.
Results: Records of 392 consecutive patients were ana-
lyzed (median age 50 [range 14–87] years, males 80%).
Underlying chronic liver disease (CLD) was present in
86% (335/392) while in 14% (57/392) there was no
underlying CLD. In CLD group most patients (71%,
237/335) had presented with complications of cirrhosis
(such as end-stage liver disease, portal hypertension,
sepsis etc.). Acute-on-chronic liver failure was the pre-
sentation in 29% (98/335) of CLD patients. Among
patients without underlying CLD the most common
presentation was with acute liver failure (68%, 39/57).
Overall, the most common cause of liver-related death
was alcohol, responsible for 30% (118/392) of deaths,
followed by NASH/cryptogenic in 23% (91/392), hepa-
totropic viruses in 19% (73/392), bacterial/other infec-
tions in 12% (45/392), and drug-induced liver injury in
6% (24/392). In 5% cases the cause was some unidenti-
fied acute hepatic insult.
Conclusion: Alcohol is the most important cause of
liver related deaths in India and NASH/cryptogenic cir-
rhosis is the second important cause. Since, both these
causes are preventable by increasing public awareness
and implementing life-style measures, urgent attention
should be paid towards these measures.
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APHPB-0688
INCIDENCE AND ASSOCIATION OF
BACTERIOBILIA AND BILIARY SEPSIS
WITH DURATION OF PRE-OPERATIVE
BILIARY DRAINAGE IN MALIGNANT
OBSTRUCTIVE JAUNDICE
S. I. Wijerathne1, S. G. Iyer1, A. W. C. Kow1, K. K.
Madhavan1 and S. K. Y. Chang1
1Division of Hepatobiliary and Pancreatic Surgery,
National University Hospital, Singapore, Singapore
Objectives: A guide to a safe duration of PBD with
minimal post-operative complications (POC) and mini-
mal incidence of bacteriobilia is not well described in
literature, which we attempt to address in this study.
Methods: Retrospective single institution study. Data
collected on patients who had surgery for malignant
obstructive jaundice secondary to periampulary or pan-
creatic head tumors from August 2002 to November
2012. Data compared between patients who had PBD
(Drainage-group) and surgery alone (Surgery-group).
The effect of Duration of PBD on the POC and inci-
dence of bacteriobilia was studied. Receiver operating
characteristic (ROC) curve analysis was used to delin-
eate an optimal duration for PBD.
Results: The Drainage-group showed a significantly
high incidence of positive intra-operative bile-cultures
(p = 0.0001) and Biliary-sepsis (p = 0.0001) compared
to Surgery-group. The ‘Duration of Drainage’ affects
the incidence of positive intra-operative bile-cultures
(p = 0.024) and Biliary-sepsis (p = 0.025). The ROC
curve analysis for the predictive value of ‘Duration of
Drainage’ on the incidence of positive intra-operative
bile-cultures showed the area under the curve was 0.758
(95% CI 0.596 – 0.920), for biliary-sepsis it was 0.745
(95% CI 0.590 – 0.900). Drainage beyond 26 days is
associated with higher incidence of positive intra-opera-
tive bile cultures (Sensitivity 51.6%, Specificity 88.9%)
and biliary sepsis (Sensitivity 51.9%, Specificity
92.3%).
Conclusion: PBD is associated with a significantly
higher incidence of bacteriobilia and biliary sepsis.
Hence, it should be used with caution only in selected
cases. We recommend limiting the duration of PBD to
26 days in such cases.
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APHPB-0689
PANCREATICODUODENECTOMY FOR
BENIGN AND PREMALIGNANT
CONDITIONS: THE IMPACT ON
QUALITY OF LIFE AND LONG TERM
OUTCOMES
S. I. Wijerathne1, N. C. H. Tan1, A. W. C. Kow1, K.
K. Madhavan1, S. K. Y. Chang1 and S. G. Iyer1
1Division of Hepatobiliary and Pancreatic Surgery,
National University Hospital, Singapore, Singapore
Objectives: The incidence of pancreaticoduodenectomy
(PD) performed for benign and premalignant condi-
tions is increasing. Our aim was to identify the long
term outcomes and quality of life (QoL) for patients
who undergo PD for benign or premalignant condi-
tions.
Methods: Retrospective case series in a single institu-
tion. Patients underwent open PD from 2002 to 2012
for benign and premalignant conditions included. Clini-
cal records assessed to identify patients who required
long-term dietary, pancreatic enzyme, vitamin and iron
supplements. Patient’s weight-gain, development of
anaemia, Diabetes-mellitus and other complications
during the follow-up were recorded. Phone interview
with patients was done using the EORTC QLQ-C30
version 3.0 questionnaire to assess their QoL.
Results: 16 patients (12.1% out-of total 132 patients
who underwent PD) with 7-males and 9-females with
mean age of 56 years (range 38–80) included. Common
histology findings were IPMN (5), ampullary adenoma
(3), solid-pseudopapillary neoplasm (2) and serous-cys-
tadenoma (2). One patient had PD for trauma related
injury. 5(31.2%) patients required pancreatic-enzyme
supplements, 3(18.7%) patients developed anaemia, 2
(12.5%) of them required iron and 1(6.2%) required
VitaminB12 supplements. 5(31.2%) patients had
weight-loss ≥7 kg during 6–24 months post-operatively
and 4 of them required dietary supplements. All
patients were alive at 3-years follow-up and none of
them developed Diabetes mellitus. The results for glo-
bal health, emotional and social functioning scales were
superior to the reference values available in literature
for ‘all cancers’.
Conclusion: Patients who undergo PD for benign or
premalignant conditions can have nutritional, enzyme
or hormonal deficiencies which require attention thus
may benefit from a multi-disciplinary approach to their
follow-up which may further improve QoL.
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APHPB-0692
HUMAN MESENCHYMAL STEM CELL
STIMULATED BY TUMOR NECROSIS
FACTOR-ALPHA PRODUCE GROWTH
FACTOR RECEPTORS
M. Ayatollahi1, Z. Sahraean2, R. Yaghobi1, M.
Kaviani1 and B. Geramizadeh1
1Transplant Research Center, Shiraz University of
Medical Sciences, Shiraz, Iran; 2Department of biology,
Zanjan Islamic Azad University, Zanjan, Iran
Objectives: Acute hepatic failure, despite recent thera-
peutic advances, remains associated with significant
morbidity and mortality. Recent evidence indicated that
insulin-like growth factor 1 receptor (IGF-I R) is
involved in liver regeneration upon activated by insu-
lin-like growth factor1 (IGF-I). We hypothesized that
inflammatory cytokines activate liver progenitor cells to
induce IGF-I/ IGF-I R signaling pathway.
Methods: Bone marrow of healthy donors was aspi-
rated from the iliac crest. The adherent cells expanded
rapidly and maintained with periodic passages until a
relatively homogeneous population was established.
The identification of these cells was carried out by dif-
ferentiation potential into osteocyte and adipocyte. The
MSCs were treated by 1 ng/mL, and 10 ng/mL of
tumor necrosis factor-a (TNF-a) for 2, 10, 24, and
48 h. Untreated MSCs were used as control. Real time
polymerase chain reaction (RT-PCR) was used to eval-
uate the expression of IGF-I R in all cell-groups.
Results: Flow cytometric analysis, and the differentia-
tion potential into osteoblast and adipocytes showed
that more than 90% of human MSCs which were iso-
lated and expanded were positive by specific markers
and functional tests. RT-PCR analysis indicated
increase IGF-I R expression in MSCs treated by 1 ng/
mL of TNF-a after 10 h incubation.
Conclusion: The data presented in this study, reflects
increase expression pattern of IGF-I R in the human
MSC upon in vitro-TNF-a stimulation, may be used
for clinical stem cell therapy and liver regeneration.
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LAPAROSCOPIC HEPATECTOMY
USING A NEW DEVICE WITH SOFT
COAGULATION
M. Yasunaga1, T. Shirahama1, Y. Nomura1, Y. Goto1,
Y. Maruyama1, H. Sakai1, R. Kawahara1, H.
Horiuchi1 and K. Okuda1
1Surgery, Kurume University School of Medicine,
Kurume, Japan
Objectives: Liver resection has dramatically evolved
over the years. Laparoscopic Hepatectomy (LH) is
gradually a recognized alternative to open surgery.
However, because of difficulties in techniques and con-
trol of bleeding, Laparoscopic Hepatectomy was not
widely accepted as standard therapy, especially in Pure
Laparoscopic Hepatectomy (PLH). This study was con-
ducted to evaluate the efficasy of the new devices and
our surgical outcomes in Laparoscopic Hepatectomy
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Methods: Between April 2005 and May 2014 at Kur-
ume University Hospital, 102 patients underwent lapa-
roscopic hepatectomy for HCC, including 40 patients
with Pure laparoscopic surgery, 62 patients with lapa-
roscope assisted surgery (Hybrid).
Results: Liver resection was carried out with the Sono-
SurgX (brade type) or CUSA using a new suction with
soft coagulation. Fourty patients underwent PLH. The
median size of tumor was 21.4 mm, median operation
time and blood loss was 286.4 min and 204.2 g. The
median duration of hospitalization was 9.8 days. One,
three, five year disease free survival rate: 97.8%,
31.4%, 23.6%. Three, five years survival rate: 94.0%,
81.0%. Postoperative complications occurred in 7
patients including PV thrombus in 5, ileus in 1, liver
infarction (S3) in 1.
Conclusion: Laparoscopic hepatectomy with these
effective devices could be done safely toward standardi-
zation of PLH.
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SINGLE-INCISION LAPAROSCOPIC
CHOLECYSTECTOMY IN ACUTE
CHOLECYSTITIS: WHAT IS THE
CONVERSION RATE?
C. Tay1, S. G. Iyer2, A. Kow2, K. Madhavan2 and S.
K. Y. Chang2
1Surgery, NUHS, Singapore, Singapore; 2Department of
Surgery, NUHS, Singapore, Singapore
Objectives: Acute cholecystitis is a relative contraindi-
cation to single-incision laparoscopic cholecystectomy
(SILC). With the more matured development in SILC
technique in recent years, we report our experience of
managing acute cholecystitis with SILC.
Methods: 232 benign gallbladder cases managed by
SILC were retrospectively studied. Cases with clinical
and histological features of acute cholecystitis were
identified. Patient’s demographics, biochemical and
radiological findings, operating time, degree of inflam-
mation observed intraoperatively, conversion rate and
complication during follow up were recorded and anal-
ysed. We further compared the operating time of SILC
and conventional laparoscopic cholecystectomy (CLC)
in acute cholecystitis cases and identify the minimal
cases required to achieve similar operating time as
CLC.
Results: 30 cases with acute cholecystitis were identi-
fied. 15, 3 and 12 cases with mild, moderate and severe
inflammation to the gallbladder respectively. No signifi-
cant difference in patient’s demographics, pre-operative
biochemical and radiological results are found between
the 3 groups. Operating time (91 min) and conversion
rate (25%) are significantly higher in severe inflamma-
tion group. 3 (10%) cases required conversion to CLC,
no open conversion required. 13 cases of SILC were
required to achieve similar operating time as CLC in
acute cholecystitis. No bile duct injuries, port-site her-
nia or wound infections were observed.
Conclusion: SILC for acute cholecystitis is safe and fea-
sible in experienced hands with acceptable operating
time, conversion rate (10% to CLC) and morbidity
rate. A randomized controlled trial is needed to further
evaluate the surgical outcomes of SILC for acute chole-
cystitis.
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LONG-TERM ONCOLOGICAL SAFETY
OF MINIMALLY INVASIVE
HEPATECTOMY IN CIRRHOTIC
PATIENTS WITH HEPATOCELLULAR
CARCINOMA: A CASE-CONTROL
STUDY
C. Tay1, S. G. Iyer2, A. W. C. Kow2, K. Madhavan2
and S. K. Y. Chang2
1Surgery, NUHS, Singapore, Singapore; 2Department of
Surgery, NUHS, Singapore, Singapore
Objectives: Minimally invasive hepatectomies (MIH) for
patients with hepatocellular carcinoma (HCC) is techni-
cally challenging, especially with large posteriorly
located tumours or a background of liver cirrhosis. This
is a case-control study of patients with HCC who have
either undergone minimally invasive (MIH) or open hep-
atectomies (OH). Most of these patients have a back-
ground of liver cirrhosis compared to other studies.
Methods: 60 patients were divided into 2 groups, 30
underwent MIH and 30 underwent OH for HCC resec-
tion. The patients in both groups were matched for
extent of tumour resection, age and cirrhosis status.
Patient bio data, risk factors of HCC and all oncologi-
cal data were studied
Results: Negative resection margins were achieved in
97% of patients in both groups. The mean blood loss
during surgery was significantly lower in the MIH
group compared to the OH group (361 vs. 740 mL,
p = 0.04). Hospitalization is significantly shorter in
MIH group (7 vs. 11 days, p = 0.04).
8 patients (27%) in the MIH group and 13 patients
(43%) in the OH group developed HCC recurrence
(p = 0.17). No statistically significant difference demon-
strated in 5 years disease-free survival, 3 year and
5 year overall survival.
Conclusion: MIH is a feasible curative treatment for
patients with HCC and liver cirrhosis. Patients under-
went MIH had less intraoperative blood loss and
shorter length of stay. MIH has been successfully per-
formed for large posteriorly located tumours up to
12 cm in size.
APHPB-0696
SYNCHRONOUS VERSUS
METACHRONOUS RESECTION IN
PATIENTS WITH COLORECTAL
CANCER AND SYNCHRONOUS LIVER
METASTASIS
C. Tay1, S. G. Iyer2, A. W. C. Kow2, S. K. Y. Chang2
and K. Madhavan2
1Surgery, NUHS, Singapore, Singapore; 2Department of
Surgery, NUHS, Singapore, Singapore
Objectives: About 20% of patients with colorectal can-
cer (CRC) have liver metastasis (LM) at diagnosis, liver
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and colorectal resection remains the only curative
option now. Various strategies such as neoadjuvant
chemotherapy, portal vein embolization have been used
to increase the resectability of LM with good results.
However, there is no evidence up to date to support
whether synchronous or metachronous resection of LM
during the time of colorectal surgery have better onco-
logic outcomes.
Our study aims to compare the outcomes between
patients undergoing synchronous and metachronous
resection of colorectal liver metastasis.
Methods: We retrospectively reviewed 22 patients who
had CRC with synchronous LM at diagnosis and
underwent either synchronous (Group 1) or metachro-
nous (Group 2) resection of their LM from 2006 to
2012 at our institute.
Results: 22 patients were studied. There was no statisti-
cal difference in total operating time, blood loss, blood
transfusion, complication rate. The mean operative
time was 354 min in Group 1 versus 450 minutes in
Group 2 (p = 0.024). The median hospital stay was
10 days and 13 days (p < 0.05). No statistically differ-
ence in 3 year and 5 year overall survival and recur-
rence free survival between group 1 and 2.
Conclusion: Synchronous liver resection including
major liver resections for CLC liver metastasis can be
safely performed with no increased morbidity and mor-
tality. Synchronous resection offers advantage in terms
of lower hospital stay and operative time without com-
promising oncologic outcomes.
APHPB-0697
AROS IS A SIGNIFICANT BIOMARKER
FOR BOTH SHORT- AND LONG-TERM
PROGNOSIS IN NON-CIRRHOTIC HCC
K. J. Kang1, K. S. Ahn1, J. H. Kwon2, Y. H. Moon2,
J. Y. Park2, H. J. Wang3, K. Y. Choi4, K. D. Kim5
and J. W. Joh6
1Surgery, Keimyung University Dongsan Medical
Center, Daegu, Korea; 2Bioscience, CbsBioscience,
Daejeon, Korea; 3Surgery, Ajou University, Suwon,
Korea; 4Science & Technology, Pohang University,
Pohang, Korea; 5Microbiology, Pukyong National
University, Busan, Korea; 6Surgery, Sungkyungkwan
University, Busan, Korea
Objectives: Despite a low risk of liver failure and pre-
served liver function, non-cirrhotic HCC has poor
prognosis. To improve clinical outcomes of the cura-
tive-intent treatment in non-cirrhotic HCC, identifica-
tion of prognostic factors accompanied by new
treatment strategies are needed. In the current study,
we evaluated AROS as a prognostic biomarker in non-
cirrhotic HCC.
Methods: mRNA levels of AROS was measured in
tumor and non-tumor tissues derived from 283 non-cir-
rhotic HCC patients. Relationships between clinical
characteristics and AROS expression were analyzed
using Chi square and Fisher’s exact test. The prognos-
tic significance of AROS expression was analyzed using
Kaplan–Meier curves and Cox regression models.
Results: AROS was significantly up-regulated in
tumors irrespective of tumor stage and BCLC stage.
Additionally, recurrent tissues revealed higher average
levels of AROS than non-recurrent tissues for follow-
up times of 2 and 5 years and the differences were sta-
tistically significant. High mRNA levels of AROS were
associated with tumor stage, BCLC stage, AFP level,
vascular invasion, tumor size, and portal vein invasion.
HCC patients with higher AROS levels showed higher
recurrence and shorter DFS for both short-term and
long-term compared to those with AROS-low group.
Cox regression analysis demonstrated that AROS is a
significant predictor for recurrence and DFS along with
large tumor size, tumor multiplicity, vascular invasion,
and poor tumor differentiation which are the known
prognostic factors.
Conclusion: Our findings on AROS as a prognostic bi-
omarker could be helpful for designing a strategy for
the effective treatment and management of non-cir-
rhotic HCC.
APHPB-0698
A PROPENSITY SCORE-MATCHED
CASE-CONTROL COMPARATIVE
STUDY OF LAPAROSCOPIC AND OPEN
LIVER RESECTION FOR
HEPATOCELLULAR CARCINOMA
K. Ahn1, K. J. Kang1, Y. H. Kim1, T. S. Kim1, T. J.
Park1 and T. J. Lilm1
1Surgery, Keimyung University Dongsan Medical
Center, Daegu, Korea
Objectives: The aim of this study was to compare the
perioperative and long-term oncologic outcomes of lap-
aroscopic liver resection (LLR) and open liver resection
(OLR) for single hepatocellular carcinoma in case con-
trolled patients groups using propensity score.
Methods: Between January 2005 and February 2013,
292 patients underwent surgical resection for HCC.
Patients of 202 patients who underwent surgical resec-
tion for initial treatment for single mass were enrolled.
These patients were divided into 2 groups according to
the method of operation: Laparo group (patients who
underwent LLR) and Open group (patients who under-
went OLR). To correct different demographic and clini-
cal factors in two groups, propensity score matching
was used at 1:1 ratio and finally, 102 patients were
enrolled in this study, 51 patients in each group. Preop-
erative characteristics, perioperative results and long
term results were retrospectively analyzed based on
prospectively recorded database.
Results: Preoperative baseline variables were well bal-
anced in both groups. There were no differences of
extent of surgery and rate of anatomical resection
between two groups. With the exception of shorter
postoperative hospital stay in Laparo group than that
of Open (8.2 days vs. 12.3 days, p = 0.004), there were
no significant differences in perioperative, pathological
and long-term outcomes. The 5- year overall survival
rates were 80.1% in Laparo group and, 85.7% in Open
group, respectively (p = 0.173) The 5-year disease-free
survival rates were 67.8% in Laparo group and 54.8%
in Open group, respectively (p = 0.519).
Conclusion: Laparoscopic liver resection for HCC is
safe and long-term oncologic outcomes were compara-
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ble to those who underwent open liver resection in
selected patients.
APHPB-0699
PROGNOSTIC FACTORS OF
INTRAHEPATIC
CHOLANGIOCARCINOMA
K. S. Ahn1, K. J. Kang1, Y. H. Kim1 and T. S. Kim1
1Surgery, Keimyung University Dongsan Medical
Center, Daegu, Korea
Objectives: The aim of this study was analyzing prog-
nostic factors of intrahepatic cholangiocarcinoma after
surgical resection.
Methods: Between January 2001 and February 2013,
78 patients underwent curative surgical resection for
intrahepatic cholangiocarcinoma. Demographics and
patient disposition, perioperative results, histopahologi-
cal results, long term survival were analyzed retrospec-
tively.
Results: There was male dominant and mean age was
60.5 years old. In 65 patients (89.4%), tumor was sin-
gle and mean tumor size was 5.9 cm. Mass forming
type was most common (75.6%). After surgical resec-
tion, 5-year overall and disease-free survival rate was
50% and 21.8% respectively. On univariate analysis,
presence of portal vein tumor thrombus, poor differen-
tiation, presence of microvascular invasion, presence of
lymph node metastasis, high CEA level and advanced
AJCC stage were poor prognostic factor for overal sur-
vival. On multivariate analysis, presence of portal vein
tumor thrombus, microvascular invasion and high
CEA level were poor prognostic factors.
Conclusion: Surgical resection for intrahepatic cholan-
giocarcinoma offers the best opportunity for long-term
survival. Presence of portal vein tumor thrombus,
microvascular invasion and high CEA level were poor
prognostic factors.
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APHPB-0700
MANAGEMENT OF HEPATOCELLULAR
ADENOMA: RECENT ADVANCES
S. Agrawal1, S. Agrawal2, T. Arnason3, S. Saini2, S.
Jain4 and J. Belghiti5
1Hepatobiliary and Pancreatic Surgery Department of
Surgical Oncology, Indraprastha Apollo Hospitals, New
Delhi, India; 2Division of Abdominal Imaging and
Intervention Department of Radiology, Massachusetts
General Hospital and Harvard Medical School,
BostonMassachusetts, USA; 3Department of Pathology,
Massachusetts General Hospital and Harvard Medical
School, BostonMassachusetts, USA; 4Surgical Oncology,
Vyedhi Institute of medical sciences, Bangalore, India;
5Hepatobiliary and Pancreatic Surgery Department of
Surgical Oncology, Beaujon Hospital University of
Paris, Clichy, France
Objectives: Hepatocellular adenoma (HCA) is a rare
benign liver neoplasm that occurs predominantly in
young women with a history of prolonged use of oral
contraceptives (OCs). Surgical resection is considered
because of the risk of hemorrhage in 25%and of malig-
nant transformation in 5%of patients with HCA.
Methods: HCA is a heterogeneous disease comprising
3 subtypes with distinct molecular and complication
profiles. The inflammatory or telangiectatic subtype is
at increased risk for hemorrhage, the b-catenin–
activated subtype is at increased risk for malignant
transformation, and the hepatocyte nuclear factor-1a–
inactivated or steatotic subtype is at the least risk for
complications. One-third of the patients with HCA
have multiple tumors on imaging with no increased risk
of complications. Magnetic resonance imaging is the
modality of choice for the diagnosis and subtype char-
acterization of HCA. Percutaneous core needle biopsy
is of limited value because the therapeutic strategy is
based primarily on patient sex and tumor size.
Results: Systematic resection of HCA is recommended
in male patients owing to the higher incidence of malig-
nant transformation, and surgical excision in women
should be reserved for tumors 5 cm or larger associated
with an increased risk of complications. Transarterial
embolization is the initial treatment for HCA compli-
cated by hemorrhage.
Conclusion: Cessation of hormonal therapy and radio-
logic surveillance in women with HCA tumors smaller
than 5 cm shows that the vast majority of HCA
remains stable or undergoes spontaneous regression.
Pregnancy should not be discouraged in the presence of
HCA, however, frequent sonographic surveillance is
recommended.
Benign HPB Diseases
APHPB-0701
ENDOSCOPIC ULTRASOUND-GUIDED
TRANSMURAL DRAINAGE OF
POSTOPERATIVE FLUID
COLLECTIONS FOR PANCREATIC
SURGERY
Y. Futagawa1, H. Imazu2, N. Mori2, K. Kanazawa2,
M. Chiba2, K. Abe1, N. Okui1, K. Furukawa1, S.
Onda1, D. Hata1, T. A. R. O. Sakamoto1, H. Shiba1,
H. Tajiri2 and K. Yanaga1
1Surgery, Jikei University School of Medicine, Tokyo,
Japan; 2Endoscopy, Jikei University School of Medicine,
Tokyo, Japan
Objectives: Recent studies showed the usefulness of
endoscopic ultrasound (EUS)-guided drainage of pan-
creatic cyst or pancreatic fistula. However, data on
early drainage defined as initial EUS-guided transmural
drainage (EUS-TD) within 30 days after pancreatic sur-
gery, is very limited. In the present study, we assessed
the feasibility and the usefulness of EUS-TD for
patients who required early drainage of postoperative
peripancreatic fluid collection.
Methods: Between May 2012 and June 2014, in 7
patients (age 39–74 [median 58] years, male:
female = 1:6) underwent EUS-TD after pancreatic
resections, consisting of open distal pancreatectomy
(DP) in 4, laparoscopic distal pancreatectomy in 2, and
pancreaticoduodenectomy in 1 patient, the median
duration of postoperative hospital stay, complications,
and prognosis were retrospectively reviewed.
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Results: EUS-TD was performed 4 to 29 [average 14]
days after the operation. The duration of postoperative
hospital stay was 8 to 49 [median 24] days and the
duration of hospital stay after EUS-TD was 10 to 38
[median 19.1] days. Two patients needed repeat-drain-
age within 2 weeks after the first proceure for tube
obstruction and septum formation in the cavity. One
patient with severe diabetes needed third drainage for
recurrent pseudocyst 2 years after the first operation.
Clinical success defined as resolution of fluid collection
was achieved in 6 of 7 patients (86%). No serious peri-
operative complications were observed.
Conclusion: Although associated with a high rate of
repeat drainage, EUS-TD is a safe, minimally invasive,
and useful method for early drainage, which seems to
be a good alternative to percutaneous drainage.
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APHPB-0703
INCIDENTALLY CONFIRMED
GALLBLADDER CANCER AFTER
CHOLECYSTECTOMY: SINGLE
CENTER EXPERIENCE
C. Park1
1Surgery, Gamgneung Asan Hospital University of Ulsan
College of Medicine, Gangneung, Korea
Objectives: Gallbladder (GB) cancer is the disease of
the serious mortality rate. In as many as 50% of cases,
GB cancers are detected at pathologic report after cho-
lecystectomy for benign GB disease. This study
described that incidentally detected gallbladder cancer
(iGBC) after cholecystectomy in single center.
Methods: Out of 4629 cholecystectomy surgeries per-
formed from 1998, January to 2014, March. In their
cases, 73(1.57%) cases were confirmed GB cancer by
pathologic analysis. We excluded 17 cases for study
because of other causes. We would analysis 73 cases
for clinical features, and 56 cases for disease free sur-
vival (DFS), overall survival (OS) and prognostic fac-
tors for iGBC.
Results: On 73 patient’s clinical features, mean age is
68.41  11.53, 41(56.2%) cases are female. GB perfora-
tion during operation is a risk factor of recurrence
(p = 0.041), but is not risk factor of survival
(p = 0.074). Patients of pT2 (n = 37) and pT3 (n = 7)
had been performed variable operation, but DFS and
OS are no difference by types of operation (p > 0.05).
In multivariable analysis, old age (>65), lymph node
metastasis, moderate or poor differentiation, and pre-
sented lymphovascular invasion are the significant
prognostic factor of recurrence and survival (p < 0.05).
Conclusion: iGBC should be suspicious patients with
old age (>65), anemia or hypertension, and severe cho-
lecystitis or GB empyema. In the presence of these risk
factors, surgeons should perform cholecystectomy with-
out GB perforation or bile spillage and prepare to per-
form an adequate R0 resection according to the cancer
stage. In our study, lymph node metastasis is more
important than tumor depth for patient’s outcome.
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APHPB-0704
UTILITY OF THE SHORT TYPE
DOUBLE BALLOON ENDOSCOPE FOR
MANAGEMENT OF BILIARY STONES
IN PATIENTS WITH ALTERED
GASTROINTESTINAL ANATOMY
M. Shimatani1, M. Takaoka1, M. Tokuhara1, T.
Mitsuyama1, K. Kato1, S. Miyamoto1, F. Inoue1, H.
Miyoshi1, T. Ikeura1 and K. Okazaki1
1The Third Department of Internal Medicine, Kansai
Medical University, Osaka, Japan
Objectives: We described our experience and data of
DB-ERCP for management biliary stones and provide
our standard technique for DB-ERCP using a short
type DBE.
Methods: Between February 2006 and February 2014,
we performed ERCP with the use of a short type DBE
for biliary stones in 111 patients with various anatomic
variations (181 procedures; 104 procedures (63 patients)
for Roux-en-Y reconstruction (R&Y), 74 procedures
(46 patients) for Billroth II gastorectomy (BII), 3 pro-
cedures (2 patients) for double tract reconstruction
(DT)), and evaluated the technique.
Results: Deep insertion of the short DBE to the papilla
was successful in 180 of the 181 procedures (99.4%).
The success rate was 99.0% (103/104) for R&Y, 100%
(74/74) for BII, 100% (3/3) for DT. Deep biliary cann-
ulation was successful in 175 of the 180 procedures
(97.2%). The success rate was 97.1% (100/103) for
R&Y, 97.3% (72/74) for BII, 100% (3/3) for DT. Ther-
apeutic intervention was achieved in all of the 175 pro-
cedures of successful deep cannulation (100%).
Complications occurred in 12 of the 181 procedures
(6.6%). The complication rate was 4.8% (5/104) for
R&Y, 9.5% (7/74) for BII, 0% (0/3) for DT.
Conclusion: ERCP by a short type DBE is highly effec-
tive and safe in patients with altered gastrointestinal
anatomy, especially in patients with Roux-en-Y recon-
struction. Occurrence of complication is within an
acceptable range, however it is remarkable that it
occurs more frequently in patients with BII unexpect-
edly.
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APHPB-0705
COLORECTAL LIVER
METASTASECTOMY BENCHMARK IN
A TERTIARY CENTER IN SAUDI
ARABIA
F. Al-Alem1, R. E. Mattar1, A. Alsharabi1, F. Alsaif1
and M. Hassanain2
1General Surgery, King Khalid University Hospital,
Riyadh, Saudi Arabia; 2Oncology, McGill University
Health Center, Montreal, Canada
Objectives: The incidence of colorectalcancer in Saudi
Arabia is rising, being the most common cancer in the
malepopulation. Almost 50% of patients develop
metastases targeting the liver, notonly mostly, but also
initially. Liver surgery has demonstrated a great impac-
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ton survival, but with considerable risks for morbidity
and mortality. Inour institution, liver surgery is young,
thus in this study we aim to evaluateour experience in
colorectal hepatic metastasectomy.
Methods: Retrospective analysis of prospectivelycollect-
ed data was done on our Hepato-Pancreato-Biliary
(HPB) database on consecutive colorectal cancer hepa-
tic metastasectomy cases performedfrom 2007 to 2014.
Results: 27 patients underwent 30 liverresections for
colorectal cancer metastasis. Mean age was 54.93 years.
Males constituted19 cases.
26 resections were majorresections; 14 formal right, 4
left, 4 extended right, 1 extended left, and 7 non-ana-
tomical. Mean operative time was 345.7 min. Preopera-
tive portal veinembolization was needed in 6 patients.
Three patients died within 60 days of surgery; all ful-
filled the 50:50 liver dysfunction criteria.
Average follow up period was 14.2 months. Recurrence
was documented in 15 patients, with the median disease
freeperiod being 12.1 months. Three patients underwent
a redo hepatectomy, 2 developed recurrence within
8 months. Median overall survival was 32.9 months.
Conclusion: Liver resection is a feasible option in our
center with acceptable survival rates. Attention should
be given to reducethe risk of postoperative liver dys-
function, as it is a major contributorto early mortality,
by utilizing parenchyma preserving surgical options
aspossible.
APHPB-0706
PANCREATICOGASTROSTOMY
THROUGH AN ANTERIOR
GASTROTOMY IN
PANCREATICODUODENECTOMY
J. W. Park1 and S. K. Lee1
1Surgery, Daejeon St. Mary’s Hospital College of
Medicine The Catholic University of K, Daejeon, Korea
Objectives: Postoperative pancreatic fistula is the lead-
ing cause of death and morbidity after pancreaticoduo-
denectomy. However, the best reconstruction method
to reduce occurrence of fistula is debated. Pancreaticog-
astrostomy (PG) has recently been reappraised as a
more secure procedure over pancreaticojejunostomy
(PJ). In this study we describe our technique of PG
after PD: one layer continuous suture method through
an anterior gastrotomy.
Methods: We retrospectively analyzed early surgical
outcomes in 9 consecutive patients who underwent this
PG after pancreaticoduodenectomy by a single surgeon
between August 2012 and August 2014. PG was com-
pleted with one layer continuous suture through the
retracted anterior gastrotomy
Results: The patients consisted of 4 men and 5 women,
with an average age of 66.4 years. Of the 9 patients, 6
patients had a soft and the remaining 3 had a firm pan-
creatic texture. The mean pancreatic duct size was
5.1 mm and the mean operating time was 591 min. The
mean blood loss was 862.5 mL and the mean duration
of postoperative hospitalization was 21.7 days. There
were 1 patient with abdominal fluid collection needed
drainage and 3 patients with wound problem with con-
servative care. And delayed gastric empting was devel-
oped in 3 patients then they recovered with
conservative care. There were no hospital mortality and
no grade B or C pancreatic fistula.
Conclusion: In our experience, this technique is simple
to perform and it has several advantages over the con-
ventional PG or PJ: it could be less traumatic to the
pancreatic stump and more secure suture is possible
due to good vision through anterior gastrotomy.
APHPB-0709
ENDOSCOPIC SNARE PAPILLECTOMY
OF AMPULLARY NEOPLASMS: LATE
COMPLICATION AND OUTCOMES
N. Okano1, Y. Igarashi1, S. Hara1, K. Takuma1, I.
Kamata1, Y. Kishimoto1, T. Mimura1 and K. Ito1
1Division of Gastroenterology and Hepatology
Department of Internal Medicine, Toho University
Omori Medical Center, Tokyo, Japan
Objectives: Recently, endoscopic snare papillectomy
has been performed to treat ampullary neoplasms. We
assessed outcomes and late complications of endoscopic
snare papillectomy for ampullary neoplasms.
Methods: Subjects were 57 patients, 28 males and 29
females, with ampullary neoplasms who were per-
formed endoscopic snare papillectomy. Reccurence and
late complication were evaluated 1 week, 3–6 months,
1 year and every 2 years after procedure.
Results: The pathological diagnosis was an adenoma in
30 patients, carcinoma in adenoma in 10, carcinoma in
11, a carcinoid tumor in 1, and regenerative atypia or
hyperplasia in 5. Recurrence was noted in 1 patient
with an adenoma, 1 with a carcinoma in adenoma, and
4 with a carcinoma. Endoscopic snare papillectomy
had a success rate of 97% (29/30) in treating adenoma,
90% (9/10) in treating carcinoma in adenoma, 55% (6/
11) in treating carcinoma, and 100% (1/1) in treating a
carcinoid tumor; overall, its success rate was 88% (50/
57). Late complications were cholecystitis in 2 patients
(4%), severe pancreatitis in 1 (2%), common bile duct
stones in 1 (2%), stenosis of the bile duct orifice in 1
(2%), stenosis of the pancreatic duct orifice in 3 (5%),
and stenosis of both the bile duct and pancreatic duct
orifices in 2 (4%). 3 patients with stenosis of the bile
duct orifice and 2 patients with stenosis of the pancre-
atic duct orifice were improved endoscopically.
Conclusion: Endoscopic snare papillectomy is indicated
for treatment of adenomas and carcinomas in ade-
noma. There is insufficient data on its outcomes in
treating carcinomas.
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APHPB-0710
LIVER METASTASES IN COLORECTAL
CANCER: A STUDY TO EVALUATE THE
OUTCOME AND PREDICTING
FACTORS FOLLOWING HEPATIC
RESECTION IN SELAYANG HOSPITAL
M. Khairil1, M. Suryati1 and R. Krishnan1
1General Surgery, Hospital Selayang, Kuala Lumpur,
Malaysia
Objectives: To evaluate the outcome and prognostic
factors for liver resections for CRLM patients.
Methods: This retrospective analysis included 75 liver
resections for CRLM performed at HPB unit, Selayang
Hospital from January 2010 to December 2013. Sur-
vival outcomes, morbidity and mortality were analyzed.
The following prognostic factors were considered: age,
gender, race and clinicopathological factors; which
include size (>5 cm or <5 cm), number of tumor (soli-
tary or multinodular), surgical margin (negative or
positive) and types of resections (major: hemihepatecto-
my or minor: segmentectomy). Survival rates were esti-
mated according to the Kaplan-Meier method and
were compared at univariate analysis using the log-rank
test. Differences were considered significant at p < 0.05.
Results: Total of 75 hepatic resections was performed
for liver metastases over this three years duration. The
mean age was 56 years old and majority were male 45
(60%) and 30 (40%) were female. Ethnic distribution
showed a Chinese predominant (53.3%), followed by
Malays (25.3%) and Indians (21.3%). The postopera-
tive morbidity and mortality was low; 22.6% and 1.3%
respectively. Complications commonly observed were
wound infection (8%), followed by pneumonia (5.3%),
bile leak (5.3%), pleural effusion (2.7%) and liver fail-
ure (1.3%). 26.7% had major resection and 72.6% had
minor resection. The univariate analysis revealed a sta-
tistically significant difference (p < 0.05) in relation to
number of tumors (multi-nodular tumors: 31% and sol-
itary tumors: 20%).
Conclusion: Most of the prognostic factors turned out
not to be associated with survival outcomes after hepa-
tic surgery for colorectal liver metastases. Hepatic
resection could be performed with low morbidity and
mortality with favorable survival outcomes.
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APHPB-0711
LAPAROSCOPIC LATERAL
PANCREATICOJEJUNOSTOMY – A
CASE SERIES
H. Nag1, A. Dangi1 and V. BG1
1G I Surgery, G B Pant Hospital, Delhi, India
Objectives: Objective of this study is to report an expe-
rience regarding laparoscopic lateral pancreaticojejun-
ostomy for patient with chronic pancreatitis
Methods: Total seven patients were treated with lapa-
roscopic lateral pancreaticojejunostomy (Roux En Y)
from March 2012 to August 2014. Prospectively col-
lected data of these patients was retrospectively ana-
lyzed.
Results: Median age was 43 years, 5 (71.4%) patients
were male, most common symptom was pain in abdo-
men and none of them had associated biliary obstruc-
tion or portal hypertension. Total laparoscopic LPJ
(Roux En Y) was successful in 3 (42.9%) patients
whereas 4 (57.1%) patients required conversion to open
method. The reasons for conversion were intra-opera-
tive hemorrhage and technical difficulty. Median
(range) duration of surgery, blood loss, and postopera-
tive hospital stay were 300 (240–320) minutes, 150 (50–
500) milliliter, and 8 (5–19) days respectively. One
patient (14.2%) required emergency operation for post-
operative hemorrhage from pancreaticiojejunostomy
site. Persistent symptomatic relief was obtained in all
but one patient during a median follow up of
10 months, and there was no mortality.
Conclusion: Laproscopic lateral pancreaticojejunostomy
is a technically demanding procedure and it is associ-
ated with a high rate of conversion and complication.
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APHPB-0712
LEAN BACK TECHNIQUE: EASY TO
ACCESS SINGLE PORT
LAPAROSCOPIC CHOLECYSTECTOMY
EVEN BY BEGINNERS
T. Yoo1, Y. J. Jeon1, A. S. Bak1, K. C. You1, Y. J.
Keun1, J. W. Hwang1, K. I. M. DJ1, J. P. Jung1, J. Y.
Jeon1 and J. S. Kim1
1Surgery, Dongtan Sacred Heart HospitalHallym
University College of Medicine, HwaSeong-Si Gyeonggi-
do, Korea
Objectives: Single port laparoscopic cholecystectomy
(SPLC) has been proposed as a minimally invasive sur-
gery with the advantages of better cosmesis and less
pain. However, the complicated arrangement of the
instruments can cause collision and it makes difficult to
provide adequate retraction of the Gallbladder. In
order to simplify procedures, we have developed new
retraction technique called ‘Lean Back technique’,
which enable to improve the dissection of Calot’s trian-
gle without collision.
Methods: 39-year-old male with chronic symptomatic
cholelithiasis was enrolled under institutional review
board protocol to perform single port laparoscopic
cholecystectomy. After 2 cm intra-umbilical skin inci-
sion was carried out, single port was placed through an
open method. One suture was performed at the parietal
peritoneum of the Rt. diaphragm and end of the thread
was clipped not to fall out from the suture site. Second
suture was punctured at the fundus of the gall bladder.
The liver was lifted by pulling the thread and the
thread was held by two metal clips. This technique pro-
vided plenty of retraction to visualize the Gallbladder
infundibulum.
Results: SPLC using lean back technique was success-
fully performed with time of 65 min and the patient
was discharged without any complication 2 days after
surgery.
Conclusion: Adequate retraction without collision can
easily simplify SPLC. Therefore, the described tech-
nique for laparoscopic cholecystectomy may enable
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wider use of minimal invasive surgery and further work
is also needed to investigate the efficacy of this
approach.
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APHPB-0713
INTRAPANCREATIC BILIARY
CARCINOMA AFTER THE
CHOLEDOCHAL CYST EXCISION
H. Jung1, J. Yun1, C. Kim1 and S. Bae1
1Surgery, Soonchunhyang University Cheonan Hospital,
Cheonan, Korea
Objectives: Although the incidence of biliary carcinoma
associated with choledochal cyst is high, there are
extremely rare reports about cancer development in the
remaining intrapancreatic biliary tract in patients who
underwent primary excision of the choledochal cyst.
Methods: We present a case of carcinoma associated
with the remnant intrapancreatic biliary tract in a
64 year-old woman, 7 years after the initial excision of
a choledochal cyst with Roux-en-Y hepaticojejunosto-
my. She was treated with liver abscess 6 months ago,
6 years after initial operation. One month later, CT
scan was performed. Liver abscess was cleared but
there was an obstructive lesion in the pancreas head, p-
duct dilation remain and abrupt narrowing at the head.
On the pathology, tubulovillous adenoma with suspi-
cious for carcinomatous change were reported.
Results: On the operative findings, we found that
Roux-en-Y hepaticojejunostomy was performed by an-
tecolic fashion, and the common hepatic artery was
originated in the SMA. Pancreaticoduodectomy was
done. On the pathologic reports, IPMN with invasive
carcinoma and the tumor cell in the remnant CBD
were diagonsed. She was discharged after POD 12,
uneventfully.
Conclusion: Long-term follow-up may be recommended
even in patients who have undergone excisional surgery
for choledochal cyst, because it is possible that cancer
associated with the intrapancreatic biliary tract may
develop.
APHPB-0714
PRIMARY MALIGNANT PERIPHERAL
NERVE SHEATH TUMOR OF THE
LIVER
C. Kim1, H. Jung1 and S. Bae1
1Surgery, Soonchunhyang University Cheonan Hospital,
Cheonan, Korea
Objectives: Primary malignant peripheral nerve sheath
tumor (MPNST) in a young female patient, not associ-
ated with von Recklinghausen‘s disease is an extremely
rare in the liver We report a case diagnosis based on
detailed immnohistochemical and electromicroscopic
examination and its follow up.
Methods: Case: a 33-year old female, with a history of
surgery for left ovary cystectomy, 8-years ago was
admitted in suncheonhyang University Hospital in che-
oan, her chief complaint was a right flank pain for a
weak, on physical examination, there was no lesion on
skin (ex cafe au lait) with neurofibromatosis type I, and
laboratory date was not specific findings. The CT scan
showed with 12.5*11 cm sized mass located at right
lobe.
Results: operative findings were a 20*16 cm sized mass
on right lobe with invasion on right diaphragm, so
right hepatecomy and shaving of diaphragm was done.
Histologically, on FNCLCC system, the tumor differ-
entiation sore was 3, mitotic count was 8 on 10 HPFs,
necrosis was 30% On immunohistochemistry, the
tumor cells were strong positive for s-100 protein,
bcl-2, vimentin, The patinents discharged at POD#13
without complication and received 30-cycles, 6000 cGy
radation therapy, and doing well 2-month after surgery
Conclusion: Eight cases of malignant shwanoma have
been reported in the liver, its prognosis are generally
poor and its associated with a highly aggressive courses
of recurrence, metastases, and death but only two cases
are not associated with von Recklinghausen‘s disease,
but we first report its follow up including radiation
therapy.
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APHPB-0715
ENUCLEATION FOR BENIGN OR LOW-
GRADE MALIGNANT LESIONS OF THE
PANCREAS: SINGLE CENTER
EXPERIENCE WITH 65 CONSECUTIVE
PATIENTS
K. Song1, S. Kim1, D. Hwang1, J. Lee1, K. Park1 and
Y. Lee1
1Division of Hepatobiliary and Pancreatic Surgery
Department of Surgery, Ulsan University College of
Medicine and Asan Medical Center, Seoul, Korea
Objectives: The aim of this study was to evaluate the
postoperative clinical outcomes and long-term func-
tional and oncologic results following pancreatic enu-
cleation, and to compare the clinical results of
laparoscopic and open enucleation.
Methods: From March 2005 to December 2013, 65
cases of enucleation of benign tumors in the pancreas
were identified through a retrospective review of medi-
cal records.
Results: Most of the patients were women (73.8%),
and the median age was 52.7 years (IQR 43.1–
60.9 years old). Median tumor size was 2.5 cm
(IQR:1.6–3.8 cm). The most common indication for
enucleation was pancreatic neuroendocrine tumor (24,
36.9%). A clinically significant pancreatic fistula (Inter-
national Study Group on Pancreatic Fistula grade B,
C) was reported in 6 patients (9.2%). The patients with
tumors of the pancreatic neck had more complications
after enucleation than those with tumors at other loca-
tions (3/4, 75%). There were no differences of clinical
outcomes between open and laparoscopic enuleaton
groups. At a median follow-up of 58.7 months there
was one case of new onset diabetes and there were no
recurrences or deaths.
Conclusion: Enucleation is a safe and effective proce-
dure for the treatment of benign and borderline pancre-
atic neoplasms. It preserves pancreatic function and is
not associated with recurrence. The incidence of post-
operative complications, including pancreatic fistula, is
© 2015 The Authors
HPB © 2015 Americas Hepato-Pancreato-Biliary Association HPB 2015, 17 (Suppl. S2), 25–266
232 Poster Abstracts
acceptable. Laparoscopic enucleation seems to be a fea-
sible and safe approach associated with favorable peri-
operative outcomes for the selected patients.
Transplantation
APHPB-0716
A RARE INFECTIOUS COMPLICATION
AFTER LDLT; SEPTIC
SPONDYLODISCITIS CASUED BY
METHICILLIN-RESISTANT
STAPHYLOCOCCUS AUREUS (MRSA)
J. Kim1, D. Kim1, J. Jeon1, T. Yoo2, Y. Kwon1, J.
Hwang3 and J. Jung3
1Surgery, Hallym University, Seoul, Korea; 2Surgery,
Hallym University, Dongtan, Korea; 3Surgery, Hallym
University, Chuncheon, Korea
Objectives: Methicillin-resistant Staphylococcus aureus
(MRSA) infection frequently complicates the postop-
erative course of liver transplant recipient. It has been
well described that MRSA associated bacteremia,
pnemonia and surgical site infection are common.
BUt, MRSA infection manifesting as pyogenic spond-
ylodiscitis is very rare. To our knoweldge, septic
spodylodiscitis caused by MRSA after LDLT has not
been reported previously.
Methods: A 50-year old male patient underwent LDLT
for HBV related cirrhosis using modified right lobe.
Immnosuppressive treatment was administered with ba-
siliximab, tacrolimus, corticosteroids and mycopheno-
late mofetil. He discharged on postoperative 28th day
without complications. At one week after discharge the
patient readmitted for abdominal pain and high fever.
Bile leakage at the anastomosis site was found by
ERCP and managed successfully with endoscopic na-
sobiliary drainage (ENBD). The culture of drained
fluid showed MRSA and the patient was treated with
vancomycin for 4 weeks.
Results: One month later the patient presented with
severe back pain. MRI showed massive spondylodiscitis
of lumbar 2–3 spine and paraspinal abscess formation.
Our patient was treated by surgical debridement and
primary bone graft. MRSA was cultured from the
abscess. Postoperatively, the patient received intrave-
nous vancomycin for 2 weeks and revealed satisfactory
outcome without any neurological sequelae. Presently
the patient is followed up without rejection and other
complications
Conclusion: MRSA infection after liver transplantation
is common and somtimes fatal. Remote site infection is
rarely seen and very fatal unless treated in early course.
High suspicion of MRSA infection is required in the
recipient with previous biliary complications.
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A SIMPLE AND INEXPENSIVE MODEL
FOR PREDICTING SEVERE CIRRHOSIS
IN VIRAL HEPATITIS PATIENTS WITH
PORTAL HYPERTENSION
G. Yuan1, W. Zhang1, L. Zhang1 and X. Chen1
1Hepatic Surgery, Tongji Hospital, Wuhan, China
Objectives: The severity of liver cirrhosis could be
underestimated by surgeons before they operate on
some liver cirrhosis patients according to CTP classifi-
cation or MELD score. In this study, we tried to study
non-invasive methods for subcategorizing cirrhosis
according to the Laennec system, which may help sur-
geons to establish optimum treatment strategies.
Methods: 52 viral hepatitis patients with portal hyper-
tension were included. Clinical characteristics were col-
lected from routine laboratory tests. A size of
1 9 1 cm2 liver specimens were collected from quadrate
lobes by wedge biopsy during laparotomy for portal
hypertension within 2 weeks after admission. The sever-
ity of liver cirrhosis was assessed according to Laennec
system after Masson-trichrome staining. The relation-
ship between clinical characteristics and the severity of
liver cirrhosis was analyzed by univariate and multivar-
iate analysis.
Results: The main cause of cirrhosis is hepatitis B virus
infection (65.4%) in this cohort. 38.5% patients are
severe cirrhosis (stage 4C). Age, white blood cell count
(WBC), lymphocyte count, AST, ALP, and AFP were
identified as predictors of severe cirrhosis by univariate
analysis. By multivariate analysis with the significant
variables from the univariate analysis, only WBC and
ALP had independent predictive value of severe cirrho-
sis, the odds ratio was 2.79 and 1.045, repectively. A
simple model consisting of WBC and ALP was made
according to multivariate analysis, which shows a diag-
nostic value of 0.78.
Conclusion: A simple model consisting of WBC and
ALP can predict severe cirrhosis in viral hepatitis
patients with portal hypertension, which may help sur-
geons to establish optimum treatment strategies.
APHPB-0718
OPTION OF BILIANY DRAINAGE FOR
SURGICAL MANAGEMENT OF
HEPATOLITHIAS
X. P. Geng1
1General Surgeon, The First Affiliated Hospital of Anhui
Medical University, Hefei, China
Objectives: To investigate the option of biliary drain-
age for surgical management of hepatolithias.
Methods: The clinical data of 146 patients with hepato-
lithiasis, who were admitted to the First Affilliated
Hospital of Anhui Medical University from March
2006 to June 2014, was analyzed retrospectively. These
patients were divided into biliary enteric drainage
group and T tube drainage group according to the
function of sphincter of Oddis.
Results: There were no significant differences of the he-
patolobectomy rate, intraoperative blood loss, intraop-
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erative blood transfusion, times and time of hepatic
portal occlusion, bile culture positive rate, hospital stay
and hospitalization expenses between two groups
(p > 0.05). But the operation time of the biliary enteric
drainage group was significantly longer than that of the
T tube drainage group (p < 0.001). Stone instant clear-
ance rate of the biliary enteric drainage group was sig-
nificantly higher than that of the T tube drainage
group (p = 0.031). The rates of stone residual, recur-
rence, morbidity,mortality and canceration were not
significantly different between two groups (p > 0.05).
Conclusion: The biliary drainage for surgical manage-
ment of hepatolithias is selected according to the func-
tion of sphincter of Oddi. Biliary enteric drainage and
Roux-en-Y anastomosis are firstly selected for patients
with the loss of function of sphincter of Oddi.
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APHPB-0719
PRIMARY SYNOVIAL SARCOMA OF
LIVER WITH SYT-SSX2 FUSION
TRANSCRIPT: A CASE REPORT
J. Chang1, B. Zhang1 and X. Chen1
1Hepatic Surgery, Tongji Hospital Tongji Medical
College Huazhong University of Science and Tech,
Wuhan, China
Objectives: A 43-year-old man,who complained of fati-
gue,nausea,and abdominal fullness,is diagnosed with
monophasic primary synovial sarcoma of the liver. CT
showed a large tumor mass extending from the right
lobe of the liver. the tumor was resected and histopa-
thology revealed spindle cell sarcoma. This case repre-
sents the first time where confirmed SYT-SSX2 fusion
transcript is ppresent and used to definitively diagnose
this condition.
Methods: A right partial hepatectomy was performed
with resection of the tumor. Immunohistochemical
staining and cytogenetical (RT-PCR).
Results: IHC showing tumor cells expressed vimentin,
CD99,and Bcl-2,but were immune negative for cytoker-
atin. Cytogenetics was crucial in ruling out differential
diagnoses,and ruling in the monophasic subtype of
synovial sarcoma due to an observed SYT-SSX2 reci-
procal translocation between chromosome 18 and X.
Conclusion: primary hepatic synovial sarcoma is an
extremely rare neoplasm. Clinical and imaging investi-
gation is necessary to exclude alternative primary
sources and metastatic sarcoma. A definitive diagnosis
rrequires histological morphology,detailed IHC staining
and cytogenetical analysis. A balanced chromosomal
translocation t (X:18)(p11.2;q11.2) is found in the
majority of synovial sarcomas resulting in a chimeric
transcript,SYT-SSX. The role of this transcript is
unclear. Surgical excision with clear margins and adju-
vant chemoradiotherapy is the currently accepted treat-
ment.
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APHPB-0720
EVALUATION OF CHEMOTHERAPHY
INDUCED LIVER INJURY IN PATIENTS
WITH COLORECTAL CANCER LIVER
METASTASES
J. Shim1, S. Yun1 and H. Seo1
1Department of Surgery, Pusan National University
Hospital, Busan, Korea
Objectives: Adjuvant chemotheraphy improves survival
in patients with curatively resected colorectal cancer.
But up to 50% of patients will develop hepatic metas-
tases during their course of disease. Surgical resection
of liver is the only potentially curative treatment for
patients with liver metastases. The aim of this study is
to show that commonly used chemotheraphic drug are
associated chemotheraphy induced liver injury which
was recognized to impair the function of the remnant
liver.
Methods: Between June 2007 and March 2012, data of
29 liver resection performed for colorectal liver metas-
tases were analyzed, retrospectively. Eleven patients
had liver resection without chemotheraphy, while 18
patients had history of adjuvant, neoadjuvant chemo-
theraphy before liver resection. We analyzed patients’
clinical data, histopatholoy of resected liver and post-
operative outcome between two groups.
Results: In the comparison of patients’ clinical date,
there was no statistically significant difference between
nonchemotheraphy group and chemotheraphy group.
Whereas, patients in the chemotheraphy group had
higher pre-operative ALT (p = 0.043), lower PLT level
(p = 0.032) compared to patients in the non-choemo-
theraphy group. In the comparison of histophathology
of resected liver, there was no significant difference in
the fibrosis stage and sinusoidal dilation, but in the
chemotheraphy group, necro-inflammatomy grade was
significantly high (p = 0.018). In the comparison of
post-operative outcomes, there was no significant dif-
ference in post-operative AST, ALT, normalization of
AST and ALT and amount of drain.
Conclusion: In this study, choemotheraphy group had
high ALP and low PLT which is related to necrosis of
hepatocytes and liver dysfunction, and had high necro-
inflammatory grade which is related to severe steato-
hepatitis.
APHPB-0721
INTRAPANCREATIC MIRIZZI’S
SYNDROME TREATED SUCCESSFULLY
BY LASER LITHOTRIPSY: A CASE
REPORT AND LITERATURE REVIEW
OF THERAPEUTIC MODALITIES
T. Kabir1 and T. J. Tan1
1General Surgery, Khoo Teck Puat Hospital, Singapore,
Singapore
Objectives: Mirizzi’s syndrome (MS) describes the phe-
nomenon of a stone impacted in the cystic duct causing
extrinsic compression of the common bile duct (CBD),
leading to obstructive jaundice (Type 1).
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Methods: Congenital anatomic variants of the cystic
duct occur commonly, with low insertion of the cystic
duct into the distal third of the CBD (intrapancreatic
insertion) present in about 9–11% of patients.
Results: We discuss an interesting case of a 41 year old
lady with Intrapancreatic MS. She presented initially
with acute cholangitis. During Endoscopic Retrograde
Cholangiopancreatography (ERCP), she was found to
have a cystic duct with a very low take off, and 2
stones just above the papilla. Balloon sweeps were
unsuccessful in removing these and a so biliary stent
was inserted for decompression. She subsequently
underwent a laparoscopic cholecystectomy and transcy-
stic CBD exploration using a Dormier basket, but we
were unable to extract the impacted stones. The proce-
dure was converted to open and a Dormier basket and
Fogarty balloon were used but these were again unsuc-
cessful. Finally we performed laser lithotripsy under
vision via a transcystic choledochoscopy, and the
stones were fragmented successfully and flushed into
the duodenum.
Conclusion: MS has traditionally been managed surgi-
cally. Laparoscopic cholecystectomy can be considered
for Type I but an Open approach is more appropriate
for Type 2, where the calculus fistulates from the cystic
duct into the CBD.
More recently, various Endoscopic modalities have also
been described for the treatment of MS and we present
a literature review of the different methods available.
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APHPB-0722
PALLIATIVE RESECTION FOR
NEUROENDOCRINE TUMOURS WITH
LIVER SECONDARIES – A REPORT OF
THREE CASES
S. Sankareswaran1, P. Thirumaraichelvan1, A. Bennet
Duraisamy1, R. Prabhakaran1, A. Amudhan1, D.
Kannan1 and S. M. Chandramohan1
1Institute of Surgical Gastroenterology, Madras Medical
College, Chennai, India
Objectives: Malignant neuroendocrine tumours of the
GIT with liver metastasis are rare presentations. The
survival as well the quality of life can be improved with
palliative resections. This is one of the few indications
where palliative cytoreduction of the liver is justified.
Methods: Case 1: 62 years old female patient found to
have a growth in the antropyloric region,ulcers in D1
and D2 with bilobar liver metastasis and serum gastrin
level of 9000 pg/mL. Patient underwent distal gastrec-
tomy and right hepatectomy. HPE confirmed gastrino-
ma.
Case 2: 47 years old male patient was referred as a case
of hydatid cyst of right lobe of liver. He underwent
resection of segment 5 and 6. HPE revealed moderately
differentiated neuroendocrine tumour. Thorough post-
operative workup could not identify primary.
Case 3: 24 years old gentleman presented with symp-
toms of pancreatitis. On evaluation found to have
2.8 cm lesion in the body of the pancreas. On laparot-
omy found to have bilobar liver metastasis. Serum
chromagranin was 4655 ng/mL. He underwent pallia-
tive distal pancreatectomy.
Results: All patients had uneventful recovery in the
postoperative period. Case1 is on followup for
8 months and is on high dose PPI and symptom free.
The remnant lesion in the liver has not increased.
Case3 is on followup for 5 months with good quality
of life. Case2 is on followup for 13 months without
any recurrence symptomatically and radiologically
Conclusion: palliative resection of primary and second-
ary of malignant neuroendocrine malignancy have good
palliation and QOL atleast in the shortterm. Palliative
cytoreduction can be safely undertaken in experienced
hepatobiliary centres.
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APHPB-0723
SURGICAL OPERATION FOR
PANCREATIC DUCT STONES:
ANALYSIS OF 46 CASES
Z. H. A. O. Hongchuan1, G. E. N. G. Xiaoping1, P. A.
N. Shubo2, X. I. E. Kun1, L. I. U. Fubao1, W. A. N.
G. Guobin1 and H. Fan1
1Hepatopancreatobiliary Surgery, The First Affiliated
Hospital of Anhui Medical University, Hefei, China;
2Hepatopancreatobiliary Surgery, the Second Affiliated
Hospital of Anhui Medical University, Hefei, China
Objectives: To analyse the effects of surgical treatment
for pancreatic duct stone.
Methods: The clinical data of 46 patients with pancre-
atic duct stone treated from January 2008 to January
2013 were retrospectively analyzed.
Results: The most common symptoms were abdominal
pain in 42 patients, diarrhea in 4 patients, diabetes in 6
patients, hematuria increased amylase in 4 patients,
high level of CA199 in 9 patients and pancreatic cancer
in 5 patients. 4 patients had history of acute pancreati-
tis. All patients were diagnosed with pancreatic duct
stones by preoperative imaging. The stones were
located in the head of the pancreas in 21 cases, 17 cases
of pancreatic body and tail, and 8 cases of the full pan-
creas. 7 cases had single stone, 28 cases had 2–3 stones,
and the 11 cases had more than three stones. Pancreatic
lithotomy plus pancreaticojejunostomy was performed
in 33 cases, pancreatoduodenectomy in 8 and resection
of the body and tail of pancreas plus splenectomy in 5
cases. 6 patients had postoperative complications, the
rate of complication was 13.0% and no case was died.
3 patients had residual stones, with a rate of 6.5%.
Follow-up time was 3 months to 57 months. 39 cases
were followed up. All patients had a pain relief rate of
85.7%, Stone recurrence occurred in 2 patients, with a
rate of 4.3%.
Conclusion: Surgery is an important treatment for pan-
creatic duct stones, and the treatments should be given
based on the situations of different patients.
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APHPB-0724
ROBOT-ASSISTED HEPATECTOMY
AND COMPLETE EXCISION OF
EXTRAHEPATIC BILE DUCT FOR A
TYPE IV – A CHOLEDOCHAL CYST
S. Choi1
1Surgery, CHA Bundang Medical Center, Gyeonggi-do,
Korea
Objectives: Complete removal of dilatated biliary tree
is regarded as inevitable in choledochal cyst for malig-
nant potential. However, technical difficulty and high
risk of postoperative complications as well as the vari-
ous presentations of the disease make a surgical option
for type IV-A cyst still challenging and controversial.
We report a case of a type IV-A choledochal cyst trea-
ted by robot-assisted approach.
Methods: A 41-years-old healthy female was admitted
with intra- and extrahepatic cysts incidentally found in
routine check-up. Preoperative studies showed two
large cystic dilatations of main biliary tract at the
hilum and distal common bile duct as well as multiple
cystic dilatations of the left intrahepatic duct. Right
anterior and posterior hepatic ducts and left hepatic
duct drained into the large hilar cyst indivisually.
Anomalous pancreatico-biliary duct union was com-
bined. Robot-assisted complete excision of distal bile
duct and left hepatectomy with hemi-caudate lobec-
tomy were performed. The right anterior and posterior
hepatic ducts were securely isolated and resected with a
help of real-time fluorescent image using an ICG.
Roux-en-Y hepaticojejunostomy was made with duc-
toplasty of the two openings of intrahepatic ducts. The
specimen was retrieved through pfannelstial skin inci-
sion.
Results: The total operation time was 540 min. The
estimated amount of intraoperative bleeding was
300 mL. She discharged on postoperative 7th day in
good condition and was followed up for 4 months
without any complication.
Conclusion: With the advantages of robot system, com-
plicated procedures for type IV-A choledochal cyst can
be performed safely as minimally invasive approach.
APHPB-0725
REDUCED PORT LAPAROSCOPIC
SPLENECTOMY
T. Misawa1, K. Haruki1, R. Saito1, T. Gocho1, T.
Akiba1 and K. Yanaga2
1Department of Surgery, Jikei University Kashiwa
Hospital, Chiba, Japan; 2Department of Surgery, Jikei
University School of Medicine, Tokyo, Japan
Objectives: Despite the wide acceptance of reduced
port laparoscopic surgery, introduction of this tech-
nique to splenectomy is regarded as highly challenging.
Since our report of the first case of reduced port lapa-
roscopic splenectomy (RPLS) in Japan, we have per-
formed RPLS for the largest number of cases
worldwide. Herein, we describe the technical refine-
ments of our RPLS.
Methods: 21 RPLS patients (8 men and 13 women,
41  19 years old) comprised hematological disorder
(n = 10), splenic disease (n = 9), and liver cirrhosis
(n = 2). In all cases, access was achieved via a 2.5-cm
mini-laparotomy at the umbilicus into which a SILSTM
Port was placed. A 5-mm flexible scope, an articulating
grasper, and straight instruments were used. Our RPLS
is characterized by the following: a) early ligation of
the splenic artery to shrink the spleen, and b) applica-
tion of our original ‘tug exposure technique,’ which
provides good exposure of the splenic hilum by retract-
ing (tugging) the spleen with a cloth tape.
Results: In 19 patients (90%), RPLS was successfully
completed with one or two port sites (only 2 patients
required two port sites). Conversion to open surgery
was necessary in 2 patients. Operation time, blood loss,
and weight of the extracted spleen were 221  78 min,
165  325 g, and 328  188 g (maximum 960 g),
respectively. No intra- or postoperative complication
occurred. The postoperative scar was nearly invisible.
Conclusion: Like conventional multiport laparoscopic
splenectomy, RPLS is safely performed even for spleno-
megaly (up to 1000 g). RPLS can be the procedure of
choice in patients who are concerned about postopera-
tive cosmesis.
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APHPB-0726
OMEGA-3 FATTY ACID-BASED
PARENTERAL NUTRITION IMPROVES
POSTOPERATIVE RECOVERY FOR
CIRRHOTIC PATIENTS WITH LIVER
CANCER
C. Wu1, B. H. Zhang1, G. Wei1, B. X. Zhang1 and X.
P. Chen1
1Institute of Hepato-Pancreato-Bililary Surgery, Tongji
Hospital Tongji Medical College Huazhong University of
Science & Technology, Wuhan, China
Objectives: A new lipid emulsion enriched x-3 fatty
acid was manufactured, and was reported to avoid he-
perinflammatory situations in patients followed major
operations. However, the role of x-3 fatty acid-based
parenteral nutrition for postoperative patients with cir-
rhosis-related liver cancer is unclear. This study aims to
evaluate the safety and efficacy of x-3 fatty acid-based
parenteral nutrition for cirrhotic patients involving liver
neoplasm after hepatectomy.
Methods: A randomized controlled clinical trial
(ChiCTR-TRC-11001715) was conducted for cirrhotic
patients with liver cancer underwent hepatectomy
between March 2010 and September 2011 in our insti-
tution. For postoperative parenteral nutrition, 20%
Structolipid and 10% Omegaven were applied to the
trial group, while only Structolipid to the control group
for 5 consecutive days postoperatively.
Results: We enrolled 320 patients; 312 (97.5%) were
included in the analysis (155 in the control group and
157 in the trial group). There were significant reduc-
tions in the trial group, when compared with control
group, in rated of total morbidity of complications (78
[50.32%] vs. 46 [29.30%]; p < 0.001), total morbidity of
infective complications (30 [19.35%] vs. 15 [9.55%];
p = 0.014), overall mortality (5 [3.23%] vs. 1 [0.64%];
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p = 0.210), and hospital stay (12.56  3.21 d vs.
10.17  3.15 d; p = 0.018).
Conclusion: This study provided evidences that x-3
fatty acid-based parenteral nutrition improves postop-
erative recovery for cirrhotic patients with liver cancer
following hepatectomy.
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APHPB-0727
DIAGNOSTIC CHALLENGES AND
MANAGEMENT OF METASTATIC
PANCREATIC NEUROENDOCRINE
NEOPLASM
V. Mansukhani1, D. Davra1, R. Shah1 and P.
Jagannath1
1Surgical Oncology, Lilavati Hospital & Research
Centre, Mumbai, India
Objectives: Pancreatic neuroendocrine neoplasm (P –
NEN) are rare slow growing neoplasms with diverse
clinical presentations. Most pancreatic NENs are well
differentiated (G1 and G2) nonfunctional tumors. Het-
erogenous nature of NEN makes it difficult to stan-
dardize a treatment strategy for the primary and liver
metastases.
Methods: A single institutional retrospective review of
79 cases was done from 2000 to 2014. Only histologi-
cally proven cases were included. Staging was done by
CT scan and/or Somatostatin receptor based scan,
ultrasound and FDG-PET scan.
Results: CT scan was the most widely used imaging
technique for the localization of the primary and stag-
ing of the disease (n = 48). Out of 76 patients, 45
underwent surgery of which 7 had been operated for
liver metastasis (Metastectomy with RFA = 4, Hepatec-
tomy = 3) achieving an R0 resection. In the study cura-
tive R0 resection was achieved for 38, curative R1 for 2
and palliative for 4. The overall survival of all the oper-
ated cases was observed to be 4 years.
Conclusion: Surgery for metastatic PNETs may be
curative or palliative with a potential of cure in some
cases and prolongation of survival and amelioration of
symptoms in the majority of patients.
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APHPB-0728
MULTIDISCIPLINARY APPROACH IN
THE MANAGEMENT OF COLORECTAL
LIVER METASTASES
V. Mansukhani1, D. Davra1, R. Shah1 and P.
Jagannath1
1Surgical Oncology, Lilavati Hospital & Research
Centre, Mumbai, India
Objectives: Colorectal cancer is the third most com-
monly diagnosed cancer. Approximately 50% of
patients diagnosed with colorectal cancer will develop
liver metastases over the course of their disease. Liver
resection remains the most important modality in the
treatment of colorectal liver metastases but variety of
other minimally invasive surgical and medical options
are available like thermal ablative techniques (e.g., ra-
diofrequency ablation, microwave ablation, cryother-
apy), chemoembolization, or radioembolization,
chemotherapy and targeted therapy.
Methods: A retrospective review of 36 cases of colon
cancer was done, who were treated in our institute
between January 2010 and April 2014. Only the histo-
logically proven adenocarcinomas of colon which were
metastatised to the liver were included. Out of 36
patients, 21 (58%) patients with synchronous and 15
(42%) with metachronous liver lesions were included.
The evolution of the criteria for resectability has
resulted in more patients being offered a hepatectomy.
This is further augmented with the utilization of
adjuncts to liver resection, including portal vein emboli-
zation and local ablative techniques. Two-stage Hepa-
tectomy is also being used to increase resectability.
Results: Out of 36 patients with liver metastasis, 18
underwent Metastatectomy, 2 Segmentectomy, 6 Hepa-
tectomy, 1 Extended Hepatectomy after liver augmen-
tation with portal vein embolisation and 2 RFA.
Remaining 7 patients underwent chemotherapy because
of extensive bilobar disease.
Conclusion: The management of colorectal liver metas-
tases has evolved over the past few years. More
patients are now offered surgery. Two-stage Hepatec-
tomy is also being used to increase resectability. A mul-
tidisciplinary approach is essential in the management
of metastatic colorectal liver metastasis.
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APHPB-0729
METACHRONOUS CANCER OF
GALLBLADDER AND PANCREAS. A
DOUBLE WHAMMY
V. Kandiah1, M. Sharif1, D. Klokol1 and S. Mokhtar2
1General Surgery, Queen Elizabeth Hospital, Kota
Kinabalu, Malaysia; 2Hepatobiliary, Hospital Selayang,
Kuala Lumpur, Malaysia
Objectives: Metachronous cancer of the Gallbladder
and pancreas or biliary tract is an extremely rare
pathology with fewer than 20 cases reported in the
world medical literature. We report a rare case of 52-
year old lady with metachronous adenocarcinoma of
Gallbladder and Head of Pancreas. Four years previ-
ously she underwent curative surgery for Ca Gallblad-
der in one of the private medical centers in Malaysia
and after the operation she was under close surgical
follow-up. She presented to us with jaundice and
abdominal pain. Initially we suspected metastasis, how-
ever CT-scan showed a tumor in the Head of Pancreas.
Subsequently we did for her a pylorus-preserving pan-
creatico-duodenal resection. The result of pathological
examination of specimen was moderately-differentiated
adenocarcinoma of pancreas. We managed to obtain
the specimen from the first surgery and sought a review
from the pathologist in our hospital. The first surgery’s
specimen was well-differentiated adenocarcinoma of
Gallbladder with negative margins hence proving the
Head of Pancreas tumor was a metachronous lesion.
She has been under our follow up for the last 2 years
and is currently free from recurrence.
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Keywords: Gallbladder cancer, Pancreatic cancer,
Metachronous cancer, pancreaticobiliary maljunction,
double biliary tract cancer.
Methods: As stated above.
Results: As stated above.
Conclusion: As stated above.
Transplantation
APHPB-0730
DE NOVO MALIGANACY WITHIN 1
YEAR AFTER LDLT; A CASE REPORT
J. Kim1, D. Kim1, J. Jeon1, T. Yoo2, Y. Kwon2, J.
Hwang3 and J. Jung3
1Surgery, Hallym University, Seoul, Korea; 2Surgery,
Hallym University, Dongtan, Korea; 3Surgery, Hallym
University, Chuncheon, Korea
Objectives: Biliary obstruction is a common morbidity
after liver transplantation. The most common cause of
biliary obstruction is a biliary anastomotic failure.
When the patient with hepatocellular carcinoma (HCC)
underwent liver trasplantation and developed a jaun-
dice, the recurrence of HCC is suggested as the main
cause. Here we describes a case of biliary obstruction
due to pancreatic head cancer at 11 months after
LDLT.
Methods: The patient was a 54-year-old male with
HBV related cirrhosis and hepatocellula carcinoma
(HCC) within Milan criteria. Our patient previously
underwent liver resection for HCC two times in 1998
and 2002. Recurrence of HCC revealed and LDLT
using the right lobe from his 23-year-old daughter was
performed in December 2008. Immnosuppressive treat-
ment was administered with basiliximab, tacrolimus,
corticosteroids and mycophenolate mofetil. He dis-
charged on postoperative 28th day with uncomplicated
course.
Results: At eleven months after operation, the patient
showed icterus. Ampullary stricture below the anasto-
mosis site was found by MRCP and finally diagnosed
in adenocarcinoma with endoscopic biopsy. Pylorus-
preserving pancreaticoduodenectomy (PPPD) was per-
formed for complete resection of pancreatic head can-
cer on 14 months after LDLT. The patient revealed
favorable outcomes except for superior mesenteric arte-
rial (SMA) pseudoaneurysmal bleeding controlled by
endovascular graft postoperatively. However, the
patient died from recurred pancreatic head cancer two
year after LDLT.
Conclusion: Our experience suggest that high suspicion
of de novo malignancy is needed for the patient with
HCC who undergo liver transplantation.
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APHPB-0731
PANCEAS DIVISUM TREATED BY
PYLOROUS-PRESERVING
PANCREATODUODENECTOMY; A
CASE REPORT
J. Kim1, D. Kim1, J. Jeon1, T. Yoo2, Y. Kwon1, J.
Hwang3 and J. Jung3
1Surgery, Hallym University, Seoul, Korea; 2Surgery,
Hallym University, Dongtan, Korea; 3Surgery, Hallym
University, Chuncheon, Korea
Objectives: Pancreas divisum is a rare anatomical vari-
ant, and the incidence is reported as 7% of autopsies.
Most cases remain without clinical symptoms. How-
ever, some patients develop symptoms of recurrent pan-
creatitis. When pancreatitis occurs, the goal of
management is the improvement of the dorsal pancre-
atic drainage. This may be achived by endosopic or
surgical approaches. The indication and method of sur-
gical options are not clearly determined. A case of
young male patient with pancreas divisum is presented,
who underwent pylorous-preserving pancreatoduoden-
ectomy (PPPD) and achived clinical improvement.
Methods: A 29 year-old male patient admitted due to
severe epigastric pain lasting for 3 months. The patient
suffered from indigestion, postprandial discomfort and
vomiting since childhood. The patient admitted to hos-
pital due to epigastric pain, nause and vomiting 5 yeras
ago, and was managed under impression of acute pan-
creatitis. The imaging studies were done. Under the
impression of pancreas divisum the patient underwent
PPPD. The head of pancreas showed chronic inflamma-
tory changes. The patient dischrged without complica-
tions.
Results: Presently the patient is obserbed at out-patient
clinic. Four years after operation, he is well without
indigestion and postprandial pain. He gained 3 kg after
operation.
Conclusion: In this case, endoscopy could not be intro-
duced through the ampulla, and endoscopic approch
failed. Variablel methods of operation are suggested by
many authors. Currently PPPD is regarded as a safe
and effective operation. Cosidering the patient age, the
PPPD is selected for this patient. The long-term result
is needed to be evaluated in this patient.
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OUR EXPERIENCES OF
LAPAROSCOPIC DEROOFING BY
REDUCED PORT SURGERY,
INCLUDING SINGLE INCISION
SURGERY FOR SYMPTOMATIC LIVER
CYST
T. Aoba1, T. Kato1 and K. Hiramatsu1
1Surgery, Toyohashi-Municipal Hospital, Toyohashi,
Japan
Objectives: Laparoscopic deroofing is considered to be
appropriate for simple liver cyst due to its minimal
invasiveness. Furthermore reduced port surgery, includ-
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ing single incision laparoscopic surgery has been
attracted due to its cosmetic benefit. We report our
experience and indicate its benefit.
Methods: Both of two cases, patients had upper
abdominal pain and distension. And their liver cysts
were about 150 mm in maximum diameter. The X-
Gate (Ethicon) were placed at the umbilicus using
25 mm incision with two 5-mm trocars and one 12-mm
trocar. One of two cases was added another 5-mm tro-
car on upper abdominal and we used flexible camera in
all cases. The Cysts contained about 1000 mL serous
liquid. We unroofed and excised the cyst walls using an
ultrasonic coagulation incision apparatus.
Results: No postoperative complications occurred and
patients were discharged from our hospital 4 days after
the surgery. Six months have passed since the opera-
tion, and no recurrence of the cyst has been detected.
The procedures were excellent from a cosmetic view
point of the surgical wound and all patients were satis-
fied with the procedure.
Conclusion: We should perform adequate use of device to
prevent surgical complications, and excise wall of cyst
completely to prevent postoperative recurrence of the
cyst. Laparoscopic deroofing by reduced port surgery,
including single incision surgery for symptomatic liver
cyst is an excellent operative procedure in terms of mini-
mal invasiveness and cosmetic. This procedure can be an
alternative to conventional derooing for simple liver cyst.
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COMPLETELY LAPAROSCOPIC ALPPS
USING THE ROUND-THE-LIVER
LIGATION TO REPLACE
PARENCHYMAL TRANSACTION
X. Cai1, S. Peng2, Y. Wang1 and H. O. N. G. Yu1
1Surgery, Sir Run Run Shaw Hospital Zhejiang
University, Hangzhou, China; 2Surgery, The Second
Affiliated Hospital Zhejiang University, Hangzhou,
China
Objectives: To report a modified totally laparoscopic
ALPPS in treating patient with HCC complicated with
cirrhosis.
Methods: Two patients with HCC underwent totally
laparoscopic ALPPS using the round-the-liver ligation
to replace parenchymal transaction in the Sir Run Run
Shaw Hospital. The first-stage operation included lapa-
roscopic ligation of the left/right branch of portal vein
and execution of a round-the-liver ligature. The sec-
ond-stage operation, laparoscopic left/right lobectomy,
was carried out on the day 11 or day 12 after the first-
stage operation.
Results: The two-stage operation was performed suc-
cessfully on the two patients. They recovered unevent-
fully. No bile leakage occurred in either of them. The
FLR volume increased 94.8% in the first patient on
day 9 and 37.9% in the second patient on day 10 after
the first-stage operation.
Conclusion: The operation can be performed safely and
result in a rapid hypertrophy of liver remnant in
patients with HCC complicated with cirrhosis.
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APHPB-0734
PYLORUS PRESERVING
PANCREATICODUODENECTOMY FOR
SUPERAGED (95 YEAR OLD) PERSON
WHO HAD PANCREATIC HEAD
CANCER INDISTINGUISHABLE FROM
GROOVE PANCREATITIS
S. Min1
1Surgery, Ewha Womans University, Seoul, Korea
Objectives: We need consideration for strategy to treat
superaged person because modern society is an aging
society. I experienced treatemt of superaged person for
pancreatic head cancer with duodenal obstruction, so I
report possibility of radical treatment by major opera-
tion for superaged person.
Methods: The patinet was 95 year old man. He has
hypertension and diabetes mellitus. The low density
small lesion at pancreatic head and neck has been
found in his abdominopelvic computed tomography
(CT) during work up study since 2013. The lesion was
slowly increasing and combined duodenal nodular
lesion around the ampulla of Vater. Initially, the lesion
was considered focal pancreatis or groove pancreatitis.
Recently, he underwent nausea and vomiting due to
duodenal obstruction. So, he has been treated with
gastroenterostomy bypass surgery because of only one
reason of superaged person. However, his condition
deteriorated slowly with dyspepsia, anorexia and hyper-
bilirubinemia. Finally, we decide radical surgery after
take consent.
Results: He underwent radical pylorus preserving pan-
creaticoduodenectomy under general anesthesia. He
took the meal at 4th day after operation. He dis-
charged at 19th day after operation without problem.
The staging of his cancer was T3, N0, M0. His condi-
tion is very good state except mild general weakness.
His laboratory results are also normal range with
9.8 U/mL of CA19-9 (preoperative value: 88.6)
Conclusion: I think the age by itself is not contraindi-
cation of radical surgery for malignancy although who
is superaged person.
Malignant HPB Diseases
APHPB-0735
TOTALLY LAPAROSCOPIC
ANATOMICAL RESECTION FOR
CENTRALLY LOCATED TUMORS: 4
CASES
W. J. Kim1
1Liver Transplantation and Hepatobiliary Division, Asan
Medical Center, Seoul, Korea
Objectives: In this report, we present 3 cases of Totally
laparoscopic right anterior sectionectomy and 1 case of
totally laparoscopic central bisectionectomy.
Methods: Case 1 was 42-year-old man who was pre-
operatively diagnosed with Hepatocellular carcinoma
(HCC) at the bprder of segment 5 and 8. He was also
HBV carrier and Child-Pugh class A liver cirrhosis was
noted.
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Case 2 was 54-year-old man who was admitted for
3 cm hepatic mass detected by follow-up CT scan for
aortic dissection. and Case 3 was 51-year-old man was
admitted for 2.3 cm hepatic mass dected by MRI at
other general hospital. He was performed liver bx at
previous hospital and resulted ‘focal atypical hepato-
cytes proliferation’
The patient visit our center and He want to further
evaluation of hepatic lesion.
After 2-month later We rechecked MRI and showed
that 3 cm sized lobulating countour that strongly sug-
gestive HCC in the S5.
At last, case 4 was 38-year-old man who was admitted
for a hepatic mass located at the border of S4, 5, 8 and
rectal mass noted on a health screening test.
Results: Operative times for case 1,2,3 and 4 were
405,470,478 and 396 min and estimated blood loss dur-
ing operations was 545,510,260 and 515 mL. All 4
cases do not necessary transfusion during operations
and Patients 1,2,3 and 4 were discharged on postopera-
tive days 9,10,11 and 11 respectively.
Conclusion: This cases shows that totally laparocospic
anatomical resection can be safely performed in
patients with centrally located tumor (S4,5,8)
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APHPB-0736
INTER- AND INTRA-OPERATOR
REPRODUCIBILITY OF POINT SHEAR
WAVE ELASTOGRAPHY IN THE
EVALUATION OF LIVER ELASTICITY
M. Tuble1 and F. L. Morabe1
1Radiological Sciences, National Kidney and Transplant
Institute, Quezon City, Philippines
Objectives: To assess the reproducibility of point shear
wave elastography in the evaluation of liver elasticity
by determining the inter- and intra-observer agreement
between measurements performed in the same patient.
Methods: This is a retrospective study approved by the
hospital research ethics committee. One hundred four
patients met the inclusion/exclusion criteria.
Two independent operators acquired the elastography
measurements, in succession, for 10 consecutive mea-
surements each. The second operator was blinded by
the results of the first operator. The average value was
obtained and assigned its corresponding METAVIR
fibrosis stage. All examinations were standardized.
Measurements were acquired in the right liver lobe
through an intercostal approach, with patient in the left
lateral decubitus position.
Results: Within operator reliability (INTRAOBSERV-
ER) was excellent at 0.9229 (95% CI) and 0.8963 (95%
CI) for Operators 1 and 2, respectively. Overall intra
observer agreement was excellent at 0.9222 (95% CI).
Also, differences in liver stiffness did not significantly
vary across 10 consecutive measurements.
Estimated reliability (INTEROBSERVER) between
two operators was poor at 0.24, with 95% CI, which is
quite wide. Correlation in liver stiffness evaluation
between two operators was significantly low
(rho = 0.196).
Age, sex and BMI were not significant factors of rela-
tive discrepancy in liver stiffness measurements.
Conclusion: This study shows that INTERobserver dif-
ferences in point shear wave elastography liver stiffness
values do exist, again proving that ultrasound imaging
techniques are subject to user dependency. However, it
is characterized by high levels of INTRAobserver
agreement.
APHPB-0737
ENDOSCOPIC BILIARY STENTING AND
OMENTAL CHOLANGIOPLASTY AS A
SALVAGE PROCEDURE FOR A SEPTIC
PATIENT WITH BILE DUCT INJURY
POST CHOLECYSTECTOMY
J. Ng1, K. Tay1 and W. Kow1
1Department of Surgery, National University Health
System, Singapore, Singapore
Objectives: Patients can present with severe intra-
abdominal sepsis when major bile duct injury post cho-
lecystectomy is not identified during surgery leading to
delayed presentation. Standard repair techniques may
be technically difficult in the presence of extensive
inflammation. We report a case where endoscopic bili-
ary stenting together with omental cholangioplasty was
utilized as a salvage procedure.
Methods: A 30-year-old female was referred to our
hospital for further management of a bile duct injury
3 weeks after an open cholecystectomy performed in a
foreign hospital. Computed tomography scan of the
abdomen revealed multiple rim-enhancing collections in
the upper abdomen. Endoscopic retrograde cholangiog-
raphy revealed a large common hepatic duct leak just
below the hepatic hilum corresponding to a Strasberg
type E2 injury. Following sphincterotomy, plastic bili-
ary stents were inserted into the left and right hepatic
ducts. Upon laparotomy, a large 1.5 cm defect was
found at the antero-lateral aspect of the common hepa-
tic duct with both biliary stents visible from within.
The bile duct and adjacent tissues were extensively
inflamed and friable such that a hepatico-jejunostomy
cannot be performed. An omental cholangioplasty was
performed with a tongue of healthy omentum secured
to the defect to seal the biliary leak.
Results: The patient recovered with resolution of sepsis
and no further evidence of bile leak.
Conclusion: A combination of biliary stent placement
and omental cholangioplasty can be a safe and viable
salvage option for patients with major bile duct injury
post cholecystectomy and severe intra-abdominal sepsis
precluding standard repair methods.
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APHPB-0738
A NOVEL TECHNIQUE FOR
LAPAROSCOPIC DISTAL
PANCREATECTOMY WITH
SPLENECTOMY
M. Aikawa1, M. Miyazawa1, S. Ishida1, Y. Watanabe1,
K. Okada1, K. Okamoto1 and I. Koyama1
1GI Surgery, Saitama Medical University International
Medical Center, Saitama, Japan
Objectives: In laparoscopic distal pancreatectomy with
splenectomy, extension of the wound is needed to
extract the spleen, as the spleen is larger than the pan-
creas.
Methods: In the report, we describe a new technique
for safe extraction of the distal pancreas along with the
spleen, wherein the spleen is stored in the bag under
pneumoperitoneum and the pancreas and spleen are
then laparoscopically divided.
Results: This technique was employed in three cases.
The average total duration of the operation was 398
(range, 317–412) minutes and the average duration of
extraction was 64 (range, 31–92) minutes. The extracted
specimens could be used for pathological staging. No
operation-related complications were noted. The
patients were discharged from the hospital on an aver-
age of 9 (range, 7–27) days after the operation.
Conclusion: Through this novel method, we could per-
form laparoscopic distal pancreatectomy with splenec-
tomy in a safe manner, without extending the wound
size to more than 2 cm.
APHPB-0739
RESPONSE TO TRANSARTERIAL
CHEMOEMBOLIZATION MAY SERVE
AS SELECTION CRITERIA FOR
HEPATOCELLULAR CARCINOMA
LIVER TRANSPLANTATION
L. Jianyong1, L. N. Yan1 and W. T. Wang1
1Liver Surgery, West China Hospital of Sichuan
University, Chengdu, China
Objectives: This study sought to extend the inclusion
criteria for hepatocellular carcinoma (HCC) liver trans-
plantation (LT), particularly addressing the safety and
effectiveness of pre-LT transarterial chemoembolization
(TACE).
Methods: Our study included 115 patients with HCC
who underwent LT after TACE. The response mea-
sured after each TACE session was based on the mRE-
CIST criteria: complete response (CR), partial response
(PR), stable disease (SD) or progressive disease (PD).
We defined CR and PR patients as responders (64
cases) and SD and PD patients as non-responders (51
cases).
Results: The majority of responders could be identified
after the first or second TACE sessions (57 cases,
89.1%). Overall survival rates at 1, 3 and 5 years were
95.3%, 89.1% and 75.0%, respectively, in the respon-
der group, and these rates were much higher than those
in the non-responder group (86.3%, 66.7% and 54.9%,
p = 0.016). In addition, the tumor-free survival rate in
the responder group was also higher than in the non-
responder group (p = 0.009). In the responder group, a
statistically improved long-term outcome was observed
in patients whose HCC did not satisfy the Milan crite-
ria (p < 0.05). Univariate and multivariate Cox analy-
ses showed that achieving CR or PR was the best
predictor of survival and tumor-free survival following
TACE.
Conclusion: The response to TACE, particularly fol-
lowing the first two sessions, primarily and robustly
predicted overall and tumor-free survival in HCC
patients, particularly those whose HCC did not satisfy
the Milan criteria.
APHPB-0740
RESPONSE TO TRANSARTERIAL
CHEMOEMBOLIZATION COULD
SERVE AS AN INCLUSION CRITERION
FOR RESECTION OF BCLC-B
(INTERMEDIATE) HEPATOCELLULAR
CARCINOMA
L. Jianyong1, L. N. Yan1 and W. T. Wang1
1Liver Surgery, West China Hospital of Sichuan
University, Chengdu, China
Objectives: Liver resection for BCLC B stage hepato-
cellular carcinoma (HCC) is still controversial, this
study attempted to demonstrate the effectiveness of
pre-resection transarterial chemoembolization (TACE)
when it served as an inclusion criterion for BCLC-B
HCC.
Methods: The study included BCLC-B HCC patients
who underwent liver resection after TACE. The tumor
response to TACE was evaluated according to the
amended Response Evaluation Criteria in Solid
Tumors (mRECIST). Complete response (CR) and par-
tial response (PR) patients were classified into the
responder group, while patients with stable disease
(SD) and progressive disease were classified into the
non-responder group.
Results: 242 patients were included, after 1–8 sessions
of TACE, 37 HCCs (15.3%) achieved CR, and the
responder group (141 cases) also included 104 HCCs
with PR. The cumulative 1-, 3- and 5-year overall sur-
vival rates in the responder group were 97.2%, 88.7%
and 75.2%, respectively, which were much higher than
those in the non-responder group (101 cases, 90.1%,
67.3% and 53.5%; p < 0.001). The tumor-free survival
rates in the responder group were also much higher
than those in the non-responder group (p < 0.001). In
multivariate analysis, independent pre-resection predic-
tors of overall survival and tumor-free survival were
the response to TACE and microvascular invasion. In
the series of TACE procedures, the first two sessions of
TACE could offer the most reliable biological selection
criteria for BCLC-B HCC liver resection.
Conclusion: Response to TACE, particularly to the first
two sessions of TACE, according to mRECIST criteria,
represents a valid selection criterion for BCLC-B HCC
liver resection.
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APHPB-0741
HEPATECTOMY ON THE PROGNOSIS
IN HEPATOCELLULAR CARCINOMA
WITH TUMOR RUPTURE
K. Hung1, Y. Chen1, P. Hsieh1, K. Hsieh1, C. Wei1, H.
Lee1, S. Chou1, M. Tsai1, C. Hung1 and P. Lee1
1Surgery, E-Da Hospital/I-Shou University, Kaohsiung,
Taiwan
Objectives: The current TNM stagingsystems classify
ruptured hepatocellular carcinoma (HCC) as T4 based
oninsufficient evidence. Ruptured HCC has been asso-
ciated with the dismal prognosis. Due to this reason,
hepatectomy was not usually considered for ruptured
HCC. Theaim of the present study was to investigate
the survival benefit by surgicaltumor resection on the
patients with ruptured HCC.
Methods: There were 2427 patients withHCC from
2007 to 2012 in E-Da hospital, Taiwan. Ruptured
HCC was diagnosedaccording to abdominal pain, and
image study (sonography or CT) withhemoperitoneum.
A modified TNM staging classification adjusted from
the 7th edition of AJCC/UICC excluded the factor of
‘tumor rupture’. The survivalcurves using the modified
classification were generated and compared toevaluate
the survival benefit by surgical tumor resection on the
prognosis.
Results: 55 patients with rupturedHCC were diag-
nosed. The analyses showed that tumor rupture was
associated withan advanced tumor status (total = 55;
Stage I = 14, II = 3, IIIA = 19, IIIB = 6,IIIC = 2,
IVA = 6, IVB = 5, according to modified AJCC 7th
ed). Hepatectomy wasdone in 11 patients, in which 8
patients were in stage I and 3 patients in stageIII. Sur-
vival was significantly better in patients received hepa-
tectomy. Instage I, survival in the operative patients
were superior to the non-operativegroup.
Conclusion: HCC rupture itself had anegative impact
on survival. Hepatectomy was advised for those resec-
tablepatients with ruptured HCC. Further study should
be made to give additionalstages to the baseline tumor
staging in cases of ruptured HCC.
APHPB-0743
IDEAL SPHERE FOR MING CULTURE
CONDITION FOR MAINTAINING A
STEMNESS IN HEPATOCELLULAR
CARCINOMA CELL LINE
K. S. Kim1, S. O. Min1, S. Y. Park1 and S. W. Lee1
1Surgery, Yonsei University College of Medicine, Seoul,
Korea
Objectives: Cancer stem cells are one of the biggest
causes of tumor metastasis and recurrence. Sphere for-
mation is culture method of cancer stem cell. In this
study, we produced three different types of culture
medium for sphere formation of hepatocellular carci-
noma cell line.
Methods: Huh7 cells were plated in different culture
media allowed for sphere formation. To confirm the
stemness characteristics of sphere cells, the prolifera-
tion, expression of stem cell markers (Oct4, Nanog,
Sox2) of Huh7 sphere-forming cells. And we evaluated
the gene expression of cancer stem cells by RT-PCR
analysis with EpCAM, Connexin32 and Connexin43
primers and Immunocytochemistry assay with E-cadh-
erin, beta-catenin, CD90, CD133 antibodies on sphere-
forming cells. Flow cytometry was provided to confirm
stem cell markers and CD133, Connexin32
Results: Cells in M3 media showed higher level of cell
proliferation than in M1 or M2 media cells on 11 days,
while M1 media cells exhibited higher level than others
on post 20 days. Proliferation of M2 media cells did
not improve; consequently, it was impossible to obtain
sufficient amount of cell for further analysis. M1 and
M3 media cells had similar tendency on expression of
cell surface markers. In results of flow cytometry, there
were no significant differences between two groups
Conclusion: Results showed that sphere-forming cells
in M1 and M3 media had similar character. So, it is
assumed that our growth factor-free medium is more
efficient tool for in vitro cultivation of cancer stem
cells, because the tool shall be reduced expense for
experiments which may occur due to the treatment of
growth factors.
APHPB-0744
IMPLANTATION OF ADIPOSE
DERIVED STEM CELLS FOR TAILORED
THERAPY ON LIVER FIBROSIS
S. O. Lee1, S. O. Min1, S. Y. Park1 and K. S. Kim1
1Surgery, Yonsei University College of Medicine, Seoul,
Korea
Objectives: Adipose derived stem cells (ADSCs) were
known as the most appropriate mesenchymal stem cells
for therapeutical application because of rapid prolifera-
tion in vitro and harmless acquisition from patients.
This study was tried to grope the effective hepatogenic
differentiation using human ADSCs and the new cell
implantation for cell therapy on liver fibrosis.
Methods: Hepatogenic induced hADSCs with Activin
A, and various growth factors such as HGF, bFGF,
EGF and OSM for 20 days expressed the bipotential
hepatic precursor genes (Foxa2, CK7, Sox17 and
CK19) on low concentration of Col I, and the hepatic
specific genes (HNF4a, ALB) on high concentration by
RT-PCR analysis. After application of bipotential hep-
atogenic differentiated hADSCs and non differentiated
hADSCs into scaffolds, grafts were implanted into
SCID mice which had liver fibrosis by intraperitoneal
injection with TAA (thioacetamide) for 6 weeks.
Implanted scaffolds were maintained without degrada-
tion for 30 days after implantation.
Results: In implantation of hepatogenic differentiated
hADSCs applied scaffolds, blood serum albumin signif-
icantly increased higher than the datum of non-differ-
entiated hADSCs from post-op 10 days. In comparison
with intrasplenic injection, blood serum albumin had
higher levels in implantation groups of scaffolds. Also,
in results by immunohistochemical and immunofluores-
cence assay, CD34, VEGF and Ang-1, related with vas-
cularization, were expressed from the membrane of
implanted scaffolds to inner space.
Conclusion: In these results, it was affirmed that neo-
vascularization of implanted scaffolds originated by the
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stricture with around tissues. Furthermore, the develop-
mental possibility of fundamental bio-artificial liver and
the endocrine effect via implanted cells were evaluated.
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APHPB-0745
THE REASONS FOR FAILURES OF
ENDOSCOPIC TRANSPAPILLARY
INTERVENTIONS IN PATIENTS WITH
BILIARY PATHOLOGY
Y. Dutka1 and S. Chooklin1
1Department of Surgery, Danylo Halytsky National
Medical University, Lviv, Ukraine
Objectives: Laparoscopic cholecystectomy is character-
ized by high effectiveness, minimal traumatic and cos-
metic effect. In the presence of obstruction the
operation is accomplished by choledochoscopy with lit-
hoextraction or endocopic transpapillary intervention
(ETPI) on biliary system. But there are patients, whom
the effective conduction of these interventions is impos-
sible due to different reasons. The aim of the research
is the ascertaining of reasons for failures of endocsopic
transpapillary methods of decompression of the bile
ducts, their analysis and classification.
Methods: The results of treatment of 290 patients with
the pathology of the biliary system and obturation
jaundice have been given.
Results: Endoscopic cholangiography has been applied
in 243 (83.8%) patients, papillotomy for the access to
ductus choledochus and with the therapeutic aim – in
198 (68.3%). The main reasons for the impossibility of
elimination of biliary pathology with the help of ETPI
were: changes of anatomy, connected with parapapil-
lary diverticulum, stenosis of papilla and distal part of
ductus choledochus, deformation of stomach and duo-
denum due to inosculation or attendant pathology,
ulcer stenosis of pylorus – in 108 (37.2%); big size of
concrements in extrahepatic bile ducts – in 87 (30.0%),
syndrome of Mirizzi II – in 47 (16.2%); strictures of
ductus hepaticus communis and ductus choledochus –
in 17 (5.9%); previous operations on stomach (Bilroth-
II resection) – in 16 (5.5%); biliodigestive fistula – in
15 (5.2%) patients.
Conclusion: The most frequent reason for impossibility
of endoscopic transpapillary interventions in biliary
pathology are the anatomic changes and big size con-
crements in the bile ducts.
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APHPB-0746
COMBINATION OF LOCAL
DESTRUCTION METHODS IN
PRIMARY AND METASTATIC LIVER
CANCER TREATMENT
D. Ionkin1, A. Chzhao1 and S. Kungurtsev1
1General Surgery, A.V. Vishnevsky Institute of Surgery,
Moscow, Russia
Objectives: to improve treatment outcomes in patients
with metastatic and primary liver cancer.
Methods: Combinations:
1. Cryoablation (CA) in pts with HCC (6) and MTS of
CRC (3)+percutaneous foci alcoholisation in the p/o
period.
2. Liver rezsection for MTS+CA of surface node
located on the branches of the VP (3), on the hepatic
vein (1)+RFA.
3. During resection for HCC due we used the following
combination: lesion on the periphery was processed
using RFA and thereafter subjected to CA (n = 2).
4. Right hemihepatectomy with RFA for MTS+CA of
subcapsular MTS, located directly on the left branch of
the portal vein (1).
5. pRFA for MTS + MBA of metastasis enveloping
the right portal vein (2).
6. CA+ a porous-permeable nickel-titanium applicators
are justified in their use (4).
It is important that over the last years all patients have
subsequently undergone appropriate adjuvant chemo-
therapy, which in 6 cases was supplemented by regional
chemoembolization.
Results: The immediate p/o period in these patients
was uneventful. Noted in 2 pts moderate hydrothorax
was treated with puncture. Wounds healed by first
intention. When monitoring in 2, 4, 6 months there
were no signs of continued growth and other manifes-
tations of the cancer progression.
Conclusion: The treatment outcomes in pts with neo-
plasms of the liver using the local destruction methods,
and their combinations, as well as at the liver resection
depends on prognosis factors.
APHPB-0747
PERCUTANEOUS TRANSHEPATIC
CHOLANGIOGRAPHY AND
INTRADUCTAL RADIOFREQUENCY
ABLATION COMBINED WITH BILIARY
STENTING FOR MALIGNANT BILIARY
OBSTRUCTION
T. Li1, X. Han1 and Z. H. E. N. Li1
1Interventional Radiology, the First Affiliated Hospital
of Zhengzhou University, Zhengzhou, China
Objectives: To determine the safety and feasibility of
percutaneous transhepatic cholangiography (PTC) and
intraductal radiofrequency ablation combined with bili-
ary stenting for malignant biliary obstruction.
Methods: We reviewed the data of unresectable malig-
nant biliary obstruction patients who underwent PTC,
intraductal radiofrequency ablation and biliary stenting
(n = 12) or PTC and biliary stenting only (control
group; n = 14). Postoperative complications, jaundice
remission and stent patency were assessed.
Results: All operations were successful. No severe com-
plications (e.g., biliary bleeding, perforation) occurred.
Two experimental-group patients developed cholangitis,
which resolved with conservative treatment. The 1-week
jaundice-remission and 3-month stent-patency rates
were similar in both groups, but the 6-month stent-
patency rate was higher in the experimental group
(p < 0.05). In the experimental group, there occurred
one death due to alimentary hemorrhage (unrelated to
stenting) by 3 months and two cases of recurrent jaun-
dice by 6 months. The latter two patients underwent
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repeat PTC, ablation and stenting. In the control
group, there occurred one death due to hepatic failure
caused by progressive jaundice at 3 months, and
another death due to disseminated intravascular coagu-
lation caused by jaundice recurrence at 138 days after
stenting. In addition, seven patients developed jaundice
recurrence (50–151 days after stenting). PTC and repeat
stenting were performed in these patients.
Conclusion: PTC and intraductal radiofrequency abla-
tion combined with biliary stenting for malignant bili-
ary obstruction is safe, feasible and effectively prolongs
stent-patency time. A large randomized controlled trial
is required to validate this finding.
APHPB-0748
PERCUTANEOUS TRANSHEPATIC
CHOLANGIOBIOPSY FOR THE
PATHOLOGICAL DIAGNOSIS OF
ANASTOMOTIC STENOSIS AFTER
CHOLANGIOJEJUNOSTOMY FOR
MALIGNANT OBSTRUCTIVE
JAUNDICE
T. Li1, X. Han1 and Z. H. E. N. Li1
1Interventional Radiology, the First Affiliated Hospital
of Zhengzhou University, Zhengzhou, China
Objectives: Cholangiobiopsy during percutaneous tran-
shepatic cholangiography provides histopathological
samples to guide clinical treatment. We aimed to dis-
cuss the feasibility and advantages of this technique in
the pathological diagnosis of anastomotic stenosis after
cholangiojejunostomy for malignant obstructive jaun-
dice.
Methods: Using biopsy forceps, we collected specimens
from the stenosis site of patients with recurrent jaun-
dice (n = 32) who had previously undergone chol-
angiojejunostomy for malignant obstructive jaundice.
Results: Stenosis occurred in all patients at the biliary-
enteric anastomosis based on percutaneous transhepatic
cholangiography, and was the location of the biopsy.
Satisfactory specimens were obtained from all patients.
The sensitivity was 90.6% (29/32). We obtained tumor
tissue in 23 cases and confirmed tumor recurrence.
Pathological changes in six patients were diagnosed as
fibroplasia and/or inflammation. We considered these
cicatricial stenoses based on pathological, imaging and
laboratory findings. The remaining three pathology-
negative patients were proven to be recurrent tumor
based by imaging, laboratory and follow-up data. No
complications occurred during biopsy, including gastro-
intestinal hemorrhage or perforation.
Conclusion: Percutaneous transhepatic cholangiobiopsy
using biopsy forceps for the diagnosis of anastomotic
stenosis after cholangiojejunostomy for malignant bili-
ary obstructive jaundice is easy to perform, safe and
has a high sensitivity.
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APHPB-0749
MANAGEMENT OF ENDOSCOPIC
RETROGRADE
CHOLANGIOPANCREATOGRAPHY
RELATED PER FOR ATIONS
J. Jeon1, T. Kim1 and Y. Ryu1
1General Surgery, Hallym University Sacred Heart
Hospital, Anyang Gyeonggi-do, Korea
Objectives: The purpose of this study is to analyze the
treatment strategies of patients with endoscopic retro-
grade cholangiopancreatography (ERCP)-related perfo-
rations. This is a retrospective study.
Methods: We experienced 15 perforations associated
with ERCP. We reviewed the medical recordsand clas-
sified ERCP-related perforations according to mecha-
nism of injury in terms of perforating device. Injury by
endoscopic tip or insertion tube was classified as type I,
injury by cannulation catheter or sphincterotomy knife
as type II, and injury by guidewire as type III.
Results: Of four type I injuries, one case was managed
by conservative management after primary closure with
a hemoclip during ERCP. The other three patients
underwent surgical treatments such as primary closure
orpancreatico-duodenectomy. Of six type II injuries,
two patients underwent conservative management and
the other four cases were managed by surgical treat-
ment such as duodenojejunostomy, duodenal diverticu-
lization and pancreatico-duodenectomy. Of five type III
injuries, four patients were managed conservatively and
the remaining patient was managed by T-tube choledo-
chostomy.
Conclusion: Type I injuries require immediate surgical
management after EPCP or immediate endoscopic clo-
sure during ERCP whenever possible. Type II injuries
require surgical or conservative treatment according to
intra- and retro-peritoneal dirty fluid collection findings
following radiologic evaluation. Type III injuries
almost always improve after conservative treatment
with endoscopic nasobilliary drainage.
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APHPB-0750
THE CURATIVE EFFECT ANALYSIS OF
BILIARY STENT COMBINED ANTI-
TUMOR THERAPY FOR
EXTRAHEPATIC
CHOLANGIOCARCINOMA
J. Ren1, K. Zhang1, M. Zhang1, X. Han1 and G.
Huang1
1Interventional Radiology, the First Affiliated Hospital
of Zhengzhou University, Zhengzhou, China
Objectives: To discuss the curative effect of biliary
stent combined Anti-tumor therapy for extrahepatic
cholangiocarcinoma.
Methods: collect the clinical and imaging data of 123
patients who were diagnosed as extrahepatic cholangio-
carcinoma by biliary forceps biopsy in percutaneous
transhepatic cholangiography (PTC) from January
2013 to march 2014.60 patients of them were treated
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by self-expanding metallic stents with subsequent anti-
tumor therapy. They were randomly divided into A?B?
C three groups, 20 patients in each group, and artery
infusion chemotherapy for A group, particles chain of
125I into biliary tract for B group and combination
treatment of A and B group for C group. Meanwhile,
we bring 60 patients who only receive biliary stent
placement into the study as control group. Observe the
operative complication and admission of jaundice of
the control group, treatment group and each subgroup
that use different therapy, closely follow and compare
the 3 months and 6 months of stent patency after the
operation.
Results: All patients with postoperative get complete
follow-up by outpatient or telephone, the total bilirubin
and direct bilirubin of these patients were significantly
decreased. The stent patency rate of treatment group
and control group for 3 months after operation is 56/
60 and 51/62 (p = 0.06), and A?B?C subgroup is 18/20?
19/20?19/20 (p = 0.7684) respectively. The stent patency
rate for 6 months after operation is 42/60?27/62
(p = 0.0032), and A?B?C subgroup is 13/20?11/20?18/20
(p = 0.0477) respectively.
Conclusion: Stent placement with anti-tumor therapy
can obviously prolong stent patency time. And between
different anti-tumor treatment, comprehensive treat-
ment methods of artery infusion chemotherapy with
particles chain internal radiation therapy have more
advantages to prolong stent patency time.
APHPB-0751
THE TREATMENT OF MALIGNANT
BILIARY OBSTRUCTION BY SELF-
EXPANDING METALLIC STENT
COMBINED WITH BILIARY STENT
J. Ren1, K. Zhang1, G. Huang1, M. Zhang1, X. Duan1
and X. Han1
1Interventional Radiology, the First Affiliated Hospital
of Zhengzhou University, Zhengzhou, China
Objectives: To investigate the feasibility and safety of
percutaneoustranshepatic biliary endovenous radiofre-
quency ablation technique for palliative treatment of
malignant obstructive jaundice
Methods: To analyze 20 cases patients with unresec-
table malignant biliary obstruction, 9 of them under-
went percutaneous liver puncture biliary tract lumen
radiofrequency ablation from the perspective and
placed metallic biliary stent; the residual 11 similar
cases placed metallic biliary stent only after successful
PTC. Then operative complications and remission of
jaundice between 2 groups need to be observed and
stent patency after percutaneous liver puncture biliary
tract lumen radiofrequency ablation 3 months and
6 months should be followed closely.
Results: All patients were followed completely by out-
patient or telephone. The stent patency of Percutaneous
liver puncture biliary tract lumen radiofrequency abla-
tion was 9/9 and the controlled group was 8/11
(p = 0.218) after 3 months. After 6 months the stent
patency was 8/9 and 3/11 (p = 0.02) respectively. Dur-
ing follow-up, 1 case in the group with Percutaneous
liver puncture biliary tract lumen radiofrequency abla-
tion died from gastrointestinal bleeding, 1 case in the
controlled group died from hepatic failure after 57 days
and 1 case died from DIC after 142 days.
Conclusion: The treatment method of Percutaneous
liver puncture biliary tract lumen radiofrequency abla-
tion is safe and feasible, and the Preliminary efficacy of
self-expanding metallic stent in liquidity is satisfactory,
but The treatment method need A large sample ran-
domized controlled studies to verify further.
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APHPB-0752
COMPARISON OF PERCUTANEOUS
TRANSHEPATIC VARICEAL
EMBOLIZATION (PTVE) FOLLOWED
BY PARTIAL SPLENIC EMBOLIZATION
VERSUS PTVE ALONE FOR THE
TREATMENT OF ACUTE
ESOPHAGOGASTRIC VARICEAL
MASSIVE HEMORRHAGE
J. Ren1, X. Duan1, K. Zhang1, G. Huang1, M. Zhang1
and X. Han1
1Interventional Radiology, the First Affiliated Hospital
of Zhengzhou University, Zhengzhou, China
Objectives: To compare the efficacy of percutaneous
transhepatic variceal embolization (PTVE) followed by
partial splenic embolization (PSE) with that of PTVE
alone for the treatment of acute massive hemorrhage of
esophagogastric varices in patients with cirrhosis
unable to undergo alternative procedures
Methods: Sixty-five patients with acute variceal massive
hemorrhage were retrospectively studied, including 31
who underwent PTVE/PSE and 34 who underwent
PTVE and refused PSE. Recurrent bleeding rate, sur-
vival rate, postoperative complications, number of days
of hospitalization after PTVE, and outcome were eval-
uated. Peripheral blood cell counts and hemoglobin lev-
els before and at 1 week and 6, 12, and 24 months
after intervention were analyzed.
Results: Cumulative recurrent bleeding rates at 6, 12,
and 24 months after intervention in the PTVE/PSE
group were 3.2%, 6.7%, and 13.3%, compared with
20.6%, 36.7%, and 53.6%, respectively, in the PTVE
group; the difference at each time point was statistically
significant (all p < 0.01). There were more cases of asci-
tes and portal hypertensive gastropathy after PTVE
than after PTVE/PSE (p < 0.05). Survival rates at 6,
12, and 24 months in the PTVE/PSE group were
100%, 96.8%, and 96.8%, compared with 94.1%,
88.2%, and 82.4%, respectively, in the PTVE group.
There were significant differences in peripheral blood
cell counts and hemoglobin levels between the PTVE/
PSE and PTVE groups at all observed time points (all
p < 0.01).
Conclusion: PTVE/PSE not only has long-term efficacy
in alleviating hypersplenism, but decreases recurrent
bleeding and maintains hepatic reserve in patients with
cirrhosis and esophagogastric variceal massive hemor-
rhage unable to undergo other procedures.
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APHPB-0753
OUTCOMES OF THROMBOLYSIS WITH
AND WITHOUT PREDILATION OF THE
INFERIOR VENA CAVA (IVC) IN
PATIENTS WITH BUDD-CHIARI
SYNDROME WITH OLD IVC
THROMBOSIS
J. Ren1, G. Huang1, K. Zhang1, X. Duan1, M. Zhang1
and X. Han1
1Interventional Radiology, the First Affiliated Hospital
of Zhengzhou University, Zhengzhou, China
Objectives: To compare the efficacy of thrombolysis
with and without predilation of the inferior vena cava
(IVC) for Budd-Chiari syndrome (BCS) with old IVC
thrombosis.
Methods: We divided 40 patients with BCS with old
IVC thrombosis into 2 groups, group A (n = 21),
thrombolysis after dilation of the obstructed IVC and
group B (n = 19), thrombolysis without predilation of
the obstructed IVC. Thrombolysis was performed via
urokinase administration through the dorsal vein of the
foot.
Results: Color Doppler ultrasonography at 30 days
showed complete resolution of the thrombus in 21
(100%) group A patients and 6 group B patients
(31.6%; p < 0.001). Thrombolysis was achieved using a
lower dose of urokinase and within a shorter time
frame in group A than in group B (p < 0.001).
Conclusion: Thrombolysis after dilation was superior
to thrombolysis alone and was safe and efficacious in
patients with BCS with old IVC thrombosis.
APHPB-0755
USE OF STREPTOKINASE FOR
ENHANCEMENT OF PERCUTANEOUS
DRAINAGE OF PANCREATIC
NECROSIS: A DOUBLE BLINDED
RANDOMIZED CONTROLLED TRIAL
R. Gupta1, R. Gupta1, M. Kang2, D. Bhasin3, M.
Khullar4 and R. Singh1
1Surgical Gastroenterology Division Department of
General Surgery, Postgraduate Institute of Medical
Education & Research, Chandigarh, India; 2Radiology,
Postgraduate Institute of Medical Education &
Research, Chandigarh, India; 3Gastroenterology,
Postgraduate Institute of Medical Education &
Research, Chandigarh, India; 4Experimental Medicine,
Postgraduate Institute of Medical Education &
Research, Chandigarh, India
Objectives: To study safety and efficacy of streptoki-
nase in enhancing percutaneous drainage of pancreatic
necrosis.
Methods: Patients of severe acute pancreatitis managed
with percutaneous catheter drainage from April 2013 to
December 2014 will be included in the trial. Currently,
27 patients have been recruited and randomized to pla-
cebo group (PG) & streptokinase group (SG). Patients
not responding to percutaneous drainage underwent
necrosectomy. Primary endpoints were sepsis reversal
and death. Secondary end points were catheter and
streptokinase related complications, need for surgical
necrosectomy and duration of hospital stay.
Results: There were twenty males and seven female.
The mean age was 35.9 years. The most common etiol-
ogy was alcohol [65.38%]. The modified CTSI,
APACHE II and MMS of the two groups at randomi-
zation were similar. Sepsis reversal was seen in 7/12 in
PG and in 4/13 patients in SG (p = 0.247). Twelve
patients expired, seven in SG and five in PG
(p = 0.551). Major complications [bleeding, enterocuta-
neous fistula] occurred in eleven, six in SG and five in
PG (p = 0.825). There were no streptokinase related
complications. Ten required surgical necrosectomy for
sepsis, five in each group while two patients in PG
required surgery for bleeding and two patients in SG
for colonic perforation. The mean duration of hospital
stay after randomization in PG was 25.3 days while it
was 19.9 days in SG (p = 0.26).
Conclusion: This is first study of its kind to demon-
strate use of streptokinase in pancreatic necrosis and its
safety. (Clinicaltrials.gov Identifier: NCT01977118).
Transplantation
APHPB-0757
AN EARLY SINGLE-CENTER
EXPERIENCE OF ABO INCOMPATIBLE
LIVING DONOR LIVER
TRANSPLANTATION: NEW SIMPLIFIED
INTRAVENOUS IMMUNOGLOBULIN
PROTOCOL WITHOUT LOCAL
INFUSION THERAPY
J. Kim1 and D. Choi1
1Department of Surgery, Catholic University of Daegu
College of Medicine, Daegu, Korea
Objectives: Since various innovative strategies including
rituximab have been introduced, the outcomes of recip-
ients in ABO incompatible (ABO-I) living donor liver
transplantation (LDLT) have markably improved.
Thus, ABO-I LDLT can be a feasible therapeutic
option for the patient with end-stage liver disease if
ABO compatible donor is not available. Herein, we
describe 22 cases of ABO-I LDLT with new simplified
protocol and compare the outcomes with those in ABO
compatible LDLT.
Methods: We analyzed the outcomes via retrospective
review of 172 adult LDLT cases including 22 ABO-I
LDLT cases from Janary 2011 to June 2014. The
desensitization protocol comprised plasma exchange,
rituximab, intravenous immunoglobluin without local
infusion therapy. The preoperative anti-ABO antibody
was achieved ≤32 by performing plasma exchange.
Splenectomy was not performed routinely.
Results: The median MELD score was 16 (range, 8–37)
and the initial range of isoagglutinin IgM and IgG titers
were 1:4–1:512 and 1:8–1:1024, retrospectively. The com-
parisons between two groups showed no significantly dif-
ferences in demographics, perioperative variables, and
survival for patients and grafts. Although significant
rebound elevation in anti-ABO titer occurred in three
cases, Neither C4d staining in the graft nor clinical signs
of antibody mediated rejection (AMR) was not apparent
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in these cases. Moreover, neither diffuse intrahepatic bil-
iary stricture nor anastomotic biliary stricture was
encountered at all ABO-I group.
Conclusion: Neither definite immunological failure nor
biliary stricture occured in 22 consecutive cases under
this desentization protocol. Therefore, this new simpli-
fied protocol could be considered as safe and effective
modality to overcome ABO blood type barrier in
ABO-I LDLT.
Benign HPB Diseases
APHPB-0758
EXTRACELLULAR HISTONES
INDICATE DISEASES ACTIVITY AND
EXACERBATE INFLAMMATION IN
ACUTE LIVER INJURY
T. Wen1 and Y. Liu2
1Beijing Institute of Hepatology, Beijing Youan Hospital
affiliated with Capital Medical University, Beijing,
China; 2Department of Liver Diseases, Beijing Youan
Hospital affiliated with Capital Medical University,
Beijing, China
Objectives: Activation of systemic inflammatory
responses syndrome (SIRS) may promote acute liver
failure (ALF), but the key factors that trigger SIRS in
this process are unknown. In this study, we used a
murine model of ALF caused by D-galactosamine
(GalN) pluslipopolysaccharide (LPS), and human
plasma samples from patients with ALF to test a puta-
tive inflammatory role of extracellular histones.
Methods: Mice were given a lethal dose of GalN/LPS
to induce ALF. Hepatic function, liver histology as well
as extracelluar histones in the plasma of mice were
measured. To further check the role of histones related
to ALF, exogenous histones and anti-histone neutral-
ized antibody were administered to GalN/LPS-treated
mice, respectively. Meanwhile, human plasma samples
from ALF patients were analyzed for the levels of cir-
culating histones.
Results: GalN/LPS caused severe liver damage in mice,
as evidenced by increased ALT levels, massive hepato-
cyte death. Extracellular histones were found increased
notably in GalN/LPS-treated mice and correlated with
ALT levels. Exogenous histones demonstrated potent
toxic effects by decreasing the survival rate in mice,
whereas anti-histone antibody significantly protected
mice from death. Similarly, extracellular histones were
elevated considerably in the plasma of patients with
ALF. It was found that the plasma in ALF patients
was cytotoxic to mouse primary hepatocytes and acti-
vated mouse NPCs, whereas anti-histone antibody
blocked such the effects.
Conclusion: Extracellular histones may act as a marker
indicating the severity of ALF. Besides, histones con-
tribute to liver damage by exacerbating inflammation
remarkably and blockade of histones shows potent pro-
tective effects, which may become a potential therapeu-
tic target.
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APHPB-0759
A STUDY OF OTHER PRIMARY
CANCER IN PATIENTS WITH TUMORS
OF THE MAJOR DUODENAL PAPILLA
S. Hara1, N. Okano1, Y. Kishimoto1, K. Takuma1,
K. Ito1, T. Mimura1 and Y. Igarashi1
1Internal Medicine, Toho University Omori Medical
Center, Tokyo, Japan
Objectives: Tumors of the major duodenal papilla is
similarly reported to be accompanied by the presence
of primary cancer in other organs. We studied that the
patients with tumor of the major duodenal papilla have
other organ’s cancer in our hospital.
Methods: 91 patients with a tumor of the major duode-
nal papilla (48 men, 43 women) who were treated from
October 2002 to February 2014. 65 patients were per-
formed endoscopic snare excision and 26 were under-
went surgical resection. Multiple primary tumors were
defined in accordance with the criteria of Warren et al.
Results: Of the 91 patients, 30 were adenocarcinoma,
11 were carcinoma in adenoma, 44 were adenoma, 5
were an endocrine tumor, and 1 was papillitis. 19 were
found to have primary cancer in other organs. Of these
19 patients, 8 had synchronous cancer while 11 had
metachronous cancer. In 11 patients with metachro-
nous cancer, multiple primary cancer was noted preop-
eratively in 7 patients and which was noted
postoperatively in 4 patients.
Conclusion: Tumors of the major duodenal papilla are
often accompanied with other organ’s cancer. When
patients with tumors of the major duodenal papilla
undergo endoscopic snare excision or surgery, they are
needed to screening examinations for not only digestive
tract but also other organs before or after treatment.
Benign HPB Diseases
APHPB-0760
COMBINED MINIMALLY INVASIVE
MANAGEMENT OF INFECTED
PANCREATIC NECROSIS: A CASE
REPORT
W. KIm1 and Y. Lee1
1Surgery, Seonam University Jesus Hospital, Jeonju,
Korea
Objectives: Infected pancreatic necrosis (IPN) is the
most threatening complication of severe acute pancrea-
titis. Open surgical necrosectomy is still the procedure
of choice in the treatment of infected pancreatic necro-
sis and debridement is usually performed through lapa-
rotomy.
Methods: A 40-year-old man was referred to surgical
department from gastrointestinal department for fur-
ther treatment of the complication of the acute pancre-
atitis after endoscopic ampullectomy due to tubular
adenoma with severe dysplasia. Computed tomography
scans revealed a diffuse acute necrotic collection (ANC)
involving the body and tail of the pancreas. The patient
received maximal conservative treatment including
intensive fluid replacement, enteral and parenteral
nutrition after endoscopic pancreatic duct insertion.
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The patient’s clinical condition deteriorated during the
4 week of the disease with fever and increased serum
C-reactive protein of 28 mg/dL despite of antibiotic
therapy, endoscopic pancreatic duct drainage, ultraso-
no-guided PCD 2 times and PCD drainage for left
pleural effusion. The patient condition was not changed
with local sepsis.
Results: He underwent laparoscopic peripancreatic nec-
rosectomy through mesocolic window. The necrotic
debris was removed piecemeal using grasping forceps
under the visual guidance of a laparoscope. The post-
necrotic cavity was thoroughly irrigated and closed suc-
tion drain was left for negative pressue drainage.
Postoperatively, the patient’s condition improved and
the inflammatory parameters normalized. Patient was
discharged on the 35th days after laparoscopic peripan-
creatic necrosectomy and he remains asymptomatic
4 years after discharge.
Conclusion: Combined minimally invasive management
of infected pancreatic necrosis is effective.
APHPB-0761
PROSPECTIVE RANDOMIZE CONTROL
STUDY OF CLINICAL USEFULNESS OF
PROPHYLACTIC ANTIBIOTICS
THERAPY IN LAPAROSCOPIC
CHOLECYSTECTOMY: PRELIMINARY
RESULT
S. Bae1, H. Yu1, J. Yang1, H. Hwang1, S. Ahn1 and B.
Cho1
1Surgery, Chonbuk National University Hospital, Jeonju,
Korea
Objectives: Laparoscopic cholecystectomy (LCC) is the
procedure of generating a low infection ratio, the role
of Antibiotics prophylaxis is debatable. We evaluated
the usefulness of prophylactic antibiotics during LCC
performed.
Methods: The clinical features of all patients performed
LCC at Chonbuk National University Hospital
between April and September 2014 were randomized
studied by comparing them with antibiotic group
(n = 49, AG, cefotetan 1 g, 1 dose/prophylactic) and
non-antibiotic group (n = 51, NAG) by table of ran-
dom numbers. The clinical variables were pre- and
post-operatively blood test, symptoms and imaging to
evaluate whether the infection.
Results: There were no significant differences in clinical
characteristics between the two groups.
One of NAG (1.96%) was fever at 2nd post-operative
day (POD). At 14th POD, Three of NAG (5.88%) had
symptoms of RUQ pain, 1 patient had a sub-hepatic
fluid collection but no bacteria growth in culture and
the other 2 patients were just a pain caused by fecal
impaction without such findings seem to suspect infec-
tion. And 1 patient in NAG (1.96%) had a serous
wound discharge at 14th POD, also bacteria were not
identified.
There was no significant difference between the two
groups in comparison of factors to suspect infection
such as fever (≥38 ?), leukocytosis (≥12,000/mm3),
Elevation of ESR (>9 mm/h) and CRP (>5 mg/L).
Conclusion: In our results, antibiotic prophylaxis is no
significant differences in both groups. Therefore it is
not necessary to use prophylactic antibiotics during
elective laparoscopic cholecystectomy in patients of
including criteria, but to confirm this result further
studies with more patients and large trials are required.
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APHPB-0762
THE ALTERNATIVE SOURCE OF
ADIPOSE DERIVED STEM CELLS
FROM FALCIFORM LIGAMENT
S. W. Lee1, S. O. Min1 and K. S. Kim1
1Surgery, Yonsei University College of Medicine, Seoul,
Korea
Objectives: We investigated the aptness as a new type
of adult stem cells or adipose derived stem cells (ADS-
Cs) for differentiation into liver therapeutic cells using
adipose tissues derived from liver falciform ligaments
(LF-ADSCs).
Methods: Adult stem cells were isolated from patient’s
liver falciform adipose tissues and abdomen subcutane-
ous adipose tissues. Cells were cultivated in MSCs cul-
ture medium. Properties as adult stem cells were
proved by flow cytometry, RT-PCR analysis, immuno-
cytochemistry assay and multilineage differentition.
And, the hepatic induction compared with ADSCs was
performed by three step differentiation protocol with
various growth factors.
Results: Morphology LF-ADSCs was similar to ADS-
Cs and had highly expansion capacity. Characteristics
as adult stem cells via various analysis was also similar
to ADSCs. However, in particular, hematopoietic and
MET related surface markers (CD133, CD34, CD45
and E-cadherin) were expressed on LF-ADSCs. And,
Foxa2, CK19 and HNF4a genes, as hepatic induction
markers, were expressed similar to hepatic induced
ADSCs on hepatic induction day 12.
Conclusion: LF-ADSCs had other type of character
compared with ADSCs on surface markers. However,
proliferation, multilineage capacity and hepatic induc-
tion of LF-ADSCs were similar to ADSCs. So, LF-
ADSCs could be used for tailored therapy as a new
source of adult stem cells.
APHPB-0763
BIOCHEMICAL ALTERATIONS IN
MALIGNANT OBSTRUCTIVE
JAUNDICE: EFFECT OF PRE-
OPERATIVE DRAINAGE
M. Afify1, N. Samy2, A. Nabila2 and Y. Ahmed3
1Biochemistry Department, National Research Center,
Agouza, Egypt; 2Biochemistry Department, National
Research Center, Cairo, Egypt; 3Surgical Department,
Faculty of Medicine Banha University Egypt, Cairo,
Egypt
Objectives: The benefit of preoperative biliary drainage
in jaundiced patients undergoing pancreaticoduodenec-
tomy for a suspected cancer head of pancreas is still
under debate. This study evaluated the postoperative
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outcomes of preoperative biliary drainage with delayed
surgery and immediate surgery.
Methods: This study conducted on 42 patients who
had malignant obstructive jaundice, besides 25 healthy
subjects. Patients divided into group (I) was taken ini-
tially for preoperative biliary drainage and stent inser-
tion for a period of 3 weeks followed by surgery and
group (II) received immediate surgical decompression.
We determined liver functions, immunoglobulins (IgA,
IgG, and IgM) and cytokines (IL-6, IL-8, and IL-10).
Results: Results, mean serum bilirubin in-group (I) was
16.3 mg/dL at admission and fell to 2.7 mg/dL by three
week post drainage. While in-group (II), it was
15.9 mg/dL at admission. The morbidity and mortality
were significantly reduced in-group (I) compared to
group (II). The serum immunoglobulin IgA level was
significantly increased at admission in both groups (I &
II). Its level was significantly decreased in-group (I)
three weeks after drainage, and one-week post-opera-
tive in both groups. At admission, the circulating IL-8
concentrations were significantly high at admission in
both groups (I & II) and reduced significantly after
drainage in group (I), and one week post-operative in
both groups (I & II).
Conclusion: In conclusion, our study point at the clini-
cal significance of the preoperative biliary drainage
when major surgery is required in patients with malig-
nant obstructive jaundice, since it improves the overall
morbidity and mortality.
APHPB-0764
CHEMORADIATION WITH OR
WITHOUT BRACHYTHERAPY FOR
UNRESECTABLE KLATSKIN TUMOURS:
PROMISING RESULTS FROM A
PROSPECTIVE STUDY
S. Jayant Sastri1, R. Engineer2, N. Kalyani2, S.
Chaudhari3, T. Dharia4, N. Shetty4, S. Mehta5, M.
Goel6 and S. Shrivastava2
1Radiation Oncology, ACTRECTata Memorial Centre,
Mumbai, India; 2Radiation Oncology, Tata Memorial
Hospital, Mumbai, India; 3Medical Physics, Tata
Memorial Hospital, Mumbai, India; 4Intervention
Radiology, Tata Memorial Hospital, Mumbai, India;
5Digestive Diseases and Clinical Nutrition, Tata
Memorial Hospital, Mumbai, India; 6Surgical Oncology,
Tata Memorial Hospital, Mumbai, India
Objectives: Klatskin tumours are rare tumours with
poor prognosis. The present study was undertaken to
evaluate outcomes in patients undergoing high dose
chemoradiation (CRT)+/-endobiliary brachytherapy
EBBT).
Methods: From Aug 2005 to July 2012, 65 patients
were included. Patients were treated with either EBBT
with high-dose-rate Iridium-192 (median dose: 14 Gy)
delivered through the PTBD catheter or CRT alone
(52.5–57.5 Gy/25 fractions with concurrent weekly
gemcitabine (300 mg/m2) or with a combination of
CRT and EBBT. Univariate and multivariate analysis
for factors impacting outcome was performed.
Results: Overall 22 (34%) received only EBBT, while
27 (41%) received both EBBT and CRT and 16 (25%)
recieved high dose CRT. A total of 42 patients had
complete (n = 21) and partial response (n = 21) Other
patients had stable or progressive disease. Peritoneum
(13 patients) and liver (n = 4) were commonest sites of
distant progression.
Median follow up for whole group was 9 months
(6–17.5 months), while the same for surviving patients
was 15 months (14–18 months). The 2 year OS was
10% for whole group and 15% for EBRT group.
Patients receiving EBBT and CTRT or high dose CTRT
alone had better OS as compared to patients receiving
EBBT alone at 1 year (57% vs. 17%, p = 0.005). Simi-
larly, OS was better for male patients patients (55% vs.
35%, p = 0.006) and for patients having complete
response (70% vs. 34%, p = 0.005). On multivariate
analysis, treatment with EBRT and complete response
were significant factors influencing OS.
Conclusion: High dose chemoradiation leads to promis-
ing survival rates in patients with unresectable Klat-
skin’s tumours.
APHPB-0765
BY DOWNREGULATING KU80, MIR-
526B FUNCTIONED AS A TUMOR
PROMOTER THROUGH APOPTOSIS IN
HCC
Z. Zhang1 and Z. Huang1
1General Surgery, Huazhong University of Science and
Techonology, Wuhan, China
Objectives: Previous study has revealed that ku80 can
function as tumor suppressor gene in HCC and Ku80
is frequently downregulated in HCC compared with the
adjacent liver tissue. But what cause the down-regula-
tion of Ku80 is still unknown. MicroRNA (miRNA) is
a new class of small, noncoding RNA which can which
can bind mRNAs and down-regulate proteins‘ expres-
sion in many species. But the relationship between
Ku80 and microRNA in has never been investigated.
Methods: Through 5 databases which can predict the
relationship between microRNA and protein, the mi-
croRNAs which were predicted to regulate the expres-
sion of Ku80 in HCC in most of the databases were
found out. All these microRNAs were trasfected in
HCC cell lines and the expression of Ku80 is detected
by Western blot. The cell growth and apoptosis was
studied in vivo and the apoptosis. Then the microRNA
expression in HCC and adjacent liver tissue were inves-
tigated by qPCR.
Results: MiR-526b was able to down-regulate the
expression of Ku80 in HepG2 and PLC cell lines. After
blocking the function of miR-526b by the anatgomir,
the expression of Ku80 was up-regulated in PLC cells.
The down-regulation of miR-526b resulted in growth
inhibition and apoptosis in PLC cells. MiR-526b was
found up-regulated in HCC comparing with its adja-
cent liver tissue in 41% patients. And the up-regulated
miR-526b was significantly correlated with poor differ-
entiation of the tumor.
Conclusion: miR-526b is involved in down-regulation
of Ku80, and increased miR-526b expression is associ-
ated with tumor progression of HCC.
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APHPB-0766
CLINICAL RESEARCH AND ANALYSIS
OF CURATIVE EFFECT OF
PROSTAGLANDIN E1 ON HBV
RELATED ACUTE ON CHRONIC LIVER
FAILURE
H. Liu1, S. You1, Z. Wan1, B. I. N. G. Zhu1 and
S. Xin1
1Center of Liver Failure Treatment and Research, 302
Military Hospital, Beijing, China
Objectives: To investigate the therapeutic effect and
safety of prostaglandin E1 (PGE1) on patients suffered
from hepatitis B related acute on chronic liver failure.
Methods: Prospective tests were progressed with ran-
dom comparison and single blind methods. 100 patients
with hepatitis B related acute on chronic liver failure
were randomly divided into the PGE1 group and con-
trol group (internal medicine general treatment). On
the basis of internal medicine general treatment, PGE1
group was treated with PGE1 10 lg every day. Both
groups were treated intravenously once a day for four
weeks. The changes of liver function index level; clini-
cal efficacy as well as gastrointestinal and systemic
symptoms of adverse reactions were observed and com-
pared before and after treatment between two groups.
Results: After 2 and 4 weeks’ treatment, the Tbil,
ALT, GGT levels of both groups were significantly
decreased than those before treatment, which were
obviously lower on the 4th week of treatment than
those on the 2nd week of treatment. The serum Tbil
level of PGE1 group was significantly lower than that
of the control group (p < 0.05), but no obvious signifi-
cance was observed in the serum ALT, GGT levels
between two groups (p > 0.05). The incidence rate of
adverse reactions of PGE1 group was 14%, but no
adverse reaction was observed in the control group.
Conclusion: Prostaglandin E1 could more effectively
treat the hepatitis B related acute on chronic liver fail-
ure than the internal medicine general treatment, and
significantly improve the liver function, promote the
jaundice vanishing, and had few adverse reactions.
APHPB-0767
MICRONUTRIENT DEFICIENCY IN
PATIENTS WITH IDIOPATHIC
TROPICAL CHRONIC PANCREATITIS
A. Tripuraneni Venkata1, K. Amarnath1, B. Jagan
Mohan1, R. A. J. U. Krishnam1, G. U. D. I.
Varaprasada Rao1 and S. Thirunavukkarasu1
1Surgical Gastroenterology, Narayana Medical College,
Nellore, India
Objectives: Tropical Chronic Pancreatitis (TCP) is one
of the common type of Idiopathic Chronic Pancreatitis
in South India. The patients presents at a younger age
with large intra-ductal pancreatic calculi and early
onset diabetes. Its cause is postulated to be multifacto-
rial, predominantly nutritional. Deficiency of micronu-
trients such as ascorbic acid, zinc and selenium are
shown to be causative in some studies, where as others
have shown no relation. Hence we analysed the levels
of these micronutrients in our patients with tropical
chronic pancreatitis
Methods: All the patients with tropical chronic pancre-
atitis and equal number of healthy volunteers who pre-
sented to our department between October 2012 and
June 2014 were investigated for serum levels of Zinc,
Ascorbic acid and Selenium.
Results: 23/48 (48%) of patients with TCP had sele-
nium deficiency when compared to 7/48 (14.5%) of
controls with a p value of 0.0008, which was statisti-
cally significant. Ascorbic acid was found to be low
only in one patient (p = 1.000). Zinc levels were low in
11/48 (22.9%) of the cases compared to 5/48 (10.4%)
of controls with a p value of 0.1697.
Conclusion: Significantly lower levels of selenium were
present in patients with tropical chronic pancreatitis in
coastal Andhra Pradesh. Few of the patients did have
low levels of zinc but it was found to be statistically
not significant. Ascorbic levels were normal.
In our population selenium deficiency may play a role
in the pathogenesis of idiopathic tropical pancreatitis,
where as the role of zinc and ascorbic acid may be
questionable.
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APHPB-0768
SURGICAL OUTCOMES AND
PROGNOSTIC FACTORS OF
INTRAHEPATIC
CHOLANGIOCARCINOMA
S. Zhou1, Z. Huang1 and X. Chen1
1Department of Surgery, Tongji Hospital Huazhong
University of Science and Technology, Wuhan, China
Objectives: This study aims to analyze the surgical out-
comes and prognostic factors of a cohort of patients
with intrahepatic cholangiocarcinoma (IHCC) undergo-
ing curative resection.
Methods: The clinicopathological data of 125 patients
with IHCC who underwent curative resection between
2002 and 2008 were retrospectively reviewed. The vari-
ables including age, sex, hepatitis B virus infection, cir-
rhosis, tumor marker, tumor size, number of tumors,
vascular invasion, perineural invasion, bile duct
thrombi, lymph node metastasis, tumor differentiation,
AJCC 7th staging, and adjuvant therapy were analyzed
by using the Kaplan–Meier method and Cox hazard
models. The correlation between CA19-9 expression
and clinicopathological factors was analyzed using the
v2 test and a logistic regression model.
Results: The cumulative 1-, 3- and 5-year survival rates
of the entire cohort were 81.6%, 39.2% and 18.4%
respectively, and the 1-, 3- and 5-year disease-free sur-
vival rates were 61.6%, 27.2% and 12.8% respectively.
Univariate analysis revealed that CA19-9 level, AJCC
7th staging, tumor size, multiple tumors and lymph
node metastasis were statistically significant factors.
Multivariate analysis further showed that lymph node
metastasis (RR: 3.939; p < 0.001), CA19-9 (>200 U/
mL) (RR: 1.912; p = 0.001), and tumor size (>5 cm)
(RR: 1.82; p = 0.005), multiple tumors (RR: 1.877;
p = 0.010) were independent adverse prognostic factors.
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The rate of lymph node metastasis in the CA19-9
(>200 U/mL) group was significantly higher than that
in the CA19-9 (≤200 U/mL) group (OR: 3.208;
p = 0.013).
Conclusion: CA19-9 (>200 U/mL), tumor size (>5 cm),
multiple tumors, lymph node metastasis were indepen-
dent adverse prognostic factors of IHCC. High preop-
erative CA19-9 level (>200 U/mL) is significantly
associated with lymph node metastasis.
Benign HPB Diseases
APHPB-0769
PROSPECTIVE STUDY OF SURGICAL
OUTCOME AND DIFFERENCES ON
HISTOPATHOLOGY IN PATIENTS
WITH ALCOHOLIC & NON
ALCOHOLIC CHRONIC PANCREATITIS
S. Rathod1, R. Gupta2, S. Shenvi2, D. K. Bhasin3, R.
Nada4, M. Kang5 and N. Sachdeva6
1Senior Resident in Department of General Surgery,
Postgraduate Institute of Medical Education &
Research, Chandigarh, India; 2Surgical Gastroenterology
Division Department of General Surgery, Postgraduate
Institute of Medical Education & Research, Chandigarh,
India; 3Department of Medical Gastroenterology,
Postgraduate Institute of Medical Education &
Research, Chandigarh, India; 4Department of Pathology,
Postgraduate Institute of Medical Education &
Research, Chandigarh, India; 5Department of
Radiodiagnosis, Postgraduate Institute of Medical
Education & Research, Chandigarh, India; 6Department
of Endocrinology, Postgraduate Institute of Medical
Education & Research, Chandigarh, India
Objectives: Alcoholic&non-alcoholic chronic pancreati-
tis appears to be two different diseases with common
final outcome of pancreatic exocrine&endocrine failure.
Present prospective study was planned to find the dif-
ferences in both these groups in relation to postopera-
tive pain relief,changes in exocrine & endocrine
function and histopathology
Methods: All patients of chronic pancreatitis admitted
in Surgical and Dept Medical Gastroenterology,PGI-
MER from January 2012 to June 2014 were included in
the study. Informed written consent was taken from all
patients. Surgery was offered in patients who continue
to suffer from symptoms despite best medical,endo-
scopic & radiological management
Results: 24 patients were included in the study with13
patients being alcoholicCP and 11 patients being non
alcoholicCP. Mean followup was 15 months. All
patients with nonalcoholicCP underwent Frey’s proce-
dure.4 patients with alcoholicCP underwent Pylorus
preserving pancreaticoduodenectomy due to head mass
and rest underwent Frey’s procedure. When we com-
pared impact of surgery on pain relief,patients with
nonalcoholicCP had statistically significant better
results compared to alcoholicCP.3 patients in non alco-
holicCP and 2 patients with alcoholicCP had complete
resolution of diabetes during follow-up. Patients with
alcoholicCP continued to have steatorrhea in follow up
period but none of non alcoholic CP patients had dete-
rioration in exocrine function. When we compared his-
topathology,patients with alcoholicCP has statistically
significant increase in intralobular inflammatory infil-
trate & fibrosis,neuritis,nerve hypertrophy and predom-
inant plasma cell infiltration. Patients with non
alcoholicCP had duct centric infiltration with predomi-
nant lymphoplasmacytes
Conclusion: In this prospective study,non-alcoholicCP
patients had better outcome after surgery than alcohol-
icCP in terms of postoperative pain relief,endocrine
and exocrine insufficiency. Histopathologically,pancre-
atic changes in patients with non-alcoholic CP mark-
edly differ from those with alcoholicCP.
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APHPB-0770
A MULTI-INSTITUTIONAL
RETROSPECTIVE STUDY TO
COMPARE HEMIHEPATIC INFLOW
OCCLUSION, IPSILATERAL
HEMIHEPATIC ARTERY OCCLUSION,
AND IPSILATERAL HEMIHEPATIC
PORTAL VEIN OCCLUSION IN
PARTIAL HEPATECTOMIES
X. Luo1, L. Chen1, X. P. Chen1, B. X. Zhang1 and W.
H. Liu2
1Hepatic Surgery, Tongji Hospital, Wuhan, China;
2Research Department, Tongji Hospital, Wuhan, China
Objectives: The aim of this study was to compare the
perioperative outcomes of partial hepatectomies using
these three techniques of vascular inflow occlusion.
Methods: A total of 1932 patients were selected from
our multi-institutional hepatectomy database in China
and classified into 3 groups: the hemihepatic inflow
occlusion (HIO) group (n = 1693), the ipsilateral hemi-
hepatic artery occlusion (IHAO) group (n = 115), and
the ipsilateral hemihepatic portal vein occlusion
(IHPVO) group (n = 124). The primary outcome was
intraoperative blood loss. Secondary outcomes were
postoperative liver function, postoperative morbidity
and perioperative mortality. This program was
approved by the ethics committee of Tongji Hospital.
Results: In the multiple covariances analysis,there were
no significant differences between the 3 groups regard-
ing intraoperative blood loss, blood transfusion
requirement and perioperative mortality. However, The
IHAO and IHPVO groups were associated with signifi-
cantly lower peaks in ALT or AST level, and lower
complication rate than the HIO group.
Conclusion: The results indicated that IHAO and
IHPVO were as efficacious as HIO in reducing intraop-
erative blood loss,with better hepatic function preserva-
tion.
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APHPB-0771
EXPRESSION AND SIGNIFICANCE OF
VASCULAR ENDOTHELIAL GROWTH
FACTOR AND MICROVESSEL DENSITY
IN PANCREATIC CARCINOMA
Z. Zhang1, H. Zhu1 and X. Geng1
1General Surgery, 1st Affiliated Hospital of Anhui
Medical University, Hefei, China
Objectives: To analyse the expression of VEGF and
microvessel density (MVD) in pancreatic carcinoma for
evaluating angiogenesis in the development of this
tumor.
Methods: Collection the samples and pathological/clini-
cal data of 43 cases of pancreatic carcinoma and 43
normal pancreatic tissues as control. Immunohisto-
chemistry was used to detect the expression of VEGF
and MVD.
Results: The positive rate of VEGF and MVD were
significantly higher in tumor group than in control
(76.7% vs. 53.5%, 50.01  26.33 vs. 12.66  5.76)
(p < 0.05). In pancreatic carcinoma, VEGF and MVD
in the group with lymph node metastasis were signifi-
cantly higher than in the LN(-) group, as well as in the
group with advanced TNM staging VS early staging
(p < 0.05). VEGF expression in pancreatic carcinoma
was consistently correlated with MVD (p < 0.05). In
the pancreatic carcinoma, survival time in the group
with higher expression of VEGF or MVD was signifi-
cantly shorter than in the lower expression group
(p < 0.05). MVD was the unique factor which could
impact the survival time (p < 0.05).
Conclusion: 1) VEGF plays an important role in the
angiogenesis, tumor growth and metastasis of pancre-
atic carcinoma. 2) VEGF and MVD may be considered
as two ideal indicators of angiogenesis in pancreatic
carcinoma. 3) VEGF and MVD can be used as predic-
tors for the biological behavior and the prognosis of
pancreatic carcinoma.
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APHPB-0772
SURGICAL MANAGEMENT OF
RECURRENT HEPATOLITHIASIS
AFTER CHOLEDOCHOJEJUNOSTOMY
F. Liu1 and C. Liang2
1General Surgery, The NO 1 hospital of Anhui Medical
University, Hefei, China; 2General Surgery, The NO 1
of Anhui Medical University, Hefei, China
Objectives: The aim of this study was to explore the
proper surgical individualized treatment for the
patients, who were suffering recurrent hepatolithiasis
after receiving choledochojejunostomy.
Methods: Analysis of 28 patients with recurrent he-
patolithiasis after biliary-enteric drainage treatment in
the No 1 Hospital of Anhui Medical University from
January 2006 to June 2013. Classified the cause of the
stone formation and analyzed the approach.
Results: According to the different types of bile ducts
after biliary-enteric drainage, 28 patients were catego-
rized into 2 groups, Group A (continuous extrahepatic
biliary tract) and Group B (discontinuous extrahepatic
biliary ducts). 16 cases in Group A,among 8 cases
underwent removal of the original anastomotic and
repaired bile duct and implemented T-tube drainage.7
cases underwent choledochojejunostomy anastomotic
demolition and reconstruction,both were acted with
normal choledochojejunostomy Roux-en-Y anastomo-
sis. Except 1 case with unresectable bile duct tumor
only removed hepatolithiasis.7 cases choledochojejunos-
tomy anastomotic stricture to rebuild it.5 cases were
removed stone from anastomosis.11 cases had hap-
pened postoperative complications (39.3%),3 cases of
biliary fistula,6 cases of wound infection,two cases of
abdominal bleeding. All of them were cured. Group A
and group B immediately stone clearance rate and
finally stone clearance rate were 68.8% vs.
66.7%,87.5% vs. 83.3%,follow-up them were all in
good condition (85.7% vs. 90%),there were no statisti-
cally significant.
Conclusion: In order to increase the stone clearance
rate and decrease the calculi residue rate, it is essential
to remove all the intrahepatic biliary duct calculi by
lobectomy of liver added cholangioscopic lithotomy,
distinguish and choose proper surgical drainage accord-
ing to the function of Oddi’s sphincter and reconstruct
the standard Roux-en-Y choledochojejunostomy.
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APHPB-0773
MIXED ADENONEUROENDOCRINE
CARCINOMA OF THE DISTAL BILE
DUCT: A CASE REPORT
C. Uchida1, S. Tsutsumi1, N. Kimura1, D. Kudou1,
K. Ishido1, Y. Toyoki1 and K. Hakamada1
1Gastroenterological Surgery, Hirosaki University
Graduate School of Medecine, Hirosaki, Japan
Objectives: A 71-year-woman was admitted to our hos-
pital because of jaundice.
Methods: Abdominal ultrasound examination and con-
trast-enhanced computed tomography revealed the dis-
tal bile duct tumor. Pancreatoduodenectomy with
regional lymph nodes dissection was performed.
Results: Pathological examination showed neuroendo-
crine carcinoma (NEC) and papillary adenocarcinoma
components were found in the mass with regional
lymph nodes metastases of adenocarcinoma. This case
was finally diagnosed as mixed adenoneuroendocrine
carcinoma (MANEC) in accordance with the 2010
WHO classification of Tumors of the Digestive System.
The post-operative chemotherapy with CDDP and
CPT-11 was done according to the regimen for the lung
small cell cancer for this patient to prevent the early
relapse.
Conclusion: MANEC of distal bile duct is extremely
rare. We herein report this case with literature reviews.
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APHPB-0774
QUALITY OF LIFE OF PATIENTS WHO
UNDERWENT CURATIVE
HEPATECTOMY AT THE NATIONAL
KIDNEY & TRANSPLANT INSTITUTE
J. Lumicday1, A. Casupang1, E. Ragaza1 and C. Teh1
1Surgery, National Kidney and Transplant Institute,
Quezon CIty, Philippines
Objectives: This study was designed to assess the qual-
ity of life in patients who underwent curative liver
resection before and after surgery from 2009 to 2013 at
the National Kidney and Transplant Institute.
Methods: This retrospective study was done on all
patients who answered the Functional Assessment of
Cancer Therapy questionnaire and underwent hepatec-
tomy at National Kidney and Transplant Institute from
2009 to 2013. Data from those who underwent liver
resection from 2009 to 2013 and completely answered
the questionnaires at pre-operative stage and post-oper-
atively on the scheduled intervals were collected and
analyzed. The QoL of the patient was assessed using
the Functional Assessment of Cancer Therapy – Hepa-
tobiliary questionnaire. Wilcoxon Signed Ranks Test
was used to determine if there was a difference in the
QoL of these patients pre and post liver resection.
Mann-Whitney U test and Kruskal-Wallis one-way
analysis of variance were chosen to compare the quan-
titative parameters between subgroup of patients.
Results: A total of 61 patients with Functional Assess-
ment of Cancer Therapy questionnaire underwent cura-
tive major liver resections for benign or malignant
hepatic lesions from 2009 to 2013. Twenty-five (41%)
patients met the inclusion criteria. The majority of
these patients were males (60%) with a median age of
61 years old. Quality of life was significantly improved
at 90 days after hepatectomy (0.001, p < 0.05). Sex,
age, tumor size and complications were significant
determinants for the quality of life of these patients.
Conclusion: Liver resections done at National Kidney
and Transplant Institute (2009–2013) significantly
improved the Quality of Life at 90 days.
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APHPB-0775
A 12-YEAR REVIEW OF PANCREATIC
INJURIES IN A TRAUMA CENTER IN
HONG KONG
C. Y. J. Chan1, W. K. M. Ng1, T. W. Lai1 and S. M.
Li1
1Surgery, Princess Margaret Hospital, Hong Kong,
Hong Kong China
Objectives: To review the mechanism of injury, man-
agement and outcomes of patients with pancreatic inju-
ries admitted to our institution over a period of
12 years.
Methods: All patients who presented to Princess Mar-
garet Hospital with a pancreatic injury during a 12-year
period between January 2002 and November 2014 were
reviewed.
Results: A total of 12 cases were identified with four of
them being females and eight males. The median age
was 33 years old. Mechanisms of injury include being
inadvertently struck (5 cases), falls (2 cases) and road
traffic accidents (3 cases). Stab injuries accounted for
two of the 12 cases. Injuries were classified according
to the AAST injury scoring scale. There was one case
of Grade I injury, two cases of Grade II injury, eight
cases of Grade III injury and one case of Grade IV
injury. There was only one case of isolated pancreatic
injury while the rest were associated with other injuries.
All cases of Grade II injuries were treated conserva-
tively without complications. Operations were per-
formed in seven of the Grade III and IV injuries - six
distal pancreatectomies (5 spleen-preserving) and one
pancreatico-jejunostomy. Two Grade III pancreatic
injuries were managed with pancreatic stents via ERCP.
There were no cases of mortality.
Conclusion: Pancreatic injuries are uncommon but had
always been associated with significant morbidity and
mortality. Our review shows that a tailor-made plan of
management involving surgery, endoscopy or even con-
servative care directed according to each particular
patient is necessary. In doing so, a low mortality rate
can ultimately be achieved.
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APHPB-0776
DA VINCI ROBOTIC SURGERY VS.
TRADITIONAL PTBD PROCEDURES IN
THE TREATMENT OF ADVANCED
HILAR CHOLANGIOCARCINOMA: A
RETROSPECTIVE COMPARATIVE
ANALYSIS
A. Li1, N. Zhou1, J. Chen1 and T. A. O. Zhang1
1Hepatobiliary Surgery, General Hospital of Second
Artillery PLA, Beijing, China
Objectives: To explore the way to improve the treat-
ment of advanced hilar cholangiocarcinoma by com-
paring the robotic surgical approach with the
traditional PTBD (percutaneous transhepatic biliary
drainage, PTBD) procedures.
Methods: We retrospectively analyzed 34 cases of
advanced hilar cholangiocarcinoma (Bismuth type IV,
unavailable to radical surgery) from January 2009 to
December 2013 in our institute, including 18 cases in
the robotic group and 16 cases in the PTBD group. We
proposed to explore the treatment of advanced hilar
cholangiocarcinoma by robotic biliary drainage, biopsy
and postoperative immune therapy, and traditional
PTBD procedures as the control group. The postopera-
tive liver functions, coagulation, and quality of life and
survival rate were observed. The measurement data
were analyzed by using a t-test; the enumeration data
were compared by x2 test; and the survival rate was
contrasted by using log-rank test. The p-value <0.05
(p < 0.05) was considered statistically significant.
Results: There were no significant differences
(p > 0.05) in the aspects of serum albumin, PT and
APTT on day 1 and day 3 postoperatively in the
robotic group and PTBD group. The robotic surgery
was more conducive to homeostasis and beneficial for
patients’ recovery. Further, the robotic group is supe-
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rior to the PTBD group in the survival rate
(9.2  3.6 months vs. 5.4  2.8 months, p < 0.05).
Conclusion: The robotic biliary drainage, biopsy and
postoperative immune therapy may be an option for
advanced hilar cholangiocarcinoma patients who had
no chance to receive radical surgery.
APHPB-0777
THE SIGNET RING CELL CARCINOMA
IN GALLBLADDER – RARE ETIOLOGY
IN UNCOMMON SITE. SINGLE
MEDICAL CENTER EXPERIENCE WITH
SYSTEMIC LITERATURE REVIEW
F. J. Hsieh1, C. H. Liao1, C. N. Yeh2, Y. Y. Jan2 and
T. S. Yeh2
1Department of Trauma and Emergency Surgery, Chang
Gung Memorial Hospital, Taoyuan County, Taiwan;
2Department of General Surgery, Chang Gung Memorial
Hospital, Taoyuan County, Taiwan
Objectives: Gallbladder carcinoma is a dismal diease
and most of them were adenocarcinoma histologically.
Signet ring cell carcinoma is a rare type of carcinoma.
In digestive system, they occurs in stomach or colon
usually. Primary gallbladder signet ring cell carcinoma
is extreme rare, till now, there were only six cases
reported in English literature.
Methods: We reported three cases with gallbladder sig-
net ring cell carcinoma in this study.
Results: The first case was 68 year old male patient
with gall bladder signet ring cell carcinoma. The tumor
was occupied gall bladder and cystic duct with liver
and mesocolon invasion. Radical surgery with en bloc
hepatectomy, pancreaticoduodenecomy and transverse
colectomy were done. There was one peri -pancreatic
lymph node metastasis. The TMN stage was
pT4N1 cM0, stage 4a. This case received adjuvant che-
motherapy after surgery and still alived. In past
20 years, this patient was the third case of gall bladder
signet ring cell carcinoma in our institute. The first two
cases in our hospital were 70 and 70 years old male
patient whose post-operative overall survival were 2.8
and 3.1 months, respecitvely.
Conclusion: Gall bladder signet ring cell carcinoma was
aggressive disease according to published literatures.
We will have a systemic literature review in this article.
According to past literatures and our results, gallblad-
der signet ring cell carcinoma is an aggressive disease
with worsen prognosis than ordinary adenocarcinoma
in gallbladder. Multidisciplinary therapy might be bene-
fit in patients with this rare diease.
APHPB-0778
A NEW CHOLANGIOJEJUNOSTOMY
FOR MULTIPLE BILIARY DUCTAL
OPENINGS: A STUDY IN PIGS
H. Yang1, J. Tang2, S. Xiang3, W. Lau4, X. Peng1 and
X. Chen3
1The Department of Hepatobiliary Surgery, First
Affiliated Hospital School of Medicine Shi Hezi
University, Shihezi, China; 2Department of Preventive
Medicine, First Affiliated Hospital School of Medicine
Shi hezi University, Shihezi, China; 3Hepatic Surgery
Center, Tongji Hospital Tongji Medical College
Huazhong University of Science and Technology,
Wuhan, China; 4Faculty of Medicine, The Chinese
University of Hong Kong Prince of Wales Hospital
Shatin, Hongkong, China
Objectives: To investigate the safety and feasibility of a
new intrahepatic cholangiojejunostomy for multiple int-
rahepatic biliary ductal openings after hepatobiliary
resection.
Methods: Forty-eight pigs were randomly assigned into
two groups: the new intrahepatic cholangiojejunostomy
group (n = 24); and the control group (n = 24) with
classical hepaticojejunostomy. Six pigs in each group
were sacrificed on postoperative day 7, 30, 90 and 180.
The primary outcomes were postoperative mortality,
morbidity, and the pathological changes in the anasto-
moses. The secondary outcomes were levels of aspartate
transaminase, bilirubin, albumin and alkaline phos-
phate.
Results: The operations were successfully carried out.
The rates of anastomotic leakage and cholangitis in the
study group were 0% and 8.3% (2/24), while in the
control group they were 4.2% (1/24) and 20.8% (5/24),
respectively. The stenotic rates of the sectional areas of
the anastomotic stomas in the study group were lower
than those in the control group on postoperative day 7,
30, 90 and 180 (p < 0.001, p = 0.002, p < 0.001, and
p = 0.001, respectively). Under microscopy, in the
study group, the anterior wall of the stoma was everted
and sunken while the posterior wall was protruded in a
semicircular-disc shaped. The liver transection plane
was epithelialized with mucosal covering by post-opera-
tive day 30. In the control group, however, the stoma
was centripetally protruded with a relative circular ste-
nosis.
Conclusion: The new intrahepatic cholangiojejunosto-
my is safe, simple, and convenient for multiple biliary
ductal openings.
APHPB-0779
IS ROUTINE INSERTION OF
NASOGASTRIC TUBE REALLY
NECESSARY IN ELECTIVE
PANCREATODUODENECTOMY?
H. Kwon1, S. Kim1, Y. Han2, J. Chun2 and Y. Hwang1
1Surgery, Kyungpoon National University Medical
Center, Daegu, Korea; 2Surgery, Kyungpoon National
University Hospital, Daegu, Korea
Objectives: The objective of this study was to investi-
gate the efficacy of inserting nasogastric (NG) tube
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after pancreatoduodenectomy (PD) by comparing clini-
copathological factors and complications of between
patients with and without a NG tube in the patient
who underwent elective PD.
Methods: 72 patients were enrolled in this trial from
September 2009 to June 2011. The patients were ran-
domly assigned to the with NG tube group (Group 1,
n = 36) and without NG tube group (Group 2, n = 36).
Clinicopathological factors and surgical outcomes such
as length of hospital stay after PD, delayed gastric
emptying (DGE), postoperative hemorrhage (PPH),
postoperative pancreatic fisula (POPF), pulomonary
complications, cardiovascular complications, wound
complications, and mortality compared prospectively.
Results: There was no difference in terms of age, gen-
der, operating time, pathological diagnosis, time to fla-
tus, length of hospital stay after PD between two
groups. Postoperative complication rates, including
DGE (Grade B)(22.2% vs. 16.7%, respectively;
p = 0.767), POPF (Grade B)(5.6% vs. 11.1%, respec-
tively; p = 0.674), PPH (Grade B)(8.3% vs. 2.5%,
respectively; p = 0.614), pulomonary complications
(63.9% vs. 66.7%, respectively; p = 1.000), and cardio-
vascular complications (5.6% vs. 2.7%, respectively;
p = 1.000), were similar in each group. There was no
leakage of duodenojejunostomy in both groups. A case
of mortality due to myocardial infarction occurred in
Group 1 but the difference was not statistically signifi-
cant.
Conclusion: Routine insertion of NG tube offers no
benefit in preventing postoperative complications after
elective PD and does not shorten length of hospital
stay after PD. Therefore, routine use of a nasogastric
tube is not required in elective PD.
APHPB-0780
THE PROGNOSTIC SIGNIFICANCE OF
R1 RESECTION FOR MIDDLE AND
DISTAL BILE DUCT CANCER
S. Kim1, H. Kwon1, Y. Han2, J. Chun2 and Y. Hwang1
1Surgery, Kyungpoon National University Medical
Center, Daegu, Korea; 2Surgery, Kyungpoon National
University Hospital, Daegu, Korea
Objectives: To identify the influence of R1 resection in
middle and distal bile duct cancers, we reviewed clinic-
o-patholocial features, and surgical outcomes of the
patients with middle and distal bile duct cancer.
Methods: From August 1990 to June 2013. For 156
patients who underwent macroscopic curative resection
(R0 and R1), the status of resection margin and clinico-
pathological factors were analyzed as variables using
univariate and multivariate analysis. Site of initial dis-
ease recurrence were classified as locoregional or dist-
nant.
Results: The 5-year survval was 39.4% after R0 resec-
tion, 15.6% after R1 resection, and 0% after R2 resec-
tion. The difference of survival between R1 and R2
was statistically significant, whereas the difference of
survival between R1 and R0 was just a little short of
statistical significance. On univariate and multivariate
analysis for patients who underwent macroscopic cura-
tive resection, resection margin was no statistical signif-
icance. Recurrence after macroscopic curative resection
occurred in 69 patients. 21 patients displayed disease
recurrence concomitantly at a locoregional and distant
site. Only locoregional recurrences and only distant
metastasis were observed in 29 and 18 patients. The
patterns of recurrence according to margin status was
not difference. The most common site of first recur-
rence was liver followed by abdominal lymph node.
Conclusion: R1 resection, if inevitable, can be per-
formed because it offers better survival than that of R2
or no resection. However the prognosis of R1 resection
was much lower than those of R0 resection. Thus,
every efforts need to be tried to achieve R0 resection
for middle and distal bile duct cancer.
APHPB-0781
OUTCOME OF PT2 GALLBLADDER
CANCER ACCORDING TO
MANAGEMENT OF REGIONAL
LYMPHADENECTOMY
G. Jung1 and K. Chae2
1Surgery, Iksan Hospital, Iksan, Korea; 2Surgery,
Wonkwang University Hospital, Iksan, Korea
Objectives: To analyze of outcome of pT2 gallbladder
cancer (GBC) and clarify its effect on long term sur-
vival according method of lymphadenectomy
Methods: The patients were divided into two groups
according to type of lymphadenectomy (sampling lym-
phadenectomy with liver wedge resection vs. radical
cholecystectomy) in each T stage. We defined as sam-
pling lymphadenectomy when were retrieved No. 12
lymph node or enlarged hilar lymph node. Forty seven
of 80 patients had pT2 lesion. We divided four groups
according to lymph node metastasis (LN (+/-)) and
type of lymphadenectomy (LND): group A was LN (-)
and sampling LND; group B was LN (-) and radical
LND; group C was LN (+) and sampling LND; group
D was LN (+) and radical LND
Results: Mean follow up months was 32.5 months.
Mean survival month of all patients was 32.6 months
( 35.3 months). 5 year survival rate of this cohort
was 36.5%. Two and 5 years survival rate according to
pT stage (T1a, T1b, T2, T3 and T4) were 100%, 86%,
52%, 20%, 0% and 100%, 72%, 37%, 0%, 1%,
respectively. In pT2 lesion, there was statistically differ-
ence between group A and B (p = 0.001), however did
not show statistically significance between groups C
and D in survival
Conclusion: When there was the lymph node metasta-
sis, it showed poor prognosis regardless of type of lym-
phadenectomy. So, in order to predict the exact
patient’ prognosis, the radical lymphadenectomy is
essential.
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APHPB-0782
MRCP IN GALLSTONE PANCREATITIS
REDUCES THE NEED FOR
UNNECESSARY ERCP
Y. M. Goh1, Y. L. Goh1, S. Lapsia2, Y. Reddy3, V.
Kaushik3, C. Harris1, A. Kausar1, D. Chang1 and D.
Subar1
1Department of Hepatobiliary Surgery, Royal Blackburn
Hospital, Blackburn, UK; 2Department of Radiology,
Royal Blackburn Hospital, Blackburn, UK; 3Department
of Gastroenterology, Royal Blackburn Hospital,
Blackburn, UK
Objectives: UK guidelines in the management of acute
gallstone pancreatitis (GSP) with cholangitis, jaundice,
a predicted or actual severe attack or dilated common
bile duct (CBD) warrants an endoscopic retrograde
cholangiopancreaticogram (ERCP) and sphincterotomy
+/- stone extraction or stenting within 72 h of the onset
of pain. However about 50% of CBD stones will pass
spontaneously. The aim of this study was to assess fac-
tors predictive of CBD stones in GSP.
Methods: This is a retrospective study of all patients
presenting with GSP over a 4 year period from January
2010 to October 2014. Patients were identified using
NHS coding K85 and K80.2. Data on admission blood
tests (C-reactive protein (CRP) and liver function test),
imaging (ultrasound (USS) magnetic resonance cholan-
giopancreaticogram (MRCP) and ERCP) results and
severity of pancreatitis were collected. All categorical
variables were analysed with Chi square or Fisher’s
exact test. Continuous variables were analysed with
logistic regression. Statistical analysis was conducted
using SPSSv20.
Results: 239 patients presented with GSP over the
study period. The mean age was 60.5  17.8 years. The
male to female ratio was 80:165. 35 patients had pre-
dicted severe pancreatitis. 98 patients went on to have
ERCP. Only elevated bilirubin (>22 lmol/L) was pre-
dictive of CBD stones on MRCP (p = 0.035). The pres-
ence of a dilated CBD (p = 0.033) or stone (p < 0.05)
on MRCP was predictive of a stone on ERCP. The
severity of the pancreatitis did not predict the presence
of CBD stones (p = 0.133).
Conclusion: Patients who present with GSP should
have further investigations to confirm the presence of
CBD stones before proceeding to ERCP except in cases
of worsening or unresolving obstructive biliopathy or
cholangitis.
APHPB-0783
A PROSPECTIVE EVALUATION OF THE
PROCEDURE OF BICLAMP FOR OPEN
HEPATIC RESECTION: EARLY
EXPERIENCE
Z. Yi-Jun1
1Hepatobiliary Surgery, The First Affiliated Hospital of
Anhui Medical University, Hefei, China
Objectives: To evaluate the efficiency and safety of Bi-
Clamp for liver parenchyma transection.
Methods: A prospective study was performed in a sin-
gle center for patients undergoing liver resection. All
the patients were operated by the same surgical group.
This study focused on the intraoperative blood loss,
resection time, and perioperative complications.
Results: There were 42 patients enrolled in this study
including 27 major and 15 minor hepatectomies. The
overall intraoperative blood loss (meanSD) was
523.5  558.6 mL (range 55.0~2474.1). The mean
blood loss per square centimeter was 6.2  7.6 mL
(range 0.6–39.8 mL). Six patients received blood trans-
fusion perioperation. Mean transection speed (paren-
chymal transection square per minute) was
3.0  1.9 cm2. There were no deaths, and the morbid-
ity rate was 25%. Mean (SD) hospital stay was 9.3
(2.3) days.
Conclusion: Reusable BiClamp allows major and minor
hepatectomies to be performed effectively and safely.
Hepatectomies assisted by BiClamp may reduce the
blood loss and the need for blood transfusion.
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APHPB-0784
ADENOCARCINOMA DEVELOPED
FROM REMNANT CYSTIC DUCT
AFTER CHOLECYSTECTOMY
Y. Choi1 and L. E. E. Seung Eun1
1Surgery, Chung-Ang University, Seoul, Korea
Objectives: Cystic duct adenocarcinoma is a rare dis-
ease because the cystic duct has a short length and a
narrow cavity. Cystic duct adenocarcinoma accounts
for 8% of all gallbladder adenocarcinoma; of these,
adenocarcinoma that develops from the remnant cystic
duct (RCD) after cholecystectomy is extremely rare.
We report a case of incidentally detected adenocarci-
noma that developed from the RCD in a patient with
history of cholecystectomy.
Methods: A 74-year-old woman visited our hospital
with pain in the right upper quadrant of the abdomen.
Her past medical history included cholecystectomy for
acute cholecystitis with gallstones 10 years previously.
Imaging of the abdomen demonstrated inflammation of
the RCD with multiple impacted stones. Complete
removal of the RCD with stones was performed. The
pathologic report showed severe inflammation with
abscess formation and an unexpected adenocarcinoma
that appeared to invade the perimuscular connective
tissue. The second operation (confirmation of the resec-
tion margin of the RCD, wedge resection of the liver,
and lymphadenectomy) was performed due to suspicion
of pT2.
Results: There were no cancer cells in the resection
margin of the RCD, liver, or lymph nodes (0/6). The
final histopathological diagnosis was pT2N0M0.
Conclusion: She recovered without any complications.
The patient is still living 1 year after surgery without
recurrence or metastasis.
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APHPB-0785
GHRELIN ATTENUATED
LIPOTOXICITY IN VITRO AND VIVO
VIA AUTOPHAGY INDUCTION AND
NF-?B INHIBITION
X. Fan1, Y. Mao1, F. Yu1 and J. I. A. N. Cheng1
1Gastroenterology, Jinshan Hospital of Fudan University,
Shanghai, China
Objectives: Nonalcoholic fatty liver disease (NAFLD)
has been the most common chronic liver disease world-
wide. Autophagy has been demonstrated to be associ-
ated with NAFLD. Ghrelin is a gut hormone
exhibiting various functions including energy metabo-
lism and inflammation inhibition. We investigated the
therapeutic effect of ghrelin on NAFLD and its associ-
ation with autophagy.
Methods: In vivo, C57bl/6 mice were fed a high fat diet
(HFD) for 1 week, with dexamethasone (0.25 Mm/kg)
subcutaneously injected in the first 4 days to induce
acute NAFLD model, ghrelin (10 lg/kg/injection) or
saline was administrated subcutaneously daily during
the week. 8-week HFD was administrated to induce
chronic NAFLD model, with ghrelin similarly treated
twice a week from 6 to 8th weeks. In vitro, L02 cells
were pretreated with ghrelin (10–8 mol/L) before the
stimulation of free fatty acid (FFA) consisted of palmi-
tate and oleic acid (1 mmol/L).
Results: Ghrelin reduced the triglyceride content both
in vivo and in vitro NAFLD models. TNF-?? and IL-6
were significantly reduced in the ghrelin treated mice
group compared with the control group. Autophagy
induction was accompanied with intracellular lipid
reduction in ghrelin treated group. Ghrelin up-regu-
lated autophagy via AMPK/mTOR restoration and
inhibited the translocation of NF-??B into the nucleus.
Conclusion: The results indicate that ghrelin attenuates
NAFLD by autophagy stimulation and inflammation
inhibition.
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APHPB-0786
EFFECTS OF 5-AZA-2DC ON SLIT2
GENE METHYLATION STATUS AND
MALIGNANT PHENOTYTE ON
HEPATOMA HEPG2 CELLS
X. P. Geng1
1General Surgeron, the First Affiliated Hospital of Anhui
Medical University, Hefei, China
Objectives: To evaluate 5-aza-2dc’s effect on SLIT2
gene methylation status and cell growth,migration,inva-
sion and apoptosis on hepatoma cell line HepG2
Methods: The changes of 5-aza-2dc’s on SLIT2 gene
methylation status and the proliferation,migration,inva-
sion and apoptosis of HepG2 cells was detected by
MSP, MTT, wound healing assay, cell migration assay
and Annexin V-FITC/PI assay, respectively.
Results: After treated with 5-aza-2dc’s, the methylation
status of SLIT2 gene had been reversed to some extent
and showed a dose-dependent. After 48 h in wound
healing assay, the control group of HCC cells moved
to the center of the scratch, and drug treatment group
was inhibited. After 24 h in cell migration assay, drug
treatment group of HCC cells’ invasive ability was
inhibited comparing with control group (p < 0.05). In
Annexin V-FITC/PI assay,the cell apoptosis rates of
the drug treatment group showed a significant increase
comparing with control group (p < 0.01).
Conclusion: 5-aza-2de’s can inhibit the proliferation,
promote the apoptosis and inhibit the migration and
invasion of HepG2 cells in vitro,Moreover,the inhibi-
tion of cell migration and invasion may be accom-
plished by reversed the methyhtion and restored the
expression of SLIT2 gene.
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APHPB-0789
CLINICAL FEATURES OF THE
GALLBLADDER ADENOMA
J. Sohn1, J. Park1 and J. Rhee1
1Surgery, Daegu Fatima Hospital, Daegu, Korea
Objectives: GB adenoma is an unusual benign disease.
The dysplasia-carcinoma pathway appear to be the pre-
dominant mechanism of gallbladder cancer, but some
studies showed GB adenoma may be precancerous
lesion of gallbladder cancer. We investigated our cases
of GB adenoma and analyzed our datas.
Methods: Among the 3793 patients who underwent
cholecystectomy in Daegu Fatima hospital during Jan-
uary 2006 to August 2014, there were 38 patients who
were diagnosed with gallbladder adenoma. We reviewed
medical records and radiologic images of all patients
and histological findings were reviewed by one patholo-
gist.
Results: There were 16 male and 22 female patients.
The average age of patients was 57.5 years old
(30–89 yr). 24 patients were diagnosed with GB polyps,
9 patients with GB stones and 4 patients with GB can-
cer preoperatively. There were 29 cases of tubular ade-
noma, 7 cases of papillary adenoma and 2 cases of
mixed adenoma. There were 16 cases of GB adenoma
accompanied with gallstones and 5 cases were com-
bined acute cholecystitis. There were 3 cases of com-
bined pathology of GB adenoma and cholesterol
polyps of gallbladder.
Conclusion: GB adenoma is a rare disease of the gall-
bladder and it is very difficult to diagnose preopera-
tively. In our cases there were no cases diagnosed as
GB adenoma preoperatively. The average size of GB
adenoma was 9.0 mm and minimal size of GB ade-
noma was only 2 mm which didn’t meet the indication
of cholecystectomy for GB polyps. There was only one
case of combined pathology of GB cancer and GB ade-
noma.
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APHPB-0790
A MODIFIED SUGIURA PROCEDURE
FOR CONTROL OF VARICEAL
BLEEDING
F. Liu1 and Q. I. Wang1
1Hepatic Surgery Center, Tongji Hospital, Wuhan,
China
Objectives: A proportion of patients with variceal bleed
need surgical intervention. This study evaluated a mod-
ified Suguira procedure in controlling variceal bleeding
after endoscopic therapy.
Methods: A modified Suguira procedure was per-
formed in 62 patients with acute variceal bleeding that
could not be controlled by endoscopic therapy or with
a history of massive bleed after endoscopic therapy.
Results: Perioperative mortality occurred in 2% (1/62)
patient. Esophageal anastomotic leak occurred in 2%
(1/62) patient, and stenosis in 5% (3/62) patient.
Twelve months after operation, esophageal varices dis-
appeared in 79% (48/61) patients, diminished in size in
18% (11/61), remained unchanged in 3% (2/61); Fun-
dal gastric varices disappeared in 98% (60/61) patients,
diminished in size in 2% (1/62). The rebleeding rate
was 3% (2/61) and 8% (5/61) in 3 years and 5 years,
respectively.
Conclusion: The modified Suguira procedure is safe
and effective for long-term control of variceal bleeding
after endoscopic therapy.
APHPB-0791
IS IT NECESSARY TO USE
PROPHYLACTIC ANTIBIOTICS IN
ELECTIVE LAPAROSCOPIC
CHOLECYSTECTOMY?
K. Kim1 and Y. Roh1
1Surgery, Dong-A University Hopsital, Busan, Korea
Objectives: Although laparoscopic cholecystectomy
(LC) is a common and widely applied procedure, the
use of prophylactic antibiotics for preventing postoper-
ative infection in elective LC remains controversial.
Elective LC has a low risk for infectious complications,
but many surgeons still use prophylactic antibiotics.
The aim of this study was investigate the role of pro-
phylactic antibiotics in patients undergoing elective LC
except patients requiring empirical antibiotics.
Methods: In this prospective, double-blind randomized
controlled trial from December, 2011 to May 2013, 200
patients were assigned to 2 groups. 100 patients (group
A) received cefazolin 1 g intravenously within one hour
before incision, and 100 patients (group B) were not
given prophylactic antibiotics. In both group, surgical
site infections (SSIs) were recorded and compared.
Results: In both groups, there was no difference in the
preoperative demographics (age, body mass index,
ASA score) and postoperative findings (operative time,
length of hospital stay). Preoperative ERCP, bile spill-
age, diabetes mellitus and presence of American Society
of Anesthesiologists (ASA) classification higher than
score II did not significant increased the rate of SSIs.
The wound infections in group A and B were 4 (4%)
cases and 5 (5%) cases, respectively. There were no sig-
nificant SSIs in both groups.
Conclusion: Based on our study, prophylactic antibiot-
ics is not necessary in elective LC except gallbladder
disease requiring empirical antibiotics.
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APHPB-0792
HEPATECTOMY PROCEDURE IN
CONFLUENT MULTINODULAR TYPE
HCC AND HCC WITH HIGH-GRADE
PORTAL INVASION
S. Fukutomi1, Y. Nomura1, Y. Maruyama1, H. Sakai1,
R. Kawahara1, H. Ishikawa1, T. Hisaka1, M.
Yasunaga1, H. Horiuchi1 and K. Okuda1
1Department of Surgery, Kurume University School of
Medicine, Kurume, Japan
Objectives: Macroscopic classification of hepatocellular
carcinoma (HCC) are classified in five types by the gen-
eral rules for the clinical and pathological study of pri-
mary liver cancer. Some reported before that confluent
multinodular type (CMN) are associated with high fre-
quent portal vein invasion (Vp), intrahepatic metastasis
and poor prognosis. In the present study, we addressed
the CMN and Vp using surgically resected liver tumors
in our institute and its individual treatment.
Methods: We used 1256 primary HCCs (pHCC) and
370 recurrent HCCs (reHCC) which undergone curative
hepatectomy at Kurume University Hospital during
1989 and 2013 to classify the macroscopic findings.
And also we compared the clinical manifestations, his-
topathological features, and imaging findings of these
cases by using 422 cases CMN which were diagnosed
pathologically.
Results: We found 126 cases (10.2%) of CMN in
pHCCs and 57 cases (16.8%) in reHCCs. Dynamic
imaging revealed that most of the CMN were found at
the peripheral area of the liver and indistinct enhance-
ment around the tumor in early phase. Histologically,
82% of CMN had high-grade Vp (simple nodular type
(SN): 8.2%, simple nodular type with extranodular
type (SG): 67%) and 8 cases (17.8%) invaded main
portal vein (SN: 0.5%, SG: 1.1%). In CMN, there were
no significant difference in overall survival between
hepatectomy procedure.
Conclusion: CMN and HCC with high-grade Vp were
related to the prognosis. For more appropriate hepatec-
tomy, we have to find the distribution of portal inva-
sion in the liver.
APHPB-0793
CARCINOSARCOMA OF THE
EXTRAHEPATIC BILE DUCT: A CASE
REPORT
S. Park1 and C. Nam1
1Surgery, Ulsan University Hospital, Ulsan, Korea
Objectives: Carcinosarcomas are rare malignant
tumors. Although they have been reported previously
in diverse organs, few cases have been reported in the
biliary system, especially in the extrahepatic bile duct.
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We report a rare case of a carcinosarcoma of the extra-
hepatic bile duct.
Methods: 52-year-old male patient presented with jaun-
dice without abdominal pain. The patient reported a
past medical history of hypertension. The total biliru-
bin levels were increased to 23.5 mg/dL, and gamma
glutamyltranspeptidase levels were increased to
2302 IU/L. The tumor marker were elevated to
192.28 U/mL. Computed tomography (CT), magnetic
resonance chol-angiopancreatography (MRCP) showed
a 3.3 cm extended soft tissue lesion in the gallbladder,
with direct invasion into adjacent structures. Endo-
scopic retrograde cholangiopancreatography (ERCP)
showed a gallbladder neck mass and hilar stricture with
upsteam duct dilatation, a endoscopic nasobiliary
drainage catheter was successfully placed into the right
intrahepatic duct. Then, the bilirubin level was
decreased.
Results: Bile duct resection and lymph node dissection
with choledochojejunostomy and liver wedge resection
(S4b,S5) were performed. Pathology showed carcinosar-
coma of cystic duct and common bile duct with inva-
sion to hepatic parenchyme. There was metastasis to 1
out of 8 lymph nodes. His postoperative course was
uneventful.
Conclusion: Carcinosarcoma of the biliary system is
extremely rare and the prognosis for patients with car-
cinosarcomas of the extrahepatic bile duct is still uncer-
tain. At present, there is no optimal therapy for bile
duct carcinosarcomas. Hence, we should consider radi-
cal local resection with adjuvant chemotherapy or irra-
diation therapy. Further discussion is required on the
subject of the optimal treatment for bile duct carcino-
sarcomas.
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APHPB-0794
THE STUDY OF THE GASTROCOLIC
TRUNK OF HENLE USING MULTI
DETECTOR-ROW COMPUTED
TOMOGRAPHY FOR THE SAFE
LAPAROSCOPIC PANCREATIC
SURGERY
K. Ishido1, Y. Toyoki1, D. Kudo1, N. Kimura1, S.
Tsutsumi1, C. Uchida1 and K. Hakamada1
1Department of Gastroenterological Surgery, Hirosaki
University Graduate School of Medicine, Hirosaki,
Japan
Objectives: The aim of this study is to clarify and clas-
sify the confluence patterns of GCTH using multi
detector-row computed tomography (MDCT) for the
safe laparoscopic pancreatic surgery.
Methods: In 80 patients undergoing MDCT scheduled
for gastrointestinal and hepatobiliary-pancreatic sur-
gery, the peripancreatic veins were reconstructed using
maximum intensity projection and multi-planar recon-
struction process. The confluence pattern of the GCTH
was analyzed.
Results: In all MDCT images, right gastroepiploic vein
(RGEV), anterior superior pancreatoduodenal vein
(ASPDV), and superior right colic vein (SRCV) were
detected. Focusing on these veins, the confluence
pattern was classified into five types (Type I-V). Type I
(n = 52, 65.0%) was that GCTH was consisted of all
three veins. Type II (n = 13, 16.3%) was that GCTH
was consisted of REGV and ASPDV, and SRCV
joined to superior mesenteric vein (SMV) directly. Type
III (n = 8, 10.0%) was that GCTH was consisted of
REGV and SRCV, and ASPDV joined to SMV
directly. Type IV (n = 4, 5.2%) was that GCTH was
consisted of REGV and ASPV, and SRCV joined to
SMV directly. Type V (n = 3, 3.8%) was that GCTH
was not formed, and three veins drained into SMV
independently. Considering both of the confluence pat-
tern of RGEV, ASPDV, and SRCV and the presence
of RCV and MCV confluent to GCTH, there were 13
types of the confluence pattern of GCTH.
Conclusion: Using abdominal MDCT, GCTH could be
classified systematically. This classification would help
us to elucidate GCTH preoperatively and lead us to
the safe pancreatic surgery.
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APHPB-0795
HEME OXYGENASE-1 EXPRESSION IS
ASSOCIATED WITH TUMOR
PROGRESSION OF HEPATOCELLULAR
CARCINOMA
H. Jang1, C. Park1 and D. Eom2
1Surgery, Gangneung Asan Hospital University of Ulsan
College of Medicine, Gangneung, Korea; 2Pathology,
Gangneung Asan Hospital University of Ulsan College of
Medicine, Gangneung, Korea
Objectives: Heme oxygenase-1 (HO-1) is an important
enzyme as Heme degradation. HO-1 degrades heme to
carbon monoxide, biliverdin, and ferrous iron. HO-1 is
major role of enzyme as antioxydative and antiapoptot-
ic effect. Some studies suggested that HO-1 may play a
role in tumor induction and can potently improve the
growth and spread of tumor. This study represented
that HO-1 expression as correlation the results with the
clinical and pathological parameters in patients with
hepatocellular carcinoma (HCC).
Methods: In this study, the expression of HO-1 in
human HCC tissues (n = 96) was investigated by
immunohistochemistry and Western Blotting (n = 10).
The correlation of HO-1 with the clinicopathological
characteristics was analyzed. That resected tumor tis-
sues was confirmed HCC by pathologic division and
stored by Paraffin block.
Results: Results showed that HO-1 was expressed in 43
HCC tissues from 96 cases (44.8%). A high HO-1
expression rate showed a close association with poor
histological differentiation (Edmondson-Steiner
grade2,3,4), positive lymphovascular invasion and cap-
sular invasion (p < 0.05). In univariable study repre-
sented that disease free survival (DFS) was slightly
improved HO-1 negative HCC but not statistical differ-
ence in HO-1 positive HCC vs. negative HCC, median
value was 20.30  2.44 vs. 26.80  26.80 (mo)
(p = 0.128).
Conclusion: Actually HCC patients stained HO-1 was
associated with histologically poor grade (E-S grade
2~4), presented lymphovascular invasion, capsular inva-
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sion and high level of preoperative AFP but, no differ-
ent recurrence rate rather than HO-1 negative HCC
patients, We thought that HO-1 was slightly related to
recurrence rate of HCC, but it needs more case studies.
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APHPB-0796
IATROGENIC BILE DUCT INJURY
ASSOCIATED WITH ANOMALIES OF
THE RIGHT HEPATIC SECTIONAL
DUCTS FOLLOWING LAPAROSCOPIC
CHOLECYSTECTOMY (IS THE
INTRAHEPATIC BILE DUCT ABLATION
– ANOTHER OPTION?)
H. Jang1, J. Kwak1 and C. Park1
1Surgery, Gangneung Asan Hospital University of Ulsan
College of Medicine, Gangneung, Korea
Objectives: Bile duct injuries remain one of the most
devastating complications of both open (OC) and lapa-
roscopic cholecystectomy (LC). Although LC has been
widely accepted as the standard operation, it continues
to have a high complication rate than OC. Bile duct
injury with LC has often been attributed to surgical
inexperience, but it is also clear that aberrant bile ducts
are present in a significant number of patients who sus-
tain biliary injuries during these procedures.
Methods: We performed 4629 LC from 1998 to 2014.
We present 6 cases (0.12%) of right sectoral duct inju-
ries, two of which had right posterior sectoral duct
(RPSD) injuries noted on intraoperative cholangio-
gram, while three of right anterior sectoral duct
(RASD) and one of RPSD injuries noted on postopera-
tive percutaneous transhepatic cholangiography.
Results: In the first two cases, demonstrated aberrant
biliary anatomy and injuries to low-lying RPSDs drain
to cystic duct in operation. Both cases were successfully
repaired immediately by hepaticojejunostomy. Three of
RASD and one of RPSD injuries noted on postopera-
tive period. One case of RASD injury was performed
delayed hepaticojejunostomy after PTBD. The other
cases were successfully performed intrahepatic bile duct
ablation using coiling, fibrin glue and alcohol for 7, 22
and 25 times.
Conclusion: We present six cases (0.12%) of right hepa-
tic duct injuries which occurred during LC for 16 years.
If RHSD injury noted on postoperative period,
Although a repeat procedure may be necessary, the
obliteration of bile ducts is a safe procedure with excel-
lent results in patients with complications from isolated
segmental ducts.
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APHPB-0797
PREDICTORS OF EARLY
REGENERATION IN REMNANT LIVER
VOLUME AFTER HEPATECTOMY
J. D. Yang1, H. C. Yu1, S. I. Bae1, S. E. Hwang2, J. H.
Lee3 and B. H. Cho1
1Surgery, Chonbuk National University, Jeonju, Korea;
2Surgery, Sun Medical Center, Daejeon, Korea;
3Surgery, Asan Medical Center, Jeongeup, Korea
Objectives: The aim of this study to investigate whether
early liver volume regeneration following hepatectomy
and its change are related to clinicopathologic factors
such as liver fibrosis/cirrhosis, apo A1, prealbumin and
body mass index (BMI).
Methods: We was studied in a series of 61 patients
who underwent hepatectomy - Right hemihepatectomy
(n = 21), left hemihepatectomy (n = 16), left lateral sec-
tionectomy (n = 9) and Rt postererior sectionectomy
(n = 15) for living donation (n = 3), malignant (n = 41)
or benign (n = 17) liver diseases between October 2012
and September 2014.
Preoperative variables evaluated with preoperative
MDCT imaging were investigated as potential predic-
tors of liver regeneration. The future remnant liver vol-
ume (FRLV) was preoperatively calculated with a
virtual surgical cut. Apoa1 and prealbumin levels were
recorded on 1, 5, 7 postoperative day. Liver volumetric
measurement which was evaluated with MDCT at a 7,
21 days after surgery, analyzed using Dr. liver. We
evaluated postoperative variable such as cirrhotic
change pathologically.
Results: The correlation of removed liver volume and
weight was found significantly high. (R2 = 0.921,
p < 0.01) There were no association between Apoa1/
prealbumin and liver regeneration rate (p > 0.05) but a
stepwise multiple regression analysis showed that a
smaller FRLV (coef?cient -0.19, p < 0.001). Pathologi-
cally, the liver cirrhosis (n = 20) was predictors of
greater liver regeneration at 7 days (p = 0.04) but not
21 days (p = 0.25) after surgery.
Conclusion: Predictors of early regeneration in the rem-
nant liver after hepatectomy were a smaller FRLV and
greater fibrotic change, as opposed to apo A1, prealbu-
min, and BMI. But, a larger patient pool is needed to
evaluate these results more accurately.
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PANCREATICOPLEURAL FISTULA: AN
UNUSUAL COMPLICATION OF
PANCREATITIS
H. Jang1 and C. Park1
1Surgery, Gangneung Asan Hospital University of Ulsan
College of Medicine, Gangneung, Korea
Objectives: Pancreatic–pleural fistula (PPF) is an
uncommon complication of chronic pancreatitis occur-
ring as a result of disruption of the main pancreatic
duct and tracking of pancreatic fluid through the retro-
peritoneum into one or both thoracic cavities. Pleural
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effusion resulting from a PPF is extremely rare and
accounts for <1% of cases.
Methods: We present the three cases of middle-aged
males with moderate left or right pleural effusion who
had a history of pancreatitis.
Results: All of patients were male (39, 43, 45 years)
and they were alcohol-associated chronic pancreatitis.
Chest X-ray showed pleural effusion with moderate left
or right pleural effusion and a thoracocentisis revealed
high amylase content. MRCP showed chronic pancrea-
titis with a PPF. Pancreatic fisula resection and pancre-
atojejunostomy to provide decompression of the
pancreatic duct were performed in two patients. Fisula
resection and distal pancreatectomy with distally
obstructed pancreatic duct were performed in the other
patient. Postoperative course was an uneventful. There
was no recurrence of PPF on subsequent 2 years fol-
low-up.
Conclusion: PPF is an uncommon complication of
chronic pancreatitis occurring as a result of disruption
of the main pancreatic duct and tracking of pancreatic
fluid through the retroperitoneum into thoracic cavities.
MRCP is a useful modality for diagnosing a PPF. The
optimal treatment strategy for pancreaticopleural fistula
is unknown; it has traditionally been medical manage-
ment followed by operative therapy for patients who
fail to respond to conservative treatment. We report
herein two patients underwent drainage procedure were
performed. One patient underwent a distal resection
with fistula tract.
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APHPB-0799
PREOPERATIVE CIRCULATING
TUMOR CELLS PREDICT IMPAIRED
TIME TO TUMOR RECURRENCE IN
HCC PATIENTS AFTER CURATIVE
RESECTION
S. L. Dong1, B. H. Zhang1 and X. P. Chen1
1Hepatic Surgery Tongji Hospital, Huazhong University
of Science and Technology, Wuhan, China
Objectives: The aim of the study is to evaluate the
prognostic significance of circulating tumor cells
(CTCs) in patients with hepatocellular carcinoma
(HCC) underwent curative resection.
Methods: A total of 156 patients with HCC were
included and 137 patients underwent curative resection.
CTCs were disclosed prospectively with CellSearch Sys-
tem in 7.5 mL of peripheral blood before and 3 days
after surgery. The patients were followed-up for recur-
rence every 1–3 months.
Results: During the 1 year’s following-up time, relapse
occurred in 36 of the curative resected patients. The
percentage of patients with CTCs ≥2 was significantly
higher in relapsed patients, when compared with that
in non-relapsed patients (36.1% vs. 18.9%; p = 0.001).
Preoperative CTCs ≥2 was an independent prognostic
factor (p = 0.01), and predicted earlier recurrence in
curative resected patients (p = 0.001). No significant
change was found between CTCs before and 3 days
after surgery. However, CTCs was significantly
increased in subgroup of patients not performed preli-
minary ligation of the inflow vessels of the tumor side
intra-operatively, when compared with patients that
performed (p = 0.013). Furthermore, none of the 5
patients with preliminary ligation of the inflow and
outflow vessels of the tumor side showed increase of
CTCs postoperatively. Patients with consistent CTCs
≥2 had reduced time to relapse than those with values
consistently <2 (p = 0.015).
Conclusion: Preoperative CTCs predict impaired time
to tumor recurrence in HCC patients after surgery.
CTC analysis could be considered as a tool for moni-
toring treatment response and a therapeutic target in
patients with HCC.
APHPB-0800
EARLY AND LONG TERM RESULTS OF
HEPATIC RESECTION FOR
HEPATOCELLULAR CARCINOMA
(HCC) AT A TERTIARY CARE CENTRE
IN INDIA
R. Panwar1, S. Pal1, N. R. Dash1, S. Shalimar2, P.
Sahni1 and S. K. Acharya2
1Gastrointestinal Surgery & Liver Transplantation, All
India Institute of Medical Sciences, Delhi, India;
2Gastroenterology & Human Nutrition, All India
Institute of Medical Sciences, Delhi, India
Objectives: To evaluate the early and long term results
of hepatic resection for the management of HCC so as
to generate data specific to Indian population.
Methods: The records of all patients who underwent
hepatic resection for HCC in the Department of GISur-
gery, AIIMS (New Delhi) were reviewed. The relevant
peri-operative and follow-up data were extracted from
a prospectively maintained database.
Results: Between January 1987 and December 2013, 81
patients [71 males; mean age: 49.2  15.6 years] under-
went hepatic resection for HCC. Of these 23(28%) were
cirrhotic and 36(44%) had hepatitis B. Hepatitis B was
significantly more common in cirrhotics (74% vs. 34%;
p = 0.001). Most patients had locally advanced disease
at presentation [Tumor size ≥10 cm in 61(75%); vascu-
lar tumor thrombus in 10(12%)]. Anatomical resection
was done in 61 (75%) including 56 major hepatic resec-
tions (≥3 segments). Overall in-hospital mortality was
13(16%) [Cirrhotic: 5(22%) vs. non-cirrhotic: 8(14%),
p = 0.503]. Grade III-V complications (Modified Cla-
vien-Dindo classification) occurred in 25(31%) patients
(cirrhotic: 48% vs. non-cirrhotic: 24%; p = 0.037). Fol-
low up information was available for 51(75%) patients.
The median time to recurrence was 12 months and
most (82%) occurred within 1 year. The recurrence free
survival at 1-, 3- and 5-years was 49%, 37% and 33%,
respectively. Positive resection margin and vascular
invasion were significantly associated with very poor
prognosis.
Conclusion: Majority of Indian HCC patients present
with locally advanced disease. Despite this surgical
resection provides a chance for long term recurrence-
free survival in a third of them.
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APHPB-0801
PREDICTING POSTOPERATIVE
PANCREATIC FISTULA (POPF) AFTER
PANCREATIC RESECTIONS USING
PREOPERATIVE ENDOSCOPIC
ULTRASOUND (EUS) ELASTOGRAPHY
(EUSE): A PROSPECTIVE STUDY
A. A. Khan1, S. Pal1, P. Garg2, N. R. Dash1, S. Datta
Gupta3 and P. Sahni1
1Gastrointestinal Surgery and Liver Transplantation, All
India Institute of Medical Sciences, Delhi, India;
2Gastroenterology and Human Nutrition, All India
Institute of Medical Sciences, Delhi, India; 3Pathology,
All India Institute of Medical Sciences, Delhi, India
Objectives: Pancreatic resections are associated with
POPF which occur less frequently with a firm pancreas.
We used EUSE to assess pancreatic texture at the
resection margin and its relation to pancreatic fibrosis
and POPF.
Methods: Between June 2012 and December 2013 all
patients who underwent EUS for diagnosis/assessment
of resectability had an EUSE done. An area (A) in the
neck/body (intended resection site) and another area
(B) in the peripancreatic soft tissue were analysed. The
strain ratio (B/A) was used to assess pancreatic texture.
The main pancreatic duct (MPD) size was measured
and the degree of fibrosis at the resected pancreatic
margin was assessed histologically.
Results: Thirty-four patients were studied. A strain
ratio of ≤2.75 defined normal/soft and >2.75 as firm/
very firm pancreas. Nine had clinically relevant POPF
(26.5%; ISGPF grades B: 6 and C: 3). A higher pro-
portion of patients with strain ratio ≤2.75 developed
POPF (34.7% vs. 9.1%; p = 0.21) and had a sensitivity
and negative predictive value of 88.9% and 91%,
respectively Patients with no/minimal fibrosis had a
higher rate of POPF (32% vs. 11.1%; p = 0.39). Strain
ratio correlated well with pancreatic texture, fibrosis
grade and MPD size (p < 0.001). POPF occurred more
frequently in those with a higher mean BMI
(22.5  3.6 vs. 20.1  2.7; p = 0.04). Strain ratio had
an accuracy, sensitivity, specificity, PPV and NPV of
88.2%, 89%, 88%, 72.7% and 95%, respectively for
assessment of fibrosis.
Conclusion: EUSE of the pancreas did not predict
POPF but correlated well with pancreatic texture,
degree of pancreatic fibrosis and MPD size.
APHPB-0802
PREDICTION OF PANCREATIC
FISTULA AND FIBROSIS IN PATIENTS
UNDERGOING PANCREATIC
RESECTIONS USING DIFFERENTIAL
PANCREATIC ENHANCEMENT
PATTERN ON MULTI PHASIC
COMPUTED TOMOGRAPHY (MPCT)
SCAN: A PROSPECTIVE STUDY
A. A. Khan1, S. Pal1, R. Sharma2, N. R. Dash1, S.
Datta Gupta3 and P. Sahni1
1Gastrointestinal Surgery and Liver Transplantation, All
India Institute of Medical Sciences, Delhi, India;
2Radiodiagnosis, All India Institute of Medical Sciences,
Delhi, India; 3Pathology, All India Institute of Medical
Sciences, Delhi, India
Objectives: Pancreatic resections are associated with
postoperative pancreatic fistula (POPF). A firm pan-
creas, which is related to pancreatic fibrosis, is less
likely to develop POPF. We used specialized MPCT to
assess pancreatic enhancement at the resection margin
and its relation to the degree of fibrosis and risk of
POPF.
Methods: Between June 2012 and December 2013 all
patients undergoing Whipple (PD), or distal (DP)/cen-
tral pancreatectomy (CP) underwent MPCT [unen-
hanced, pancreatic and hepatic venous phase]. CT
attenuation value (late/early [L/E] ratio) at the intended
pancreatic resection site, and the body and tail region
was calculated. Fibrosis at the resected margin was
assessed histologically. L/E ratio and degree of fibrosis
were correlated with POPF.
Results: Sixty-three patients (PD 58, DP 3, CP 2) were
analysed. Eleven patients had clinically relevant POPF
(17.4%; ISGPF grades B: 7 and C: 4). Based on AUC
on ROC curve and histology as gold standard a L/E
ratio of ≤0.84 defined normal and >0.84 delayed
enhancement. POPF were more frequent in patients
with an L/E ratio ≤0.84 (21% vs. 12%; p = 0.4), with
absent/mild fibrosis (22.5% vs. 8.9%; p = 0.30) and
with a smaller pancreatic duct [2.5 vs. 4.15 mm;
p = 0.001]. L/E ratio correlated positively with degree
of fibrosis, pancreatic duct size and surgeon’s assess-
ment of pancreatic firmness (p < 0.001). For assessment
of fibrosis, L/E ratio had an accuracy, sensitivity and
specificity of 87.3%, 87% and 87.5%, respectively.
Conclusion: Although pancreatic CT attenuation values
(L/E ratio) correlated well with pancreatic texture and
fibrosis and pancreatic duct size, it did not predict
POPF.
APHPB-0803
THE POSSIBILITY OF SUGGESTION OF
SIMPLE CHOLECYSTECTOMY FOR
THE GALLBLADDER CANCER WITH
T1B
B. Kim1, C. Nam1 and Y. Nah1
1Surgery, Ulsan University Hospital, Ulsan, Korea
Objectives: The aim of this study is to investigate the
qualification of gallbladder cancer patients with stage
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T1b operated only simple cholecystectomy that can get
similar treatment results for the extended cholecystec-
tomy.
Methods: A review of 60 patients with the diagnosis of
gallbladder cancer treated from 2000 to 2010 was per-
formed. These patients underwent surgical treatment
for GB cancer stage T1b and T2, and were retrospec-
tively reviewed.
Results: Simple cholecystectomy was performed in 18
patients (30.0%) with T1b and in 42 patients (60.0%)
with T2. Lymph node metastasis was observed in 0.0%
of T1b patients and in 16.6% of T2 patients. A signifi-
cant difference in overall survival rates was observed
between lymph node metastasis and none lymph node
metastasis patients. However, no significant overall sur-
vival rates difference was observed between those who
underwent simple cholecystectomy or extended chole-
cystectomy with T1b patients, regardless of whether
lymph node dissection was performed or whether
lymph node metastasis was present. On multivariate
analysis, above 60 years old and poorly differentiated
type of cell differentiation were independently associ-
ated with node metastasis.
Conclusion: We suggest that the simple cholecystec-
tomy is possible for T1b patients that had limited qual-
ifications to be expected no lymph node metastasis.
There was a controversy about the treatment of GB
cancer patients with T1b. Though relatively few
patients enrolled in this study, simple cholecystectomy
and extended cholecystectomy showed similar survival.
To be assured the qualification for simple cholecystec-
tomy to the GB cancer patients with T1b, further eval-
uation is needed.
APHPB-0804
INTRAHEPATIC SARCOMATOID
CHOLANGIOCARCINOMA FOR
RESECTION OF SEGMENT 3 AND 4 OF
THE LIVER
H. Jang1, C. Park1 and D. Eom2
1Surgery, Gangneung Asan Hospital University of Ulsan
College of Medicine, Gangneung, Korea; 2Pathology,
Gangneung Asan Hospital University of Ulsan College of
Medicine, Gangneung, Korea
Objectives: Sarcomatoid features are occasionally seen
in various types of epithelial tumors, and it is some-
times difficult to differentiate between sarcomatoid car-
cinoma and true sarcoma. Most sarcomatoid
carcinomas in the liver are thought to be sarcomatoid
hepatocellular carcinomas. Recently, there have been
reports demonstrating sarcomatous changes in cholan-
giocarcinomas. This type of tumor is defined as ‘sarco-
matous intrahepatic cholangiocarcinoma’ in the WHO
classification of tumors.
Methods: We report herein a patient with intrahepatic
sarcomatous cholangiocarcinoma who underwent a
hepatic resection. The main part of the tumor consisted
of pleomorphic spindle and giant cells.
Results: A 63-year-old male patient presented with a
liver mass. Computed tomography revealed a well-
demarcated, low-attenuated mass in the left lobe of the
liver. A radical surgery, which included segment 4 and
3 resection with preservation of the left hepatic duct
and the segment 2 was performed. The histopathologi-
cal examination revealed that the tumor did not involve
the liver parenchyma and had no lymph node metasta-
sis. The tumor was 3 9 4 ? in size. Microscopically, the
tumor cells were contained in the sarcomatous compo-
nent, and adenocarcinoma component on histological
mapping. Immunohistochemical staining for cytokera-
tin was positive in the sarcomatous components. The
diagnosis confirmed a sarcomatoid cholangiocarcino-
ma. 4 months after surgery, the patient died of pneu-
monia.
Conclusion: To the best of our knowledge, only 17
cases of intrahepatic sarcomatoid cholangiocarcinoma
have been reported in the English-language literature.
It has been reported that the prognosis for intrahepatic
sarcomatoid cholangiocarcinoma is worse than that for
intrahepatic cholangiocarcinoma. We report herein a
patient with intrahepatic sarcomatoid cholangiocarcino-
ma who underwent a hepatic resection.
APHPB-0805
THE KIDNEY-TYPE GLUTAMINASE
(GLS1) IS A BIOMARKER FOR
PATHOLOGIC DIAGNOSIS AND
PROGNOSIS OF HEPATOCELLULAR
CARCINOMA
D. Yu1 and X. Shi1
1Department of Hepatobiliary Surgery the Affiliated
Drum Tower Hospital Medical School of Nanjing
University, Affiliated Drum Tower Hospital of Medical
School Nanjing University, Nanjing, China
Objectives: Observe the expression and distribution of
glutaminases (GLS1 and GLS2) in hepatocellular carci-
noma (HCC), and identify the unique role of glutamin-
ases in HCC pathological diagnosis and prognosis.
Methods: Four clusters of the samples from HCC, nor-
mal liver, and other liver diseases from multiple clinical
centers were enrolled. Immunohistochemical staining
and qRTRCR were performed to investigate the
expression and/or biodistribution of GLS1 and GLS2.
Enzyme activity of GLS1 was determined in tumor and
non-tumor tissues, four HCC and one normal liver cell
lines. Tissue microarray was used to evaluate the sensi-
tivity and specificity in diagnosis, and prognosis of
HCC. The roles of GLS1 and GLS2 in HCC progres-
sion, clinical relevance were evaluated.
Results: GLS1 was intensively expressed in HCC,
whereas GLS2 mainly expressed in nontumor hepato-
cytes. The sensitivity and specificity of GLS1 for HCC
reached to 96.51% and 75.21%, respectively. A meta-
bolic switch from GLS2 to GLS1 was observed in a
serial of liver tissues from normal liver to fibrotic liver
to dysplasia nodule and to HCC, which mimics HCC
oncogenic transformation. Both GLS1 and GLS2 in
HCC were conversely correlated to survival time of
HCC patients and were independent indexes for sur-
vival time, however, GLS1 dominantly determined the
prognosis.
Conclusion: GLS1 is a sensitive and specific biomarker
for pathological diagnosis and prognosis of HCC.
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APHPB-0806
CELL DEATH-ASSOCIATED
BIOMARKERS MAY NOT BE USEFUL
TO DISCRIMINATE BETWEEN
DISPLASIA AND HEPATOCELLULAR
CARCINOMA: A PILOT STUDY
E. Ulukaya1, D. Nart2, F. Yilmaz2, Z. Karasu3 and S.
Ulukaya4
1Medical Biochemistry, Uludag University Faculty of
Medicine, Bursa, Turkey; 2Pathology, Ege University
Faculty of Medicine, Izmir, Turkey; 3Gastroenterology,
Ege University Faculty of Medicine, Izmir, Turkey;
4Anaestesiology and Intensive Care, Ege University
Faculty of Medicine, Izmir, Turkey
Objectives: Hepatocellular carcinoma (HCC) is one of
the most common diseases worldwide, with extremely
poor prognosis because there is no reliable biomarker
(s) to screen and diagnose it early. Alpha-fetoprotein
(AFP) is the only available biomarker for HCC diagno-
sis. However, to discriminate displasia from HCC is
difficult. Furthermore, there is currently no biomarker
for this aim.
Methods: Therefore, we investigated the possible role
of these novel biomarkers (M30 antigen and M65) to
discriminate displasia from HCC. 13 HCC and 13 dis-
plasia patients were enrolled the study. The histologic
material contained primary HCC and surrounding liver
tissue from 26 patients who underwent hepatectomy at
the time of liver transplantation.
Results: The mean of M30 antigen was 146,04
(SD140,47) U/L in HCC patients, while it was 264,93
(SD247,11) in displasia patients. The mean M65 was
629,87 (SD240,12) in HCC patients, while it was
827,90 (SD423,83 in displasia patients. There was no
statistically difference between the groups (p > 0.05). In
addition, we analysed the correlations between these
two biomarkers and the classical tumor markers (AFP,
CA-125, CEA, CA-19.9). Only correlation (r = 0.495)
was found to be between AFP and M30 antigen in
HCC patients.
Conclusion: In conclusion, because neither M30 antigen
nor M65 are significantly changed between HCC and
displasia in liver, the cell death-related parameters may
not be useful to discriminate these two neoplastic pro-
cesses of liver.
APHPB-0807
COMPARING SURGICAL OUTCOMES
OF LAPAROSCOPIC VERSUS OPEN
LIVER RESECTION AS A CURATIVE
TREATMENT FOR HEPATOCELLULAR
CARCINOMA
W. Q. Leong1, I. S. Ganpathi2, A. W. Kow2,
K. K. Madhavan2 and S. K. Y. Chang2
1Yong Loo Lin School of Medicine, National University
of Singapore, Singapore, Singapore; 2Department of
Hepatobiliary & Pancreatic Surgery, National University
Health System, Singapore, Singapore
Objectives: Hepatocellular carcinoma (HCC) is the
sixth most prevalent cancer worldwide, with about
750,000 new cases diagnosed yearly. In this study, we
compared the surgical outcomes between patients who
underwent laparoscopic (LLR) and open liver resection
(OLR) for curative treatment of HCC in our institu-
tion.
Methods: Case records of patients undergoing curative
resection of HCC at the National University Hospital
(NUH) Singapore from 2005 to 2012 were retrieved
and manually culled for data. Vital status and the
death date for subjects were supplemented from the
National Death Registry Database. All analyses were
performed using SPSS version 21.0.
Results: Of the 152 patients included in our study, 42
underwent LLR and 110 underwent OLR. Intraopera-
tive duration in the LLR group was significantly
shorter (mean 250.43 min vs. 349.90 min, p < 0.001).
Intraoperative blood loss was also significantly lower
(495.83 mL vs. 1085.00 mL, p < 0.001), as was the
requirement for blood transfusion (9.5% vs. 39.1%,
p < 0.001). For post-operative outcomes, there was no
difference in the complication rate or post-operative
mortality. The total length of hospital stay was signifi-
cantly shorter in the LLR group (7.55 days vs.
11.42 days, p < 0.001). In terms of long-term oncologic
outcomes, there was no significant difference in overall
survival in both groups, however recurrence-free sur-
vival was higher in the LLR group compared to the
OLR group (p = 0.023).
Conclusion: In this study, LLR for HCC was associ-
ated with better intra-operative outcomes and compara-
ble post-operative outcomes compared to OLR.
Benign HPB Diseases
APHPB-0808
EXPERIENCE IN PANCREATIC
TRAUMA AT A TERTIARY REFERRAL
CENTRE IN INDIA
P. Subramanian1, B. Seshukumar1, S. Munde1,
N. Chakaravarthy1 and G. Vikram1
1surgical Gastro Enterology and HPB Surgery, Kovai
Medical Center and Hospital, Coimbatore, India
Objectives: Background: Pancreatic injury is rare, if
undiagnosed can result in significant morbidity and
mortality. Correct diagnosis is challenging, particularly
in blunt trauma patients. The optimal management of
pancreatic injury is also not well established.
Aim: To analyse the management of pancreatic trauma
at a tertiary referral center in India.
Methods: A retrospective review of 10 cases of pancre-
atic trauma managed in a tertiary referral unit between
2008 and 2014.
Results: Results: Nine cases were secondary to blunt
injury abdomen and a single case of penetrating injury.
Age ranged from 4 to 41 years (median 25). Patients
presented between one hour to after four days of
injury. There were 9 males and 1 female, 3 patients pre-
sented with perotinitis, 3 with pancreatitis, 3 with
haemorrhagic shock & perotinitis and 1 with pain.
CECT was the imaging of choice in all the cases and
MRCP confirmed pancreatic injury in one. Surgeries
ranged from emergency whipples (1), mid segment pan-
createctomy (1), distal pancreatectomy with splenec-
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tomy (4) and with spleen preservation (2), on table
ERCP & stenting of pancreatic duct (1) and drain
placement (1). Three patients underwent colectomies,
one angioembolisation and duodenal perforation clo-
sure. Hospital stay ranged from 10 days to 2 months.
Half of the patients had significant morbidity (ISGPF
grade B fistula in 2, grade A fistula in 1 and duodenal
fistula in 1) and 1 died of sepsis.
Conclusion: Pancreatic injuries vary in their presenta-
tion from mild pain to frank peritontitis. Management
ranges from conservative to major abdominal surgeries.
The type of management should be tailored to the indi-
vidual case.
Malignant HPB Diseases
APHPB-0809
LIVER RESECTION: A 5 YEAR
REGIONAL HOSPITAL EXPERIENCE IN
HONG KONG
C. C. Lee1 and C. Cheung1
1Department of Surgery, Tuen Mun Hospital, Hong
Kong, Hong Kong China
Objectives: In Hong Kong, most of the liver resections
were performed in tertiary major hospitals because of
its complexity and high morbidity.
Since 2009, The Tuen Mun Hospital (TMH) hepatobil-
iary surgeons started to perform the liver resections for
their regional residents using a multi disciplinary team
approach.
This is a summary of the liver resection statistics in
TMH.
Methods: Data of liver resections performed between
May 2009 and May 2014 of TMH were collected pro-
spectively and reviewed with special attention to patient
survival, post-operative complications and mortality.
Results: There were 386 liver resections during the
study period.
Most of the patients (90%) received open hepatectomy.
The average blood loss was 634 mL and 66 patients
received blood transfusion (14.5%)
Hepatocellular carcinoma (HCC) was the most fre-
quent pathology (n = 194). Followed by metastatic
colorectal adenocarcinoma (mCRC) (n = 108), 24 were
cholangiocarcinoma. 19 were for benign conditions.
For complications, 42 patients had post-operative
wound infections; 26 patients had intra-abdominal col-
lections; 29 patients had significant bile leaks and 6
patients had haemorrhage. 25 of them had post-op liver
failure. The overall complication rate was 26%
(n = 101)
There were in total 11 deaths in hospital (30 day surgi-
cal mortality 2.8%)
Overall three year survival rate was 76% (n = 172).
74% for Patients with HCC (Total 130 patients and 97
patients still alive)
Conclusion: Liver resection provides the best hope of
cure for patients with primary or metastatic hepatic
malignancy. With adequate expertise and team
approach, liver resections can be performed safely in a
regional hospital with comparable morbidity and mor-
tality.
APHPB-0810
IMPACT OF PREOPERATIVE DIABETES
AND DEGREE OF HYPERGLYCEMIA
ON PROGNOSIS OF PATIENTS WITH
RESECTED PANCREATIC DUCTAL
ADENOCARCINOMA
Y. S. Yoon1, W. H. Lee1, H. S. Han1, J. Y. Cho1, Y.
R. Choi1, J. Y. Jang1 and H. L. Choi1
1Surgery, Seoul National University Bundang Hospital,
Seong-nam si Gyounggi-do, Korea
Objectives: The purpose of this study was to evaluate
the oncologic outcomes of patients with resected pan-
creatic ductal adenocarcinoma (PDAC) according to
the presence of preoperative DM and the degree of
hyperglycemia using glycosylated hemoglobin (HbA1c).
Methods: 142 patients with R0 or R1 resection who
underwent pancreatectomy in Seoul National Univer-
sity Bundang Hospital between September 2003 and
June 2012, were selected for this study. The patients
were divided into three groups according to the pres-
ence of DM and level of HbA1c: non-DM (n = 69),
DM with HbA1c <8.8% (n = 48), and DM with
HbA1c ≥8.8% (n = 25). We compared the survival out-
comes of the three groups with retrospective analysis
using a prospectively collected database.
Results: There was no significant difference in age,
presence of jaundice, preoperative biliary drainage,
tumor site, tumor size, cancer stage, postoperative com-
plication and adjuvant chemotherapy among three
groups. The 3-year overall survival rate was similar
between non-DM and DM groups. However, DM with
HbA1c ≥9.0% group showed a significantly lower
3-year OS (22.3%) compared with non-DM (34.3%) and
DM with HbA1c <9.0% (40.2%) groups (p = 0.028).
The multivariate analysis revealed that DM with HbA1c
≥9.0% (p = 0.007; RR = 2.531) and presence of
angiolymphatic invasion (p = 0.039; RR = 1.842) were
independent prognostic factors for OS.
Conclusion: This study shows that severely uncon-
trolled hyperglycemia over prolonged periods of time
rather than the presence of preoperative DM negatively
affects the survival outcome in patients with resected
PDAC.
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APHPB-0811
QUALITY OF LIFE TRENDS IN
PATIENTS UNDERGOING SURGERY
FOR CHRONIC PANCREATITIS
S. H. S. Reddy1, R. Gupta1, S. Shenvi1, P. Kohli1, S.
S. Rana2, D. K. Bhasin2 and R. Singh1
1General Surgery, PGIMER, Chandigarh, India;
2Gastroenterology, PGIMER, Chandigarh, India
Objectives: To evaluate the post-operative trends of
chronic pancreatitis by comparing the quality of life
amongst our cohort of operated chronic pancreatitis
patients.
Methods: A retrospective analysis of cases with a mini-
mum follow up of 1 year was done. They were admin-
istered the disease-specific EORTC QLQ-PAN28(CP)
questionnaire. Izbicki pain scores, steatorrhoea and dia-
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betes outcomes were measured simultaneously. The
cohort was divided into alcoholic and non-alcoholic
pancreatitis groups. Short-term (<3 year) and long-term
(≥3 year) follow-up subgroups were compared.
Results: 41 of the 70 cases could be followed-up and
19(46.3%) of them belonged to alcoholic and 22
(53.7%) to non-alcoholic groups. Reliefs in exocrine/
endocrine insufficiency were similar in both groups.
Postoperative Izbicki pain score improvements were
significant in all the subgroups.
The global health status, role functioning and social
functioning was significantly better post-operatively in
all subgroups. Improvement in physical functioning,
fatigue, body image and sexuality was significant only
in the short-term subgroups. Cognitive and emotional
functioning improvements were significantly better only
in non-alcoholic subgroups.
Among the symptom scores pain scores were signifi-
cantly better in all the subgroups. Betterments in nau-
sea-vomiting, eating related items, weight loss and loss
of muscle strength were not significant in alcoholic
long-term subgroup (some of them had resumed alco-
hol consumption).
Conclusion: Improvements in postoperative outcomes
and QOL using the EORTC QLQ PAN 28(CP) were
similar among short-term (<3 year) and long-term
(≥3 year) subgroups which may imply that the benefit
of surgery is preserved over time. Physical scores
though, didn’t show such a trend of sustained improve-
ment.
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APHPB-0812
THE ENHANCED RECOVERY
PROGRAMME DOES NOT INFLUENCE
FITNESS FOR CHEMOTHERAPY OR
NUMBER OF CYCLES IN PATIENTS
HAVING ADJUVANT CHEMOTHERAPY
FOR COLORECTAL LIVER
METASTASES
A. Chan1, Z. Ali1, S. Lapsia2, H. Coleman1, A. Krige3,
A. Kausar1, D. Chang1, C. Harris1 and D. Subar1
1Department of Surgery, Royal Blackburn Hospital,
Blackburn, UK; 2Department of Radiology, Royal
Blackburn Hospital, Blackburn, UK; 3Department of
Anaesthesia, Royal Blackburn Hospital, Blackburn, UK
Objectives: The Enhanced Recovery Programme (EPR)
reduces length of hospital stay in patients undergoing
liver resection for colorectal liver metastasis (CRLM).
Progression free survival is improved by perioperative
chemotherapy with time to chemotherapy shown to
affect survival in other malignancies. The aim of this
study was to assess the effect of ERP on time to adju-
vant chemotherapy and the completion of chemother-
apy in patients CRLM resection.
Methods: This retrospective study of patients undergo-
ing liver resection for CRLM between April 2005 and
March 2013 compares 50 patients who received stan-
dard care and 50 patients on the ERP. Demographic
and clinical outcome data was analysed, in particular,
details of neo-adjuvant and adjuvant chemotherapy.
Results: The mean age was 65.7  9.6 years (range 42–
88 years), with a male:female ratio of 65:35, with no
statistical difference in age (p = 0.21) and sex distribu-
tion (p = 0.83) between the groups. ERP significantly
decreased the length of hospital stay (p = 0.007). 54
patients proceeded to adjuvant chemotherapy, but ERP
did not influence this (p = 0.229). ERP did not affect
the number of cycles that patients had (p = 0.511) or
the number of patients completing 6 or more cycles of
chemotherapy (p = 0.606). Patients who had received
neo-adjuvant chemotherapy were less likely to complete
at least 6 cycles of adjuvant chemotherapy (p = 0.0610)
Conclusion: Although ERP reduces length of hospital
stay in patients undergoing CRLM resection it did not
affect the ability of patients to complete 6 or more
cycles of adjuvant chemotherapy post-hospital dis-
charge. Neo-adjuvant chemotherapy may decrease the
ability of patients to tolerate adjuvant chemotherapy.
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